Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.726057591182255,-2.8795728586753393,0.0,0.0,0.0,58/87,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6949107593948792,-2.745054888978499,0.0,0.0,0.0,58/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,protein targeting to ER (GO:0045047),-0.6787746324427412,-2.7401124145306315,0.0,0.0,0.0,60/99,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;CHMP4B;CHMP4A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cytoplasmic translation (GO:0002181),-0.6721562729290564,-2.6967956903772383,0.0,0.0,0.0,59/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;EIF3M;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL22L1;TMA7;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5993348939061613,-2.475859410581017,0.0,0.0,0.0,59/110,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.7119669308629407,-2.3011086834540913,0.0,0.0,0.0,19/32,14.47%,RHOJ;RHOA;MEOX2;THBS1;NOTCH1;JCAD;AKT3;KDR;STARD13;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;KLF4;VEGFA;SRPX2
prerank,peptide biosynthetic process (GO:0043043),-0.5309078914296353,-2.2775610004752362,0.0,0.0,0.0,74/153,20.60%,RPLP1;PCSK5;RPS15;RPL38;RPL18A;RPL41;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;GGTA1;RPL6;RPL18;RPS25;AGO2;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;RPL21;MRPL10;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;MRPS12;MRPL55;MRPL43;MRPL36;DMD;MRPL35;GGT7;RPL3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6559192877712742,-2.2261448676909583,0.0,0.0,0.0,19/39,13.82%,NRP1;COL4A1;SLIT2;LRP6;TIE1;ENG;LRP5;PKD1;BMP4;RASIP1;SIX1;TGFBR2;KDR;MET;FGF2;NOTCH4;SEMA3E;BMP2;VEGFA
prerank,epithelial tube morphogenesis (GO:0060562),-0.6788091782457197,-2.1819169945243164,0.0,0.0005637672264344531,0.004,14/32,7.55%,MEF2C;PODXL;COL4A1;SLIT2;ACVR1;ACVRL1;PKD1;BMP4;MTSS1;RASIP1;SOX17;MET;HES1;PRKX
prerank,regulation of ossification (GO:0030278),-0.6454428341331846,-2.151566584037587,0.0,0.0012684762594775193,0.009,18/36,13.74%,MEF2C;BMPR2;ZBTB16;PTN;SGMS2;LRP6;ACVR1;TGFB2;NOTCH1;BMP4;S1PR1;WNT5A;MDK;NBR1;TWIST1;BMP2;ECM1;ENPP1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5389705598673195,-2.1493286320587295,0.0,0.001153160235888654,0.009,29/88,12.61%,PTPRM;NRP1;TEK;CAV1;SPARC;NRP2;BMPR2;ACVRL1;TIE1;VEGFC;THBS1;CDH13;F3;BMP4;AKT3;KDR;XDH;PRKD1;WNT5A;PPP1R16B;FLT4;FGF2;APOE;AGGF1;CAV2;PIK3CD;NRAS;BMP2;ECM1
prerank,extracellular matrix organization (GO:0030198),-0.45797097517896423,-2.114510229694721,0.0,0.001797008034259819,0.016,97/276,14.58%,COL8A1;SH3PXD2A;ELN;COL12A1;ADAMTSL3;VWF;FLRT2;PECAM1;SPARC;LAMA2;TLL1;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;COL25A1;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;DST;GSN;COL6A1;TGFB2;LAMC3;COL4A2;NDNF;THBS1;GAS6;ITGA5;CYP1B1;VCAM1;PLOD2;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;CREB3L1;ICAM1;P4HA1;CAPN2;ADAMTS6;RECK;SH3PXD2B;ADAM10;LOX;LUM;ITGB5;ADAMTS1;PLOD3;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;CRTAP;MMP11;CAPG;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;P4HA2;ICAM2;TNC;HAS1;ADAM15;AGRN
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7010739488983343,-2.093606522508437,0.0,0.0021466521314234942,0.021,11/22,13.07%,SLIT2;TMSB4X;GSN;KANK1;SSH2;KANK3;KANK4;PRKCD;TMSB10;HIP1R;PFN1
prerank,positive regulation of chemotaxis (GO:0050921),-0.6009673102334728,-2.091137728655297,0.0,0.0021745307305328903,0.023,18/43,13.91%,NRP1;NTRK3;PTN;TMSB4X;THBS1;CDH13;F3;KDR;STX3;PRKD1;MET;IL6R;MDK;FGF2;HSPB1;EDN3;VEGFA;RARRES2
prerank,negative regulation of vascular permeability (GO:0043116),-0.8222361203049041,-2.077045536050211,0.0,0.0029597779387808784,0.033,11/12,15.34%,PDE3A;CLDN5;SLIT2;RAMP2;PTPRJ;PDE2A;CEACAM1;DDAH1;SH3GL2;VEGFA;FERMT2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.831013980133754,2.0751887129936124,0.0,0.09168185835819247,0.101,5/14,4.28%,ACTN2;ATP1B3;ANK2;LRRC38;ATP1B2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4761852272878441,-2.0724631082047966,0.0,0.0030126311162591082,0.036,68/168,16.39%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;AGO1;RPL32;RPL5;TENT2;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;CNOT6L;DCP1B;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;CNOT11;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;TENT4B;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;PAN3;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;NBAS;RPS13;RPS15A;TNKS1BP1
prerank,external encapsulating structure organization (GO:0045229),-0.46268162879944064,-2.0689078377380543,0.0,0.0035069637762025533,0.043,78/205,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;HRNR;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.5369486078218264,-2.0652447969494165,0.0,0.0035235451652153318,0.045,28/75,13.82%,NRP1;TEK;NRP2;BMPR2;VEGFC;CDH13;F3;PLCG1;JCAD;BMP4;AKT3;KDR;PRKD1;WNT5A;AGTR1;PPP1R16B;MDK;GATA2;FLT4;IGF2;FGF2;AGGF1;PIK3CD;NRAS;BMP2;ITGA4;ECM1;VEGFA
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5806908750743929,-2.0625897493674032,0.0,0.0036051430532518967,0.049,22/48,14.47%,RHOJ;NOS3;TMSB4X;ETS1;THBS1;PLCG1;JCAD;AKT3;KDR;PTGS2;PIK3C2A;PRKD1;ANXA1;HDAC7;HDAC9;GATA2;ATP5F1B;FGF2;HSPB1;CD40;VEGFA;SRPX2
prerank,extracellular structure organization (GO:0043062),-0.4591549873352358,-2.0623445308192503,0.0,0.003424885900589302,0.049,77/204,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5671491870106178,-2.051955953233545,0.0,0.004228254198258398,0.064,22/54,10.48%,NRP1;TEK;LIMS1;VCL;RHOA;ACVRL1;THBS1;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;PTPRJ;KDR;PHLDB2;APOD;MYOC;EFNA5;SRC;MAP4K4;DUSP3;FAM107A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.6204304109083324,-2.0446755096086715,0.0,0.005073905037910078,0.077,18/34,11.50%,NRP1;SEMA6A;DAB2IP;GAB1;VEGFC;RAMP2;NOTCH1;KDR;PRKD1;ERN1;ANXA1;FLT1;SPRY2;PIK3CA;FLT4;MT1G;MAPKAPK2;HSPB1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6254880718046227,-2.026860744504741,0.0,0.006507834722536837,0.1,8/33,2.97%,PTPRM;PTPRG;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;CORO1C
prerank,regulation of endothelial cell migration (GO:0010594),-0.5185142200748349,-2.0146393188443086,0.0,0.007980829799212726,0.121,30/85,10.62%,PTPRM;NRP1;FOXP1;TEK;RHOJ;SPARC;NRP2;DCN;BMPR2;DAB2IP;PTN;SLIT2;ETS1;ACVRL1;SCARB1;BMPER;THBS1;BMP4;KDR;PRKD1;WNT5A;PRCP;EMP2;CEACAM1;FLT4;FGF2;BCAR1;APOE;EDN1;PIK3CD
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7352702774810239,-2.012520949597353,0.0,0.00786455280876062,0.124,13/18,14.47%,RHOJ;JCAD;AKT3;KDR;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;VEGFA;SRPX2
prerank,blood vessel morphogenesis (GO:0048514),-0.5562721742385122,-2.011355643356507,0.0,0.00785479529907233,0.128,28/54,14.36%,NRP1;CAV1;LAMA1;COL4A1;ENG;RAMP2;LRP5;CYP1B1;ID1;RASIP1;TGFBR2;KDR;TBX1;SOX17;HES1;LOX;FLT1;STRA6;CCBE1;HEY2;FLT4;AGGF1;ADM;SOX18;SLC1A1;ITGB8;VEGFA;CDH2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6422414077435691,-2.0106633821905904,0.0,0.007610857556865115,0.129,17/30,12.49%,ACTB;PECAM1;LAMA2;SLC12A2;CLDN5;VCL;TJP1;ESAM;ACTG1;LSR;F11R;ITGB1;TJP2;OCLN;JAM3;MFSD2A;SLC1A1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7890617260083127,-2.0061100271330123,0.0,0.007882673898181728,0.137,5/12,7.11%,PDE4D;CAV1;GJD3;CAMK2D;CALM3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5730125222892799,-2.0020525388248602,0.0,0.008660631012984444,0.157,17/46,12.40%,NRP1;TMEFF2;TEK;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;VAMP3;NTN4;PXN;LAMB2;PARVA;MICALL2;ITGA4
prerank,translation (GO:0006412),-0.44731382062213015,-1.9937399977344816,0.0,0.009936397365907233,0.184,82/208,17.86%,RPLP1;GATB;RPS15;RPL38;WARS2;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;LARS2;AGO2;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;MRPL23;RPL17;YARS2;NDUFA7;RPS9;RPS27;ASMT;ABCE1;RPL22L1;TMA7;RPL21;MRPL10;EEF1E1;RPL34;GARS1;RPL10A;RPL12;RPL35;RPL14;GFM2;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;PTCD3;EEF1G;MRPS12;MRPL55;MRPL43
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.7059888288119012,-1.9920742652963472,0.0,0.009943217130743136,0.189,8/18,12.51%,MTUS1;PTN;SLIT2;LYN;IL6R;MDK;EDN3;PTK2B
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6100741536891437,-1.9915459219506075,0.0,0.009751411244733431,0.192,13/35,9.64%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;GUCY1B1;PDE9A;CAP2;PDE2A;ADCY2;CAP1;AHR;APOE
prerank,circulatory system development (GO:0072359),-0.4833512985658771,-1.984637681328026,0.0,0.011108776939060698,0.221,36/118,13.73%,TEK;MEF2C;NTRK3;HEG1;PDLIM5;PLCE1;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;RAMP2;NOTCH1;PKD1;TGFBR2;FN1;TBX1;FBN1;SOX17;CRIP1;SH3PXD2B;STRA6;HDAC9;CXADR;PIK3CA;HEY2;ZFPM2;FLT4;NOTCH4;WDR11;LDB3;SOX18;BMP2;FBXW7;NCOA6
prerank,positive regulation of cell migration (GO:0030335),-0.42735508905411934,-1.9754518914483945,0.0,0.012610146344217692,0.255,82/253,13.82%,NRP1;LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK1;RAPGEF2;BMPR2;DAB2IP;GAB1;SEMA3C;ITGA6;TJP1;SEMA7A;ACVR1;TGFB2;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;PLCG1;STAT3;KDR;FN1;MGAT5;PLCG2;CPNE3;ITGB1;ARHGEF2;NIPBL;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;AGO2;BCAR1;NEDD9;S100A11;EPHB2;RIPOR1;EDN1;FAM107A;NSMF;PIK3CD;SEMA3E;FBXO5;CCN4;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;HDAC6;PFN1;SHTN1;AKT2;PTPRC;VEGFA
prerank,regulation of angiogenesis (GO:0045765),-0.4456454145230353,-1.9692239939411942,0.0,0.01384451231772607,0.285,62/192,13.82%,PTPRM;TEK;RHOJ;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;GAB1;NOS3;HIPK1;ETS1;TIE1;TGFB2;COL4A2;VEGFC;BMPER;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;AGO1;KDR;SERPINF1;ITGB1;PIK3R6;ADGRA2;PRKD1;WNT5A;ISM1;PPP1R16B;ADAMTS1;FLT1;SPRY2;ECSCR;EMP2;CEACAM1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;PIK3CD;SEMA3E;HGS;HSPB1;TWIST1;HHEX;THBS2;ECM1;TSPAN12;ITGB8;STAB1;CD40;AMOT;VEGFA
prerank,endothelial cell migration (GO:0043542),-0.6038665413361527,-1.964248567081354,0.0,0.014939831500513007,0.309,18/37,13.82%,NRP1;NOS3;RHOA;FAP;MYH9;CDH13;CYP1B1;ID1;STARD13;CCN3;ADGRA2;PXN;PRKX;EMP2;PIK3CA;PTP4A3;SOX18;VEGFA
prerank,artery morphogenesis (GO:0048844),-0.6166746697283645,-1.9604046642344262,0.0,0.015530263393062604,0.327,14/30,13.83%,NRP1;BMPR2;JAG1;TGFB2;ENG;NOTCH1;BMP4;TBX1;HES1;STRA6;HEY2;TBX2;VEGFA;LRP1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.655647324523643,-1.9573411802345098,0.0,0.015989477060256097,0.341,12/24,15.34%,NRP1;TEK;LIMS1;PIK3R1;PTPRJ;KDR;MYOC;MAP4K4;DUSP3;VEGFA;S100A10;FERMT2
prerank,regulation of epithelial cell migration (GO:0010632),-0.5528445953814041,-1.9534839347796538,0.0,0.016327566211736273,0.357,15/51,8.77%,PTPRG;RHOJ;DOCK1;BMPR2;DAB2IP;PTN;TGFB2;BMPER;CORO1C;PLCG1;MACF1;PLCG2;EMP2;CEACAM1;SRC
prerank,smooth muscle cell differentiation (GO:0051145),-0.7810946343958802,-1.9530008416131293,0.001869158878504673,0.016014512775903683,0.36,9/12,17.19%,MEF2C;MRTFB;TMEM204;BMP4;TBX18;HEY2;MYOCD;APLNR;HEY1
prerank,sodium ion export across plasma membrane (GO:0036376),0.8013460913899408,1.9456960015641103,0.0,0.48229280111116374,0.627,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,retinoic acid metabolic process (GO:0042573),0.7800094556639445,1.944521137626098,0.0019230769230769232,0.32640796070941913,0.634,4/14,2.49%,ALDH1A2;ALDH8A1;ADH7;CYP26B1
prerank,positive regulation of neuron migration (GO:2001224),-0.7972228875995063,-1.9419995677470672,0.0,0.01899620544680968,0.422,8/11,13.40%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;SHTN1
prerank,sodium ion transport (GO:0006814),0.5334173205666493,1.9375479118308239,0.0,0.27003774247518036,0.659,11/85,2.73%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC5A5;SLC24A3;ATP1B3;SLC6A9;SLC5A10;SLC23A1
prerank,regulation of vasculogenesis (GO:2001212),-0.7546512895506561,-1.9373113784688116,0.0,0.01957077657479601,0.439,9/14,8.50%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;XDH;EMP2;CEACAM1;HEY2
prerank,cAMP-mediated signaling (GO:0019933),-0.6417030140871128,-1.9337988345867383,0.0021141649048625794,0.019882627881112745,0.45,10/24,9.63%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;CAP2;PDE2A;ADCY2;CAP1;AHR
prerank,regulation of cell junction assembly (GO:1901888),-0.6306675008582158,-1.925440288661285,0.0,0.022025360505473292,0.489,11/27,7.71%,PRKCH;MEF2C;PDLIM5;RAPGEF2;CLDN5;TJP1;RAP1A;RUNX1;F11R;CBFB;OCLN
prerank,positive regulation of angiogenesis (GO:0045766),-0.4731262547848746,-1.9211056942417746,0.0,0.022917137754560512,0.507,41/108,13.82%,TEK;GAB1;TJP1;NOS3;HIPK1;ETS1;TIE1;VEGFC;BMPER;RAMP2;THBS1;F3;ITGA5;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;SMAD1;PRKD1;WNT5A;FLT1;MDK;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;JAK1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7459654383597155,-1.9149376514563166,0.004016064257028112,0.023723204937888074,0.533,3/14,3.05%,ABCG2;ABCC1;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.7459654383597155,-1.9149376514563166,0.004016064257028112,0.023723204937888074,0.533,3/14,3.05%,ABCG2;ABCC1;SLCO2B1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6368497977284251,-1.9108604692298201,0.0,0.024867420003507203,0.55,9/25,13.79%,SPTBN1;PDE4D;RUNX1;PLCG2;ANXA1;RPS3;MALT1;PTPRC;CD86
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4887599490558165,-1.9083553498452241,0.0,0.0250588779423314,0.561,25/79,15.07%,BMPR2;DAB2IP;SLIT2;HTRA3;BMPER;THBS1;NOTCH1;CRIM1;SMURF1;CASK;CREB3L1;SMAD5;SMAD1;UBE2D3;EPN2;SPRY2;PTPN1;FGF2;HGS;LEMD3;HHEX;BMP2;SPRY1;GPC1;SKIL
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5727954290019635,-1.9034714526513208,0.0,0.026460414772701054,0.588,11/36,9.64%,PTPRM;MEF2C;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;NOTCH1;ANGPT2;FGF2;APOE
prerank,carboxylic acid transport (GO:0046942),0.549210258577761,1.8927101712069443,0.0,0.3987775620689111,0.846,11/55,3.99%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC38A1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.49855593200367265,-1.8893074911664065,0.0,0.03183626690453382,0.662,22/70,12.40%,NRP1;TMEFF2;TEK;MEF2C;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;ACTN1;TBCD;VAMP3;SIPA1L3;NTN4;PXN;ARL13B;LAMB2;PARVA;MICALL2;ITGA4
prerank,sodium ion transmembrane transport (GO:0035725),0.5159394376308802,1.889091790574684,0.0,0.3502914700296205,0.861,10/84,5.43%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC24A3;ATP1B3;SLC6A9;ATP1B2;NALCN
prerank,regulation of potassium ion transport (GO:0043266),0.6343887830927695,1.8849947407914427,0.0,0.3170893564585264,0.872,11/31,11.94%,CACNA1D;KCNIP3;ACTN2;ANK2;ADRA2A;DLG1;KCNH2;DRD3;VIP;DPP10;KCNIP4
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6965369731986044,-1.8836336162858147,0.001984126984126984,0.03395613371524436,0.692,6/15,6.52%,NTRK3;VEGFC;CDH13;F3;KDR;CXCL12
prerank,cell-cell junction assembly (GO:0007043),-0.5058417510293047,-1.880953117244174,0.0,0.03463179523516925,0.708,15/63,5.72%,CDH11;ACTB;CLDN5;VCL;TJP1;RHOA;GJC1;GJD3;RAMP2;CD9;ACTG1;WDR1;CTNNA1;TBCD;PAK2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49592441385392283,-1.879926100762865,0.0,0.034436781414704506,0.715,16/67,9.72%,UTRN;NRP1;LIMS1;LIMS2;DOCK1;VIT;NDNF;CDH13;FN1;FLNA;MDK;MYOC;FBLN2;EMP2;ECM2;NEDD9
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.6669922883920258,-1.8773703375200583,0.004424778761061947,0.03500994476157953,0.722,8/18,7.50%,HEG1;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7389425570825094,-1.875320304542341,0.0,0.03556263798892331,0.738,8/13,13.82%,NRP1;COL4A1;ENG;TGFBR2;KDR;NOTCH4;SEMA3E;VEGFA
prerank,cellular zinc ion homeostasis (GO:0006882),-0.610965997492024,-1.874050372126344,0.0,0.03525028763179633,0.741,15/26,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC39A7;SLC30A5;MT3
prerank,endothelial cell development (GO:0001885),-0.6292359584809774,-1.8708768698664378,0.0020964360587002098,0.03571416778839292,0.748,10/25,6.89%,PDE4D;PECAM1;RAPGEF2;COL15A1;RAP1A;ICAM1;MET;PDE2A;PPP1R16B;ROBO4
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6633999496580183,-1.869268272885503,0.0,0.03581832963202622,0.758,10/19,15.34%,NRP1;TEK;LIMS1;PTPRJ;KDR;MYOC;MAP4K4;VEGFA;S100A10;FERMT2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6312829478628001,-1.8673011889198754,0.0,0.03600358449817025,0.767,14/23,25.81%,BMP5;SLIT2;THBS1;LYN;IL34;MAPK1;MDK;STK10;RARRES2;CSF1R;MAPK3;MSN;CMKLR1;AIF1
prerank,endoderm formation (GO:0001706),-0.5638284899945091,-1.866881054883934,0.0,0.03562130872926214,0.769,12/35,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;SOX17;ITGB5;SOX7;ITGA7;ITGA4
prerank,cation transmembrane transport (GO:0098655),0.5735943866373805,1.8630962061668466,0.0,0.36740156474422714,0.938,4/44,2.09%,TRPM3;ATP1A2;TRPM6;SLC6A9
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.613164727149806,-1.859780233267828,0.002053388090349076,0.038565770147018126,0.8,14/25,23.22%,NRP1;ITGA6;THBS1;EGFR;APP;AR;PTGES3;SRC;NCKAP1L;PTH1R;KCTD20;GLMN;EGF;BCL10
prerank,negative regulation of angiogenesis (GO:0016525),-0.47607631219776037,-1.8558816942816283,0.0,0.03986639672643632,0.814,28/84,13.94%,PTPRM;TEK;SPARC;SEMA6A;SLC12A2;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;CREB3L1;ISM1;ADAMTS1;EPN2;SPRY2;ECSCR;SERPINE1;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT;KLF2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.49180246338441835,-1.854159584427725,0.0,0.04035340100462858,0.824,25/67,12.51%,NRP1;ABI1;NRP2;DOCK1;DAB2IP;RHOA;WASF2;VEGFC;PIK3R1;KDR;CLEC14A;PAK2;PRKD1;NCK1;PXN;FLT1;PIK3CA;SRC;FLT4;VAV2;MAPKAPK2;BCAR1;NCF2;HSPB1;PTK2B
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7195386520244905,-1.8528078255818639,0.0,0.04045463516764458,0.829,6/14,9.91%,RHOA;MEOX2;THBS1;NOTCH1;STARD13;KLF4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.6656018410154825,-1.8503881811470901,0.006437768240343348,0.040879530362252774,0.841,9/17,15.78%,PTN;NOTCH1;TNFRSF1B;HES1;IL34;MDK;PTPRZ1;BMP2;ID2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7070229790457232,-1.8480689296732546,0.001937984496124031,0.041216012192277,0.846,7/14,12.75%,ECE1;NOS3;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5415961091658253,-1.8478555456752357,0.0022172949002217295,0.04075912686703499,0.847,16/39,17.68%,TEK;RAMP2;NDNF;THBS1;GAS6;PLCG1;KDR;ICAM1;ECSCR;GATA2;SERPINE1;PDCD4;ITGA4;CD40;SEMA5A;GPER1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5666554931828197,-1.8475326486842099,0.004651162790697674,0.04037063573641495,0.848,15/32,10.64%,JAG1;ACER2;ACVRL1;THBS1;CORO1C;PHLDB2;CASK;AJAP1;APOD;MYOC;SRC;MAP4K4;SERPINE1;FAM107A;SEMA3E
prerank,cellular response to copper ion (GO:0071280),-0.6896056445040188,-1.846653674655612,0.0,0.040138213067752934,0.851,10/16,19.01%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT3;MT2A
prerank,lipid translocation (GO:0034204),-0.6381321309595603,-1.8456682953688641,0.0,0.039948069242137084,0.855,8/21,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;TMEM30A;ATP11B;ATP11C
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.650035803323364,-1.8451748917070219,0.0,0.039692736286150714,0.857,7/21,13.72%,CAV1;LRP6;CSNK1A1;APC;PPP1CA;AMER1;FZD1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6566081213527288,-1.8444566841331285,0.004366812227074236,0.0394965279149644,0.862,11/18,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;BMP2;TBX2
prerank,zinc ion homeostasis (GO:0055069),-0.5918524073759998,-1.8439607456241056,0.002,0.0391513483330629,0.864,15/28,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC39A7;SLC30A5;MT3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5710349644436683,-1.8434673364744185,0.0,0.03889993862397726,0.865,11/33,9.91%,MEF2C;RHOA;ACVRL1;MEOX2;THBS1;NOTCH1;STARD13;ANGPT2;FGF2;APOE;KLF4
prerank,regulation of T cell migration (GO:2000404),-0.6671900562704809,-1.8405693353953407,0.0,0.03985685931095152,0.877,7/18,9.84%,LRCH1;RHOA;CD200;APP;CXCL12;APOD;DOCK8
prerank,regulation of cation transmembrane transport (GO:1904062),0.6288608648490616,1.835991696949407,0.0018248175182481751,0.44865043852034237,0.977,10/29,11.94%,CACNA1D;KCNIP3;WNK3;SNTA1;DLG1;FGF12;KCNH2;PDZK1;DPP10;KCNIP4
prerank,epiboly involved in wound healing (GO:0090505),-0.6842276799977475,-1.8352332135251799,0.0,0.04256808642194688,0.894,7/16,8.02%,TMEFF2;RHOA;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5406655321954655,-1.8224851143456122,0.0,0.04974703689412476,0.931,14/38,16.35%,BMP5;NOS3;TNFSF10;THBS1;BCL2L1;FAS;ICAM1;ARHGEF2;FEM1B;SERPINE1;GPX1;MADD;TMBIM1;SP100
prerank,cardiac myofibril assembly (GO:0055003),0.7302923832927508,1.8185636019900304,0.0038461538461538464,0.49292481493757595,0.992,4/15,3.95%,NEBL;PDGFRA;OBSL1;CSRP3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5456702863966699,-1.8179118103184715,0.0,0.05192724333101643,0.938,19/39,14.55%,ACTN4;GCNT2;JAG1;RHOA;ACER2;THBS1;NOTCH1;CORO1C;KANK1;TBCD;CASK;AJAP1;MYOC;EFNA5;MAP4K4;SEMA3E;FZD4;AP1AR;ADAM15
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4690945218191684,-1.8112879667756363,0.0,0.05549583635214146,0.946,24/72,11.03%,NRP1;HEG1;ARHGEF28;NET1;ARHGEF3;STARD8;BCR;ABCA1;KANK1;RASIP1;STMN1;STARD13;F11R;ARHGEF2;EPS8;MET;ARHGDIB;KCTD10;ARHGAP35;MYOC;EPS8L2;APOE;LPAR6;ADGRG1
prerank,gliogenesis (GO:0042063),-0.6826758760169911,-1.810437746384481,0.002036659877800407,0.05537446979645072,0.948,8/15,26.61%,TGFB2;CD9;ANXA1;CDH2;CDK6;METTL3;METRN;METTL14
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6384139133170575,-1.8080579419017848,0.008032128514056224,0.05598311686645296,0.948,9/19,14.75%,LIFR;RUNX1;WNT5A;CBFB;KLF4;TLE5;CD24;IFIH1;IRAK2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5264358992092961,-1.804875526450713,0.0,0.05749406853198106,0.955,18/42,21.29%,UTRN;NRP1;TEK;LIMS1;CDH13;PTPRJ;KDR;MYOC;EMP2;MAP4K4;PTK2B;VEGFA;S100A10;FERMT2;CCL25;CDK6;JUP;ROCK1
prerank,endothelial cell differentiation (GO:0045446),-0.721805701058648,-1.801248040316252,0.0,0.05943717330123234,0.957,5/12,3.61%,BMPR2;JAG1;ACVRL1;TIE1;KDR
prerank,aggrephagy (GO:0035973),-0.5778582695570691,-1.799147914413733,0.00437636761487965,0.060170544449568916,0.964,13/27,17.93%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;DYNC1I1;SQSTM1;HDAC6;DYNLL1;CFTR;ATG5;ACBD5;DYNC1H1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.537043441516455,-1.7990659609471806,0.0,0.059500386403864104,0.964,12/35,10.32%,HEG1;DAB2IP;TGFB2;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC;SPRY2;EPHB2
prerank,collagen fibril organization (GO:0030199),-0.45361500375261404,-1.7979287046371626,0.0,0.059705865316786684,0.966,29/88,9.90%,COL8A1;COL12A1;TLL1;COL6A3;COL4A1;ITGA6;COL25A1;COL15A1;COL6A2;COL8A2;DST;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;COL23A1;COL5A2;ITGB4;LAMA3;COL4A6;P4HA1;LOX;LUM;PLOD3;ADAMTS14;COL27A1;COL14A1;CRTAP
prerank,positive regulation of cell motility (GO:2000147),-0.39945073265365555,-1.7946509841916964,0.0,0.06130488104043056,0.969,64/205,13.82%,LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;SPOCK2;SEMA3C;ITGA6;TJP1;NTN1;SEMA7A;ACVR1;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;STAT3;KDR;MGAT5;CPNE3;ITGB1;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;PDGFC;TIAM1;SEMA5B;MAP4K4;BCAR1;NEDD9;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;TWIST1;CCDC25;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;AKT2;VEGFA
prerank,cell-matrix adhesion (GO:0007160),-0.4476686012910085,-1.7931435039902062,0.002421307506053269,0.061913043496296,0.97,31/95,15.59%,ITGBL1;THSD1;VCL;PKD1;PEAK1;CD34;VCAM1;BCR;CD44;ITGA1;FN1;ITGB4;ITGA8;MKLN1;PTPRK;ACTN1;MSLN;ITGB1;ITGB5;EMP2;SRC;ECM2;TIAM1;WHAMM;BCAM;ITGA7;ITGA4;ITGB8;ADAM15;FERMT2;VTN
prerank,regulation of vasoconstriction (GO:0019229),-0.5749606675849096,-1.792835989563762,0.0021598272138228943,0.061366062597390206,0.97,9/27,12.75%,CAV1;BMPR2;ECE1;ADRA1B;ATP2B1;AGTR1;KCNMB2;ADM;ACE2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5019060381261043,-1.7919598521725968,0.0,0.06130503944156187,0.971,19/54,13.82%,MEF2C;NOS3;TMSB4X;ETS1;ACVRL1;THBS1;PLCG1;AKT3;KDR;ANGPT2;PRKD1;PRCP;GATA2;ATP5F1B;FGF2;APOE;HSPB1;CD40;VEGFA
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6869013279327493,-1.787426196230702,0.00404040404040404,0.06409941445990203,0.98,8/14,13.82%,NRP1;GAB1;VEGFC;KDR;PIK3CA;FLT4;PIK3CD;VEGFA
prerank,monosaccharide transmembrane transport (GO:0015749),0.6907982702748325,1.7873739422594008,0.00931098696461825,0.6318974225421027,0.998,6/16,8.55%,SLC2A12;SLC5A3;SLC5A10;SLC23A2;SLC23A1;SLC45A3
prerank,cardiac ventricle development (GO:0003231),-0.6275638426121611,-1.786795759635528,0.006185567010309278,0.06390119651238901,0.98,12/20,25.43%,ENG;NOTCH1;HES1;PDE2A;HEYL;STRA6;HEY2;HEY1;DLL4;SALL1;GJA5;MATR3
prerank,motor neuron axon guidance (GO:0008045),-0.6634335934334765,-1.7838140377272764,0.008492569002123142,0.06523206636504605,0.981,4/15,2.63%,SLIT2;NTN1;TMEFF1;CHN1
prerank,epithelial cell migration (GO:0010631),-0.5424872388810751,-1.7837602047715078,0.002150537634408602,0.0645721177982451,0.981,15/37,14.76%,NRP1;NOS3;RHOA;FAP;CDH13;CYP1B1;KANK1;STARD13;ADGRA2;PXN;PRKX;PIK3CA;PTP4A3;FAT2;PKN3
prerank,endothelial cell proliferation (GO:0001935),-0.6561704833236217,-1.7805367875747,0.0021413276231263384,0.06650251056198286,0.984,8/17,7.55%,TEK;BMPR2;ACVRL1;BMPER;CD34;BMP4;ERN1;PRKX
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5774343635245801,-1.7795501793296673,0.006276150627615063,0.06668000460902959,0.985,8/24,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;ICAM1;GATA2;SERPINE1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6175456487302786,-1.7746500919124346,0.00205761316872428,0.06961087064765407,0.987,13/20,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5562884109095151,-1.7741852368951967,0.0022471910112359553,0.06931774306841797,0.987,9/30,9.75%,BMP5;NOS3;TNFSF10;BCL2L1;FAS;ICAM1;ARHGEF2;SERPINE1;GPX1
prerank,cellular response to drug (GO:0035690),-0.5846725610875905,-1.7729576948280386,0.002178649237472767,0.06961397712012626,0.987,7/25,7.09%,MEF2C;ACER2;GAS6;RAP2A;TFRC;AIM2;KCNQ1
prerank,phospholipid translocation (GO:0045332),-0.5731898248228207,-1.7720164118118844,0.0021008403361344537,0.06972851675860581,0.987,10/28,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;PLSCR1;PLSCR4;TMEM30A;ATP11B;ATP11C
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.652560025750918,-1.7715261134643205,0.006097560975609756,0.06935580489319731,0.989,5/16,7.92%,ST3GAL4;RHOA;ETS1;MDK;NFAT5
prerank,regulation of interleukin-1 production (GO:0032652),-0.6775996267617238,-1.7713337723420064,0.00202020202020202,0.06878096999205772,0.989,5/15,8.02%,FOXP1;GAS6;TMED10;ANXA1;CEACAM1
prerank,carnitine shuttle (GO:0006853),0.7378672375123121,1.7706468832435815,0.004048582995951417,0.6865866899737467,0.999,2/11,1.77%,PRKAG2;PRKAA2
prerank,histone lysine demethylation (GO:0070076),0.6237133479030983,1.7686189601119382,0.003875968992248062,0.6468104732523029,0.999,10/25,19.45%,KDM7A;PHF8;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A;KDM1A;KDM3B
prerank,actin cytoskeleton reorganization (GO:0031532),-0.48056259969072235,-1.7639372409116783,0.0,0.07434002693764885,0.99,23/63,13.24%,NRP1;GAB1;RHOA;GSN;PARVB;MYH9;THSD7A;MKLN1;TNIK;FLNA;RAP2A;S1PR1;CDC42BPA;ANXA1;CXADR;PTPN1;BCAR1;NEDD9;FGF7;WHAMM;PARVA;MICALL2;TRPV4
prerank,membrane repolarization (GO:0086009),0.6907337630893657,1.7636139172794214,0.003952569169960474,0.6310969697789622,1.0,5/15,8.02%,ATP1A2;KCND3;ATP1B3;ATP1B2;KCNH2
prerank,endocardial cushion development (GO:0003197),-0.6077138925970802,-1.7635877267473743,0.006521739130434782,0.07388572193299532,0.99,11/21,12.91%,BMPR2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;HEYL;BMP2;TBX2
prerank,regulation of fatty acid oxidation (GO:0046320),0.6947586618696356,1.7620809965240447,0.0020242914979757085,0.5979608935608273,1.0,7/16,11.97%,PRKAG2;APPL2;PPARA;LONP2;PPARGC1A;ABCD1;SOX9
prerank,morphogenesis of an epithelium (GO:0002009),-0.5755589461971834,-1.759817062590824,0.006535947712418301,0.07618037611164045,0.991,14/25,24.50%,ACTB;VCL;LRP6;ACTG1;TBX18;LAMA3;PRKX;LIN7C;TIMELESS;TRAF3IP1;SOX8;KDM2B;ARHGAP12;LHX1
prerank,positive regulation of heart rate (GO:0010460),-0.6269179481545158,-1.7596829902993207,0.008385744234800839,0.07556324932625896,0.991,6/17,11.67%,PDE4D;ADRA1B;KCNQ1;EDN1;ADM;EDN3
prerank,positive regulation of vasculature development (GO:1904018),-0.4429511162485804,-1.7581641363548834,0.0,0.07622602707415833,0.991,34/94,13.82%,TEK;GAB1;NOS3;HIPK1;ETS1;TIE1;VEGFC;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;PRKD1;WNT5A;FLT1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,positive regulation of cellular component movement (GO:0051272),-0.5757286597485973,-1.7578190267206981,0.00408997955010225,0.07577109105924888,0.991,11/24,15.76%,ACTN4;SPOCK2;NTN1;ETS1;LYN;TWIST1;CCDC25;AKT2;VEGFA;CAVIN1;CSF1R
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4712150906860778,-1.7565333495713906,0.0,0.07618929678516337,0.992,20/64,10.64%,UTRN;JAG1;VCL;RHOA;ACER2;THBS1;ACTG1;CDH13;PEAK1;LIMCH1;CORO1C;MACF1;CASK;AJAP1;MYOC;EMP2;EFNA5;MAP4K4;DUSP3;SEMA3E
prerank,amide transport (GO:0042886),-0.5721012883498675,-1.7557120047836996,0.002207505518763797,0.07632570213558874,0.993,9/26,6.72%,ABCG2;DISP1;CERT1;SLC5A6;PLTP;PLEKHA8;AQP11;SLC38A5;TAP2
prerank,phospholipid transport (GO:0015914),-0.4868050449219477,-1.7526984007711666,0.004640371229698376,0.07823780357563129,0.993,16/52,7.63%,ATP10A;ATP8B1;PITPNC1;ATP8A1;SCARB1;ABCC1;ABCA1;SCARB2;PLTP;TMEM30A;ATP11B;TNFAIP8L3;NPC2;MTTP;ATP11C;ABCA3
prerank,protein localization to cell-cell junction (GO:0150105),-0.6590799787563455,-1.7507586767829322,0.005813953488372093,0.07903841896443552,0.993,8/15,10.02%,ACTB;TJP1;ACTG1;LSR;F11R;TJP2;PAK2;JAK1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7631388141601456,-1.7497190883002705,0.0,0.07921300430895141,0.993,6/10,8.02%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;CEACAM1
prerank,xenobiotic transport (GO:0042908),-0.631175964572548,-1.7466761921556215,0.0021691973969631237,0.08110526900815825,0.996,6/17,9.11%,ABCG2;SLC47A1;ABCC1;SLC7A5;ABCA3;SLC22A18
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.43214983772673704,-1.744948508354017,0.0,0.08198074583881863,0.996,32/100,12.90%,ROR1;TEK;NTRK3;DCN;DAB2IP;GAB1;PIP5K1B;TGFB2;PIP4K2A;INSR;PIK3R1;EGFR;KDR;FN1;PIK3IP1;LYN;PPP1R16B;MAPK1;FLT1;MYOC;PPP2R5C;CEACAM1;PIK3CA;SRC;PDGFC;IER3;FGF2;PIK3CD;UNC5B;TWIST1;PDGFD;ROR2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7192118960626541,-1.7444811054051161,0.007920792079207921,0.08159446434895565,0.996,6/11,10.14%,MECOM;CD34;RUNX1;WNT5A;ARIH2;ETV6
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6200643601919873,-1.7437321003663757,0.008403361344537815,0.08160172276011736,0.996,7/17,17.68%,PRKG1;MEF2C;TAFA5;TGFB3;PDCD4;PTEN;GPER1
prerank,regulation of neuron migration (GO:2001222),-0.5785626563330637,-1.740524900703189,0.0,0.08360217901749734,0.997,10/26,13.45%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;ADGRG1;SHTN1;IGSF10
prerank,regulation of dopamine secretion (GO:0014059),0.6129651313949858,1.7404681269001057,0.007874015748031496,0.6911772031898606,1.0,9/25,11.44%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;DTNBP1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7243517115680315,-1.7403599747100562,0.005703422053231939,0.08305348308929057,0.997,8/11,16.60%,NDNF;CD34;KDR;ADIPOR2;PRCP;GATA2;VEGFA;MCAM
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.44296768076225507,-1.7379527981052691,0.0,0.08446374564140804,0.998,29/84,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;BMPR2;NOS3;TMSB4X;ETS1;SCARB1;THBS1;PLCG1;BMP4;AKT3;KDR;PRKD1;WNT5A;MET;GATA2;FLT4;ATP5F1B;FGF2;BCAR1;EDN1;PIK3CD;HSPB1;PTK2B;CD40;VEGFA
prerank,sprouting angiogenesis (GO:0002040),-0.48153515236980765,-1.7373948165520563,0.0,0.08430168452330923,0.998,21/51,10.80%,NRP1;TEK;RSPO3;SLIT2;ACVRL1;ENG;VEGFC;BMPER;RAMP2;THBS1;CDH13;BMP4;KDR;ADGRA2;RECK;CCBE1;FLT4;FGF2;PARVA;SEMA3E;ESM1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6696704234149323,-1.7362875394032655,0.01002004008016032,0.0844103917384024,0.998,7/14,8.94%,GHR;PIK3R1;SOCS2;STAT3;LYN;PXN;PTPN1
prerank,cellular glucan metabolic process (GO:0006073),0.7221224909426592,1.7357190203437654,0.007952286282306162,0.6800681989733248,1.0,5/11,13.55%,PRKAG2;PHKG2;PHKB;PYGL;PYGM
prerank,heart development (GO:0007507),-0.4073461482903468,-1.732966927766988,0.0,0.08690085342146392,0.998,41/150,13.82%,TEK;MEF2C;FLRT2;NTRK3;BMP5;HEG1;PDLIM5;PLCE1;BMPR2;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;INSR;RAMP2;NOTCH1;PKD1;BMP4;TGFBR2;FN1;TBX1;FBN1;SGCD;SOX17;CRIP1;NIPBL;SH3PXD2B;STRA6;HDAC9;CXADR;ZFPM2;WDR11;MYOCD;LDB3;SOX18;BMP2;TBX2;NCOA6;VEGFA
prerank,positive regulation of transporter activity (GO:0032411),0.7109653676444683,1.7316831297732636,0.003898635477582846,0.6676254092768843,1.0,7/13,9.58%,WNK3;PON1;STK39;KMT2A;NR1H3;RXRA;PDZK1
prerank,response to copper ion (GO:0046688),-0.6104817213519174,-1.7315058490473172,0.0021141649048625794,0.08758574876440374,0.998,11/20,19.01%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT3;ATP5F1D;MT2A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6937441016211627,-1.7311891342881762,0.008130081300813009,0.08721277647502976,0.998,8/13,18.96%,LTBP1;GREM2;FBN1;BMP2;NRROS;CD46;CHRDL1;GREM1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5776957312054437,-1.727280221888244,0.010706638115631691,0.09013173043720578,0.999,12/24,22.00%,NRP1;SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;VEGFA;SEMA5A;SEMA6D;SEMA3F;SEMA4C
prerank,presynapse assembly (GO:0099054),0.6786020472433744,1.7254630545302556,0.012096774193548387,0.6693870489947108,1.0,8/16,10.84%,CEL;IL1RAPL1;NLGN2;WNT7A;NLGN3;LRP4;PTPRD;BSN
prerank,microvillus organization (GO:0032528),-0.6848539444081323,-1.7234205480979483,0.004048582995951417,0.09333210477936935,1.0,9/13,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.6821000953682902,-1.717451942397435,0.006342494714587738,0.09837082557994653,1.0,4/13,7.11%,PDE4D;CAV1;CAMK2D;CALM3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.49256397626365367,-1.7155027539074976,0.0023148148148148147,0.09958514387867357,1.0,16/50,13.79%,LIMS1;ACTN4;RHOA;EGFR;APP;NOD1;NR3C2;RPS3;NFAT5;IFI35;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5956600088884287,-1.7144688179386056,0.0078125,0.10019994147384252,1.0,6/21,7.25%,FOXP1;PRKCH;SLC39A10;RUNX1;LYN;CBFB
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7378350170203385,-1.7141343046438153,0.006160164271047228,0.0998252377534278,1.0,4/10,5.88%,FAP;NOTCH1;TNFRSF1B;CST3
prerank,secretion (GO:0046903),0.6819202354732039,1.713150564347402,0.023762376237623763,0.7147332773016399,1.0,6/14,12.82%,SLC22A6;RIMS1;PRKCI;DRD3;VIP;SLC22A2
prerank,vasoconstriction (GO:0042310),-0.6984871504488553,-1.7118183459181573,0.008048289738430584,0.10150671300465593,1.0,5/11,11.67%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,establishment of endothelial barrier (GO:0061028),-0.5535266526623847,-1.7118072113018221,0.012711864406779662,0.1007775989432662,1.0,12/29,7.33%,PDE4D;PECAM1;RAPGEF2;TJP1;RAP1A;F11R;ICAM1;TJP2;PDE2A;PPP1R16B;ROBO4;RAPGEF6
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7287197042458912,-1.7100036409298995,0.007766990291262136,0.10188213393714624,1.0,4/10,8.02%,PRKG1;CD9;PRKCD;CEACAM1
prerank,sodium-independent organic anion transport (GO:0043252),-0.7393979945773168,-1.7092426411524,0.002008032128514056,0.10201906857474342,1.0,5/10,8.49%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1;SLC16A2
prerank,cellular protein metabolic process (GO:0044267),-0.35852896177200944,-1.7090635582918214,0.0,0.10138551125021049,1.0,127/396,17.44%,MSRB3;DAB2IP;ST8SIA4;LTBP1;RPLP1;PCSK5;ST3GAL6;GAS6;RPS15;RPL38;PLOD2;RPL18A;ATG3;RPL41;BMP4;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;APP;FN1;RPS10;RPL10;RPS23;RPS24;FBN1;RPL7;RPL37A;PDIA6;MSLN;IGFBP6;RPS17;RPS16;RPL39;RPS27A;ST3GAL1;UBE2D3;CST3;MSRB2;RPL13;ADAM10;MRPL52;LOX;RPLP0;RPL30;RPS5;RPL35A;PAPPA;RPS8;CCN1;RPS7;RPL22;CSNK1G3;ABCA3;RPS3;SPPL3;LAMB2;RPS28;KTN1;MFGE8;RPL29;RPL7A;RPS26;MGAT4A;RPL6;VCAN;RPL18;IGF2;RPS25;AGO2;RPL36;APOE;RPL28;YES1;RPL27;CPE;RPL24;RPS29;SFTPA2;SFTPA1;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;PNPLA2;UBE2L3;RPL21;MRPL10;FBXW2;STK38;EVA1A;RPL34;AKT2;RPL10A;UBL5;RPL12;LMCD1;HM13;TNC;RPL35;CDH2;RPL14;D2HGDH;PPP4R2;ST8SIA2;GOLM1;ICMT;PHKA2;RPL19;RPL37;RPS18;RPS13;ZDHHC2;RPS15A;PHEX;CHRDL1;RRBP1;MRPS12;IGFBP4;UBE2G1;MMP2;MRPL55
prerank,regulation of regulated secretory pathway (GO:1903305),0.5552500611814529,1.708570115547399,0.008992805755395683,0.7091677959439217,1.0,11/34,11.44%,SYT11;SYT12;UNC13D;SYT9;SYT1;SNAPIN;SYT13;RIMS1;LRRK2;SYT10;DTNBP1
prerank,embryonic eye morphogenesis (GO:0048048),-0.7067489385780652,-1.705362065757646,0.016194331983805668,0.10450222169565157,1.0,8/11,22.99%,MFAP5;LRP6;FBN1;RARG;TBX2;ALDH1A3;EFEMP1;KDM2B
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.41144120690442626,-1.702773947717039,0.0,0.10649725142519893,1.0,29/118,10.57%,FMNL2;MEF2C;SHANK3;SPARC;PDLIM5;PID1;NEDD4L;ETS1;BMPER;PHLDB1;CHN1;HECW2;TBX1;PHLDB2;TNIK;RAP2A;PAK2;ADGRA2;ARHGAP35;EMP2;CEACAM1;EFNA5;CDK5;FLT4;MYO19;FGF2;ABI3;CFL1;NSMF
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5901064565403936,-1.7013460806447476,0.010309278350515464,0.10715906229171872,1.0,12/21,28.79%,MTUS1;THBS1;IL34;MAPK1;MDK;PTK2B;RARRES2;CSF1R;MAPK3;CMKLR1;DDT;MIF
prerank,regulation of platelet aggregation (GO:0090330),-0.6119603836832708,-1.7001710970285329,0.018442622950819672,0.10765854891608137,1.0,6/17,8.02%,PRKG1;CD9;F11R;LYN;PRKCD;CEACAM1
prerank,cellular response to fluid shear stress (GO:0071498),-0.6838881906934883,-1.6990684332363508,0.011904761904761904,0.10817779931177998,1.0,7/12,22.49%,MEF2C;MTSS1;KLF4;SREBF2;KLF2;ASS1;HAS2
prerank,regulation of striated muscle contraction (GO:0006942),0.5868434870181147,1.6988010296794813,0.0074487895716946,0.7381475211894503,1.0,3/27,1.72%,ATP1A2;SLC8A3;ANK2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5261302487689933,-1.6942222115294552,0.008639308855291577,0.11267262550967448,1.0,17/35,22.00%,NRP1;SEMA6A;NRP2;SEMA3C;SEMA7A;FLNA;MET;SEMA5B;SEMA3E;SEMA3G;ARHGDIA;SEMA5A;SEMA6D;PLXNA4;PLXND1;SEMA3F;SEMA4C
prerank,limb morphogenesis (GO:0035108),-0.5985512133935118,-1.6925848451658974,0.010330578512396695,0.11351100749741191,1.0,7/20,5.55%,MBNL1;LRP6;PCSK5;TGFB2;TBX3;GLI3;NIPBL
prerank,regulation of protein localization to membrane (GO:1905475),-0.5477980961578498,-1.6924386954874435,0.008247422680412371,0.11286814275709624,1.0,14/28,19.96%,SPTBN1;GPC6;ACTB;GSN;AR;CDK5;STX7;ZDHHC7;STX8;GPC1;ZDHHC2;LDLRAP1;CRIPT;GPC4
prerank,microvillus assembly (GO:0030033),-0.6549618396199182,-1.6922159702202144,0.00808080808080808,0.11239916006068949,1.0,9/14,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,positive regulation of locomotion (GO:0040017),-0.546939361948586,-1.6919199199238406,0.002178649237472767,0.11191067081063909,1.0,10/27,15.76%,SPOCK2;NTN1;THBS1;STX3;TWIST1;CCDC25;AKT2;RARRES2;CAVIN1;CSF1R
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5978152093796613,1.6915099560276765,0.011472275334608031,0.7522133033582645,1.0,5/23,5.38%,PRKAG2;BMP7;SPHK1;WNK3;PLK1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.42415161625124276,-1.690485315022736,0.0,0.11263726352738893,1.0,29/92,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;DOCK1;BMPR2;ETS1;SCARB1;TGFB2;THBS1;PLCG1;BMP4;KDR;PLCG2;PRKD1;WNT5A;SRC;FLT4;MAP4K4;FGF2;BCAR1;FGF7;EDN1;PIK3CD;PTK2B;HDAC6;PFN1;VEGFA
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6768946457344687,1.688448036220753,0.011904761904761904,0.7400998755070474,1.0,6/14,19.63%,MOXD1;DAGLA;SLC6A4;SLC22A2;ALDH9A1;ACHE
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5847319273121605,1.687664528545217,0.010869565217391304,0.7156732089587575,1.0,7/26,11.59%,ATP1A2;CRHR1;ADRA2A;GNB5;GSTM2;DRD3;GSTO1
prerank,regulation of cell migration (GO:0030334),-0.3527244576908196,-1.6870441686314572,0.0,0.11571227730750631,1.0,106/382,13.82%,LEF1;TMEFF2;FRMD5;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK10;CLDN5;JAG1;SEMA3C;ITGA6;VCL;SLIT2;TJP1;SRGAP1;RHOA;TMSB4X;CLIC4;SEMA7A;ACVR1;ACVRL1;ENG;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;LIMCH1;EGFR;CYP1B1;FOXO3;PRR5L;CORO1C;CDH1;MACF1;STAT3;SPATA13;PTPRJ;KANK1;KDR;ADARB1;MGAT5;PTPRK;DACH1;FLNA;CPNE3;RAP2A;ITGB1;NUMB;RECK;RACK1;ADAM10;TWIST2;CXCL12;ANXA1;ROBO4;FLT1;CCN1;PPP3CA;MDK;MYOC;PRKX;APC;SPRY2;CEACAM1;STK24;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;FGF2;SERPINE1;ABI3;BCAR1;NEDD9;FGF7;DUSP3;TMSB10;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;PLXNC1;CD74;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SST;SMO;ROR2;IGSF10;AKT2;AMOT;VEGFA
prerank,ribosomal small subunit assembly (GO:0000028),-0.6128642294595776,-1.686612123310529,0.012578616352201259,0.11551590469641941,1.0,8/16,23.34%,RPS15;XRCC5;RPS5;RPS28;RPS27;RRP7A;PWP2;RPS19
prerank,response to progesterone (GO:0032570),-0.6026908905237037,-1.6865542710359174,0.01263157894736842,0.11479290123020067,1.0,6/18,9.46%,CAV1;ABHD2;TGFB2;THBS1;SRC;TGFB3
prerank,rRNA metabolic process (GO:0016072),-0.3930421990489999,-1.6857061936260833,0.0,0.11497235149224856,1.0,74/160,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;TRIR;RPL19;DDX49;RPL37;RRP12;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6306031656781337,1.685578094330947,0.02766798418972332,0.7008298746055623,1.0,6/18,7.82%,UNC13C;NAPB;GRID2;GRIK5;GRIK2;NAPA
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4403209314578439,-1.685311710730995,0.0022727272727272726,0.11467688641237285,1.0,32/70,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,sulfation (GO:0051923),0.7052755573726601,1.6851545499901752,0.016701461377870562,0.6770418466432718,1.0,2/11,1.22%,UST;CHST4
prerank,regulation of wound healing (GO:0061041),-0.4846786521632322,-1.6831940926882443,0.006726457399103139,0.11637034151882074,1.0,12/42,10.32%,CAV1;ACTG1;KANK1;CD109;CASK;ITGB1;AJAP1;ANXA1;OCLN;FGF2;SERPINE1;EPHB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.43698346950674644,-1.6803372729703496,0.0022471910112359553,0.11895852198558207,1.0,32/71,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7182443177265099,-1.6801318675444257,0.006198347107438017,0.118431773841603,1.0,4/10,6.52%,RAPGEF2;GAS6;LYN;CXCL12
prerank,potassium ion transport (GO:0006813),0.43391639846804814,1.6796458290001055,0.0032102728731942215,0.6835966653814326,1.0,21/120,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;KCNH7;KCNK4;SLC9A9
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4729954884526419,-1.678929536194098,0.013333333333333334,0.11898630492563968,1.0,16/47,16.70%,NRP1;LIMS1;ACTN4;LIMS2;DOCK1;CORO1C;KANK1;FLNA;MDK;MYOC;EFNA5;NEDD9;AP1AR;S100A10;FERMT2;RREB1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.43296024687595175,-1.6786278396911383,0.0,0.11857041693812331,1.0,23/75,13.69%,PTPRM;TEK;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;ISM1;ADAMTS1;SPRY2;ECSCR;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5335545030175535,-1.6760469688302417,0.010438413361169102,0.12077649114610167,1.0,12/27,7.50%,TMEFF2;SHANK3;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,heart morphogenesis (GO:0003007),-0.47882635404713025,-1.6746411648933461,0.002331002331002331,0.12135353814888993,1.0,18/50,13.82%,FLRT2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;INSR;TBX3;NOTCH1;TBX1;SOX17;NIPBL;HES1;HEYL;HEY2;BMP2;TBX2;VEGFA
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6428399992113774,1.6744894962978718,0.013916500994035786,0.6904698634394152,1.0,3/17,1.31%,ATP1A2;BMP7;TFPI
prerank,receptor metabolic process (GO:0043112),-0.47530692722458423,-1.6738713970307708,0.0,0.12141129912141971,1.0,30/53,31.60%,CAV1;CALCRL;DNM3;RAMP2;CD9;SMURF1;RAB31;ITGB1;TFRC;SNX1;ACKR3;ADM;LRP1;RAB11B;PIK3R4;LDLRAP1;ARRB2;NEDD4;SYK;AP2M1;PHETA1;GRB2;PHETA2;DNM1;NSG1;DNM2;CD36;LMTK2;SH3GLB1;GRK2
prerank,regulation of interleukin-2 production (GO:0032663),-0.4953752691880254,-1.6721988104743841,0.006578947368421052,0.12258805134802496,1.0,11/43,13.79%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;ANXA1;RPS3;HDAC7;MALT1;PTPRC;CD86
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.645468139730323,-1.6702581416092566,0.016913319238900635,0.12435736580644638,1.0,3/14,3.88%,IL6ST;OSMR;PTGS2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3594844044950247,-1.6685761303755493,0.0,0.12556368046559785,1.0,125/306,25.44%,ST3GAL4;RPLP1;PTMA;EXT1;RPA1;KAT7;RPS15;RPL38;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;TIPIN;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;AGO2;RPL36;APOE;RPL28;GOLPH3;RPL27;B4GALT5;RPL24;RPS29;GCNT1;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;BLM;KIN;RPL21;MRPL10;ORC1;RPL34;RPL10A;RPL12;RPL35;RPL14;NR4A2;TIMELESS;RPL19;RPL37;RPS18;RPS13;RPS15A;ING4;RRBP1;EEF1G;MRPS12;MRPL55;ORC2;ST3GAL2;RHNO1;MRPL43;NBN;BARD1;RPA2;EPC1;RMI1;CDC45;MRPL36;ORC5;PCLAF;POLA1;POLR3A;MRPL35;DUT;SET;RPL3;POLR2I;RFC4;CHEK1;POLA2;THAP1;TOP1;BCL3;MCM3;RPL15;RPS21;POLR2F;RPS19;RPL8;RPL13A;EXT2;RPL23A;RBMS1;SRBD1;MRPL11;POLE3;TYMS
prerank,lamellipodium organization (GO:0097581),-0.539068063668707,-1.66841374560849,0.012474012474012475,0.12493337995617676,1.0,13/29,14.74%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;SNX1;GOLPH3;WHAMM;ABLIM2;SNX2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5787130593823234,1.6673916397234738,0.015717092337917484,0.7102904309442262,1.0,9/25,9.58%,ACTN2;ATP1B3;ANK2;SLC6A9;WNK3;STK39;ATP1B2;WNK4;PDZK1
prerank,protein localization to synapse (GO:0035418),0.687037151781747,1.6667921271169128,0.02734375,0.691180309785766,1.0,5/12,10.84%,NLGN2;ZDHHC12;SHANK1;DLG4;BSN
prerank,mesenchyme morphogenesis (GO:0072132),-0.6047553957869285,-1.6647460529716942,0.0211864406779661,0.12854402190922185,1.0,9/17,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;HEYL;BMP2;TBX2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5557840599462341,-1.6624267890277116,0.012605042016806723,0.13081256371689723,1.0,10/24,18.44%,NCKAP5;STMN1;MAP7D3;TPPP3;FGF13;TRPV4;NCKAP5L;KATNB1;KIF24;STMN4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4290020403040059,-1.6589687960152844,0.0022522522522522522,0.13437542851143697,1.0,32/73,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,cGMP-mediated signaling (GO:0019934),-0.6544112370479853,-1.6584172596701188,0.01639344262295082,0.13423331020411808,1.0,5/13,9.64%,PDE3A;GUCY1B1;PDE9A;PDE2A;APOE
prerank,modified amino acid transport (GO:0072337),0.6557503386932414,1.6582613951812548,0.01782178217821782,0.7186480541317456,1.0,4/15,7.83%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,lamellipodium assembly (GO:0030032),-0.5615899566631806,-1.6574128242454589,0.014830508474576272,0.13471217875651254,1.0,11/26,13.00%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;GOLPH3;WHAMM;ABLIM2
prerank,mesonephros development (GO:0001823),0.701232953737,1.6566519791938343,0.013916500994035786,0.7062561490179986,1.0,3/11,1.12%,BMP7;FGF1;OSR1
prerank,regulation of glucose import (GO:0046324),0.5503897265788535,1.6565544694460457,0.01303538175046555,0.6862543451255212,1.0,8/30,9.68%,PRKAG2;OSBPL8;IGF1;APPL2;PRKCI;SORBS1;RHOQ;CREBL2
prerank,histone H3-K9 demethylation (GO:0033169),0.6977956206841763,1.656463554429071,0.01440329218106996,0.6669992773377167,1.0,5/11,19.45%,KDM7A;PHF8;KDM4A;KDM1A;KDM3B
prerank,positive regulation of response to wounding (GO:1903036),-0.5528060130490839,-1.6551985560522455,0.013157894736842105,0.13695092808464307,1.0,8/24,7.71%,PTN;ACTG1;KANK1;SCARF1;ITGB1;ANXA1;MDK;OCLN
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4665576341998008,-1.655192262698106,0.0,0.13615470175856956,1.0,11/51,5.76%,BMPR2;HTRA3;GREM2;BMPER;NOTCH1;CRIM1;SMURF1;FBN1;SMAD5;SMAD1;UBE2D3
prerank,intraciliary retrograde transport (GO:0035721),0.67319223222778,1.6551616595178595,0.02976190476190476,0.6555552486526964,1.0,7/12,10.31%,TTC21B;DYNLT2B;WDR19;WDR35;DYNC2LI1;DYNC2I2;IFT122
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6844262509548905,-1.6541269495434683,0.01509433962264151,0.13673147564587734,1.0,8/11,20.85%,LIMD1;STAT3;PUM2;PUM1;FMR1;FXR1;XPO5;AJUBA
prerank,heterocycle biosynthetic process (GO:0018130),-0.6346270310774073,-1.6533958316884647,0.01694915254237288,0.13689337471533825,1.0,7/14,21.80%,GPHN;GCH1;LIAS;NFS1;MOCS1;NOXRED1;PYCR3
prerank,regulation of microtubule-based movement (GO:0060632),0.700104804894589,1.6532744055307738,0.019455252918287938,0.6480822529049244,1.0,4/11,8.39%,MAP2;TTC21B;DYNLT2B;DRC1
prerank,negative regulation of anoikis (GO:2000811),-0.6358096375996435,-1.650643547469452,0.014644351464435146,0.13961212133598,1.0,6/14,8.77%,CAV1;NOTCH1;ITGA5;ITGB1;PIK3CA;SRC
prerank,regulation of anoikis (GO:2000209),-0.576284469257022,-1.6505238038102903,0.01016260162601626,0.1389558084245828,1.0,8/19,11.20%,CAV1;NOTCH1;ITGA5;ITGB1;MYBBP1A;PIK3CA;SRC;TLE5
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6098171827935905,1.6503311069095155,0.03302752293577982,0.6469024888621953,1.0,6/19,15.79%,DDO;ALDH7A1;ASPA;GCDH;GOT1;GOT2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.580054784727549,1.6489584577187424,0.02631578947368421,0.636854072344626,1.0,3/23,1.72%,ATP1A2;CACNB1;ANK2
prerank,positive regulation of hemostasis (GO:1900048),-0.6858742944812426,-1.648216637955282,0.017928286852589643,0.1404302987037303,1.0,7/10,25.72%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,positive regulation of coagulation (GO:0050820),-0.6858742944812426,-1.648216637955282,0.017928286852589643,0.1404302987037303,1.0,7/10,25.72%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,neurotransmitter uptake (GO:0001504),0.6941144262866411,1.6445979008254359,0.022494887525562373,0.6425434442918699,1.0,6/12,15.95%,ATP1A2;SLC29A2;SLC38A1;SNAP25;SLC22A2;GLUL
prerank,intestinal lipid absorption (GO:0098856),0.7004780262646239,1.6445722003653749,0.020833333333333332,0.627097146368026,1.0,3/11,2.07%,CEL;ABCG5;SOAT2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.440550190301669,-1.643495545612099,0.0023148148148148147,0.1454354093478052,1.0,28/67,22.09%,TEK;GHR;ABI1;INSR;EGFR;KDR;BMX;TEC;LYN;FLT1;SRC;FLT4;ABI3;IL15;EPHB2;DYRK1A;PIBF1;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;MAPK3;BTK;JAK3;HCK;SYK;FYN
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5788983603583429,-1.6430080071672486,0.012048192771084338,0.1453250967941411,1.0,13/19,24.99%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;HEY2;BMP2;HEY1;SLIT3;ZFPM1;SMAD6;OLFM1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5894896517633214,-1.6413086349374952,0.013157894736842105,0.1468208709174256,1.0,9/18,16.64%,SPTBN1;ACTB;AR;CDK5;STX7;ZDHHC7;STX8;ZDHHC2;LDLRAP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.57399841847812,-1.640801819588467,0.02178217821782178,0.14669021886386455,1.0,9/19,19.05%,THBS1;IL34;MPP1;MAPK1;MDK;JAM3;RARRES2;CSF1R;MAPK3
prerank,negative regulation of calcium ion transport (GO:0051926),0.6488303836171728,1.6391943406470222,0.028846153846153848,0.6411676661052222,1.0,2/15,4.37%,ATP1A2;ADRA2A
prerank,substantia nigra development (GO:0021762),-0.4939407926437177,-1.638550629437782,0.015873015873015872,0.14878602682887954,1.0,11/37,15.36%,ACTB;RHOA;YWHAE;GNB4;CALM3;MAOB;YWHAQ;NDRG2;CNP;DYNLL1;GLUD1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5086936193785231,-1.6373473349779069,0.0071090047393364926,0.14954232076405624,1.0,17/33,15.20%,RHOJ;SEMA6A;TJP1;BMPER;THBS1;ITGA5;CREB3L1;SMAD1;PPP1R16B;EPN2;CEACAM1;FGF2;KLF4;JAK1;VEGFA;KLF2;CEMIP2
prerank,triglyceride biosynthetic process (GO:0019432),0.5975935705779468,1.636275336419752,0.028680688336520075,0.6401783856044981,1.0,5/18,12.75%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5696044320489911,1.6361476609290684,0.018867924528301886,0.6262242135833452,1.0,6/25,2.89%,ERRFI1;SNX6;SLC6A9;CHMP6;GPRC5A;PPARA
prerank,calcium-ion regulated exocytosis (GO:0017156),0.573035667412062,1.6327609707372968,0.009487666034155597,0.6279736475667864,1.0,8/27,10.21%,SYT11;SYT12;SYT9;VAMP7;SYT1;SYT13;RIMS1;SYT10
prerank,myelination in peripheral nervous system (GO:0022011),-0.6559434365002894,-1.6303029461134204,0.010183299389002037,0.15856638906311954,1.0,6/13,10.76%,ADGRG6;PARD3;LGI4;MYOC;SOD1;PRX
prerank,supramolecular fiber organization (GO:0097435),-0.34725019897501713,-1.6300969744025116,0.0,0.15796621289396656,1.0,83/333,13.75%,HIP1;COL8A1;COL12A1;MYO1D;PGM5;TLL1;COL6A3;MYO1B;COL4A1;RHOBTB1;ITGA6;COL25A1;SHROOM4;RHOA;COL15A1;COL6A2;COL8A2;B2M;DST;GSN;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;NCKAP5;CORO1C;COL23A1;H3-3A;APP;COL5A2;STMN1;ITGB4;UBC;LAMA3;ACTN1;COL4A6;ARHGEF2;P4HA1;RPS27A;UBB;CST3;TPM4;TNXB;ADAM10;LOX;LUM;IAPP;PLOD3;CLIP4;MAP7D3;ALDOA;MFAP4;ADAMTS14;EMP2;TGFBI;MFGE8;TPM2;MYH11;COL27A1;TMOD3;MYO19;TPPP3;TPM3;BCAR1;COL14A1;MYO1F;CRTAP;CD2AP;WHAMM;FGF13;CDC42EP2;GFAP;CLIP2;COL1A1;HIP1R;ITM2B;RND3;TRPV4;P4HA2;MARCKS;NCKAP5L;AVIL
prerank,cilium-dependent cell motility (GO:0060285),0.5834712095109698,1.6298702657988495,0.01949317738791423,0.6288933320226102,1.0,6/22,13.59%,CFAP44;DNAH1;TEKT2;TEKT5;DRC1;DNAAF2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6845721232763313,-1.6290532980283445,0.014553014553014554,0.15853918254817423,1.0,3/11,9.62%,NRP1;STMN1;BCAR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.45911019785535906,-1.6283490441110686,0.015873015873015872,0.15888339871370546,1.0,21/51,25.81%,PTN;VEGFC;THBS1;GAS6;CXCL12;IL6R;IL34;MAPK1;MDK;SERPINE1;EDN3;VEGFA;RARRES2;CSF1R;MAPK3;HMGB1;PLA2G7;CCR2;ANO6;CMKLR1;AIF1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.585471222803687,-1.6272152521234955,0.00881057268722467,0.1598749892963703,1.0,9/20,13.32%,GSN;THBS1;PLCG1;SFRP4;PLA2R1;ECSCR;PDCD4;ITGA4;CD40
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6351374572500377,-1.6271785313397984,0.013333333333333334,0.15908027532015964,1.0,8/13,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;SPI1;CDCA4;ZMIZ1;CHEK1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4472206470838808,-1.6271203400109775,0.006896551724137931,0.1582938829562653,1.0,26/58,20.23%,SGMS1;ST3GAL4;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ST8SIA6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;ST3GAL2;SGPP1;SPTSSA;PPM1L;ACER3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5405201708257886,-1.62710850521788,0.012121212121212121,0.15746943564920143,1.0,12/24,27.26%,PECAM1;VCAM1;F11R;ITGB1;ICAM1;ITGA4;NT5E;SYK;MSN;ROCK1;SEMA4D;SELP
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5426862122164887,-1.6271018967664117,0.00851063829787234,0.15666667666925194,1.0,10/24,4.34%,NRP1;NRP2;BMPR2;SEMA3C;ACVR1;TGFB2;ENG;BMP4;TGFBR2;TBX1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5262539237418071,-1.6269124987281707,0.010940919037199124,0.15608796528993474,1.0,12/29,13.07%,SHANK3;SLIT2;TJP1;KANK1;SSH2;KANK3;KANK4;PRKCD;PIK3CA;LIMA1;HIP1R;PFN1
prerank,endodermal cell differentiation (GO:0035987),-0.5104872870382494,-1.625536437172299,0.017857142857142856,0.1571349360201998,1.0,12/31,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;ITGB5;RTF1;PAF1;ITGA7;ITGA4
prerank,triglyceride homeostasis (GO:0070328),0.5566250655740371,1.623844288445734,0.02524271844660194,0.6445269066307473,1.0,7/26,9.10%,RORA;IL18;FITM2;ACSM2A;PNPLA8;C1QTNF3;NR1H3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5767353362894804,-1.6235398196507518,0.014141414141414142,0.1591161087526239,1.0,9/18,11.68%,PTN;DAAM2;NOTCH1;TNFRSF1B;HES1;IL34;TNFRSF21;MDK;PTPRZ1
prerank,cellular response to cadmium ion (GO:0071276),-0.5433582764600975,-1.622796288569753,0.022026431718061675,0.15931289143143545,1.0,14/24,19.05%,EGFR;JUN;MAPK1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT3;MT2A;MAPK3
prerank,receptor internalization (GO:0031623),-0.4688132023458757,-1.62132855287593,0.013215859030837005,0.160378963029092,1.0,14/44,13.83%,CAV1;CALCRL;DNM3;RAMP2;CD9;RAB31;ITGB1;TFRC;LMBRD1;SNX1;CEACAM1;ACKR3;ADM;LRP1
prerank,neuron cell-cell adhesion (GO:0007158),0.6442258710257162,1.6196262946025102,0.015717092337917484,0.6516602677420543,1.0,4/14,7.03%,CEL;NLGN2;NRXN3;NLGN3
prerank,monocyte differentiation (GO:0030224),-0.6932492619466695,-1.6189975423536065,0.016359918200409,0.16265817683089115,1.0,5/10,15.76%,MYH9;BMP4;MT1G;VEGFA;CSF1R
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6506937675478662,-1.618547299263442,0.022494887525562373,0.1624030155009068,1.0,5/12,17.64%,TMEFF2;AR;EDN1;AP2A1;HDAC2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4850129310373742,-1.618033325311778,0.01020408163265306,0.16230185294150667,1.0,11/34,16.70%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;MDK;MYOC;NEDD9;S100A10;FERMT2;RREB1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3766570160330381,-1.6167870735779917,0.0,0.16340109281121054,1.0,42/151,15.76%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;MFHAS1;TNFRSF11A;ICAM1;TNFAIP8L3;GAREM1;SPRY2;CCL13;PDGFC;FLT4;FGF2;APOE;ACKR3;CD74;PHB2;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;P2RY6;MTURN;MT3;FERMT2;CSF1R
prerank,acylglycerol homeostasis (GO:0055090),0.5827334634374217,1.6157116965535432,0.02729044834307992,0.6572917864527316,1.0,5/20,9.10%,RORA;IL18;ACSM2A;PNPLA8;NR1H3
prerank,regulation of catecholamine secretion (GO:0050433),0.549371436815661,1.6152298353512788,0.03238095238095238,0.6463648057831022,1.0,10/29,11.44%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;CHGA;DTNBP1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6410969558719325,1.6147360152864358,0.02976190476190476,0.6359267604953815,1.0,4/15,5.08%,OSBPL8;FITM2;PPARA;ABHD5
prerank,activation of protein kinase B activity (GO:0032148),0.542359413557808,1.6134376767639822,0.02819548872180451,0.6295793806099987,1.0,8/29,6.82%,FGF1;OSBPL8;IGF1;IL18;RICTOR;ADRA2A;PDPK1;NRG1
prerank,platelet degranulation (GO:0002576),-0.39093207495729193,-1.612039153584559,0.0024691358024691358,0.1695634077693693,1.0,34/118,13.91%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;TAGLN2;APP;WDR1;FN1;CD109;ACTN1;FLNA;LYN;ALDOA;CHID1;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;ECM1;VEGFA;TMX3;RARRES2
prerank,regulation of spindle organization (GO:0090224),-0.5663910775597409,-1.611785015556355,0.022774327122153208,0.169067987721538,1.0,9/18,23.88%,SENP6;MAP9;DYNC1H1;DCTN1;GPSM2;TPX2;FSD1;PARP3;NUP62
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6838123822849933,-1.6090646981886536,0.02564102564102564,0.17233951599496522,1.0,5/10,16.62%,PDE3A;PDE4D;PDE2A;RNF157;APLNR
prerank,clathrin coat assembly (GO:0048268),-0.6237701801847708,-1.608539789301417,0.02702702702702703,0.17226646521914116,1.0,5/15,5.93%,HIP1;PIK3C2A;FCHO2;SGIP1;CLTB
prerank,cell-substrate junction assembly (GO:0007044),-0.49862162413283273,-1.6081746703398216,0.008492569002123142,0.17195513196714332,1.0,12/33,10.16%,THSD1;ITGA6;DST;PEAK1;BCR;FN1;ITGB4;PTPRK;LAMA3;ACTN1;SRC;WHAMM
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6151964337033328,-1.6081107656929154,0.023809523809523808,0.1712381965859099,1.0,7/14,19.05%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3
prerank,cyclooxygenase pathway (GO:0019371),0.6802759068531459,1.6079878398091947,0.03225806451612903,0.643023149591667,1.0,2/10,0.31%,PTGDS;PTGS1
prerank,histone H3-K36 demethylation (GO:0070544),0.7053963050182682,1.6079587006285119,0.03829787234042553,0.6312151847935187,1.0,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5816154717483037,-1.607822841009648,0.02982107355864811,0.17083158505030496,1.0,6/17,9.74%,MAML2;PBX1;NOTCH3;NOTCH1;HEYL;NOTCH4
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.46834023650793355,-1.607373635496047,0.010638297872340425,0.17071274307311263,1.0,14/43,16.62%,MEF2C;MICAL2;ACVR1;ENG;TBX3;NOTCH1;TGFBR2;SOX17;HES1;SOX18;SMO;TBX2;STIL;APLNR
prerank,organic anion transport (GO:0015711),-0.4182952236783074,-1.6057939610098881,0.002320185614849188,0.17236848962909684,1.0,14/76,8.49%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO3A1;LRRC8D;SLCO1C1;SLCO2A1;LRRC8C;SLCO2B1;SLC39A8;CA4;LRRC8A;SLC16A2
prerank,regulation of blood coagulation (GO:0030193),-0.5242894394638894,-1.60526924414071,0.013245033112582781,0.17227941952422743,1.0,10/27,11.56%,ST3GAL4;CAV1;FAP;THBS1;CD34;SERPINE1;APOE;EPHB2;EDN1;ENPP4
prerank,hemopoiesis (GO:0030097),-0.4037403696510208,-1.6043182534571054,0.005050505050505051,0.17288199912033986,1.0,24/87,10.14%,MECOM;KITLG;TEK;SNRK;ZBTB16;JAG1;MFAP5;HIPK1;TGFB2;RUNX2;CD34;RUNX1;BMP4;TGFBR2;KDR;KAT6A;WNT5A;FLT1;PRKX;ARIH2;FLT4;NOTCH4;TAL1;ETV6
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5440653767266339,-1.6041868764894265,0.021696252465483234,0.17232309259593664,1.0,9/24,15.59%,DAB2IP;ITGA5;TMEM204;EPN2;PTPN1;HGS;HHEX;MT3;VTN
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6611696518676871,1.6041412556874082,0.030927835051546393,0.6380188850482188,1.0,4/12,6.71%,ATP1B3;WNK3;ATP1B2;WNK4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7057889760879617,1.6034071592470023,0.029296875,0.6296799182467153,1.0,2/10,4.37%,ATP1A2;ADRA2A
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6705839273945573,1.6024105733010043,0.024096385542168676,0.6234312302687998,1.0,3/12,3.76%,IL18;NUPR1;TAFA3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5495933983445522,1.6023719679342967,0.03024193548387097,0.6128683832121535,1.0,6/26,11.40%,PRKAG2;LPGAT1;PRKAA2;SLC45A3;NR1H3;WDTC1
prerank,B cell receptor signaling pathway (GO:0050853),-0.49745554908140915,-1.601632494421957,0.020618556701030927,0.1753506181764249,1.0,15/32,21.23%,MEF2C;RFTN1;PLCG2;BMX;TEC;CD38;BCAR1;PIK3CD;NFATC2;SH2B2;PTPRC;NCKAP1L;LAT2;BTK;SYK
prerank,maturation of 5.8S rRNA (GO:0000460),0.6072906266884,1.6014034449247185,0.029296875,0.6071948058392809,1.0,2/17,0.35%,NSA2;MPHOSPH6
prerank,platelet aggregation (GO:0070527),-0.4972758792872767,-1.600992551082695,0.010416666666666666,0.1755019121041003,1.0,12/33,11.50%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;UBASH3B;PPIA;CLIC1;MYL9;HSPB1
prerank,regulation of osteoblast differentiation (GO:0045667),0.4426079793228805,1.6002800865840046,0.006688963210702341,0.6024807834966934,1.0,15/82,6.95%,RANBP3L;SMOC1;BMP7;BMP6;WNT4;TMEM64;IGF1;DDX5;SUFU;BMPR1A;LRP3;WWTR1;NPNT;CITED1;FGFR2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6121785622221616,-1.6000540704395174,0.021825396825396824,0.17611360712229815,1.0,9/14,24.61%,THBS1;PLCG1;ECSCR;PDCD4;ITGA4;CD40;GPER1;RGCC;ANO6
prerank,inorganic cation transmembrane transport (GO:0098662),0.3773090198958438,1.6000227621915137,0.0,0.5936902374962385,1.0,25/268,6.47%,TRPM3;ATP1A2;KCNK2;SLC6A13;SLC6A1;CACNA1D;SLC6A12;SLC8A3;SLC41A1;SLC24A3;TRPM6;KCND3;ATP1B3;TRPV1;KCNA3;SLC30A6;LRRC38;SLC6A9;TMEM175;KCNJ10;SLC30A10;ATP6V1H;NALCN;SLC39A13;KCNC3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.625759543048343,-1.5990106819174181,0.020676691729323307,0.1767662398470989,1.0,5/13,12.09%,DAB2IP;EPN2;PTPN1;HGS;HHEX
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6388049179803839,-1.5985375413686105,0.023952095808383235,0.17659043013219455,1.0,6/12,14.93%,CBLB;F3;PTPRJ;APOD;HGS;CBL
prerank,positive regulation of vasoconstriction (GO:0045907),-0.6324976967174651,-1.5974279793049917,0.029106029106029108,0.17759244212803216,1.0,2/13,1.51%,CAV1;ADRA1B
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.525652675326106,-1.597408095932737,0.014675052410901468,0.1768405138212777,1.0,11/24,7.50%,TMEFF2;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4612758896674849,-1.5972611628378341,0.013636363636363636,0.17627820306820247,1.0,16/44,14.78%,YWHAE;THBS1;GAS6;NGF;CD44;CAST;RPS6KA3;CARD16;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5913930304512236,-1.5964463498541661,0.021321961620469083,0.1765286647382302,1.0,9/16,20.36%,THBS1;JCAD;AGTR1;PPP1R16B;GATA2;FGF2;VEGFA;APLNR;DLL4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6480864368417373,1.5962189165892544,0.03428571428571429,0.6012505715181814,1.0,4/13,2.43%,ERRFI1;SNX6;CHMP6;GPRC5A
prerank,histone H3-K4 trimethylation (GO:0080182),0.6752079771361291,1.5951322597996551,0.038461538461538464,0.5961216309895225,1.0,5/11,19.43%,CTR9;KMT2A;BEND3;TET2;SETD1B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.49189325082723817,-1.5943954872537875,0.012738853503184714,0.17871358157522785,1.0,9/35,10.48%,PTPRM;MEF2C;CAV1;SPARC;THBS1;XDH;FLT1;APOE;CAV2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.423950961868803,-1.5938811216945366,0.009685230024213076,0.17867474707387118,1.0,22/65,17.80%,HIP1;DAB2IP;PTPN12;BCAR3;CDH13;EGFR;AFAP1L2;PTPRJ;ITGA1;ARAP1;SPRY2;CEACAM1;MVB12B;DUSP3;HGS;SH3GL2;HIP1R;SPRY1;CBL;PLAUR;GPER1;PDE6H
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5792952245719114,-1.5931902488815415,0.01991150442477876,0.17817341644687534,1.0,7/16,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5792952245719114,-1.5931902488815415,0.01991150442477876,0.17817341644687534,1.0,7/16,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,regulation of muscle contraction (GO:0006937),0.5492719301201777,1.5923552176452533,0.009523809523809525,0.5988934418750098,1.0,5/26,7.44%,ATP1A2;ANXA6;ENO1;CHRM2;TNNI1
prerank,sterol metabolic process (GO:0016125),0.4537378618475905,1.5918529233281054,0.0186219739292365,0.5919198868196216,1.0,22/60,18.60%,PRKAG2;LIPA;SOAT2;CYP26B1;CYP11B1;INSIG2;APOF;SOAT1;CLN8;SC5D;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;FDX2;MSMO1;ABCA5;HMGCR
prerank,response to hydroxyurea (GO:0072710),-0.6532899807894268,-1.5913223234163136,0.029296875,0.1803016606015239,1.0,7/11,21.67%,KAT7;DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3684377941036092,-1.5907823134883585,0.0,0.18026764798443837,1.0,44/151,10.10%,NRP1;PDE3A;LIMS1;MEF2C;NTRK3;SEMA6A;RAPGEF2;PDE8A;BMPR2;DAB2IP;PTPN12;ACVR1;ACVRL1;RAMP2;NDNF;NOTCH1;RAP1A;IQGAP1;EGFR;RUNX2;PLCG1;CD44;BMP4;EEF1A1;TGFBR2;KDR;TBX1;CPNE3;TMEM100;PRKD1;WNT5A;ERN1;RACK1;PDE2A;ANXA1;FLT1;GAREM1;SPRY2;FLT4;MT1G;MAPKAPK2;BCAR1;KLF4;DUSP3
prerank,positive regulation of protein modification process (GO:0031401),-0.3572880408864765,-1.587638061253807,0.0,0.1843978423288298,1.0,66/203,18.58%,TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;NIBAN1;ENG;INSR;VEGFC;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;NOS1AP;CARD14;TBX1;RALB;FAM161A;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;NPTN;PPIA;LYN;PPP1R16B;IL34;PRKCD;NNMT;CALM3;CCN1;RB1CC1;SPPL3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;NSMF;TERF2IP;DYRK1A;CD74;KRAS;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PLAUR;FMR1;CSF1R;RAB3GAP2;ALG10B;FXR1;CEP295;GPER1;TAOK1;C3;CCND1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.418951022847178,-1.5870598797111628,0.009174311926605505,0.1843738480009402,1.0,28/73,15.34%,NRP1;ITGBL1;DOCK1;PTN;SEMA7A;DST;MYH9;ITGA5;FN1;ITGB4;LAMA3;ITGB1;TEC;PRKD1;ADAM10;ITGB5;ADAMTS1;CEACAM1;SRC;BCAR1;NEDD9;ISG15;PTK2B;ITGB8;NME2;ADAM15;PLPP3;FERMT2
prerank,vasculogenesis (GO:0001570),-0.49766632082574924,-1.5866481045465475,0.017817371937639197,0.18418056584810222,1.0,14/32,13.82%,CAV1;ENG;RAMP2;NOTCH1;RASIP1;TGFBR2;KDR;SOX17;HEY2;AGGF1;ADM;SOX18;ITGB8;VEGFA
prerank,cellular potassium ion homeostasis (GO:0030007),0.6549401933763673,1.5863045813411254,0.04743083003952569,0.6068932793535048,1.0,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4580460084287602,-1.5841390251435088,0.006864988558352402,0.18754394275854536,1.0,11/42,8.79%,LIMS1;GCNT2;RHOA;VIT;NDNF;NOTCH1;CORO1C;TBCD;FBLN2;EMP2;ECM2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5222718299313641,-1.5834096746538984,0.010964912280701754,0.18799468666102723,1.0,9/26,10.10%,PDE8A;DAB2IP;PTPN12;IQGAP1;EGFR;PLCG1;EEF1A1;GAREM1;DUSP3
prerank,sterol biosynthetic process (GO:0016126),0.5187130420069821,1.5823415307893884,0.029013539651837523,0.6148192550906154,1.0,11/33,20.27%,PRKAG2;ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6107115786751716,1.582010965089106,0.03802281368821293,0.6071940377078905,1.0,3/17,1.72%,ATP1A2;CACNA1D;ANK2
prerank,regulation of membrane repolarization (GO:0060306),-0.610982859275412,-1.5791771169540847,0.02391304347826087,0.19401209444425735,1.0,6/13,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;CACNA2D1;KCNQ1
prerank,ncRNA processing (GO:0034470),-0.3581074986938709,-1.5775058084602414,0.0,0.19599570678749043,1.0,86/200,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;AGO1;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;SMAD1;RPL39;HELQ;INTS11;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;AGO2;RPL36;DDX54;RPL28;RPL27;DROSHA;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;INTS10;DDX49;RPL37;RRP12;RPP21;ADAT1;PWP2;AGO4;RCL1;MRPL44;INTS9;MRTO4;NOP58;EBNA1BP2;METTL3;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;TARBP2;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,metal ion export (GO:0070839),0.5340847721980979,1.5773057156608252,0.021235521235521235,0.6177778418270701,1.0,4/31,4.28%,ATP1A2;KCND3;ATP1B3;ATP1B2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.6379981109747168,-1.576307651278243,0.026565464895635674,0.19705805452085784,1.0,7/11,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;CDCA4;ZMIZ1;CHEK1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6062348202414113,1.5762886701704542,0.043151969981238276,0.613079778646626,1.0,7/16,18.41%,NUPR1;PPIF;COX7A1;COX7A2L;ABCD1;ATP7A;MLXIPL
prerank,energy reserve metabolic process (GO:0006112),0.5815012805280505,1.5759362435818962,0.029069767441860465,0.6057795507994381,1.0,7/19,13.55%,PRKAG2;LEPR;PHKG2;MRAP2;PHKB;PYGL;PYGM
prerank,regulation of neuroinflammatory response (GO:0150077),0.5882286142262118,1.5755639026082613,0.03531598513011153,0.5989175179932762,1.0,5/19,3.39%,IGF1;IL18;NUPR1;SPHK1;DAGLA
prerank,ceramide biosynthetic process (GO:0046513),-0.46261343671018734,-1.5744546721418937,0.024229074889867842,0.19932132416781626,1.0,11/40,9.26%,SGMS1;ST6GALNAC3;ST8SIA4;SGMS2;DEGS2;AGK;ST6GALNAC5;CERS5;CERS6;ST8SIA6;SAMD8
prerank,cellular sodium ion homeostasis (GO:0006883),0.6272459404663644,1.5730770218154604,0.03278688524590164,0.600739387545375,1.0,3/15,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,positive regulation of GTPase activity (GO:0043547),-0.3599389580153651,-1.5726347956908957,0.0,0.20133743474175606,1.0,54/188,15.77%,DOCK9;LIMS1;TBC1D4;NTRK3;RABGAP1L;DOCK10;RAPGEF2;ARHGAP42;ITGA6;NET1;BCAR3;SIPA1L2;RAP1A;TBC1D8;CORO1C;BCR;F11R;TBC1D12;SNX18;SNX13;TIAM2;USP6NL;TBC1D5;ARAP1;ITGB1;TBC1D2B;SIPA1L3;ARHGEF15;RACK1;TBC1D1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;ABR;TIAM1;MAP4K4;TBC1D13;DOCK8;CAV2;RGS10;SIPA1;RALGAPA1;TAX1BP3;CD40;TBC1D7;TBC1D10A;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP;TBC1D25
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5882699727158801,1.5720709000534154,0.0497131931166348,0.596900329706097,1.0,7/16,15.98%,UPB1;DPYD;CRMP1;NT5C3A;UPP2;DPYSL2;TET2
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3706831684906056,-1.5713598011607106,0.0,0.20264965308702937,1.0,37/137,15.39%,DOCK9;LIMS1;DOCK10;RAPGEF2;ITGA6;RHOA;CD200;NET1;BCAR3;RAP1A;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;CALM3;RAPGEF6;RGS6;TGM2;EVI5L;RPS3;CCL13;MAP4K4;DOCK8;CAV2;RGS10;PSAP;BMP2;CD40;TBC1D7;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP
prerank,heart looping (GO:0001947),-0.46972305156561944,-1.5712919431370609,0.014767932489451477,0.20196668476627128,1.0,12/39,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5440842319704703,1.5705005395443712,0.03766478342749529,0.5953619568477042,1.0,10/26,18.35%,EYA1;HSPA1A;EYA4;EYA2;HTRA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,regulation of integrin activation (GO:0033623),-0.597230182665585,-1.5692775476936374,0.021367521367521368,0.20415653648921445,1.0,12/15,32.06%,PIEZO1;RASIP1;SRC;JAM3;FERMT2;KIF14;SELP;FARP2;PTGER4;FBLIM1;RAP1B;SKAP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.671323481095432,-1.5690493837855197,0.03792415169660679,0.20372355135238332,1.0,5/10,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,positive regulation of wound healing (GO:0090303),-0.47658209239162647,-1.5658834793616225,0.022573363431151242,0.20830563623362588,1.0,18/36,25.72%,ST3GAL4;THBS1;ACTG1;KANK1;ITGB1;ANXA1;OCLN;SERPINE1;ENPP4;PLPP3;FERMT2;VTN;RREB1;MYLK;HPSE;PRKCE;F2R;DMTN
prerank,autophagy of peroxisome (GO:0030242),-0.6235871869236946,-1.5649194214748057,0.023706896551724137,0.20905006501601547,1.0,7/12,17.12%,MAP1LC3B;RB1CC1;NBR1;PIK3C3;SQSTM1;PIK3R4;ACBD5
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6751084341529783,1.564873703743361,0.04703476482617587,0.6108643413098539,1.0,5/10,15.22%,USH1C;WHRN;ADGRV1;PDZD7;TSKU
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5667791054586687,-1.5638115396955663,0.026052104208416832,0.21001016705691222,1.0,6/18,3.88%,LTBP1;CD200;TGFB2;CD34;FN1;PTGS2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6207084197428515,-1.5635385280264007,0.04225352112676056,0.20965293448141803,1.0,7/13,11.83%,SEMA7A;TGFB2;IRAK3;PLCG2;WNT5A;TGFB3;CD74
prerank,cardiac cell development (GO:0055006),-0.6297344614888823,-1.5626277371128938,0.0395010395010395,0.2102857437737873,1.0,5/11,13.82%,JAG1;NOTCH1;MYH11;CXADR;VEGFA
prerank,cardiac muscle cell action potential (GO:0086001),0.520427055671935,1.5604110679050878,0.03208556149732621,0.6219818139387012,1.0,6/30,8.02%,ATP1A2;CACNA1D;KCND3;ANK2;FGF12;KCNH2
prerank,mesenchymal cell differentiation (GO:0048762),0.4736878467957842,1.55891864396712,0.021778584392014518,0.6200131362855096,1.0,11/51,7.14%,RANBP3L;BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;FGFR2;DDX17
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3704815604857314,-1.5580287380347229,0.002785515320334262,0.21734245435481478,1.0,31/140,10.13%,ARHGAP31;ARHGAP10;RHOJ;CHN2;PLCE1;ARAP2;SLIT2;SRGAP1;RHOA;NET1;ARHGEF3;MCF2L;STARD8;CHN1;BCR;RASGRF2;ARAP3;STARD13;TIAM2;ARAP1;ARHGEF2;ARHGAP32;ARHGDIB;ARHGAP35;TGM2;ABR;SRC;TIAM1;VAV2;ARHGEF12;CD2AP
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6687415100794432,-1.5565798837853673,0.03621730382293763,0.2189795936261231,1.0,6/10,19.05%,FAS;LYN;MAPK1;NBR1;GREM1;MAPK3
prerank,genitalia development (GO:0048806),-0.6112265206759373,-1.5565296676098836,0.024242424242424242,0.21818802401068696,1.0,5/12,12.24%,TBX3;PKD1;WNT5A;STRA6;FOXF2
prerank,negative regulation of cell adhesion (GO:0007162),-0.4112913006438536,-1.5560223564281432,0.02112676056338028,0.21818798390203395,1.0,24/72,13.79%,PODXL;GCNT2;SEMA6A;JAG1;RHOA;ACER2;ACVRL1;NOTCH1;CDH13;CYP1B1;CDH1;TBCD;ARHGDIB;ADAM10;MDK;TGFBI;SERPINE1;EPHB2;PLXNC1;JAM3;FZD4;SIPA1;PTPRC;ARHGDIA
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5604150474584725,-1.5559717726795588,0.027600849256900213,0.2174158281264156,1.0,7/19,7.71%,PRKCH;CLDN5;TJP1;RUNX1;F11R;CBFB;OCLN
prerank,filopodium assembly (GO:0046847),-0.589479997807979,-1.555467086046603,0.0437375745526839,0.21735390646157507,1.0,4/16,3.19%,FGD5;DNM3;FGD6;SPATA13
prerank,peptidyl-tyrosine modification (GO:0018212),-0.42868609215547526,-1.554491575697277,0.020689655172413793,0.21829730263102534,1.0,24/56,22.09%,TEK;ABI1;INSR;EGFR;KDR;TEC;LYN;FLT1;SRC;FLT4;ABI3;EPHB2;DYRK1A;TPST2;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;BTK;JAK3;HCK;SYK;FYN
prerank,entry into host (GO:0044409),-0.6068816131034027,-1.5533206236717612,0.03765690376569038,0.21947612280194237,1.0,10/13,32.81%,CDH1;MET;PPIA;SRC;CBL;CXCR4;GRB2;CBLL1;ITGAV;CTNNB1
prerank,amino sugar metabolic process (GO:0006040),-0.6569396337894631,-1.5532273445960267,0.04150943396226415,0.21874552273845982,1.0,3/10,10.72%,CSGALNACT1;ST3GAL1;GFPT2
prerank,cell junction assembly (GO:0034329),-0.3872652622873108,-1.5504839371231818,0.0,0.22251433547067273,1.0,17/100,4.67%,CDH11;ACTB;LIMS1;SHANK3;FARP1;LIMS2;DNM3;SPOCK2;CLDN5;ITGA6;TJP1;RHOA;GJC1;ACTG1;CDH1;FN1;FLNA
prerank,regulation of glycolytic process (GO:0006110),0.4452755569420037,1.549920425278241,0.022071307300509338,0.6515253602101653,1.0,8/68,3.98%,PRKAG2;IGF1;NUPR1;GCK;PRKAA2;PPARA;POM121;NUP155
prerank,regulation of protein phosphorylation (GO:0001932),-0.33807629820119584,-1.5452280487241052,0.0,0.230676570738962,1.0,72/256,15.94%,TEK;NTRK3;PECAM1;SLCO3A1;PLCE1;PID1;PDE8A;DAB2IP;SLIT2;NIBAN1;LRP6;ENG;INSR;VEGFC;BMPER;GAS6;LIMCH1;EGFR;PRR5L;LIMK2;CORO1C;BMP4;KDR;APP;FN1;CARD14;FNIP2;TBX1;RALB;FAS;TNIK;BRD4;RAP2A;TFRC;XDH;AXIN2;RACK1;NPTN;PPIA;LYN;IL34;CCN1;RB1CC1;OCLN;PPP2R5C;EFNA5;TMEM119;SOD1;FLT4;EIF2AK3;IGF2;FGF2;FGF7;EPHB2;TERF2IP;HSPB1;CD74;KRAS;SH3GL2;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PAQR3;PLPP3;PLAUR;FMR1;CSF1R;ATF4;FKBP8
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3218410344625681,-1.5449136964498318,0.0,0.23032601619205265,1.0,104/390,16.25%,NRP1;PTPRG;ACTB;ROR1;TEK;GHR;FLRT2;ABI1;NTRK3;NRP2;ARHGEF28;DOCK1;RAPGEF2;GAB1;RHOA;BCAR3;TIE1;WASF2;COL4A2;INSR;MERTK;VEGFC;FOXO1;RAB14;ACTG1;ANKS1A;PIK3R1;CHN1;EGFR;NGF;GRB14;SOCS2;STAT3;ATP6V0A4;PTPRJ;MTSS1;KDR;STMN1;AP2B1;PIK3C2A;COL4A6;ANGPT2;SPRED2;UBASH3B;PAK2;PRKD1;MET;LYN;NCK1;PXN;MAPK1;FLT1;SHOC2;APC;GRIN2B;ATP6V0D1;EFNA5;PIK3CA;SRC;PDGFC;FLT4;ATP6V0A1;TIAM1;EIF2AK3;VAV2;IGF2;FGF2;MAPKAPK2;BCAR1;NEDD9;SORT1;FGF7;GTF2F1;NCF2;YES1;EPHB2;CAV2;MPZL1;NCBP2;COL1A1;RET;SH2B2;PTK2B;PDGFD;ROR2;ATP6V1D;FGFRL1;AKT2;IRS1;VEGFA;RARRES2;AP2A1;RBFOX2;POLR1G;ALK;CBL;ARPC2;NCBP1;GIT1;FOXO4;CSF1R;NCKAP1L;DDIT4;SHC4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5095451368541921,-1.5443986545041906,0.018633540372670808,0.23042527361819215,1.0,10/25,17.80%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;CBL;PLAUR;RTN4;GPER1;PDE6H
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.328669690641473,-1.5439623127200501,0.0,0.23033011285642557,1.0,75/348,9.88%,NRP1;TEK;GHR;NTRK3;CAV1;BMP5;PECAM1;SLCO3A1;RAPGEF2;PDE8A;BMPR2;NIBAN1;BCAR3;ACVR1;ACVRL1;TGFB2;ENG;INSR;VEGFC;RPS6KA5;RBPMS;GAS6;RASSF2;RAP1A;LIMCH1;IQGAP1;EGFR;ITGA5;LIMK2;NGF;CD44;BMP4;PTPRJ;CSPG4;KDR;APP;CARD14;CACUL1;FNIP2;TBX1;PLCG2;RALB;FAS;TNIK;CAB39;RAP2A;TFRC;ARHGEF2;PAK2;TEC;PRKD1;AXIN2;RACK1;XRCC5;NPTN;PPIA;LYN;IL6R;IL34;MAPK1;CALM3;CCN1;RB1CC1;SPRY2;EFNA5;TMEM119;SRC;PDGFC;FLT4;IGF2;FGF2;TGFB3;IL15;RPTOR;FGF7
prerank,regulation of monooxygenase activity (GO:0032768),-0.5194773203090953,-1.5433764731983877,0.03532008830022075,0.23046236162210762,1.0,8/23,15.53%,CAV1;NOS3;NOSTRIN;EGFR;NOS1AP;DDAH1;CYGB;POR
prerank,positive regulation of leukocyte migration (GO:0002687),-0.5036593021722875,-1.5433683689882363,0.019189765458422176,0.2296038126340634,1.0,8/27,16.03%,PTN;ICAM1;IL6R;MDK;JAM3;EDN3;VEGFA;NCKAP1L
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6838468571280236,1.543154775544542,0.0502092050209205,0.6732356798577901,1.0,5/10,16.53%,KMT5A;SETD4;SETD7;SMYD2;METTL18
prerank,sodium ion homeostasis (GO:0055078),0.5626958884385993,1.5429104501660005,0.041916167664670656,0.6660560030491529,1.0,3/21,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,regulation of cardiac conduction (GO:1903779),0.45970484174628756,1.5424788980360948,0.0108499095840868,0.6598970405603247,1.0,11/54,11.04%,ATP1A2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2;CORIN;FXYD4;ITPR2;RYR2
prerank,transepithelial transport (GO:0070633),-0.5688934125368588,-1.5418031353711543,0.03497942386831276,0.23139878994589524,1.0,7/15,12.77%,ABCG2;SLC12A2;ABCC1;SLC1A3;CXADR;SLC1A1;SLC26A6
prerank,regulation of MAPK cascade (GO:0043408),-0.3585701513442742,-1.538512095270881,0.0026595744680851063,0.23628469992801357,1.0,45/157,13.67%,ROR1;TEK;NTRK3;CAV1;DAB2IP;ADRA1B;BCAR3;INSR;STK3;IQGAP1;EGFR;JCAD;PTPRJ;KDR;FN1;TBX1;PLCG2;FAS;TNIK;DHX33;PAK2;LYN;IAPP;MAPK1;FLT1;CCN1;MYOC;NBR1;CEACAM1;FLT4;ATP6AP2;MAP4K4;IGF2;FGF2;DUSP3;YWHAZ;CAV2;PHLPP1;CD74;RET;BMP2;ROR2;PEBP1;PTPRC;CD24
prerank,substrate-dependent cell migration (GO:0006929),-0.593928212016597,-1.5380899896337976,0.03718199608610567,0.23615987409126593,1.0,7/14,13.63%,NRP1;NTN1;VEGFC;ANKS1A;CD2AP;SHTN1;PTPRC
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6275253598055897,1.5377947448779743,0.05625,0.672599722247102,1.0,7/13,15.95%,DDO;ASPA;MTHFS;GAD1;GOT1;GOT2;GLUL
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5442482193600257,1.5373381887259492,0.04905660377358491,0.6666562499765125,1.0,6/23,4.22%,ERRFI1;SNX6;SH3BP5L;CHMP6;GPRC5A;SH3BP5
prerank,response to lipid (GO:0033993),-0.37589793772343744,-1.5372061409595876,0.005208333333333333,0.2368642758555708,1.0,19/105,9.38%,FOXP1;NOS3;ACER2;PPARD;FOXO1;FOXO3;SOCS2;STAT3;ALPL;IRAK3;RPS6KA3;ESR1;TNFRSF11A;GCH1;STRN3;ANXA1;SRR;TRIM16;MAPKAPK2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.558516597475893,1.5368775075387335,0.054474708171206226,0.653150374162507,1.0,9/21,18.35%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.558516597475893,1.5368775075387335,0.054474708171206226,0.653150374162507,1.0,9/21,18.35%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.40415757209354636,-1.536661635052386,0.004842615012106538,0.2368372495622989,1.0,15/73,8.78%,BMPR2;HTRA3;ACVRL1;ENG;BMPER;NOTCH1;CRIM1;SMURF1;BMP4;SFRP4;SMAD5;SMAD1;UBE2D3;CCN1;XIAP
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.533460025753405,-1.536053708483128,0.03938730853391685,0.2370688167759078,1.0,9/21,10.10%,VCL;RHOA;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;EFNA5;DUSP3
prerank,response to cadmium ion (GO:0046686),-0.4994014565476636,-1.5358071126918598,0.028888888888888888,0.2367042230323917,1.0,14/26,19.05%,EGFR;JUN;MAPK1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT3;MT2A;MAPK3
prerank,protein depolymerization (GO:0051261),-0.49765071580675774,-1.5346230920806148,0.029166666666666667,0.23786261623033408,1.0,10/27,18.44%,MICAL2;GSN;NCKAP5;WDR1;STMN1;CFL1;NCKAP5L;KATNB1;KIF24;STMN4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3630206674319752,-1.5339399298233243,0.002652519893899204,0.23815293289201558,1.0,29/138,12.90%,PTPRG;ROR1;TEK;ABI1;NTRK3;BMPR2;IL6ST;PTN;LIFR;TIE1;INSR;MERTK;EGFR;NGF;MTSS1;KDR;MET;LYN;FLT1;SRC;FLT4;BCAR1;NEDD9;YES1;EPHB2;MPZL1;RET;PTK2B;ROR2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43877341539394515,1.5333889825915492,0.02617801047120419,0.6618397612398561,1.0,10/65,7.57%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;LMNA;PGK1;KCND2;CPEB4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6638859664737926,-1.5329193982745086,0.047619047619047616,0.23907073910831597,1.0,6/10,23.95%,RUNX1;CBFB;NCKAP1L;SH3RF1;HMGB1;SOCS1
prerank,positive regulation of cell development (GO:0010720),-0.4803928514185918,-1.5305860441417107,0.02748414376321353,0.2425003723254968,1.0,12/31,22.64%,PDE3A;BMP4;SERPINF1;NUMB;TGM2;SPEN;GPER1;NKX6-1;LIG4;NUMBL;SNW1;SOX11
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6303619451778203,-1.5304145713159163,0.06037735849056604,0.24192507906752586,1.0,5/11,8.96%,CD200;THBS1;CD34;PTGS2;ATP6AP2
prerank,regulation of cellular component organization (GO:0051128),-0.3622983597425178,-1.5294214758198759,0.0024154589371980675,0.24282848596142392,1.0,31/135,12.45%,HIP1;LTBP4;PLCE1;RAPGEF2;DAB2IP;TJP1;MLLT3;NET1;STON2;HJURP;STK38L;RAP1A;CDH13;SOCS2;IRAK3;TFRC;CAMK2D;WNT5A;AGTR1;ANKRA2;CEACAM1;PTPN1;ZFYVE16;BCAR1;APOE;RPTOR;FAM107A;BAG5;GFAP;DCUN1D5;HIP1R
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.606632902026085,1.5288657560257262,0.052830188679245285,0.6742101060261693,1.0,2/15,4.00%,MOXD1;SAT1
prerank,regulation of biomineral tissue development (GO:0070167),-0.5005801946666859,-1.528736237265217,0.02466367713004484,0.24325998137239208,1.0,11/26,13.74%,SGMS2;NOS3;NOTCH1;GAS6;S1PR1;NBR1;HEY2;FBXO5;TWIST1;ECM1;ENPP1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6063778402466656,1.5281357543168457,0.04093567251461988,0.6698030205330131,1.0,5/16,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,organic hydroxy compound transport (GO:0015850),-0.46414605486421845,-1.5277392229917162,0.02869757174392936,0.2440475579076498,1.0,9/36,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;NPC2;OSBP;STRA6;CEACAM1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6026090316317974,-1.5273707528230758,0.045454545454545456,0.24380113707157922,1.0,5/13,11.49%,CD9;CDH13;ABCA1;ITGB1;SREBF2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5291053003522477,1.5273580192098501,0.048355899419729204,0.6658448465748763,1.0,7/26,4.79%,CACNA1D;ACTN2;ATP1B3;ANK2;STK39;ATP1B2;DLG1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.42047867058149907,-1.527285032724715,0.008602150537634409,0.24312311168306133,1.0,18/56,15.90%,NRP1;TEK;LIMS1;CAV1;CLDN5;PTPRJ;KDR;CLSTN2;MYOC;IL1RAP;MAP4K4;EPHB2;ACE2;VEGFA;SRPX2;S100A10;FERMT2;NPHP1
prerank,glycogen metabolic process (GO:0005977),0.5119713641430782,1.5269875206824355,0.05565529622980251,0.6602803999904951,1.0,8/27,15.02%,PRKAG2;PHKG2;PGM1;PHKB;GYG1;PYGL;PYGM;PER2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4333798193100508,-1.5266083844122824,0.013824884792626729,0.2435294492486273,1.0,17/50,15.24%,YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;CARD16;PAK2;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3;PLAUR
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3549076398853481,-1.5265058261030082,0.002840909090909091,0.24284372884181102,1.0,32/149,8.37%,PRKCH;ROR1;CAV1;SLCO3A1;TRAF5;RPS6KA5;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;MID2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6627150885881435,1.5257989590957077,0.061224489795918366,0.6582620091565325,1.0,5/10,12.39%,KMT2A;CAMK1;PIH1D1;SPHK2;RAPGEF3
prerank,membrane depolarization during action potential (GO:0086010),0.5256295352905146,1.525406127526849,0.051001821493624776,0.652931900999304,1.0,2/26,0.44%,ATP1A2;CACNA1D
prerank,atrioventricular valve development (GO:0003171),-0.5956610010109746,-1.525220773279302,0.023605150214592276,0.24436480504322028,1.0,11/14,25.01%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;BMP2;APLNR;SLIT3;ZFPM1;GJA5
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5885143140317657,-1.5249451721573288,0.03968253968253968,0.2440726354990463,1.0,8/15,23.54%,EGFR;KDR;BMX;TEC;DYRK1A;PTK2B;MAPK3;IGF1R
prerank,glycerolipid catabolic process (GO:0046503),-0.5316080221267182,-1.5239636195206783,0.04132231404958678,0.24491349317604413,1.0,6/19,12.54%,PLA2G4A;ABHD2;GPCPD1;MGLL;PRDX6;ABHD6
prerank,potassium ion transmembrane transport (GO:0071805),0.38796458101041126,1.5227678022199156,0.010954616588419406,0.657124351320229,1.0,24/135,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;ATP1B2;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;SLC12A5;KCNH7;SLC12A1;KCNK4;SLC9A9
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.5165266877414008,-1.5211427407181184,0.03441295546558704,0.24927105421000914,1.0,16/22,44.28%,RUNX1;CBFB;MDK;NFATC2;SOX12;CD46;LAG3;SOCS1;IL2RA;IL4I1;VSIR;FANCA;BCL6;CTLA4;TNFRSF18;FOXP3
prerank,long-chain fatty acid transport (GO:0015909),0.4970006034751991,1.5204084897526897,0.037243947858473,0.659890414219174,1.0,3/30,1.77%,PRKAG2;ACSL1;PRKAA2
prerank,lipid transport (GO:0006869),-0.36754838373663967,-1.5199744826573294,0.002512562814070352,0.2506385764646796,1.0,22/97,8.27%,ABCC4;ATP8B1;PITPNC1;SLCO3A1;SLCO1C1;ATP8A1;SCARB1;PPARD;SLCO2A1;CERT1;SLCO2B1;ABCA1;PLTP;PLEKHA8;TNFAIP8L3;NPC2;SPNS2;OSBP;MTTP;ABCA3;CEACAM1;ABCD2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5981993060037606,-1.5197281023214202,0.04008016032064128,0.2502892395171144,1.0,4/13,7.92%,RHOA;ETS1;MDK;NFAT5
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3971061816549037,-1.5183858143986837,0.011990407673860911,0.25202436247784726,1.0,21/72,12.90%,ROR1;TEK;NTRK3;DCN;GAB1;TGFB2;INSR;PIK3R1;KDR;FN1;LYN;FLT1;MYOC;PIK3CA;SRC;PDGFC;FGF2;PIK3CD;UNC5B;PDGFD;ROR2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4424765655239235,-1.5183545090311648,0.02100840336134454,0.25122804377569535,1.0,12/42,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of water loss via skin (GO:0033561),-0.5853673381491505,-1.518256912502204,0.046218487394957986,0.24972964010819532,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,establishment of skin barrier (GO:0061436),-0.5853673381491505,-1.518256912502204,0.046218487394957986,0.24972964010819532,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,aortic valve development (GO:0003176),-0.46307002711717654,-1.5175882897664543,0.02207505518763797,0.2500926067367837,1.0,14/34,12.38%,ELN;BMPR2;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;HEY2;TWIST1;BMP2
prerank,bile acid and bile salt transport (GO:0015721),-0.5096735151185026,-1.5171421732711077,0.04357298474945534,0.25015211820801414,1.0,5/24,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6212807609096316,-1.5167792333405232,0.04430379746835443,0.2499455332230619,1.0,5/11,8.57%,JAG1;TGFB2;BMP4;HEY2;ZFPM2
prerank,negative regulation of wound healing (GO:0061045),-0.49025731654960986,-1.5166593985721175,0.02608695652173913,0.24935168167365662,1.0,10/28,10.45%,SLC12A2;CD34;CD109;PHLDB2;CASK;AJAP1;FGF2;SERPINE1;APOE;EDN1
prerank,regulation of glycogen metabolic process (GO:0070873),0.6155754022329738,1.5164810966665774,0.07042253521126761,0.6692197833309659,1.0,6/12,20.59%,GCGR;PPP1R3F;RUBCNL;AKT1;KHK;INPP5K
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5620808354635733,1.5162425485984796,0.052434456928838954,0.6635120058500115,1.0,5/20,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6345709261999268,-1.5154775140891288,0.04642166344294004,0.2508518218910375,1.0,5/10,13.83%,PTPN12;PTPRJ;APOD;HGS;LRP1
prerank,cellular response to zinc ion (GO:0071294),-0.5773295353319673,-1.5142701535339442,0.06118143459915612,0.25229101897949363,1.0,11/15,19.01%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MT3;GLRA2;MT2A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6158626685639206,-1.5134483276844943,0.05102040816326531,0.25292993788561907,1.0,5/12,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,cellular response to interleukin-7 (GO:0098761),-0.5472732247226745,-1.5126601557653723,0.035416666666666666,0.2525653839690156,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.5472732247226745,-1.5126601557653723,0.035416666666666666,0.2525653839690156,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,vascular transport (GO:0010232),0.42049963898405335,1.5124182935787474,0.022298456260720412,0.673290121366033,1.0,16/81,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,SNARE complex assembly (GO:0035493),-0.6396683650852673,-1.5114307379603082,0.04950495049504951,0.2540217903385376,1.0,2/10,5.49%,STXBP6;VAMP3
prerank,response to laminar fluid shear stress (GO:0034616),-0.6405034309145505,-1.5113679702156144,0.04814814814814815,0.2533364066378885,1.0,7/10,29.21%,ABCA1;KLF4;SREBF2;KLF2;ASS1;SMAD6;SMAD7
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5723880443332896,-1.5111745515775352,0.06097560975609756,0.25289673569281634,1.0,7/15,26.95%,LEF1;JUN;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5527384337505409,1.5105776516035772,0.058823529411764705,0.667605720362391,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5527384337505409,1.5105776516035772,0.058823529411764705,0.667605720362391,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5754970685440193,-1.5097976749345332,0.03854389721627409,0.2544455597483321,1.0,8/15,16.30%,TMSB4X;KDR;PRKD1;MET;FGF2;HSPB1;VEGFA;SEMA5A
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5015905920201891,-1.5096277287511592,0.04025423728813559,0.2539348988761218,1.0,6/25,7.36%,BMPR2;ACVRL1;ENG;NOTCH1;BMP4;CCN1
prerank,negative regulation of ion transport (GO:0043271),0.5366219577190073,1.5091338336575717,0.05671077504725898,0.6668312416970188,1.0,6/24,10.46%,SYT11;ACTN2;WNK3;ADRA2A;WNK4;VIP
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6085361968540854,1.508685525731293,0.04572564612326044,0.6622499831332378,1.0,5/13,13.27%,IGF1;SOAT1;GOLGA2;PLCB1;ABCA2
prerank,hippo signaling (GO:0035329),-0.49460516053384285,-1.5082198922281045,0.05664488017429194,0.2556144400023757,1.0,11/26,20.14%,TJP1;YWHAE;STK3;TEAD4;YWHAB;TJP2;TEAD1;AMOT;LATS1;AMOTL1;TEAD3
prerank,negative regulation of platelet activation (GO:0010544),-0.5609262656414841,-1.507911881318668,0.0425531914893617,0.2553783433724805,1.0,6/16,9.64%,PRKG1;NOS3;CD9;PRKCD;CEACAM1;APOE
prerank,regulation of acrosome reaction (GO:0060046),0.6447871827645434,1.507793722519129,0.06458333333333334,0.6596875104872665,1.0,3/10,10.18%,SERPINA10;GLRA1;PLCB1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.5058952452372986,-1.5059287629609612,0.03870967741935484,0.25821266412280447,1.0,9/24,8.02%,TMEFF2;RHOA;ACVRL1;ITGA5;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6466036654759536,-1.5058670666747849,0.0562015503875969,0.25745173625234885,1.0,3/10,1.54%,BMP5;SLIT2;CD200
prerank,mesoderm formation (GO:0001707),-0.5626870731555316,-1.50480446698139,0.038539553752535496,0.25865938494942065,1.0,4/17,5.13%,BMPR2;ITGB4;ITGA8;ITGB1
prerank,endothelial tube morphogenesis (GO:0061154),-0.6224337119989303,-1.5037689850141065,0.05394190871369295,0.2597377378472003,1.0,4/10,3.79%,RHOA;ACVRL1;BMP4;STARD13
prerank,transport across blood-brain barrier (GO:0150104),0.41694899544765146,1.5030853433040159,0.023972602739726026,0.6731978988722027,1.0,16/83,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5531798395384799,-1.5029633162507883,0.044145873320537425,0.2603123350580013,1.0,7/16,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,rRNA processing (GO:0006364),-0.34403540519073483,-1.5028579118668721,0.002583979328165375,0.2596470230431476,1.0,86/172,27.88%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;THUMPD1;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RRP15;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;MRPL1;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;NHP2;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;RIOK1;MDN1;WDR55;WDR18;EXOSC3;TEX10;XRN2;ERI1;LYAR
prerank,protein export from nucleus (GO:0006611),0.512176582527878,1.5025863850325538,0.05075187969924812,0.6689510479918406,1.0,1/27,0.01%,RANBP3L
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5646305651717303,-1.5017708167526875,0.05410821643286573,0.2608123671108635,1.0,6/15,9.04%,RSPO3;DAAM2;SFRP4;CSNK1E;ZNRF3;TIAM1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3832019882491865,-1.5011139532387896,0.014457831325301205,0.26118606438049413,1.0,25/85,13.75%,ROR1;NTRK3;BMP5;RAPGEF2;DAB2IP;PTN;ITGA6;NDNF;RAP1A;SCARF1;SCARB2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;RETREG3;APOE;VLDLR;RET;PTK2B;ROR2;FZD1;AVIL
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.4200590049062418,-1.5008447800281997,0.04017857142857143,0.26089525078970804,1.0,28/56,34.79%,ALPK1;UBC;RPS6KA3;NOD1;PLCG2;RPS27A;UBB;MAPKAPK2;CTSB;SFTPA2;SFTPA1;IRAK2;TAB1;CTSS;NOD2;HMGB1;MYD88;BCL10;TLR4;CD36;TLR6;MAPKAPK3;TLR1;CD14;TLR3;S100A9;IRAK4;TLR2
prerank,anion transmembrane transport (GO:0098656),0.4331199115996626,1.5005003628459772,0.02268760907504363,0.6714638592599408,1.0,11/67,6.01%,SLC6A13;SLC13A4;SLC13A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC25A5;SFXN2;SLC25A11
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6157287639439115,-1.4994266295761176,0.06995884773662552,0.2626302555163377,1.0,4/10,15.99%,ABCA1;ZDHHC8;APOE;PRKACA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3892382987614752,-1.499025501800207,0.011574074074074073,0.2625111618988726,1.0,25/86,13.82%,NRP1;GHR;PECAM1;ACVR1;EGFR;ITGA5;CD44;PTPRJ;CSPG4;APP;PLCG2;ARHGEF2;PAK2;TEC;IL6R;PRKCD;EFNA5;SRC;IGF2;IL15;FGF7;CD74;PTK2B;PTPRC;VEGFA
prerank,macrophage activation (GO:0042116),-0.4591045975935865,-1.4974029042995227,0.03938730853391685,0.26462153494053603,1.0,15/34,29.40%,FOXP1;CD93;APP;PLCG2;IFI35;DYSF;CRTC3;SYK;NMI;SBNO2;TLR4;AIF1;TREM2;MAPT;TMEM106A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6140149259482679,-1.4973086776589795,0.05443548387096774,0.2639927579274114,1.0,8/11,32.81%,LRP6;WNT5A;FZD1;NR4A2;RYK;LMX1A;WNT2;CTNNB1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3670965782936023,-1.4966420485280583,0.005089058524173028,0.2644596278311939,1.0,33/121,13.82%,NRP1;GHR;PECAM1;IL6ST;ACVR1;GAS6;ITGA5;STAT3;CD44;PTPRJ;CSPG4;PLCG2;ARHGEF2;PAK2;TEC;HES1;LYN;IL6R;IL34;EFNA5;SRC;PTPN1;IGF2;IL15;NEDD9;FGF7;PIBF1;CD74;ARL2BP;PTK2B;CD40;PTPRC;VEGFA
prerank,regulation of macrophage migration (GO:1905521),-0.6449637910225061,-1.4965294977678374,0.04246284501061571,0.26384306197132407,1.0,3/10,12.51%,MTUS1;CD200;PTK2B
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5662525794718231,1.496065234331323,0.06779661016949153,0.6833549398682647,1.0,4/17,6.99%,PRKAG2;PRKAA2;PPARA;PANK2
prerank,regulation of defense response (GO:0031347),-0.39020222453578113,-1.4954554368159054,0.007211538461538462,0.2651037322230509,1.0,37/76,27.07%,FOXP1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;WNT5A;AGTR1;ANXA1;PSMA6;XIAP;APOE;SPATA2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;CCR2;AREL1;CASP8;LRP8;AKNA;TREM2
prerank,skeletal muscle organ development (GO:0060538),-0.4887911433352037,-1.4944170451804883,0.04175365344467641,0.2662088091055643,1.0,7/26,7.63%,MEF2C;CAV1;DISP1;SVIL;SIX1;MYL6;STRA6
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6491518740123952,1.4935324019781775,0.07172131147540983,0.6881560962014779,1.0,4/10,16.37%,IL18;PRKCZ;SPHK2;RARA
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4890947309068487,1.4922788773965514,0.04945054945054945,0.6872216515759756,1.0,11/32,18.41%,PRKAG2;PRKAA2;FITM2;PPARA;SORBS1;CREBL2;STAR;CREB1;AKT1;MID1IP1;MLXIPL
prerank,sensory perception (GO:0007600),0.45902348237801377,1.4919118902567272,0.03441682600382409,0.6825500733936265,1.0,15/45,20.11%,USH1C;RETREG1;WHRN;PCDH15;PTGES;NTSR2;CHRNB2;ADGRV1;TTC8;KCNK4;OPRM1;PENK;P2RX4;SCN9A;OPRL1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5406966071233866,1.491748865168929,0.049484536082474224,0.6770811781998392,1.0,7/21,10.07%,BMP6;DAB2;OVOL2;BMPR1A;WWTR1;VEPH1;TGFBR1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.5671478556985027,-1.491731157935782,0.05894308943089431,0.2704453451322743,1.0,5/14,7.96%,LIMS1;LIMS2;FLNA;PRKD1;EMP2
prerank,ERBB signaling pathway (GO:0038127),-0.4001451015648966,-1.4915738305091581,0.013953488372093023,0.26993793570588676,1.0,15/64,9.62%,PLCE1;GAB1;PTPN12;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;CPNE3;MAPK1;GAREM1;PIK3CA;SRC;BCAR1
prerank,ganglion development (GO:0061548),-0.6271842911414313,-1.4913283849367815,0.058823529411764705,0.26959939952573114,1.0,2/11,0.78%,NRP1;NRP2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4821102891505775,-1.4906308958340255,0.035269709543568464,0.27008934658238754,1.0,13/25,20.99%,CD200;ITGA5;VCAM1;ITGB1;CXADR;CTNNA3;PARVA;JAM3;ITGA7;ITGA4;DSG2;DSP;JUP
prerank,regulation of stress fiber assembly (GO:0051492),-0.3855004983072522,-1.4873832104517246,0.009779951100244499,0.27543946427095833,1.0,17/74,7.50%,NRP1;TMEFF2;TJP1;RHOA;WASF2;ACTG1;PIK3R1;LIMCH1;STMN1;F11R;PHLDB2;ARAP1;PAK2;ARHGEF15;MET;PXN;MYOC
prerank,nuclear migration (GO:0007097),0.6080882266893022,1.4872440173017392,0.04609218436873747,0.6903104629322727,1.0,5/13,11.14%,SYNE3;SYNE2;CLMN;PCM1;DOCK7
prerank,positive chemotaxis (GO:0050918),-0.5411269820520385,-1.4868085832361297,0.054878048780487805,0.275748399394613,1.0,6/17,16.30%,NRP1;PTPRJ;MET;FGF7;VEGFA;SEMA5A
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5367057499082831,-1.4846886173843306,0.05752212389380531,0.2790266847048898,1.0,5/17,9.34%,BTG1;BMP4;SFRP4;TMEM100;FGF2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.5064967626873457,-1.484216047289422,0.05219206680584551,0.27909895758306413,1.0,12/24,25.81%,SLIT2;CCN3;LYN;CXCL12;SERPINE1;GREM1;HMGB1;DUSP1;PLA2G7;CCR2;ANO6;AIF1
prerank,macrophage activation involved in immune response (GO:0002281),-0.5872456716991921,-1.4831862359430663,0.06273764258555133,0.28023480444081117,1.0,9/13,33.08%,PLCG2;IFI35;DYSF;SYK;NMI;SBNO2;TREM2;GRN;TYROBP
prerank,positive regulation of developmental growth (GO:0048639),-0.42332988425502177,-1.4828600303280615,0.024943310657596373,0.2799821572369978,1.0,9/49,3.36%,GHR;NEDD4L;NTN1;SEMA7A;INSR;NGF;SMURF1;MACF1;ITSN2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3653494931348146,-1.4828115010467697,0.0025188916876574307,0.27918898989384583,1.0,33/98,20.04%,PID1;ECE1;SLCO1C1;PPARD;INSR;THBS1;NFKBIA;SFRP4;TGFBR2;TBC1D5;VAMP3;XDH;AGTR1;ACACB;APOE;KLF4;FASN;GHITM;STARD4;ACE2;AGPAT1;VEGFA;ROMO1;MT3;RAB1B;FMR1;IFNAR1;DHRS4;GREM1;ZC3H12A;CBR1;RIPK1;ARRB2
prerank,carbohydrate homeostasis (GO:0033500),0.42820952058775663,1.482376556320043,0.019469026548672566,0.705596454338465,1.0,18/67,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;USF1;PYGL;HECTD4;IL6;BACE2;RBP4
prerank,ribosome biogenesis (GO:0042254),-0.337645333987508,-1.481587392243502,0.0,0.2806635075185969,1.0,87/187,26.25%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;SURF6;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;ABCE1;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;GTF3A;PWP2;URB2;RCL1;MRPL36;LTV1;MRTO4;NOP58;EBNA1BP2;RPL3;SDAD1;RRS1;RPL15;NOP16;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;CUL4A;RIOK1;MDN1;WDR55;WDR18
prerank,purine ribonucleotide transport (GO:0015868),-0.5491552035759806,-1.4803123644524758,0.05091649694501019,0.2821368095600721,1.0,4/16,6.87%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,cytoskeleton organization (GO:0007010),-0.36158417846769925,-1.4797603348856396,0.013227513227513227,0.2824075851100303,1.0,28/114,12.96%,FMNL2;ARHGAP10;FGD5;SEMA6A;PLCE1;RHOBTB1;MICAL2;MARK1;RHOA;FGD6;DST;LIMD1;ARAP3;PALLD;TNIK;SIPA1L3;MAST4;MDK;CCL13;CNN2;BRWD1;APOE;NEDD9;CFL1;RANBP9;NECTIN2;SIPA1;RND3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5389841911534059,-1.4789066376926403,0.0391304347826087,0.28312687701276523,1.0,6/19,10.11%,CYTH3;PARD3;RHOA;RAP2A;SIPA1L3;GOLPH3
prerank,apical junction assembly (GO:0043297),-0.4215160901881436,-1.4782288485689277,0.028199566160520606,0.28360829585072667,1.0,15/53,7.76%,PECAM1;CLDN5;VCL;ESAM;PARD3;RHOA;RAMP2;WDR1;F11R;CTNNA1;TBCD;PAK2;CLDN14;OCLN;APC
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6384385131631908,1.477032164982154,0.07755102040816327,0.722384921119504,1.0,5/11,17.36%,DAB2;RAB21;MTMR2;EIPR1;PTPN23
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4739947187868716,-1.4749967803756086,0.057203389830508475,0.2890165835406053,1.0,8/27,12.38%,PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;SRC;NSMF;BMP2
prerank,regulation of multicellular organismal development (GO:2000026),-0.48816819118365706,-1.4744126923099048,0.04487179487179487,0.2893674592623222,1.0,9/25,17.73%,PTN;INSR;RAB14;SOX17;NIPBL;SPAAR;CD24;TDG;DUSP6
prerank,regulation of GTPase activity (GO:0043087),-0.338986252625226,-1.4736988588296405,0.002551020408163265,0.2899663194309987,1.0,37/177,11.07%,PRKG1;DOCK9;LIMS1;LRCH1;CHN2;FGD5;DOCK10;RAPGEF2;DAB2IP;ITGA6;FGD6;NET1;BCAR3;RAP1A;SH3BP4;CHN1;RASIP1;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;EFNA5;SOD1;MAP4K4;VAV2;DOCK8;CAV2;RGS10;PLXNC1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4532692285840139,1.473245450614571,0.05226480836236934,0.7325973383401579,1.0,5/48,3.98%,PRKAG2;GCGR;GCK;POM121;NUP155
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6473776325373216,1.472573173356028,0.06212424849699399,0.7293835122456055,1.0,3/10,4.13%,ATP1A2;OSR1;STK39
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6171647370410049,-1.4722957092106987,0.07370517928286853,0.29184852482146495,1.0,7/11,18.85%,MAP3K5;CYP1B1;PRKCD;STK24;GSKIP;DIABLO;PRODH
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.62195902175223,-1.4707214763188936,0.06809338521400778,0.2940635035768014,1.0,5/10,17.31%,IRAK3;KLF4;TLE5;PTPRC;SIGIRR
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.38164633343449733,-1.4701425527448,0.022613065326633167,0.2943703282734051,1.0,26/76,25.56%,NRP1;TEK;NTRK3;WDR1;CDC42EP5;CDC42EP3;NCK1;SYNPO2;CDK5;EDN1;CDC42EP2;PTK2B;PFN1;LIMK1;NCKAP1L;SEMA5A;DYNC1H1;FCHSD1;HCK;CDC42;GPSM2;HCLS1;NUP62;FES;PRKCE;CARMIL1
prerank,neutrophil migration (GO:1990266),-0.408248026076562,-1.4688561491910923,0.03278688524590164,0.2961183318399784,1.0,29/58,40.70%,PECAM1;BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;PRTN3;S100A9;IRAK4;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,regulation of axon guidance (GO:1902667),-0.625688511589543,-1.4677837022042357,0.07128712871287128,0.29740331957921495,1.0,1/10,0.06%,NRP1
prerank,ceramide metabolic process (GO:0006672),-0.41145821260104937,-1.4666143707583341,0.040268456375838924,0.2988725217522802,1.0,11/49,9.26%,SGMS1;ST6GALNAC3;SGMS2;ACER2;DEGS2;AGK;CERS5;CERS6;ORMDL3;PLPP1;SAMD8
prerank,thyroid hormone generation (GO:0006590),0.6449694536897429,1.4664558522932356,0.07216494845360824,0.7501673969605689,1.0,2/10,2.36%,SLC5A5;CPQ
prerank,striated muscle tissue development (GO:0014706),-0.4786662006420631,-1.4655137978159731,0.04,0.3002793217996683,1.0,9/29,5.91%,MEF2C;PGM5;CAV1;BMP5;BMPR2;SVIL;SIX1;SGCD;MYL6
prerank,meiosis I (GO:0007127),0.5252816406979299,1.4653869914686422,0.06547619047619048,0.748367369677825,1.0,4/23,6.97%,MEI1;DNMT3L;TDRD9;MEIOB
prerank,protein localization to vacuole (GO:0072665),-0.5763891402864659,-1.4653041502654225,0.0779467680608365,0.29976285995924834,1.0,6/13,17.84%,SH3BP4;LMBRD1;KPTN;MFSD1;RTN4;RNF128
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.44883237463122005,-1.4641087666803718,0.03803131991051454,0.30133477695130506,1.0,10/33,11.66%,ETS1;TGFB2;FOXO3;STAT3;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,striated muscle contraction (GO:0006941),0.4363354434277057,1.4638494719185426,0.043029259896729774,0.7488053143033814,1.0,8/53,11.04%,ATP1A2;DTNA;CSRP3;TNNI1;ARHGEF11;KCNH2;MYH14;RYR2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5344484959022531,-1.4626257386970951,0.05148514851485148,0.3035874603774323,1.0,8/18,12.40%,MEF2C;PLCG1;AKT3;FLT1;MDK;IGF2;FGF2;ITGA4
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.42014959387475925,-1.4619278106781646,0.023980815347721823,0.3040958043963733,1.0,20/49,24.31%,MEF2C;THBS1;KMT2E;RUNX1;H3-3A;AGO1;CBFB;DPY30;MYL9;PITHD1;KMT2C;MTURN;PRMT6;AGO4;L3MBTL1;ZFPM1;TESC;KMT2B;PRMT1;ASH2L
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5079619736692131,1.461553820476836,0.06764168190127971,0.7521636158330308,1.0,10/26,12.52%,SLC8A3;PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;LRRK2;DLG4;MTMR2
prerank,skeletal system morphogenesis (GO:0048705),0.4592765334959338,1.4615143668594386,0.036036036036036036,0.7460619978850009,1.0,11/42,10.07%,WWOX;PDGFRA;RFLNA;CYP26B1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,endochondral bone morphogenesis (GO:0060350),-0.5992919566738109,-1.4607751609218544,0.07184466019417475,0.30554643972339024,1.0,6/11,17.34%,MEF2C;BMPR2;BMP4;TMEM119;TRPV4;FGFR3
prerank,lymphocyte chemotaxis (GO:0048247),-0.45092129839484146,-1.4607019597761286,0.045174537987679675,0.3048169710903129,1.0,19/34,42.05%,CYP7B1;SLC12A2;GAS6;CCL13;PIK3CD;CCL25;HSD3B7;PIK3CG;CXCL16;CCL5;GPR183;CCL11;CCL4;CH25H;CCL7;CCL8;CCL19;CCL14;MSMP
prerank,purine nucleotide catabolic process (GO:0006195),-0.5810047979108948,-1.460374011718005,0.06198347107438017,0.3046145036373716,1.0,7/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;HINT1;GDA
prerank,plasma membrane invagination (GO:0099024),-0.46701894085670304,-1.4596391681740999,0.04487179487179487,0.3050896816753347,1.0,17/29,30.48%,DOCK1;RHOA;GSN;MYH9;SNX18;GULP1;CDC42;FCGR1A;ALKBH4;FCGR2B;ARHGAP12;AIF1;BIN2;MSR1;CD36;SPIRE2;ARHGAP25
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5730327569998837,1.4585745416957283,0.08333333333333333,0.7524000091078994,1.0,5/15,14.83%,DAB2;PIK3CB;TNK2;WASL;DGKD
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3699492050916744,-1.457866126549673,0.0075,0.3077372598477594,1.0,26/93,17.70%,PDE4D;NTRK3;CAV1;BCAR3;GAS6;RASSF2;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;RACK1;NCK1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;PAQR3;MAD2L2;DDIT4;TNKS1BP1;PTEN;LATS1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.44433252745552126,-1.4578134818955373,0.034934497816593885,0.30701330373033797,1.0,10/33,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;CAST;ICAM1;MDK;GATA2;SERPINE1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5990056564948869,-1.4574912005948435,0.05154639175257732,0.3067895446957833,1.0,4/12,13.15%,WAPL;CTCF;AXIN2;RAD21
prerank,ERBB2 signaling pathway (GO:0038128),-0.4607396510821822,-1.4572153271376844,0.042826552462526764,0.3064938337838113,1.0,8/31,8.77%,GAB1;PTPN12;PIK3R1;EGFR;CPNE3;MYOC;PIK3CA;SRC
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.37971528979223396,-1.4568817518828843,0.018518518518518517,0.3062935756960306,1.0,24/78,14.30%,SPTBN1;PRKCH;ACTB;PID1;PIK3R1;EGFR;BCL2L1;NKD2;ITGB1;STX3;NUMB;TMEM59;ZDHHC8;AR;CDK5;ABI3;STAC;EPHB2;SQSTM1;STX7;ZDHHC7;LRP1;TMBIM1;STX8
prerank,response to zinc ion (GO:0010043),-0.4839274006723938,-1.456632706326196,0.060215053763440864,0.30596271219381116,1.0,13/25,14.92%,CRIP1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC30A5;D2HGDH;MT3;GLRA2
prerank,cellular response to hydroxyurea (GO:0072711),-0.6102350224276583,-1.4564234650130428,0.07722007722007722,0.30558180668372326,1.0,6/10,21.67%,DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5408340418869741,-1.4563174303430642,0.05708245243128964,0.3049823667454115,1.0,3/17,0.51%,NRP1;TEK;NTRK3
prerank,UV protection (GO:0009650),-0.6178237069990886,-1.4561188398155633,0.060240963855421686,0.30450649198042856,1.0,6/10,20.32%,MFAP4;CAT;GPX1;ERCC2;SCARA3;XPA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.4150058295616713,-1.4559276893235906,0.048034934497816595,0.30400919131196896,1.0,19/47,19.05%,DAB2IP;TGFB2;FOXO1;EGFR;MID1;FAS;RAP2A;PPIA;MAPK1;NBR1;MAP4K4;PER1;PHLPP1;TAOK3;KLHDC10;NOD2;TAOK1;GREM1;MAPK3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.41625442687792386,-1.4554438421067315,0.03416856492027335,0.30415393824959885,1.0,12/45,9.62%,PLCE1;GAB1;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;GAREM1;PIK3CA;SRC;BCAR1
prerank,cation transport (GO:0006812),0.36326816603514145,1.4546490734380821,0.0128,0.7639465855570531,1.0,14/167,3.16%,TRPM3;ATP1A2;SLC8A3;SLC5A5;SLC41A1;TRPM6;KCND3;KCNA3;KCNJ13;NDFIP1;SLC6A9;SLC5A10;SLC23A1;KCNJ5
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5835634834468355,-1.4540306479201484,0.06708595387840671,0.3061460632484157,1.0,3/12,6.90%,PRKG1;MEF2C;ADAMTS1
prerank,axon guidance (GO:0007411),-0.32835623540443254,-1.4535906132306822,0.0057306590257879654,0.306233294074239,1.0,47/201,12.66%,PTPRM;NRP1;SPTBN1;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;NTN1;SEMA7A;NOTCH3;TMEFF1;RPS6KA5;NOTCH1;PIK3R1;CHN1;PLCG1;PALLD;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;SRC;SEMA5B;EPHB2;PIK3CD;SEMA3E;DSCAML1;PLXNC1;UNC5B;VLDLR;RANBP9;RET;SEMA3G;SMO
prerank,negative regulation of blood pressure (GO:0045776),-0.5752225519071044,-1.4534284247012519,0.060784313725490195,0.3058316611486815,1.0,3/13,6.88%,BMPR2;NOS3;PRCP
prerank,arachidonic acid metabolic process (GO:0019369),0.47292998125252184,1.4532113068841017,0.07352941176470588,0.7640175573822076,1.0,6/35,7.75%,PTGDS;PTGS1;DAGLA;PLA2G4C;PNPLA8;PTGES
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5457017658268917,1.452129607772465,0.07171314741035857,0.7629718026421706,1.0,4/20,6.84%,ATP1A2;ATP1B3;ATP1B2;LACC1
prerank,prostaglandin metabolic process (GO:0006693),0.4958599728517821,1.4520842044241415,0.07142857142857142,0.7570387622695379,1.0,5/26,7.80%,PTGDS;PTGS1;PNPLA8;PTGES;PTGR1
prerank,regulation of microglial cell activation (GO:1903978),0.5887468227472947,1.4515825586023219,0.07518796992481203,0.7533224038286231,1.0,3/15,3.76%,SYT11;SPHK1;TAFA3
prerank,T cell mediated immunity (GO:0002456),-0.5602015303376602,-1.451196343591094,0.07113821138211382,0.30952173772594915,1.0,6/13,20.91%,JAG1;EMP2;CD55;CD46;GNL1;CADM1
prerank,negative regulation of ATPase activity (GO:0032780),0.5576176645182817,1.4510449447504543,0.08022388059701492,0.7499169127301443,1.0,9/16,22.87%,PPIF;IFIT1;PAM16;TSC1;SIRT1;OXA1L;ATP5IF1;VCPKMT;TNNI3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.48390817394470403,-1.4502768790843863,0.04956896551724138,0.3106214976466306,1.0,11/24,21.47%,PKD1;UBB;APOE;GPX1;TMF1;PTK2B;PRKACA;LATS1;PSMD14;UCHL5;PSME1
prerank,prostaglandin biosynthetic process (GO:0001516),0.535544226895803,1.4497217407142522,0.08,0.7499983329362969,1.0,4/18,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5040621812004734,-1.4487564971061295,0.058577405857740586,0.3125868698520954,1.0,8/20,15.85%,NOTCH1;RUNX2;SMAD5;SMAD1;BMP2;VEGFA;MT3;ATF4
prerank,positive regulation of phosphorylation (GO:0042327),-0.3185583031178469,-1.448341084193476,0.0,0.31267939796120847,1.0,63/240,16.03%,NRP1;ROR1;TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;ITGA6;NIBAN1;TIE1;ENG;INSR;MERTK;VEGFC;THBS1;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;CARD14;TBX1;RALB;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;MET;NPTN;PPIA;LYN;IL34;AR;FLT1;CCN1;RB1CC1;PTGES3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;EPHB2;CD74;KRAS;RET;BMP2;ROR2;CD40;AKT2;VEGFA;RARRES2;MT3;ALK;PLAUR;FMR1;CSF1R;NCKAP1L
prerank,regulation of transport (GO:0051049),-0.43630906244702583,-1.447217519532867,0.053304904051172705,0.3141570556618928,1.0,15/36,24.52%,NRP1;ACTB;ACTG1;ICA1;DNAJA1;CDK5;GAPVD1;REEP5;EPB41;RAB11A;CLDN10;DISP3;POFUT2;MUL1;FES
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3674967468322884,-1.4469565947482208,0.014251781472684086,0.31379765992680053,1.0,22/87,6.74%,GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,prostanoid biosynthetic process (GO:0046457),0.5666673598578524,1.4467900482263842,0.06841046277665996,0.7571783625997249,1.0,4/15,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,positive regulation of telomerase activity (GO:0051973),-0.4505888449995804,-1.4461383301902078,0.04793028322440087,0.314672004368813,1.0,14/33,22.80%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,selective autophagy (GO:0061912),-0.40539232243764606,-1.446091791850347,0.033816425120772944,0.31392795050980415,1.0,29/56,30.21%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;MAP1LC3B;RB1CC1;UFC1;NBR1;DYNC1I1;SQSTM1;PHB2;HDAC6;DYNLL1;AUP1;KLHL3;CFTR;ATG5;ACBD5;DYNC1H1;ULK2;ULK1;UBQLN1;TEX264;WDFY3;ATG14;STBD1;PARK7;USP30
prerank,negative regulation of heart contraction (GO:0045822),0.618710179977651,1.4458756089212061,0.0925553319919517,0.7554916827785647,1.0,1/11,0.03%,ATP1A2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6248427676365068,1.4457501105285442,0.06827309236947791,0.7503811075861125,1.0,4/10,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,potassium ion import across plasma membrane (GO:1990573),0.4515844527270183,1.4455020963118173,0.05291005291005291,0.7459787929267271,1.0,10/41,11.41%,ATP1A2;ATP1B3;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.40541016913636474,1.4450925969097792,0.04006968641114982,0.7421768898888293,1.0,14/75,11.47%,ATP1A2;SLC6A1;SLC8A3;ATP1B3;TRPV1;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1;TRPM2
prerank,negative regulation of cell motility (GO:2000146),-0.35832431711919444,-1.444951711597981,0.013054830287206266,0.31567836729007764,1.0,21/108,5.90%,TMEFF2;FRMD5;CLDN5;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;RAP2A;RECK
prerank,positive regulation of developmental process (GO:0051094),-0.3344588022257851,-1.4447986914280129,0.008522727272727272,0.31517010394987005,1.0,41/164,16.70%,SLC6A6;SHANK3;BMP5;DCN;BMPR2;DAB2IP;ZBTB16;PTN;ACVR1;INSR;PHLDB1;CORO1C;BMP4;KDR;RPS6KA3;MFF;PHLDB2;TFRC;WNT5A;AR;MDK;SHLD1;TMEM119;SRC;VHL;AGO2;APOE;B4GALT5;CFL1;FBXO5;EDN3;VLDLR;FZD4;BMP2;VEGFA;ALK;MAD2L2;FMR1;PA2G4;RTN4;RREB1
prerank,smooth muscle tissue development (GO:0048745),-0.6123058289432584,-1.4442238346223675,0.08713692946058091,0.3154354509249824,1.0,5/10,12.66%,ENG;BMP4;STRA6;PTCH1;SMO
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.38044857866135007,-1.4440869946629027,0.03211009174311927,0.31483186415280895,1.0,24/71,18.30%,FAP;UBC;CAPN2;RPS27A;UBB;ZYG11B;PSMA6;CHMP4B;OTUD7B;DDI2;CTSO;MALT1;CTSB;ISG15;FBXO44;HDAC6;RNF123;HM13;RHBDD1;CTSF;ADAMTS12;CTSS;RSPRY1;ATE1
prerank,regulation of inclusion body assembly (GO:0090083),0.6177314021342832,1.4440375545280566,0.08159392789373814,0.7409766028951754,1.0,3/11,2.94%,HSPA1A;SNCAIP;DNAJB8
prerank,microtubule depolymerization (GO:0007019),-0.5194548424472016,-1.4416961378627458,0.05511811023622047,0.3187251459214314,1.0,8/17,26.55%,NCKAP5;STMN1;NCKAP5L;KATNB1;KIF24;STMN4;KIF14;CCSAP
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.37915034312577617,-1.4414003786264922,0.03414634146341464,0.3185019655337071,1.0,23/74,15.55%,LEF1;GCNT2;BMP5;DAB2IP;TGFB2;PHLDB1;SDHAF2;TGFBR2;IL17RD;PHLDB2;SPRED2;AXIN2;MDK;SPRY2;VASN;TIAM1;TGFB3;TWIST1;COL1A1;BMP2;SPRY1;FERMT2;MAD2L2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2943374359783977,-1.4406790104706173,0.00390625,0.31908862697921125,1.0,111/509,13.82%,HIP1;ROR1;KITLG;VWF;TEK;LIMS1;ACTN4;NTRK3;CAV1;GCNT2;DCN;RAPGEF2;DAB2IP;GAB1;RHOA;ADRA1B;TRAF5;BCAR3;TNFSF10;TGFB2;ENG;INSR;THBS1;GAS6;RPS15;PIK3R1;CDH13;F3;IQGAP1;EGFR;BCL2L1;JCAD;PTPRJ;RPS20;ALPK1;KDR;APP;MIER1;FN1;NOS1AP;MFHAS1;REL;NOD1;ESR1;MID2;TBX1;PLCG2;FLNA;DHX33;BRD4;CARD16;ITGB1;TFRC;TNFAIP8L3;PRKD1;WNT5A;S100A13;RACK1;MET;SLC44A2;NR3C2;LYN;TRIM14;PLK2;IAPP;TRIM25;FLT1;PUM2;MYOC;TGM2;SPRY2;RPS3;BCAP31;NFAT5;IFI35;SCHIP1;PIK3CA;SRC;PDGFC;FLT4;IGF2;FGF2;RPTOR;FGF7;GOLPH3;CAV2;MALT1;PIK3CD;TERF2IP;RPL23;PTP4A3;EDA2R;UNC5B;PDCD4;CD74;PHB2;RET;BMP2;BIRC3;TNFRSF19;PDGFD;ECM1;RRAGA;ROR2;TCIM;CD40;AKT2;PTPRC;IRS1;CD86;VEGFA
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5480577200440566,-1.440462583289919,0.0649895178197065,0.3187680840067006,1.0,5/15,9.83%,PTPN12;CDH13;EGFR;CEACAM1;MVB12B
prerank,response to molecule of bacterial origin (GO:0002237),-0.3823525349421178,-1.4400362460330982,0.027906976744186046,0.31880928515374757,1.0,30/69,33.31%,FOXP1;NOS3;IRAK3;RPS6KA3;TNFRSF11A;GCH1;C4B;SRR;MAPKAPK2;LIAS;CD24;IFNAR1;ERBIN;IRF5;GGT7;FCGR2B;GGT1;SMAD6;TLR4;F2R;PELI1;SELP;TRIB1;LGALS9;NOCT;MAPKAPK3;NOS2;NOS1;CD14;S100A9
prerank,cellular response to misfolded protein (GO:0071218),0.5219374612618249,1.4399643590312419,0.07590132827324478,0.7528857105487207,1.0,7/20,14.15%,DERL1;DNAJC18;DNAJB14;RNF126;UBE2W;BAG6;RNF5
prerank,positive regulation of T cell activation (GO:0050870),-0.3887817275630018,-1.439924225688455,0.03837471783295711,0.3181901506905203,1.0,17/62,20.27%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;MDK;ZBTB1;IL15;DOCK8;PTPRC;CD86;NCKAP1L;CD46;NOD2;JAK3;ZMIZ1
prerank,muscle organ development (GO:0007517),-0.4033552504286752,-1.4390964308416796,0.03508771929824561,0.31906535287056287,1.0,10/54,4.50%,UTRN;MEF2C;LAMA2;COL6A3;TCF12;SMTN;TEAD4;FHL1;TBX1;SGCD
prerank,hepaticobiliary system development (GO:0061008),0.5178327518252784,1.4388677257393654,0.08237547892720307,0.7521421523543622,1.0,4/20,8.14%,TGFBR3;WNT4;CEBPA;PHF2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.48117241919790055,1.4381180781491347,0.0687732342007435,0.7498964131366929,1.0,9/31,11.28%,SYT11;SYT12;SYT9;RAB3GAP1;ADRA2A;SYT1;SYT13;SYT10;SCAMP5
prerank,intracellular cholesterol transport (GO:0032367),-0.5467806543001559,-1.4375044394961538,0.09218436873747494,0.32145570832500475,1.0,6/15,16.64%,LRP6;ABCA1;NPC2;OSBP;STARD4;LDLRAP1
prerank,negative regulation of viral life cycle (GO:1903901),-0.5356723203139301,-1.4371252884108248,0.08008213552361396,0.32143509548390586,1.0,5/15,6.36%,GSN;LY6E;MID2;IFITM3;PPIA
prerank,regulation of ATP metabolic process (GO:1903578),0.43332643699231427,1.436777707065442,0.045454545454545456,0.750393368718066,1.0,17/54,21.55%,PRKAG2;GCK;POM121;NUP155;COX7A1;COX7A2L;ABCD1;NUP98;BEND3;SPHK2;NUP37;ATP7A;NUP88;NDC1;EIF6;ATP5IF1;JMJD8
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5431692707840926,-1.436660333537735,0.07920792079207921,0.321469041536982,1.0,5/15,13.61%,PRKCH;BMP4;SFRP4;TRIM16;NME2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5565046920575527,1.4363244446392047,0.10940499040307101,0.7470090335603913,1.0,4/15,7.09%,CHST4;RENBP;LARGE1;GNPDA1
prerank,regulation of ruffle assembly (GO:1900027),-0.4803311024319841,-1.435446625874627,0.06666666666666667,0.3233815673091177,1.0,6/23,13.07%,CAV1;KANK1;EPS8;ABI3;EPS8L2;PFN1
prerank,regulation of cell killing (GO:0031341),-0.5410283069491965,-1.4345768491850972,0.0651685393258427,0.3244143969245156,1.0,6/16,8.48%,TGFB2;CR1L;ICAM1;WNT5A;CD55;CFH
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.48981849365782215,-1.434471075988741,0.06694560669456066,0.3238016139857251,1.0,5/22,6.07%,GHR;NOTCH1;CYP1B1;MGAT5;HES1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6049233619716753,-1.4337853373574427,0.07184466019417475,0.32437474907359126,1.0,6/10,34.79%,KDR;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,muscle tissue development (GO:0060537),-0.5706801710329931,-1.4337057506313702,0.07258064516129033,0.3237398150217151,1.0,7/13,12.66%,PGM5;ENG;BMP4;STRA6;CSRP2;PTCH1;SMO
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6061605452788987,-1.4335486100289374,0.07128712871287128,0.32324056721611216,1.0,7/10,32.81%,LRP6;WNT5A;FZD1;RYK;WNT2;WNT3;CTNNB1
prerank,regulation of hydrolase activity (GO:0051336),-0.3796493420203834,-1.4332717768109977,0.03009259259259259,0.3230522602766134,1.0,20/71,17.63%,PRKG1;CAV1;CHN2;FGD5;DAB2IP;FGD6;CHN1;RASIP1;SCARB2;RAPGEF6;EFNA5;SOD1;VAV2;PLXNC1;ARHGAP27;RAP1GAP;PAFAH1B1;RAB3GAP2;PLXNA4;TDG
prerank,sympathetic nervous system development (GO:0048485),-0.5567256875451686,-1.4320000201239957,0.07854406130268199,0.3249434283313055,1.0,2/15,0.78%,NRP1;NRP2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5703264218599693,-1.431863500646377,0.08235294117647059,0.3243822659699437,1.0,8/13,23.64%,PLCG1;AKT3;MDK;IGF2;FGF2;ITGA4;HMGB1;SIRT6
prerank,pulmonary valve development (GO:0003177),-0.5112323505243782,-1.4317194468194738,0.06962025316455696,0.32389572744772155,1.0,12/18,8.50%,BMPR2;JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;STRA6;HEY2
prerank,fatty acid transmembrane transport (GO:1902001),0.520205513302605,1.4310559175703021,0.08348794063079777,0.763873420145238,1.0,2/19,1.77%,PRKAG2;PRKAA2
prerank,protein trimerization (GO:0070206),-0.5422864654608175,-1.4309434747480378,0.08383233532934131,0.32397754189979017,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,protein homotrimerization (GO:0070207),-0.5422864654608175,-1.4309434747480378,0.08383233532934131,0.32397754189979017,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,hexose biosynthetic process (GO:0019319),0.45099476958514184,1.429698975540398,0.05807622504537205,0.7645598552646116,1.0,19/42,21.46%,CHST15;SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4531726512162084,1.4294254619346995,0.06239168110918544,0.7603393043813992,1.0,5/41,6.84%,PRKAG2;GCK;POM121;NUP155;LACC1
prerank,thymus development (GO:0048538),-0.5615515306115004,-1.429322339904883,0.08459869848156182,0.3265473480694083,1.0,5/13,8.86%,SIX1;TBX1;HES1;ZBTB1;SOD1
prerank,response to interleukin-6 (GO:0070741),-0.6014889325743402,-1.4290334004520333,0.08080808080808081,0.3263139708283242,1.0,3/10,2.73%,PID1;ST3GAL6;PTGIS
prerank,ethanol metabolic process (GO:0006067),0.6121382206408135,1.4283992683336713,0.08793456032719836,0.7594035721081419,1.0,5/12,10.60%,ADH7;ADH4;ALDH1A1;ACSS2;ALDH2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6063342407424299,1.428056624053371,0.09019607843137255,0.7557071776626484,1.0,2/12,3.69%,IL18;IL17D
prerank,dicarboxylic acid transport (GO:0006835),0.4811694731490577,1.4274698836703885,0.07142857142857142,0.7530323789242996,1.0,6/28,9.70%,SLC22A6;SLC13A3;SLC26A1;PDPN;SLC19A1;SLC25A12
prerank,extracellular matrix disassembly (GO:0022617),-0.39043325396309364,-1.427316076605078,0.029850746268656716,0.32901064401236496,1.0,23/53,31.98%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2;HPN
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.319664877577644,-1.4271533109890457,0.0058997050147492625,0.3285230359011874,1.0,61/214,18.34%,NRP1;ROR1;TEK;NTRK3;GCNT2;SEMA6A;RAPGEF2;PDE8A;DAB2IP;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;FN1;MFHAS1;SPRED2;ICAM1;TNFAIP8L3;LYN;CCN1;GAREM1;SPRY2;CEACAM1;CCL13;PDGFC;PTPN1;FLT4;FGF2;APOE;DUSP3;YWHAZ;EPHB2;ACKR3;CD74;PHB2;RANBP9;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;SPRY1;P2RY6;MTURN;MT3;FERMT2;CSF1R;FGFR3;PTEN;GPER1;DUSP6;NOD2;PTPN6;CCL25
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4845089113668275,-1.426760378148646,0.072,0.3285384225757658,1.0,6/21,13.63%,FOXP1;PRKCH;SLC39A10;RPS3;NECTIN2;PTPRC
prerank,positive regulation of DNA replication (GO:0045740),-0.524364781263389,-1.4262895180021098,0.079002079002079,0.32876514762849585,1.0,7/16,24.66%,BCAR3;KAT7;EGFR;BRPF3;FAF1;EGF;CTC1
prerank,ribosomal large subunit assembly (GO:0000027),-0.466700504711785,-1.4253344368733112,0.08126410835214447,0.3298099406027549,1.0,12/24,28.85%,RPL5;RPL10;MRPL20;RPLP0;RPL6;RPL24;RPL3;RRS1;RPL23A;PPAN;MDN1;RSL24D1
prerank,blood vessel diameter maintenance (GO:0097746),-0.43878307651075654,-1.4251348010567815,0.046875,0.32941047785484584,1.0,11/34,13.94%,EDNRA;ECE1;NOS3;AGTR1;KCNMB2;GCLC;EDN1;EDN3;ACE2;GCLM;KLF2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4261946689209867,-1.4235288193478897,0.05555555555555555,0.33192708029176965,1.0,11/39,11.21%,RAPGEF2;DAB2IP;TJP1;HJURP;TIE1;NOTCH1;RAP1A;ANKRA2;APOE;BAG5;GFAP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5974436565153852,1.4233914654545083,0.10441767068273092,0.7658813035923526,1.0,1/11,0.51%,TAS1R2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5450820189394813,1.4224729230059387,0.10450819672131148,0.764730395199404,1.0,2/16,1.88%,RANBP3L;IGFBP3
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5761777577559095,-1.422324485572584,0.07884615384615384,0.33352125190879606,1.0,5/12,16.62%,NIPBL;PRKD1;SAP30BP;VEGFA;APLNR
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.49053769451932716,-1.4222236413508194,0.08733624454148471,0.3329341483526986,1.0,3/20,1.51%,PDE4D;RAPGEF2;ADRA1B
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.374019084236146,-1.4215834573171424,0.03110047846889952,0.3335216709770522,1.0,19/73,17.70%,NTRK3;CAV1;BCAR3;GAS6;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;MAD2L2;TNKS1BP1;LATS1
prerank,positive regulation of immune system process (GO:0002684),-0.5280848890965678,-1.4207029724112687,0.07644628099173553,0.33446495044137997,1.0,7/16,16.03%,TGFB2;ANXA1;IL15;PIK3CD;RSAD2;VEGFA;NCKAP1L
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5808552149732317,-1.4201612505893773,0.09727626459143969,0.33471240976682515,1.0,6/11,28.79%,SLIT2;CCN3;GREM1;DUSP1;DDT;MIF
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3460100459921373,-1.420035250288628,0.01201923076923077,0.33422400242034855,1.0,21/104,5.76%,CAV1;BMPR2;HTRA3;ACVR1;BMPER;NOTCH1;CRIM1;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;CCN3;ASPN;SPRED2;SMAD5;SMAD1;RPS27A;UBB;UBE2D3
prerank,stabilization of membrane potential (GO:0030322),0.5329123162655175,1.419719156795978,0.10116731517509728,0.7714233901256043,1.0,4/16,16.88%,KCNK2;KCNN4;KCNK4;KCNK10
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4201797953782532,-1.419216942566132,0.04460093896713615,0.3350991175096154,1.0,15/37,17.68%,PRKG1;MEF2C;JUN;ERN1;ADAMTS1;TAFA5;FGF2;TGFB3;PDCD4;P2RY6;HTR1B;LDLRAP1;MMP2;PTEN;GPER1
prerank,neurotransmitter transport (GO:0006836),0.3991830969252724,1.419129461929994,0.050590219224283306,0.7689411391006518,1.0,17/73,15.95%,ATP1A2;SLC29A2;SLC38A1;SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SLC6A4;GLS2;GAD1;SYN3;SLC22A2;CPLX1;NAAA;SYN1;GLUL
prerank,metanephric mesenchyme development (GO:0072075),0.620627737381887,1.418512721519233,0.11287128712871287,0.7667315700884308,1.0,2/10,1.12%,WNT4;OSR1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.463627343548229,1.4179966216005924,0.07020872865275142,0.7639732475142944,1.0,3/31,1.84%,RANBP3L;TMEM64;SUFU
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4583074570813583,1.4178637728946202,0.072992700729927,0.7595842216752646,1.0,6/37,6.60%,PRKAG2;BMP7;SPHK1;WNK3;PLK1;PPEF2
prerank,histone H2A acetylation (GO:0043968),0.5460659464542093,1.417757902230832,0.10344827586206896,0.7550971084489481,1.0,7/16,13.06%,BRD8;RUVBL2;MEAF6;DMAP1;EP400;SPHK2;YEATS4
prerank,lipid catabolic process (GO:0016042),0.530744112265331,1.4177062884460632,0.08317214700193423,0.7504392479991773,1.0,6/18,23.27%,CEL;PLA1A;PLAAT3;HSD11B1;LIPC;LIPH
prerank,ATP transport (GO:0015867),0.6153622091691688,1.4168551200799575,0.10505836575875487,0.7490068045928587,1.0,2/10,4.92%,SLC25A42;SLC25A5
prerank,T cell migration (GO:0072678),-0.5647176607158473,-1.4164617875869123,0.08464566929133858,0.3401665323415808,1.0,9/13,35.90%,SLC12A2;S1PR1;PIK3CD;MSN;PIK3CG;CXCL16;MYO1G;GPR183;ZAP70
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4825535826542696,1.416070467484945,0.0872865275142315,0.7474944641873182,1.0,3/28,2.62%,PRKAG2;PRKAA2;FITM2
prerank,regulated exocytosis (GO:0045055),-0.32694537127632284,-1.415937245729806,0.008174386920980926,0.3404459264110392,1.0,45/173,14.34%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;MYH9;TAGLN2;APP;WDR1;FN1;STX1A;RAB31;CD109;TMED10;ACTN1;RAB11FIP5;FLNA;LYN;RAB11FIP1;ALDOA;CHID1;CDK5;SYT4;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;STEAP2;RAB3A;ECM1;VEGFA;TMX3;RARRES2;RAB11B
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5279303137811809,-1.4150173452348016,0.07613168724279835,0.3416746263701788,1.0,4/16,11.60%,BMPR2;PRCP;DDAH1;ADM
prerank,regulation of cell population proliferation (GO:0042127),-0.28130700640867345,-1.4147201040822763,0.0,0.3415431603234785,1.0,144/691,14.08%,LEF1;ELN;KITLG;LIMS1;ABI1;NTRK3;GCNT2;BMP5;ZBTB7C;RAPGEF2;BMPR2;IL6ST;CLDN5;DAB2IP;OSMR;PTN;JAG1;TJP1;LIFR;NOS3;RHOA;CD200;ACER2;ETS1;ACVRL1;TGFB2;ENG;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;CDH13;SH3BP4;TBC1D8;EGFR;CYP1B1;CTCF;NGF;RUNX1;BTG1;STAT3;BMP4;PTPRJ;SFRP4;SIX1;TGFBR2;KDR;APP;ITGA1;ADARB1;FN1;PTPRK;JUN;CACUL1;TBX1;CBFA2T3;GNL3;NUAK1;TNFRSF11A;IGFBP6;STX3;TFRC;CNOT6L;ARHGEF2;JAG2;AQP11;DNAJA2;AGTR1;S100A13;AXIN2;HES1;ADAM10;XRCC5;LYN;IL6R;IL34;AR;ADAMTS1;FLT1;KLF11;NACC2;GAREM1;APC;PPP2R5C;RPS6KA2;EMP2;IFI35;CDC123;TIPIN;RBBP4;PLPP1;XIAP;PDGFC;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;FGF7;KLF4;S100A11;S1PR3;EDN1;BTG3;HGS;ESM1;SERTAD1;RPL23;TES;ADGRG1;PBRM1;MYOCD;SOX7;FBXO5;DDAH1;GRK5;EDN3;RPS9;KRAS;WNT9A;HHEX;BMP2;PTK2B;PDGFD;SST;RARG;ACE2;ROR2;TBX2;NACC1;EEF1E1;CSNK2A1;RERG;AKT2;IRS1;CD86;VEGFA;RBFOX2;COPS9
prerank,regulation of T cell differentiation (GO:0045580),-0.4421827887464682,-1.4143328718087564,0.06181015452538632,0.3415778891546899,1.0,23/33,44.28%,RUNX1;CBFB;MDK;ZBTB1;SOD1;NFATC2;PRDM1;METTL3;ZMIZ1;CCR2;TCF7;IL2RA;ZAP70;CLPTM1;PRELID1;FANCA;GATA3;CRTAM;IL4;CTLA4;XBP1;TNFRSF18;FOXP3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5871270048979628,-1.4135424596465498,0.08858267716535433,0.34248564011414073,1.0,3/11,6.52%,MERTK;GAS6;CXCL12
prerank,negative regulation of cell migration (GO:0030336),-0.3359177274850111,-1.4135166606548668,0.01662049861495845,0.34172338396272567,1.0,25/137,6.09%,PTPRG;TMEFF2;CLDN5;DAB2IP;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CORO1C;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;PHLDB2;RAP2A;RECK;ARHGDIB
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.43405761508421825,-1.4129300133209997,0.05077262693156733,0.34208338236493047,1.0,16/33,28.95%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;FBXW7;CBL;PLAUR;GPER1;PDE6H;EGF;NUP62;SHKBP1;AGT;BTC;NEU3
prerank,hemidesmosome assembly (GO:0031581),-0.5854863907170486,-1.4126335906741716,0.09580838323353294,0.34188218223973427,1.0,4/11,4.22%,ITGA6;DST;ITGB4;LAMA3
prerank,embryonic organ development (GO:0048568),-0.3875786599504422,-1.4120912263569785,0.02806122448979592,0.34227230608842024,1.0,24/61,17.71%,KITLG;PBX1;RARB;PCSK5;TGFB2;TEAD4;PBX3;TGFBR2;KDR;RPL10;GLI3;SOX17;STRA6;HEY2;TAL1;TEAD1;MFSD2A;SOX18;TBX2;RARRES2;ATF4;STIL;HEY1;ALDH1A3
prerank,positive regulation of heart contraction (GO:0045823),0.5153434866605269,1.4120866017026585,0.0931098696461825,0.7597374547046344,1.0,1/19,0.03%,ATP1A2
prerank,regulation of neuron projection development (GO:0010975),-0.3287243379377848,-1.4118840301460196,0.013736263736263736,0.3418528939105024,1.0,41/163,14.84%,ROR1;NTRK3;SHANK3;PDLIM5;RAPGEF2;DAB2IP;PTN;ITGA6;MARK1;NDNF;MBOAT1;DISC1;RAP1A;CHN1;KANK1;SCARF1;SCARB2;PAK2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;NCS1;RETREG3;CDK5;ABI3;APOE;CFL1;BAG5;MFSD2A;RET;PTK2B;ROR2;TRPV4;FZD1;AVIL;CDH2;MT3;PAQR3
prerank,positive regulation of behavior (GO:0048520),-0.5974211261676126,-1.4110471395836752,0.0933852140077821,0.34287844285427427,1.0,3/10,7.63%,MEF2C;SGIP1;STRA6
prerank,positive regulation of protein binding (GO:0032092),-0.3958347801782441,-1.4109273040789871,0.04176334106728538,0.34236957970048953,1.0,22/56,21.74%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;BMP4;APP;RALB;SPPL3;TIAM1;APOE;NMD3;BMP2;HIP1R;LRP1;VTN;EPB41;MARK3;PPP2CA;RIPK2;DTX3L
prerank,positive regulation of cell adhesion (GO:0045785),-0.36862564650837715,-1.4107549466896574,0.024752475247524754,0.34191516928409793,1.0,14/74,8.79%,LIMS1;FRMD5;ZFHX3;VIT;TGFB2;NDNF;PTPRJ;STX3;CXCL12;PPP3CA;MDK;FBLN2;TGM2;ECM2
prerank,calcium ion transmembrane transport (GO:0070588),0.3830595932775137,1.4105125379321186,0.03454231433506045,0.7614279850042135,1.0,10/86,5.43%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;TRPV1;CACNB3;AFG3L2;GRIN2D;NALCN
prerank,cellular response to glucose starvation (GO:0042149),0.44124770765008053,1.4098587612371347,0.0683453237410072,0.7595630095135502,1.0,7/41,8.36%,PRKAG2;PRKAA2;PRKAG3;NIM1K;CPEB4;IMPACT;SESN1
prerank,limb development (GO:0060173),0.4771524373771167,1.4097149261729682,0.08007448789571694,0.755452961905605,1.0,7/28,10.31%,SMOC1;RSPO2;INTU;LRP4;IQCE;MEGF8;IFT122
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5374271363622497,-1.4094850685973173,0.0649895178197065,0.34370505590230155,1.0,7/17,21.23%,PODXL;TGFB2;PIEZO1;RET;NCKAP1L;RAC3;SYK
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4351555134784243,1.4092894846888169,0.06315789473684211,0.7525207746442509,1.0,13/44,10.67%,ACTN2;ATP1B3;ANK2;WNK3;KCNJ5;ATP1B2;KCNJ10;WNK4;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,regulation of activated T cell proliferation (GO:0046006),0.47013255813711463,1.4086922583454218,0.06994328922495274,0.7503619147258921,1.0,3/30,1.23%,IGF1;IL18;IDO1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5304246249363986,1.4083715379130866,0.09770114942528736,0.7471488931575121,1.0,7/18,9.52%,PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;DLG4
prerank,cellular component disassembly (GO:0022411),-0.3865631371264939,-1.4080319021878358,0.030107526881720432,0.3458817640530326,1.0,22/53,31.23%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5320471191791672,1.4079976019449643,0.08151093439363817,0.7441195658464469,1.0,4/18,10.64%,MCM3AP;PABPN1;PCID2;DDX19B
prerank,cellular response to inorganic substance (GO:0071241),-0.4887824577327742,-1.4074299252373914,0.07113821138211382,0.3462796370203619,1.0,13/21,31.93%,FOXO1;GUCY1B1;DDI2;BLM;TIMELESS;MT3;FMR1;SPIDR;NSMCE3;ADCY10;CDK2;MMP3;AQP1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.34175256779681906,-1.4072791498455255,0.02072538860103627,0.34577744479504163,1.0,27/112,6.74%,PDE3A;LIMS1;MEF2C;GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;WNT5A;PDE2A;ITGB5;PXN
prerank,response to metal ion (GO:0010038),-0.37230366172663215,-1.407101923416378,0.03529411764705882,0.3454178253037281,1.0,19/67,15.61%,CAV1;NEDD4L;TRPC3;THBS1;PLSCR1;GPHN;CRIP1;CALM3;PPP3CA;PPP1CA;MT1A;MT1X;TRPC1;SEC31A;SLC30A5;ITPR3;D2HGDH;MT3;ATP5F1D
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5497117714558118,-1.406884405736932,0.09760956175298804,0.345082681148132,1.0,4/12,2.65%,PODXL;JAG1;PROM1;IQGAP1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.588307588633165,-1.4067559190857635,0.11198428290766209,0.3446179198697835,1.0,3/10,6.94%,LRCH1;CD200;APOD
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5418168024556524,-1.4066843238887823,0.08301158301158301,0.34401303686404217,1.0,7/13,34.79%,KDR;EDN1;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,actin filament organization (GO:0007015),-0.3277064883832796,-1.406528140143669,0.008379888268156424,0.3435612612582199,1.0,37/151,14.25%,HIP1;MYO1D;ABI1;MYO1B;RHOBTB1;SHROOM4;RHOA;SVIL;GSN;CORO1C;PLS3;ACTN1;FLNA;ARHGEF2;EPS8;TPM4;ALDOA;EMP2;TPM2;TMOD3;MYO19;TPM3;BCAR1;NEDD9;MYO1F;CD2AP;WHAMM;CAPG;CDC42EP2;HIP1R;RND3;TRPV4;VILL;GAS2L1;MARCKS;AVIL;SHROOM1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5901164640451504,-1.4061740410913792,0.09456740442655935,0.34273720010533115,1.0,5/10,20.10%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5901164640451504,-1.4061740410913792,0.09456740442655935,0.34273720010533115,1.0,5/10,20.10%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5973246202196644,-1.4061323645904638,0.08893280632411067,0.3420516704584435,1.0,3/10,6.29%,SHANK3;APP;NPTN
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5542305695101989,1.406025813550974,0.10256410256410256,0.7478518054413782,1.0,3/13,3.48%,BMP6;DAB2;BMPR1A
prerank,T-helper cell differentiation (GO:0042093),-0.5404611906382265,-1.4053748349743038,0.09404990403071017,0.342910477950109,1.0,2/14,0.18%,LEF1;FOXP1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5486552504523088,-1.4052679230115037,0.0949367088607595,0.3423510782520399,1.0,6/14,14.97%,THBS1;CREB3L1;SPRY2;FGF2;SPRY1;GPC1
prerank,negative regulation of protein polymerization (GO:0032272),-0.45611017168946594,-1.4052484311274946,0.07096774193548387,0.3416317385459056,1.0,11/27,13.07%,SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;PRKCD;DYRK1A;HIP1R;PFN1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4850335719943165,1.4048146090026472,0.08880994671403197,0.7481715743663012,1.0,5/26,4.37%,ERRFI1;SNX6;CHMP6;GPRC5A;ADRA2A
prerank,neuron migration (GO:0001764),-0.39963926686083995,-1.4046048275055825,0.033860045146726865,0.34217566199491817,1.0,14/48,16.20%,NRP1;MEF2C;RAPGEF2;MARK1;NDNF;DISC1;CEP85L;CDK5;FGF13;VEGFA;NR4A2;MAP1B;PAFAH1B1;DDIT4
prerank,lipid droplet formation (GO:0140042),0.613445569173203,1.4041751419043331,0.1324110671936759,0.7463229788379832,1.0,4/10,14.04%,FITM2;PLA2G4C;CDS1;SQLE
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4569104845961926,-1.4036593754763682,0.08278867102396514,0.34346712888767,1.0,6/27,9.67%,UTRN;NEDD4L;FXYD5;CAMK2D;SLMAP;FXYD6
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.56919039744592,-1.403652018124917,0.084070796460177,0.342736165469223,1.0,4/11,5.60%,CACNB2;CACNA2D1;NOS1AP;CAMK2D
prerank,carboxylic acid transmembrane transport (GO:1905039),0.43810356334284783,1.4033642271675584,0.06851851851851852,0.7452439020062233,1.0,10/40,9.21%,SLC13A3;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC38A1;SLC7A13;SLC25A11;SLC19A1;SLC38A9
prerank,cellular response to oxygen levels (GO:0071453),0.6091675854469674,1.4030406411392924,0.11176470588235295,0.7422151749330823,1.0,4/10,7.57%,ATP6V0A2;CCDC115;TMEM199;CPEB4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4788123874860194,1.4026680642404634,0.08745247148288973,0.7393164864893055,1.0,8/26,15.17%,LGR4;APPL2;NLRP2B;OTUD4;FLOT2;CACTIN;TYRO3;TLR5
prerank,basement membrane organization (GO:0071711),-0.5460451885776205,-1.4019884131072913,0.099601593625498,0.3453780512976963,1.0,5/14,8.04%,FLRT2;COL4A1;RAMP2;NTN4;LAMB2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4932993307261859,1.401820280991847,0.08610567514677103,0.7384358237980347,1.0,7/23,10.39%,BMP7;UACA;CPNE1;C1QTNF3;NLRC3;NLRP3;ADGRG3
prerank,activation of GTPase activity (GO:0090630),-0.35698314784032076,-1.4016724949718038,0.024128686327077747,0.3452027969023537,1.0,27/89,15.77%,TBC1D4;NTRK3;RABGAP1L;ARHGAP42;SIPA1L2;TBC1D8;CORO1C;BCR;TBC1D12;TIAM2;USP6NL;TBC1D5;TBC1D2B;SIPA1L3;ARHGEF15;TBC1D1;EVI5L;ABR;TIAM1;TBC1D13;SIPA1;RALGAPA1;TAX1BP3;TBC1D7;TBC1D10A;RAP1GAP;TBC1D25
prerank,wound healing (GO:0042060),0.4079833592937102,1.4015675444093534,0.05615942028985507,0.735205047578357,1.0,13/62,10.07%,FGF1;SYT11;ANXA6;IGF1;SMAD3;PDGFRA;WNT7A;MYOF;CORO1B;NRG1;FZD7;TGFBR1;CFLAR
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3085666597540721,-1.40042476423351,0.009009009009009009,0.34711756115833076,1.0,63/245,14.78%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;DAB2IP;ADRA1B;SEMA7A;BCAR3;TGFB2;INSR;BMPER;NOTCH1;GAS6;RAP1A;IQGAP1;EGFR;JCAD;CD44;PTPRJ;MID1;KDR;APP;MFHAS1;TBX1;PLCG2;DHX33;ICAM1;TNFAIP8L3;PIK3R6;IL34;IAPP;FLT1;GAREM1;SPRY2;CCL13;PDGFC;FLT4;IGF2;FGF2;APOE;EDN1;CAV2;ACKR3;EDN3;CD74;PHB2;RET;BMP2;PTK2B;PDGFD;ROR2;HTR2A;CD40;PTPRC;FBXW7;CD24;VEGFA;P2RY6;MTURN;MT3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.49562740443379394,1.399588904324165,0.08076923076923077,0.739149007204023,1.0,12/26,24.97%,CTR9;EEF2KMT;KMT2A;ANTKMT;SETD4;KMT5C;BEND3;TET2;SETD1B;VCPKMT;SETD2;SETD5
prerank,nitrogen compound transport (GO:0071705),-0.32552258638683296,-1.397817951626267,0.0158311345646438,0.35174570919603027,1.0,27/141,9.19%,ABCG2;SLC6A6;CALCRL;SLC12A2;LRRC8D;RAMP2;SEC14L1;CERT1;MYH9;SLC1A5;ABCC1;SLC7A5;LMAN2L;SCARB2;TMEM30A;ATP11B;CHMP2B;SLC38A5;SLC43A2;SLC44A2;SLC7A7;SLC7A1;CMTM6;CUBN;SLC7A14;SLC43A1;TXNIP
prerank,regulation of myelination (GO:0031641),-0.45375960604585963,-1.3977270264526889,0.07838983050847458,0.35116705887106053,1.0,7/25,11.68%,PTN;PARD3;TNFRSF1B;LGI4;TNFRSF21;EIF2AK3;PTPRZ1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.45927004286808665,-1.3977045284214134,0.05399568034557235,0.350467360643436,1.0,9/27,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.5607848808602028,-1.397660714233057,0.09316770186335403,0.3498035611449021,1.0,5/12,17.95%,KAT7;TIPIN;BLM;WRNIP1;NBN
prerank,cellular response to mechanical stimulus (GO:0071260),-0.40636131860932717,-1.3959942026787042,0.059602649006622516,0.3523411513502168,1.0,25/46,33.02%,PIEZO2;PIEZO1;F11R;FAS;CRADD;PDE2A;CASP8AP2;CNN2;CD40;BAK1;MAPK3;MYD88;CHEK1;CASP1;BCL10;CASP8;TLR4;MAP3K14;PTGER4;FADD;HABP4;AQP1;TMEM150C;TLR3;MAPK8
prerank,mitochondrion disassembly (GO:0061726),-0.4217014686495718,-1.3951325911102255,0.061611374407582936,0.3534384044794523,1.0,14/34,25.57%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4303731505544831,-1.3944970270287307,0.07068607068607069,0.3541825257042423,1.0,10/32,16.70%,PLCE1;WASF2;PIK3R1;CORO1C;OCLN;PIK3CA;SRC;AVIL;ARPC2;RREB1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3676324314835146,-1.394340225584397,0.03587443946188341,0.3537527678920207,1.0,32/76,23.12%,MAML2;IL6ST;JAG1;NOS3;NOTCH3;TGFB2;NOTCH1;EGFR;STAT3;CCN3;JAG2;EPN2;SRC;GATA2;NOTCH4;MFNG;SREBF2;TCIM;FBXW7;LFNG;CD46;HEY1;NOD2;PRAG1;YJEFN3;METTL3;ZMIZ1;DLL4;MAML3;SNW1;DLL1;EGF
prerank,actin filament depolymerization (GO:0030042),-0.5648833156881712,-1.3938577418032811,0.1188118811881188,0.3540051619104686,1.0,4/11,10.52%,MICAL2;GSN;WDR1;CFL1
prerank,negative regulation of response to stimulus (GO:0048585),-0.37924582928155015,-1.3938505949678404,0.041379310344827586,0.35326117202374674,1.0,18/60,11.58%,SLIT2;ACVR1;CD34;VPS13C;AKT3;KLF7;CASK;UBASH3B;AQP11;HHIP;LYN;PTPN1;SOCS5;KLF4;TLE5;FBXO5;DDAH1;TWIST1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4909036879831494,1.3926381872052989,0.11372549019607843,0.7639553189522412,1.0,2/23,1.35%,METAP2;NMT2
prerank,alpha-amino acid catabolic process (GO:1901606),0.474483276137203,1.3920259679150488,0.08743169398907104,0.7619872557491674,1.0,6/29,9.06%,DDO;IDO1;ACAT1;HAAO;ACADSB;KMO
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.4779250204152953,-1.3918056378753159,0.09615384615384616,0.3567063197077122,1.0,11/20,13.85%,ACVRL1;TGFB2;ENG;TBX3;NOTCH1;BMP4;HEYL;HEY2;PDCD4;BMP2;SPRY1
prerank,neutrophil mediated immunity (GO:0002446),-0.2854920400513008,-1.3910339557121052,0.0,0.35751101166267885,1.0,115/432,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;KMT2E;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5095677538434047,1.390157857629478,0.09523809523809523,0.7654214228064107,1.0,7/22,16.04%,AEBP1;MAP2;PRUNE1;ARL2;EFEMP2;ABL1;GBA2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.34075943576439455,-1.3895634220922093,0.03282828282828283,0.3598952017806164,1.0,38/113,22.14%,DAB2IP;RPA1;PIEZO1;ABCA1;ICE1;RASIP1;UNC13B;ESR1;FNIP2;DHX33;TFRC;GBP5;RACK1;RPS3;CHD1L;SRC;TPPP3;GTF2H5;TAL1;CAPG;CDC42EP2;GTF2H1;ISG15;ERCC2;VEGFA;PSMC4;FERMT2;BAK1;USP50;SLF2;RPA2;XPA;SPIDR;MYD88;AJUBA;SYK;FAF1;BIK
prerank,vesicle organization (GO:0016050),-0.40620424240116176,-1.3895096293729494,0.05726872246696035,0.35926304883912447,1.0,14/46,16.55%,CAV1;CD34;WASHC4;CHMP2B;ALS2CL;ZFYVE16;RAB22A;SORT1;CAV2;SQSTM1;SNX10;FNBP1L;SAR1A;USP50
prerank,regulation of peptide hormone secretion (GO:0090276),0.3952354612352874,1.3888118784502086,0.046181172291296625,0.7667827069825297,1.0,22/67,18.39%,CACNA1D;GCK;ITPR1;PASK;CACNA2D2;ADRA2A;SNAP25;KCNC2;CLOCK;ITPR2;GRP;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;HFE;PICK1;DPP4
prerank,nucleoside catabolic process (GO:0009164),0.5796711827222716,1.3883294783739588,0.11976047904191617,0.7644702873307354,1.0,4/11,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,carboxylic acid catabolic process (GO:0046395),0.5639047381236214,1.3880760649167858,0.11591355599214145,0.7612247966987775,1.0,4/12,11.76%,PON1;RENBP;GNPDA1;NPL
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5564998499730986,-1.3876346174111307,0.09467455621301775,0.36253265584687666,1.0,3/12,1.96%,MBNL1;LRP6;TGFB2
prerank,adherens junction organization (GO:0034332),-0.39768395960008907,-1.3874999660780747,0.07017543859649122,0.3620605111235844,1.0,11/48,6.00%,CDH11;ACTB;VCL;TJP1;RAMP2;CDH13;CDH1;CTNNA1;TBCD;PAK2;NECTIN3
prerank,neutrophil degranulation (GO:0043312),-0.28496249440671667,-1.3872799328247165,0.0,0.3617955448906836,1.0,114/425,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5433558073079587,-1.3863571017602445,0.10638297872340426,0.36305545670630784,1.0,7/13,20.93%,DCN;CSPG4;VCAN;HEXA;BGN;NCAN;BCAN
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.44122474504194464,1.3863118889639727,0.08145580589254767,0.7639530568992668,1.0,4/41,3.98%,PRKAG2;GCK;POM121;NUP155
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5643452376007407,1.385852726333251,0.10588235294117647,0.7615927056552204,1.0,2/14,3.69%,IL18;IL17D
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.518343529264924,-1.3849105485686173,0.10515463917525773,0.36542996508651004,1.0,7/16,12.60%,NRP1;PTPRJ;PIK3C2A;PDGFC;PTPN1;BCAR1;PDGFD
prerank,cardiac conduction system development (GO:0003161),0.48778451889412855,1.384824307219105,0.08317929759704251,0.7617883795968908,1.0,4/24,3.48%,NOTCH2;GJB6;MSX2;BMPR1A
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6106025618621252,1.3846991189081301,0.11198428290766209,0.7581506834802921,1.0,4/10,15.61%,HSPA1A;DNAJB8;HSPA1B;DNAJB2
prerank,protein maturation (GO:0051604),0.36930300906613833,1.3846300112051846,0.047285464098073555,0.75433575888498,1.0,10/95,4.65%,AEBP1;NNAT;METAP2;TSPAN5;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3923915842616794,-1.3845029273622584,0.06192660550458716,0.3655859803202307,1.0,21/53,22.11%,DAB2IP;PKD1;GABARAPL2;UBB;ECSCR;PRKCG;APOE;GPX1;TMF1;RAD23B;FOXF2;FBXW7;GNA12;FMR1;PRKACA;PSMD14;PSME3IP1;UCHL5;PSME1;TMTC3;GLMN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5902821501054671,-1.3842080395869778,0.09939148073022312,0.3654453676965994,1.0,2/10,2.85%,PODXL;PIEZO1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4164795091518444,-1.384199741480138,0.05980861244019139,0.3647146148299833,1.0,10/36,12.82%,CAV1;NOS3;NOSTRIN;SCARB1;EGFR;NOS1AP;GCH1;APOE;DDAH1;CYGB
prerank,actin polymerization or depolymerization (GO:0008154),-0.3910550298064864,-1.3837311001154167,0.06221198156682028,0.36499220104397645,1.0,14/50,13.75%,ABI1;MICAL2;SVIL;GSN;WDR1;MSRB2;WASHC3;FAM107A;CFL1;CAPG;MICALL2;PSTPIP2;VILL;AVIL
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5085272582463451,1.3829164009523722,0.1075050709939148,0.7570070059558389,1.0,2/18,4.22%,PRKAG2;CLIP3
prerank,positive regulation of cellular process (GO:0048522),-0.2805151769545577,-1.3828782549734697,0.0,0.3661510561001154,1.0,165/565,22.77%,LEF1;SLC6A6;KITLG;FRMD5;ACTN4;NTRK3;CAV1;GCNT2;BMP5;IL6ST;CLDN5;OSMR;ZFHX3;PTN;TJP1;LIFR;PARD3;LRP6;ACER2;ETS1;TGFB2;TRPC3;INSR;MERTK;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;TBC1D8;EGFR;BMP4;PTPRJ;H3-3A;TGFBR2;KDR;TNFRSF1B;FN1;RPS6KA3;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;AXIN2;HES1;ADAM10;LYN;CXCL12;IL6R;IL34;PRKCD;AR;FLT1;PPP3CA;MDK;TGM2;GAREM1;DOCK2;APC;EMP2;CDC123;TIPIN;SMC5;PDGFC;GATA2;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;ACACB;CDKN2AIP;RPTOR;FGF7;TAL1;FASN;S1PR3;EDN1;ESM1;SERTAD1;RPL23;ADGRG1;PABIR1;FBXO5;GRK5;EDN3;RPS9;KRAS;MFSD2A;PTK2B;PDGFD;RAB27A;USP47;TBX2;AGPAT1;NACC1;CSNK2A1;AKT2;IRS1;CD86;VEGFA;LRP1;COPS9;ROMO1;MT3;NCBP1;PTGFR;KLHL22;DDX49;FMR1;CSF1R;PA2G4;RPS15A;UBE2A;TBRG4;TCIRG1;FXR1;FGFR3;PTEN;HDAC2;GPER1;GRIN1;DYNC1H1;PTPN6;CCND1;KIF20B;PRODH;GREM1;ZC3H12A;CRLF1;PRC1;HCK;CDC42;CCPG1;ACER3;PSMD10;PTHLH;POU3F3;NOXO1;CHEK1;NSMCE4A;POFUT2;CCND2;RIPK2;FAF1;MYRF;RPRD1B;FXN;HAS2;CDKN1B;FCGR2B;CEP131;DLL1;SOX11;CTF1;EXOSC4
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.378387782469852,-1.3818935083196644,0.04708520179372197,0.36764320811361045,1.0,17/63,16.58%,MEF2C;IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;CD38;IL15;EPHB2;NFATC2;CD74;CD40;PTPRC;CD86;NCKAP1L;CD46
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41537710476226064,-1.3817124724740177,0.0746606334841629,0.3673062626902337,1.0,10/37,8.86%,CAV1;BCL2L1;UBB;RACK1;NCK1;RPS7;NACC2;RPS3;BCAP31;SOD1
prerank,acute inflammatory response (GO:0002526),-0.4636633233654694,-1.3816383031629442,0.0824524312896406,0.366746240996346,1.0,11/23,36.33%,F3;PLSCR1;IL6R;SIGIRR;ANO6;CEBPB;AHSG;VNN1;HPR;HP;CRP
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2836281110911097,-1.3812689626291539,0.0,0.3667615474759138,1.0,114/428,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5289061912495537,1.38037548786519,0.11960784313725491,0.7632505438370244,1.0,5/16,7.85%,LEPROT;CHMP6;STAM;VTA1;SNF8
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5858927121838698,-1.379895934144647,0.09381237524950099,0.36888225386781287,1.0,4/10,8.94%,GHR;STAT3;LYN;PTPN1
prerank,Golgi to endosome transport (GO:0006895),-0.5077990644958071,-1.3792560288508795,0.09437751004016064,0.3694508441305239,1.0,8/16,13.98%,RAB14;VPS13C;WIPI1;SORT1;VPS13A;AP1AR;SYS1;AP2A1
prerank,mesoderm development (GO:0007498),-0.4988277317816213,-1.379032070395548,0.1016597510373444,0.3691757773221011,1.0,8/18,20.01%,TIE1;TBX3;TBX1;BMX;VEGFA;BTK;MEST;HCK
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5136882709843346,1.3789673337381485,0.10018214936247723,0.7647066928909096,1.0,6/19,11.47%,IGF1;PICALM;RTN1;FLOT2;NTRK2;CLU
prerank,neutrophil activation (GO:0042119),-0.5540779017926474,-1.3778960305048045,0.108,0.37083425506705103,1.0,5/12,21.23%,KMT2E;PRKCD;IL15;PREX1;SYK
prerank,sensory perception of sound (GO:0007605),0.3800278676972464,1.377045416083766,0.06343906510851419,0.7684546639338533,1.0,16/88,9.16%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;KIT;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5251834296898666,1.3768525907455482,0.11262135922330097,0.7651927662626903,1.0,7/18,17.40%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2;RELA
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3621081490177547,1.376644917401084,0.03164556962025317,0.7619609908928769,1.0,32/117,17.36%,ALDH1A2;IGF1;ALDH8A1;ADH7;CYP26B1;PPARA;ME2;PCCA;AASDH;PNPLA8;GLYAT;PANK2;ACADSB;ECHDC3;PTGR1;CPT1C;FA2H;AMACR;MTHFS;CROT;SLC27A4;VDAC1;LDHB;NAAA;PER2;GGT5;GOT2;GBA2;ACOT1;MSMO1;AASDHPPT;ACOT6
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.4544865672948795,-1.3764589145736417,0.08617234468937876,0.37322851372102467,1.0,7/24,14.95%,PLCE1;WASF2;PIK3R1;OCLN;PIK3CA;AVIL;ARPC2
prerank,ribosome assembly (GO:0042255),-0.39119338124772596,-1.3764001911486754,0.05853658536585366,0.37261297149090344,1.0,19/47,26.01%,RPS15;RPL5;RPL10;MRPL20;RPLP0;RPS5;RPS28;RPL6;RPL24;RPS27;RRP7A;MTERF3;PWP2;RPL3;RRS1;RPS19;RPL23A;PPAN;MDN1
prerank,aorta morphogenesis (GO:0035909),-0.4882361505641789,-1.3759447651161754,0.10395010395010396,0.37283187742380036,1.0,10/17,21.06%,JAG1;ACVRL1;ENG;TBX1;HEY2;TBX2;LRP1;HEY1;DLL4;MYLK
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.32260608278986985,-1.3759033148935371,0.02535211267605634,0.3721786222656101,1.0,48/151,20.23%,SGMS1;ST3GAL4;PLA2G4A;SGMS2;ELOVL7;ACER2;PCSK5;CERT1;CEPT1;DEGS2;PRKD3;GPHN;GCH1;PRKD1;SPNS2;SLC44A2;ELOVL5;AKR1A1;CERS5;CERS6;PLPP1;SAMD8;APOE;GOLPH3;B4GALT5;ELOVL6;GCNT1;MFSD2A;SLC44A1;LPIN3;CSNK2A1;NFS1;ESD;ELOVL1;GSTT1;PLPP3;VAPB;MOCS1;ELOVL4;ST3GAL2;STARD10;SGPP1;ASS1;SPTSSA;LCMT2;DMD;PPM1L;ACER3
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.43902676345225256,-1.3755922476319062,0.0915032679738562,0.37215968191872495,1.0,15/30,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,neural crest cell migration (GO:0001755),-0.4148132620612288,-1.3737934103897989,0.08590308370044053,0.3752903141772503,1.0,10/36,12.43%,NRP1;SEMA6A;SEMA3C;SEMA7A;CORO1C;FN1;TBX1;SEMA5B;SEMA3E;SEMA3G
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4591745803829719,1.373157396717197,0.07846715328467153,0.7720849986238696,1.0,9/31,10.07%,PDGFRA;OSR1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5345654396139567,-1.3728501837943206,0.11553784860557768,0.3765260363549103,1.0,5/14,16.62%,NIPBL;NNMT;SAP30BP;DYRK1A;APLNR
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5116474115000376,-1.3714709026760483,0.11816192560175055,0.37870498538713904,1.0,9/15,32.10%,BMP4;SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4477860317353902,-1.3713554438621247,0.07407407407407407,0.37821395543085506,1.0,5/27,7.92%,RHOA;ETS1;CD44;MDK;NFAT5
prerank,artery development (GO:0060840),-0.45774772264670677,-1.3711702068013154,0.08647450110864745,0.3778666714435198,1.0,8/23,7.63%,NRP1;BMPR2;ACVRL1;ENG;TBX1;HES1;PDE2A;STRA6
prerank,positive regulation of tissue remodeling (GO:0034105),0.6043049126077198,1.3709740082799757,0.13877551020408163,0.7772419659351184,1.0,2/10,0.87%,ROCK2;IL18
prerank,cell projection assembly (GO:0030031),-0.4615053713165846,-1.3700045802170242,0.07368421052631578,0.37977219007604335,1.0,8/22,21.07%,RHOJ;GSN;PARVB;PARVA;CAPG;NCKAP1L;CDC42;RAC3
prerank,keratinocyte differentiation (GO:0030216),-0.42160792507273753,-1.3699068242702932,0.09190371991247265,0.3792617924758312,1.0,8/29,12.12%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG
prerank,regulation of centriole replication (GO:0046599),-0.5037209543335879,-1.3698185381241959,0.12215320910973085,0.37869805026746806,1.0,7/17,23.88%,TRIM37;PLK2;CEP76;STIL;CEP295;CDK5RAP2;NUP62
prerank,in utero embryonic development (GO:0001701),-0.44593692913047317,-1.3691999471900678,0.09401709401709402,0.37933970927238503,1.0,12/25,20.39%,MBNL1;PKD1;FUT8;ADAM10;IGF2;TGFB3;BMP2;VEGFA;STIL;LIG4;SOX8;LMX1B
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.41048546865444185,-1.3689736137426711,0.08368200836820083,0.37912398937909714,1.0,10/36,11.84%,LEF1;FZD6;NFATC1;AGO1;WNT5A;GNB1;GNG2;PPP3CA;AGO2;FZD4
prerank,regulation of leukocyte activation (GO:0002694),-0.5249430298960004,-1.3678303120744506,0.10019646365422397,0.3809281743796651,1.0,6/14,17.68%,CD200;PLSCR1;MFHAS1;LYN;CD74;GPER1
prerank,innate immune response in mucosa (GO:0002227),-0.5811957962252277,-1.3677290060317564,0.12,0.38042551881924896,1.0,2/10,5.46%,DEFA6;RPL39
prerank,cGMP metabolic process (GO:0046068),-0.5377815355601326,-1.3669884181944323,0.1069182389937107,0.38130545885582967,1.0,5/12,18.89%,GUCY1B1;PDE9A;PDE2A;GUCY1A1;NPPC
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2847190227845432,-1.3667368869980123,0.0035842293906810036,0.3811422950560677,1.0,89/423,13.82%,LEF1;FOXP1;PRKCH;KITLG;MEF2C;NTRK3;GCNT2;BMP5;PID1;IL6ST;CLDN5;OSMR;PTN;TJP1;LIFR;ACER2;TGFB2;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;CDH13;TBC1D8;EGFR;BMP4;TGFBR2;KDR;FN1;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;HES1;ADAM10;LYN;IL6R;IL34;AR;FLT1;CCN1;MDK;GAREM1;EMP2;CDC123;TIPIN;ZFPM2;TMEM119;PDGFC;FLT4;TIAM1;IGF2;FGF2;TGFB3;TSPAN31;IL15;S100A6;FGF7;S1PR3;EDN1;ESM1;SERTAD1;RPL23;FBXO5;GRK5;EDN3;RPS9;CD74;CCN4;KRAS;BMP2;PTK2B;PDGFD;TBX2;NACC1;CSNK2A1;AKT2;NME2;PTPRC;IRS1;CD86;VEGFA
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4668486409140078,-1.3656114842816822,0.10706638115631692,0.3828737960578339,1.0,9/22,18.96%,RASSF2;RAP2A;CALM3;PDGFC;PDGFD;VEGFA;TNKS1BP1;NBN;GREM1
prerank,positive regulation of binding (GO:0051099),-0.3530682862409854,-1.3654274073225052,0.054373522458628844,0.3825323044767723,1.0,33/84,23.31%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;NGF;BMP4;APP;STMN1;RALB;MET;HES1;SPPL3;TIAM1;HMBOX1;APOE;NMD3;BMP2;HIP1R;LRP1;NCBP1;PLAUR;VTN;EPB41;DPH3;MARK3;HMGB1;RIPK2;DTX3L;SKI;EGF;TRIB3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.32657309445330873,-1.3650665412325222,0.03608247422680412,0.3826001336870868,1.0,28/128,6.74%,GCNT2;BMP5;BMPR2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;RUNX2;SMURF1;ID1;BMP4;TGFBR2;RNF111;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;TMEM100;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,negative regulation of response to wounding (GO:1903035),-0.4741582871836955,-1.3644654469768756,0.10216110019646366,0.38310944459394963,1.0,8/19,16.66%,CD109;CASK;AJAP1;MDK;FGF2;SERPINE1;GIT1;RTN4RL1
prerank,cellular metal ion homeostasis (GO:0006875),0.36375439721614267,1.3640660939812683,0.038869257950530034,0.8016384337957921,1.0,11/102,4.28%,ATP1A2;SLC8A3;SLC41A1;SLC24A3;ATP1B3;ATP13A5;ANK2;DMPK;CSRP3;ATP13A3;ATP1B2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.31975648545805835,-1.3638550862300525,0.02824858757062147,0.3836315559585661,1.0,28/148,9.78%,RAPGEF2;DAB2IP;RHOA;TGFB2;INSR;GAS6;RASSF2;STK3;RAP1A;IQGAP1;TGFBR2;CACUL1;RALB;TNIK;CAB39;PAK2;XRCC5;IL6R;IL34;PRKCD;CALM3;CCN1;EMP2;SRC;PTPN1;MAP4K4;NEDD9;RPTOR
prerank,calcium ion transport (GO:0006816),0.3515407521401486,1.3629770156875058,0.06554621848739496,0.802067112168206,1.0,11/113,3.93%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;CACNG7;TRPV1;ANK2;CACNB3;GRIN3A;ITPR1
prerank,response to X-ray (GO:0010165),-0.5271376947375696,-1.3625483841723958,0.1023454157782516,0.3857790298445874,1.0,10/14,35.29%,NIPBL;XRCC5;ANXA1;BLM;LIG4;NUCKS1;IKBIP;BRCC3;XRRA1;XRCC4
prerank,manganese ion transport (GO:0006828),-0.5217374379858908,-1.3617297340419647,0.10614525139664804,0.3867944784412224,1.0,5/14,9.94%,TRPC3;SLC39A8;TRPC6;TRPC4;TRPC1
prerank,L-serine metabolic process (GO:0006563),-0.5783321456945754,-1.361577029285238,0.147117296222664,0.3863906023753645,1.0,6/10,28.59%,SERINC5;SRR;SERINC3;SHMT2;CBS;SHMT1
prerank,ncRNA transcription (GO:0098781),-0.5362730836705376,-1.3614401043682052,0.10126582278481013,0.3859858385944242,1.0,6/13,19.88%,SPIN1;USPL1;POLR1G;CAVIN1;GTF3A;SIRT7
prerank,neutrophil chemotaxis (GO:0030593),-0.38511556165768374,-1.3610075145098663,0.06221198156682028,0.3862144303495736,1.0,26/53,40.70%,BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,heart contraction (GO:0060047),0.4298243636270068,1.3605857955494873,0.09615384615384616,0.8078962591476289,1.0,7/41,11.04%,ATP1A2;CSRP3;SGCZ;TNNI1;KCNH2;SGCG;RYR2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5278391564633264,1.3604087268779688,0.13157894736842105,0.8046008962667356,1.0,2/17,4.28%,ATP1A2;ATP1B2
prerank,dendrite self-avoidance (GO:0070593),-0.497924552559373,-1.3600481962974516,0.11752577319587629,0.3875986248681422,1.0,6/16,13.17%,BSG;PALLD;NPTN;ROBO4;DSCAML1;EMB
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4826398316360624,-1.3597209618831683,0.11252653927813164,0.38757295795564745,1.0,9/19,33.02%,SLCO1C1;APP;KLF4;KLF2;EGF;WFS1;TMEM106A;HPN;MAPK8
prerank,positive regulation of chromatin organization (GO:1905269),-0.5411011581151882,-1.359634139955341,0.10743801652892562,0.38698227453333767,1.0,4/12,10.66%,H3-3A;MIER1;TAL1;TERF2IP
prerank,cardiac muscle cell differentiation (GO:0055007),-0.46807466954064614,-1.3594970133200026,0.10278372591006424,0.38659476839419815,1.0,7/21,13.82%,MEF2C;ACVR1;MYH11;CXADR;MYOCD;BMP2;VEGFA
prerank,regulation of smoothened signaling pathway (GO:0008589),0.41250125034423124,1.3593722210409853,0.0905861456483126,0.8048836027063572,1.0,11/50,10.53%,RORA;DCDC2;SUFU;INTU;TULP3;FGFR2;EVC;ARMC9;MEGF8;IFT122;TEDC2
prerank,negative regulation of hydrolase activity (GO:0051346),0.40672344351320566,1.3592994269126235,0.08611599297012303,0.8011060975125163,1.0,9/49,8.07%,CPEB2;MAP2;GCHFR;SH3RF2;SH2D4A;GMIP;ARL2;GPSM1;LRRK2
prerank,T cell activation involved in immune response (GO:0002286),-0.54380828205342,-1.3590738804997442,0.130879345603272,0.3868200232187274,1.0,3/12,11.83%,ICAM1;MDK;CD74
prerank,response to alcohol (GO:0097305),0.45342272993714394,1.3589670604544106,0.10674157303370786,0.7984488296478685,1.0,9/27,15.79%,TGFBR3;ADH7;GRIN3A;GLRA1;CHRNB2;DRD3;TGFBR1;ABCA2;GOT2
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5443726917490264,-1.3587467354239229,0.12603305785123967,0.3868177356895685,1.0,4/12,9.84%,RHOA;APP;CXCL12;DOCK8
prerank,glucose homeostasis (GO:0042593),0.3739405767478521,1.3579071214309955,0.06429780033840947,0.7986812636079353,1.0,22/83,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;HKDC1;PPARGC1A;USF1;PYGL;HECTD4;SIRT1;IL6;BACE2;HK1;RBP4
prerank,aortic valve morphogenesis (GO:0003180),-0.42875197762541706,-1.3572158252854079,0.07032967032967033,0.3895762581123623,1.0,10/30,8.50%,ELN;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;HEYL;HEY2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.575577198232567,-1.3569562663470935,0.12,0.3886165254153935,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.575577198232567,-1.3569562663470935,0.12,0.3886165254153935,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,cellular response to superoxide (GO:0071451),-0.5781350714383681,-1.3563870345601337,0.13102119460500963,0.3890153419159924,1.0,3/10,14.78%,NOS3;SOD1;MT3
prerank,regulation of cartilage development (GO:0061035),-0.4880667245773309,-1.3553117361217137,0.1090146750524109,0.3906715771656375,1.0,5/18,7.43%,BMPR2;ZBTB16;TRPS1;BMP4;MDK
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5807255430302942,-1.3544400039635482,0.13293650793650794,0.39184948390047836,1.0,3/10,2.86%,RAPGEF2;RAP1A;NGF
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5538325434534551,1.354400763890766,0.14770459081836326,0.8091215774058584,1.0,3/13,5.71%,CHST4;RENBP;LARGE1
prerank,linoleic acid metabolic process (GO:0043651),0.5274710969633081,1.3540325401056743,0.12284069097888675,0.8066159043938286,1.0,4/17,9.07%,ACSL1;PNPLA8;GSTM2;ABCD1
prerank,nucleotide catabolic process (GO:0009166),-0.5031872793378168,-1.3537146452719262,0.10567514677103718,0.3926350502154983,1.0,7/16,21.88%,XDH;GPX1;NT5C1A;DERA;NT5E;NT5C;GDA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3530244332954023,-1.3536258940525796,0.03990610328638498,0.39210881587208735,1.0,22/80,15.68%,NRP1;PLCE1;WASF2;PIK3R1;CDC42EP5;CDC42EP3;ARAP1;EPS8;ARHGAP35;OCLN;APC;PIK3CA;TGFB3;EPS8L2;CDC42EP2;FNBP1L;PFN1;AVIL;CCP110;AGRN;ARPC2;FMR1
prerank,positive regulation of cell projection organization (GO:0031346),-0.3319351368941507,-1.3534741265254975,0.03333333333333333,0.39169361400834507,1.0,32/115,13.79%,ROR1;NTRK3;RAPGEF2;DAB2IP;PTN;ITGA6;SLIT2;RHOA;NDNF;RAP1A;NGF;SCARF1;TIAM2;SCARB2;PRKD1;WNT5A;NPTN;LYN;FBXW8;ARHGAP35;MDK;RETREG3;TIAM1;APOE;PLXNC1;FZD4;RET;PTK2B;ROR2;FZD1;AVIL;ARHGDIA
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5490500126007813,-1.352875380344349,0.11982570806100218,0.3923804118915889,1.0,4/11,5.85%,LRP5;TGFBR2;TBX1;WNT5A
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5571221207632004,-1.352805213253561,0.12396694214876033,0.39180326206845006,1.0,3/12,8.27%,FOXP1;LYN;ORMDL3
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4357775012625353,-1.3519712033642026,0.09052631578947369,0.3929659287934176,1.0,9/29,16.03%,MEF2C;TFRC;CD38;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.4696670036288397,-1.3504754333367368,0.0875,0.395602209168667,1.0,7/21,13.85%,DAB2IP;SLIT2;TGFB2;SPRY2;CD2AP;EPHB2;SPRY1
prerank,response to ketone (GO:1901654),-0.44459482193515,-1.3499721816409955,0.08757637474541752,0.3960535236605337,1.0,5/24,2.26%,CAV1;SLIT2;ABHD2;TGFB2;THBS1
prerank,regulation of embryonic development (GO:0045995),-0.40954667154852553,-1.3497830979215375,0.1054945054945055,0.395764592956986,1.0,8/34,10.52%,INSR;RAB14;PHLDB1;PHLDB2;SOX17;NIPBL;B4GALT5;CFL1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5305887640358654,-1.3496050349274926,0.12550607287449392,0.3954486440731678,1.0,7/14,13.85%,CAV1;ZEB1;SPRED2;XDH;SPRY2;NOTCH4;SPRY1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5014629971938527,-1.3489471144377936,0.12156862745098039,0.3961804102206822,1.0,3/15,9.64%,SCARB1;PLTP;APOE
prerank,regulation of developmental growth (GO:0048638),-0.4361926024472506,-1.34894689743277,0.08798283261802575,0.39545213740777646,1.0,12/29,17.70%,GHR;INSR;SIX1;APP;NIPBL;SPAAR;SOD1;APOE;MFSD2A;SIX4;FGFR3;LATS1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.27350574497555064,-1.348159368077566,0.0,0.39639533986766196,1.0,153/532,21.87%,LIMS1;GHR;ACTN4;IL6ST;IL1R1;OSMR;ZEB1;LIFR;TMSB4X;TRAF5;B2M;GREM2;FOXO1;RPS6KA5;PIK3R1;F3;FOXO3;VCAM1;BCL2L1;NFKBIA;SOCS2;STAT3;CD44;PTPRJ;MID1;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;NOD1;ADIPOR2;CARD14;IFITM3;MTAP;TNFRSF11A;ITGB1;STX3;ICAM1;RPS27A;IRF9;S1PR1;CAMK2D;UBB;PAK2;TEC;AIM2;PPIA;RPLP0;CXCL12;IL6R;ANXA1;IL34;PRKCD;PSMA6;TNFRSF11B;INPP5D;PSMB7;IL20RB;TRIM25;XAF1;IFI35;CEACAM1;CCL13;CNN2;IL1RAP;PIK3CA;BRWD1;SRC;CNTFR;SOD1;FGF2;SOCS5;IL15;IRF2;PSMB6;JAK1;YWHAZ;IL4R;CFL1;ACKR3;MAOA;PIK3CD;PSMB5;IL1RL2;CEBPD;EDA2R;SQSTM1;TWIST1;ISG15;PTPRZ1;PDCD4;UGCG;BIRC3;PTK2B;POU2F1;CD40;RSAD2;IRS1;CD86;VEGFA;PSMB8;IL17RE;IRAK2;MT3;CBL;TAB1;PSMC4;PSMD11;CSF1R;PRKACA;SP100;IFITM1;BOLA2;CISH;IFNAR1;SOCS3;MMP2;MAP3K8;PSMB4;JUNB;EDAR;PSMD14;NOD2;IL33;PTPN6;CCL25;CCND1;MT2A;MAPK3;MCL1;CRLF1;IRF5;RIPK1;SPI1;SMARCA4;JAK3;HCK;CDC42;PSMD10;CAPZA1;MYD88;TNFSF8;SYK;MSN;PSME1;RIPK2;IFITM2;NUMBL;F13A1;HNRNPF;FCGR1A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4226004359698166,-1.3478585520341766,0.09482758620689655,0.39639186143694743,1.0,10/29,17.39%,BMP5;DAB2IP;SDHAF2;IL17RD;SPRED2;SPRY2;VASN;SPRY1;MAD2L2;PTEN
prerank,cellular amide metabolic process (GO:0043603),0.36592503730282516,1.3467130766657878,0.0642504118616145,0.8335624224554478,1.0,28/102,17.36%,AEBP1;ALDH1L1;CPN1;ACSM2A;ACSM2B;PLAAT5;PM20D1;PCCA;SMPD3;GLYAT;PANK2;SLC19A1;ORMDL2;CLN8;SMPD2;MTHFS;PLA2G15;ABCA2;NAAA;MTHFD1;MTHFR;CERK;PLAAT3;ACOT1;FPGS;AASDHPPT;MTHFD2;ACOT6
prerank,carbohydrate derivative transport (GO:1901264),-0.48438831229664236,-1.3464125905063957,0.1115702479338843,0.3987607014163004,1.0,6/18,12.19%,SCARB1;SLC10A7;PLTP;NPC2;VLDLR;MFSD2A
prerank,positive regulation of synapse assembly (GO:0051965),0.4588685332802763,1.346334723272883,0.11132437619961612,0.8313227608399482,1.0,10/27,17.49%,IL1RAPL1;NLGN2;WNT7A;VSTM5;GRID2;NLGN3;PTPRD;BDNF;EPHB1;SYNDIG1
prerank,retina homeostasis (GO:0001895),-0.4643331996769133,-1.3458813854927698,0.09090909090909091,0.39925058793284945,1.0,6/23,11.50%,ACTB;POTEF;B2M;ACTG1;SOD1;HSPB1
prerank,mucosal immune response (GO:0002385),-0.5170180547456759,-1.3455259679617682,0.14256198347107438,0.3992534803009042,1.0,3/15,7.56%,DEFA6;RPL39;OTUD7B
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5322380113394207,-1.3454773194157192,0.1342685370741483,0.3986267366624616,1.0,4/12,4.62%,GSN;LY6E;MID2;IFITM3
prerank,axonogenesis (GO:0007409),-0.29708513206471904,-1.3452403019323023,0.0196078431372549,0.3985041333358939,1.0,48/237,12.43%,NRP1;SPTBN1;ACTB;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;PARD3;SEMA7A;NOTCH3;RPS6KA5;NOTCH1;PIK3R1;PLCG1;PALLD;APP;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;CDK5;SRC;SEMA5B;S100A6;B4GALT5;EPHB2;PIK3CD;SEMA3E;DSCAML1;UNC5B;VLDLR;RAB3A;RANBP9;RET;SEMA3G
prerank,positive regulation of axon extension (GO:0045773),-0.4635896252594106,-1.3447820551809886,0.10652173913043478,0.3988162894652942,1.0,8/22,16.30%,NRP1;NTN1;SEMA7A;MACF1;SHTN1;VEGFA;LIMK1;SEMA5A
prerank,regulation of macroautophagy (GO:0016241),0.36231159393502504,1.344576081424133,0.07167235494880546,0.8345539936966835,1.0,26/105,15.49%,PRKAG2;SNX6;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;ATP6V0B;QSOX1;ATP6V1H;CASP3;IKBKG;GPSM1;LRRK2;SESN1;ATP6V1B2;SLC38A9;ATP6V1E1;PAFAH1B2;ATG13;LAMTOR2;ATP6V0E2;TSC1;ATP6V1C1;ATP6V0D2;LAMTOR3;SIRT1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.35694445921346446,-1.344099897806262,0.05392156862745098,0.39947368176634435,1.0,12/67,6.61%,MYO10;PODXL;CAV1;ATP8B1;TBC1D8;ATG3;USP6NL;TBC1D5;IFT140;TBC1D2B;TBC1D1;PPP1R16B
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4063227850060921,-1.3438508913101812,0.07066381156316917,0.39928839252979453,1.0,13/40,12.38%,LEF1;GCNT2;JAG1;TGFB2;NOTCH1;TGFBR2;AXIN2;MDK;TIAM1;TGFB3;TWIST1;COL1A1;BMP2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.503018729529446,-1.3437196935340747,0.11022044088176353,0.39883864803626035,1.0,6/16,13.24%,NOS3;NDNF;GUCY1B1;APOE;DDAH1;GUCY1A1
prerank,positive regulation of apoptotic process (GO:0043065),-0.28687700298518193,-1.3435852331113238,0.003246753246753247,0.398427024242616,1.0,85/293,20.44%,DAB2IP;ITGA6;SLIT2;NET1;FAP;TNFSF10;ARHGEF3;TGFB2;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;PTGIS;NGF;BTG1;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;MYBBP1A;RPS3;RPS6KA2;CTSD;CDK5;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TLE5;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;ZC3H12A;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,cellular response to interleukin-6 (GO:0071354),-0.4376049106828028,-1.3431814280736736,0.11158798283261803,0.3985679938105171,1.0,8/26,10.02%,PID1;IL6ST;ST3GAL6;PTGIS;STAT3;IL6R;SRC;JAK1
prerank,mononuclear cell differentiation (GO:1903131),-0.4497850033968678,-1.3422173842368346,0.10602910602910603,0.3999837541354632,1.0,8/24,15.76%,GAS6;MYH9;BMP4;LYN;RELB;MT1G;VEGFA;CSF1R
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.39889457990345933,-1.3421980155660833,0.07725321888412018,0.3993181418341627,1.0,12/39,9.74%,MAML2;IL6ST;JAG1;NOS3;TGFB2;NOTCH1;STAT3;CCN3;JAG2;EPN2;SRC;NOTCH4
prerank,myoblast differentiation (GO:0045445),0.5361571199558346,1.3416632362435168,0.14538310412573674,0.8431842765239748,1.0,6/14,8.75%,EPAS1;IGF1;DDX5;NRG1;DDX17;HINFP
prerank,adenine nucleotide transport (GO:0051503),-0.4906170764907618,-1.3414183654530745,0.10810810810810811,0.40024729745253246,1.0,4/17,6.87%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,protein phosphorylation (GO:0006468),-0.27449677291551483,-1.3408791914289728,0.0,0.4007186597743037,1.0,153/479,23.22%,PRKG1;PRKCH;TEK;ABI1;ERG;SNRK;BMPR2;DAB2IP;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;STK38L;PKD1;GAS6;STK3;PEAK1;EGFR;LIMK2;EEF2K;BCR;BMP4;AKT3;TGFBR2;IRAK3;KDR;APP;CRY1;CDK14;RPS6KA3;FNIP2;BMX;TNIK;CAB39;NUAK1;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;TEC;PRKD1;CIT;TNKS;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;FLT1;CSNK1G3;PRKX;PRKCG;RPS6KA2;STK24;CDK5;SRC;FLT4;MAP4K4;EIF2AK3;STK33;MAPKAPK2;ABI3;GTF2H5;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GTF2H1;VRK3;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;INCENP;BMP2;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;PKN3;ALK;LIMK1;CSF1R;PRKACA;MKNK2;TAOK3;CAD;MAST2;FGFR3;COQ8A;LATS1;MASTL;STRADA;TAOK1;HUNK;PTPN6;PRAG1;STK26;MAPK12;CDK16;EFEMP1;CDK6;MAPK3;BTK;CAMK1G;MARK3;STK17B;RIPK1;JAK3;HCK;TRIB2;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;SYK;ROCK1;TOP1;CDKL4;CCNH;SLK;FYN;SIK3;MAP4K3;RYK;CDK11B;PRKAR1B;STK32C;USP15;CDK18
prerank,regulation of cell size (GO:0008361),-0.44532529753189176,-1.3405304500732205,0.1069182389937107,0.4007414437615197,1.0,9/23,21.28%,RHOA;VAV2;RPTOR;EDN1;RARG;PRR16;PTEN;AKT1S1;MSN
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.42802436209141076,-1.34034646592572,0.1,0.4004261868839114,1.0,10/29,12.95%,RPA1;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3941962289044736,-1.3401949563632327,0.08163265306122448,0.400062568368088,1.0,10/41,10.46%,MEF2C;JAG1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;HEY2;CPE
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5557684994584,1.3395458975585044,0.15495867768595042,0.847875692921734,1.0,2/12,0.41%,NOTCH2;DOCK11
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3374685487948172,-1.3394841497768382,0.04591836734693878,0.40091707617026195,1.0,24/91,10.04%,ABCG2;SLC39A10;SCARA5;SLC40A1;APP;SLC30A1;SLC39A8;TFRC;SLC30A9;SLC31A1;ATOX1;ATP6V0D1;SOD1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;CAND1;SLC39A7;FTL
prerank,regulation of exocytosis (GO:0017157),0.4165775273283546,1.339394168702578,0.11030741410488246,0.8444418553842347,1.0,16/46,16.47%,IL1RAPL1;UNC13D;CHMP6;RAB21;SYT1;CLASP1;RAB3C;STXBP5L;NSF;CPLANE2;RAB2B;RAB13;CPLX1;CADPS2;STX4;CPLX2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.538111533824027,-1.338970915559425,0.1388888888888889,0.40132482193183355,1.0,4/13,7.25%,RUNX1;TGFBR2;GLI3;CBFB
prerank,superoxide metabolic process (GO:0006801),-0.4327681226704409,-1.3382477079825954,0.12343096234309624,0.40219646111571244,1.0,8/29,16.67%,SH3PXD2A;NOS3;SH3PXD2B;SOD1;NCF2;MT3;NRROS;PREX1
prerank,negative regulation of axon extension (GO:0030517),-0.4232426427778698,-1.3381590808672963,0.12147505422993492,0.40170945880686126,1.0,13/30,22.00%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;MT3;SEMA5A;RTN4;SEMA6D;SEMA3F;RTN4R;SEMA4C
prerank,natural killer cell activation (GO:0030101),-0.45202141327730183,-1.337418961479295,0.11618257261410789,0.4027133460339481,1.0,7/23,16.52%,PBX1;KAT7;ELF4;PIK3CD;NFIL3;PTPRC;ULBP1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5214746608734441,1.337416196958077,0.15204678362573099,0.8486496916189965,1.0,4/15,11.59%,CPEB2;PPIF;GSTO2;GSTO1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5259782706794012,-1.3370061022071065,0.1267605633802817,0.40286583461311365,1.0,4/13,14.31%,TMEM30A;SEC16B;INSIG1;SAR1A
prerank,protein homotetramerization (GO:0051289),0.4105802829600526,1.3367164946468952,0.07747747747747748,0.8474866656837464,1.0,4/49,1.13%,ALDH1A2;UPB1;APPL2;TRPV1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3808002346334317,-1.3365992545570295,0.06622516556291391,0.403020010581248,1.0,22/48,30.26%,ACTB;ARID1B;MYBBP1A;ARID1A;SERTAD1;ATAD2;POLR1F;POLR1G;POLR1A;ZMIZ2;CDCA4;ZMIZ1;CHEK1;POLR1H;MYO1C;POLR2F;POLR1E;POLR2H;DDX21;POLR1C;POLR2E;SMARCA5
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4611524104378681,-1.3364812604600926,0.1127659574468085,0.4025593678853761,1.0,9/21,26.39%,MYH9;ADAM10;ADAM19;SPPL3;HM13;PSEN2;PSENEN;ERAP1;PRTN3
prerank,bone morphogenesis (GO:0060349),-0.519541782789087,-1.3359743092728742,0.12269938650306748,0.4030389611745133,1.0,4/14,3.34%,BMPR2;LRP6;LRP5;SFRP4
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5783809871486133,1.3354275295746427,0.15481171548117154,0.848991161495461,1.0,3/11,3.73%,LEPROT;ACTN2;PICALM
prerank,cholesterol metabolic process (GO:0008203),0.37430368182488033,1.334313453660902,0.08442776735459662,0.8495121559838166,1.0,21/68,18.60%,CEL;ACAT2;SOAT2;CYP11B1;INSIG2;DHCR24;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;MSMO1;GGPS1;ABCA5;HMGCR
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.530962491265763,-1.3342196927998613,0.14313725490196078,0.40634554126774974,1.0,8/13,35.75%,RACK1;NCK1;PTPN1;ATF6B;WFS1;HSPA5;ABCA7;DDRGK1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33820479230349826,-1.3341248073892134,0.05089058524173028,0.40586828211943304,1.0,33/93,22.51%,DAB2IP;SH3RF3;TRAF5;TGFB2;MAP3K5;RASSF2;MID1;APP;MFHAS1;XDH;FLT4;EDA2R;BMP2;PTK2B;TNFRSF19;ANKRD6;VEGFA;MTURN;TAOK3;KLHDC10;EDAR;RELL1;NOD2;TAOK1;ZC3H12A;SH3RF1;RIPK1;SPI1;HMGB1;TRAF4;MAP3K4;SEMA4C;FCGR2B
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4174234425659925,-1.3338737462810897,0.10904872389791183,0.40571860804871934,1.0,13/35,13.79%,NRP1;TEK;NTRK3;TJP1;ESAM;F11R;ARHGDIB;MDK;CDK5;ABI3;SEMA3E;PTK2B;ARHGDIA
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.46010454929314404,-1.3332770329559955,0.11464968152866242,0.4064070428220305,1.0,9/22,12.95%,UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,retinoid metabolic process (GO:0001523),0.3822509250991621,1.3330373907892243,0.08571428571428572,0.8508491194903705,1.0,7/71,2.49%,ALDH1A2;ALDH8A1;ADH7;ADH4;ABCA4;RBP1;CYP26B1
prerank,positive regulation of histone methylation (GO:0031062),0.4666029717558077,1.3322989530935236,0.11909262759924386,0.8499626745966288,1.0,6/24,8.14%,CTR9;KMT2A;TET1;AUTS2;JARID2;PHF1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4191882677290926,1.3322647392008529,0.10476190476190476,0.8461525013459883,1.0,9/46,10.26%,ATP1A2;CACNG7;NLGN2;SYT1;NLGN3;ATAD1;LRRK2;DRD3;DGKI
prerank,indolalkylamine catabolic process (GO:0046218),0.5875410584216905,1.33217316434183,0.146484375,0.8425904686187241,1.0,3/10,9.06%,IDO1;HAAO;KMO
prerank,negative regulation of cell cycle (GO:0045786),0.3790871045690465,1.3320738679975999,0.08020477815699659,0.8390929220727222,1.0,14/73,7.55%,BMP7;NUPR1;SMAD3;CDKN2A;GMNC;ANGEL2;TSPYL2;PLK1;NLRP2B;CEBPA;HTRA2;NR2F2;TRIM35;INHA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.42641939153987635,1.3315520203293665,0.108348134991119,0.8374566618328566,1.0,11/37,11.69%,TTC21B;WDR19;IFT74;WDR35;DYNC2LI1;KIF3C;DYNC2I2;IFT122;PCM1;KIF3A;IFT80
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5533495430526685,-1.331179365463541,0.150390625,0.41023575637393195,1.0,4/10,11.47%,ACER2;CYP1B1;SERPINE1;JAM3
prerank,liver development (GO:0001889),0.42639015308669037,1.33079836339947,0.125,0.8366932619915716,1.0,5/32,9.21%,TGFBR3;WNT4;CEBPA;PHF2;E2F8
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2902464714053749,-1.330380277576625,0.005797101449275362,0.41129959322633847,1.0,61/259,15.14%,NRP1;ABCC4;FGD5;DNM3;RAPGEF2;ABLIM1;VCL;FGD6;NTN1;FXYD5;GSN;PARVB;NOTCH1;PKD1;DISC1;RAP1A;CDH13;EMP1;SPATA13;MTSS1;EXOC6;EXOC4;FAM161A;TNIK;FLNA;IFT140;RAP2A;ITGB1;S1PR1;ABLIM3;ARL13B;RAPGEF6;BBS9;EMP2;ATP6V0D1;PDE6D;MAP4K4;RP2;GOLPH3;CD2AP;WHAMM;PARVA;EHD2;EXOC1;WDR11;TCTN3;PIBF1;SNX10;FNBP1L;EHD4;ATP6V1D;ABLIM2;HDAC6;SHTN1;DYNLL1;AVIL;CYS1;DZIP1L;BBIP1;TMEM216;CFAP43
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.504370750341298,-1.3295361420012883,0.12159329140461216,0.4125653423109624,1.0,5/15,20.12%,TGFB2;IRAK3;TGFB3;JAK3;CUEDC2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.35134058958483894,-1.3294262775129138,0.07090464547677261,0.4120670236446257,1.0,26/71,20.23%,SGMS1;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;ST6GALNAC5;CERS5;CERS6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3
prerank,regulation of B cell proliferation (GO:0030888),-0.3908715451076708,-1.3290642407811897,0.0757238307349666,0.4121588857813673,1.0,12/44,16.03%,MEF2C;TFRC;LYN;TNFRSF21;CD38;AHR;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5065095710012981,-1.327326555355065,0.13861386138613863,0.41520295814081476,1.0,11/14,47.19%,TYROBP;POU4F1;ATP6AP1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;IL12B
prerank,macrophage differentiation (GO:0030225),-0.5190928287021738,-1.3269754978430874,0.13163064833005894,0.4152478670109472,1.0,7/13,28.72%,BMP4;IL15;VEGFA;CSF1R;CDC42;CASP8;PARP1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.451627764178281,-1.326937061878523,0.12631578947368421,0.4146247750167048,1.0,11/21,21.29%,NOS3;NOTCH1;GAS6;ASPN;HEY2;PTK2B;ECM1;ENPP1;HEY1;GREM1;ROCK1
prerank,positive regulation of synaptic transmission (GO:0050806),0.37182085766020045,1.3265154607162308,0.09271523178807947,0.8510944847330331,1.0,14/72,9.52%,SLC8A3;CACNG7;PRKCZ;NLGN2;ZDHHC12;ADCY1;GRIN2D;SYT1;ADCY8;NLGN3;GRIK2;SHISA7;RIMS1;DLG4
prerank,primary alcohol metabolic process (GO:0034308),0.46392502264517477,1.326297679486385,0.1360153256704981,0.8481942718560219,1.0,4/25,2.63%,IGF1;ADH7;ADH4;CYP11B1
prerank,metal ion homeostasis (GO:0055065),-0.39802222714224517,-1.3262510474112565,0.1145374449339207,0.4154519506019485,1.0,17/40,28.40%,TMTC2;CAV1;SLC12A7;SLC12A2;SLC12A6;JPH2;CNNM2;MT3;SLC7A8;GRIN1;SLC12A8;SLC8A1;LETM1;WFS1;SELENON;SLC12A4;TESMIN
prerank,tryptophan metabolic process (GO:0006568),0.5714164362720192,1.3259775096791326,0.15247524752475247,0.8456828311006652,1.0,5/11,19.53%,IDO1;HAAO;KMO;ATP7A;KYAT1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.48811420819745716,1.3259728236543424,0.14849624060150377,0.8419246585462988,1.0,3/20,6.77%,WNT4;GCK;C1QTNF3
prerank,negative regulation of cell development (GO:0010721),0.4634331382351717,1.3258988875975377,0.1320754716981132,0.8384464314212409,1.0,5/25,5.27%,IGF1;APPL2;RFLNA;WNT7A;PAX6
prerank,regulation of histone methylation (GO:0031060),0.5452749992113383,1.3257508106519875,0.1669902912621359,0.8353603399041895,1.0,6/13,15.32%,CTR9;TET1;JARID2;NSD1;PIH1D1;MTHFR
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5571269185266483,-1.3246536941959373,0.16188524590163936,0.41840484128841016,1.0,4/10,16.85%,ETFBKMT;HDAC6;MT3;AOC3
prerank,potassium ion homeostasis (GO:0055075),0.4809871612778751,1.3244922210650811,0.127134724857685,0.8368358095816595,1.0,6/23,11.41%,ATP1A2;ATP1B3;ATP1B2;KCNH2;SLC12A5;SLC12A1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3215364628801419,-1.3241027298771109,0.04556962025316456,0.4189660592336539,1.0,29/114,21.47%,LIMS1;ACTN4;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;AIM2;PSMA6;TNFRSF11B;PSMB7;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;PSMB4;EDAR;PSMD14;RIPK1;PSMD10;TNFSF8;PSME1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4372691307846929,-1.3239307096338253,0.12938596491228072,0.41858639757784044,1.0,15/27,22.98%,VPS13C;RAB6A;TMED10;GBP5;GOLPH3;RIPOR1;VPS13D;VPS13A;ARL5A;SYS1;PAQR3;BICD2;COG7;CSNK1D;GAK
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3355529593992126,-1.3235173803858782,0.061611374407582936,0.4187992618451931,1.0,37/80,26.85%,TNFSF10;MAP3K5;YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;NOD1;CARD16;BCAP31;CTSD;SRC;XIAP;GPX1;KLF4;MALT1;SOX7;USP47;CSNK2A1;VEGFA;ACVR1C;MT3;GPER1;SH3RF1;FOXL2;HMGB1;BEX3;SYK;CASP1;BCL10;TRIAP1;DAPK1;EPHA7;F2R;ARL6IP1;RPS6KA1
prerank,catecholamine metabolic process (GO:0006584),0.5323615366302576,1.3229063072341483,0.1425891181988743,0.8397276976692089,1.0,5/14,18.63%,SNCAIP;DRD3;COMT;ATP7A;RNF180
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4828968818332319,1.3223122248756831,0.13295880149812733,0.8385133744781512,1.0,2/22,2.46%,ALDH1A2;RBP1
prerank,intracellular lipid transport (GO:0032365),0.47183246508221943,1.3219872551370733,0.12430426716141002,0.836244399404067,1.0,2/21,1.77%,PRKAG2;PRKAA2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.45654057930417113,1.321934934849844,0.12686567164179105,0.8328410830689584,1.0,7/26,9.68%,OSBPL8;IGF1;CLIP3;PRKCI;SORBS1;RHOQ;CREBL2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5585791979395458,-1.3210431442639692,0.12075471698113208,0.4235358523840243,1.0,6/10,22.57%,ACTN4;RARB;TBX1;RARG;SNW1;RXRG
prerank,cellular response to calcium ion (GO:0071277),0.3794338297165968,1.3203649665394137,0.09666080843585237,0.8357899924510968,1.0,16/67,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SYT10;TRPM2;CPNE6
prerank,organic cation transport (GO:0015695),-0.4694565536871224,-1.319846985343308,0.13807531380753138,0.42561449628600856,1.0,5/20,12.51%,SLC47A1;SEC14L1;SLC44A2;SLC22A18;SLC44A1
prerank,heterochromatin organization (GO:0070828),-0.4949218615987292,-1.3197525634431133,0.11900191938579655,0.42512136898577096,1.0,3/14,6.30%,MECOM;PRDM16;EZH1
prerank,ganglioside biosynthetic process (GO:0001574),-0.49757147876240815,-1.3197260873200076,0.11904761904761904,0.42446974090294026,1.0,8/15,17.75%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2;ST3GAL2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.536800162338237,1.3196457945570939,0.1726315789473684,0.8352978804419212,1.0,2/12,1.72%,ANXA6;ANK2
prerank,tight junction assembly (GO:0120192),-0.3805209243461686,-1.318940701165251,0.08297872340425531,0.42558551046550963,1.0,13/49,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;ACTG1;LSR;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.38345686481559826,-1.318025972736632,0.09843400447427293,0.4269444204760224,1.0,15/44,14.84%,DAB2IP;BMP4;PTPRJ;IRAK3;DNAJA1;LYN;PRKCD;SPRY2;PTPN1;APOE;AIDA;PDCD4;STK38;SPRY1;PAQR3
prerank,granulocyte chemotaxis (GO:0071621),-0.3699878476809391,-1.3179496037894822,0.09154929577464789,0.42637800325271813,1.0,27/55,40.70%,BSG;TGFB2;PPIA;ANXA1;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,inorganic anion transport (GO:0015698),0.3887299164527938,1.3177057701354848,0.0975177304964539,0.8397387880628683,1.0,11/53,9.87%,SLC13A4;SLC5A5;ENPP3;SLC26A1;GLRA1;CLCN6;SLC25A11;CLCN2;NMUR1;SLC34A3;CLCN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5342022972275587,-1.3175112930204973,0.14468085106382977,0.42597931627956576,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5342022972275587,-1.3175112930204973,0.14468085106382977,0.42597931627956576,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,vasodilation (GO:0042311),-0.5147585089981153,-1.31706350985308,0.14760914760914762,0.42622916445543774,1.0,4/13,17.68%,NOS3;SOD1;KLF2;GPER1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4966485503363591,-1.3169288167243236,0.1656441717791411,0.4258555514118463,1.0,3/14,1.27%,PRKG1;MEF2C;SLIT2
prerank,regulation of viral entry into host cell (GO:0046596),-0.4186189276578807,-1.3162910579580362,0.11538461538461539,0.42655990945576333,1.0,8/30,12.21%,GSN;LY6E;MID2;IFITM3;TRIM14;TRIM25;CD74;NECTIN2
prerank,tryptophan catabolic process (GO:0006569),0.5760528196089231,1.3160442150708613,0.137524557956778,0.842633813657763,1.0,3/11,9.06%,IDO1;HAAO;KMO
prerank,sphingolipid metabolic process (GO:0006665),-0.3232195409266716,-1.3159612949200086,0.04415584415584416,0.42662243416805695,1.0,38/108,22.64%,SGMS1;ST6GALNAC3;ESYT2;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ORMDL3;PLPP1;SAMD8;ESYT3;HEXA;ELOVL6;PSAP;UGCG;ARSA;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3;ARV1;PPP2CA;GLTP;CERS4;PLPP2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.48612232453865656,1.315850748358623,0.13358778625954199,0.8397456241039811,1.0,5/21,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,regulation of ion transport (GO:0043269),0.3664240300673052,1.3154347814894447,0.09782608695652174,0.837957816929037,1.0,16/76,11.44%,SYT11;SYT12;SNX6;KCNJ13;KCNJ5;SYT9;KCNJ10;SYT1;SYT13;CHRNB2;DRD3;PDZK1;KCNJ16;SYT10;CHRM1;DTNBP1
prerank,histone H2B ubiquitination (GO:0033523),0.5823870992632262,1.3149659959976387,0.1626984126984127,0.8364278177296772,1.0,4/10,11.83%,CTR9;LEO1;RNF20;CDC73
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4885292423342913,-1.3148695245873372,0.164969450101833,0.4283837539871264,1.0,6/16,16.12%,INSR;IRAK3;MTRF1;HDAC6;TBC1D25;CLEC16A
prerank,blood circulation (GO:0008015),-0.3682777455794364,-1.3142169421854026,0.08874458874458875,0.4292230130375518,1.0,17/49,13.59%,ELN;NOS3;ACVRL1;MEOX2;GUCY1B1;TBC1D8;SGCD;AGTR1;CXCL12;SOD1;GPX1;GCLC;EDN3;ACE2;GCLM;GUCY1A1;CYB5R3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4916137223281801,1.3139180057106326,0.1637323943661972,0.8372058113210238,1.0,4/18,8.02%,ATP1A2;STK39;PPIF;KCNH2
prerank,regulation of establishment of protein localization (GO:0070201),-0.5164484885510855,-1.3137916792390976,0.137524557956778,0.4294189845409457,1.0,8/13,27.30%,DNAJA1;CTSD;GAPVD1;PTP4A3;CEP295;SPIDR;TREM2;SCFD1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3884923645902521,1.3134660660626916,0.1054421768707483,0.835595390998627,1.0,18/57,19.03%,CACNG7;ACTN2;NLGN2;NPTX1;DLG1;SHISA7;SHANK1;GSG1L;DLG4;NPTXR;CNIH3;OPRM1;SHISA8;LRRC7;GRIA2;NEFL;MINK1;MAPK8IP2
prerank,positive regulation of macrophage migration (GO:1905523),-0.4724173882957962,-1.3132613316307014,0.11578947368421053,0.429946580067816,1.0,9/19,27.07%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3;CMKLR1;TREM2
prerank,embryonic limb morphogenesis (GO:0030326),-0.40324401105528473,-1.313113403838379,0.1137855579868709,0.42961288051251767,1.0,12/34,12.91%,MBNL1;ECE1;LRP6;TGFB2;TBX3;GLI3;MAP3K20;NIPBL;TWIST1;PTCH1;RARG;TBX2
prerank,lung development (GO:0030324),0.436659081061358,1.3130771306128206,0.12701252236135957,0.8337106205519053,1.0,7/33,6.95%,FGF1;ERRFI1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,regulation of kinase activity (GO:0043549),-0.3396183364400541,-1.3127280338402936,0.06619385342789598,0.4297510085988492,1.0,21/89,12.90%,ROR1;TEK;NTRK3;PLCE1;TIE1;INSR;MERTK;EGFR;EEF1A1;KDR;MET;NLRC5;FLT1;EMP2;CDKN1C;SOD1;FLT4;EPHB2;CD74;RET;ROR2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.33303315685862417,-1.3125858777651036,0.05013192612137203,0.4293230681626388,1.0,25/86,14.01%,ARHGEF28;PLCE1;DAB2IP;TGFB2;NOTCH1;STARD8;NGF;BCR;KANK1;STARD13;ARHGEF2;EPS8;ARHGDIB;LYN;SHOC2;SPRY2;EPS8L2;EPHB2;LRRC59;SQSTM1;GABARAP;ARHGDIA;DENND4B;SPRY1;MADD
prerank,steroid hormone biosynthetic process (GO:0120178),0.4386573072648923,1.3121128506738176,0.127134724857685,0.8340858780761832,1.0,9/29,23.22%,HSD17B2;CYP11B1;MED1;FDX1;STAR;FDX2;HSD17B11;FDXR;TSPOAP1
prerank,response to muramyl dipeptide (GO:0032495),-0.5325809629986626,-1.311959943231457,0.13717693836978131,0.43010895099387075,1.0,6/12,21.51%,NOD1;ARHGEF2;NOD2;ERBIN;IRF5;RIPK2
prerank,lipid homeostasis (GO:0055088),0.3821624395046034,1.3117432222216339,0.11655405405405406,0.8321816154015481,1.0,22/57,21.69%,PRKAA2;RBP1;FITM2;ABHD5;PNPLA8;CEBPA;ADCK1;ORMDL2;CLN8;ABCD1;NR1H3;USF1;DGAT2;ABCA2;ABCB4;SIRT1;TM6SF2;TLCD3A;MLXIPL;DDX3X;ATP13A2;RCN3
prerank,glucose import (GO:0046323),-0.5196672789516233,-1.3115834287261763,0.15384615384615385,0.4302103559574058,1.0,4/13,13.54%,SLC2A1;SLC2A3;SORT1;ZDHHC7
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.37738498887810645,-1.3113988342971183,0.08486238532110092,0.4299617196521336,1.0,24/47,30.39%,PID1;THBS1;TGFBR2;PLCG2;XDH;AGTR1;PRKCD;SOD1;ACE2;RAB27A;ROMO1;GRIN1;DHRS4;ZC3H12A;CBR1;RIPK1;SYK;TLR4;GRB2;DCXR;AGT;MAPT;CD36;TLR6
prerank,negative regulation of protein transport (GO:0051224),0.4525080868563889,1.310559766257423,0.11940298507462686,0.8338451756078035,1.0,10/25,18.74%,NDFIP1;PKDCC;SERGEF;DRD3;CYP51A1;SNX3;NDFIP2;IL12A;HMGCR;RHBDF1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5392057139716087,-1.3104359679379105,0.17270788912579957,0.4315401685031949,1.0,5/11,13.94%,SEMA6A;THBS1;CREB3L1;EPN2;KLF2
prerank,magnesium ion transport (GO:0015693),0.5321095028404919,1.3088368986518226,0.1683366733466934,0.8372404286303753,1.0,5/12,19.09%,SLC41A1;TUSC3;MAGT1;MMGT1;MRS2
prerank,regulation of acute inflammatory response (GO:0002673),-0.47785815287813055,-1.3084464271230458,0.15631691648822268,0.4353946788912967,1.0,2/18,1.02%,IL6ST;OSMR
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3506495679460012,-1.3074982630426686,0.07586206896551724,0.4368088604957943,1.0,26/65,28.72%,LEF1;FOXP1;MYH9;RUNX1;BMP4;TGFBR2;CBFA2T3;TNFRSF11A;MT1G;IL15;PIK3CD;SNX10;VEGFA;CSF1R;SPI1;CDC42;SBNO2;OSTM1;CASP8;PRTN3;EFNA2;TREM2;CDK2;BATF2;FARP2;PARP1
prerank,mismatch repair (GO:0006298),0.45284440603977383,1.3074051101481887,0.14071294559099437,0.8395933576682706,1.0,10/27,15.25%,RNASEH2A;ERCC1;PMS2;POLD2;MSH4;MSH6;MLH3;MSH3;RPA3;ABL1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.40904904696690614,-1.307131428267351,0.10752688172043011,0.4369561494154813,1.0,9/34,14.95%,PLCE1;SLIT2;WASF2;PIK3R1;OCLN;PIK3CA;ABI3;AVIL;ARPC2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.301782782256423,-1.306892544970024,0.033426183844011144,0.4368176571411444,1.0,44/161,18.06%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;SFRP4;TBX18;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11;IGFBP4;LATS1;PSMB4;PSMD14
prerank,gluconeogenesis (GO:0006094),0.41711717817175165,1.3066967141053236,0.1252302025782689,0.8390825486755568,1.0,17/39,21.46%,ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5266434573031841,-1.3066328838515515,0.14675052410901468,0.4352793646793574,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5266434573031841,-1.3066328838515515,0.14675052410901468,0.4352793646793574,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5266434573031841,-1.3066328838515515,0.14675052410901468,0.4352793646793574,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,regulation of stem cell proliferation (GO:0072091),0.5047512101868288,1.3063852929300817,0.16666666666666666,0.8369666424312409,1.0,6/17,17.54%,FBLN1;HNRNPU;EIF2AK2;AGO3;TERT;KDM1A
prerank,erythrocyte differentiation (GO:0030218),0.4105461724209409,1.306286705558844,0.11545293072824156,0.8340106602840169,1.0,9/44,8.34%,TGFBR3;KIT;FLVCR1;SLC25A5;IKZF1;ABCB10;CASP3;INHA;MED1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3484504595190558,-1.3061650841429144,0.07196029776674938,0.4356114701819559,1.0,25/69,26.41%,SLIT2;ESAM;KANK1;SSH2;KANK3;CDC42EP5;CDC42EP3;KANK4;PRKCD;NCK1;CDC42EP2;HIP1R;PLEKHG2;PTK2B;PFN1;NCKAP1L;LATS1;FCHSD1;HCK;RASA1;HCLS1;SSH1;PRKCE;CARMIL1;TWF2
prerank,response to histamine (GO:0034776),0.5596957437471088,1.306003453301007,0.17995910020449898,0.8317686364569029,1.0,4/10,18.56%,DRD3;GABRB2;HRH1;GABRB3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4519468213813256,-1.3059954880453182,0.14444444444444443,0.43528892866963065,1.0,9/21,19.95%,PDE4D;CAV1;RASSF2;RACK1;NCK1;PAQR3;DDIT4;PTEN;DMD
prerank,regulation of cell growth (GO:0001558),-0.2948358857888557,-1.3059440884232265,0.020710059171597635,0.4346909581697024,1.0,51/204,17.54%,APBB2;LTBP4;PLCE1;BMPR2;SLIT2;NET1;ACVRL1;TGFB2;DCUN1D3;SH3BP4;EGFR;SOCS2;BTG1;PTPRJ;H3-3A;FHL1;RPS6KA3;CCN3;SOX17;CCDC85B;TFRC;CAMK2D;AGTR1;RACK1;ADAM10;CEACAM1;BCAR1;CDKN2AIP;RPTOR;FAM107A;PABIR1;NME6;DCUN1D5;MFSD2A;SIPA1;USP47;CSNK2A1;RERG;ENPP1;PTCH2;ADAM15;MT3;NCBP1;KLHL22;MAD2L2;DDX49;RTN4;CDA;CISH;NUBP1;OSGIN1
prerank,cellular amino acid catabolic process (GO:0009063),0.3623813254008586,1.3056814755031114,0.09359605911330049,0.8296887422294973,1.0,18/87,11.65%,DDO;IDO1;ALDH7A1;IVD;SLC25A44;DBT;ACAT1;GLDC;HAAO;ACADSB;ECHS1;BCAT2;ASPA;KMO;GLS2;BCKDHB;GAD1;GCDH
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5147013258840727,1.3054642931255773,0.16346153846153846,0.827276824625184,1.0,8/15,22.55%,FANCD2;EME2;MDC1;MRE11;CHEK2;RAD17;RAD9B;ATF2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5478752164445428,-1.3049476132880746,0.15942028985507245,0.4362320299773416,1.0,5/11,18.03%,WIPI1;APOE;PIK3C3;UGCG;WDR45B
prerank,sensory perception of taste (GO:0050909),0.562820194781738,1.3044475074303374,0.17901234567901234,0.8280448919202503,1.0,1/10,0.51%,TAS1R2
prerank,myofibril assembly (GO:0030239),0.40983347529366215,1.3039577223470398,0.11071428571428571,0.82676252672178,1.0,8/42,10.07%,ACTN2;PDGFRA;OBSL1;CAPN3;CSRP3;CSRP1;TMOD2;CFLAR
prerank,steroid biosynthetic process (GO:0006694),0.3843732589845465,1.3036088587500811,0.09719626168224299,0.8248497001275374,1.0,18/56,21.56%,PRKAG2;CYP11B1;INSIG2;PRLR;SC5D;DHRS11;CYP27A1;AMACR;OSBPL9;SQLE;CYP51A1;STAR;MSMO1;HMGCR;HSD17B4;LBR;FDXR;HSD11B1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4855909198121249,1.3035059882279756,0.1727447216890595,0.8220579916004249,1.0,10/18,22.48%,ASPG;ADI1;ASPA;SLC25A12;GOT1;MTHFD1;MTHFR;GOT2;SLC25A13;MSRA
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3434768971728235,-1.3031802249854352,0.06950672645739911,0.43948649751089397,1.0,16/65,8.91%,CAV1;LTBP1;HTRA3;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;FBN1;ASPN;SPRED2;RPS27A;UBB;SPRY2;VASN
prerank,melanocyte differentiation (GO:0030318),0.5569864663833382,1.3025404824946958,0.18253968253968253,0.8225736022830052,1.0,3/11,6.63%,LRMDA;KIT;CITED1
prerank,gland development (GO:0048732),-0.351286683888946,-1.302250094538435,0.08436724565756824,0.4408774352378301,1.0,16/59,9.74%,CAV1;IGSF3;TBX3;LSR;SIX1;TBX1;MET;HES1;ANXA1;ARHGAP35;MDK;STRA6;ZBTB1;SOD1;TGFB3;NOTCH4
prerank,focal adhesion assembly (GO:0048041),-0.4504626882257915,-1.3017643196643844,0.1375,0.4411893741662057,1.0,7/21,10.16%,THSD1;PEAK1;BCR;PTPRK;ACTN1;SRC;WHAMM
prerank,prostanoid metabolic process (GO:0006692),0.535796829808777,1.3016290447267154,0.176,0.8229269481673495,1.0,3/13,7.80%,PTGS1;PTGES;PTGR1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4145683512292355,-1.3015024614324058,0.11904761904761904,0.44113127329594676,1.0,8/28,19.85%,DAB2IP;NGF;CRADD;CASP8AP2;SORT1;GABARAP;DIABLO;SPI1
prerank,negative regulation of chemotaxis (GO:0050922),-0.41101247454810574,-1.3014118021846126,0.14757709251101322,0.44063442381802814,1.0,13/31,16.65%,SEMA6A;SEMA3C;SLIT2;SEMA7A;THBS1;NOTCH1;ANGPT2;SEMA5B;DUSP3;SEMA3E;SEMA3G;SEMA5A;SEMA6D
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3469687761347304,1.3009715655680476,0.07084019769357495,0.8222632079733504,1.0,22/107,12.83%,ATP1A2;SLC8A3;CEL;SNCAIP;NLGN2;NPTX1;GRID2;IQSEC2;SYT1;NLGN3;GRIK5;GRIK2;RIMS1;LRRK2;CHRNB2;DLG4;DGKI;LRRC4C;NPTXR;SYN3;BDNF;CPLX1
prerank,anterograde axonal transport (GO:0008089),0.41328380181841146,1.3005085306410802,0.11403508771929824,0.8210326730638714,1.0,16/37,23.72%,TRAK1;KIF5C;RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1;MAP1A;DLG2;SPAST
prerank,negative regulation of complement activation (GO:0045916),-0.5423057825526303,-1.3003750341407065,0.1704781704781705,0.44238260319039907,1.0,4/10,16.58%,CR1L;CD55;SUSD4;CD46
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5270538040008916,-1.3000493345073725,0.168,0.4424393008907672,1.0,3/12,4.28%,BMP5;SLIT2;CCN3
prerank,transition metal ion transport (GO:0000041),-0.3970337523391585,-1.2997776305826443,0.1279826464208243,0.4423335025841551,1.0,12/35,14.78%,TRPC3;SLC30A1;SLC39A8;TFRC;SLC30A9;TRPC6;SLC31A1;TRPC4;ATOX1;TRPC1;SLC30A5;MT3
prerank,presynapse organization (GO:0099172),0.5635965079405311,1.299546005223809,0.20876826722338204,0.8217420847938433,1.0,3/10,7.03%,NLGN2;WNT7A;NLGN3
prerank,regulation of JUN kinase activity (GO:0043506),-0.40745468697698484,-1.2993953854025184,0.12268518518518519,0.4425021409402587,1.0,8/33,11.79%,DAB2IP;MAP3K5;DNAJA1;TNFRSF11A;RPS3;AIDA;EDN1;PDCD4
prerank,carbohydrate catabolic process (GO:0016052),0.41245516539513716,1.2989628730737064,0.12681159420289856,0.8210169521927543,1.0,9/38,7.77%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;NAGA;HKDC1;MAN2C1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5119076100486364,-1.2988197986362333,0.1592356687898089,0.4431596602520468,1.0,5/13,14.72%,GAS6;WNT5A;CD74;AGPAT1;IFIH1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.45124032973628964,-1.2986761549329604,0.15031315240083507,0.4428039209126107,1.0,7/21,18.14%,YWHAE;MFHAS1;YWHAB;PPP1R16B;BOD1L1;PPP1R11;MASTL
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5448327369612724,-1.298616012518869,0.18997912317327767,0.44223423501533365,1.0,3/10,20.69%,CAV1;KCNE4;KCNAB1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.40324225339987535,-1.2974958462248531,0.16344086021505377,0.44421322852273554,1.0,17/32,26.63%,CDK17;CDK14;BRD4;KLF11;CDK5;FBXO5;ORC1;DHFR;ID2;CDK16;CDC45;POLA1;CDK18;E2F7;TYMS;NPAT;TFDP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4570070937153249,-1.297229676922062,0.1515748031496063,0.4441056475278726,1.0,6/19,13.74%,SLC26A2;BPNT2;PAPSS2;SLC35B3;TPST2;ENPP1
prerank,organic substance transport (GO:0071702),-0.3095173125829267,-1.2971744168274577,0.044009779951100246,0.4435167781438483,1.0,22/121,9.19%,ABCG2;SLC47A1;CALCRL;ATP8A1;DISP1;SLCO2A1;RAMP2;MYH9;SLCO2B1;ABCA1;LMAN2L;PLTP;PLEKHA8;CHMP2B;SPNS2;TAP2;ABCA3;CMTM6;ABCD2;CUBN;SLC22A18;TXNIP
prerank,proton transmembrane transport (GO:1902600),0.41967169634396706,1.2970650654189266,0.11861313868613138,0.8254853254456264,1.0,2/36,5.32%,ATP1A2;ATP6V1H
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4213374376692629,-1.2969887685904966,0.12017167381974249,0.443218665815443,1.0,15/27,34.79%,IRAK3;UBC;RPS27A;UBB;IRAK2;TAB1;BTK;MYD88;TLR4;CD36;TLR6;TLR1;CD14;IRAK4;TLR2
prerank,mitochondrial fission (GO:0000266),-0.4860906135658232,-1.296820038199246,0.14855875831485588,0.44289777234925426,1.0,9/16,33.24%,DNM3;MFF;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2;MTFR1L
prerank,homeostasis of number of cells (GO:0048872),-0.5235401219516693,-1.2965049343059216,0.15187376725838264,0.4428816800197559,1.0,3/12,4.28%,NOS3;NOTCH1;CCN3
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4254234871054834,-1.2962650630324135,0.12448132780082988,0.44271200234308333,1.0,10/26,12.95%,RNF111;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5412413899440434,-1.2955866157088924,0.1450980392156863,0.4435851646243587,1.0,4/10,8.59%,PARD3;DGKH;PRKD3;PLPP1
prerank,DNA damage checkpoint signaling (GO:0000077),0.4402136967639805,1.2952824022841722,0.14388489208633093,0.8291523299188198,1.0,10/28,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4811853296035904,-1.2948556968492992,0.1488933601609658,0.44464609141431327,1.0,7/15,15.55%,RPL5;RPS7;RPL23;BAG5;FBXO5;LIMK1;MAD2L2
prerank,acidic amino acid transport (GO:0015800),0.49763838633882296,1.2941995601953782,0.1619047619047619,0.830375688558486,1.0,2/17,0.21%,SLC6A13;SLC6A1
prerank,protein tetramerization (GO:0051262),0.37024406211208266,1.2935194631553695,0.10186757215619695,0.8299852571909911,1.0,18/67,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;CPSF6;KCNC3;CPSF7;GOLGA2;SSBP1;CUTC;TRPM2;ACACA;CTH;FARSA;OXA1L;ALDH9A1;ACOT13;USP16
prerank,positive regulation of programmed cell death (GO:0043068),-0.2779008760384524,-1.2926103991189155,0.012658227848101266,0.4490915701714968,1.0,77/272,20.44%,DAB2IP;ITGA6;SLIT2;NET1;TNFSF10;ARHGEF3;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;NGF;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;RPS6KA2;CTSD;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;HDAC6;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,neuromuscular process controlling balance (GO:0050885),0.5336687007400437,1.292357242102177,0.1816326530612245,0.8314329457549245,1.0,3/12,7.70%,USH1C;PCDH15;SHANK1
prerank,regulation of T cell proliferation (GO:0042129),-0.35737740338908724,-1.2918141302103068,0.0979020979020979,0.450193578134104,1.0,17/61,22.73%,IL6ST;VCAM1;TNFRSF1B;TFRC;ANXA1;NCK1;SLC7A1;TNFRSF21;IL15;PTPRC;CD86;NCKAP1L;CD46;JAK3;TNFSF8;GLMN;CD276
prerank,response to cytokine (GO:0034097),-0.30174789157539894,-1.2917062828001926,0.029333333333333333,0.4497168559255799,1.0,56/141,25.19%,LEF1;PID1;IL6ST;IL1R1;OSMR;LIFR;RHOA;PTPN12;BCL2L1;STAT3;PLSCR1;IRAK3;APP;REL;IFITM3;TNFRSF11A;GCH1;ADAM10;TRIM56;IL6R;ANXA1;RELB;XAF1;NFAT5;SRC;MAPKAPK2;IL1RL2;TLE5;ISG15;CD74;CD40;IRAK2;CSF1R;SP100;IFITM1;LDLRAP1;SIGIRR;PTPN6;MCL1;ASAH2;KYNU;RIPK1;JAK3;GGT7;MYD88;MAP2K7;IFITM2;CASP1;GGT1;MAP4K3;HCLS1;TAF9;CXCR4;CASP8;SHMT2;PTPN11
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4157187547628705,-1.2916929178951304,0.14345991561181434,0.4490581593724807,1.0,7/27,7.04%,MAP3K5;KAT7;UBC;MAP3K20;RPS27A;UBB;MAPK1
prerank,positive regulation of cell differentiation (GO:0045597),-0.28183805932955663,-1.29134750497238,0.026865671641791045,0.44912048452883374,1.0,46/237,9.46%,LEF1;PRKCH;SLC6A6;KITLG;MEF2C;GCNT2;RAPGEF2;BMPR2;IL6ST;ZBTB16;PTN;ZEB1;RHOA;ACVR1;ACVRL1;TGFB2;PPARD;BOC;LRP5;RAP1A;RUNX2;CD34;NGF;ZHX3;BTG1;BMP4;TGFBR2;KDR;RPS6KA3;CTNNA1;ARHGEF2;TMEM100;PRKD1;AGTR1;AXIN2;IL6R;AR;LRRC8A;CCN1;MDK;HEYL;CEACAM1;TMEM119;TIAM1;VHL;TGFB3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3900969757421254,-1.290921009454325,0.13544018058690746,0.44944720864373944,1.0,5/36,2.53%,DOCK1;RHOBTB1;GSN;THBS1;MYH9
prerank,positive regulation of signal transduction (GO:0009967),-0.2834126265395764,-1.2908569730821011,0.01744186046511628,0.4488968481625436,1.0,57/238,14.23%,NRP1;VWF;TEK;LIMS1;NTRK3;MAML2;SHANK3;LIMS2;IL6ST;DAB2IP;JAG1;RSPO3;NOS3;TGFB2;NOTCH1;GAS6;DISC1;PIK3R1;F3;ITGA5;PTGIS;JCAD;MACF1;STAT3;KANK1;MGAT5;CCN3;FAS;FLNA;CRADD;JAG2;ERN1;NPTN;EPN2;RPS3;EMP2;CCBE1;SPIN1;SRC;ATP6AP2;IGF2;TRIM16;CDKN2AIP;NOTCH4;CAV2;ESM1;CD74;HHEX;BMP2;PTK2B;SMO;AGPAT1;CSNK2A1;PTPRC;IRS1;KLF2;P2RY6
prerank,lymphocyte migration (GO:0072676),-0.402886653910769,-1.2906782697670613,0.11889596602972399,0.448621649567508,1.0,22/32,48.38%,S1PR1;CCL13;RET;CCL25;MSN;MYO1G;CCL5;CCL11;ZAP70;CCL4;GATA3;CRTAM;CCL7;CCL8;CCL19;CCL14;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,Notch signaling pathway (GO:0007219),-0.35247318104042474,-1.2895507048019657,0.08295964125560538,0.45049111298229166,1.0,24/59,22.60%,SORBS2;MAML2;PBX1;JAG1;NOTCH3;NOTCH1;JAG2;HES1;ADAM10;MDK;HEYL;HEY2;NOTCH4;BMP2;HEY1;PSEN2;PSENEN;DLL4;PLXND1;MAML3;DTX3L;SNW1;SUSD5;DLL1
prerank,bicarbonate transport (GO:0015701),-0.42441534212686727,-1.2894099720403451,0.1496881496881497,0.45011764048389696,1.0,7/25,16.14%,SLC4A10;SLC26A7;SLC39A8;CA4;SLC26A6;CA2;CFTR
prerank,regulation of heart contraction (GO:0008016),0.34879675841076563,1.2893061970935624,0.09967320261437909,0.8406776798921252,1.0,8/90,4.28%,ATP1A2;CELF2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2
prerank,regulation of T cell cytokine production (GO:0002724),-0.4956470254279075,-1.289289095792806,0.15308151093439365,0.44970475998481396,1.0,4/15,10.53%,B2M;TNFRSF1B;CD55;MALT1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.435946655144735,-1.2886251201688868,0.14489795918367346,0.4506367939444755,1.0,12/23,24.50%,BMP4;SIX1;MDK;FGF2;PIK3CD;SMO;VEGFA;SIX4;SOX8;EGF;SIRT6;LHX1
prerank,regulation of fibroblast migration (GO:0010762),-0.4454067381640157,-1.2885280759048436,0.14672686230248308,0.4501839568537211,1.0,7/20,14.60%,THBS1;PRR5L;CORO1C;ITGB1;FGF2;HAS1;GNA12
prerank,skeletal system development (GO:0001501),-0.30283371026940725,-1.287946122724339,0.03233830845771144,0.4509529199128905,1.0,35/148,12.38%,CDH11;BMP5;TLL1;ZBTB16;TRPS1;EXT1;PCSK5;TGFB2;TBX3;SLC10A7;PKD1;TEAD4;PLS3;BPNT2;CD44;ALPL;RPS6KA3;KIAA1217;PAPSS2;FBN1;WNT5A;SH3PXD2B;HHIP;RPL13;TNFRSF11B;MYOC;TGM2;VCAN;EIF2AK3;IGF2;XYLT1;ETS2;COL1A1;COMP;BMP2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4753034663326159,-1.2879298140551876,0.15476190476190477,0.450316748218964,1.0,8/17,22.00%,TGFB2;MID1;LYN;TAOK3;KLHDC10;NOD2;TAOK1;SEMA4C
prerank,oogenesis (GO:0048477),-0.49923393809166017,-1.2877810064734305,0.16966067864271456,0.44995075631312614,1.0,12/15,46.81%,PTN;MDK;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;IHO1;MARF1;NANOS2;FMN2;HORMAD1
prerank,regulation of adaptive immune response (GO:0002819),-0.45904042386083344,-1.2877499613273446,0.14519427402862986,0.4493371476200781,1.0,9/18,33.94%,IL6ST;ADCY7;AHR;FCGR2B;SAMSN1;FADD;IL4I1;SKAP1;SASH3
prerank,receptor-mediated endocytosis (GO:0006898),-0.3063430436840359,-1.2876328008629898,0.05263157894736842,0.44896036091091823,1.0,33/132,14.61%,CAV1;CALCRL;SPARC;DNM3;LRP6;SCARB1;INSR;RAMP2;CD9;SCARF1;AP2B1;RAB31;SCARB2;FCHO2;ITGB1;TFRC;SGIP1;LMBRD1;CLTB;SNX1;CUBN;APOE;GPR107;CAV2;ACKR3;ADM;VLDLR;FNBP1L;HIP1R;STAB1;LRP1;AP2A1;ARHGAP27
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5222260254745867,-1.2875827615424347,0.15430861723446893,0.4483786992203972,1.0,5/12,19.05%,LYN;IL34;MAPK1;CSF1R;MAPK3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.31022618122018936,1.28667895820311,0.04852941176470588,0.8479948962136022,1.0,50/224,17.62%,SLC6A1;UNC13C;DTNA;CEL;APBA3;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;DLG1;SYT1;SYN2;HTR7;NLGN3;HRH2;GRIK2;KCND2;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;CPLX1;SPG11;GABRG3;GABRB2;RIT2;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;PTCHD1;MINK1
prerank,mRNA splice site selection (GO:0006376),0.4328614940973587,1.2864405617798707,0.1487279843444227,0.8458785686226025,1.0,12/30,23.82%,CELF2;SRSF5;SRSF10;PSIP1;YTHDC1;NOL3;SRSF6;CELF6;PUF60;LUC7L;CELF1;SNRPC
prerank,intestinal absorption (GO:0050892),-0.5049526662226258,-1.2849467193914619,0.17338709677419356,0.45387832813593215,1.0,5/13,12.77%,F11R;TJP2;KCNQ1;UGCG;SLC26A6
prerank,negative regulation of growth (GO:0045926),-0.311546188541425,-1.2849461508113886,0.06069364161849711,0.453197850882355,1.0,35/121,17.54%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;NOTCH1;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;CDKN2AIP;NME6;SIPA1;RERG;ENPP1;ADAM15;MT3;RTN4;CDA;ING4;FGFR3;OSGIN1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.33453474213684886,-1.2849030821779317,0.07537688442211055,0.4526219524798541,1.0,20/72,13.07%,SHANK3;SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;ARHGEF2;ATXN7;PRKCD;IAPP;APC;PIK3CA;APOE;FGF13;LIMA1;DYRK1A;HIP1R;PFN1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4211009252982385,1.2848222718351492,0.13188976377952755,0.8493215858102043,1.0,10/33,14.03%,CEL;NLGN2;GRID2;IQSEC2;NLGN3;GRIK5;GRIK2;LRRC4C;BDNF;PSMC5
prerank,chloride transport (GO:0006821),-0.3324383620622823,-1.2847360660746774,0.07673267326732673,0.45234166785466867,1.0,20/74,16.14%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;ANO1;CLIC5;SLC1A3;SLC12A6;LRRC8A;CLIC1;GABRA3;GLRB;SLC1A1;SLC26A6;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,response to estrogen (GO:0043627),-0.3987063122385706,-1.2846459494614957,0.11713665943600868,0.45189750731108896,1.0,8/31,14.83%,CAV1;ESR1;AR;TRIM25;PELP1;SERPINB9;CD24;ARID5A
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.44220375112374866,-1.2842902767094404,0.15466101694915255,0.452053935881282,1.0,8/21,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,regulation of JNK cascade (GO:0046328),-0.32300484776682536,-1.2841365438982442,0.06329113924050633,0.45174177074687566,1.0,29/101,20.49%,MECOM;DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;EGFR;APP;MFHAS1;RAP2A;FLT4;MAP4K4;AIDA;DUSP3;PER1;EDA2R;PHLPP1;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,regulation of cytoplasmic translation (GO:2000765),0.5137859887402046,1.284015820349073,0.16085271317829458,0.8494989244247583,1.0,3/14,7.57%,CPEB2;UNK;CPEB4
prerank,reverse cholesterol transport (GO:0043691),-0.5036283230104263,-1.2840010307496497,0.15789473684210525,0.45137587384240085,1.0,3/13,9.64%,SCARB1;ABCA1;APOE
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.47923059372377164,1.2839472215743437,0.15195071868583163,0.8466355523537445,1.0,7/20,19.10%,EPAS1;HSPA1A;TGFBR1;HSPA1B;DNAJB2;HSP90AA1;WASHC1
prerank,neuromuscular junction development (GO:0007528),0.4599047126724428,1.28329638987929,0.16888045540796964,0.8461718715887458,1.0,6/24,8.27%,UNC13C;CACNB1;CACNB3;PDZRN3;LRRK2;LRP4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3603768816123212,-1.2828983993057417,0.1070615034168565,0.45314526458192683,1.0,13/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;RACK1;ZDHHC8;STAC;EPHB2;ACSL3;SQSTM1
prerank,gene expression (GO:0010467),-0.27110235490565127,-1.282728318584034,0.01107011070110701,0.4529287104933514,1.0,119/348,23.88%,RPLP1;PTMA;RBPMS;RPS15;RPL38;RPL18A;RPL41;RBM3;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;ADARB1;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;ANGPT2;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;CDC40;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;NUP107;RPL6;RPL18;RPS25;EIF4E;AGO2;RPL36;DDX54;RPL28;GOLPH3;RPL27;DROSHA;CPSF4;RPL24;RPS29;WDR33;RPL23;MRPL23;RPL17;YARS2;ATXN1;RPS9;RPS27;ASMT;NCBP2;HHEX;SYNCRIP;TPR;RPL21;MRPL10;THOC3;RPL34;CLP1;RPL10A;RBM6;RPL12;RPL35;RPL14;NR4A2;NCBP1;SRSF3;DHX38;RPL19;RPL37;RPS18;SEC13;RPS13;RPS15A;DDX25;RRBP1;MRPS12;MRPL55;MRPL43;EPC1;MRPL44;MRPL36;NUP50;NUFIP1;POLR3A;MRPL35;NUP85;RPL3;POLR2I;THAP1;BCL3;HNRNPF;EIF4A3;AAAS;RPL15;DKC1;TESC;RPS21;POLR2F;RPS19;RPL8;SLU7;RPL13A;NUP62
prerank,positive regulation of innate immune response (GO:0045089),-0.4023204932939826,-1.2826653372972052,0.14347826086956522,0.4524031838091597,1.0,12/30,23.34%,POLR3F;PLSCR1;GBP5;WNT5A;NLRC5;IFI35;POLR3B;SPI1;ZBP1;POLR3D;NMI;RPS19
prerank,Wnt signaling pathway (GO:0016055),-0.32200262171406785,-1.2822900951334666,0.08478802992518704,0.45264741535207914,1.0,26/92,15.34%,LEF1;LRP6;FZD6;LRP5;SFRP4;UBC;PLCG2;CSNK1E;RPS27A;UBB;CSNK1G1;WNT5A;CSNK1A1;CSNK1G3;APC;VPS26A;CPE;AMER1;FZD4;WNT9A;RARG;CD24;FZD1;NR4A2;PLPP3;FERMT2
prerank,anion transport (GO:0006820),0.42134171397060166,1.282222820419318,0.162426614481409,0.8475185851602822,1.0,3/33,0.32%,SLC13A4;SLC22A6;SLC13A3
prerank,positive regulation of JNK cascade (GO:0046330),-0.3436864387908597,-1.282066389122977,0.0924170616113744,0.45246623011920606,1.0,21/70,20.49%,DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;APP;MFHAS1;FLT4;EDA2R;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.5286935367168264,-1.2818805370742625,0.18181818181818182,0.4521977753521214,1.0,6/11,29.56%,AGK;TIMM22;ROMO1;TIMM29;TIMM10;TIMM8B
prerank,positive regulation of cartilage development (GO:0061036),-0.46914514238674254,-1.2816579587798265,0.16176470588235295,0.45208307347152393,1.0,5/17,7.43%,BMPR2;ZBTB16;ACVRL1;BMP4;MDK
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.507874536279531,-1.2813449657796259,0.18108651911468812,0.45208978181211185,1.0,5/12,15.37%,DAB2IP;PIK3R1;ERN1;PTPN1;BAK1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5453814818961664,1.281338313076276,0.17892644135188868,0.8481883872113692,1.0,3/11,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3199404545591795,-1.2812826793122247,0.07951807228915662,0.4515626688870822,1.0,25/99,16.14%,PDE3A;ACTB;MEF2C;RAPGEF2;SLIT2;RAP1A;SH3BP4;CDH1;CTNNA1;CAPN2;PDE2A;KCNQ1;SPAAR;AHR;RPTOR;GOLPH3;NSMF;IPO5;SLC26A6;RRAGA;P2RY6;HTR1B;GLRA2;NR1H4;CFTR
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.3529089720637996,-1.281230625414037,0.10227272727272728,0.4509925263802408,1.0,17/55,15.32%,GPC6;DCN;GNS;CD44;CSPG4;LUM;VCAN;FGF2;SDC3;HEXA;CEMIP;BGN;NAGLU;AGRN;GPC1;CEMIP2;SGSH
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4786483638485272,-1.2808372403821817,0.14644351464435146,0.45118995840582315,1.0,12/16,47.19%,TNFRSF21;JAK3;TRIB2;FCGR2B;DLL1;VSIR;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,gas transport (GO:0015669),-0.5336560108461627,-1.2805009478549019,0.1732283464566929,0.45130718701066297,1.0,8/10,42.32%,IPCEF1;CYGB;CA2;MYC;AQP1;MB;NGB;RHAG
prerank,positive regulation of glucose import (GO:0046326),0.46161445617726593,1.2801024435970692,0.15819209039548024,0.8500465551377563,1.0,6/21,9.68%,OSBPL8;IGF1;PRKCI;SORBS1;RHOQ;CREBL2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3907233019321929,1.2791753129252128,0.12614259597806216,0.8506442466652654,1.0,10/45,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,amyloid fibril formation (GO:1990000),-0.366577463605851,-1.2787902991505038,0.10981308411214953,0.45450650813349014,1.0,12/51,8.14%,B2M;GSN;H3-3A;APP;UBC;RPS27A;UBB;CST3;ADAM10;IAPP;TGFBI;MFGE8
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5541476542883854,1.2787366870762835,0.2,0.8493101834950981,1.0,6/10,18.41%,LPGAT1;SLC45A3;ABCD1;NR1H3;MID1IP1;MLXIPL
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5109214154716244,1.2783020728514303,0.16161616161616163,0.8478893448745093,1.0,4/14,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.46696712731097584,-1.2781792941451544,0.15665236051502146,0.4552611148043574,1.0,10/18,29.68%,AGTR1;RFK;EDN1;EDN3;POR;NOD2;FXN;PDP1;AGT;PARK7
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5091435755581613,-1.2777659964607484,0.17137096774193547,0.45554706783134447,1.0,5/13,23.99%,PLA2G4A;MGLL;ABHD6;AWAT2;MOGAT3
prerank,protein catabolic process (GO:0030163),0.3744291865196486,1.2763832285427312,0.15111940298507462,0.8524035717613746,1.0,18/59,15.07%,MAGEA2;SIAH2;CAPN3;RNF41;SOCS6;HTRA2;CTRL;CLN8;FBXO6;LAMP2;PRPF19;CHEK2;FBXO17;BAG6;CLN5;RNF5;UCHL3;ADAMTS9
prerank,regulation of amyloid-beta formation (GO:1902003),0.4224241050292633,1.2757604957011672,0.13620071684587814,0.8518588259627953,1.0,9/34,13.27%,IGF1;ROCK2;PICALM;RTN1;CASP3;NTRK2;CLU;EPHA4;ABCA2
prerank,regulation of exosomal secretion (GO:1903541),0.4709135657843815,1.2756575523335998,0.16463414634146342,0.8492652494577394,1.0,4/19,7.85%,CHMP6;STAM;SMPD3;SNF8
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.48200161576401196,-1.2753051433720963,0.16032064128256512,0.46053236481245646,1.0,4/15,11.38%,STOX2;TGFB2;RAI2;SCEL
prerank,histone monoubiquitination (GO:0010390),0.45584947650532426,1.275249267988829,0.15900383141762453,0.8478130376280443,1.0,6/24,12.26%,DDB2;CTR9;LEO1;RNF20;CDC73;RING1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2626697769548084,-1.275176260686482,0.017482517482517484,0.4601664195106331,1.0,91/417,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;HMBOX1;AHR;CIR1;KLF4;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,chemical synaptic transmission (GO:0007268),0.30238093517634773,1.273802289378908,0.047058823529411764,0.850358359853894,1.0,60/284,17.26%,SLC6A1;UNC13C;DTNA;CEL;APBA3;NQO1;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;NAPB;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;GRID2;DLG1;GRIN2D;SYT1;SYN2;SNAPIN;HTR7;NLGN3;HRH2;GRIK5;GRIK2;KCND2;NAPA;RIMS1;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;SYN3;CPLX1;SPG11;GABRG3;GABRB2;RIT2;NAAA;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;KIF1B;PTCHD1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.43481490434974884,-1.273473921618942,0.17586912065439672,0.46344909102239207,1.0,11/22,36.31%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMB4;PSMB3;PSMB9;PSMA5;ENC1;PSMA3
prerank,regulation of inflammatory response (GO:0050727),-0.2909185890410059,-1.27322455100061,0.04788732394366197,0.4633347835304836,1.0,38/190,12.75%,FOXP1;TEK;IL1R1;TMSB4X;CD200;SEMA7A;ETS1;PPARD;PTGIS;NFKBIA;ABCC1;APP;TNFRSF1B;MFHAS1;PTGS2;CCN3;BRD4;MGLL;VAMP3;WNT5A;AGTR1;PDE2A;ANXA1;PRKCD;PSMA6;MDK;IFI35;XIAP;SERPINE1;IL15;APOE;KLF4;SPATA2;IL1RL2;PDCD4;CCN4;BIRC3;ACE2
prerank,negative regulation of apoptotic process (GO:0043066),-0.26535473152500105,-1.2729926962315319,0.007905138339920948,0.46321348427803527,1.0,150/444,24.15%,LEF1;ARHGAP10;PRKCH;TEK;MEF2C;CAV1;IL6ST;TJP1;PTMA;MERTK;YWHAE;FOXO1;TBX3;NDNF;THBS1;NOTCH1;GAS6;PIK3R1;EGFR;ITGA5;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SIX1;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;TBX1;FAS;FLNA;CARD16;ITGB1;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;ADAM10;ANXA1;PRKCD;TPT1;PLK2;MAPK1;MDK;SPRY2;CD38;PRKCG;FOXQ1;PIK3CA;SRC;XIAP;SOD1;FLT4;VHL;MAP4K4;CAT;TGFB3;APOE;GPX1;KLF4;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;UNC5B;GRK5;PTPRZ1;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;CSNK2A1;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;NR4A2;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157;HDAC2;BARD1;PSEN2;GREM1;MAPK3;ZC3H12A;SH3RF1;MCL1;CRLF1;LIG4;ASAH2;SOX8;RIPK1;HCK;PSMD10;HYPK;AGAP2;MYD88;SET;POU3F3;BEX3;CCND2;RIPK2;BCL3;UBE2Z;FXN;RASA1;DDAH2;DLL1;KDM2B;SMAD6;NFATC4;HCLS1;IGF1R;TAF9;TAX1BP1;PTRH2;NUP62;EGR3;FANK1;NAA15;AATF;TMBIM6;TRIAP1
prerank,peptidyl-serine modification (GO:0018209),-0.29398395761298485,-1.2727690009089423,0.048295454545454544,0.4630578068549454,1.0,56/166,21.40%,PRKCH;MARK1;HIPK1;RPS6KA5;NDNF;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;PRKCD;PLK2;CSNK1A1;MAPK1;GALNT13;CSNK1G3;PRKX;PRKCG;RPS6KA2;HPF1;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;POGLUT3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;NAA10;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;GALNT4;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.40995572500697386,-1.2724585192825562,0.13097713097713098,0.4630978680140287,1.0,7/28,11.52%,SHANK3;PTN;APP;APOE;EPHB2;FAM107A;SQSTM1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.43662481364764966,-1.2722542620249617,0.17410714285714285,0.462939159008455,1.0,4/22,2.86%,NTRK3;RAPGEF2;RAP1A;NGF
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2636313821686351,-1.2721509065946404,0.015384615384615385,0.4625188385776968,1.0,106/416,20.01%,LEF1;GHR;LRCH1;SLC12A2;PID1;IL6ST;DAB2IP;IL1R1;OSMR;ZEB1;LIFR;RHOA;PTPN12;GREM2;ST3GAL6;FOXO1;GAS6;PIK3R1;F3;FOXO3;PTGIS;VCAM1;BCL2L1;SOCS2;STAT3;PTPRJ;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;GBP4;ITGB1;STX3;ICAM1;ARHGEF2;RPS27A;S1PR1;UBB;GBP5;TEC;WNT5A;AIM2;YBX3;PDE2A;CXCL12;IL6R;ANXA1;IL34;INPP5D;TNFRSF21;IL20RB;RPS3;NFAT5;CCL13;IL1RAP;PIK3CA;CNTFR;MT1X;FGF2;SOCS5;DOCK8;JAK1;YWHAZ;IL4R;MAOA;PIK3CD;IL1RL2;CEBPD;TWIST1;PTPRZ1;SYNCRIP;TPR;POU2F1;SLC26A6;CD40;CD86;VEGFA;IRAK2;CBL;CSF1R;PRKACA;LDLRAP1;IFNAR1;ADAMTS12;SOCS3;SIGIRR;MMP2;GPER1;GAPDH;JUNB;ERBIN;PTPN6;CCL25;CCND1;USP10;MT2A;ZC3H12A;MCL1;CRLF1;IRF5;ASAH2;RIPK1;JAK3;HCK
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4001656443805115,-1.2714223529580793,0.1425661914460285,0.46352812127130943,1.0,10/33,24.80%,LEF1;RUNX1;IL34;CD74;ID2;RIPK1;TESC;HCLS1;FES;CASP8
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4476717719561764,-1.2713449152269845,0.14519427402862986,0.4630337581394927,1.0,9/18,27.04%,SEC14L1;RNF125;PUM2;BIRC3;PUM1;ZCCHC3;USP15;UFD1;OASL
prerank,sensory perception of pain (GO:0019233),0.45913653907461904,1.2713077268712467,0.1718146718146718,0.8568404271399797,1.0,8/21,20.11%,RETREG1;PTGES;CHRNB2;KCNK4;OPRM1;P2RX4;SCN9A;OPRL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.47016175277160926,1.2712166112408232,0.1814814814814815,0.8541824227447595,1.0,2/18,0.87%,IGF1;IL18
prerank,negative chemotaxis (GO:0050919),-0.40262128693282684,-1.2709329091103942,0.12666666666666668,0.4632167241091741,1.0,6/33,1.72%,SEMA6A;SEMA3C;SLIT2;RHOA;NTN1;SEMA7A
prerank,myelination (GO:0042552),-0.3668954999572065,-1.2706756603142726,0.11627906976744186,0.46312592995457535,1.0,20/46,24.61%,ADGRG6;PARD3;CMTM8;LGI4;TNFRSF21;MYOC;EIF2B2;ABCD2;B4GALT5;GPC1;ARHGEF10;PMP22;NFASC;ACER3;MYRF;SKI;MPZ;PLLP;MARVELD1;CXCR4
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5215613563491766,-1.2705212986559067,0.20905172413793102,0.46282036787039166,1.0,4/11,14.73%,TIPIN;FBXO5;BLM;TIMELESS
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3301478840941294,-1.2703851353963254,0.10022271714922049,0.46184607991201165,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3301478840941294,-1.2703851353963254,0.10022271714922049,0.46184607991201165,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5353898445679459,1.2702477894722048,0.19029126213592232,0.8548948074009186,1.0,3/12,8.01%,UNC13C;SYT1;RIMS1
prerank,positive regulation of embryonic development (GO:0040019),0.47256842535310334,1.2701539483789124,0.16600790513833993,0.8522965860289796,1.0,2/19,1.12%,WNT4;OSR1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5443783885359931,-1.269617419988797,0.1831275720164609,0.46293985699612533,1.0,5/10,30.42%,TGFBR2;CD55;NCKAP1L;SOCS1;LGALS9
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.514091784526006,1.2688728061745789,0.19161676646706588,0.8543309281069016,1.0,3/13,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5189497794446221,-1.2685568645991794,0.169921875,0.464684537485737,1.0,4/12,10.72%,CSGALNACT1;FUT8;PARG;GFPT2
prerank,epithelial cell development (GO:0002064),0.45400609626767435,1.2685038600563507,0.15551181102362205,0.8527638640948443,1.0,6/20,12.70%,WNT5B;WNT7A;RILPL2;RILPL1;DACT2;PDZD7
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.29353722571621554,-1.2682338594899345,0.05080213903743316,0.4647521186333227,1.0,52/153,21.40%,PRKCH;MARK1;HIPK1;RPS6KA5;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;ERN1;PRKCD;PLK2;CSNK1A1;MAPK1;CSNK1G3;PRKX;PRKCG;RPS6KA2;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;RIPK1;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.32495381551406743,-1.2680211062063553,0.07862407862407862,0.46460988779693396,1.0,29/88,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;AP2M1;PSMB3
prerank,regulation of intracellular transport (GO:0032386),0.4070376276638775,1.2680142758892932,0.15083798882681565,0.851856599161611,1.0,18/38,26.60%,MAP2;TTC21B;DYNLT2B;ANTKMT;LRRK2;GRIPAP1;RINT1;GAS1;SPAG5;RNF139;CAPN10;ATP13A2;WWC1;LAMP1;MLC1;ATP9A;HAP1;RBM4
prerank,organic acid transport (GO:0015849),0.3420156548339543,1.2679800395944234,0.12006578947368421,0.8491070071749549,1.0,15/94,7.83%,SLC6A13;SLC22A6;SLC13A3;SLC6A12;ACSL1;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC26A1;SLC38A1;SLC25A11;STARD5;PDPN;SLC19A1
prerank,regulation of interleukin-12 production (GO:0032655),-0.3610973642964413,-1.2670419325037177,0.13800904977375567,0.46616591991106265,1.0,16/47,25.71%,FOXP1;THBS1;IRAK3;PLCG2;MDK;PIBF1;CD40;MAST2;IRF5;JAK3;HMGB1;SYK;RIPK2;MAPK11;CMKLR1;TLR4
prerank,positive regulation of defense response (GO:0031349),-0.3201649634589022,-1.2659308808860839,0.09975669099756691,0.46816242882009523,1.0,17/89,11.84%,MEF2C;ETS1;NFKBIA;POLR3F;ABCC1;PLSCR1;APP;GBP5;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3281401850996326,-1.2653147583375446,0.08373205741626795,0.469045412025958,1.0,17/73,10.46%,HIP1;ACER2;TNFSF10;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;ATP2A3;EIF2AK3;IFT57
prerank,Rap protein signal transduction (GO:0032486),-0.5426851196347986,-1.2652772064916975,0.19517102615694165,0.46847393720108227,1.0,4/10,6.89%,RAPGEF2;RAP1A;RAP2A;PLK2
prerank,response to ethanol (GO:0045471),0.49955468298458267,1.265103481315466,0.17543859649122806,0.8574242738669406,1.0,5/14,8.73%,ADH7;GRIN3A;GLRA1;CHRNB2;DRD3
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.42936567440003415,-1.2646437114417979,0.15416666666666667,0.46929707648675434,1.0,5/22,12.97%,B2M;ZBTB1;CD55;MALT1;STX7
prerank,regulation of receptor binding (GO:1900120),-0.5295621400854574,-1.2642903799717713,0.19166666666666668,0.46946057642427796,1.0,4/10,14.55%,B2M;GREM2;ATP2A3;ADAM15
prerank,protein localization to lysosome (GO:0061462),-0.41351593446967655,-1.2642585673115205,0.1732283464566929,0.4688838223756797,1.0,11/28,20.84%,SH3BP4;SCARB2;LMBRD1;ZFYVE16;KPTN;MFSD1;HGS;RTN4;RNF128;NEDD4;GGA3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3651760956017112,-1.2638411908680731,0.13394919168591224,0.4690687021586638,1.0,12/43,11.66%,ETS1;TGFB2;PPARD;FOXO3;STAT3;BMP4;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3905494959752331,1.2636272193859648,0.14909090909090908,0.8606002761323177,1.0,11/45,13.62%,BMP7;SMAD3;ZWINT;ANGEL2;FZD3;TOM1L2;TRIM35;MAD2L1;GAS1;PRCC;FOXC1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4548963972625105,-1.2635678566400397,0.17073170731707318,0.46905846039616894,1.0,6/18,12.40%,VCAM1;SLC39A8;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,regulation of vasculature development (GO:1901342),-0.4162151499580299,-1.263035328198551,0.16806722689075632,0.4696524517315379,1.0,14/26,35.45%,ETS1;BMPER;ADGRA2;EMP2;FGF2;TSPAN12;SP100;PLXND1;HMOX1;GPNMB;VASH2;CTNNB1;PROK2;HTATIP2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3277293716933981,-1.262759082782153,0.10067114093959731,0.46961672744653876,1.0,33/79,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3533771819583482,1.2621660144353712,0.1138353765323993,0.8634424800913656,1.0,18/69,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4336225313864955,1.26213471538251,0.1542649727767695,0.85781044148144,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4336225313864955,1.26213471538251,0.1542649727767695,0.85781044148144,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.49272486233619545,1.2619993160356686,0.18163672654690619,0.8554620053175341,1.0,5/15,9.10%,LPGAT1;PPARA;SLC45A3;PPARGC1A;NR1H3
prerank,skin development (GO:0043588),-0.3381526736912825,-1.2614621367953511,0.11347517730496454,0.47193130702086317,1.0,17/65,12.26%,JAG1;ITGA6;CLIC4;PKD1;BCR;LSR;COL5A2;STMN1;ITGB4;WNT5A;MET;ANXA1;TXNIP;HRNR;SCEL;UGCG;COL1A1
prerank,regulation of myoblast differentiation (GO:0045661),0.4152661049148279,1.2613615510816882,0.16310679611650486,0.8550142249475196,1.0,8/32,11.97%,RANBP3L;IGFBP3;FLOT2;SOSTDC1;PLCB1;MAPK14;SOX9;SRA1
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.28615199151436715,-1.2613210267585544,0.055248618784530384,0.47161630648141567,1.0,40/175,20.71%,LIMS1;ACTN4;PID1;DAB2IP;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;ARHGEF2;AIM2;YBX3;PSMA6;TNFRSF11B;PSMB7;TNFRSF21;RPS3;CCL13;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;ADAMTS12;GPER1;PSMB4;EDAR;PSMD14;ERBIN;CCL25;ZC3H12A;RIPK1;PSMD10;TNFSF8
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3433298057193248,1.2612169455240156,0.10745233968804159,0.8527623512116148,1.0,7/90,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4271552831966643,-1.2610033521938275,0.17467248908296942,0.47171329132395795,1.0,8/23,21.79%,DAB2IP;MAP3K5;TNFRSF11A;RPS3;EDN1;TAOK3;ARHGEF5;MAP3K4
prerank,iron ion transmembrane transport (GO:0034755),-0.5438603693989004,-1.2605301856654607,0.1937984496124031,0.47216265480892045,1.0,3/10,4.90%,SCARA5;SLC40A1;SLC39A8
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5105892229709476,1.2597386359284517,0.1851145038167939,0.8557730276619183,1.0,3/14,3.76%,SYT11;IGF1;TAFA3
prerank,glycerol metabolic process (GO:0006071),0.5369433597952619,1.259231408112954,0.20634920634920634,0.8549345369690149,1.0,5/10,20.39%,GK;TKFC;GOT1;COQ3;TPI1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.451275047319081,1.25882646846838,0.19776119402985073,0.8537112761135104,1.0,4/22,4.37%,TIMP3;SH3D19;FURIN;ADRA2A
prerank,response to fatty acid (GO:0070542),-0.45267720172221104,-1.257988145808505,0.19421487603305784,0.4774884536245674,1.0,6/17,15.58%,PID1;FOXO1;FOXO3;IRS1;SCD;NR1H4
prerank,cellular response to glucagon stimulus (GO:0071377),0.4807321200414491,1.257619117720993,0.1944990176817289,0.8556939766511754,1.0,4/17,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,vesicle transport along actin filament (GO:0030050),-0.44927000117205246,-1.2575850660747026,0.19198312236286919,0.4777081593192337,1.0,6/19,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,electron transport chain (GO:0022900),-0.4794476122992206,-1.2574930939299631,0.17786561264822134,0.4772703078720918,1.0,6/15,15.53%,ENOX2;PDIA5;NDUFA5;ETFA;UQCRFS1;POR
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.329537021132587,-1.2573117799039648,0.09297052154195011,0.4770447828765194,1.0,29/72,25.19%,LIFR;HIPK1;GAS6;RUNX1;IRAK3;RACK1;CBFB;PTPN1;JAK1;SPATA2;CD74;ABCE1;BIRC3;AGPAT1;PTPRC;CD24;MADD;IRAK2;SOCS3;SIGIRR;PTPN6;RIPK1;ZBP1;SYK;CYLD;TAX1BP1;SOCS1;CASP8;PTPN11
prerank,secondary alcohol metabolic process (GO:1902652),0.38721906558120456,1.2572662329478517,0.15065913370998116,0.854242077083476,1.0,13/42,16.04%,SOAT2;CYP11B1;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;TSKU;IDH2;GBA2
prerank,calcium ion import across plasma membrane (GO:0098703),0.4928549314207086,1.257226882698821,0.17450980392156862,0.8516000651188171,1.0,2/14,1.13%,SLC8A3;TRPV1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4532227881789648,-1.2563979706125183,0.1926782273603083,0.4785256992381168,1.0,7/17,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3127599082652233,-1.256303800760416,0.10513447432762836,0.4780954882840619,1.0,28/94,21.51%,IL1R1;RPS6KA5;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;IL1RAP;PSMB6;PSMB5;SQSTM1;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;MAP3K8;PSMB4;PSMD14;NOD2;MAPK3;PSMD10;MYD88;PSME1;RIPK2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3464751797842085,1.2561844122167303,0.12086092715231789,0.8529274445940126,1.0,15/85,9.16%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,protein K63-linked ubiquitination (GO:0070534),0.4036124668036843,1.2559942971361915,0.1781609195402299,0.8509151575091025,1.0,7/41,11.03%,RNF152;UBE2E2;RNF126;TRIM5;PELI3;RNF135;PRPF19
prerank,B cell activation (GO:0042113),-0.3359465584185658,-1.2559052368353933,0.08888888888888889,0.4783927889716093,1.0,17/68,13.79%,MEF2C;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;EPHB2;MALT1;PIK3CD;PHB2;HHEX;ITGA4;CTPS1;CD40;PTPRC;CD86
prerank,histone H3-K4 methylation (GO:0051568),0.43653184010667734,1.2552117626453587,0.16634799235181644,0.8511202933759389,1.0,8/26,19.43%,CTR9;KMT2A;DYDC2;SETD4;BEND3;MEN1;TET2;SETD1B
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.4530282047056192,-1.2551389976801126,0.21161825726141079,0.4796176412288495,1.0,6/17,13.82%,CLDN5;VCL;PPP1R12A;F11R;S1PR3;VEGFA
prerank,lipid biosynthetic process (GO:0008610),0.35363930479019384,1.2549404254234457,0.12416107382550336,0.8494240320773008,1.0,23/77,23.27%,ACSL1;PRKAA2;FITM2;ACSM2A;ACSM2B;AGPAT4;PCYT2;PRLR;CLN8;DHRS11;ACSS2;CYP51A1;STAR;ACACA;GGPS1;HMGCR;FDXR;PAM;ALOX5;DOLPP1;CBR4;LIPC;LIPH
prerank,regulation of mast cell activation (GO:0033003),-0.5482510568094983,-1.2545892756152943,0.18410041841004185,0.48028808753659735,1.0,7/10,33.12%,PLSCR1;LYN;NECTIN2;MILR1;CD300LF;TSLP;CD84
prerank,rRNA methylation (GO:0031167),0.44532640402732093,1.254524807632551,0.19144981412639406,0.8482423907230214,1.0,5/22,15.06%,FDXACB1;MRM3;NSUN3;MTERF4;METTL5
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5106710517401751,-1.2544586670059907,0.1875,0.47993050203740706,1.0,3/11,2.83%,FAP;PTGIS;BCL2L1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4546348991588162,-1.254094421479874,0.1762208067940552,0.4801476430901853,1.0,6/16,10.56%,BCL2L1;CXCL12;TPT1;NACC2;RPS3;ACKR3
prerank,negative regulation of viral release from host cell (GO:1902187),0.5151703511797378,1.2532301691957273,0.20121951219512196,0.8507063320276333,1.0,9/13,28.72%,TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3;TRIM28;TRIM8;TRIM11
prerank,insulin receptor signaling pathway (GO:0008286),-0.330756190594364,-1.2523182870587182,0.10952380952380952,0.4836536024673972,1.0,20/69,13.91%,GAB1;BCAR3;INSR;FOXO1;PIK3R1;GRB14;ATP6V0A4;PIK3C2A;APC;ATP6V0D1;PIK3CA;ATP6V0A1;IGF2;BCAR1;CAV2;SH2B2;ATP6V1D;AKT2;IRS1;RARRES2
prerank,DNA methylation (GO:0006306),0.44267811221001735,1.2521775464591562,0.18461538461538463,0.8520823487448388,1.0,13/23,24.14%,DNMT3L;DNMT3A;N6AMT1;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3;PICK1;BAZ2A;HELLS;ATRX;METTL4
prerank,amino acid import across plasma membrane (GO:0089718),-0.4115656600688317,-1.2519247314759376,0.1740976645435244,0.48391162867842313,1.0,7/24,8.49%,SLC47A1;SLC6A6;SLC1A5;SLC7A5;SLC1A3;SLC7A1;SLC16A2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.46986876063953675,-1.2515423563721937,0.1690427698574338,0.4841155995075416,1.0,5/17,8.78%,SLIT2;TMEM204;SFRP4;CASK;XIAP
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3950169687498011,-1.25141727502727,0.17136659436008678,0.4837260307009176,1.0,16/32,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,regulation of cholesterol efflux (GO:0010874),-0.39189635860705596,-1.2507101572864217,0.14660831509846828,0.484666069150652,1.0,13/30,21.58%,CAV1;NFKBIA;PLTP;ZDHHC8;TTC39B;ABCA3;APOE;SREBF2;PTCH1;LRP1;NAXE;YJEFN3;EEPD1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4777227705926148,1.250630046846618,0.21880998080614203,0.855186166648002,1.0,4/16,7.89%,TOP2B;MEIOB;EME2;MSH4
prerank,peptidyl-lysine methylation (GO:0018022),0.44820987541833335,1.2502780874303367,0.18992248062015504,0.8539134770108225,1.0,8/26,13.15%,KMT5A;EEF2KMT;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4938704441127411,-1.2499899936423433,0.20724346076458752,0.4857526986242716,1.0,8/12,32.10%,SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,epithelial to mesenchymal transition (GO:0001837),0.3864268531838763,1.2492292242000513,0.15469613259668508,0.8551375432809791,1.0,9/47,7.14%,BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;DDX17
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.37573256297218205,-1.249049226859892,0.1473922902494331,0.48735337205391677,1.0,14/36,23.57%,EIF3H;GABARAPL2;AQP11;PRKCG;UBXN1;USP7;BAG5;N4BP1;RYBP;PSME3IP1;UCHL5;FHIT;GIPC1;TAF9
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.4846769253487161,-1.2475471768470288,0.20335429769392033,0.49026436475132334,1.0,8/13,42.28%,CBLB;IPO5;KPNA2;KPNA1;NUP35;NUP54;KPNB1;KPNA7
prerank,aminoglycan catabolic process (GO:0006026),-0.4092079054369025,-1.247454055436984,0.17567567567567569,0.48980426698228907,1.0,9/28,22.25%,GPC6;GNS;SDC3;NAGLU;AGRN;GPC1;SGSH;GPC4;HPSE
prerank,cardiac muscle tissue development (GO:0048738),0.37245672407306835,1.2469761970006508,0.15397923875432526,0.86097894848231,1.0,9/50,7.98%,NOTCH2;BMP7;GJB6;MSX2;BMPR1A;CSRP3;SGCZ;NRG1;KDM6B
prerank,phosphorylation (GO:0016310),-0.26036136352160877,-1.2468706137729384,0.0035460992907801418,0.49054909452875106,1.0,74/385,12.51%,PRKG1;PRKCH;ERG;SNRK;BMPR2;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;DGKH;STK38L;GAS6;STK3;PEAK1;LIMD1;LIMK2;BCR;STAT3;AKT3;DGKZ;TGFBR2;IRAK3;APP;CDK14;AGK;FNIP2;BMX;TNIK;NUAK1;PANK3;MAP3K20;CSNK1E;CAMK2D;PAK2;TEC;PRKD1;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;PRKCG;STK24;PIK3CA;CDK5;MAP4K4;EIF2AK3;MAPKAPK2;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;BMP2;PTK2B
prerank,DNA methylation or demethylation (GO:0044728),0.46298443870507366,1.2458823515397162,0.1830708661417323,0.8598111507509036,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,DNA alkylation (GO:0006305),0.46298443870507366,1.2458823515397162,0.1830708661417323,0.8598111507509036,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,detection of mechanical stimulus (GO:0050982),-0.44059189117508635,-1.2455742576790678,0.17699115044247787,0.492906037295202,1.0,3/19,2.85%,PIEZO2;PKD1;PIEZO1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.44355246328827985,1.2450064498287117,0.18773946360153257,0.8604639660722946,1.0,2/23,6.95%,TGFBR3;FGFR2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3921351033198071,-1.244628889498312,0.15695067264573992,0.49453740453445205,1.0,8/30,12.65%,DCN;CSGALNACT1;NDNF;CSPG4;VCAN;HEXA;CHSY3;BGN
prerank,glycolytic process (GO:0006096),0.4282452692426253,1.2445910961237754,0.19288389513108614,0.8594330809235686,1.0,7/28,7.67%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4933996452833442,-1.243950292335971,0.2,0.49547667589744104,1.0,4/13,4.67%,PKD1;NFKBIA;YWHAB;FLNA
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4380641170259944,-1.2431440656827053,0.18725099601593626,0.496703421722522,1.0,10/20,24.78%,TTC39B;APOE;SREBF2;ACADVL;NR1H4;LDLRAP1;ARV1;SREBF1;LPCAT3;MBTPS2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.37098558788485547,-1.242966583656956,0.16279069767441862,0.4964738175846098,1.0,11/39,12.41%,RPS15;RPS24;RPS17;RPS16;RPS5;RPS7;RPS28;SURF6;RPS25;RPS27;RRP7A
prerank,amino sugar biosynthetic process (GO:0046349),0.513375095591502,1.2427152772514045,0.21584158415841584,0.864006760965468,1.0,3/12,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4487916657578256,-1.2427107265587447,0.19230769230769232,0.49641395589232895,1.0,10/17,8.50%,JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;HEYL;STRA6;HEY2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4169696024414029,-1.242498913847304,0.1812366737739872,0.49631202737834057,1.0,12/26,24.80%,ALPK1;UBC;NOD1;RPS27A;UBB;IFIH1;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,autonomic nervous system development (GO:0048483),-0.45854647222471456,-1.2423754319817029,0.18532818532818532,0.4959590362238812,1.0,2/17,3.71%,NRP1;FN1
prerank,Rho protein signal transduction (GO:0007266),-0.3493372879647104,-1.241954724857464,0.12679425837320574,0.49633302946536306,1.0,21/53,14.86%,RHOJ;RHOA;NTN1;ARHGEF3;CDH13;CDC42EP5;CDC42EP3;EPS8;AGTR1;ARHGDIB;EPS8L2;RIPOR1;CFL1;ADGRG1;CDC42EP2;ARHGAP1;TAX1BP3;SHTN1;ARHGDIA;GNA12;LIMK1
prerank,bile acid biosynthetic process (GO:0006699),-0.41404919637115983,-1.24116830397842,0.15728155339805824,0.4974109266408477,1.0,4/24,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31811110496487854,-1.2410491939055057,0.1,0.4970427616954819,1.0,30/85,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;RYK;AP2M1;PSMB3
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.38470390358532774,-1.240621795198414,0.15869565217391304,0.49730645310389143,1.0,14/32,23.40%,FOXO3;RBM3;APP;RPL10;TMED10;PRKCD;SAMD8;EIF4E;PGAM1;NR1H4;DDX25;TIGAR;ROCK1;NANOS3
prerank,mRNA metabolic process (GO:0016071),0.3353549978785863,1.2402298759445303,0.11937716262975778,0.870839736885846,1.0,18/90,14.28%,HSPA1A;DDX5;CPSF3;SRSF5;CPSF6;HNRNPA2B1;PRMT9;SON;PTBP1;LSM5;PPARGC1A;SRRM4;SLBP;LSM11;AGO3;USP39;SRSF11;HSPA1B
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.40303475820059986,-1.2400612321997946,0.175054704595186,0.49806041685207664,1.0,11/27,20.85%,EGFR;LIMD1;STAT3;BMP4;PUM2;AGO2;PUM1;FMR1;FXR1;RIPK1;AJUBA
prerank,organonitrogen compound catabolic process (GO:1901565),0.3625792357925649,1.2400083678833742,0.15780141843971632,0.8689970417936941,1.0,15/57,16.79%,ADAMTS13;CPQ;RENBP;CAPN3;PNPLA8;GNPDA1;CTRL;CLN8;SMPD2;PLA2G15;NPL;CLN5;UCHL3;TRHDE;CTH
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4398671108476405,1.239993406614723,0.17953667953667954,0.866378672695218,1.0,3/25,2.79%,IGF1;MSX2;DOT1L
prerank,calcium ion import into cytosol (GO:1902656),0.47870276032998627,1.2395155949101269,0.18518518518518517,0.8656376155477197,1.0,2/15,1.13%,SLC8A3;TRPV1
prerank,modulation by symbiont of host process (GO:0044003),-0.5253198424370672,-1.2392350406339268,0.21188118811881188,0.49928597803289476,1.0,5/10,10.78%,B2M;UBC;RPS27A;UBB;HGS
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.30399893859503163,-1.239120966997741,0.1111111111111111,0.498855446798713,1.0,31/107,15.04%,CAV1;SLC39A10;STIM2;ATP2B1;SLC10A7;SLC30A1;SLC39A8;SLC30A9;NPTN;CXCL12;TPT1;CCL13;ATP2A3;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SLC39A7;TMCO1;EDN1;EDN3;HTR2A;SLC30A5;TRPV4;CD40;MT3;VAPB
prerank,positive regulation of protein secretion (GO:0050714),0.3512425304320717,1.2388982257988002,0.15156794425087108,0.865241666031474,1.0,7/69,2.86%,BMP6;IGF1;NNAT;FRMD4A;WLS;GCK;NLGN2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.42680359657617944,1.2388698223513281,0.17234848484848486,0.8626983969068414,1.0,5/24,8.19%,IGF1;PPP1R3F;GCK;PASK;SORBS1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.44924722693050984,-1.2387946602874298,0.1755424063116371,0.49897850333342,1.0,8/17,13.74%,CAV1;KLF7;AJAP1;PRKX;CEACAM1;APOLD1;CD24;MAFF
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.25502011027678445,-1.2384327417844048,0.006968641114982578,0.4991862460391702,1.0,111/476,17.36%,MECOM;LEF1;MEF2C;ZBTB16;ZFHX3;MLLT3;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PPARD;FLI1;MAP3K5;FOXO1;NOTCH1;LRP5;KMT2E;EGFR;RUNX2;FOXO3;CTCF;AFAP1L2;RUNX1;CDH1;STAT3;BMP4;NFATC1;PRDM16;SIX1;RNF111;GLI3;JUN;NAA16;ESR1;TBX1;KAT6A;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;SMAD5;XPC;NFYA;WNT5A;HES1;TRIM56;SP3;AR;ELF4;CD38;ACTA2;CDKN1C;HEY2;SPIN1;ARID1A;VHL;TRIM16;FGF2;ELK1;TGFB3;AHR;APOE;NOTCH4;FGF7;KLF4;TAL1;ETS2;PITHD1;MYOCD;GTF2H1;NFATC2;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;BMP2;NFIL3;HNRNPAB;NME2;FZD1;NCOA6;CD86;KLF2;ZNF318;YAF2;MRPL12;MT3;MAD2L2;NR1H4;ENY2;BRCA2;ID2;ATF4;SIX4;SP100;RREB1;DNAJC2;HEY1;ZBTB48;ZNF496;MED14
prerank,cilium movement (GO:0003341),0.3766577275273961,1.2382126537914655,0.15978456014362658,0.8625869083132093,1.0,15/47,22.29%,DNAH1;TEKT2;RSPH4A;TEKT5;CFAP61;ROPN1L;CFAP251;DNHD1;DNAH9;DNAAF2;DNAAF5;SPA17;CFAP54;CFAP91;DNAH5
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4431472982400756,-1.238129528227746,0.20518358531317496,0.49931187480512274,1.0,3/18,4.16%,DCN;KDR;MFF
prerank,positive regulation of vascular permeability (GO:0043117),-0.49756014375123064,-1.237944360476698,0.21579961464354527,0.49908805236265813,1.0,7/12,13.82%,PDE3A;TJP1;TJP2;PDE2A;OCLN;TRPV4;VEGFA
prerank,regulation of adenylate cyclase activity (GO:0045761),0.44559578766227864,1.2372996177704159,0.21001926782273603,0.8634839444080531,1.0,6/22,10.67%,CACNA1D;CRHR1;DRD3;ADGRV1;LTB4R2;GABBR2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4137414050213737,-1.2371249310283314,0.18801652892561985,0.5004055828176807,1.0,9/25,26.05%,TMTC2;CAV1;JPH2;CNNM2;MT3;GRIN1;SLC8A1;WFS1;SELENON
prerank,positive regulation of protein processing (GO:0010954),-0.4371540983266078,-1.2360196969779425,0.19254658385093168,0.5024094545315692,1.0,4/19,7.99%,GSN;MYH9;NKD2;CCBE1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5114323002071024,-1.2355033704128526,0.21850393700787402,0.5029690525993563,1.0,8/11,34.02%,CREB3L1;ATF6B;ATF4;ATF3;MBTPS2;CEBPB;HSPA5;TP53
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.38208961896561566,-1.2349063437448518,0.15074309978768577,0.5036545352510341,1.0,16/33,27.78%,ACER2;TGFB2;CYP1B1;LYN;SERPINE1;JAM3;RET;NCKAP1L;RAC3;SYK;TESC;ADA;PTPN11;PIK3CG;SNAI2;CIB1
prerank,cardiac muscle contraction (GO:0060048),0.40465720206701367,1.2346320664746813,0.1973929236499069,0.871230598681482,1.0,5/34,11.04%,ATP1A2;CSRP3;TNNI1;KCNH2;RYR2
prerank,alcohol catabolic process (GO:0046164),0.5266626777951104,1.2344174302667594,0.2310838445807771,0.869470330337914,1.0,3/10,9.35%,CEL;ADH4;CYP27A1
prerank,glucose transmembrane transport (GO:1904659),-0.4415395071839464,-1.2342195567228438,0.1822125813449024,0.5045925887082539,1.0,5/18,13.11%,SLC2A1;PPARD;SLC2A3;SORT1;SLC2A9
prerank,response to estradiol (GO:0032355),-0.38711596848609686,-1.233521315606651,0.18004338394793926,0.5056354209040324,1.0,7/31,7.72%,EGFR;SOCS2;STAT3;ESR1;STRN3;ANXA1;NRIP1
prerank,positive regulation of transferase activity (GO:0051347),-0.29210102638511026,-1.233187179919819,0.0921409214092141,0.5057909058066535,1.0,48/142,23.60%,ROR1;TEK;NTRK3;NEK7;CD200;TIE1;INSR;MERTK;DCUN1D3;EGFR;EPM2AIP1;KDR;SERINC5;TNKS;MET;XRCC5;MAPK1;FLT1;PTGES3;FLT4;IGF2;HMBOX1;KLF4;EPHB2;DCUN1D5;CD74;RET;UBE2L3;ROR2;FBXW7;CCT2;ALK;CSF1R;PARM1;FGFR3;NBN;GREM1;MAPK3;MAP2K7;RFC4;EPHB6;DTX3L;MAP3K4;RYK;DKC1;TRIB3;IGF1R;POLG2
prerank,neutral amino acid transport (GO:0015804),-0.39572555846688773,-1.2331843838017196,0.19477911646586346,0.5051381769437643,1.0,9/28,14.08%,SLC6A6;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,translesion synthesis (GO:0019985),-0.35569516189167566,-1.2330802076253515,0.1489841986455982,0.5047483926184173,1.0,22/42,29.64%,RPA1;UBC;RPS27A;UBB;REV3L;TRIM25;ZBTB1;ISG15;MAD2L2;USP43;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4;DTL;UFD1;RFC2;VCP;RCHY1;FAAP20
prerank,positive regulation of kinase activity (GO:0033674),-0.3070524025894006,-1.2326907504470679,0.11330049261083744,0.5050586735649825,1.0,25/107,13.63%,ROR1;TEK;NTRK3;RAPGEF2;TIE1;INSR;MERTK;GAS6;RASSF2;RAP1A;IQGAP1;EGFR;KDR;CACUL1;MET;XRCC5;FLT1;CCN1;FLT4;EPHB2;CD74;RET;PTK2B;ROR2;PTPRC
prerank,osteoclast differentiation (GO:0030316),-0.4275291945442615,-1.2324351472833266,0.19527896995708155,0.5050371033922871,1.0,10/22,28.52%,FOXP1;TNFRSF11A;SRC;SNX10;CSF1R;SBNO2;OSTM1;EFNA2;TREM2;FARP2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4655379390458369,-1.2318693191777865,0.18947368421052632,0.5057701276659978,1.0,5/14,18.05%,ENTPD1;ENTPD6;ENTPD2;ADPRM;NUDT16
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2724966202414893,-1.2316551661046018,0.04216867469879518,0.5056692338151961,1.0,54/234,15.25%,PRKCH;ROR1;CAV1;SLCO3A1;LRP6;CD200;TRAF5;RPS6KA5;STK3;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;ESR1;MID2;PLCG2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP;EDN1;MALT1;TERF2IP;MYOCD;EDA2R;FZD4;PHB2;SMO;CD40;FZD1;VEGFA;JMY;IRAK2;ALK;PLPP3;TAB1;CRTC3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3667328401228883,1.2310909247927244,0.15439856373429084,0.8795377957093059,1.0,19/52,19.84%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;HNRNPL;PTBP1;SRRM4;YTHDC1;FXR2;RBM5;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST
prerank,regulation of keratinocyte migration (GO:0051547),-0.4952454101528708,-1.231056860619184,0.23251028806584362,0.5064485336472259,1.0,5/12,24.54%,MAP4K4;FGF7;PTEN;MAPRE2;EPB41L4B
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.44441825464201434,1.2307641418145114,0.1974169741697417,0.8781772043235688,1.0,2/20,5.27%,IGF1;PAX6
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4978386776517361,-1.2304850111722858,0.2053941908713693,0.5072062649512635,1.0,3/12,6.07%,JAG1;NOTCH1;HES1
prerank,regulation of cellular localization (GO:0060341),0.38727792373552283,1.23009077743657,0.16758747697974216,0.8781798532099284,1.0,4/46,2.25%,PARD6G;ADCY5;MAP2;UNC13D
prerank,mitotic spindle assembly (GO:0090307),-0.3611849250176668,-1.2300862844766711,0.17084282460136674,0.5075370543216277,1.0,16/42,23.01%,RHOA;FLNA;SMC1A;STAG1;MAP9;PIBF1;KIF23;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;PRC1;TPX2;AAAS;KIFC1
prerank,response to iron ion (GO:0010039),0.5001136850777426,1.2293995708523966,0.23651452282157676,0.8783196559517732,1.0,3/12,10.41%,BMP6;ACO1;BCL2
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.3589389382044998,-1.2284882395858747,0.14318706697459585,0.5107796121560733,1.0,12/45,16.53%,GCNT2;FOXO3;RBM3;APP;ZC3H7A;RPL10;PUM2;EIF4E;PER1;TDRD7;PUM1;DDX25
prerank,regulation of glucose metabolic process (GO:0010906),0.4057165775604404,1.2284636348787095,0.18363636363636363,0.8793293606587186,1.0,9/34,19.03%,RORA;GCGR;PDK2;SLC45A3;PDK1;SIRT1;RUBCNL;AKT1;KHK
prerank,neural tube development (GO:0021915),0.4697543077146246,1.2281215393714973,0.23246492985971945,0.878005892348658,1.0,2/15,5.66%,ALDH1A2;TRIM71
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.37353857125147905,-1.227965919913419,0.17167381974248927,0.5113421078106093,1.0,13/36,25.74%,NRP1;SHANK3;ITGB1;EPHB2;EDN1;HDAC6;FBXW7;HDAC2;GREM1;NCOA3;EGF;CCR2;BUD31
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.33395033224451287,-1.227699894150784,0.14087759815242495,0.5112916360212423,1.0,24/62,24.52%,MEF2C;ZBTB16;THBS1;KMT2E;RUNX1;H3-3A;AGO1;LYN;CBFB;DPY30;MYL9;PAF1;PTK2B;KMT2C;PRMT6;AGO4;CDK6;SPI1;L3MBTL1;ZFPM1;KMT2B;PRMT1;ASH2L;FES
prerank,regulation of lipid metabolic process (GO:0019216),0.33709513887844456,1.2275884222774187,0.14432989690721648,0.8774447830176153,1.0,24/88,19.41%,PRKAG2;RORA;PPARA;NFYB;SMARCD3;NFYC;PANK2;CHD9;MED1;SC5D;RXRA;SQLE;CYP51A1;TBL1XR1;RUBCNL;ACACA;TM6SF2;NCOR2;GGPS1;MID1IP1;HMGCR;NCOR1;SIN3A;OPA3
prerank,signal release from synapse (GO:0099643),0.38757470077964296,1.2275487328052406,0.17463235294117646,0.8750230071071915,1.0,22/43,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,error-prone translesion synthesis (GO:0042276),-0.4189371944555986,-1.2273377048513632,0.20253164556962025,0.5113968151443767,1.0,9/21,20.96%,RPA1;UBC;RPS27A;UBB;REV3L;MAD2L2;RPA2;PRIMPOL;RFC4
prerank,regulation of dendrite development (GO:0050773),-0.37220417583968374,-1.2271720101733883,0.17659574468085107,0.5111457759826498,1.0,8/37,5.07%,BMP5;DAB2IP;PTN;NEDD4L;MARK1;HECW2;TNIK;RAP2A
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.38215626949947434,1.2269616832775982,0.1704119850187266,0.8746676363181737,1.0,8/36,9.08%,AFDN;VAMP5;OPTN;RILPL2;RILPL1;GGA2;NSF;AMN
prerank,antibacterial humoral response (GO:0019731),-0.45457528834098326,-1.2267641545129515,0.19693654266958424,0.5115061840876819,1.0,3/16,14.39%,DEFA6;RPL39;PLA2G6
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3449334945387782,-1.226439182386709,0.15384615384615385,0.5116365102015489,1.0,22/51,30.42%,STAT3;APP;TMED10;GBP5;WNT5A;S100A13;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;HMGB1;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,postreplication repair (GO:0006301),-0.3507857273343018,-1.2256026193775384,0.14549653579676675,0.5129656745426376,1.0,17/45,22.58%,RPA1;UBC;UBE2V2;RPS27A;UBB;TRIM25;ZBTB1;WDR33;ISG15;USP43;UBE2A;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4
prerank,cell projection organization (GO:0030030),-0.3821806540284719,-1.2250541581260084,0.17286652078774617,0.5136089349970504,1.0,10/30,21.07%,RHOJ;GSN;PARVB;ITGB1;PARVA;CAPG;NPHP1;NCKAP1L;CDC42;RAC3
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5011440504861591,-1.2246781405815614,0.22268041237113403,0.5139499247525645,1.0,3/11,6.22%,PID1;TFRC;VAT1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.47454463400483093,1.22450927103274,0.21657250470809794,0.8814728765695397,1.0,3/16,7.14%,DDX5;PQBP1;DDX17
prerank,positive regulation of secretion (GO:0051047),-0.507671218132292,-1.2243787623714257,0.22478991596638656,0.5140058483341057,1.0,7/11,48.12%,ACSL3;AQP1;SCIN;GPLD1;XBP1;TRH;ABCB11
prerank,organelle fission (GO:0048285),-0.40769985960489497,-1.2240170403325745,0.17735042735042736,0.5142668959536368,1.0,10/24,29.78%,DNM3;CORO1C;MFF;SEC16B;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.32321936320042133,-1.2234179333506907,0.13383838383838384,0.5150269871308926,1.0,21/76,13.79%,LIMS1;ACTN4;RHOA;TMSB4X;RASSF2;EGFR;NFKBIA;APP;NOD1;CCN3;NR3C2;RPS3;NFAT5;IFI35;HDAC7;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4398595720587781,1.2233487876606168,0.21706864564007422,0.8833315026220924,1.0,4/23,6.34%,TGFBR3;SMAD3;DKK3;NREP
prerank,cellular response to hormone stimulus (GO:0032870),0.3446578710386792,1.2232446921287736,0.1377551020408163,0.8811887199817552,1.0,8/69,4.37%,ATP1A2;SLC5A5;TFPI;GCK;THRB;CYP11B1;BRD8;ADRA2A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4810437538096456,-1.223028009865634,0.2129817444219067,0.5152844890880084,1.0,7/13,31.48%,TMEM30A;SEC16B;BCAP31;SAR1A;EDEM2;EDEM1;TMEM30B
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.506247976742611,-1.2227682468789343,0.23061224489795917,0.5152521809608929,1.0,7/11,38.75%,ANXA1;SOCS5;ZC3H12A;JAK3;SMAD7;RC3H2;IL4
prerank,copper ion transport (GO:0006825),-0.5113453339453006,-1.2223084002074898,0.22903885480572597,0.5157385135892296,1.0,9/11,31.12%,STEAP3;SLC31A1;ATOX1;STEAP2;SLC31A2;ATP7B;STEAP4;SLC11A2;COX17
prerank,apoptotic cell clearance (GO:0043277),-0.38674518018609794,-1.2222797889577732,0.17849462365591398,0.5151607176618775,1.0,6/30,7.67%,RHOBTB1;SCARB1;THBS1;GAS6;ANXA1;TGM2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.47663608549577985,-1.2217052258597276,0.21224489795918366,0.5158703551216178,1.0,6/13,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.49227772770978645,1.2215606894721056,0.25047801147227533,0.885275250276874,1.0,5/13,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,cardiac muscle cell contraction (GO:0086003),-0.4391205616019358,-1.2214693434392465,0.2088607594936709,0.5158152208025752,1.0,8/19,15.01%,GSN;KCNJ2;CACNA2D1;CACNA1G;CAMK2D;PIK3CA;SCN4B;ATP1A1
prerank,negative regulation of cellular process (GO:0048523),-0.24803071575560626,-1.221345974733226,0.016666666666666666,0.5154585843300125,1.0,106/521,13.79%,APBB2;ABI1;PODXL;BMP5;ZBTB7C;RAPGEF2;PDE8A;BMPR2;DAB2IP;SLIT2;NOS3;CD200;ETS1;ACVRL1;TGFB2;CD9;NOTCH1;DCUN1D3;MYH9;CDH13;SH3BP4;CYP1B1;CD34;CTCF;VPS13C;NGF;BTG1;BMP4;PTPRJ;SFRP4;PLSCR1;APP;TNFRSF1B;ITGA1;ADARB1;FHL1;PTPRK;CCN3;TBX1;ACTN1;CBFA2T3;CASK;SOX17;IGFBP6;CCDC85B;VAMP3;AQP11;PRKD1;AXIN2;RACK1;ARHGDIB;ADAM10;LYN;NCK1;AR;ADAMTS1;CHMP4B;TNFRSF21;KLF11;CCN1;MDK;NACC2;APC;PPP2R5C;RPS6KA2;TGFBI;IFI35;RBBP4;PLPP1;VHL;EIF2AK3;TXNIP;FGF2;TGFB3;CDKN2AIP;NOTCH4;KLF4;S100A11;EPHB2;BTG3;HGS;TES;ADGRG1;PBRM1;PLXNC1;DYSF;MYOCD;SOX7;FBXO5;DDAH1;NME6;PDCD4;CCN4;WNT9A;BLM;BMP2;PTK2B;SST;RARG;SIPA1;ROR2;EEF1E1;RERG;SUZ12;ENPP1;ARHGDIA
prerank,male meiosis I (GO:0007141),0.4754353013916811,1.2212464722581275,0.22132796780684105,0.8840650714975506,1.0,3/16,14.13%,DNMT3L;TDRD9;MYBL1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3436281118837449,-1.2210576422329171,0.15665236051502146,0.5155626620926916,1.0,9/48,9.72%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;FBXW8;MDK;MYOC;NEDD9
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.49875591251351836,-1.2207497113865962,0.23782771535580524,0.515655394675169,1.0,4/12,13.63%,RUNX1;LYN;CBFB;PTPRC
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2949690778082485,-1.220581651044799,0.10103626943005181,0.515422077912737,1.0,31/119,18.23%,PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;TTC7A;SOCS2;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;EFR3B;PLEKHA4;INPP5D;PIK3CA;FGF2;SOCS5;PIGC;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12;PIK3R4;PI4KB;MTMR1;CISH;SOCS3;PTEN;PIGL
prerank,intracellular sterol transport (GO:0032366),-0.48780076959250135,-1.218457181433563,0.23647294589178355,0.5199741674061981,1.0,4/13,11.36%,ABCA1;NPC2;OSBP;STARD4
prerank,activation of adenylate cyclase activity (GO:0007190),0.39200625058754124,1.2183996991762707,0.19850187265917604,0.8922753332738275,1.0,5/35,6.20%,ADCY5;LGR4;ADCY1;CRHR1;ADCY8
prerank,positive regulation of blood coagulation (GO:0030194),-0.44709146711544673,-1.2182269366761613,0.20087336244541484,0.5198606982622892,1.0,5/17,11.56%,ST3GAL4;THBS1;F3;SERPINE1;ENPP4
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4156142060196353,-1.2181869987141574,0.2079207920792079,0.5192968474141284,1.0,5/21,8.21%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2583493326343401,-1.2181177131552003,0.035842293906810034,0.5188366921721244,1.0,72/351,13.33%,ABI1;BMP5;ZBTB7C;RAPGEF2;BMPR2;DAB2IP;NOS3;CD200;B2M;FAP;ETS1;ACVRL1;TGFB2;TBX3;NOTCH1;CDH13;SH3BP4;CYP1B1;CTCF;NGF;BTG1;BMP4;PTPRJ;SFRP4;MTSS1;APP;ITGA1;ADARB1;PTPRK;CCN3;CBFA2T3;IGFBP6;AQP11;WNT5A;AXIN2;HES1;LYN;AR;ADAMTS1;APOD;KLF11;NACC2;APC;PPP2R5C;RPS6KA2;IFI35;RBBP4;CDKN1C;SLC16A2;PLPP1;GATA2;VHL;TGFB3;KLF4;S100A11;BTG3;HGS;TES;ADGRG1;PBRM1;MYOCD;SOX7;DDAH1;MORC3;WNT9A;BMP2;PTK2B;SST;RARG;ROR2;EEF1E1;RERG
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4157330027529353,-1.2177671542563735,0.18526785714285715,0.519018988757073,1.0,6/23,12.51%,GHR;NOTCH1;CYP1B1;HES1;PIBF1;PTK2B
prerank,cellular response to interleukin-4 (GO:0071353),-0.5198201799146505,-1.2177275665129015,0.226,0.5184739720978286,1.0,1/10,0.18%,LEF1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4554668998267213,1.2176012445331013,0.2366412213740458,0.8928269041945553,1.0,8/19,22.39%,OBSL1;IL1RAPL1;PTPRD;CDKL3;CDKL5;CAPRIN2;CUL7;DBNL
prerank,regulation of cholesterol storage (GO:0010885),-0.4700740706235579,-1.2171563983593527,0.2139917695473251,0.5191266531138622,1.0,5/15,11.49%,SCARB1;PPARD;ABCA1;TTC39B;SREBF2
prerank,positive regulation of catabolic process (GO:0009896),-0.3252591988451547,-1.2171462212119646,0.13921113689095127,0.5185108123324272,1.0,9/65,7.76%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;WNT5A;PLK2;APC
prerank,regulation of plasminogen activation (GO:0010755),-0.49015142293721103,-1.2169846924953749,0.21774193548387097,0.5183250506837418,1.0,3/12,9.35%,THBS1;RUNX1;SERPINE1
prerank,neurotransmitter secretion (GO:0007269),0.382307907406172,1.2169498804959997,0.1912568306010929,0.8927457671832406,1.0,22/44,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3867940848604846,1.2169477011182077,0.19930675909878684,0.8902155017915707,1.0,9/40,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;WNT6;PKDCC;ADGRV1
prerank,bone development (GO:0060348),0.38056866871600137,1.2169163798998839,0.17680608365019013,0.8877937286428492,1.0,3/39,2.49%,RANBP3L;DYM;CYP26B1
prerank,cellular protein modification process (GO:0006464),-0.23725974057367222,-1.2165678324582943,0.011049723756906077,0.5186396386980244,1.0,272/983,22.21%,PRKG1;PTPRM;PTPRB;PTPRG;PRKCH;ST3GAL4;FBXL7;ERG;GCNT2;SNRK;BMPR2;ZBTB16;ST8SIA4;LTBP1;MARK1;NEK7;PTPN12;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;PTP4A2;ST3GAL6;MAP3K5;INSR;MERTK;RPS6KA5;THBS1;DCUN1D3;STK38L;B3GNT2;GAS6;STK3;PEAK1;PLOD2;SDHAF2;LIMK2;ATG3;SOCS2;BCR;BMP4;PTPRJ;WIPI1;AKT3;PPP1R12A;TGFBR2;IRAK3;APP;FN1;BTBD1;CDK14;SSH2;PTPRK;DCAF6;LMO7;FNIP2;FBN1;BMX;TNIK;NUAK1;PDIA6;MSLN;COP1;MAP3K20;CSNK1E;CAMK2D;ST3GAL1;PAK2;TEC;UBE2D3;PRKD1;CST3;TNKS;ERN1;ART3;ADAM10;LYN;DCAF10;LOX;FBXW8;CDC42BPA;KLHL2;DCLK1;ANXA1;PRKCD;PSMA6;PLK2;CDKL2;CSNK1A1;COG3;PSMB7;MAPK1;CCN1;PPP3CA;CSNK1G3;FBXO31;TGM2;FEM1B;PPP2R5C;FBXO30;PRKCG;LAMB2;PPM1H;KTN1;MFGE8;STK24;ST8SIA6;STT3B;MGAT4A;CDK5;PTPN1;VCAN;PTAR1;VHL;MAP4K4;AGA;EIF2AK3;FBXO4;PPP1CA;MAPKAPK2;CAND1;SOCS5;APOE;PSMB6;FBXO32;JAK1;YWHAZ;YES1;NEK3;BCKDK;B4GALT5;CPE;UBE2F;PIK3CD;MTMR7;PSMB5;SIRT5;OARD1;METAP1D;PIK3C3;GRK5;STK10;ISG15;DYRK1A;MORC3;ILKAP;PTPRZ1;RAB3A;PNPLA2;UGCG;PRKG2;RET;BMP2;DCAF13;PTK2B;DCAF5;UBE2L3;FBXW2;FBXO44;PPP2R3A;CSNK2A1;STK38;EVA1A;AKT2;PTPRC;FBXW7;UBL5;FBXL18;PPP1CC;TNC;RAB11B;CDH2;PSMB8;PIK3R4;ACVR1C;PPP4R2;ST8SIA2;PKN3;MT3;LIMK1;RAB1B;RHBDD1;GOLM1;TAB1;PSMC4;ICMT;KLHL22;KBTBD7;PHKA2;PSMD11;KLHL3;PRKACA;CTTNBP2NL;ALG10B;ASB13;MKNK2;PHEX;TAOK3;GPS1;ST6GALNAC2;PIGK;ATG5;CISH;CHRDL1;MAST2;SOCS3;IGFBP4;PTEN;COQ8A;LATS1;DUSP6;ST3GAL2;PSMB4;WDR45B;PSMD14;KCTD6;STRADA;TAOK1;HUNK;PTPN6;ATE1;CCNF;C3;PRAG1;STK26;CTDNEP1;CDK16;FBXL4;RAB11A;DSP;CDK6;CKAP4;MAPK3;MATN3;BTK;FBXW5;MARK3;STK17B;SIRT7;JAK3;HCK;PPM1L;PSMD10;LCMT1;TRIB2;PPP2R5B;PARP8;ENGASE;COPS6;CALU;COG7;CSNK1D;MAP3K6;DYRK2;PPP2CA;CHEK1;KLHL11;SYK;RCE1;ROCK1;PSME1;CDKL4;PTPRF;F13A1;DUSP1;KLHL25;FYN;CHM;ASB1;JMJD4;CCDC22
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.41324937209668317,-1.216374918692738,0.21748400852878466,0.5184541755695503,1.0,6/22,17.68%,ASXL3;APOD;CEACAM1;CCDC3;ALK;GPER1
prerank,protein autoubiquitination (GO:0051865),0.35279383754381916,1.2161381297816556,0.17224080267558528,0.8884303165867808,1.0,15/61,20.65%,RNF220;DDB2;SH3RF2;RNF41;TRIM71;RNF10;RNFT1;OBI1;RNF213;MDM2;RNF13;TRIM13;BFAR;NFX1;RNF146
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5115476197487422,-1.215874862080545,0.23529411764705882,0.5190218389270522,1.0,5/11,10.62%,MEF2C;RAPGEF2;LYN;ANXA1;PIK3CD
prerank,regulation of apoptotic process (GO:0042981),-0.24425023442306634,-1.215680984944048,0.00510204081632653,0.5188363619654834,1.0,182/676,20.51%,HIP1;LEF1;ARHGAP10;TEK;MEF2C;ACTN4;IL6ST;DAB2IP;ITGA6;SLIT2;TJP1;PTMA;STEAP3;NET1;ACER2;TNFSF10;ARHGEF3;MAP3K5;FOXO1;TBX3;THBS1;DCUN1D3;MCF2L;GAS6;APAF1;RASSF2;STK3;PIK3R1;EGFR;CYP1B1;FOXO3;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SFRP4;RASGRF2;KDR;UNC13B;UBC;RPS6KA3;RPL10;JUN;CARD14;NAA16;DNAJA1;TIAM2;ACTN1;FAS;FLNA;ITGB1;TFRC;MAP3K20;ARHGEF2;RNF144B;CRADD;RPS27A;UBB;PAK2;WNT5A;RACK1;ADAM10;PERP;PPIA;ANXA1;TPT1;PLK2;IAPP;KLF11;TGM2;APC;SPRY2;CD38;RPS3;RPS6KA2;CTSD;CDK5;ABR;SRC;XIAP;SOD1;FLT4;TIAM1;VHL;MAP4K4;VAV2;ARHGEF12;CAT;TGFB3;BCAR1;GCLC;GOLPH3;YWHAZ;BABAM2;IFT57;CFL1;MALT1;NSMF;CTSB;TCTN3;TNFAIP8;HSPB1;PHLPP1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BMP2;HIP1R;PLEKHG2;BIRC3;PTK2B;SAP18;RARG;USP47;TCIM;EEF1E1;AKT2;NME2;ARHGDIA;VEGFA;MADD;HIGD2A;LANCL1;JMY;ACVR1C;MT3;ALK;CBL;RHBDD1;PLAUR;BAK1;NR1H4;PA2G4;ATF4;BAG1;NCKAP1L;STIL;SIX4;RNF157;RTN4;PREX1;RBM25;ING4;DIABLO;TMEM219;OSGIN1;TOP2A;HDAC2;GPER1;LATS1;DUSP6;BARD1;PTPN6;STK26;PSEN2;GREM1;SH3RF1;MCL1;IRF5;RYBP;SOX8;ARHGEF5;STK17B;RIPK1;JAK3;HCK;AKT1S1;FOXL2;TRIO;PSMD10;PSENEN;HYPK;LCMT1;HMGB1;RHOB;MYD88;POU3F3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5287222016375277,1.21550555015239,0.23809523809523808,0.8883342232773142,1.0,7/10,29.88%,E2F8;SSBP1;DBF4;CDC7;ATRX;WIZ;STOML2
prerank,negative regulation of protein modification process (GO:0031400),-0.3168363692688727,-1.2150153452057095,0.13101604278074866,0.519835872581911,1.0,18/79,10.66%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;MFHAS1;YWHAB;XDH;PPIA;LYN;PPP1R16B;OCLN;CRTAP;EPHB2;TERF2IP
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4802276292730151,-1.2149861217826476,0.22828282828282828,0.5192694656774979,1.0,3/13,1.43%,PID1;NOS3;TMSB4X
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4677617570164221,1.2149456414600963,0.2003853564547206,0.8879630506494941,1.0,5/16,6.95%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.45941988951222457,1.2149382163795641,0.2407766990291262,0.8854969063083404,1.0,8/17,19.13%,EMC2;EMC4;BAG6;MMGT1;GET1;UBL4A;EMC10;EMC1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4663008233436877,1.214712973944208,0.22574257425742575,0.8839013370235952,1.0,6/18,15.60%,SMAD3;CLASP1;PDPN;IER3IP1;EFEMP2;IL6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.48238971456758356,-1.2140727231227986,0.22937625754527163,0.520827358055522,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,cellular response to alcohol (GO:0097306),-0.3535891199821083,-1.2140622248997994,0.18061674008810572,0.5202162081923916,1.0,17/42,16.14%,LRP6;CDH1;CTNNA1;GNB1;ADCY7;GNG2;ADCY2;AHR;GOLPH3;GRAMD1A;PTCH1;BLM;SMO;ADAM15;GLRA2;PTGFR;CFTR
prerank,melanosome organization (GO:0032438),0.4189948091698039,1.213983299305348,0.20676691729323307,0.884214946331875,1.0,8/26,18.93%,GPR143;SNAPIN;DTNBP1;AP1M1;SHROOM2;HPS1;HPS4;RAB38
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5141073184456466,-1.2135552879684801,0.23493975903614459,0.5207651937171573,1.0,4/10,11.60%,UBC;RPS27A;UBB;ISG15
prerank,muscle contraction (GO:0006936),-0.29112434855744174,-1.2133497040159347,0.10275689223057644,0.5206562007019382,1.0,21/126,9.93%,UTRN;EDNRA;CALD1;VCL;GJC1;SMTN;SNTB1;MYL12B;ITGA1;MYL6;TPM4;ITGB5;PXN;ALDOA;ACTA2;TPM2;MYH11;MYL9;TMOD3;TPM3;CHRNB1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3424840375525695,-1.2127885330382626,0.1789709172259508,0.5213329405359948,1.0,15/50,16.53%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;TNFAIP8L3;PIK3CA;PIK3CD;EXOC1;PIK3C3;IRS1;CSF1R;PI4KB
prerank,regulation of microtubule nucleation (GO:0010968),0.5249502925656503,1.2126357640675318,0.21764705882352942,0.8868252395025703,1.0,2/10,5.19%,HSPA1A;EML2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.36892593031139354,-1.2124856965298478,0.1875,0.5214146416828497,1.0,10/36,14.54%,SGMS1;DAB2IP;FAS;CRADD;PPIA;RPS3;PTPMT1;CSNK2A1;MADD;NR4A2
prerank,ketone body metabolic process (GO:1902224),0.534093532080463,1.211951805201825,0.25387596899224807,0.8869427959376583,1.0,3/10,10.55%,OXCT1;ACAT1;BDH1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4126876539134278,-1.2115919946704208,0.21767241379310345,0.5228877738203284,1.0,8/24,16.06%,B2M;SEC24D;TAP2;BCAP31;SEC23A;SEC31A;SEC24B;SEC13
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.35979818247833717,-1.211277524828842,0.17647058823529413,0.5230304316836203,1.0,10/38,13.94%,CAV1;INSR;PTGIS;CD34;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4745230544163994,1.2109270300336652,0.24015748031496062,0.8883786188601835,1.0,6/15,18.79%,SH3D19;FURIN;ADRA2A;NRDC;SNX33;SNX9
prerank,ventricular septum development (GO:0003281),-0.35991070799146224,-1.210926572330739,0.160676532769556,0.5232249574368585,1.0,12/37,8.57%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;TGFBR2;HES1;PDE2A;HEYL;STRA6;HEY2;ZFPM2
prerank,neuron apoptotic process (GO:0051402),-0.43384177295618254,-1.210855254291038,0.2222222222222222,0.5227533311367476,1.0,8/19,19.46%,APP;FAS;CIT;TNFRSF21;CDK5;DIABLO;GAPDH;LIG4
prerank,regulation of protein binding (GO:0043393),-0.2927096133037039,-1.2104181180985376,0.1191588785046729,0.5231974337973955,1.0,38/114,21.74%,ACTB;CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;DISC1;BMP4;APP;BTBD1;RALB;CARD16;CSNK1E;RACK1;PRKCD;SPPL3;TIAM1;PPP1CA;GTF2F1;PRMT7;TLE5;NMD3;BMP2;HIP1R;LRP1;VTN;PRKACA;EPB41;LDLRAP1;PEX14;MARK3;PSME3IP1;PPP2CA;EFHB;ROCK1;RIPK2;DTX3L
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2809415771630423,-1.2097898074205486,0.07932011331444759,0.5240306477256494,1.0,40/150,16.20%,PDE4D;NTRK3;CAV1;PID1;DAB2IP;SLIT2;PARD3;NIBAN1;LRP6;ENG;RASSF2;PRR5L;CORO1C;SPRED2;UBASH3B;XDH;PAK2;RACK1;PPIA;LYN;PRKCD;NCK1;CALM3;OCLN;SPRY2;CEACAM1;EPHB2;TERF2IP;HSPB1;TWIST1;SH3GL2;GSKIP;DBNDD2;PTPRC;ENPP1;PAQR3;PLPP3;TAB1;FKBP8;DDIT4
prerank,modulation by host of symbiont process (GO:0051851),-0.3790949993925283,-1.2097628099466848,0.19181034482758622,0.5234711148780227,1.0,15/31,37.10%,LEF1;JUN;SAP30BP;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1;POU2F3;AQP1;HPN;CCL5;HDAC1;SAP30;CCL4
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4017825028311658,-1.2096818277750903,0.1963882618510158,0.5230121476411798,1.0,9/22,15.73%,RPS15;RPS20;PLA2R1;SPRED2;UBB;RPS7;RPL23;EEF1E1;RPL37
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37943910575026335,1.2093021192424904,0.20833333333333334,0.8920603529704557,1.0,8/41,9.07%,PTGS1;ACSL1;DAGLA;PLA2G4C;PNPLA8;GSTM2;PTGR1;ABCD1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4031225392713873,-1.2088391448044822,0.2076749435665914,0.5244402273604033,1.0,7/24,16.62%,PDE3A;PDE4D;RAPGEF2;PDE2A;PRKAR2B;RNF157;APLNR
prerank,negative regulation of cell differentiation (GO:0045596),0.29477860847521997,1.2084182893981228,0.09800918836140889,0.8929202173733165,1.0,27/181,10.07%,RANBP3L;BMP7;RORA;COL5A1;TMEM64;SMAD3;OSR1;OVOL2;CTR9;SUFU;DTX1;PPARA;LRP3;MEIS1;LEO1;HNRNPU;WWTR1;E2F1;CITED1;USF3;PTBP1;MED1;ADGRV1;NR1H3;SPRED3;SOSTDC1;TGFBR1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3116418499833357,-1.2082752261449898,0.13202933985330073,0.5252374926998631,1.0,36/82,27.46%,ACTB;ARHGEF28;RHOA;ACTG1;ANKS1A;CHN1;AP2B1;LYN;GRIN2B;EFNA5;SRC;TIAM1;VAV2;YES1;EPHB2;AP2A1;ARPC2;GIT1;MMP2;GRIN1;PSEN2;CDC42;PSENEN;EPHB6;ARPC3;ROCK1;FYN;RASA1;AP2M1;EPHA7;PTPN11;ACTR3;VAV3;EFNA2;ARPC1B;DNM1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4526501247581373,1.2075141640822746,0.22156862745098038,0.8940187641564363,1.0,3/19,8.03%,IGF1;NLRP2B;NLRP3
prerank,UV-damage excision repair (GO:0070914),0.4948087341219829,1.2060265049922272,0.24789915966386555,0.8972748440507055,1.0,2/12,3.27%,DDB2;ERCC1
prerank,protein localization to chromosome (GO:0034502),-0.36518965547514426,-1.205434459180126,0.1751054852320675,0.5314139840289543,1.0,10/34,18.16%,RPA1;WAPL;CTCF;ESR1;TNKS;XRCC5;TERF2IP;RAD21;SLF2;RPA2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2945471734104038,-1.2044217246270383,0.12935323383084577,0.5332203263537577,1.0,51/110,31.13%,DAB2IP;HJURP;GSN;ABCA1;ICE1;FNIP2;RALB;TFRC;RACK1;IAPP;ANKRA2;RPS3;SRC;APOE;TAL1;AIDA;CDC42EP2;GFAP;HDAC6;VEGFA;SAR1A;BAK1;NCLN;TRAF3IP1;SLF2;LATS1;ATF7IP;HCK;CDC42;LCMT1;SPIDR;AJUBA;SYK;FAF1;BIK;SVIP;PTPN11;ULK1;BBS10;SELP;MPP7;VCP;FARP2;HRK;PARK7;CD36;MMP3;FBLIM1;SH3GLB1;HSPA5;BMF
prerank,synapse organization (GO:0050808),0.31014476109797723,1.2038373528076478,0.14307931570762053,0.9031422958987456,1.0,12/125,3.51%,SDK1;SLC6A1;UNC13C;SLC8A3;CACNB1;CACNB3;OBSL1;PDZRN3;SDK2;NLGN2;PCDHB11;FLRT3
prerank,response to prostaglandin E (GO:0034695),0.5227988660370079,1.2037582026923692,0.26720647773279355,0.9010068061186429,1.0,1/10,0.29%,TGFBR3
prerank,visual system development (GO:0150063),0.3827634022080151,1.2036726936484545,0.205607476635514,0.8988766415347537,1.0,16/37,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;FOXC1;ADAMTS18;ITGAM;RBP4;HIPK2;C1QA;SOX2;MEIS3
prerank,peptide metabolic process (GO:0006518),0.33480477127211,1.2034966227706867,0.1738382099827883,0.897194394046076,1.0,6/75,3.24%,AEBP1;ADAMTS13;CPQ;CPN1;ETHE1;FURIN
prerank,cellular copper ion homeostasis (GO:0006878),-0.45159996694043864,-1.2031982013052682,0.220675944333996,0.5354168494714016,1.0,8/14,29.00%,APP;SLC31A1;ATOX1;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,ERAD pathway (GO:0036503),0.32381639439126914,1.2031073716065992,0.17003367003367004,0.8962312900641538,1.0,20/83,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;CCDC47;UBXN6;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,positive regulation of ion transport (GO:0043270),0.3647587821736038,1.202662428687535,0.21455938697318008,0.895481042649391,1.0,7/48,5.33%,CACNA1D;ACTN2;ANK2;WNK3;ADRA2A;DLG1;VAMP7
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3359297181213451,1.202561595704883,0.17413793103448275,0.8934611245016929,1.0,29/77,19.03%,IGF1;HSPA1A;SIAH2;SLC25A5;PPIF;FZD9;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;CSNK2A2;CAAP1;PIH1D1;CLU;QARS1;BDNF;TMEM14A;NOC2L;SCG2;NDUFA13;HGF;NOL3;RELA;TCF7L2;AKT1;CX3CL1;MAPK8IP2
prerank,protein localization to cell surface (GO:0034394),-0.3979894086056554,-1.2024279213078921,0.18695652173913044,0.5366382019172403,1.0,9/26,16.42%,VCL;SMURF1;PTPRK;FLNA;EMP2;FGF7;JAM3;UNC50;PIGK
prerank,regulation of DNA metabolic process (GO:0051052),-0.34526072441708167,-1.2021083187095738,0.1895734597156398,0.536774347644203,1.0,23/44,34.14%,KAT7;UBE2V2;XRCC5;PARG;TERF2IP;YLPM1;WRNIP1;KPNA2;NBN;SIRT7;NUCKS1;TOM1L1;USP1;HNRNPD;TERF2;WDR18;KPNA1;STOX1;HELB;MYC;PIF1;TICRR;IL7R
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.49878802868839217,-1.201964141672013,0.25903614457831325,0.536444506506597,1.0,5/11,18.96%,MEF2C;TGFB2;MYOCD;GPER1;GREM1
prerank,regulation of interleukin-10 production (GO:0032653),-0.35117303708067454,-1.201938771499302,0.1836734693877551,0.5358723260886333,1.0,20/44,33.08%,CD34;STAT3;PLCG2;TNFRSF21;ISG15;PIBF1;CD46;NOD2;JAK3;HMGB1;TRIB2;SYK;FCGR2B;DLL1;TLR4;LGALS9;VSIR;TSLP;CD47;TYROBP
prerank,mitochondrial transport (GO:0006839),0.359459070185032,1.2016088631304516,0.1882770870337478,0.8947155451632206,1.0,13/53,13.05%,PITRM1;FLVCR1;COX18;SLC25A5;PPIF;ABCB10;TOMM40;TIMM17A;MTX2;TOMM22;BCL2;MFN2;TMEM14A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.38860599284541814,-1.201461646482746,0.18181818181818182,0.5364674185712783,1.0,9/28,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.32156779673481095,-1.2013810316633033,0.14651162790697675,0.5360532464428122,1.0,16/66,10.48%,PTPRM;CAV1;SPARC;DAB2IP;B2M;TGFB2;THBS1;MTSS1;PTPRK;CASK;XDH;AQP11;CEACAM1;CDKN1C;APOE;CAV2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3837388380981132,1.2012772089617043,0.20297951582867785,0.8936457703731145,1.0,13/41,21.26%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.4016425500824351,-1.2010417781356901,0.2281449893390192,0.5362314106301603,1.0,4/23,5.66%,SLC12A7;SLC12A2;ATP6V0A4;SLC12A6
prerank,regulation of cell-cell adhesion (GO:0022407),-0.36232106380043577,-1.2010041851692934,0.18161434977578475,0.5356847384603487,1.0,7/39,8.77%,PTPRG;PODXL;JAG1;CDH1;CEACAM1;EFNA5;SRC
prerank,regulation of lipid kinase activity (GO:0043550),0.5089804895627372,1.2007549500237527,0.25544554455445545,0.8932863929794655,1.0,2/11,3.14%,PIK3R3;WDR91
prerank,pharyngeal system development (GO:0060037),-0.45335163710760473,-1.2003132345813692,0.2330508474576271,0.5367876287488164,1.0,6/15,6.07%,BMP5;BMPR2;TGFB2;BMP4;TBX1;HES1
prerank,pore complex assembly (GO:0046931),0.45755812791540795,1.2003121079688848,0.20841683366733466,0.8925170718679929,1.0,3/19,5.72%,AFDN;PLEKHA7;GSDMD
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4100401131325096,1.1997580399135006,0.22692307692307692,0.8923546929280245,1.0,9/27,16.09%,PLAAT5;LPIN1;ETNK2;PNPLA8;PCYT2;CHKB;PLA2G15;NAAA;PLAAT3
prerank,dopamine metabolic process (GO:0042417),0.44655368120439365,1.199038387155018,0.24187725631768953,0.8927271788912965,1.0,4/18,11.40%,MOXD1;SNCAIP;DRD3;COMT
prerank,regulation of histone deacetylation (GO:0031063),-0.474454431950799,-1.1986410407556674,0.2388663967611336,0.5401324849709257,1.0,5/13,17.53%,NIPBL;CAMK2D;SAP30BP;APLNR;PRMT6
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.44949780303051373,-1.198503440384595,0.23617021276595745,0.5398407323510537,1.0,8/15,13.82%,TJP1;BMPER;ITGA5;SMAD1;FGF2;KLF4;JAK1;VEGFA
prerank,sulfate transport (GO:0008272),0.4742569914735655,1.1981979924586121,0.23138832997987926,0.8935632131995003,1.0,3/14,6.01%,SLC13A4;SLC26A1;SLC25A11
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24431831356146083,-1.198196978595441,0.02,0.5399011913187015,1.0,100/497,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;BMPR2;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;ACVRL1;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;WAPL;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;RACK1;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;RPS3;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;EIF2AK3;HMBOX1;AHR;CIR1;KLF4;S100A11;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;SYNCRIP;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;ENPP1;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4218753957552376,1.1970957859771043,0.2320754716981132,0.8929654063792242,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,canonical glycolysis (GO:0061621),0.4218753957552376,1.1970957859771043,0.2320754716981132,0.8929654063792242,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3585528084587887,-1.1969767517392473,0.1896551724137931,0.5422190669060613,1.0,13/39,17.11%,PIP4K2A;PIK3R1;TTC7A;SOCS2;PIK3C2A;EFR3B;PIK3CA;SOCS5;PIK3CD;PIK3C3;PI4KB;CISH;SOCS3
prerank,regulation of intracellular signal transduction (GO:1902531),-0.25084874994472794,-1.1968642584624758,0.03484320557491289,0.5418408266734059,1.0,63/420,9.37%,ARHGAP31;SGMS1;ARHGAP10;VWF;TEK;NTRK3;RHOJ;CHN2;DAB2IP;PIP5K1B;ARAP2;SRGAP1;RHOA;TMSB4X;TRAF5;NET1;HIPK1;ARHGEF3;RPA1;PIP4K2A;MCF2L;RASSF2;STK3;STARD8;CHN1;EGFR;NFKBIA;BCR;MOB3B;RASGRF2;ARAP3;RPL5;STARD13;TIAM2;PLCG2;KAT6A;TNIK;NUAK1;ARAP1;ARHGEF2;PAK2;WNT5A;ARHGAP32;ARHGDIB;PDE2A;LYN;PPP1R16B;ARHGAP35;MAPK1;MYOC;PPP2R5C;CEACAM1;USP7;RBBP4;CDK5;ABR;XIAP;ATP6AP2;TIAM1;MAP4K4;VAV2;IER3;ARHGEF12
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.450931496796806,1.1963778522093322,0.2357563850687623,0.8932577698782773,1.0,6/18,17.36%,DAB2;RAB21;DENND10;MTMR2;SNX3;PTPN23
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5132168570338671,-1.1962578936349744,0.24903474903474904,0.5427021402034901,1.0,3/10,7.43%,BMP4;GLI3;MDK
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3792618255308235,1.1961629973050592,0.2074074074074074,0.8917039862718333,1.0,13/43,21.26%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,negative regulation of cellular component organization (GO:0051129),0.3411002682282741,1.1960845732288465,0.18688524590163935,0.8896526968047467,1.0,15/74,12.52%,BMP6;SYT11;HSPA1A;PRKCZ;PON1;DNAJB8;OPRD1;TFIP11;IMPACT;SCAMP5;CLU;WASL;RTEL1;RAPGEF3;MTMR2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4863744449147491,1.196047708771616,0.24509803921568626,0.8874679818894744,1.0,3/13,5.83%,BMP7;METRNL;HNRNPU
prerank,positive regulation of bone mineralization (GO:0030501),0.39024302017511475,1.1957212941444681,0.20212765957446807,0.8863524389835999,1.0,8/35,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;PKDCC;ADGRV1
prerank,regulation of proteolysis (GO:0030162),-0.3397953401412695,-1.195325908501263,0.1744186046511628,0.544386239203868,1.0,13/48,15.37%,CAV1;LTBP4;DNAJC1;SPOPL;CST3;PERP;CDK5;GSAP;HDAC6;IST1;TBC1D10A;PLAUR;BAK1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4244713702594406,1.1952760551657684,0.2167689161554192,0.8857284139517183,1.0,6/22,11.06%,NOTCH2;CDH3;FGFR2;MED1;CRNN;STXBP4
prerank,cellular response to organic substance (GO:0071310),-0.2852149636148813,-1.195133804865147,0.12760416666666666,0.544255130370665,1.0,16/116,6.03%,LEF1;GHR;PID1;BMPR2;SLIT2;RHOA;PTPN12;ACVR1;ACVRL1;RAMP2;CYP1B1;SOCS2;STAT3;TGFBR2;CPNE3;RACK1
prerank,digestive tract development (GO:0048565),-0.3663936551149052,-1.1949996387636164,0.2109704641350211,0.543940147019302,1.0,9/32,13.91%,RARB;PCSK5;TGFB2;PKD1;GLI3;NIPBL;STRA6;SMO;RARRES2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3681677307220818,-1.1947476419568759,0.18969555035128804,0.5439300380537817,1.0,14/34,26.87%,PTPRB;PTPN12;PTPRJ;UBASH3B;PTPN1;DUSP3;PTPRZ1;DUSP6;PTPN6;PTPRF;DUSP1;PTPN11;DUSP7;DUSP18
prerank,2-oxoglutarate metabolic process (GO:0006103),0.48439972253878966,1.194678807230005,0.251984126984127,0.8856437335380968,1.0,4/13,15.79%,ADHFE1;GOT1;IDH2;GOT2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.47410657522366606,-1.194358718250491,0.2434077079107505,0.5442726365271479,1.0,5/13,21.28%,RHOA;RAP2A;ZDHHC7;CDC42;MSN
prerank,positive regulation of calcium ion transport (GO:0051928),-0.36212686357342094,-1.194239922232756,0.22004357298474944,0.5439587353740317,1.0,7/36,6.52%,CAV1;STIM2;ATP2B1;TRPC3;CACNB2;TRPC6;CXCL12
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.29591026287041394,-1.194164557399073,0.13959390862944163,0.5435139873854993,1.0,28/113,13.82%,NRP1;TEK;BMP5;NRP2;BMPR2;PTN;VEGFC;CDH13;F3;EGFR;BMP4;AKT3;KDR;TBX1;PRKD1;WNT5A;PPP1R16B;MDK;FLT4;FGF2;AGGF1;FGF7;PIK3CD;NRAS;BMP2;ECM1;NME2;VEGFA
prerank,autophagy of mitochondrion (GO:0000422),-0.35414556084803706,-1.1941073939643279,0.20531400966183574,0.543030404282847,1.0,18/38,30.21%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;PHB2;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2;ATG14;WIPI2;USP30
prerank,autophagy of nucleus (GO:0044804),-0.43446523287876376,-1.1938703935850177,0.23829787234042554,0.5429668379521679,1.0,9/16,28.64%,ATG3;WIPI1;RB1CC1;ATG12;ATG5;WDR45B;ULK2;ULK1;WIPI2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4477209303490208,1.1935120204445626,0.22285714285714286,0.8878054375472924,1.0,3/18,6.37%,HSPA1A;SLC25A5;FZD9
prerank,organelle fusion (GO:0048284),0.420180229813853,1.1935001231658282,0.2316831683168317,0.8855685228758646,1.0,8/22,20.76%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2;STX4;MIGA1;BAX
prerank,positive regulation of protein maturation (GO:1903319),-0.4963637123437294,-1.1934847614933044,0.26653696498054474,0.5432231165471195,1.0,3/11,15.00%,NKD2;CCBE1;RHBDD1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3843268284747064,-1.193384565995632,0.21141649048625794,0.5428313184467578,1.0,11/27,8.57%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;BMP4;TGFBR2;HES1;HEYL;HEY2;ZFPM2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.32813488506016847,-1.1931125364655664,0.16161616161616163,0.5428490452552437,1.0,15/55,20.95%,PID1;THBS1;CYP1B1;TGFBR2;XDH;AGTR1;SIRT5;ACE2;ROMO1;MT3;DHRS4;ZC3H12A;CBR1;RIPK1;NOXO1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4463729844167273,1.1925520265551603,0.2729007633587786,0.8868799613056159,1.0,7/19,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4922936238560393,-1.1917779950647027,0.24285714285714285,0.5453611073776594,1.0,4/11,8.36%,CAV1;FOXO1;FAS;ATP6V0D1
prerank,regulation of small molecule metabolic process (GO:0062012),0.40578956278240585,1.1912110493713428,0.23863636363636365,0.889664652972321,1.0,8/28,16.53%,RORA;PPARA;PDK2;PANK2;PDK1;EPHX2;SIRT1;NCOR2
prerank,positive regulation of myelination (GO:0031643),-0.4931845517198206,-1.1910207968203452,0.24950884086444008,0.5465519587151085,1.0,2/11,3.66%,PARD3;TNFRSF1B
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3767671621119496,-1.190711623064449,0.20909090909090908,0.5466898317838275,1.0,10/30,11.83%,BCL2L1;CD44;CXCL12;TPT1;RPS3;ACKR3;FBXO5;TWIST1;DYRK1A;CD74
prerank,organelle organization (GO:0006996),-0.24601804048930534,-1.1905069414916605,0.02631578947368421,0.5465464785688587,1.0,70/388,12.97%,FMNL2;ARHGAP10;SYNE1;CAV1;ATP8B1;FGD5;SEMA6A;PLCE1;MICAL2;MARK1;NOS3;FGD6;DST;RAB14;ATL3;TMEM135;LIMD1;VPS13C;ARAP3;PALLD;FAF2;LMAN2L;RAB31;TMED10;USP6NL;FAM161A;TNIK;CHMP2B;SIPA1L3;MAST4;ATXN7;PRKD1;PPIA;NRF1;FBXW8;CHMP4B;CHMP4A;CSNK1A1;COG3;SEC16B;MDK;ABCA3;CCL13;CNN2;ABCD2;CXADR;PEX7;BRWD1;ZFYVE16;ATP5F1B;EIF2AK3;APOE;NEDD9;SORT1;GOLPH3;CAV2;CFL1;SIRT5;BAG5;SEC31A;PHB2;FNBP1L;RANBP9;NECTIN2;UBXN2A;VPS13D;SIPA1;SEC61A1;STX7;ODF2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4513084963428629,1.190472617071436,0.24904214559386972,0.8901081826554086,1.0,5/17,13.30%,CTR9;CPSF6;CPSF7;RNF20;ZC3H3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3820034233081946,-1.1902802977228613,0.23060796645702306,0.5464940611079425,1.0,10/27,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;XYLT1;CHSY3;BGN;B3GAT1;B3GAT3;NCAN
prerank,regulation of cell differentiation (GO:0045595),-0.2797073402775298,-1.1900216700355903,0.10309278350515463,0.5464665791261207,1.0,42/148,21.29%,SLC6A6;LTBP4;SPOCK2;ZFHX3;TRPS1;PHLDB1;RUNX2;NGF;RUNX1;SIX1;RPS6KA3;TBX1;PHLDB2;AR;CBFB;MDK;APC;EMP2;HEY2;TIAM1;VHL;IGF2;NOTCH4;KLF4;CEBPD;EDN3;SUZ12;CD24;ALK;ID2;PA2G4;ATF4;PRKACA;BCL6B;HEY1;GREM1;CDK6;PTHLH;MOSMO;MCRIP1;PPP2CA;ROCK1
prerank,regulation of transmembrane transport (GO:0034762),-0.37441157877139813,-1.1898410954967016,0.19308943089430894,0.5462452438356242,1.0,10/31,16.03%,ACTB;SLC2A1;NEDD4L;KCNJ2;OCLN;KCNJ12;ACE2;KCNJ8;KCNJ15;CTTNBP2NL
prerank,skeletal muscle tissue development (GO:0007519),-0.3755804525084285,-1.1897748401333814,0.20876826722338204,0.5457695564500331,1.0,5/32,5.91%,MEF2C;CAV1;SVIL;SIX1;MYL6
prerank,stem cell differentiation (GO:0048863),0.3678293377076893,1.1897374185738485,0.20441988950276244,0.8905416392356935,1.0,10/39,10.98%,OSR1;DNMT3L;KIT;LMBR1L;WNT7A;FGFR2;JARID2;HOXB4;GPM6A;BATF
prerank,synapse assembly (GO:0007416),0.3416387856150723,1.189513501596947,0.18491921005385997,0.8890828953391102,1.0,14/67,12.49%,SDK1;OBSL1;SDK2;NLGN2;PCDHB11;FLRT3;WNT7A;CBLN4;GRID2;NLGN3;GPM6A;FZD5;PCDHB3;BDNF
prerank,plasma membrane repair (GO:0001778),0.4858272588250391,1.1894693638418992,0.26272912423625255,0.8869758702011354,1.0,3/13,6.61%,SYT11;ANXA6;MYOF
prerank,negative regulation of neuron differentiation (GO:0045665),0.4224143442166428,1.1894398513030051,0.2326007326007326,0.8848425875577953,1.0,4/22,11.97%,BMP7;DTX1;MED1;SOX9
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.35318055102519763,1.1890566878047961,0.1989247311827957,0.8839666597147551,1.0,14/57,16.59%,ADCY5;ADCY1;ADRA2A;CHRM2;ADCY8;LPAR1;DRD3;GABBR1;GPR37;HTR1F;CHRM1;OPRM1;HTR1A;GRM8
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3009806650084447,1.188720442115328,0.14797507788161993,0.8830217476508483,1.0,18/142,9.59%,ATP1A2;ADCY5;CCR9;ACKR2;SMAD3;PDGFRA;TAC1;C5AR2;BDKRB1;LPAR2;BDKRB2;ADCY8;FZD9;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,positive regulation of cytokine production (GO:0001819),-0.2552713627310815,-1.1885637690030646,0.050314465408805034,0.5480733885946864,1.0,80/292,23.27%,SPTBN1;FOXP1;PDE4D;IL6ST;IL1R1;RFTN1;LRRFIP1;CD200;F3;CYP1B1;CD34;POLR3F;AFAP1L2;RUNX1;STAT3;SLC7A5;APP;PTGS2;NOD1;PLA2R1;TMED10;PLCG2;DHX33;ARHGEF2;GBP5;WNT5A;S100A13;XRCC5;IL6R;ANXA1;MDK;RPS3;CCBE1;G3BP1;SOD1;FLT4;EIF2AK3;SERPINE1;IL15;MALT1;PIK3CD;TWIST1;ISG15;POLR3H;PIBF1;CD74;AGPAT1;CD40;PTPRC;CD86;IFIH1;NR1H4;CSF1R;ATF4;NFKB2;CD46;POLR3B;GAPDH;NOD2;IL33;C3;IRF5;RIPK1;POLR3A;HMGB1;MYD88;ZBP1;POLR3D;CADM1;TICAM1;SYK;RIPK2;PAEP;GLMN;HPSE;MAPK11;CD276;ZFPM1;BCL10;POLR2F
prerank,B cell proliferation (GO:0042100),-0.4337218533410313,-1.1884415328382005,0.2404040404040404,0.5477143905642267,1.0,4/17,13.63%,MEF2C;CTPS1;CD40;PTPRC
prerank,mitochondrion organization (GO:0007005),0.29687746259378167,1.1881028270094884,0.14240506329113925,0.8831312789036729,1.0,37/165,14.67%,IFIT2;TRAK1;MIGA2;SPATA18;ESRRA;PITRM1;NIPSNAP2;POLRMT;AFG3L2;AIFM1;COX7A1;TOMM40;SUPV3L1;CHCHD3;MIEF2;FMC1;TIMM17A;NDUFS1;ADCK1;LRRK2;MTX2;COX7A2L;WASF1;PPARGC1A;TOMM22;MYH14;AFG1L;MPV17;CYCS;SSBP1;MFN2;GABPA;ATAD3A;TERT;TMEM11;AIFM2;GABPB1
prerank,regulation of autophagy (GO:0010506),0.2850085116392818,1.1877693815743797,0.11323529411764706,0.8821374455609323,1.0,45/216,16.00%,PRKAG2;RNF152;SNX6;LEPR;NUPR1;CTSA;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;PLEKHF1;ITPR1;OPTN;PIK3CB;TRIM5;ATP6V0B;ATP6V1H;CASP3;ZKSCAN3;HTRA2;KAT5;MTMR4;RMC1;LRRK2;GOLGA2;ATP6V1B2;SLC38A9;ATP6V1E1;BCL2;CSNK2A2;FZD5;IL10RA;ATG13;KDM4A;LAMTOR2;TBC1D14;ATP6V0E2;ATP6V1C1;VDAC1;ATP6V0D2;NPRL2;LAMTOR3;ABL1;HGF;ATM
prerank,homotypic cell-cell adhesion (GO:0034109),-0.35650781456913444,-1.1870454584187538,0.22055674518201285,0.5504287131714956,1.0,12/39,8.66%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;TJP2;UBASH3B;PPIA;CLIC1;MYL9
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.39727325824508763,-1.18700222457838,0.23030303030303031,0.5498866330142351,1.0,6/21,12.65%,DCN;CSGALNACT1;CSPG4;VCAN;CHSY3;BGN
prerank,cellular response to interleukin-1 (GO:0071347),-0.2780499357449819,-1.1867575888178754,0.11170212765957446,0.549842465547974,1.0,39/143,23.25%,DAB2IP;IL1R1;RPS6KA5;PTGIS;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;CCL13;IL1RAP;PSMB6;PSMB5;SQSTM1;CD40;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;ADAMTS12;MAP3K8;PSMB4;PSMD14;NOD2;CCL25;USP10;MAPK3;ZC3H12A;PSMD10;MYD88;PSME1;RIPK2;HAS2;MAPK11;PSMB3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4941136470653391,-1.1866917299441773,0.2723735408560311,0.5493731627506365,1.0,2/11,4.43%,CDH13;PLCG2
prerank,arachidonate transport (GO:1903963),0.5194920878170809,1.1866857101416122,0.2556237218813906,0.8817570642565029,1.0,3/10,8.73%,BDKRB2;PNPLA8;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.5194920878170809,1.1866857101416122,0.2556237218813906,0.8817570642565029,1.0,3/10,8.73%,BDKRB2;PNPLA8;DRD3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.4955098777966532,-1.1863231518165926,0.27416173570019725,0.5496446326759041,1.0,4/10,24.12%,TNFRSF1B;ZBTB1;HMGB1;CCR2
prerank,positive regulation of response to stimulus (GO:0048584),-0.3572088291020239,-1.1862868192930356,0.22823529411764706,0.5491102406072706,1.0,18/40,26.05%,B2M;TGFB2;WNT5A;PRKCD;ABI3;IL15;CDKN2AIP;EEF1E1;RSAD2;IFIH1;FMR1;FXR1;YPEL3;NSMCE4A;FCGR2B;TAF9;IER5;SELENON
prerank,rRNA transcription (GO:0009303),-0.4340446751255077,-1.1862841526114392,0.24892703862660945,0.548493458948964,1.0,8/17,24.16%,GTF3C5;SPIN1;POLR1G;CAVIN1;GTF3A;SIRT7;GTF3C3;POLR1E
prerank,positive regulation of potassium ion transport (GO:0043268),0.3804864857018268,1.185902844013455,0.2291296625222025,0.8824045138604016,1.0,11/38,10.67%,ACTN2;ANK2;KCNJ5;ADRA2A;DLG1;KCNJ10;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,transcription by RNA polymerase I (GO:0006360),-0.36775327708300337,-1.1853733003500948,0.2039045553145336,0.5500982708836549,1.0,16/34,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,autophagosome assembly (GO:0000045),-0.3313609394739531,-1.1845644452437283,0.18266978922716628,0.551512480168004,1.0,15/52,18.91%,ATG3;SMURF1;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6
prerank,negative regulation of cation channel activity (GO:2001258),0.4087470639899625,1.1843769401244673,0.2375,0.8857918980373221,1.0,6/26,11.59%,SLC6A9;CRHR1;GNB5;GSTM2;DRD3;GSTO1
prerank,spindle assembly (GO:0051225),-0.317306872452915,-1.184250263685664,0.18271604938271604,0.5516593196597045,1.0,20/67,23.01%,RHOA;NEK7;STARD9;FLNA;SMC1A;TNKS;STAG1;RPS3;MAP9;PIBF1;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;MAPRE2;CSNK1D;TPX2;AAAS;KIFC1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2797870413469558,1.1842310277296182,0.125,0.8841623534936244,1.0,81/241,24.68%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2;U2SURP
prerank,muscle cell differentiation (GO:0042692),0.3867016615671624,1.1838691352311395,0.240234375,0.8832752860346497,1.0,6/32,4.75%,RORA;NEBL;DUSP29;SPEG;WNT5B;SGCZ
prerank,nucleic acid-templated transcription (GO:0097659),0.37440616603701776,1.1838465621254717,0.23738317757009345,0.8812067001007673,1.0,16/42,23.54%,THRB;RRAGC;DTX1;E2F1;CREBL2;DRG1;TOPORS;XAB2;TERT;POLR2D;RNPS1;MEF2A;POLR2A;BAZ2A;MMS19;POLR2B
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4054864755370283,-1.183747005484959,0.24618736383442266,0.5522764832850307,1.0,10/21,24.73%,NGF;AIM2;GRIN2B;BIRC3;MT3;USP50;GRIN1;BEX3;FYN;EPHA7
prerank,relaxation of muscle (GO:0090075),0.48787142017497676,1.1837020737911783,0.26774847870182555,0.87957771448654,1.0,1/13,0.03%,ATP1A2
prerank,regulation of protein secretion (GO:0050708),0.3077436073197035,1.1832726526130033,0.17478991596638654,0.8788811980850288,1.0,35/119,18.74%,BMP6;CACNA1D;IGF1;FRMD4A;GCK;ITPR1;CACNA2D2;ADRA2A;LLGL2;STXBP5L;SERGEF;DRD3;SNAP25;KCNC2;LLGL1;CLOCK;MYO18A;ITPR2;IER3IP1;RAPGEF3;ENSA;CYP51A1;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;IL1A;PICK1;APBB1;IL12A;DPP4;HMGCR;RHBDF1
prerank,ureteric bud development (GO:0001657),0.45650412455914346,1.183175985648713,0.23572744014732966,0.8770895908394125,1.0,4/17,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,positive regulation of neuron differentiation (GO:0045666),-0.35378549148132854,-1.1823198357100726,0.23503325942350334,0.5551611763922804,1.0,6/40,7.43%,MEF2C;ZEB1;RHOA;NGF;ARHGEF2;HEYL
prerank,cAMP biosynthetic process (GO:0006171),0.5135279629559324,1.1818045382252493,0.2606060606060606,0.8800770246151757,1.0,3/10,6.20%,ADCY5;ADCY1;ADCY8
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.2665173784839224,-1.1816326673388313,0.11411411411411411,0.5562182496482094,1.0,49/199,17.52%,PTPRG;MEF2C;BMP5;BMPR2;DAB2IP;NOS3;ATP2B1;PLCL1;RPS6KA5;NOTCH1;GAS6;EGFR;SDHAF2;CORO1C;ID1;BMP4;ADAMTS5;TBX18;IL17RD;KLF7;RAB11FIP5;SPRED2;ARHGDIB;NPTN;TLE3;NOVA2;RAB11FIP1;MDK;SPRY2;HDAC9;HEY2;VASN;IL15;MYOCD;ADM;PTCH1;BMP2;ABHD6;LNPEP;SPRY1;ACVR1C;MAD2L2;NR1H4;BRCA2;ATF4;HEY1;N4BP1;PTEN;RAB11FIP3
prerank,pentose-phosphate shunt (GO:0006098),-0.4831022860483144,-1.1812675274928717,0.2651072124756335,0.5564906885631623,1.0,5/11,25.90%,PGM2;RPE;DERA;RBKS;H6PD
prerank,relaxation of cardiac muscle (GO:0055119),0.48085760930506116,1.1809344740754988,0.2682445759368836,0.8810539471149323,1.0,1/13,0.03%,ATP1A2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3826239478663346,-1.1809072272255683,0.24604966139954854,0.5567125176279893,1.0,6/27,9.60%,BMPR2;ACVRL1;DACH1;TNKS;FGF2;HMBOX1
prerank,myotube differentiation (GO:0014902),0.44830690256342803,1.1804971884513817,0.26095617529880477,0.8805541339853248,1.0,4/17,5.03%,IGF1;ADAM12;ADAMTS15;ADGRB3
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.28214039226156334,-1.1799681336295231,0.13895781637717122,0.5583450096427531,1.0,35/124,20.24%,LEF1;RHOA;FZD6;PRICKLE2;SMURF1;NFATC1;SFRP4;AGO1;AP2B1;WNT5A;GNB1;PSMA6;GNG2;PSMB7;PPP3CA;TIAM1;AGO2;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;AGO4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10
prerank,actomyosin structure organization (GO:0031032),-0.31100473763001757,-1.1795262006519047,0.16578947368421051,0.5587637922998473,1.0,14/75,8.89%,FRMD5;PGM5;TJP1;RHOA;MYH9;WDR1;F11R;ITGB1;CIT;CDC42BPA;ITGB5;CSRP2;SRC;TMOD3
prerank,eye morphogenesis (GO:0048592),-0.41476443419242776,-1.1795021355609638,0.22594142259414227,0.5581964659368822,1.0,10/19,18.80%,MFAP5;STAT3;COL5A2;FBN1;NIPBL;RARG;VEGFA;AGTPBP1;ALDH1A3;EFEMP1
prerank,sulfur compound transport (GO:0072348),0.40096626611121006,1.179095514251027,0.24528301886792453,0.8834949153116087,1.0,4/27,6.01%,SLC6A13;SLC13A4;SLC26A1;SLC25A11
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4670858716810214,-1.1788351880249943,0.25244618395303325,0.5592600907466608,1.0,3/12,4.22%,ACTB;ACTG1;LAMA3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.344542362807085,1.1786126858154675,0.2119089316987741,0.883126834081839,1.0,10/61,12.11%,EYA1;DNMT3L;EYA4;EYA2;SMOC2;OTUD4;ABRAXAS1;MRE11;RTEL1;PML
prerank,kinetochore organization (GO:0051383),0.4698484583800026,1.1784317505701871,0.26879699248120303,0.8816371969898866,1.0,6/13,21.79%,NDC80;CENPC;POGZ;NUF2;CENPA;CENPH
prerank,acylglycerol metabolic process (GO:0006639),-0.3594876840900978,-1.1780607831554577,0.22573363431151242,0.5605344033384124,1.0,8/37,12.54%,CAV1;ABHD2;DGKH;DGKZ;MGLL;APOE;PNPLA2;ABHD6
prerank,toll-like receptor signaling pathway (GO:0002224),-0.3052831316175859,-1.1777700106097007,0.1507177033492823,0.5606267781261268,1.0,28/84,21.51%,RFTN1;IRAK3;UBC;RPS6KA3;PLCG2;RPS27A;UBB;UBE2D3;MAPKAPK2;CTSB;SFTPA2;SFTPA1;TRIL;PIK3C3;BIRC3;PIK3R4;IRAK2;SCARA3;TAB1;NR1H4;CTSS;BTK;RIPK1;HMGB1;MYD88;TICAM1;NMI;RIPK2
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4298798441541513,-1.1776351608568916,0.27346938775510204,0.5603079318358257,1.0,8/18,19.30%,MDFIC;MFHAS1;CTNNA1;APOD;OTUD7B;LATS1;POLR1A;CABP1
prerank,mitochondrial membrane organization (GO:0007006),0.39431271897233355,1.1775600517287912,0.23605947955390336,0.8825397206140975,1.0,11/32,17.15%,SLC25A5;PPIF;CHCHD3;MTX2;APOO;BCL2;MICOS10;MFN2;TMEM11;APOOL;HSPA9
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3368283990494285,1.176468346336761,0.2038327526132404,0.88444924813864,1.0,6/61,6.99%,PRKAG2;NQO1;PPARA;PSMD3;PDK2;PANK2
prerank,lipid oxidation (GO:0034440),-0.46248018568224225,-1.175674024814805,0.2693069306930693,0.5645299795820481,1.0,2/12,5.09%,ADIPOR2;ACOX1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3792851963871018,1.175598241961924,0.24866785079928952,0.8854526752972761,1.0,5/34,4.82%,LEPROT;ROCK2;ACTN2;PICALM;TTBK2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3005579774287123,1.175564111097848,0.15814696485623003,0.8834848833085763,1.0,16/141,8.34%,ATP1A2;RORA;ADCY5;SLC5A5;ROCK2;IL18;TRPV1;TFPI;ADCY1;RUVBL2;ADCY8;CASP3;KAT5;LRRK2;IMPACT;MED1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4172874936369184,1.1744046589163637,0.26120857699805067,0.8855812464416828,1.0,4/23,6.77%,NUPR1;GCK;PPARA;C1QTNF3
prerank,regulation of protein dephosphorylation (GO:0035304),-0.34757320475070175,-1.1743415646280955,0.2025862068965517,0.5671743414116004,1.0,9/37,11.70%,MFHAS1;YWHAB;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF;PPP1R2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.45438576220648763,1.1740704615866846,0.26653696498054474,0.8846296672228978,1.0,7/17,19.71%,BMP6;TRIM5;CACTIN;SASH1;PRKCA;CX3CL1;NFKBIL1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3650426403994239,-1.1739327095090213,0.24532224532224534,0.5675484847917077,1.0,9/32,20.14%,CAV1;TRPC3;PLCG1;TRPC1;CEMIP;APLNR;GPER1;GRIN1;NPSR1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3837521244553319,-1.1739062359217844,0.24121779859484777,0.5669933671423418,1.0,7/25,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,regulation of nervous system process (GO:0031644),0.4484210122874744,1.173776715012512,0.26356589147286824,0.8835935403743864,1.0,3/18,4.08%,SLC8A3;ROCK2;NPTX1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.42147192596527366,-1.1736941781393515,0.24329896907216494,0.566876402688239,1.0,9/19,32.81%,LRP6;VEGFA;NR4A2;MANF;LMX1B;RYK;LMX1A;WNT2;CTNNB1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.3717787667484341,-1.1736719002449836,0.24838012958963282,0.566314816070888,1.0,8/31,15.55%,TFRC;VAMP3;SHLD1;EPHB2;PHB2;PTPRC;CD86;MAD2L2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2939536763471242,-1.1734495261661766,0.14511873350923482,0.5662382394385646,1.0,30/86,26.29%,APP;WDR1;CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;SYNPO2;APOE;GPX1;EDN1;CDC42EP2;PTK2B;PFN1;TRPV4;CLIP1;LIMK1;KATNB1;NCKAP1L;SEMA5A;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,response to lipopolysaccharide (GO:0032496),-0.2772445747660194,-1.1733088871900257,0.13846153846153847,0.565966574160834,1.0,35/138,23.22%,FOXP1;MEF2C;DAB2IP;NOS3;RHOA;SCARB1;IRAK3;TNFRSF1B;RPS6KA3;DEFA6;TNFRSF11A;GCH1;CARD16;WNT5A;SRR;SERPINE1;MAPKAPK2;PAF1;PDCD4;LIAS;CD86;GIT1;IFNAR1;NOD2;ERBIN;ZC3H12A;HMGB1;GGT7;MYD88;TICAM1;SBNO2;CASP1;GGT1;SMAD6;BCL10
prerank,regulation of histone modification (GO:0031056),-0.4682219383201337,-1.1732746234396965,0.2759295499021526,0.5654162767535894,1.0,5/13,11.27%,NNMT;HPF1;IGF2;PARG;MYOCD
prerank,bicellular tight junction assembly (GO:0070830),-0.34304222752226005,-1.1726313563860937,0.20815450643776823,0.5663361049979989,1.0,11/46,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,dephosphorylation (GO:0016311),-0.2717390334672797,-1.1726134109224,0.1348314606741573,0.5657558126528613,1.0,50/147,25.75%,PTPRM;PTPRB;PTPRG;PTPN12;SDHAF2;PTPRJ;ALPL;PPP1R12A;SSH2;PTPRK;PPP3CA;PPP2R5C;PPM1H;PLPP1;PTPN1;PPP1CA;DUSP3;MTMR7;ILKAP;PTPRZ1;DUSP23;PPP2R3A;PTPRC;PPP1CC;PPP4R2;PLPP3;THNSL2;TAB1;NT5C;CTTNBP2NL;PTEN;DUSP6;PTPN6;SGPP1;CTDNEP1;PPM1L;PPP2R5B;PPP2CA;PTPRF;DUSP1;ACP3;PLPP2;TIMM50;CTDSP1;SSH1;PDP1;PLPP6;DUSP7;PLPP5;PPP2R2A
prerank,negative regulation of neurogenesis (GO:0050768),-0.35963568963637405,-1.1725501466941353,0.22294372294372294,0.5652956758388658,1.0,5/34,2.27%,RAPGEF2;PTN;RHOA;B2M;NOTCH1
prerank,negative regulation of ossification (GO:0030279),-0.38688237075997806,-1.1725244694114973,0.24596774193548387,0.5647429535229351,1.0,6/23,13.74%,MEF2C;NOTCH1;MDK;PTK2B;ECM1;ENPP1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.46764434598130267,-1.1723556100689114,0.2606060606060606,0.5645458950293798,1.0,3/13,3.22%,TBX3;NOTCH1;BMP4
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3138037732434384,-1.171942716041258,0.19128329297820823,0.5649389020025785,1.0,18/68,14.92%,LEF1;CAV1;LRP6;FZD6;LRP5;SFRP4;CSNK1E;WNT5A;CSNK1A1;APC;PPP1CA;AMER1;FZD4;WNT9A;RARG;FZD1;NR4A2;PLPP3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3933926990155405,1.1717244292747666,0.24214417744916822,0.8890049453656171,1.0,5/30,6.34%,TGFBR3;SMAD3;TWSG1;DKK3;NREP
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4921325969627037,-1.171535734313614,0.27253668763102723,0.5652795273780307,1.0,3/10,9.64%,TMEM30A;ABCA3;APOE
prerank,cellular response to lipid (GO:0071396),0.2863838361431828,1.1712818652107386,0.1393939393939394,0.8885168239763037,1.0,28/191,12.34%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;PABPN1;CTR9;WNT5B;PTK7;ADCY1;RUVBL2;TNIP3;ADCY8;WNT6;HTRA2;KAT5;NLRP3;MED1;TNIP2;CACTIN;NR1H3;FZD7;LCOR;MAPK14;CDC73;SOX9;KCNK4;SPHK2
prerank,embryonic digestive tract development (GO:0048566),-0.4250977085690305,-1.1712589757765532,0.2463157894736842,0.5653412311497038,1.0,6/18,7.63%,RARB;PCSK5;TGFB2;GLI3;NIPBL;STRA6
prerank,cellular protein localization (GO:0034613),-0.25163104026244726,-1.1710809805459386,0.08157099697885196,0.5651888399033015,1.0,73/285,16.84%,TBC1D4;RABGAP1L;VCL;ESAM;RAB14;TBC1D8;EGFR;SMURF1;ID1;SCFD2;WIPI1;PTPRK;TBC1D12;RAB6A;STX1A;HERC2;SNX13;RAB31;TMED10;USP6NL;TBC1D5;FLNA;RAP2A;STX3;TBC1D2B;ARHGEF2;NIPBL;WNT5A;SH3PXD2B;AXIN2;SNX1;TBC1D1;COG3;OCLN;EVI5L;EMP2;HEY2;VPS26A;RAB22A;TBC1D13;FGF7;DNAJC27;CPE;HGS;WDR11;SEC31A;JAM3;CD74;HHEX;RRAGA;STX7;HDAC6;ARL5A;AMOT;TBC1D10A;CNTLN;AP2A1;STX8;SAR1A;RAB5C;RAB1B;FERMT2;TBC1D25;BICD2;NPHP1;RAB3GAP2;SEC13;UNC50;ARF5;PIGK;COPA;COPB2;IFT27
prerank,synaptic vesicle exocytosis (GO:0016079),0.37204038978544807,1.1709944296971793,0.24064171122994651,0.8874824818944461,1.0,11/40,16.47%,UNC13C;SYT1;SNAP29;SNAPIN;SNAP47;RIMS1;SNAP25;SYT10;CPLX1;STX4;CPLX2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3300232986195347,-1.17063153501686,0.2088167053364269,0.565686286372357,1.0,11/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;ZDHHC8;STAC;EPHB2;SQSTM1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.28811191092815824,-1.1698116564210332,0.16,0.5670144332378587,1.0,40/109,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,cellular component assembly (GO:0022607),-0.25796081906752194,-1.16969669042943,0.07667731629392971,0.5666973081192214,1.0,48/253,14.65%,SPTBN1;ACTB;LIMS1;SLC2A1;RHOJ;LIMS2;MYO1B;CALD1;PARD3;RHOA;GSN;PARVB;ACTG1;GAS6;PLS3;DARS1;FAS;FLNA;WIPF1;VAMP3;WNT5A;EPS8;HES1;CLDN14;ABCA3;OCLN;APC;IL1RAP;RBBP4;CAPZA2;NEDD9;CD2AP;YWHAZ;PARVA;FAM107A;CAPG;LIMA1;TEAD1;CD74;RANBP9;PTK2B;STX7;RAD21;CD40;FZD1;SHROOM1;HAS1;ZW10
prerank,mitochondrion distribution (GO:0048311),0.4896310718555261,1.169560833142365,0.29345794392523367,0.8905535636474162,1.0,7/12,26.43%,TRAK1;LRRK2;ARMC1;MEF2A;DNM1L;MTM1;HAP1
prerank,positive regulation of cell growth (GO:0030307),-0.2932459912695967,-1.1694464561711715,0.16625916870415647,0.566717013950737,1.0,26/96,16.33%,NEDD4L;NTN1;SEMA7A;TGFB2;EGFR;NGF;SMURF1;MACF1;H3-3A;ITSN2;RPS6KA3;ADAM10;SYT4;CDKN2AIP;RPTOR;EDN1;PABIR1;MFSD2A;USP47;CSNK2A1;SHTN1;LIMK1;NCBP1;KLHL22;DDX49;RNF157
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4182126803363969,-1.1688205656625543,0.2510822510822511,0.5676610892876204,1.0,3/20,1.53%,CAV1;PLCE1;ATP2B1
prerank,epidermal cell differentiation (GO:0009913),-0.33419592121701225,-1.168788128836709,0.20909090909090908,0.5671317328037455,1.0,9/41,12.95%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG;ERCC2
prerank,atrial septum development (GO:0003283),0.46433916314330836,1.1687462293747448,0.2784313725490196,0.891288245323711,1.0,2/13,1.72%,NOTCH2;ANK2
prerank,organophosphate ester transport (GO:0015748),-0.38978404255606147,-1.1686376528072508,0.23766816143497757,0.5668806615819605,1.0,7/24,7.63%,PITPNC1;SCARB1;PLTP;TNFAIP8L3;NPC2;MTTP;ABCA3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.48477185590587807,-1.1681911753994898,0.2791164658634538,0.5673724903018714,1.0,3/10,4.34%,LRP5;TGFBR2;TBX1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4914262346666638,-1.1678915618893309,0.2868525896414343,0.5674615221397787,1.0,4/10,24.54%,MAP4K4;FGF7;MAPRE2;EPB41L4B
prerank,negative regulation of secretion by cell (GO:1903531),-0.3536252805866255,-1.1675457849274362,0.23010752688172043,0.5676740478018217,1.0,11/38,14.79%,STXBP6;NOTCH1;TNFRSF1B;SLC30A1;VAMP3;GRM7;ANXA1;SYT4;APOE;RSAD2;HTR1B
prerank,cellular glucose homeostasis (GO:0001678),-0.34662678817997805,-1.1672653692017259,0.22401847575057737,0.5677488324711463,1.0,8/41,6.87%,LRRC8D;FOXO1;GAS6;PIK3R1;UNC13B;ERN1;RACK1;LRRC8A
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.460561193042487,-1.1668576801450836,0.2894736842105263,0.56811554781499,1.0,5/13,14.67%,ENTPD1;ENTPD6;ENTPD2;ENPP1;SMPDL3A
prerank,negative regulation of hormone secretion (GO:0046888),-0.5017242767411491,-1.166781987184853,0.2938856015779093,0.5676609340982344,1.0,3/10,17.52%,RAB11FIP5;RAB11FIP1;RAB11FIP3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48652918517815863,-1.1662025683736517,0.2692307692307692,0.5684470417606807,1.0,5/10,8.77%,DCN;KDR;RACK1;MYOC;SRC
prerank,regulation of cytokine production (GO:0001817),-0.27837497795077154,-1.166157568045619,0.16326530612244897,0.5679397417932445,1.0,55/126,30.42%,FOXP1;ATP2B1;RPS6KA5;AFAP1L2;TNFRSF1B;PLA2R1;S100A13;NPTN;LYN;TRIM56;ANXA1;HDAC9;SOD1;MAPKAPK2;IL15;PER1;PIK3CD;TRIL;ISG15;CCN4;ACE2;AGPAT1;PTPRC;IFIH1;BCL6B;MAST2;N4BP1;GAPDH;PPP1R11;IL33;POLA1;PLD3;ZBP1;CADM1;GLMN;ASB1;FCGR2B;CD276;ACKR1;CCR2;RGCC;CASP8;PIK3CG;PLD4;SNAI2;HILPDA;TREM2;NFAM1;AGT;MIF;IGF2BP2;PTGER4;IGF2BP1;IRF3;LGALS9
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.31868318342771185,-1.1658087482872437,0.1909307875894988,0.5681831501857522,1.0,12/54,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;NOS1AP;FHL1;FLNA;CAB39;GNB1;KCNMB2;GNG2;KCNQ1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.41701361494768263,1.1657420153544642,0.26476190476190475,0.8998582460556661,1.0,4/21,8.02%,CACNA1D;ANK2;SNTA1;KCNH2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4503058767045483,-1.1653937659852174,0.27,0.5686333559703627,1.0,5/14,20.25%,ADAM10;ADAM19;DYRK1A;PSEN2;PSENEN
prerank,RNA processing (GO:0006396),0.29085712152855536,1.165273355660203,0.16124031007751938,0.899490034869251,1.0,55/176,23.03%,CELF2;PABPN1;RRAGC;NOVA1;SRSF5;TFIP11;CCAR2;CPSF6;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;TENT4A;DDX17;PRMT9;SON;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;SRRM4;BICD1;LSM4;TUT4;MPHOSPH10;USP39;SRSF11;DICER1;RBM5;USB1;RNPS1;AKAP8L;DHX8;PRPF6;NOL3;PRPF3;DDX39B;THOC1;DDX47;ADAR;FASTKD5;SF3B2;SF3B1;SUPT4H1;SNRPB;HNRNPH1;CDK12;SCNM1;SF3B3;TSEN34;SRPK1;SNRPN;CELF1
prerank,negative regulation of receptor binding (GO:1900121),-0.4870481828370526,-1.1648099185986167,0.2577962577962578,0.5695022408917614,1.0,4/10,21.70%,B2M;ATP2A3;ADAM15;PTPRF
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.27425375887587394,1.164413405619624,0.13134328358208955,0.9006144642805992,1.0,87/264,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;STRAP;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;DDX17;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;SNUPN;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;DCPS;PPIL1;HNRNPH1;DDX39A;PRMT5;SCNM1;SART3;PRPF38A;PPIL3;SF3B3;SRPK1;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,negative regulation of developmental process (GO:0051093),-0.30381575883961115,-1.163796713148737,0.18181818181818182,0.5713383117862344,1.0,21/69,19.85%,NOS3;NOTCH1;GAS6;BMP4;KANK1;TBX1;KLF7;TFRC;ARHGEF15;CST3;VAT1;HEY2;NOTCH4;BMP2;TBX2;SUZ12;HEY1;FGFR3;GREM1;CDK6;SPI1
prerank,cobalamin metabolic process (GO:0009235),-0.42767040384792976,-1.163393644005232,0.2787878787878788,0.5717537777459115,1.0,4/17,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,Golgi ribbon formation (GO:0090161),0.463006675212432,1.162571823359684,0.27920792079207923,0.905210447188794,1.0,4/13,10.19%,OPTN;STX16;GOLGA2;MYO18A
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.4597748500949742,-1.1623759154167315,0.26693227091633465,0.5736636349580142,1.0,6/13,28.87%,UBE2J1;BCAP31;OS9;SVIP;EDEM2;EDEM1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.45054736470549017,1.1622181086063699,0.2803180914512923,0.9044845102389218,1.0,5/16,11.46%,IGF1;IGFBP3;CDH3;PHIP;MYORG
prerank,negative regulation of programmed cell death (GO:0043069),-0.24579417688479513,-1.1620507989833824,0.06521739130434782,0.5739237794244799,1.0,81/355,16.33%,MECOM;LEF1;ARHGAP10;TEK;IL6ST;TJP1;PTMA;FOXO1;TBX3;THBS1;GAS6;PIK3R1;EGFR;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;FAS;FLNA;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;MET;ADAM10;ANXA1;TPT1;PLK2;SPRY2;CD38;SRC;XIAP;FLT4;VHL;MAP4K4;CAT;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157
prerank,peptidyl-amino acid modification (GO:0018193),0.49551777233503935,1.1618451132061118,0.30724070450097846,0.9036981507273416,1.0,4/10,23.24%,METAP2;ATP7A;TTLL4;METAP1
prerank,regulation of bone mineralization (GO:0030500),-0.31804041633223273,-1.1617129573918388,0.20238095238095238,0.5742213138977111,1.0,18/55,13.74%,MEF2C;BMPR2;PTN;SGMS2;ATP2B1;ACVR1;BMP4;S1PR1;CCN1;NBR1;TMEM119;TGFB3;TWIST1;ISG15;BMP2;PTK2B;ECM1;ENPP1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4088506851453855,-1.1616616838019884,0.2535496957403651,0.5737357380753987,1.0,5/19,9.75%,ACOX1;MAOB;SOD1;CAT;GPX1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.42040454138368993,-1.1616020595837155,0.2678185745140389,0.5732768916780059,1.0,8/17,26.33%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3
prerank,catecholamine biosynthetic process (GO:0042423),0.5044099671297025,1.1614202015980226,0.3036053130929791,0.9031451154611997,1.0,1/11,0.23%,MOXD1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3622577555949836,-1.1612845583973965,0.2415966386554622,0.5734606905586179,1.0,5/30,9.41%,BMPR2;ACVRL1;DACH1;SRC;TENT4B
prerank,cartilage development (GO:0051216),-0.3306835796531218,-1.160848930602123,0.20869565217391303,0.5739288308147498,1.0,13/49,13.24%,MEF2C;ZBTB16;PKD1;RUNX2;RUNX1;CD44;BMP4;CCN3;SNX19;FGF2;BMP2;ITGB8;TRPV4
prerank,extracellular matrix assembly (GO:0085029),-0.39479640380553305,-1.1607662974249033,0.25158562367864695,0.5735157263546743,1.0,7/23,8.19%,RAMP2;GAS6;TNXB;NTN4;MFAP4;LAMB2;MYH11
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.377724339145471,-1.1604642542086343,0.26,0.57363943692665,1.0,8/29,25.41%,RUNX1;ESR1;STRN3;CBFB;LATS1;KCTD6;SRARP;YAP1
prerank,response to peptide (GO:1901652),-0.3578536714646004,-1.1604197377241776,0.2309322033898305,0.5731400807655588,1.0,12/33,22.09%,KAT7;STAT3;ANXA1;EIF2B2;CACNA1B;IRS1;MMP2;EIF2B1;NOD2;ERBIN;IRF5;FYN
prerank,positive regulation of type 2 immune response (GO:0002830),0.46692725740807345,1.1602230886575455,0.27708333333333335,0.9053554863943591,1.0,5/14,16.37%,IL18;PRKCZ;NLRP3;IL6;RARA
prerank,icosanoid biosynthetic process (GO:0046456),-0.49241521058626736,-1.1600469699410962,0.280561122244489,0.57345876727193,1.0,1/10,0.90%,PLA2G4A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3594304407707201,1.15929428667114,0.25043478260869567,0.9066745124190435,1.0,8/43,6.45%,BMP7;BMP6;WNT4;IGF1;BMPR1A;LRP3;WWTR1;NPNT
prerank,ameboidal-type cell migration (GO:0001667),-0.3297043662524079,-1.1592649814990004,0.20388349514563106,0.5747271297769228,1.0,19/51,22.00%,SEMA6A;SEMA3C;SEMA7A;CORO1C;CCN3;TBX1;SEMA5B;SEMA3E;ITGA4;SEMA3G;FAT2;AMOT;PKN3;SEMA5A;SEMA6D;AMOTL1;SOX8;SEMA3F;SEMA4C
prerank,regulation of cell morphogenesis (GO:0022604),-0.36333672909954184,-1.159129166081487,0.23060796645702306,0.5744427488559474,1.0,7/30,12.19%,FMNL2;SPARC;MACF1;CD44;EFNA5;CFL1;MFSD2A
prerank,positive regulation of ossification (GO:0045778),-0.3393732149543401,-1.1582262887034458,0.22666666666666666,0.5760717289279769,1.0,14/39,12.38%,MEF2C;BMPR2;ZBTB16;PTN;ATP2B1;ACVR1;TGFB2;BMP4;WNT5A;CCN1;TMEM119;TGFB3;ISG15;BMP2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4678056626238348,1.1581130088124783,0.31092436974789917,0.9088930983816873,1.0,4/13,8.19%,PRKCZ;ECHDC3;GKAP1;SORBS1
prerank,central nervous system development (GO:0007417),-0.25204903019744096,-1.15793844793011,0.08734939759036145,0.5762494966868222,1.0,63/250,20.93%,ADGRL2;SLC2A1;ZBTB16;PBX1;ZFHX3;COL4A1;SHROOM4;VIT;GSN;WWP1;TBX3;PKD1;PBX3;STAT3;LSR;TGFBR2;EML1;RPS6KA3;BPTF;CHST8;NIPBL;ADGRA2;DCLK1;APOD;UFC1;EIF2B2;GRIN2B;CDK5;PDGFC;ATP6AP2;VCAN;CAPG;BTD;DSCAML1;ADGRG1;PTPRZ1;ATXN1;PTCH1;MFSD2A;SH3GL2;SMO;SNTG2;MARCKS;NCOA6;SOX12;CDH2;NR4A2;ALDH5A1;DDIT4;PTEN;NCAN;ECRG4;GRIN1;UGP2;C3;HAPLN3;LIG4;SOX8;CHD8;POU3F3;ADGRL3;NKX2-2;BCAN
prerank,positive regulation of ATP metabolic process (GO:1903580),0.38668041605024195,1.157871673889279,0.2504854368932039,0.9076994254778478,1.0,5/32,4.10%,IGF1;NUPR1;PRKAA2;PPARA;ENO1
prerank,negative regulation of signal transduction (GO:0009968),-0.2557076560588713,-1.1577297306192136,0.12320916905444126,0.576147530964373,1.0,63/249,17.39%,BMP5;SEMA6A;PID1;DCN;DAB2IP;NTN1;PTPN12;ACVR1;NOTCH3;PIP4K2A;THBS1;EGFR;GRB14;PTPRJ;NFATC1;KANK1;SFRP4;IRAK3;CRY1;GLI3;YWHAB;NKD2;CARD16;CREB3L1;UBASH3B;XDH;RACK1;HHIP;LYN;PRKCD;NCK1;APOD;EPN2;SPRY2;GATA2;PTPN1;FGF2;SOCS5;HGS;HERC4;PTCH1;HHEX;BMP2;TCIM;TAX1BP3;CSNK2A1;PTPRC;FBXW7;IRS1;ENPP1;LRP1;SPRY1;PTCH2;TMBIM1;NR4A2;GPC1;DDIT4;CILP;RNF157;ADAMTS12;HEY1;SIGIRR;PTEN
prerank,mitotic chromosome condensation (GO:0007076),0.40135205918833744,1.157213919380323,0.27121771217712176,0.907987397888587,1.0,6/26,10.44%,KMT5A;NCAPD2;PHF8;PLK1;TENT4A;CSNK2A2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2974194508133104,-1.1571566034799396,0.1949367088607595,0.5768402466164858,1.0,26/84,24.17%,CDC27;UBC;ANAPC5;RPS27A;UBB;PSMA6;PSMB7;CDC16;FBXO31;PSMB6;PSMB5;FBXO5;FZR1;PSMB8;PTTG1;PSMC4;PSMD11;ECRG4;PSMB4;PSMD14;CDC26;PSMD10;PSME1;PSMB3;CDC23;CUL3
prerank,folic acid metabolic process (GO:0046655),0.4368607877402629,1.1567804424786206,0.29831144465290804,0.9075245482808508,1.0,7/18,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,neuron projection morphogenesis (GO:0048812),0.2959219647717557,1.1567179514997101,0.17,0.9057403083056061,1.0,28/137,12.64%,ALCAM;BMP7;MAP2;DCDC2;BAIAP2;CPNE1;FLRT3;WNT7A;ATL1;GAS7;AFG3L2;FGFR2;SHANK1;CNTNAP2;FLRT1;LRRK2;IMPACT;LRP4;KLK8;GPM6A;LLGL1;DLG4;SLITRK4;DOCK7;DTNBP1;WASL;BDNF;NYAP2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3041183974173851,-1.1566391005519818,0.19101123595505617,0.5775048287707083,1.0,20/73,21.47%,KITLG;TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;SPI1;METTL3;PSMD10;PSME1
prerank,respiratory tube development (GO:0030323),0.3992058512310536,1.1561123247566893,0.2550091074681239,0.9059040766345208,1.0,6/28,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4869875978878523,-1.1556832623940956,0.2966804979253112,0.5792539476761552,1.0,3/10,11.79%,DNAJA1;AIDA;PDCD4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2850057365292403,-1.155430888470498,0.17771883289124668,0.5792690504482008,1.0,28/101,15.76%,RAPGEF2;DAB2IP;RHOA;PKD1;EGFR;RALB;CAB39;PIK3R6;WNT5A;CCNY;IL34;CALM3;FLT1;SRC;PDGFC;FGF2;RPTOR;EDN1;EDN3;CEMIP;INCENP;PDGFD;TCIM;CD40;CD24;VEGFA;FERMT2;CSF1R
prerank,import into cell (GO:0098657),0.369529287612487,1.155308146524371,0.24214417744916822,0.9069691247546231,1.0,5/41,3.99%,ATP1A2;SLC6A13;SLC5A3;SLC29A2;SLC38A1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.42307360132938643,-1.1549299407613765,0.27235772357723576,0.5798585259021647,1.0,6/16,12.38%,BMPR2;TGFB2;ENG;NOTCH1;HEY2;BMP2
prerank,glial cell development (GO:0021782),-0.3850526153028967,-1.1548927092977612,0.23880597014925373,0.5793536192488429,1.0,15/25,34.79%,APP;MDK;EIF2B2;MT3;NRROS;EIF2B1;CDK6;MYRF;DLL1;SOX11;MXRA8;NSUN5;PRDM8;S100A9;TLR2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.43981591662537756,-1.1547377188624126,0.29707112970711297,0.5791390239322078,1.0,3/14,2.88%,TMSB4X;PKD1;NFKBIA
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4006893053840819,-1.154581295521094,0.26369168356997974,0.5789023440745303,1.0,4/20,6.54%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4150497819662802,-1.1544219906499997,0.2775423728813559,0.5786846955606398,1.0,2/17,1.51%,RAPGEF2;ADRA1B
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4485540034859532,1.1543293622153632,0.28680688336520077,0.9085096236636426,1.0,8/16,22.08%,HNRNPA2B1;TNKS2;SMG5;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,response to steroid hormone (GO:0048545),0.38027923270430675,1.1540562782564552,0.2674199623352166,0.9074302978586702,1.0,7/31,14.78%,ATP1A2;TFPI;MED1;NR1H3;PAQR7;ABCA2;WBP2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.28200481697579916,-1.1539437868347164,0.21243523316062177,0.5792769977952665,1.0,24/108,11.28%,HIP1;ACER2;GSN;TNFSF10;MAP3K5;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;RPS3;BCAP31;CTSD;ATP2A3;EIF2AK3;IFT57;MALT1;SOX7
prerank,cellular response to glucose stimulus (GO:0071333),-0.3610868980467927,-1.1537785055218241,0.25217391304347825,0.5790937670168483,1.0,15/30,29.41%,GAS6;UNC13B;RAB11FIP5;ERN1;RACK1;RAB11B;KCNB1;PRKACA;GPER1;RAB11FIP2;IGF1R;TRA2B;SELENOT;SLC39A14;PDK3
prerank,regulation of insulin secretion (GO:0050796),0.3083978868014417,1.153535058467322,0.21535893155258765,0.9073033576985235,1.0,27/101,18.39%,CACNA1D;ADCY5;NNAT;GCK;NLGN2;ITPR1;CACNA2D2;ADRA2A;BMP8A;SNAP25;KCNC2;CLOCK;ITPR2;STXBP4;CHGA;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;RBP4;PRKCA;PICK1;TCF7L2;DPP4
prerank,amide biosynthetic process (GO:0043604),-0.3275776715647159,-1.1531513637693753,0.22769953051643194,0.580090956881021,1.0,23/47,32.14%,SGMS1;SGMS2;PCSK5;DEGS2;AGK;CERS5;CERS6;SAMD8;ASMT;ASS1;SPTSSA;ASAH2;DMD;CERS4;SMPD1;TLCD3B;NANP;CERS3;SPTLC3;SPTSSB;NMRAL1;ALOXE3;AANAT
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3340863975940985,-1.1526441695345768,0.22629310344827586,0.5807181890984966,1.0,11/45,10.02%,B2M;VCAM1;CD44;MID1;ICAM1;IRF9;CAMK2D;PRKCD;TRIM25;IRF2;JAK1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.35602938912367504,-1.1524967897700196,0.2405857740585774,0.5804708063372924,1.0,7/32,10.57%,ITGA1;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.34057524923410254,-1.152158618453289,0.21212121212121213,0.5807436962814992,1.0,10/43,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IGF2;IRS1;ENPP1
prerank,negative regulation of TOR signaling (GO:0032007),0.37226722910261745,1.1519823682923842,0.2523020257826888,0.9109639579765991,1.0,14/36,22.75%,RNF152;PRKAA2;NPRL3;DEPTOR;SESN1;TSC1;NPRL2;SIRT1;ATM;FNIP1;CASTOR2;PDCD6;TMEM127;EPM2A
prerank,Ras protein signal transduction (GO:0007265),-0.27159044704368723,-1.1511638516218121,0.1671018276762402,0.5825119024986561,1.0,42/137,16.70%,PLCE1;RAPGEF2;RHOA;NTN1;ARHGEF3;RASGRP3;RAP1A;CDH13;CDC42EP5;JUN;CDC42EP3;RALB;RAP2A;PRKD1;EPS8;AGTR1;GNB1;ARHGDIB;PLK2;RAPGEF6;SHOC2;G3BP1;TIAM1;FGF2;EPS8L2;RIPOR1;CFL1;GRAP;ADGRG1;CDC42EP2;KRAS;NRAS;ARHGAP1;TAX1BP3;RERG;SHTN1;ARHGDIA;GNA12;LIMK1;RAP2B;USP50;RREB1
prerank,regulation of hemopoiesis (GO:1903706),-0.4851047348420872,-1.1508465026406518,0.3001949317738791,0.5826626203769599,1.0,3/10,7.25%,PTN;RUNX1;CBFB
prerank,regulation of organelle organization (GO:0033043),-0.2949296048876568,-1.1507206255682745,0.21153846153846154,0.5823578442554754,1.0,35/80,30.91%,TJP1;CLIC4;F11R;MFF;USP6NL;SCARB2;CAPN2;PAK2;PDE2A;ARMH3;MAPK1;GOLPH3;SQSTM1;SAR1A;SURF4;TBC1D25;CLEC16A;PRMT6;TAOK1;MAPK3;ARHGEF5;SIRT7;MSN;STX5;RHOT2;MUL1;AKAP9;ARL6IP1;CAMSAP2;MAPT;STOX1;LMAN1;CAMSAP3;VPS35;CLN3
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3321679781318556,-1.15067913574954,0.23198198198198197,0.5818702405264661,1.0,9/43,9.16%,KAT7;LIMK2;BMP4;MFHAS1;CTNNA1;TFRC;OTUD7B;ORMDL3;EIF2AK3
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2815676297979764,-1.1503391435054133,0.1658653846153846,0.5820931521123123,1.0,25/103,13.40%,ARHGAP31;PLCE1;RAPGEF2;NTN1;RASGRP3;BCR;JUN;TIAM2;RALB;PRKD1;ARHGAP32;GNB1;PLK2;RAPGEF6;SHOC2;G3BP1;ABR;TIAM1;FGF2;GRAP;KRAS;NRAS;ARHGAP1;RERG;SHTN1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3372866113086649,1.1498280758585415,0.22631578947368422,0.916662784345499,1.0,10/56,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,positive regulation of inflammatory response (GO:0050729),-0.28999490052722565,-1.1493158866511006,0.20476190476190476,0.5840090852784179,1.0,15/86,11.84%,IL6ST;OSMR;ETS1;NFKBIA;ABCC1;APP;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,protein complex oligomerization (GO:0051259),0.3153678012674891,1.148808719152692,0.21783876500857632,0.9182791658341793,1.0,30/85,23.72%,UPB1;WDCP;TMEM120B;VSTM5;ATL1;CPSF6;GSDMD;ADCY8;KCNC3;CPSF7;ELAVL1;RNF135;KCNC2;CUTC;BEND3;MICU1;RNF213;NOL3;ALAD;TRMT61B;OXA1L;NLRC4;HGSNAT;PYCARD;DNM1L;MAT2A;IKZF4;ALS2;MPP2;SPAST
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3993417465575668,1.1486755642358415,0.2713472485768501,0.9167623349516386,1.0,4/25,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,cellular response to sterol (GO:0036315),0.455893959755418,1.1484798488255676,0.27835051546391754,0.9154732972561909,1.0,3/13,5.58%,RORA;INSIG2;GRAMD1B
prerank,regulation of chromosome organization (GO:0033044),-0.3920092091157942,-1.148453759141051,0.2905982905982906,0.5854507822758889,1.0,12/22,34.31%,WAPL;XRCC5;TERF2IP;YLPM1;SHCBP1L;LIG4;HNRNPD;TERF2;MAPT;MYC;PIF1;BUB1
prerank,regulation of phospholipase C activity (GO:1900274),-0.42649007790480475,-1.1479563034293456,0.29850746268656714,0.5860464720124369,1.0,5/15,9.34%,NTRK3;PLCG1;ESR1;FLT1;FGF2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2806284660900839,-1.1479409693499047,0.15724815724815724,0.5854728440635119,1.0,28/108,13.83%,RSPO3;MDFIC;DAAM2;DISC1;RUNX1;MACF1;NFATC1;KANK1;SFRP4;APP;CDK14;ESR1;NKD2;RACK1;CCNY;CBFB;SPIN1;ATP6AP2;TIAM1;PPP1CA;AMER1;SOX7;HHEX;BMP2;GSKIP;TAX1BP3;CSNK2A1;LRP1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3880682065178764,1.147900293810665,0.27692307692307694,0.9156238990173785,1.0,7/31,11.04%,TGFBR3;BMPR1A;RBPJ;NRG1;FGFR2;TGFBR1;RYR2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3067728547011105,-1.1476233613260494,0.21728395061728395,0.5856466331090208,1.0,22/59,18.12%,PTPRM;HMCN1;PECAM1;BSG;PKD1;CDH13;CDH1;PALLD;ITGB1;NECTIN3;NPTN;ROBO4;CEACAM1;DSCAML1;NECTIN2;FAT2;EMB;CDH2;KIRREL3;PVR;DSG2;CELSR2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3491332592281356,-1.1473930519472386,0.24330357142857142,0.5856145074600799,1.0,21/36,42.93%,LEF1;GLI3;MDK;ZBTB1;SOX12;NCKAP1L;CD46;ZMIZ1;SOCS1;IL4I1;VNN1;VSIR;ZAP70;GATA3;TESPA1;BCL6;IL4;TNFSF9;XBP1;IL23A;SOX4
prerank,regulation of hippo signaling (GO:0035330),-0.4250635558996605,-1.1470479612618032,0.2897959183673469,0.5858826710193737,1.0,7/17,22.64%,LIMD1;MOB3B;CIT;SCHIP1;MARK3;AJUBA;SOX11
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.41493141784319315,1.1470379064717742,0.2830188679245283,0.9167542394944261,1.0,6/22,13.27%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2
prerank,neural crest cell differentiation (GO:0014033),-0.41342083663105794,-1.146960326303615,0.2714570858283433,0.5855050116225993,1.0,7/18,26.11%,MEF2C;LRP6;CDH2;SOX8;SOX11;TAPT1;SNAI2
prerank,amino acid transport (GO:0006865),-0.32113148469460234,-1.1469056818963863,0.24618736383442266,0.5850386308116013,1.0,11/49,9.02%,SLC6A6;SLC38A11;SH3BP4;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC7A14;SLC43A1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.4057505659784002,-1.1468654694663,0.2678185745140389,0.5845278537723505,1.0,7/19,21.23%,GAS6;MDK;ZBTB1;NCKAP1L;BTK;ZMIZ1;SYK
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.26752318305797035,-1.1467344793839453,0.14363143631436315,0.584220039845913,1.0,27/150,10.62%,HIP1;KITLG;TEK;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;MET;IAPP;MYOC;SPRY2;PIK3CA;SRC;IGF2;FGF2;FGF7;PIK3CD
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.33510705980769667,-1.146588528822445,0.24503311258278146,0.5840020735135191,1.0,11/39,14.93%,DAB2IP;PTPN12;EGFR;PTPRJ;ITGA1;SPRY2;DUSP3;HGS;SH3GL2;SPRY1;CBL
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4398432271268422,-1.1459842787040164,0.26692456479690524,0.5848812276260956,1.0,4/13,10.46%,NOTCH1;TGFBR2;HEY2;CPE
prerank,regulation of multicellular organism growth (GO:0040014),-0.43165017722251137,-1.1459161494796946,0.28888888888888886,0.5844294673383804,1.0,5/15,12.19%,GHR;APP;SOD1;PTCH1;MFSD2A
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.281066944667926,-1.1454892613436414,0.2,0.5848397453249604,1.0,22/109,12.35%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;PLCG1;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;PLEKHA4;INPP5D;PIK3CA;FGF2;MTMR11;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12
prerank,response to glucagon (GO:0033762),0.42615665704999334,1.1453475835018645,0.29672447013487474,0.920848165481237,1.0,4/19,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,bile acid metabolic process (GO:0008206),-0.37452203510168464,-1.1451071132634636,0.26679841897233203,0.5851770738430083,1.0,4/27,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.37983143274852543,-1.144882828734102,0.25274725274725274,0.5851843774325955,1.0,9/25,15.39%,SLIT2;LIMK2;KANK1;PRKCD;EVI5L;ABI3;TBC1D7;CCP110;RAP1GAP
prerank,mitochondrial fusion (GO:0008053),0.4264897368451664,1.1448227952216747,0.2766798418972332,0.920805630913207,1.0,5/18,11.63%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2
prerank,mesonephric tubule development (GO:0072164),0.4545560074694107,1.1447022531340654,0.31499051233396586,0.919180356161553,1.0,4/15,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,negative regulation of phosphatase activity (GO:0010923),0.3983560044079707,1.144698241127427,0.2902621722846442,0.9171928911635118,1.0,3/25,5.02%,SH3RF2;SH2D4A;PPP4R4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.33675241416866575,-1.1446657103897246,0.2463157894736842,0.5851376885094398,1.0,14/40,22.21%,SMURF1;RPL5;RPS7;RPL23;RAD23B;FOXF2;PTK2B;CSNK2A1;FBXW7;GNA12;PTEN;LATS1;GLMN;CCDC22
prerank,sarcomere organization (GO:0045214),0.39629774524639705,1.1441025184446865,0.28440366972477066,0.9173344405854745,1.0,4/27,8.50%,ACTN2;CAPN3;CSRP3;CSRP1
prerank,negative regulation of endocytosis (GO:0045806),0.40022163253789905,1.1437883103429887,0.30185185185185187,0.9164726395311737,1.0,6/24,12.52%,SYT11;PICALM;NR1H3;SCAMP5;CD300A;MTMR2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3444118711552943,-1.1436866772024012,0.24384787472035793,0.5870053634331742,1.0,9/41,10.02%,PODXL;GCNT2;TJP1;PIEZO1;CD44;DENND6A;MDK;ADAM19;JAK1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.29770239127311127,-1.1433084825243944,0.234192037470726,0.5873891587277027,1.0,14/79,10.87%,ST3GAL4;GCNT2;BMPR2;ST8SIA4;CSGALNACT1;ST3GAL6;B3GNT2;CHST8;COG3;ST8SIA6;XYLT1;GOLPH3;B4GALT5;GCNT1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3719649884178496,1.1430353375513702,0.2595978062157221,0.917235486062727,1.0,8/33,11.76%,DNAJC6;CEL;NLGN2;PICALM;SYT1;NLGN3;SYNJ2;CANX
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.49283866159542045,1.1427618110547584,0.308,0.9162361807210545,1.0,3/10,6.35%,DNMT3L;DNMT3A;PCGF5
prerank,response to chemokine (GO:1990868),-0.45480882295780467,-1.142204181680066,0.3125,0.5896108286098688,1.0,5/13,9.84%,LRCH1;SLC12A2;RHOA;CXCL12;DOCK8
prerank,autophagosome organization (GO:1905037),-0.32038445642709856,-1.1421009372844604,0.23853211009174313,0.589300022253657,1.0,15/50,21.01%,ATG3;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6;ULK2
prerank,regulation of AMPA receptor activity (GO:2000311),0.4036727198650519,1.1420445534504642,0.2815533980582524,0.916828546113621,1.0,13/25,23.77%,CACNG7;NLGN2;NLGN3;SHISA7;SHANK1;GSG1L;CNIH3;SHISA8;MINK1;MAPK8IP2;CACNG4;CACNG5;CACNG8
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.44290892748557514,1.1416983348593357,0.30343511450381677,0.9161840095916619,1.0,4/17,16.09%,LPGAT1;PLA2G4C;LCLAT1;PLAAT3
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3247471197518825,-1.1415163768266179,0.23296703296703297,0.5900690703084447,1.0,22/52,31.09%,PDIA5;WIPI1;PDIA6;ERN1;TATDN2;ATP6V0D1;SEC31A;KDELR3;ACADVL;VAPB;SRPRA;EXTL3;PPP2R5B;DCTN1;YIF1A;DNAJB11;WFS1;GOSR2;EDEM1;PLA2G4B;ADD1;HSPA5
prerank,histone H2A monoubiquitination (GO:0035518),0.43728838175831425,1.1415157401944525,0.2819548872180451,0.9149090270773675,1.0,5/17,12.26%,DDB2;PCGF2;PCGF5;PCGF6;RING1
prerank,protein modification process (GO:0036211),-0.2998370208336383,-1.14135171293419,0.22,0.5898593445116616,1.0,20/76,16.26%,ST8SIA4;ST3GAL6;PLOD2;ATG3;ST3GAL1;UBE2D3;LOX;CSNK1G3;YES1;CPE;UBE2L3;FBXW2;STK38;AKT2;UBL5;PPP4R2;ST8SIA2;ICMT;PHKA2;PHEX
prerank,mRNA export from nucleus (GO:0006406),0.3077401227940153,1.1412585373106128,0.22741935483870968,0.9138407750357505,1.0,27/102,19.97%,MCM3AP;PABPN1;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;PCID2;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;POLR2D;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.4299452227535181,-1.1410905826591289,0.28542914171656686,0.5898899537132438,1.0,5/15,18.32%,ENTPD1;ENTPD6;ENTPD2;NME2;AK4
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3416973503236533,-1.1410556335890354,0.23464912280701755,0.5893914384262972,1.0,8/39,10.59%,UTRN;NEDD4L;FXYD5;HECW2;CAMK2D;SLMAP;FXYD6;FGF13
prerank,epidermis development (GO:0008544),0.3399782636245555,1.1405651298690602,0.2376599634369287,0.9141928462393742,1.0,7/56,6.95%,OVOL2;LAMB3;CRABP2;CCN2;SPRR1A;FLOT2;FGFR2
prerank,negative regulation of autophagy (GO:0010507),0.3343084075631736,1.1404064381865404,0.252129471890971,0.912805418077471,1.0,12/54,13.71%,LEPR;NUPR1;CTSA;QSOX1;ZKSCAN3;LRRK2;GOLGA2;BCL2;IL10RA;KDM4A;TBC1D14;TSC1
prerank,mRNA processing (GO:0006397),0.2657030796536504,1.1401488480138502,0.16296296296296298,0.9117746880309117,1.0,92/287,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;CPSF6;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;PRMT9;SON;CPSF7;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;ELAVL1;CACTIN;IK;SRRM4;RNMT;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;RPRD2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;AKAP8L;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;THOC1;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;SARNP;SUPT4H1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;CELF1;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4406110995654413,1.1393357468462335,0.2947761194029851,0.9127766582665204,1.0,3/16,6.63%,FGF1;NPNT;CITED1
prerank,regulation of lipase activity (GO:0060191),-0.4464528187566222,-1.1392835256879994,0.2965235173824131,0.5932087811691534,1.0,2/13,1.78%,RHOA;PCSK5
prerank,cellular response to light stimulus (GO:0071482),-0.30144533365478543,-1.1388189159585695,0.22779043280182232,0.593755034352285,1.0,28/66,34.02%,PTPRK;GNB1;PRKCD;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;N4BP1;RHNO1;GPR88;METTL3;NEDD4;NSMCE3;TRIAP1;SMPD1;GPR52;PARP1;SDE2;BMF;MYC;AQP1;RRH;OPN1MW3;OPN1MW;TP53
prerank,regulation of protein import into nucleus (GO:0042306),-0.34291930990240804,-1.138499582402673,0.2639175257731959,0.5939506628082396,1.0,9/36,12.56%,MDFIC;PIK3R1;CDH1;BMP4;FLNA;PRKCD;APOD;IPO5;TPR
prerank,positive regulation of phagocytosis (GO:0050766),-0.3253710512770551,-1.1380838565591531,0.24455205811138014,0.594364295928577,1.0,20/47,30.30%,MERTK;GAS6;PTPRJ;RAB31;C4B;DOCK2;GATA2;IL15;RAB27A;PTPRC;NCKAP1L;C3;FCGR2B;ANO6;CD300LF;TREM2;LYAR;IL2RG;AHSG;PLA2G5
prerank,regulation of cellular respiration (GO:0043457),-0.4123406225442688,-1.1376577741263163,0.28227571115973743,0.5948354516906095,1.0,9/17,38.75%,PRDM16;CBFA2T3;IFNAR1;SHMT2;VCP;IFNLR1;NOS2;PRELID1;IL4
prerank,regulation of synapse maturation (GO:0090128),-0.4980600547886749,-1.1373108372628598,0.32113821138211385,0.5951257223973274,1.0,3/10,10.16%,DAB2IP;ARHGEF15;YWHAZ
prerank,nuclear export (GO:0051168),0.3199473352600803,1.137250712074804,0.22608695652173913,0.9182027563473382,1.0,16/80,18.54%,RANBP3L;SRSF5;POM121;NUP155;NUP62CL;STRADB;NEMF;RITA1;UPF3B;SRSF11;DESI1;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3588682538608139,-1.1371026683226737,0.25792811839323465,0.5951141189611621,1.0,9/29,17.48%,SLC4A10;APP;APOE;EPHB2;NSMF;RAB3A;ZDHHC2;MCTP1;SYNGR1
prerank,response to interleukin-1 (GO:0070555),-0.2969598829184729,-1.1362995055519296,0.22682926829268293,0.5965151886941978,1.0,20/73,23.57%,DAB2IP;IL1R1;PTGIS;IRAK3;APP;TNFRSF11A;ANXA1;CCL13;SRC;TLE5;CD40;IRAK2;ADAMTS12;CCL25;USP10;ZC3H12A;MYD88;HAS2;MAPK11;TAF9
prerank,positive regulation of fat cell differentiation (GO:0045600),0.343147945419139,1.1358448663216532,0.2643478260869565,0.9214623730569227,1.0,15/47,19.50%,BMP7;TMEM64;LMO3;METRNL;HNRNPU;CREBL2;AAMDC;ADIG;CDS1;TFE3;CREB1;AKT1;FNDC5;PIM1;ASXL2
prerank,nervous system development (GO:0007399),0.25613140967595593,1.1355712686253796,0.13183730715287517,0.9205326041887478,1.0,88/429,16.70%,SDK1;ROBO1;ALDH1A2;NOTCH2;TRAK1;NR2E1;ESS2;OBSL1;INTU;SDK2;RAPGEF5;VXN;ARNT2;TENM1;NLGN2;ADAM22;LRCH4;CELSR1;PCDHB11;DAGLA;FLRT3;NPTX1;IL1RAPL2;GFRAL;CHRM2;CRMP1;NRTN;ADGRB2;PAX6;MAB21L2;MARCKSL1;TRIM71;WWTR1;FGF12;FZD9;IGSF8;DPF1;ATN1;NRG1;NLGN3;JARID2;SCRG1;WDR62;LSAMP;LPAR1;CLN8;ADGRV1;TMOD2;WDPCP;ZIC2;GPM6A;DLG4;SRRM4;APC2;TGFBR1;LDB2;LDB1;NES;RITA1;CHRM1;FZD5;FKTN;PCDHB3;CHERP;CPNE6;DPYSL2;ARHGAP26;BDNF;ZIC5;HDAC4;L1CAM;CLN5;TYRO3;FUT10;CYP51A1;GFRA4;CSPG5;SCN8A;DPF3;NRSN2;EPHB1;GBA2;KALRN;HPCAL4;AXL;TRIM3;NAV3;NRSN1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4194544306079956,1.135549154636494,0.2962962962962963,0.918646543853834,1.0,7/20,12.77%,ROCK2;DLG1;LLGL2;RHOQ;LLGL1;FHOD1;RAB13
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4281462018765853,-1.1351937511227816,0.3004032258064516,0.5985653934973775,1.0,7/16,25.86%,RBM3;PRDX6;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3841773183403804,-1.1349653187981812,0.2980561555075594,0.5985100128461923,1.0,6/22,9.34%,NTRK3;PLCG1;ESR1;AGTR1;FLT1;FGF2
prerank,protein transport (GO:0015031),-0.23933284731082038,-1.1349591454922474,0.13496932515337423,0.5979289424943117,1.0,76/332,16.89%,SPTBN1;TBC1D4;CALCRL;RABGAP1L;STEAP3;RAB14;RAMP2;SLC10A7;MYH9;TBC1D8;MACF1;SCFD2;ABCA1;ATP6V0A4;TBC1D12;LMAN2L;RAB6A;STX1A;HERC2;SNX13;RAB31;MIA2;TMED10;USP6NL;TBC1D5;CHMP2B;STX3;TBC1D2B;TFRC;MON1A;ARHGEF2;SNX1;TBC1D1;MTTP;CMTM6;EVI5L;ATP6V0D1;ATP6V0A1;VPS26A;RAB22A;TXNIP;TBC1D13;APOE;GOLPH3;DNAJC27;WDR11;SEC31A;VLDLR;CD74;RAB3A;SCAMP1;PDIA4;ARHGAP1;ATP6V1D;STX7;HDAC6;ARL5A;SYS1;TBC1D10A;LRP1;AP2A1;STX8;SAR1A;RAB11B;RAB5C;RAB1B;HIKESHI;TBC1D25;RAB3GAP2;SEC13;ARF5;COPA;COPB2;TCIRG1;IFT27;LRP1B
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4745141914645367,-1.1348368879485715,0.2903846153846154,0.5970685034727006,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.4745141914645367,-1.1348368879485715,0.2903846153846154,0.5970685034727006,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2852736658405115,1.1347736281291971,0.22790697674418606,0.9195830884558001,1.0,17/159,5.82%,SDK1;ROBO1;ALCAM;CLDN20;OBSL1;IL1RAPL1;SDK2;TENM1;CDH15;CDH3;PCDHB11;CDH17;FLRT3;MPZL2;GRID2;CDH10;IGSF9
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3321745062475291,-1.134329455574225,0.2281449893390192,0.5976962076037416,1.0,15/40,21.10%,CRY1;UBE2V2;PRKCD;FEM1B;IER3;WDR76;PARG;FBXO5;WRNIP1;FMR1;FXR1;RPA2;MCL1;SIRT7;NSMCE4A
prerank,cellular response to metal ion (GO:0071248),0.29341240637367555,1.1341875912628812,0.2222222222222222,0.9197275035985395,1.0,24/123,12.42%,BMP6;SYT11;SYT12;SLC41A1;PRKAA2;CYP11B1;CPNE1;CAPN3;SYT9;ADCY1;CHUK;GLRA1;CPNE4;PPIF;SYT1;ADCY8;SYT13;LRRK2;ADGRV1;DLG4;SYT10;TRPM2;CPNE6;MAPK9
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4378930611096986,1.1340684653472455,0.3016194331983806,0.9182143940199928,1.0,6/16,20.52%,CTR9;KMT2A;AUTS2;PIH1D1;KDM1A;SMAD4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.30216988809200296,-1.1335529553657784,0.21927710843373494,0.5990109113208537,1.0,26/75,18.34%,HEG1;DAB2IP;LRP6;LRP5;BMP4;PTPRJ;RASIP1;IRAK3;LYN;PRKCD;APC;SPRY2;CDKN1C;IPO7;PTPN1;APOE;MYOCD;IPO5;HHEX;STK38;SPRY1;PAQR3;PRKAR2B;PTEN;LATS1;UCHL1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.3940043560689155,1.1333621146850184,0.28014842300556586,0.9188451996330697,1.0,5/26,4.43%,GCHFR;SPHK1;NQO1;PM20D1;ARG2
prerank,neuron projection extension (GO:1990138),0.3739053818824469,1.1331955278556898,0.28076923076923077,0.9175793889191408,1.0,8/32,8.15%,ALCAM;CPNE1;FLRT3;AUTS2;NLGN3;LLPH;FLRT1;IMPACT
prerank,establishment of vesicle localization (GO:0051650),0.43125121286637846,1.1330958888558866,0.29273084479371314,0.9160209182582401,1.0,4/18,6.54%,SYT11;KIF5C;IKBKG;SNAPIN
prerank,eye development (GO:0001654),0.3398368292828684,1.1330682491467639,0.25045372050816694,0.9142051758896125,1.0,16/54,15.93%,SMOC1;COL5A1;PBX2;RAB3GAP1;MEIS1;PAX6;MAB21L2;PBX4;CEP290;ZDHHC16;CPAMD8;SHROOM2;FOXC1;TSKU;ADAMTS18;RBP4
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.419275780793844,1.1330009342271907,0.3015267175572519,0.9125452969013116,1.0,2/19,0.40%,AFDN;BMP6
prerank,DNA modification (GO:0006304),-0.38596524754439815,-1.1329265998551943,0.2809734513274336,0.5998675672737476,1.0,17/22,41.10%,TERF2IP;TDG;NEIL3;MUTYH;EXOSC4;SMUG1;EXOSC5;PARP3;TINF2;TERF2;EXOSC3;PARP1;OGG1;UNG;PARP2;NTHL1;TERF1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.34211279569809666,1.1328315583071171,0.30363636363636365,0.911266352143051,1.0,10/48,11.49%,ROBO1;NLRP2B;OTUD4;USP18;PELI3;CACTIN;NR1H3;OAS3;PARP14;STAT2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.43950111649773266,1.132753205084766,0.32727272727272727,0.9096400283030428,1.0,3/17,2.36%,ROBO1;EFNB2;PIK3R3
prerank,action potential (GO:0001508),-0.32245925711998297,-1.1324632504327652,0.23198198198198197,0.6003565271992963,1.0,14/44,21.60%,KCNJ2;CACNA1G;GNA11;KCNMB2;KCNQ1;CACNA1I;KCNB1;KCNE4;SCN3A;GPER1;CACNA1H;GNA14;DMD;SCN7A
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.40075108117110564,1.1322251050782561,0.29850746268656714,0.9096896746868666,1.0,6/22,10.27%,APPL2;TAFA3;TRIM71;FZD9;LRRK2;NES
prerank,cell-cell junction organization (GO:0045216),0.3116552005138902,1.132206911719953,0.25754884547069273,0.9078897549005165,1.0,12/79,8.04%,SDK1;AFDN;SMAD3;SDK2;NLGN2;CDH15;CDH3;CDH17;PKP4;CDH10;CDH18;PRKCI
prerank,protein processing (GO:0016485),0.2981400831209337,1.1320295486665546,0.20967741935483872,0.9067018776245046,1.0,11/102,8.52%,AEBP1;METAP2;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2;HTRA2;SPRTN;LONP2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4530309477669998,-1.1318639948794949,0.316008316008316,0.6012589991900337,1.0,4/12,15.78%,NOTCH1;HES1;BMP2;ID2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4590207951313511,1.131681532103552,0.3191489361702128,0.9060513889982281,1.0,6/12,22.71%,PLK1;GOLGA2;CDC14B;RAB1A;UBE2S;BTRC
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.35511867352178583,-1.1313761579977957,0.2972972972972973,0.6018557072014469,1.0,11/29,18.18%,TEK;DGKZ;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,regulation of monocyte differentiation (GO:0045655),-0.4337471856834892,-1.1309610512337114,0.31020408163265306,0.6023162685605978,1.0,3/14,11.83%,FOXP1;IL34;CD74
prerank,response to organonitrogen compound (GO:0010243),0.35811658742247376,1.1304857236994368,0.28807339449541286,0.9084915878373698,1.0,10/38,15.60%,TRPV1;RRAGC;DERL1;GLRA1;DRD3;TRPM2;CCDC47;UBXN6;RNF5;IL6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2861133609362575,1.1304688388327122,0.215962441314554,0.9067024949814819,1.0,32/148,18.35%,PRKAG2;KMT5A;PRKAA2;PRKAG3;RICTOR;CHD4;TTC5;MEAF6;MAP2K6;PDPK1;KAT5;CHD3;TAF10;RFC5;MRE11;BRD7;CSNK2A2;MAPK14;TAF1;PML;CHEK2;SMYD2;NOC2L;RPA3;BANP;ATM;CHD5;MDM2;CDK5R1;RAD17;HIPK2;AKT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4372496412372323,-1.1303558544010202,0.3244274809160305,0.603204158890499,1.0,3/13,6.06%,PDE8A;RACK1;MET
prerank,regulation of cell cycle (GO:0051726),-0.24294373141987882,-1.1297788017231398,0.14098360655737704,0.6039269104095338,1.0,84/271,23.40%,APBB2;MECOM;TTC28;DAB2IP;NEK7;LRP6;FAP;PLAGL1;TGFB2;TBX3;THBS1;NOTCH1;DCUN1D3;PKD1;IQGAP1;AFAP1L2;STAT3;BMP4;ADARB1;PTPRK;JUN;MAP3K20;ERN1;RACK1;ADAM10;APC;MYBBP1A;RPS6KA2;CDC123;RBBP4;CDK5;XIAP;WHAMM;RPL23;FBXO5;GRK5;PDCD4;BMP2;BIRC3;LIN54;SIPA1;CSNK2A1;AKT2;GAS2L1;PTPRC;MADD;PUM1;JMY;FOXO4;ID2;PRKACA;RPS15A;TBRG4;ING4;GPER1;JUNB;NBN;BARD1;MASTL;CCND1;MAPK12;KIF20B;CDC26;CDK6;ASAH2;PCLAF;CCPG1;METTL3;RHOB;L3MBTL1;CHEK1;JUND;THAP1;TTLL12;DUSP1;RPRD1B;FBXL6;CCNB2;CDKN1B;RNF40;CDK11B;CYLD;PRDM11;NANOS3
prerank,regulation of signal transduction (GO:0009966),-0.25679810518580753,-1.1295528386881917,0.16020671834625322,0.6038956293511987,1.0,49/190,16.63%,PLCE1;RSPO3;RGS3;LIFR;RGS12;ACVR1;MDFIC;RGS5;TMEM204;SOCS2;RUNX1;PLSCR1;APP;ESR1;IGFBP6;MGLL;UBASH3B;PRKD1;HHIP;PPIA;NCK1;PXN;CBFB;RGS6;CD55;SRC;PTPN1;SOCS5;CDKN2AIP;WDR11;MFNG;SREBF2;GRK5;PTCH1;UGCG;CDC42SE2;GSKIP;TSPAN12;ZDHHC7;CD24;RGS4;IRAK2;GIT1;GIT2;LFNG;SEMA5A;SP100;CD46;NCLN
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.41743384887328994,1.1294393904216575,0.3313840155945419,0.9084440092412194,1.0,6/18,14.80%,RAB3GAP1;SNAPIN;RIMS1;LRRK2;DTNBP1;SYN1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2458660298701237,-1.1293827552621254,0.15210355987055016,0.6036901342455522,1.0,53/248,13.10%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;DAAM2;STK3;EGFR;LIMD1;SDHAF2;KANK1;SFRP4;CDK14;GLI3;TLE4;NKD2;SOX17;IGFBP6;CSNK1E;CSNK1G1;ADGRA2;WNT5A;TNKS;AXIN2;CCNY;PLEKHA4;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;CSNK1G3;INVS;APC;XIAP;ATP6AP2;PPP1CA;APOE;PSMB6;AMER1;PSMB5;TLE5;SOX7;SCEL;FZD4;DKK2;HHEX;COL1A1;BMP2;GSKIP;USP47;ANKRD6
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4162836514117577,1.1291160070200164,0.3151750972762646,0.9077468194254259,1.0,9/19,16.66%,HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3601348096376933,-1.1289175699851564,0.2874743326488706,0.6042237429520048,1.0,17/29,32.89%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,positive regulation of metabolic process (GO:0009893),0.3015333455160342,1.128730818189848,0.22564102564102564,0.907292628578151,1.0,7/103,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2901532569952076,-1.1286193400614808,0.21377672209026127,0.6044009839526557,1.0,33/73,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;CD86;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;BCL10;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,renal filtration (GO:0097205),-0.47812735274768714,-1.1283644745939592,0.32673267326732675,0.6044624492447619,1.0,7/10,41.01%,CD34;MCAM;MYO1E;JCHAIN;SULF1;SULF2;ITGA3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4808206869867748,-1.1282693071782317,0.33001988071570576,0.604115848437208,1.0,4/10,24.43%,UBE2J1;INSIG1;OS9;SVIP
prerank,protein oxidation (GO:0018158),0.48721064726445895,1.1275859603972862,0.33403361344537813,0.9094768753079989,1.0,3/11,7.13%,LOXL3;SUMF1;LOXL1
prerank,positive regulation of immune response (GO:0050778),-0.29898729265669977,-1.1271548313414026,0.23684210526315788,0.6063093545960055,1.0,16/64,22.51%,IL6ST;TGFB2;POLR3F;PLSCR1;GBP5;IFI35;IL15;CD74;RSAD2;PTPRC;CD46;POLR3B;NOD2;POLR3D;NMI;FCGR2B
prerank,regulation of protein localization (GO:0032880),0.32825435831486743,1.1264072349352703,0.28650646950092423,0.9118853092842557,1.0,9/58,10.46%,AFDN;MAP2;PICALM;TRIM5;CAMK1;DLG1;CEP290;WDPCP;VIP
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.433064834401946,1.1262654427686452,0.31237721021611004,0.9105651872946726,1.0,4/15,12.98%,NLGN2;ZDHHC12;SYN3;ZDHHC3
prerank,regulation of steroid metabolic process (GO:0019218),0.3947567738812713,1.1262266624159563,0.297244094488189,0.9088899020644979,1.0,5/23,15.67%,RORA;PANK2;ABCA2;EPHX2;STAR
prerank,regulation of phosphatase activity (GO:0010921),0.39505452426713117,1.1259782129245173,0.295668549905838,0.9078960417006495,1.0,4/24,13.71%,SH3RF2;SH2D4A;HTT;TSC1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4434399279232336,1.1257183654640657,0.30278884462151395,0.9069184837508091,1.0,6/14,18.54%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3018159957719137,-1.1253753906327542,0.24,0.6101024297498913,1.0,17/65,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;PABIR1;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;CHEK1;PSME1;PSMB3
prerank,regulation of type I interferon production (GO:0032479),-0.2868504122746662,-1.1245132105769309,0.22409638554216868,0.6116787863599231,1.0,26/84,23.79%,LRRFIP1;POLR3F;DHX33;RNF125;XRCC5;NLRC5;TRIM56;TRIM25;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;TRAF3IP1;PCBP2;GAPDH;IRF5;POLA1;POLR3A;MYD88;ZBP1;POLR3D;POLR2F;CYLD;TAX1BP1
prerank,amino acid transmembrane transport (GO:0003333),-0.3267478481355298,-1.1243995394322186,0.2679738562091503,0.6113351547830715,1.0,10/45,8.49%,SLC47A1;SLC6A6;LRRC8D;SLC38A11;SLC7A5;SFXN1;SLC38A5;SLC7A7;SLC7A1;SLC16A2
prerank,cholesterol biosynthetic process (GO:0006695),0.37305683893946084,1.1240170219881636,0.2755905511811024,0.9109641942971389,1.0,10/31,20.27%,ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4157451081139147,1.123946099880782,0.311284046692607,0.9093950818095422,1.0,6/20,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,regulation of telomerase activity (GO:0051972),-0.3280241392370239,-1.123746330415067,0.2517162471395881,0.6124099730946377,1.0,15/45,22.80%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;SRC;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,regulation of neuron projection arborization (GO:0150011),-0.4262971819731233,-1.1231599983232288,0.32091097308488614,0.6131510987430138,1.0,4/15,12.19%,MACF1;WNT5A;FZD4;MFSD2A
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2818777634687826,1.122965009404276,0.20504731861198738,0.9108940396166492,1.0,24/152,10.46%,CACNA1D;ADCY5;LGR4;GCGR;PTH2R;ADGRG4;ADCY1;CRHR1;ADRA2A;LPAR2;CHRM2;ADGRB2;ADGRB3;ADCY8;GPR12;GPR26;LPAR1;PTGER1;GABBR1;ADGRL1;GPR37;HTR1F;ADGRG3;VIP
prerank,cell junction organization (GO:0034330),0.313332821923111,1.1229581960745805,0.27986348122866894,0.9091142257366984,1.0,7/71,2.86%,SDK1;SLC6A1;SLC8A3;SMAD3;SDK2;FLNC;NLGN2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4435158761246549,-1.1229580113402866,0.3132780082987552,0.613045955493042,1.0,4/13,12.38%,BMP5;SOD1;APOE;BMP2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.42721225856674955,1.1227265454293625,0.3290676416819013,0.9081256269478456,1.0,4/17,11.47%,IGF1;RTN1;NTRK2;CLU
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.338793306131442,-1.1222891300373614,0.28859060402684567,0.6140630825002414,1.0,10/39,15.55%,PODXL;JAG1;FXYD5;NOTCH1;CDH1;NOTCH4;KLF4;BMP2;VEGFA;MAD2L2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4871604820152257,1.1217850686554451,0.30518234165067176,0.9095009662293244,1.0,4/11,13.38%,ARR3;ARRB1;DRD3;GRK3
prerank,regulation of chromatin organization (GO:1902275),-0.435681036335852,-1.1215864004019058,0.3184584178498986,0.6152466310128031,1.0,4/14,10.36%,MLLT3;HPF1;IGF2;PARG
prerank,regulation of cell adhesion (GO:0030155),-0.2692526218921535,-1.1215262885179584,0.2005420054200542,0.6147910256522684,1.0,50/129,25.85%,FRMD5;PODXL;ZFHX3;ACVRL1;CDH13;PTPRJ;PPP1R12A;NUAK1;STX3;ARHGDIB;ADAM10;LYN;CXCL12;PPP3CA;MDK;PRKX;TGM2;TGFBI;EFNA5;SRC;EPHB2;ADGRG1;PLXNC1;RET;PTK2B;SIPA1;ARHGDIA;VEGFA;ZDHHC2;SEMA5A;PLXNA4;CELSR2;GPR4;PLXND1;PPP2CA;ROCK1;DUSP1;RASA1;DLL1;TESC;LPXN;ATXN3;FES;EPB41L4B;CXCR4;EPHA7;PTPN11;PIK3CG;RND1;KIF14
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.34514435101171714,1.121518402321124,0.2846153846153846,0.9086477093938019,1.0,12/44,20.27%,PRKAG2;INSIG2;SC5D;CYP27A1;AMACR;OSBPL9;SQLE;PER2;MSMO1;HMGCR;HSD17B4;LBR
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.29592013778229986,-1.1213942632550324,0.2358490566037736,0.6145031417443545,1.0,10/70,7.46%,DAB2IP;HIPK1;TGFB2;BCL2L1;NGF;TNFRSF1B;FAS;CRADD;IL6R;CASP8AP2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4753272354742341,-1.1211612510532187,0.3167701863354037,0.6145246605274594,1.0,4/10,7.11%,CACNB2;CACNA2D1;NOS1AP;CALM3
prerank,receptor signaling pathway via STAT (GO:0097696),-0.37196049105650975,-1.1209560088870416,0.2946058091286307,0.6144028832102502,1.0,4/25,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,vasculature development (GO:0001944),-0.4180715774134215,-1.1205183980881166,0.3128964059196617,0.614941878057701,1.0,9/16,16.62%,BMPR2;ACVRL1;STRA6;PIK3CA;FLT4;NOTCH4;SOX18;FBXW7;APLNR
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4522842598420701,-1.120370070941377,0.3192389006342495,0.6147209482935617,1.0,3/11,4.88%,CAV1;NEDD4L;CAB39
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.26066130285936234,-1.1200719902159317,0.1889763779527559,0.6148935615660731,1.0,50/145,28.00%,FBXL7;YWHAE;RAD51B;FHL1;DYNC1I2;BRD4;CSNK1E;PSMA6;PSMB7;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;USP47;ODF2;DYNLL1;PSMB8;CCP110;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;PRKACA;PSMB4;DYNC1H1;PSMD14;CCND1;RAB11A;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDK5RAP2;CEP152;DTL;HMMR;KIF14;AKAP9;ACTR1A;CUL1;CDK2;CNTRL;AVEN
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4187058167393141,-1.1197228855758943,0.3191489361702128,0.6151695164304216,1.0,8/16,29.65%,SMC1A;NIPBL;RAD21;MAU2;REC8;SGO1;DSCC1;NAA50
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4593728179606942,-1.119476593645926,0.32251908396946566,0.6151866155053964,1.0,9/11,41.45%,LYN;JAK1;PLAUR;SYK;CCL5;ANK3;RDX;TNFSF11;BLK
prerank,ganglioside metabolic process (GO:0001573),-0.3853675978682677,-1.1193400506838704,0.31759656652360513,0.6149395173188968,1.0,6/20,14.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6;HEXA;ST8SIA2
prerank,Fc receptor signaling pathway (GO:0038093),-0.27387060378003086,-1.1190246160657338,0.22330097087378642,0.6150905839772888,1.0,40/110,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4011336052049174,-1.1189758550553617,0.31160896130346233,0.614627778370975,1.0,7/20,14.97%,THBS1;CREB3L1;NPTN;SPRY2;FGF2;SPRY1;GPC1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3130343167192533,-1.118791834235956,0.26576576576576577,0.6144899572359465,1.0,15/51,20.10%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;SYNPO2;TGFB3;PFN1;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,secondary palate development (GO:0062009),-0.4309480750493495,-1.1186874985402189,0.31950207468879666,0.6141292642180559,1.0,5/14,9.46%,LEF1;TGFB2;TGFBR2;WNT5A;TGFB3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4018527414594839,1.1183411867634905,0.3193612774451098,0.9179681708352085,1.0,6/22,15.46%,KRI1;EXOSC8;NOP9;PES1;EXOSC2;WDR12
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2787013892683765,-1.1182642726686967,0.23037974683544304,0.6146015841670198,1.0,21/110,11.60%,ADGRL4;ADGRL2;CALCRL;RAPGEF2;ADGRG6;ADRA1B;RAMP2;ABCA1;ADCY4;ADGRE5;S1PR1;GNB1;ADCY7;GNG2;IAPP;ADGRD1;ADCY2;S1PR3;ADGRG1;ADGRG2;ADM
prerank,actin filament-based transport (GO:0099515),-0.3920636215659461,-1.1181363017262498,0.3078602620087336,0.6143600900351344,1.0,6/21,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,acylglycerol biosynthetic process (GO:0046463),0.39150361357171726,1.1175502579853225,0.30518234165067176,0.9190027463266518,1.0,6/23,12.75%,LPGAT1;GK;LPIN1;MOGAT1;PLA2G15;DGAT2
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.33493551938328475,-1.1173426125146735,0.26280623608017817,0.6158192256545256,1.0,11/40,14.23%,NTRK3;EDNRA;EGFR;PLCG1;ESR1;FLT1;FGF2;PHB2;HTR2A;CD86;P2RY6
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2717679612469494,-1.1173199859325618,0.2324455205811138,0.6152943428579339,1.0,23/107,16.14%,DAB2IP;NIBAN1;MAP3K5;THBS1;PIK3R1;RASGRF2;JUN;CREB3L1;ERN1;NCK1;UFC1;BCAP31;ATP2A3;EIF2AK3;TMCO1;PDIA4;BBC3;RHBDD1;ATF6B;BAK1;ATF4;OS9;CFTR
prerank,metal ion transport (GO:0030001),0.3047060928948349,1.1172867015469534,0.24655172413793103,0.9181479629748265,1.0,15/86,11.47%,CACNA1D;SLC8A3;SLC41A1;CACNG7;CACNB3;NDFIP1;GRIN3A;ITPR1;TUSC3;NMUR1;CHRNB2;KCNN4;MAGT1;RYR2;TRPM2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.42128860265407503,-1.1171935753764288,0.32142857142857145,0.6150178781382083,1.0,5/14,25.25%,THBS1;IRAK3;PIBF1;JAK3;CMKLR1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3723011458986686,-1.1165026292491358,0.31777777777777777,0.6161900758871821,1.0,6/25,10.53%,B2M;SLC7A5;PLCG2;WNT5A;CD55;MALT1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4026118644243445,1.116166196920877,0.29608938547486036,0.9203586681652106,1.0,4/21,10.53%,DCDC2;EVC;ARMC9;TEDC2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.32372515790420875,-1.1159769845906051,0.26785714285714285,0.6168733763860831,1.0,16/43,17.35%,FOXP1;THBS1;CDH13;BMP4;JUN;ERN1;IL6R;ADAMTS1;FGF2;EDN1;CCN4;P2RY6;HTR1B;ID2;LDLRAP1;MMP2
prerank,negative regulation of nuclear division (GO:0051784),0.48057797100332245,1.1157625076677886,0.34629629629629627,0.9200748785774462,1.0,2/11,6.64%,BMP7;TOM1L2
prerank,fatty acid metabolic process (GO:0006631),0.2971001811600644,1.1157313555518313,0.24561403508771928,0.9183909934579386,1.0,25/115,17.36%,ACSL1;CEL;PON1;ACSM2A;ACSM2B;PPARA;LPIN1;AASDH;PNPLA8;ACADSB;ECHDC3;PPARGC1A;CPT1C;SLC27A6;FA2H;PLA2G15;CROT;SLC27A4;NAAA;PER2;GGT5;ACACA;ACOT1;MSMO1;ACOT6
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.45198579240502446,-1.1155697885074356,0.32245681381957775,0.6173122757413291,1.0,3/12,11.83%,FOXP1;KLF4;CD74
prerank,regulation of metal ion transport (GO:0010959),0.43127470591294015,1.115416658015692,0.33669354838709675,0.9176879469185455,1.0,5/16,15.47%,ANK2;DLG1;SLC30A10;BCL2;ORAI1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44933328205539325,-1.1153028359776638,0.365702479338843,0.6173776154386145,1.0,3/12,8.65%,NOTCH1;CCN3;TMEM119
prerank,negative regulation of microtubule polymerization (GO:0031115),0.46763574802574076,1.11512408820347,0.32098765432098764,0.9168769272626943,1.0,5/12,15.52%,MAP2;CLIP3;EML2;TUBB4A;MAPRE1
prerank,L-amino acid transport (GO:0015807),-0.36176928534108,-1.1149860015626467,0.3271604938271605,0.6176278175076468,1.0,8/28,17.44%,SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.42579542864349185,1.1148822475483333,0.3141683778234086,0.915937658944583,1.0,10/17,26.15%,CORO1B;WASF1;CYFIP1;WASF3;PICK1;CTNNA2;BRK1;ARF1;GMFB;ARFIP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.266046434132984,-1.1137938203256628,0.21108179419525067,0.6199980736413516,1.0,39/136,20.24%,DAB2IP;TMSB4X;CD200;FZD6;PKD1;GAS6;CYP1B1;PTGIS;NFKBIA;ID1;SFRP4;IRAK3;ESR1;FLNA;BHLHE40;TRIM37;AIM2;HES1;NLRC5;DAP;HEYL;USP7;KLF4;PHB2;PTCH1;MTURN;IRAK2;MAD2L2;ID2;SP100;SIGIRR;PEX14;HDAC2;ERBIN;LRRC14;ZC3H12A;SPI1;ARRB2;PSMD10
prerank,cellular response to virus (GO:0098586),0.3715753786131916,1.1137471309361997,0.2891089108910891,0.918073335865422,1.0,11/30,20.76%,CHUK;GSDME;VWCE;MAPK14;IL6;GBF1;IL12A;HSP90AA1;POU2F2;DDX3X;BAX
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4465525421290953,1.11345685579812,0.3286573146292585,0.9173168383846564,1.0,3/14,8.03%,IL18;PRKCZ;NLRP3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3659303332148887,-1.1134111634359158,0.2711864406779661,0.6203256547718625,1.0,8/27,17.44%,SLC47A1;SLC7A5;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.41000917696099515,1.1133501831205523,0.3217726396917148,0.9159561111526229,1.0,5/20,10.40%,PRKAA2;RUVBL2;ARRB1;PPARGC1A;BRD7
prerank,tetrapyrrole metabolic process (GO:0033013),-0.40521723409658206,-1.113123283525138,0.3141683778234086,0.620432220988299,1.0,4/18,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,axonal transport of mitochondrion (GO:0019896),0.468288593670983,1.1122171014163043,0.3333333333333333,0.9181905519212862,1.0,5/11,26.43%,TRAK1;ACTR10;NEFL;SPAST;HAP1
prerank,regulation of platelet activation (GO:0010543),-0.3770826266298207,-1.1120953008402017,0.3072033898305085,0.6224077936055571,1.0,5/21,9.64%,PLA2G4A;NOS3;TEC;LYN;APOE
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2848572237492716,-1.1119612469964266,0.24305555555555555,0.6221738564735497,1.0,34/83,27.24%,ACVR1;CDK17;CDK14;CACUL1;BRD4;PLK2;KLF11;CDK5;EIF4E;FBXO5;NASP;ORC1;DHFR;LATS1;CCND1;CDK16;CDC45;CDK6;POLA1;CCNH;CDKN1B;CDK18;CUL3;LATS2;PLK3;CDC34;PIM2;CDKN3;TYMS;CUL4A;NPAT;TFDP1;CUL1;CDK2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3735856896366392,1.1118489833655132,0.31589147286821706,0.9176851389940749,1.0,8/28,16.04%,MAP2;PRUNE1;CLASP1;ARL2;SKA2;ABL1;MAPRE1;GBA2
prerank,postsynaptic membrane organization (GO:0001941),0.42286799007944564,1.1117626266051608,0.33739837398373984,0.9162282113332483,1.0,6/17,9.52%,CEL;NLGN2;NLGN3;SHISA7;LRP4;DLG4
prerank,monocyte chemotaxis (GO:0002548),-0.3460592738778534,-1.1116762285157424,0.2850877192982456,0.6223189917036126,1.0,5/32,8.06%,TNFRSF11A;IL6R;ANXA1;FLT1;CCL13
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.29421304163643286,-1.1116408566948297,0.2529274004683841,0.6218158928044595,1.0,34/73,30.26%,ACTB;CTCF;H3-3A;MYBBP1A;RBBP4;IGF2;GPX1;PRMT7;MTA1;DNMT3B;HDAC6;SUZ12;POLR1F;POLR1G;TASOR;ZFP57;TDG;EPC1;POLR1A;SPI1;AEBP2;DNMT1;GLMN;POLR1H;MYO1C;POLR2F;POLR1E;BMI1;POLR2H;PHF19;DDX21;POLR1C;POLR2E;SMARCA5
prerank,chordate embryonic development (GO:0043009),-0.3144564724682964,-1.1109028406574601,0.2699530516431925,0.623092467567843,1.0,18/55,16.19%,MBNL1;BMP5;PCSK5;PKD1;FUT8;KIAA1217;TBX1;WNT5A;ADAM10;IGF2;TGFB3;XYLT1;PTCH1;COL1A1;BMP2;VEGFA;STIL;SIX4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.35834673342143686,1.1103524018931683,0.30017761989342806,0.9194274588675644,1.0,5/38,3.16%,CACNA1D;DSC2;KCND3;ANK2;KCNJ5
prerank,regulation of postsynapse organization (GO:0099175),-0.3505172742404968,-1.1101223339444377,0.2980132450331126,0.6244238157687175,1.0,7/28,13.56%,SHANK3;PDLIM5;WNT5A;CDK5;ABI3;CFL1;ABHD17C
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4459108964740319,-1.1097541719946005,0.3352380952380952,0.6248114234277081,1.0,6/12,32.25%,CHMP4B;CHMP4A;SEC61A1;SEC62;HSPA5;GET3
prerank,acyl-CoA metabolic process (GO:0006637),0.367516013153702,1.109704180790087,0.2949640287769784,0.9198768019632358,1.0,10/35,22.41%,ACSM2A;ACSM2B;SUCLA2;GLYAT;ACACA;ACOT1;ACOT6;ACOT13;SUCLG2;ACOT9
prerank,positive regulation of T cell migration (GO:2000406),-0.3917004042684282,-1.108918027419582,0.3238512035010941,0.6263704859850369,1.0,6/20,9.84%,RHOA;APP;WNT5A;ADAM10;CXCL12;DOCK8
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3822115285119084,1.1088704529722246,0.2992831541218638,0.9209437168967687,1.0,7/26,13.78%,SLC5A3;PPARA;SLC30A10;ABCD1;SPHK2;TRAP1;CYBA
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33728555421013595,-1.1088030411115248,0.3130434782608696,0.6260536073566815,1.0,13/34,18.18%,TEK;DAB2IP;PIK3R1;TNFAIP8L3;PIK3IP1;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.41969258641890916,1.1088016289773301,0.3377862595419847,0.9194448029006491,1.0,6/18,23.59%,KMT2A;SETD4;SETD7;SMYD2;SETD1B;SETD2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.38035711498632085,1.108492663052301,0.3278084714548803,0.9187717187017012,1.0,4/27,6.49%,IGF1;PDGFRA;SPHK1;E2F1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3693530514572007,1.1084735638989125,0.3013698630136986,0.9170958237316582,1.0,10/29,18.41%,LPGAT1;PPARA;SORBS1;SLC45A3;NR1H3;CREBL2;CREB1;AKT1;MID1IP1;MLXIPL
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3064909685099187,-1.1083325089030147,0.28162291169451076,0.6266082865690306,1.0,12/56,11.93%,RAD51B;CDC27;KMT2E;EGFR;ANAPC5;BRD4;ANXA1;ADAMTS1;CDC16;RPTOR;FBXO5;PHB2
prerank,positive regulation of dendrite development (GO:1900006),-0.46611387201479226,-1.108269520098925,0.3518886679920477,0.6261898256961494,1.0,3/10,1.04%,BMP5;DAB2IP;PTN
prerank,DNA dealkylation (GO:0035510),-0.4593978565650211,-1.1081446601520286,0.35390946502057613,0.6253481464015819,1.0,2/10,4.43%,FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4593978565650211,-1.1081446601520286,0.35390946502057613,0.6253481464015819,1.0,2/10,4.43%,FTO;ALKBH1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.39124948165751405,1.1078390060099645,0.3301158301158301,0.9174492049329611,1.0,9/25,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,regulation of MAP kinase activity (GO:0043405),0.30106208037918425,1.1076851663636513,0.2743801652892562,0.9162792785327588,1.0,11/92,8.22%,ROBO1;BMP7;FGF1;TENM1;KIT;ADRA2A;PIK3CB;PPEF2;SNF8;LRRK2;KSR1
prerank,regulation of nervous system development (GO:0051960),-0.331176525321741,-1.1076521979008158,0.3108108108108108,0.6259605241759809,1.0,8/37,11.68%,PTN;TNFRSF1B;BHLHE40;HES1;LGI4;HEYL;HEY2;PTPRZ1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4692386829903936,-1.1075375575339677,0.33648393194706994,0.6256587893767068,1.0,3/10,13.61%,PRKCH;TRIM16;NME2
prerank,chondrocyte differentiation (GO:0002062),-0.35276900477036227,-1.1075248646008817,0.3141025641025641,0.6251098205821847,1.0,8/32,9.16%,MEF2C;BMPR2;RUNX2;RUNX1;BMP4;CCN3;SNX19;EIF2AK3
prerank,response to organophosphorus (GO:0046683),-0.4046277538203543,-1.1071298342661862,0.3169291338582677,0.6255851411285691,1.0,3/16,9.27%,TRPC3;ABCC9;TRIM16
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.43826176336921413,1.1070588222645728,0.35271317829457366,0.9167721543067745,1.0,4/16,15.49%,RORA;PDK2;PDK1;SIRT1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4142237811856322,-1.1064290050730818,0.34210526315789475,0.6267615398639562,1.0,10/17,21.83%,CACNA1G;STX1A;SYT4;RAB3A;RAB27A;CACNA1I;KCNB1;CACNA1H;RAB3D;SLC4A8
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.45285362444947164,-1.1063539663339506,0.35,0.6263660460876421,1.0,4/11,15.84%,H3-3A;RBBP4;NASP;UBN1
prerank,Golgi inheritance (GO:0048313),0.4596751728191869,1.1062003469694928,0.32172131147540983,0.9180292683861744,1.0,4/11,16.60%,PLK5;GOLGA2;STK25;GBF1
prerank,chloride transmembrane transport (GO:1902476),-0.3109543710909928,-1.1056552954543724,0.28110599078341014,0.6275160284860326,1.0,14/48,16.14%,SLC12A7;SLC12A2;ANO1;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.39172842322222595,-1.1055573394929823,0.3178947368421053,0.6272121806793203,1.0,7/19,11.67%,PLCE1;NFATC1;PPP3CA;NFAT5;EDN1;NFATC2;EDN3
prerank,protein monoubiquitination (GO:0006513),0.35658097775060293,1.1049624424291211,0.31785714285714284,0.9204900786901562,1.0,9/36,14.73%,CTR9;RNF126;LEO1;TOPORS;RNF20;UBE2W;OBI1;CDC73;UBE2R2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4533397991367506,-1.1049195744315312,0.3434959349593496,0.6281973195779915,1.0,4/11,8.77%,CORO1C;CD44;KANK1;SRC
prerank,mitotic nuclear division (GO:0140014),-0.28855445422010273,-1.1048012361441075,0.2681318681318681,0.6279227123544663,1.0,31/71,27.78%,RHOA;SMC4;FLNA;SMC1A;PPP2R2D;EPS8;CHMP4B;STAG1;NCAPG2;MAP9;PIBF1;MZT1;ZW10;KLHL22;STAG2;TOGARAM1;NUSAP1;ARHGEF10;RAB11A;TPX2;KNSTRN;AAAS;KIFC1;NUP62;NSL1;NDEL1;CENPK;MIS12;CDCA8;SGO1;TUBG2
prerank,glycoprotein metabolic process (GO:0009100),-0.30789377455676337,-1.1047760347847886,0.2802547770700637,0.6274026473285003,1.0,14/53,14.69%,ST3GAL4;ST6GALNAC3;ST8SIA4;FUT8;ST8SIA6;STT3B;MGAT4A;AGA;GOLPH3;B4GALT5;GCNT1;FBXO44;MGAT4B;ST8SIA2
prerank,BMP signaling pathway (GO:0030509),0.3190329105838217,1.1047571117515653,0.30612244897959184,0.9195006811913394,1.0,7/62,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,regulation of translational initiation (GO:0006446),-0.29769867266222144,-1.1046557884707788,0.2809278350515464,0.6271374711202083,1.0,16/63,15.85%,EIF3E;ALKBH1;EIF3H;NCK1;CDC123;EIF2B2;EIF2AK3;AGO2;HSPB1;NCBP2;TPR;EIF1B;NCBP1;EIF4G3;FMR1;ATF4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25557938939144126,-1.1045681401932224,0.21798365122615804,0.6267839319226963,1.0,46/163,23.25%,PDE4D;MEF2C;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;BMX;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;CD38;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;NFATC2;SH2B2;PTPRC;PSMB8;PSMC4;PSMD11;NCKAP1L;DENND1B;LAT2;EIF2B1;PSMB4;PSMD14;ZC3H12A;BTK;PSMD10;SYK;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,macroautophagy (GO:0016236),0.2893968680246606,1.103020550949188,0.2532258064516129,0.923762586110837,1.0,21/118,12.89%,PRKAG2;PRKAA2;PRKAG3;CHMP6;STAM;SNX14;VAMP7;VTA1;TOMM40;SNAP29;SNF8;AMBRA1;VPS16;TOMM22;CSNK2A2;LAMP2;LIX1L;MFN2;ATG13;UBXN6;VPS39
prerank,membrane organization (GO:0061024),-0.24394068829758214,-1.1029959644111273,0.1918238993710692,0.6301266781426631,1.0,51/227,16.64%,HIP1;SPTBN1;ACTB;DNM3;STON2;ACTG1;CERT1;EGFR;CORO1C;UBC;AP2B1;PIK3C2A;SCARB2;PLEKHA8;CHMP2B;FCHO2;TFRC;SGIP1;RPS27A;VAMP3;UBB;WNT5A;CLTB;FNBP1;CHMP4B;CHMP4A;EPN2;NEMP1;GAPVD1;CHRNB1;RABIF;HGS;DYSF;SUN1;LEMD3;FZD4;FNBP1L;SH3GL2;HIP1R;UBXN2A;AP2A1;REEP3;SAR1A;CBL;ARPC2;VAPB;TLCD1;CFTR;SYNGR2;SNAP23;LDLRAP1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4190907784079549,-1.102890873965474,0.32943469785575047,0.6297885437430027,1.0,8/15,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;ARPC5
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.33260864935201695,-1.1026921046954323,0.29375,0.6297075242752214,1.0,14/34,24.19%,INSR;LRP5;CDC27;ANAPC5;CDC16;IGF2;EDN1;EDN3;NUSAP1;EGF;CDC23;NUP62;CUL3;RGCC
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3391249449600281,-1.1026573534107722,0.2818371607515658,0.6291980041421029,1.0,10/32,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,cellular response to chemokine (GO:1990869),-0.3165324914706543,-1.1021577832633367,0.3076923076923077,0.6299031994024717,1.0,8/46,12.51%,LRCH1;SLC12A2;RHOA;CXCL12;CCL13;DOCK8;ACKR3;PTK2B
prerank,lymphocyte mediated immunity (GO:0002449),-0.43958562040751803,-1.1016387122066582,0.33548387096774196,0.6306012885475171,1.0,4/12,17.01%,JAG1;CD55;CD46;GNL1
prerank,mesenchyme development (GO:0060485),0.4427195714517881,1.101306112117552,0.31906614785992216,0.9278102299331272,1.0,4/15,10.07%,BMP7;FGFR2;CRELD1;TGFBR1
prerank,copper ion homeostasis (GO:0055070),-0.39317135508233453,-1.1009568364103282,0.3291139240506329,0.6317488031599497,1.0,9/17,29.00%,APP;SLC31A1;ATOX1;XIAP;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,peptide cross-linking (GO:0018149),-0.3548349507813877,-1.1009047224855983,0.3172866520787746,0.6312868624671665,1.0,5/25,7.67%,NDNF;THBS1;FN1;ANXA1;TGM2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2533912259468538,-1.1007680970343063,0.23460410557184752,0.6310959262075128,1.0,37/172,14.60%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;DGKH;PIK3R1;CEPT1;DGKZ;PLSCR1;AGK;PIK3C2A;PLCG2;BMX;PLEKHA8;CPNE3;PIK3R6;SLC44A2;PLEKHA4;INPP5D;PIK3CA;FGF2;PIK3CD;MTMR7;FIG4;PIK3C3;MFSD2A;MTMR12;SLC44A1;AGPAT1;LPIN3;CSNK2A1;ABHD4;ABHD8;ETNK1;PIK3R4;AGPAT5
prerank,regulation of RNA metabolic process (GO:0051252),0.3297968373392226,1.100554815058985,0.2949640287769784,0.9286491487200504,1.0,24/59,19.61%,OAS2;NOVA1;HNRNPH3;PQBP1;FASTK;PTBP2;SON;HNRNPL;PTBP1;MED1;OAS3;SRRM4;CLK3;AFF2;GRSF1;PCBP4;MBNL3;CLK2;FAM50A;METTL18;HNRNPH2;PTBP3;MITF;CLK1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.451328263823279,1.1005138491111484,0.36345776031434185,0.9270733989220111,1.0,4/12,17.22%,UCKL1;DCK;UPP2;UMPS
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.47165126375156774,1.100457944188214,0.3592814371257485,0.9255320836606816,1.0,4/11,13.14%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,response to interleukin-4 (GO:0070670),-0.4698161222031746,-1.100180969691746,0.35542168674698793,0.6320290117233957,1.0,1/10,0.18%,LEF1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4750845998031895,1.0997881230166793,0.34279918864097364,0.9261223090465025,1.0,3/10,15.49%,KLF15;NOC2L;SIRT1
prerank,negative regulation of transposition (GO:0010529),0.420983786023961,1.09930856961875,0.32432432432432434,0.9260538443261561,1.0,4/16,14.13%,TDRD9;SPOCD1;TUT4;MYBL1
prerank,microtubule nucleation (GO:0007020),0.4111970700373786,1.0992467365171195,0.3346303501945525,0.9245655854742646,1.0,5/19,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,oligosaccharide metabolic process (GO:0009311),-0.3164440975055145,-1.0990945893429158,0.32207207207207206,0.634162900763517,1.0,7/46,8.21%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,'de novo' posttranslational protein folding (GO:0051084),0.36317064395667475,1.09901806515931,0.3333333333333333,0.9236233902533252,1.0,4/30,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,pancreas development (GO:0031016),-0.4381944013877791,-1.0986955110252532,0.36327345309381237,0.63461971329904,1.0,9/12,43.04%,MET;NKX6-1;FOXF1;ZIC3;SELENOT;NPHP3;CCDC40;ISL1;DNAAF1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.35776713202007204,-1.098600475852876,0.3347107438016529,0.634284340167156,1.0,12/28,24.88%,NOTCH3;EGFR;GATA2;TCIM;FBXW7;LFNG;HEY1;METTL3;DLL4;DLL1;EGF;ZBTB7A
prerank,positive regulation of B cell activation (GO:0050871),-0.3082643091205162,-1.098528281500712,0.2828054298642534,0.6338872500455102,1.0,14/50,21.23%,MEF2C;TFRC;CD38;SHLD1;EPHB2;NFATC2;CD74;CD40;PTPRC;MAD2L2;NCKAP1L;NOD2;BTK;SYK
prerank,phagosome acidification (GO:0090383),0.3719938997271189,1.0974810927069105,0.3235294117647059,0.9270707612366291,1.0,8/26,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3047548027744942,1.0971158461058472,0.2747068676716918,0.9266335113836505,1.0,11/85,7.28%,FGF1;TGFBR3;BMP6;IGF1;NUPR1;OSR1;FGF9;MCC;FUT2;FGFR2;NLRC3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3001602430399292,1.0967875309345183,0.27759197324414714,0.9259678612867684,1.0,26/84,20.57%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;C1QBP;YTHDC1;NUP98;FXR2;RBM5;PCBP4;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST;LARP7
prerank,neuron development (GO:0048666),-0.2625164527615865,-1.0965279394569607,0.23204419889502761,0.6383629839025333,1.0,25/141,12.27%,PTPRM;FRY;MEF2C;RAPGEF2;PBX1;TGFB2;PBX3;RUNX1;APP;STMN1;TBCD;STX3;VSX1;MAP4;ETV1;LYN;LGI4;MYOC;CDK5;APOE;B4GALT5;FRYL;MICALL2;UGCG;SH3GL2
prerank,membrane assembly (GO:0071709),0.3557728357602003,1.0963504166005147,0.30451127819548873,0.9257609908871061,1.0,8/34,8.56%,CEL;IL1RAPL1;NLGN2;PICALM;FLOT2;NLGN3;LRP4;PTPRD
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.45859099708621687,1.096253717626614,0.33984375,0.9243809450508064,1.0,4/12,13.27%,ROCK2;PICALM;FLOT2;ABCA2
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.31955081885132675,-1.0959636432245912,0.2949640287769784,0.6391564995404939,1.0,16/42,22.58%,RPA1;UBC;RPS27A;UBB;TRIM25;ZBTB1;ISG15;WRNIP1;USP43;RPA2;PRIMPOL;USP10;PCLAF;POLA1;RFC4;POLD4
prerank,response to sterol (GO:0036314),0.45793753312650376,1.095747860466638,0.374749498997996,0.9244359341072229,1.0,3/11,13.27%,RORA;TGFBR1;ABCA2
prerank,cellular response to hypoxia (GO:0071456),0.28203570667734057,1.0954367454652079,0.2802653399668325,0.9238631682371325,1.0,21/126,16.70%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;PSMD3;LMNA;PGK1;KCND2;HIF3A;NDRG1;ANGPT4;TERT;PSMD1;ARNT;PSMC5;PSMA1;SIRT1;PSMD12;MDM2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.44144163277279963,1.0951635771446406,0.35728952772073924,0.9231135053639952,1.0,4/13,8.19%,IGF1;GCK;PHKG2;SORBS1
prerank,negative regulation of cholesterol transport (GO:0032375),0.48139971839991336,1.0950720144138453,0.3407707910750507,0.9217482560292687,1.0,4/10,23.75%,ABCG5;ABCA2;NFKB1;SHH
prerank,respiratory system development (GO:0060541),0.3621876770512811,1.094800678979085,0.3299145299145299,0.9209535807039194,1.0,6/32,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.41357317845991215,-1.0945547980685533,0.33544303797468356,0.6423577590802791,1.0,6/15,27.62%,APP;IAPP;APOE;PFDN6;TREM2;LDLR
prerank,positive regulation of macroautophagy (GO:0016239),0.3328597756098234,1.0944932539281633,0.31560283687943264,0.920398189555501,1.0,10/48,10.33%,PRKAA2;OPTN;RAB3GAP1;FYCO1;SLC25A5;IKBKG;GPSM1;SESN1;HTT;PAFAH1B2
prerank,leukocyte tethering or rolling (GO:0050901),-0.4033657247509753,-1.0942010998626335,0.34232365145228216,0.6426229533179534,1.0,5/17,12.40%,VCAM1;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.42534855469930777,-1.0939110994600816,0.3360995850622407,0.642802642454471,1.0,8/13,29.06%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38081415815753417,-1.0936348113586092,0.32340425531914896,0.6429280530729178,1.0,11/20,32.10%,ACVR1;ACVRL1;AIDA;DSCAML1;PTCH1;GREM1;LMX1B;LHX1;BMPR1B;TBX20;NOG
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.23334886380697575,-1.0935906544586045,0.14331210191082802,0.6424591404330949,1.0,54/308,13.83%,LEF1;PRKCH;GHR;CAV1;GCNT2;BMPR2;ZBTB16;PTN;ADRA1B;ACVR1;TGFB2;GAS6;EBF2;ABCA1;BMP4;PRDM16;SIX1;TGFBR2;GATM;PLA2R1;ADIPOR2;TFRC;WNT5A;S100A13;AXIN2;MDK;APC;SHLD1;TMEM119;PDGFC;SOD1;TIAM1;TRIM16;FGF2;SERPINE1;TGFB3;AGO2;IL15;APOE;B4GALT5;ELOVL6;IL4R;CFL1;PIK3CD;FBXO5;HADH;TWIST1;COL1A1;BMP2;SMO;AGPAT1;NME2;VEGFA;LRP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.4034232333222931,-1.0929303094729486,0.3346534653465347,0.6434807038209147,1.0,7/18,5.58%,TEK;BMP5;ADGRG6;TGFB2;ENG;NOTCH1;S1PR1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.31284422047316757,-1.0927511443795388,0.28045977011494255,0.6433418510522663,1.0,10/47,10.45%,FOXO3;NFKBIA;RBM3;APP;RPL10;AGTR1;EIF4E;APOE;KLF4;EDN1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33545176156697865,-1.0921868020986523,0.3139784946236559,0.6441445976227405,1.0,10/35,18.38%,HIP1;B2M;MKLN1;SGIP1;SERPINE1;HIP1R;CBL;VTN;LDLRAP1;C3
prerank,negative regulation of protein processing (GO:0010955),-0.43935591211335623,-1.0920882382962114,0.3592436974789916,0.6438065547122779,1.0,3/12,9.35%,THBS1;TMEM59;SERPINE1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3899959404876723,-1.091967104899951,0.35040983606557374,0.6435581762789172,1.0,8/19,15.99%,VCAM1;PTPRJ;KDR;STIMATE;BCAP31;PTPRC;PTGFR;PRKACA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.38430478160506343,1.0919183570887978,0.3353174603174603,0.9276435533976137,1.0,7/24,12.68%,LEPR;COQ10A;NDUFS1;PPARGC1A;CYCS;MRAP2;COX10
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.24646096360829367,-1.0916598603983596,0.21306818181818182,0.6437402945242343,1.0,43/186,15.64%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;NFATC1;SFRP4;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;RACK1;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;TAX1BP3;LRP1;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11
prerank,pre-replicative complex assembly (GO:0036388),-0.29601275140674693,-1.091194302374587,0.286697247706422,0.6442890660661021,1.0,19/64,23.25%,UBC;RPS27A;UBB;PSMA6;PSMB7;PSMB6;PSMB5;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;ORC5;PSMD10;PSME1;MCM3;PSMB3
prerank,regulation of microtubule-based process (GO:0032886),-0.3316437308084799,-1.0909799456043285,0.30885529157667385,0.6442071689234325,1.0,14/36,23.36%,PHLDB1;MACF1;PHLDB2;APC;EFNA5;FAM107A;HDAC6;BICD2;MEMO1;TRAF3IP1;TAOK1;ROCK1;CYLD;MAP6D1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.43364414131912954,-1.090928644739379,0.3466135458167331,0.6437454446270588,1.0,2/13,0.78%,NRP1;NRP2
prerank,protein localization to membrane (GO:0072657),-0.24698708542444828,-1.0907745312297477,0.22535211267605634,0.6435698412892171,1.0,44/187,15.35%,SPTBN1;CAV1;SHANK3;RAPGEF2;PTN;BSG;RFTN1;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;SH3PXD2B;EFR3B;RAPGEF6;SLMAP;EMP2;CPE;EHD2;FGF13;HGS;RAB3A;PTCH1;EHD4;ITGA4;LIN7C;ARL5A;KCNB2;RAB11B;PPIL2;AGRN;S100A10;FERMT2;KCNB1
prerank,DNA replication initiation (GO:0006270),-0.32993933164778383,-1.090694246286429,0.32805429864253394,0.6431799220996602,1.0,16/37,27.24%,RPA1;ORC1;ORC2;RPA2;CDC45;ORC5;POLA1;POLA2;MCM3;PURA;CDC34;PRIM2;POLE3;MCM5;MCM6;CDK2
prerank,cellular response to hexose stimulus (GO:0071331),-0.36502752230120467,-1.0900522504498593,0.3072033898305085,0.6441669631436682,1.0,12/23,29.41%,GAS6;UNC13B;ERN1;RACK1;SLC26A6;KCNB1;PRKACA;GPER1;IGF1R;TRA2B;SLC39A14;PDK3
prerank,fat cell differentiation (GO:0045444),0.3194207422633655,1.0899954725221672,0.31314878892733566,0.9323187538798925,1.0,20/57,22.09%,OSBPL8;WNT5B;TMEM120B;METRNL;CLIP3;CEBPA;C1QTNF3;MED1;PPARGC1A;ADIG;CTBP2;FAM120B;PER2;SIRT1;TCF7L2;OSBPL11;INHBB;TRIM32;NR4A3;BBS2
prerank,regulation of gene expression (GO:0010468),0.2335128460471645,1.0899260738264689,0.16160388821385177,0.930893905921785,1.0,127/903,12.42%,PRDM6;ROBO1;DENND4A;NOTCH2;BMP7;AFDN;RORA;FGF1;BMP6;WNT4;PPARGC1B;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;PABPN1;OVOL2;CTR9;ANK2;PRKAA2;SUFU;NDFIP1;ZBTB38;SCRT1;MYBL2;PIK3R3;NOVA1;CRABP2;CPNE1;ARNT2;ZNF431;OPRD1;NFYB;CDH3;ESRRA;POU1F1;TULP3;BMPR1A;PICALM;FGF9;CCAR2;HNRNPH3;TNRC6A;PIK3CB;TRIM5;LRP3;ASCC2;PEG3;CCAR1;PQBP1;PAX6;RBPJ;ACTR8;MZF1;TRIM71;WWTR1;ZNF462;PDCD5;RNF14;NFYC;E2F1;CIAO3;WNT6;CEBPA;CITED1;FASTK;PTBP2;FLOT2;SRSF10;SON;CHD3;AFF3;NTRK2;FAM98B;SNF8;KDM6B;RIMS1;HNRNPL;PTBP1;PHF1;HES6;MED1;CRNN;MAFA;PPARGC1A;HINFP;CACTIN;ZNF711;FZD7;PARP14;NKAP;SSBP2;CLOCK;CREBL2;SRRM4;PRDM2;GON4L;MEGF8;NSD1;TGFBR1;LDB1;HRG;RNF20;RNF6;CLK3;MAPK14;YTHDC1;ZFPL1;FUBP1;MAGED1;TAF1;CTSH;DTNBP1;CLU;ATRAID;DMTF1;KDM4A;SOX9;RLIM;PML;CHEK2;RBAK;MAPK9
prerank,positive regulation of phosphatase activity (GO:0010922),-0.37029177575941274,-1.0898918815667025,0.33471933471933474,0.6439778509375361,1.0,4/21,12.38%,MEF2C;ITGA1;CALM3;BMP2
prerank,DNA-dependent DNA replication (GO:0006261),-0.2577580928458541,-1.0896234350036795,0.2375,0.6441231840179737,1.0,47/128,27.75%,RPA1;UBC;RPS27A;UBB;REV3L;PSMA6;PSMB7;RPAIN;PSMB6;PSMB5;BLM;WRNIP1;ORC1;PSMB8;DDX23;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;PRIMPOL;CDC45;ORC5;SIRT7;POLA1;PSMD10;RFC4;POLA2;MCMBP;PSME1;MCM3;WDHD1;PURA;POLD4;PSMB3;POLB;POLG2;CDC34;PRIM2;POLE3;GINS3;MCM5;MCM6;RFC2;CDK2;RECQL5
prerank,regulation of T cell chemotaxis (GO:0010819),0.45645427755147516,1.0894173360440405,0.3639921722113503,0.9308852498412732,1.0,2/11,4.13%,OXSR1;STK39
prerank,positive regulation of DNA repair (GO:0045739),0.3353305749780789,1.0888791678979937,0.3163444639718805,0.9310020445095138,1.0,5/46,6.74%,EYA1;EYA4;EYA2;XRCC1;ABRAXAS1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.45248209480281054,1.0887628988131486,0.33849129593810445,0.9297288860854253,1.0,4/12,13.99%,CCDC115;TMEM199;LRRK2;CLN5
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.31110825928905333,-1.0886879821363085,0.3190045248868778,0.6459644629028681,1.0,14/49,17.34%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.438017943263107,1.0884126939347134,0.35908141962421714,0.9292293290092525,1.0,1/14,0.12%,PPP2R2B
prerank,positive regulation of ATPase activity (GO:0032781),0.34110544844953455,1.0884109368523347,0.3048128342245989,0.9275813795682007,1.0,16/41,25.45%,ATP1B3;ATP1B2;ALDOB;HNRNPU;MSH6;DNAJC10;SSBP1;RYR2;MSH3;DNAJB2;ATP2A1;FGF10;DNAJB1;VMP1;TOR1AIP1;DNAJC9
prerank,negative regulation of interleukin-6 production (GO:0032715),0.38025437143992147,1.088146572336949,0.34953271028037386,0.9269026711416888,1.0,5/27,7.55%,SYT11;C5AR2;C1QTNF3;NLRC3;ARRB1
prerank,cellular response to peptide (GO:1901653),-0.3008263204376546,-1.087738111247939,0.2972972972972973,0.6477911541582039,1.0,22/56,23.54%,CAV1;CACNA2D1;VCAM1;ABCC1;APP;NOD1;ICAM1;ARHGEF2;CDK5;SRC;RPL23;ITGA4;LRP1;TIMELESS;GPER1;GRIN1;NOD2;CASP4;RIPK2;FYN;FCGR2B;IGF1R
prerank,cellular response to dsRNA (GO:0071359),0.42441838752153754,1.0874678568493095,0.35877862595419846,0.9275049650399396,1.0,3/15,7.53%,COLEC12;PQBP1;IFIT1
prerank,negative regulation of synaptic transmission (GO:0050805),0.3802496116660174,1.0874532781659167,0.31985294117647056,0.9259151802519253,1.0,5/23,12.52%,SYT11;ATAD1;LRRK2;DRD3;MTMR2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4561942796349294,1.0873325955451365,0.3559670781893004,0.9246958130607805,1.0,4/12,16.23%,LPIN1;PLK1;PRKCB;PRKCA
prerank,regulation of protein localization to cell surface (GO:2000008),0.3544513807153292,1.0871614085347092,0.3548387096774194,0.9236465197675088,1.0,11/33,18.46%,LEPROT;ACTN2;PICALM;BDNF;ABCA2;STX4;GBF1;SNX33;HFE;GPM6B;GPD1L
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3566173844470194,-1.087135161430772,0.3540772532188841,0.6488114874411451,1.0,8/23,19.05%,GNB1;GNG2;MAPK1;KCNQ1;TGM2;ATF4;PRKACA;MAPK3
prerank,long-term synaptic potentiation (GO:0060291),0.403708498350058,1.0867617563110976,0.34509803921568627,0.9233754261565414,1.0,3/21,5.02%,SLC8A3;PRKCZ;GRIN2D
prerank,monocarboxylic acid transport (GO:0015718),0.3281798931406663,1.0865545444134972,0.34465195246179964,0.9224458790484906,1.0,5/51,3.04%,SLC16A6;SLC6A13;SLC6A12;SLC16A11;SLC16A12
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4400062580934609,1.0864826232517542,0.3483606557377049,0.9210816615896165,1.0,4/12,11.38%,THRB;BRD8;MED1;CTSH
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3655951526525058,1.0864022803783324,0.34137291280148424,0.9197627007129726,1.0,9/32,16.47%,SYT11;SNCAIP;SNAPIN;RIMS1;LRRK2;DTNBP1;CPLX1;SYN1;CPLX2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.42880098271874056,1.0858569897040202,0.356,0.9183191181989007,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.42880098271874056,1.0858569897040202,0.356,0.9183191181989007,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,nuclear membrane disassembly (GO:0051081),0.4371675125501635,1.0854919802523226,0.3575757575757576,0.9179487350289074,1.0,5/14,16.67%,LPIN1;PLK1;PRKCB;PRKCA;AKAP8L
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3557695866716144,-1.0847354127396498,0.33402922755741127,0.6543994539163094,1.0,12/25,29.59%,CSGALNACT1;EXT1;B3GNT2;HAS1;HAS2;B3GNT3;B3GALT5;B3GNT8;EXT2;B3GALT1;CSGALNACT2;B3GNT6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.280583556335741,-1.0846260634793923,0.2805755395683453,0.6541143070739328,1.0,31/69,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4390857960022978,1.0845081931057765,0.33532934131736525,0.9196296692791915,1.0,5/14,11.92%,ANGEL2;ELAVL4;ELAVL1;MAPK14;BOLL
prerank,response to hydrogen peroxide (GO:0042542),-0.32138685399820766,-1.0843776058628651,0.30176211453744495,0.6541901572979127,1.0,10/45,9.75%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3;STK24;SOD1;CAT;GPX1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3250753304180082,1.0841190143963133,0.33570159857904086,0.9193104618224899,1.0,12/54,14.94%,HSPA1A;SPHK1;CPNE1;CHUK;CLIP3;NLRP2B;IKBKG;PELI3;CFLAR;RNF31;HSPA1B;RBCK1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.46435513413028817,1.0838965221579384,0.3811252268602541,0.9184449107665841,1.0,6/11,20.96%,NECAB1;SOAT1;ABCA2;BACE2;NECAB3;ITM2C
prerank,positive regulation of growth (GO:0045927),-0.29307777396898355,-1.0837078617355995,0.3130841121495327,0.6552912339388722,1.0,16/64,15.63%,RFTN1;TGFB2;INSR;EGFR;H3-3A;RPS6KA3;ADAM10;CDKN2AIP;RPTOR;PABIR1;MFSD2A;USP47;CSNK2A1;NCBP1;KLHL22;DDX49
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.37999910372661083,1.0837047087350615,0.3493282149712092,0.9174850505235533,1.0,6/25,8.07%,GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.2685217023939717,1.083585170422693,0.3033175355450237,0.9163209273066025,1.0,17/182,4.65%,ROBO1;NOTCH2;WNT4;IGF1;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;CPNE1;OPRD1;BMPR1A;PICALM;OPTN;TNRC6A;LRP3;TET1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2753591274460826,1.0834198613700674,0.2949526813880126,0.9153308455152602,1.0,18/132,9.07%,RNF152;IGF1;PRKAA2;GTPBP1;SH3D19;PPARA;FURIN;PLEKHF1;PHKG2;OPTN;ADRA2A;PIK3CB;TRIM5;ABHD5;SUPV3L1;KAT5;LRRK2;ABCD1
prerank,organophosphate catabolic process (GO:0046434),0.464219402383219,1.0831664718681633,0.36062378167641324,0.9145497098688126,1.0,4/11,26.58%,PON1;PLBD2;ABHD12;ANGPTL3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.45445047094289504,1.0829972857291121,0.35826771653543305,0.9104123572640448,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.45445047094289504,1.0829972857291121,0.35826771653543305,0.9104123572640448,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.45445047094289504,1.0829972857291121,0.35826771653543305,0.9104123572640448,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,negative regulation of cytokine production (GO:0001818),-0.24898553154782177,-1.0829071750467267,0.2507042253521127,0.6567310926306651,1.0,51/163,24.19%,LEF1;TMSB4X;ATP2B1;CD200;RPS6KA5;THBS1;GAS6;CD34;IRAK3;FN1;RNF125;NPTN;NLRC5;ANXA1;ADCY7;APOD;TNFRSF21;TRIM25;OTUD7B;CEACAM1;HDAC7;HDAC9;ABCD2;CHID1;KLF4;ISG15;PIBF1;PDCD4;PTPRC;IFIH1;NR1H4;NCKAP1L;TRAF3IP1;PCBP2;SIGIRR;N4BP1;PPP1R11;PTPN6;ZC3H12A;JAK3;CUEDC2;HMGB1;TRIB2;BCL3;ASB1;FCGR2B;DLL1;ZFPM1;CYLD;TAX1BP1;RGCC
prerank,RNA interference (GO:0016246),-0.39693510132442394,-1.0827455362657974,0.3486973947895792,0.6565201679831867,1.0,7/17,23.33%,AGO1;AGO2;DROSHA;CLP1;AGO4;MRPL44;TARBP2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4672911921884035,1.0823247357396841,0.35177865612648224,0.9110580944853401,1.0,2/10,4.13%,OXSR1;STK39
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.35140855745920246,-1.0820223884991573,0.3246753246753247,0.657772293260836,1.0,4/27,7.53%,MARK1;MBOAT1;DISC1;NCS1
prerank,protein localization to cell periphery (GO:1990778),-0.2596788026810397,-1.081763499792587,0.26854219948849106,0.6578737342411727,1.0,23/133,7.96%,SPTBN1;CAV1;RAPGEF2;BSG;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;EFR3B;RAPGEF6;SLMAP;EMP2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4542587904373402,1.0817427401195407,0.3953033268101761,0.9114570867742741,1.0,1/12,0.26%,BMP7
prerank,positive regulation of exosomal secretion (GO:1903543),0.4237190132243449,1.0816279562528992,0.3544857768052516,0.910279723141564,1.0,3/15,7.85%,STAM;SMPD3;SNF8
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2709640079818848,-1.0814882934480778,0.2907268170426065,0.657935776324829,1.0,26/104,14.89%,ST3GAL4;DCN;CSGALNACT1;SLC26A2;ST3GAL6;SLC10A7;B3GNT2;CSPG4;B4GALT4;PAPSS2;GSS;ST3GAL1;LUM;AKR1A1;GGTA1;VCAN;GCLC;SLC35B3;B4GALT5;CHSY3;LIAS;BGN;GCLM;CHST1;ESD;GSTT1
prerank,positive regulation of cellular respiration (GO:1901857),0.4679685111591683,1.0811487264436368,0.37476099426386233,0.9103013257720343,1.0,1/11,0.90%,NUPR1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3861708024209041,-1.081015506089882,0.3741935483870968,0.658617952356926,1.0,4/17,7.77%,PARD3;SPRED2;CALM3;SPRY2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.34972468514690247,1.0809954697023503,0.33516483516483514,0.9092698825420603,1.0,7/34,8.07%,GABRG1;GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.45007101693962415,1.0807573874488603,0.35714285714285715,0.9084756781118992,1.0,5/12,15.92%,BICD1;PCM1;KIF3A;CCDC120;NINL
prerank,carnitine metabolic process (GO:0009437),0.45200754507101076,1.0807544764099724,0.35470941883767537,0.9069502267480223,1.0,5/12,19.14%,BBOX1;CPT1C;CROT;ALDH9A1;CPT2
prerank,negative regulation of JNK cascade (GO:0046329),-0.3448363080138679,-1.0806958583305364,0.3356164383561644,0.6588324749919626,1.0,6/31,11.79%,MECOM;DNAJA1;AIDA;DUSP3;PER1;PDCD4
prerank,AMP metabolic process (GO:0046033),-0.4184585562149423,-1.080644617718702,0.34368530020703936,0.6583660010743194,1.0,6/13,19.90%,XDH;NT5C1A;NT5E;ADSS1;AK4;AMPD2
prerank,regulation of immune response (GO:0050776),-0.25691193476887336,-1.0802506850933733,0.2558746736292428,0.6588170904989877,1.0,28/135,17.43%,FOXP1;CLEC2D;CD200;B2M;TGFB2;CD34;VCAM1;PLSCR1;ITGB1;ICAM1;LYN;ADCY7;CXADR;XIAP;IL15;AHR;NECTIN2;COL1A1;ITGA4;BIRC3;CD40;RSAD2;ICAM2;IFITM1;ULBP1;PVR;N4BP1;DENND1B
prerank,lipid modification (GO:0030258),-0.32514771396898123,-1.0798960630608259,0.367170626349892,0.6591100820068264,1.0,14/37,27.98%,DGKH;MBOAT1;DGKZ;PLPP1;PLPP3;SGPP1;DGKB;PLPP2;LPCAT3;PLA2G7;PLPP6;DGKG;PLPP5;DGKA
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.315525896844055,1.0792144409171727,0.32006920415224915,0.9105366688321092,1.0,7/62,8.53%,ROBO1;NOTCH2;IGF1;PIK3CB;AUTS2;ARRB1;LPAR1
prerank,plasma membrane organization (GO:0007009),0.3097770456954952,1.078857961831928,0.3262786596119929,0.9100847409661056,1.0,10/61,10.09%,COL5A1;SYT11;ANXA6;ANK2;MICALL1;PLSCR2;MYOF;NSF;ABCD1;FA2H
prerank,regulation of chromosome segregation (GO:0051983),-0.40646122127263185,-1.078606612178358,0.37037037037037035,0.661781230241123,1.0,10/16,37.61%,PUM2;SMC5;CSNK2A1;PUM1;MKI67;CDC6;BUB1;SMC6;IHO1;KIF2C
prerank,phagolysosome assembly (GO:0001845),-0.43749844083308076,-1.0783817377086422,0.37398373983739835,0.6617692988437147,1.0,7/12,32.71%,RAB14;ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3944958514696906,1.0783285243348621,0.37570093457943926,0.9104125527069123,1.0,3/22,7.55%,BMP7;CDKN2A;INHA
prerank,protein alkylation (GO:0008213),0.39011216249994923,1.078297958074885,0.35977859778597787,0.9089743819304321,1.0,8/22,21.67%,EEF2KMT;PRMT2;FAM98B;PCMT1;PRMT3;ETF1;SNRPB;VCPKMT
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.30135294032646864,-1.0779024003776583,0.32653061224489793,0.6624394725426699,1.0,15/55,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3
prerank,protein-containing complex disassembly (GO:0032984),-0.30597373926015425,-1.0776337744213864,0.33410672853828305,0.6625403809340082,1.0,11/54,13.72%,CAV1;LRP6;GABARAPL2;CSNK1A1;MAP1LC3B;APC;PPP1CA;AMER1;RPL23;GABARAP;FZD1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43957808870978,1.0771451622244963,0.37065637065637064,0.911311777471075,1.0,3/12,7.53%,COLEC12;PQBP1;IFIT1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.21344084807755095,-1.0770380057843354,0.1330049261083744,0.6634841716932632,1.0,140/834,13.94%,LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MICAL2;RARB;LRP6;ACVR1;NOTCH3;ETS1;ACVRL1;PLAGL1;TCF12;TGFB2;MEOX2;PPARD;ENG;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;NFKBIA;ASXL3;LMO2;RUNX1;STAT3;BMP4;NFATC1;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;GNL3;TFEB;BRD4;SOX17;ARHGEF2;SMAD5;SMAD1;RPS27A;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;NFAT5;HEY2;ZFPM2;GATA2;IGF2;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;NOTCH4;IRF2;KLF4;TAL1;SS18;GTF2F1;RFXAP;EDN1;PER1;TCF20;TMF1;MYOCD;SREBF2;SQSTM1;TWIST1;TEAD1;ATAD2;HHEX;SOX18;FOXF2;FOSL2;BMP2;POU2F1;RARG;LPIN3;CD40;NME2;NCOA6;MAFF;SOX12;VEGFA;KMT2C;KLF2
prerank,alpha-amino acid metabolic process (GO:1901605),0.33279413621442017,1.0767864436941477,0.32849364791288566,0.9110009545758476,1.0,14/45,16.57%,ASPG;RIMKLA;MMUT;ASPA;KMO;SLC25A12;GLS2;GOT1;KYAT3;MTHFD1;MTHFR;GOT2;GLUL;ATP7A
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4710367356749087,1.0767520272164621,0.36616702355460384,0.9095612846283864,1.0,4/11,12.05%,ENPP3;NT5C3A;DCK;THTPA
prerank,COPII-coated vesicle budding (GO:0090114),0.30331397355717793,1.07673077094525,0.3309608540925267,0.9081109871525119,1.0,21/68,17.94%,F5;BET1;SEC23B;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;MIA3;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC31B;SEC22B;TFG;F8
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.461557043879703,-1.0766072985184045,0.35876288659793815,0.6640589745055318,1.0,4/10,21.28%,RHOA;RAP2A;CDC42;MSN
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3087992497224212,-1.0763356057952655,0.3231441048034934,0.6641892492501292,1.0,13/44,20.10%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;TGFB3;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.37609328480840143,1.0760975123664753,0.350844277673546,0.9087405643812049,1.0,6/24,11.96%,ANXA6;ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,leukotriene biosynthetic process (GO:0019370),-0.41229035776583156,-1.0756156577421483,0.3702213279678068,0.6655024690564146,1.0,6/14,30.47%,PLA2G4A;GGTA1;GGT7;GGT1;PLA2G5;ALOX5AP
prerank,microtubule anchoring at centrosome (GO:0034454),0.46237002017372764,1.0755907703804786,0.3835616438356164,0.9088745061165557,1.0,4/10,15.92%,PCM1;KIF3A;CCDC120;NINL
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3573009454082682,-1.0755261222044548,0.34684684684684686,0.6651497671719435,1.0,17/26,38.21%,CDC27;HECW2;ANAPC5;CDC16;FBXO5;LCMT1;DUSP1;CDC23;CDK5RAP2;CUL3;ANAPC11;NSMCE2;CDC6;ESPL1;UBE2C;CENPE;CCNB1
prerank,iron ion homeostasis (GO:0055072),0.31444872729019446,1.075111398476202,0.3469750889679715,0.9089696090528927,1.0,10/58,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;PICALM;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,Notch signaling involved in heart development (GO:0061314),0.449431985048134,1.0750682559672144,0.3674698795180723,0.9076244610190312,1.0,3/11,5.34%,NOTCH2;GALNT11;RBPJ
prerank,sulfur amino acid metabolic process (GO:0000096),0.3715199357549695,1.0748861880447025,0.35543278084714547,0.9067812339322416,1.0,7/24,16.79%,ADI1;MMUT;CDO1;MTHFD1;MTHFR;AHCY;CTH
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.355174250156979,1.07425644090969,0.36231884057971014,0.9074192670107486,1.0,8/31,13.42%,MAGEA2;PLK1;ARRDC3;DCUN1D4;GOLGA2;TOPORS;CDC14B;RAB1A
prerank,regulation of TORC1 signaling (GO:1903432),0.3568605559194151,1.074052262765773,0.3563218390804598,0.9065855181865078,1.0,9/33,18.67%,RNF152;RRAGC;GPR137C;SESN1;PIH1D1;ATM;TELO2;RRAGB;CASTOR2
prerank,neuron projection organization (GO:0106027),-0.4084567111069566,-1.0738093531907595,0.3658008658008658,0.6691096148423736,1.0,3/15,8.27%,INSR;APP;ABCD2
prerank,intracellular pH reduction (GO:0051452),0.3512866755935609,1.0732939833857214,0.33976833976833976,0.9075898544398092,1.0,9/33,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;CLCN3;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3240342991400106,1.0731577981042306,0.3474576271186441,0.9065228751127694,1.0,11/53,16.00%,EYA1;DDX5;EYA4;EYA2;CCAR2;ABRAXAS1;SPRED3;FXR2;MSX1;SIRT1;ATM
prerank,retinol metabolic process (GO:0042572),0.4297662376361028,1.0726203191024295,0.3720472440944882,0.9067523150475297,1.0,2/14,1.22%,ADH7;ADH4
prerank,regulation of axonogenesis (GO:0050770),0.32201105264097607,1.0725191517612511,0.34115523465703973,0.9056169524787588,1.0,11/51,11.82%,ROBO1;PLXNA2;RUFY3;PLXNA1;NTRK2;KIF13B;LRP4;PLXNA3;SIPA1L1;LRRC4C;EPHA4
prerank,embryonic skeletal system development (GO:0048706),0.34756087579244715,1.0724769296451158,0.3424408014571949,0.9042646414040076,1.0,8/35,11.20%,PDGFRA;OSR1;HOXB9;HOXB3;HOXA3;HOXB4;MEGF8;UCMA
prerank,actin filament capping (GO:0051693),-0.38830724716093784,-1.0718892666229258,0.37448559670781895,0.6729680550085511,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,barbed-end actin filament capping (GO:0051016),-0.38830724716093784,-1.0718892666229258,0.37448559670781895,0.6729680550085511,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.29867913908336363,-1.0718382290839736,0.3458823529411765,0.6725317734781344,1.0,10/55,7.91%,CAV1;DAB2IP;TNFSF10;BCL2L1;FAS;CRADD;PAK2;RACK1;RPS3;BCAP31
prerank,negative regulation of MAPK cascade (GO:0043409),-0.274227115143319,-1.0716631172567286,0.3033419023136247,0.6723772764909216,1.0,26/87,18.34%,CAV1;SEMA6A;DAB2IP;FOXO1;BMP4;PTPRJ;IRAK3;SPRED2;PPIA;LYN;PRKCD;SPRY2;PTPN1;APOE;DUSP3;EPHB2;RANBP9;STK38;PEBP1;PTPRC;SPRY1;PAQR3;PTEN;GPER1;DUSP6;UCHL1
prerank,protein localization to nucleus (GO:0034504),0.28705695592167413,1.0716616586801422,0.3089171974522293,0.9055175998602587,1.0,23/102,17.12%,BMP7;APPL2;IPO13;FAM53A;POM121;NUP155;LMNA;PLK1;NUP62CL;HNRNPU;ARL2;TNPO3;TOR1B;TOPORS;NXT1;PML;IPO8;MSX1;TNPO2;BANP;IPO4;MDM2;NUP88
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.31388141647733586,-1.0716239554438658,0.3438914027149321,0.6718817042897648,1.0,15/40,20.04%,HIP1;B2M;INSR;SFRP4;TBC1D5;SGIP1;SERPINE1;VEGFA;CBL;VTN;FMR1;LDLRAP1;C3;GREM1;ARRB2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4189583466984295,-1.0710697900398023,0.375,0.6726576682760311,1.0,5/13,16.11%,SHANK3;APP;EPHB2;SQSTM1;ZDHHC2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2820713590315092,-1.070659907524631,0.31065759637188206,0.6730761467891229,1.0,17/69,17.39%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;PIK3CA;EDN1;PIK3CD;EXOC1;PIK3C3;HTR2A;IRS1;CSF1R;PI4KB;PTEN
prerank,negative regulation of glycolytic process (GO:0045820),0.46982239761876965,1.07039366741027,0.3885350318471338,0.9067351601870977,1.0,2/10,2.89%,NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.46982239761876965,1.07039366741027,0.3885350318471338,0.9067351601870977,1.0,2/10,2.89%,NUPR1;PPARA
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.30747291154453726,-1.0703640336836298,0.3473451327433628,0.6732127492161087,1.0,19/45,30.42%,STAT3;APP;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.2086174205851082,-1.070234330788249,0.11538461538461539,0.6729518935022774,1.0,256/1082,20.67%,MECOM;LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;ZBTB16;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MLLT3;RARB;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PLAGL1;TCF12;MEOX2;PPARD;ENG;FLI1;MAP3K5;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;KMT2E;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;CTCF;NFKBIA;AFAP1L2;ASXL3;LMO2;RUNX1;CDH1;STAT3;BMP4;ICE1;NFATC1;PRDM16;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;NAA16;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;DHX33;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;ARHGEF2;SMAD5;SMAD1;RPS27A;XPC;NFYA;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;TRIM56;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;CD38;NFAT5;ACTA2;CDKN1C;HEY2;SPIN1;ZFPM2;ARID1A;GATA2;VHL;EIF2AK3;IGF2;TRIM16;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;APOE;NOTCH4;RPTOR;IRF2;FGF7;KLF4;TAL1;SS18;GTF2F1;RFXAP;ETS2;EDN1;PER1;TCF20;PITHD1;SERTAD1;TMF1;MYOCD;GTF2H1;NFATC2;SREBF2;SQSTM1;TWIST1;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;FOSL2;BMP2;POU2F1;RARG;NFIL3;LPIN3;CD40;HNRNPAB;NME2;FZD1;NCOA6;MAFF;SOX12;CD86;VEGFA;KMT2C;KLF2;ZNF318;TFCP2;YAF2;NR4A2;AGRN;MRPL12;MT3;E2F5;ATF6B;CRTC3;FOXO4;MAD2L2;NR1H4;ENY2;BRCA2;ID2;RGMA;ATF4;SIX4;NFKB2;SP100;RREB1;DNAJC2;CSRNP2;FOXD2;HEY1;ZBTB48;IER2;ZNF496;ELL;SP7;MED14;HDAC2;GPER1;JUNB;GRIN1;NOD2;NR2F1;IL33;ATF7IP;EPC1;HIVEP1;PCBP1;NKX6-1;GREM1;FOXE1;MAPK3;ZC3H12A;ZMIZ2;NUFIP1;UBTF;IRF5;RYBP;SOX8;PAX3;SSBP4;RIPK1;TGFB1I1;SPI1;SIRT7;SMARCA4;FOXL2;CDCA4;NFATC3;ZMIZ1;HMGB1;LMX1B;CHD8;ATF3;POU3F3;NUP85;MAP2K7;MED13;MAML3
prerank,histone ubiquitination (GO:0016574),0.38772722249093683,1.0700241343482915,0.3821892393320965,0.9064909858459823,1.0,10/21,28.22%,CTR9;LEO1;RNF20;CDC73;PHC1;UBR2;RNF8;UBE2B;UBE2N;UHRF1
prerank,cellular response to BMP stimulus (GO:0071773),0.3066504447508608,1.0700236433627213,0.3378839590443686,0.9050194095702584,1.0,7/66,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,regulation of microtubule polymerization (GO:0031113),0.33552891404858554,1.0696203185300515,0.35648994515539306,0.9048562256958198,1.0,13/40,17.57%,MAP2;CLIP3;EML2;PRUNE1;CLASP1;ARL2;DRG1;TUBB4A;ABL1;MAPRE1;GBA2;NAV3;CDK5R1
prerank,acute-phase response (GO:0006953),-0.43379743393935793,-1.0687174149260443,0.3801980198019802,0.6763302723749917,1.0,5/12,29.29%,PLSCR1;IL6R;SIGIRR;CEBPB;AHSG
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.35004670247259173,-1.0683378372513939,0.3638211382113821,0.676745229262961,1.0,12/24,26.60%,ZBTB16;TRPS1;ACVRL1;MDK;WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2;BMPR1B
prerank,regulation of tissue remodeling (GO:0034103),0.39996126843762747,1.0682960124406349,0.3567251461988304,0.9075633808888891,1.0,2/18,0.87%,LEPR;IL18
prerank,embryonic heart tube development (GO:0035050),-0.4096943071119016,-1.0681858940620403,0.3724696356275304,0.676567368575302,1.0,5/14,12.91%,ACVR1;SOX17;HES1;SOX18;TBX2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.33924575687451203,-1.0681281883186076,0.3658008658008658,0.676132838750055,1.0,9/30,21.23%,CD34;STAT3;PLCG2;ISG15;PIBF1;CD46;NOD2;HMGB1;SYK
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.226899006017368,-1.0680134804370762,0.2469879518072289,0.675878239300523,1.0,58/291,15.58%,PDE3A;ACTB;MEF2C;PID1;RAPGEF2;DAB2IP;SLIT2;RHOA;FOXO1;GUCY1B1;RAP1A;SH3BP4;EGFR;TNFRSF1B;PTPRK;JUN;ESR1;TBX1;DEFA6;CARD16;CAPN2;PRKD1;WNT5A;GNB1;PDE2A;LYN;PRKCD;PXN;GNG2;MAPK1;KCNQ1;TGM2;NRIP1;RPS3;SPAAR;SERPINE1;AHR;INSIG1;RPTOR;NSMF;IPO5;PAF1;PDCD4;FZD4;WNT9A;RET;PTK2B;SLC26A6;RRAGA;IRS1;CD86;P2RY6;ROMO1;MT3;GLRA2;ZFAND1;GIT1;NR1H4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3854353452753812,-1.0667817255689367,0.3567251461988304,0.6785452850052602,1.0,7/17,15.87%,NRP1;ADAMTS1;MDK;S100A11;CCN4;VTN;DOCK4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.42261634161360606,1.0666028552602866,0.4020408163265306,0.9115699120094982,1.0,3/14,5.75%,CTR9;KMT2A;AUTS2
prerank,cellular response to starvation (GO:0009267),0.2694058307775254,1.0665921137801948,0.3068535825545171,0.9101456155772691,1.0,19/147,9.50%,PRKAG2;RNF152;GCGR;PRKAA2;NPRL3;RRAGC;PRKAG3;PPARA;ATP6V0B;NIM1K;ATP6V1H;CPEB4;LRRK2;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.42994060561017455,-1.0665507291781149,0.39227642276422764,0.6785682665317125,1.0,7/12,42.32%,ABCC9;KCNJ8;CACNA1H;ABCC8;P2RX3;KCNJ11;RHAG
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.41190993913363527,1.0660424993708364,0.3716475095785441,0.9106278032843919,1.0,3/16,7.14%,PPARGC1B;DDX5;DDX17
prerank,muscle cell development (GO:0055001),0.35423795047084944,1.0658519463222045,0.36607142857142855,0.9097917633156918,1.0,5/30,6.61%,IGF1;NEBL;ANK2;SGCZ;MYOF
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3894620954471471,1.0652609864907465,0.3757455268389662,0.9088734645540352,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),0.3894620954471471,1.0652609864907465,0.3757455268389662,0.9088734645540352,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.248910779207252,-1.0652433821137226,0.2903225806451613,0.6813232274563242,1.0,35/144,16.87%,YWHAE;GAS6;PIK3R1;PRR5L;CDH1;ICE1;MFF;YWHAB;FLNA;TMEM30A;UBE2D3;SAE1;ABLIM3;PRKCD;SEC16B;ARIH2;YWHAQ;YWHAZ;RIPOR1;SREBF2;IPO5;MICALL2;CEMIP;TPR;UBE2L3;AKT2;FBXW7;UBL5;SAR1A;BBC3;ZFAND1;UBE2J2;KCNB1;ZDHHC2;B3GAT3
prerank,transcription by RNA polymerase II (GO:0006366),0.24881214194742762,1.0650429518582947,0.3092006033182504,0.9081329987215304,1.0,39/305,11.83%,MAF;NOTCH2;RORA;DDX5;NR2E1;PABPN1;SOX5;CTR9;THRB;DTX1;NR6A1;CCN2;PPARA;CPSF3;ESRRA;GLIS3;GTF2I;CCNT2;TCEA1;PCID2;LEO1;RBPJ;WWTR1;INTS4;ZC3H8;CPSF7;MED1;PPARGC1A;TAF10;EAF2;NR1H3;RXRA;RNMT;MBD1;TSC22D1;TAF1;SLBP;MLLT1;CDC73
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4303871062968232,1.064081238837772,0.3733075435203095,0.9097960490987199,1.0,4/13,6.95%,TGFBR3;BMPR1A;RBPJ;FGFR2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3810848606948064,-1.0639905440388973,0.3908523908523909,0.6839406226938067,1.0,7/19,7.99%,SEMA6A;DCN;DAB2IP;JCAD;XDH;SPRY2;CCBE1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.45094716904093535,-1.0639446276113087,0.371868978805395,0.6834780718112052,1.0,4/10,20.34%,ESR1;PSMC4;ATF7IP;HMGB1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3613386739561204,-1.0637892087706056,0.35496957403651114,0.6832847914837502,1.0,10/21,19.19%,PDE4D;PDE9A;XDH;PDE2A;HPRT1;NT5C1A;NT5E;HINT1;NUDT16;MLYCD
prerank,regulation of cellular component movement (GO:0051270),-0.30228584768938827,-1.0636242471283763,0.3333333333333333,0.6831504874222771,1.0,19/49,24.52%,ACTN4;RHOA;ETS1;CD9;EGFR;ACTN1;ARAP1;LYN;HDAC6;VEGFA;MEMO1;SP100;PRAG1;CDK6;ROCK1;NRG2;EGF;RPS19;FES
prerank,response to interferon-gamma (GO:0034341),-0.2826724613207379,-1.0635452535518068,0.3221957040572792,0.6827722667224299,1.0,21/67,25.81%,IFITM3;GBP4;GCH1;GBP5;WNT5A;CCL13;CD74;SYNCRIP;SLC26A6;CD40;SP100;IFITM1;GAPDH;CCL25;KYNU;IFITM2;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,lymphocyte differentiation (GO:0030098),-0.2816450159137252,-1.0633406183701979,0.32860520094562645,0.6827535520766738,1.0,15/68,13.63%,PBX1;KAT7;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;JAG2;RELB;HDAC9;PIK3CD;HHEX;ITGA4;NFIL3;PTPRC
prerank,protein glycosylation (GO:0006486),-0.2546868421220925,-1.0633255737745393,0.3181818181818182,0.682212746800878,1.0,32/125,19.41%,ST3GAL4;GCNT2;ST8SIA4;ST3GAL6;B3GNT2;FUT8;PLOD2;EOGT;MGAT5;SLC39A8;AQP11;ST3GAL1;COG3;PLOD3;ST8SIA6;STT3B;MGAT4A;B4GALT5;GFPT2;PMM1;MGAT4B;GALNT10;ST8SIA2;GALNT6;ALG10B;ST6GALNAC2;KRTCAP2;ST3GAL2;ALG6;TMEM258;POMT2;GALNT9
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.34207675922434044,-1.0630516114528528,0.35368421052631577,0.682365547682605,1.0,4/29,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,signal transduction in response to DNA damage (GO:0042770),0.3252681964216622,1.062891015376429,0.3694158075601375,0.9121971976399954,1.0,19/49,22.83%,DOT1L;E2F1;HINFP;CLOCK;NDRG1;FBXO6;MAPK14;BATF;PRPF19;CHEK2;ABL1;GADD45A;ATM;CLSPN;RAD17;MYO6;CASP9;ATRX;MDM4
prerank,cellular response to leucine (GO:0071233),-0.45522665145801394,-1.0627469672097334,0.4024390243902439,0.6819658995938708,1.0,5/10,20.24%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,response to leucine (GO:0043201),-0.45522665145801394,-1.0627469672097334,0.4024390243902439,0.6819658995938708,1.0,5/10,20.24%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,regulation of protein sumoylation (GO:0033233),0.3990667019088249,1.0623281003698342,0.3784860557768924,0.912533341232661,1.0,5/17,13.52%,MAGEA2;CAPN3;GNL3L;PIAS4;HDAC4
prerank,mammary gland epithelium development (GO:0061180),0.42280527665310896,1.062268539019843,0.38703339882121807,0.9112797749688701,1.0,1/14,0.43%,WNT4
prerank,apoptotic process (GO:0006915),-0.23627404862429263,-1.061757700707683,0.28205128205128205,0.6839213760482699,1.0,69/203,25.20%,HIP1;SEMA6A;MAGI3;ZBTB16;FAP;PLAGL1;PPARD;FOXO1;APAF1;STK3;BCL2L1;NFKBIA;PLSCR1;TGFBR2;APP;TBX1;FAS;CIT;PPIA;PRKCD;DAP;IAPP;TNFRSF21;CASP7;FEM1B;EFNA5;PIK3CA;RFK;CDK5;IER3;AHR;IFT57;PDCD4;PTK2B;TNFRSF19;ERCC2;ADAM15;BBC3;BAK1;DDIT4;RTN4;ING4;DIABLO;FXR1;ATCAY;GAPDH;LIG4;PAX3;RIPK1;RHOB;MYD88;PPP2CA;CHEK1;CASP4;PAEP;BIK;CASP1;CDK11B;EGLN3;TRAIP;BOK;DAPK1;PLK3;MRPS30;CXCR4;CASP8;BNIP2;JADE1;PRKCE
prerank,B cell homeostasis (GO:0001782),-0.44464958237373864,-1.0616764093374633,0.39096267190569745,0.683564166597524,1.0,3/10,6.40%,MEF2C;DOCK10;LYN
prerank,inorganic anion transmembrane transport (GO:0098661),-0.28400720739452634,-1.0613462001807177,0.3349397590361446,0.6838488074384441,1.0,17/63,16.14%,SLC12A7;SLC12A2;ANO1;SLC26A2;SLC5A6;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC37A3;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,cardiac muscle cell development (GO:0055013),-0.37166809290717673,-1.0612589028527826,0.38085106382978723,0.6835084181332022,1.0,5/20,8.50%,SORBS2;PDLIM5;MYH11;CXADR;HEY2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.34390487867345115,1.0612498125901115,0.35714285714285715,0.9131131543325539,1.0,6/37,9.82%,ALCAM;IL1RAPL1;TENM1;GRID2;PTPRD;ADGRL1
prerank,renal system development (GO:0072001),-0.2899800561389637,-1.0611508003291734,0.3340961098398169,0.683214869589426,1.0,10/52,7.63%,PCSK5;TGFB2;PKD1;BMP4;TBX18;SIX1;ITGA8;SOX17;AGTR1;STRA6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3723641469707324,-1.060762793764891,0.3887640449438202,0.6836775294418365,1.0,9/20,28.90%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3;STOX1
prerank,regulation of chemokine production (GO:0032642),-0.32576997526540574,-1.0606912017442744,0.37155963302752293,0.6833091499476922,1.0,14/36,27.07%,FOXP1;APP;WNT5A;IL6R;CD74;CSF1R;SIGIRR;IL33;ACKR1;TLR4;AIF1;SNAI2;HMOX1;TREM2
prerank,nucleoside salvage (GO:0043174),0.4559421671114311,1.0606546538911459,0.39603960396039606,0.9135549150367123,1.0,3/10,11.30%,UCKL1;DCK;UPP2
prerank,chromosome condensation (GO:0030261),0.34471874087834947,1.060500917760612,0.36594202898550726,0.912575091547236,1.0,10/36,16.67%,KMT5A;NCAPD2;AIFM1;PHF8;PLK1;TENT4A;CSNK2A2;ACIN1;CHMP1A;AKAP8L
prerank,regulation of protein acetylation (GO:1901983),0.44481516275676103,1.0604876514379342,0.40041928721174,0.9111784581072362,1.0,5/12,15.49%,MAGEA2;CAMK1;KAT5;RAPGEF3;SIRT1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2980315077408433,-1.0602544030057104,0.34615384615384615,0.6838686048420226,1.0,19/55,24.12%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;RPS3;IGF2;IL15;PTPRC;CD24;CD86;NCKAP1L;CD46;JAK3;HMGB1;SYK;CD276;CCR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.38241228736471844,1.0601872323644999,0.3686274509803922,0.910668464488125,1.0,5/21,13.20%,SLC8A3;ANXA6;AFG3L2;SLC25A23;MICU1
prerank,cytosolic calcium ion transport (GO:0060401),-0.3467115884858851,-1.0601727403677226,0.3760504201680672,0.6834899640807554,1.0,10/28,14.31%,ATP2B1;MICU3;CACNA2D1;SLC35G1;ATP2A3;MCUB;JPH2;MICU2;ITPR3;SMDT1
prerank,regulation of response to external stimulus (GO:0032101),-0.2552091129687088,-1.0599441826275589,0.30077120822622105,0.6835158611838003,1.0,43/121,25.72%,FOXP1;CAV1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;ADGRA2;WNT5A;AGTR1;ANXA1;PSMA6;STK24;CD55;SPAAR;XIAP;SPATA2;EPHB2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;GUCA1B;CCR2;CXCR4;AREL1;CASP8;LRP8;F2R
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.43140568146013103,-1.0597034596775523,0.40038684719535783,0.6835866732308888,1.0,6/11,30.20%,LANCL1;STK26;FYN;UBQLN1;PARK7;MMP3
prerank,negative regulation of TORC1 signaling (GO:1904262),0.4321437420203788,1.0596376546380928,0.37573385518590996,0.9110979462212566,1.0,4/13,18.67%,RNF152;SESN1;ATM;CASTOR2
prerank,RNA polyadenylation (GO:0043631),-0.3459837587482928,-1.059356928695954,0.38412017167381973,0.683319718720683,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,mRNA polyadenylation (GO:0006378),-0.3459837587482928,-1.059356928695954,0.38412017167381973,0.683319718720683,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,O-glycan processing (GO:0016266),0.31686443478833426,1.0591165128507694,0.3771626297577855,0.9113358911908093,1.0,6/54,4.00%,GXYLT2;CHST4;MUC19;ST3GAL3;GALNT11;GALNT14
prerank,chemical homeostasis (GO:0048878),0.30902895969479405,1.059010208478379,0.3518850987432675,0.9102547609718707,1.0,17/61,17.29%,WNK3;RBP1;FITM2;SLC4A9;ABHD5;PNPLA8;CEBPA;WNK4;ADCK1;CLN8;NR1H3;USF1;SLC4A3;SLC66A1;ABCB4;TM6SF2;TLCD3A
prerank,anterior/posterior pattern specification (GO:0009952),-0.29378518064370346,-1.0589711168078952,0.3578199052132701,0.6837172457860562,1.0,12/53,12.38%,BMPR2;PCSK5;LRP5;TBX1;BHLHE40;HES1;HEYL;HEY2;ATP6AP2;HOXA6;HHEX;BMP2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4434871074124403,1.0589641672454169,0.39139344262295084,0.908976561662348,1.0,2/11,3.93%,STX18;ATL1
prerank,response to thyroid hormone (GO:0097066),0.4209916455969479,1.0589636609416289,0.39243027888446214,0.9075540631307949,1.0,4/13,11.38%,THRB;BRD8;MED1;CTSH
prerank,negative regulation of mitochondrion organization (GO:0010823),0.35353174657066694,1.0589313011172505,0.38271604938271603,0.906249167663005,1.0,11/33,18.35%,IGF1;HSPA1A;SLC25A5;PPIF;FZD9;ADCK1;CLU;TMEM14A;HGF;NOL3;AKT1
prerank,lipid droplet organization (GO:0034389),0.3807197505153348,1.0585908218760889,0.38181818181818183,0.9059098859527087,1.0,5/22,14.04%,FITM2;RAB3GAP1;PLA2G4C;CDS1;SQLE
prerank,regulation of protein kinase B signaling (GO:0051896),-0.2418462613527177,-1.0585111098703983,0.29914529914529914,0.6843029353777513,1.0,30/193,9.88%,HIP1;KITLG;TEK;NTRK3;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;XDH;RACK1;MET;IAPP;MYOC;SPRY2;PPP2R5C;PIK3CA;SRC;IGF2;FGF2;FGF7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3334054413686111,1.058203836116613,0.37122557726465366,0.9056724658768682,1.0,6/43,4.47%,ERRFI1;SNX6;CHMP6;GPRC5A;STAM;RNF126
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.24285266370490488,1.0575620154132217,0.2904624277456647,0.9063512009791413,1.0,39/348,9.01%,ROBO1;BMP7;AFDN;FGF1;BMP6;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;OVOL2;MAGI2;ANK2;PIK3R3;CDH3;FGF9;TNRC6A;PIK3CB;LRP3;PAX6;RBPJ;PDCD5;E2F1;WNT6;CITED1;ATAD1;ARRB1;NTRK2;FAM98B;SNF8;PPHLN1;RIMS1;MED1;PPARGC1A;HINFP;NSF
prerank,response to interferon-alpha (GO:0035455),-0.38083725369307597,-1.0575392888760282,0.3738738738738739,0.6862467223237744,1.0,6/16,21.58%,GAS6;IFITM3;TPR;IFITM1;IFNAR1;IFITM2
prerank,amino acid import (GO:0043090),0.38110703868078355,1.0574228691106566,0.3771760154738878,0.9053529678072899,1.0,2/21,0.21%,SLC6A13;SLC6A1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3759606645705684,-1.057375156366742,0.4012096774193548,0.6860635325818966,1.0,6/20,12.86%,PLOD2;PLSCR1;GATM;GSS;GCLC;GCLM
prerank,camera-type eye morphogenesis (GO:0048593),-0.44764680513506794,-1.0571194552344678,0.39921722113502933,0.6860807118972885,1.0,5/10,22.99%,LRP6;TBX2;VEGFA;SKI;KDM2B
prerank,positive regulation of protein depolymerization (GO:1901881),-0.42976961665789004,-1.0563969714211665,0.378099173553719,0.6874322611598835,1.0,4/11,16.30%,WDR1;TRPV4;KATNB1;SEMA5A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.37146210017353665,-1.0562093040358174,0.38762886597938145,0.6872570377835545,1.0,8/20,18.68%,AGO1;ZC3H7A;PUM2;AGO2;DROSHA;PUM1;AGO4;MRPL44
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3463035051451429,-1.055748490983453,0.3782051282051282,0.687794365048951,1.0,9/26,13.98%,ITSN2;AP2B1;FCHO2;SGIP1;LMBRD1;CLTB;GPR107;FNBP1L;AP2A1
prerank,regulation of membrane depolarization (GO:0003254),-0.3799263254215054,-1.05561326371641,0.38125,0.6875459506031903,1.0,3/18,5.60%,NEDD4L;FHL1;CAMK2D
prerank,regulation of dendrite extension (GO:1903859),-0.38746229250497305,-1.0554611623361756,0.38413361169102295,0.6873636534147222,1.0,6/18,17.70%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,regulation of cell communication (GO:0010646),-0.32870955507299005,-1.055426169177978,0.3668763102725367,0.6868777768505501,1.0,10/35,12.26%,SOCS2;TBX18;MGLL;CAMK2D;ANXA1;CXADR;PTPN1;GRK5;UGCG;CDC42SE2
prerank,proteolysis (GO:0006508),0.24882110437789662,1.0550691041745588,0.322884012539185,0.9115175075947751,1.0,48/252,17.78%,AEBP1;METAP2;ADAMTS13;PCSK4;CTSA;SUFU;CPQ;CPNE1;CPN1;PGPEP1;FURIN;PITRM1;CAPN3;AFG3L2;DPP8;CASP3;PLAT;HTRA2;SPRTN;NAPSA;PLG;CTRL;LONP2;ATG4D;ADGRV1;CPA2;FBXO6;CTSH;ENDOU;NEDD8;APH1A;DESI2;DESI1;ATG4C;CNDP2;VASH1;ADAMTS9;TRHDE;GGT5;HGF;BACE2;PAPPA2;MDM2;CAPN7;SRGN;ADAMTS7;TRABD2B;ST14
prerank,regulation of cell projection organization (GO:0031344),-0.41826015374987274,-1.0548606282079838,0.38509316770186336,0.6878294002976364,1.0,3/13,12.19%,MACF1;SPRY2;MFSD2A
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.33527387943230524,-1.054756050418436,0.3524590163934426,0.6869311194018184,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.33527387943230524,-1.054756050418436,0.3524590163934426,0.6869311194018184,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,engulfment of apoptotic cell (GO:0043652),-0.3946658031491186,-1.0547007849978578,0.3657505285412262,0.6864968188979333,1.0,2/15,2.26%,RHOBTB1;THBS1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3612211458789999,-1.0546514843334047,0.3603238866396761,0.6860569138582635,1.0,4/22,7.99%,DAB2IP;MFHAS1;LYN;IFI35
prerank,cellular response to interferon-gamma (GO:0071346),-0.2664015199985362,-1.0546348017515808,0.32790697674418606,0.6855197592487832,1.0,29/88,25.81%,B2M;VCAM1;CD44;MID1;GBP4;ICAM1;IRF9;CAMK2D;GBP5;WNT5A;PRKCD;TRIM25;CCL13;IRF2;JAK1;SYNCRIP;SLC26A6;SP100;GAPDH;CCL25;MT2A;IRF5;HCK;FCGR1A;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,positive regulation of endocytosis (GO:0045807),-0.3023137996326145,-1.0545620693602895,0.3755656108597285,0.6851298183399552,1.0,15/45,18.38%,HIP1;NEDD4L;B2M;ANKFY1;RAB31;SGIP1;SERPINE1;APOE;LRP1;CBL;VTN;NCKAP1L;LDLRAP1;CD151;C3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.33675528734034704,-1.054292902510537,0.3982102908277405,0.6852401312495929,1.0,11/29,24.36%,LEF1;TLE4;AXIN2;TLE3;RUVBL1;SMARCA4;BCL9;TRRAP;BCL9L;ASH2L;TCF7
prerank,regulation of tube diameter (GO:0035296),-0.41447421910274135,-1.0542624142377066,0.41115702479338845,0.6841843824556869,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.41447421910274135,-1.0542624142377066,0.41115702479338845,0.6841843824556869,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,positive regulation of dendrite extension (GO:1903861),-0.3931993720761249,-1.0538074132710573,0.399581589958159,0.6848051122050777,1.0,6/17,17.70%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,positive regulation of cell division (GO:0051781),0.3364556967251824,1.053394583180175,0.3817504655493482,0.9153433063908186,1.0,5/38,8.73%,FGF1;TAS1R2;PKP4;FGFR2;DRD3
prerank,positive regulation of response to external stimulus (GO:0032103),-0.25019577306634494,-1.0528223404992954,0.3148148148148148,0.6867939316531286,1.0,19/128,9.58%,PTN;ETS1;THBS1;NFKBIA;POLR3F;ABCC1;PLSCR1;SCARF1;APP;STX3;GBP5;WNT5A;AGTR1;PDE2A;PUM2;MDK;IFI35;SERPINE1;IL15
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.41652858964412276,-1.0526852251598566,0.374,0.6865619898458452,1.0,6/13,8.59%,ABHD2;BMP4;ESR1;NR3C2;AR;PLPP1
prerank,glycine transport (GO:0015816),0.4510288223652119,1.0526063537453059,0.38235294117647056,0.9164422965526988,1.0,1/10,2.09%,SLC6A9
prerank,regulation of dephosphorylation (GO:0035303),0.4121150501716076,1.0519346940227823,0.3937621832358674,0.9171550547655973,1.0,5/15,15.53%,PPP1R16A;MTMR4;SMG5;MTMR2;SMG6
prerank,keratan sulfate metabolic process (GO:0042339),-0.3316063993151367,-1.051439625983963,0.3518930957683742,0.6891782227791993,1.0,9/31,10.33%,ST3GAL4;ST3GAL6;B3GNT2;GNS;B4GALT4;ST3GAL1;LUM;B4GALT5;HEXA
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3892586291229616,-1.0513385982705168,0.39957716701902746,0.6883280889845362,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,stress fiber assembly (GO:0043149),-0.3892586291229616,-1.0513385982705168,0.39957716701902746,0.6883280889845362,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,GTP metabolic process (GO:0046039),0.4142937834112905,1.051101197423695,0.392578125,0.918436617440637,1.0,5/15,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,positive regulation of actin nucleation (GO:0051127),-0.4321570017231166,-1.051068965736886,0.40080160320641284,0.6885163854838101,1.0,3/11,10.16%,GSN;WASF2;WHAMM
prerank,DNA integrity checkpoint signaling (GO:0031570),0.34000830483840405,1.0508357933353067,0.3738489871086556,0.9178794143929211,1.0,10/36,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.41423271701793146,-1.0497403435423691,0.44129554655870445,0.6913644170724498,1.0,5/13,18.64%,PTGIS;PTGS2;NNMT;NUDT12;NAXE
prerank,regulation of mitotic spindle assembly (GO:1901673),0.39660935134219527,1.0496299922678012,0.4053030303030303,0.9203121725771793,1.0,7/19,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,regulation of epidermal cell differentiation (GO:0045604),0.382222067566922,1.0494533170031695,0.4027504911591356,0.9194229401296055,1.0,3/21,4.58%,ERRFI1;ROCK2;MAFG
prerank,synaptic vesicle recycling (GO:0036465),0.34991586597052754,1.0490347523590522,0.389413988657845,0.9193481614104339,1.0,7/31,11.76%,CEL;NLGN2;WNT7A;SYT1;NLGN3;SYNJ2;CANX
prerank,aorta development (GO:0035904),0.41878602246967517,1.0490344126948825,0.3930530164533821,0.9179436083131465,1.0,1/14,0.08%,ROBO1
prerank,cellular response to ATP (GO:0071318),0.41396545460258266,1.0486745070395982,0.3972602739726027,0.9177113481016999,1.0,2/14,11.18%,TRPV1;TAF1
prerank,positive regulation of cellular component organization (GO:0051130),-0.2566347943115758,-1.0485596255364145,0.3333333333333333,0.6938179489205624,1.0,18/107,9.95%,ATP10A;SHANK3;DAB2IP;NEDD4L;TGFB2;INSR;RUNX1;ICE1;FNIP2;TMEM30A;TFRC;RACK1;AR;RPS3;TGFB3;APOE;GPX1;TAL1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3452452957951852,1.0485563378459835,0.40545454545454546,0.916684696875468,1.0,5/34,6.49%,RORA;SMAD3;LRP3;WWTR1;E2F1
prerank,mitochondrion morphogenesis (GO:0070584),-0.42998775833586944,-1.048357048066802,0.4168336673346693,0.6938034003962447,1.0,3/11,8.00%,PID1;MFF;NUBPL
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.262561559160673,-1.0483373332953774,0.36496350364963503,0.6932893937033456,1.0,21/98,15.35%,SPTBN1;PRKCH;YWHAE;PIK3R1;EGFR;MFF;YWHAB;NKD2;ITGB1;STX3;ZDHHC8;YWHAQ;YWHAZ;STAC;EPHB2;SQSTM1;CEMIP;AKT2;LRP1;BBC3;KCNB1
prerank,keratan sulfate catabolic process (GO:0042340),0.4577698147245116,1.0481614147844303,0.4036885245901639,0.9165652896253693,1.0,3/11,6.66%,OGN;OMD;GALNS
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.34280742117261326,-1.0481515935426013,0.3874458874458874,0.6931942029692136,1.0,7/25,13.94%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.42853653713951145,1.0479082758485283,0.40551181102362205,0.9160059962955132,1.0,4/13,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,cellular response to heat (GO:0034605),0.33795010559024985,1.0478617890377335,0.3790035587188612,0.9147516177745862,1.0,3/35,1.13%,FGF1;HSPA1A;TRPV1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.44239459210091114,-1.047852711651399,0.40816326530612246,0.693380705476512,1.0,7/11,15.93%,RAPGEF2;TJP1;F11R;TJP2;RAPGEF6;RAB1B;RAP2B
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4532235038295669,1.047379475122289,0.412573673870334,0.914934517890683,1.0,5/10,19.13%,EMC2;EMC4;MMGT1;EMC10;EMC1
prerank,positive regulation of DNA recombination (GO:0045911),-0.34317931243159117,-1.0472719970377427,0.3696581196581197,0.6942997540019583,1.0,7/27,15.55%,TFRC;SHLD1;FUS;ERCC2;FANCB;TIMELESS;MAD2L2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4024334668635438,1.0466055039490985,0.40076335877862596,0.9160131809690576,1.0,8/16,21.77%,BMP7;METRNL;HNRNPU;TFE3;SIRT1;FNDC5;PIM1;NAPEPLD
prerank,regulation of cellular component size (GO:0032535),-0.33917733153300694,-1.0464253820843366,0.3707627118644068,0.6958406472820203,1.0,12/30,27.40%,EPS8;RAB22A;VAV2;PPP1CA;RPTOR;RARG;PTEN;MSN;RAB3B;AP2M1;VAV3;NEB
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2474972197394414,-1.0463569908564518,0.3333333333333333,0.6954649086684426,1.0,47/122,29.48%,NIBAN1;BCAR3;TGFB2;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;KDR;RPL5;EIF3E;EEF2;NLRC5;AR;IGF2;FGF2;KLF4;NMD3;AKT2;IRS1;FMR1;BRPF3;PRR16;FXR1;NOD2;IL33;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;EGF;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;METTL14;RPS4X;SLC25A37;NSUN5;PCIF1;TMEM106A;GLI1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.28107874707092106,1.0462742935596046,0.37623762376237624,0.9156664213059769,1.0,32/102,21.43%,CPEB2;ADCY5;GCGR;GCK;CYP11B1;ADCY1;CRHR1;INSIG2;LPIN1;SLC30A10;ADCY8;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;PRKDC;GOT1;RELA;AKT1;ADCY6;NFKB1;INHBB;RAB15;INPP5K;MYO5A;PRKAR1A;DENND4C;CAPN10;NR4A3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3115374664464655,-1.0460024618750987,0.38913043478260867,0.6958125561008585,1.0,14/37,23.57%,RPL5;EIF3H;RPS7;UBXN1;USP7;RPL23;BAG5;CSNK2A1;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.33756792091303744,-1.0455774258626713,0.3877995642701525,0.6963169026332549,1.0,10/28,23.39%,ESAM;WDR1;CXCL12;ARHGAP35;PLEKHG2;PFN1;LATS1;FCHSD1;RASA1;HCLS1
prerank,lipoprotein catabolic process (GO:0042159),-0.43654395322497175,-1.045553374075767,0.39156626506024095,0.6958052325561388,1.0,5/11,28.35%,CTSD;APOE;ABHD17C;ABHD17B;LYPLAL1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.35676370319454886,-1.0455106933292948,0.4149377593360996,0.6953656701354218,1.0,10/24,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36628986622019427,1.044521470660156,0.4015748031496063,0.9198131733507253,1.0,10/25,21.98%,CCAR2;CCNT2;EAF2;LDB1;ALYREF;DDX39B;THOC1;SUPT4H1;HTATSF1;WDR43
prerank,myeloid cell differentiation (GO:0030099),-0.302759865630099,-1.0441117441927363,0.3795454545454545,0.6984752537724146,1.0,9/47,9.95%,SNRK;ZBTB16;KMT2E;RUNX1;MFHAS1;KAT6A;LYN;PRKX;TAL1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2589452349230325,1.0440739543066644,0.3675344563552833,0.9199304943862766,1.0,31/170,15.44%,PRDM6;IGF1;ROCK2;NOVA1;TRIM5;PEG3;ZNF462;CIAO3;KIF16B;MTMR4;AFF3;KDM6B;CRNN;HINFP;CACTIN;ZNF711;NKAP;RSPO1;PRDM2;MEGF8;HRG;FUBP1;ATRAID;MTMR2;AFF2;ZFP64;ZNF507;TSKU;PCBP4;TAPBP;TBC1D16
prerank,spliceosomal complex assembly (GO:0000245),0.3214713096324891,1.0440500112270845,0.3850267379679144,0.9186305558631177,1.0,18/46,23.03%,CELF2;SRSF5;SRSF10;YTHDC1;PRPF19;USP39;RBM5;PRPF6;NOL3;DDX39B;SRSF6;CELF6;PUF60;SF3B1;GCFC2;LUC7L;SRPK1;CELF1
prerank,cellular macromolecule catabolic process (GO:0044265),0.31303543395365446,1.0433703920261976,0.37924865831842575,0.9193982709685394,1.0,11/49,15.07%,MAGEA2;RNASEH2A;SIAH2;SUPV3L1;HTRA2;FBXO6;CHEK2;FBXO17;RNF5;SND1;ADAMTS9
prerank,negative regulation of neuron death (GO:1901215),-0.25960287093276785,-1.0433010233145474,0.37037037037037035,0.7000813291392487,1.0,23/93,16.19%,MEF2C;CD200;NDNF;CD34;NGF;SIX1;TNFRSF1B;CHMP4B;CHMP4A;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;NENF;ATF4;SIX4
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4565799617815533,1.0431198101398391,0.4279918864097363,0.9187856782461556,1.0,3/10,8.73%,CRHR1;GNB5;DRD3
prerank,synaptic vesicle cycle (GO:0099504),0.3501474537201009,1.0427758469510953,0.3795066413662239,0.918504776870805,1.0,10/30,22.60%,WNT7A;SNAPIN;RIMS1;SNAP25;SYT10;CPLX1;CPLX2;SYNDIG1;SLC32A1;SYT7
prerank,post-translational protein modification (GO:0043687),-0.22248702334039394,-1.0425630529393104,0.30194805194805197,0.7013931795408794,1.0,91/332,22.21%,FBXL7;ZBTB16;LTBP1;PTP4A2;DCUN1D3;GAS6;SOCS2;BMP4;APP;FN1;BTBD1;DCAF6;LMO7;FBN1;PDIA6;MSLN;COP1;CST3;ADAM10;DCAF10;FBXW8;KLHL2;PSMA6;PSMB7;CCN1;FBXO31;FEM1B;FBXO30;LAMB2;KTN1;MFGE8;STT3B;MGAT4A;VCAN;VHL;FBXO4;CAND1;SOCS5;APOE;PSMB6;FBXO32;UBE2F;PSMB5;RAB3A;PNPLA2;DCAF13;DCAF5;FBXW2;FBXO44;EVA1A;FBXW7;FBXL18;TNC;RAB11B;CDH2;PSMB8;RAB1B;RHBDD1;GOLM1;PSMC4;ICMT;KLHL22;KBTBD7;PSMD11;KLHL3;ASB13;GPS1;ATG5;CISH;CHRDL1;SOCS3;IGFBP4;PSMB4;PSMD14;KCTD6;CCNF;C3;FBXL4;RAB11A;CKAP4;MATN3;FBXW5;PSMD10;COPS6;CALU;KLHL11;PSME1;KLHL25;CHM;ASB1;CCDC22
prerank,activation of protein kinase activity (GO:0032147),0.27998724191924496,1.0420612378353646,0.3766891891891892,0.9194719229653926,1.0,13/106,7.86%,FGF1;OSBPL8;ADCY5;IGF1;IL18;RICTOR;ADCY1;ADRA2A;ADCY8;STRADB;PDPK1;NRG1;PRLR
prerank,leukotriene metabolic process (GO:0006691),-0.37076812851470303,-1.0419748099251227,0.39300411522633744,0.702411521434202,1.0,4/19,14.97%,PLA2G4A;ABCC1;MAPKAPK2;ABCC10
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3806082970268181,1.0415453432081554,0.3898916967509025,0.9196760954095943,1.0,4/20,4.37%,ACTN2;OSR1;STK39;ADRA2A
prerank,epithelial cell differentiation (GO:0030855),0.2841057220810379,1.041526296623789,0.386986301369863,0.9183628997222867,1.0,12/88,11.20%,MAF;DAB2;OVOL2;HNRNPH3;PGK1;CITED1;FGFR2;KDM6B;E2F8;FZD7;E2F4;PIH1D1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3430185678687308,-1.0414133862427075,0.3839479392624729,0.703282125847693,1.0,8/25,10.59%,CAV1;TBX18;NOS1AP;CAMK2D;CALM3;CXADR;CTNNA3;FGF13
prerank,aromatic amino acid family catabolic process (GO:0009074),0.41720713878586985,1.0413325420494257,0.3897338403041825,0.9176302927120467,1.0,5/15,19.53%,IDO1;HAAO;KMO;GSTZ1;KYAT1
prerank,protein localization to mitochondrion (GO:0070585),0.44048698401958525,1.0411745112011788,0.40899795501022496,0.916799122351112,1.0,6/11,20.60%,COX18;LRRK2;HK1;MTCH2;AKT1;MAIP1
prerank,neuron projection fasciculation (GO:0106030),-0.44226250185014443,-1.0411298363491897,0.41330645161290325,0.7034235386886255,1.0,4/10,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,myoblast fusion (GO:0007520),0.43113788605588055,1.040823340263031,0.4091816367265469,0.9165556752281557,1.0,3/12,5.03%,ADAM12;ADAMTS15;ADGRB3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2918368267299904,-1.040224776111617,0.3681710213776722,0.7051587914720902,1.0,13/54,11.60%,CAV1;DCUN1D3;RPL5;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;SQSTM1;ISG15
prerank,regulation of protein processing (GO:0070613),-0.3629394918232351,-1.0400204182383292,0.4309623430962343,0.7051609362627992,1.0,4/21,7.99%,RUNX1;NKD2;TMEM59;CCBE1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.334987250272188,-1.0399257040863403,0.3824175824175824,0.7048410876541087,1.0,13/26,30.39%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2;ASS1;DDAH2;TLR4;TMEM106A;CD36;TLR6
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3454766051845727,1.0398043397935395,0.37573385518590996,0.9183526068328853,1.0,9/30,20.27%,ACAT2;INSIG2;DHCR24;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,positive regulation of exocytosis (GO:0045921),0.335222749083389,1.0397071124285817,0.4166666666666667,0.9172835803276129,1.0,7/35,13.80%,UNC13D;STAM;CLASP1;SMPD3;SNF8;RAB2B;CADPS2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3826414588694235,-1.0396195022129342,0.40756302521008403,0.705070950654705,1.0,4/16,8.21%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,regulation of centrosome duplication (GO:0010824),-0.33012627033885855,-1.0394423852886285,0.3961456102783726,0.704990234129375,1.0,11/29,24.56%,CHMP2B;PLK2;CHMP4B;CEP76;STIL;CEP295;CCNF;CHMP1B;FBXW5;CEP131;XRCC3
prerank,DNA geometric change (GO:0032392),0.36542573056738453,1.0391919951092077,0.39738805970149255,0.91753667070162,1.0,5/24,11.77%,RECQL4;HNRNPA2B1;SUPV3L1;MRE11;RTEL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.32543802578320863,1.0386963134108662,0.4232142857142857,0.9176935622752614,1.0,8/41,11.96%,SLC8A3;TRPV1;ITPR1;GRIN2D;ITPR2;RYR2;TRPM2;CHERP
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.27641166684376417,-1.0386429900391194,0.3735763097949886,0.7065013809046883,1.0,30/68,30.12%,PAPOLA;GTF2H5;CPSF4;WDR33;GTF2H1;NCBP2;ERCC2;CLP1;POLR1F;POLR1G;SNRPE;CAVIN1;NCBP1;CSTF1;SMN1;POLR1A;UBTF;MED18;CCNH;POLR1H;POLR2F;SSU72;POLR1E;POLR2H;PCF11;SCAF8;SETX;POLR1C;CSTF3;POLR2E
prerank,negative regulation of cell growth (GO:0030308),-0.24955005125893215,-1.0386012708476842,0.37464788732394366,0.7060404277238662,1.0,23/121,14.78%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;CDKN2AIP;FGF13;NME6;SEMA3G;SIPA1;RERG;ENPP1;ADAM15;MT3
prerank,central nervous system neuron differentiation (GO:0021953),0.33671355800439795,1.0385360085952713,0.3915343915343915,0.91685035412974,1.0,11/33,20.12%,MAP2;GRID2;NTRK2;MDGA2;GBA2;CHD5;ATP7A;FAIM2;SIN3A;SPOCK1;KNDC1
prerank,glucose metabolic process (GO:0006006),0.30413392798845945,1.038295853510182,0.3885017421602787,0.9162305597993258,1.0,21/58,21.46%,SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;BRAT1;G6PC3;HECTD4;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;OMA1;SLC25A13
prerank,regulation of coagulation (GO:0050818),-0.43062540096484825,-1.0375719269564019,0.41603053435114506,0.7081896828758355,1.0,2/11,10.32%,CAV1;EPHB2
prerank,protein localization to plasma membrane (GO:0072659),0.26840988957301304,1.0374160328122595,0.3685950413223141,0.9176320099094897,1.0,16/129,6.93%,AFDN;ROCK2;ANK1;KCNIP3;ACTN2;ATP1B3;TSPAN5;FYB1;ANK2;CACNB3;WNK3;PLEKHF1;DLG1;FYB2;RAB3C;FLOT2
prerank,regulation of protein catabolic process (GO:0042176),-0.2591333242524609,-1.0373778507047253,0.33668341708542715,0.7081434549098146,1.0,30/99,23.30%,DAB2IP;NEDD4L;WWP1;FOXO1;EGFR;SMURF1;EEF1A1;HECW2;IRAK3;FLNA;WNT5A;PLK2;APC;PRKCG;HGS;GFAP;CSNK2A1;FZR1;MAD2L2;ZDHHC2;BARD1;HACE1;NEDD4;AGAP2;FAF1;AZIN1;CDKN1B;ODC1;STX5;OAZ1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4433109987980894,-1.0367073754774607,0.41851106639839036,0.7093198921295217,1.0,8/10,47.65%,MALT1;ZC3H12A;SMAD7;NFKBID;RC3H2;IL4;FOXP3;TBX21
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.38103580756901645,-1.0363348127579628,0.42323651452282157,0.7097404857295883,1.0,7/18,22.15%,PLCG2;DOCK2;IFI35;DYSF;SYK;NMI;SBNO2
prerank,cellular iron ion homeostasis (GO:0006879),0.3060719755017882,1.035812060682089,0.39497307001795334,0.9214163455218178,1.0,9/55,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,negative regulation of blood coagulation (GO:0030195),0.32758700117267214,1.035495234188165,0.38847583643122674,0.9210396241466152,1.0,7/38,10.36%,PDGFRA;TFPI;F10;PLAT;PLG;THBD;HRG
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4278209411762981,-1.03511729445528,0.4,0.7122606181226738,1.0,2/11,2.27%,FOXO1;NOTCH1
prerank,base conversion or substitution editing (GO:0016553),-0.4170079467956749,-1.0349406063027813,0.43584521384928715,0.7121288788491948,1.0,3/11,20.15%,ADARB1;NUDT16;METTL3
prerank,negative regulation of cyclase activity (GO:0031280),0.4190160943997568,1.0346024896367547,0.4254032258064516,0.9225382808243309,1.0,4/14,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,atrial septum morphogenesis (GO:0060413),-0.42338035801016777,-1.034206015463082,0.41762452107279696,0.7134741904439591,1.0,4/10,8.50%,BMPR2;ACVR1;TGFB2;HEY2
prerank,neural crest cell development (GO:0014032),-0.2972762232915922,-1.0341964674427195,0.3886363636363636,0.7129334219070018,1.0,19/44,27.06%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;SEMA5B;SEMA3E;SEMA3G;CDH2;SEMA5A;SEMA6D;SOX8;SEMA3F;SEMA4C;SOX11;TAPT1;SNAI2;SEMA4D;SEMA4F
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3772128534149126,-1.0341528894884273,0.3894523326572008,0.7124960114814696,1.0,10/16,39.92%,SHLD1;SMCHD1;FANCB;MAD2L2;SHLD3;CGAS;HELB;RADX;POLQ;SHLD2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3716832485757792,-1.0335756260152091,0.3887733887733888,0.7133815170137388,1.0,10/18,25.41%,IL6ST;STAT3;IL6R;SRC;JAK1;CBL;SOCS3;SPI1;PTPN11;YAP1
prerank,positive regulation of protein acetylation (GO:1901985),0.42202108151001777,1.0334570972003754,0.42827868852459017,0.9247636323145784,1.0,4/12,12.39%,PRKAA2;CAMK1;KAT5;RAPGEF3
prerank,DNA replication (GO:0006260),-0.2547866224173988,-1.0333162228117023,0.3756345177664975,0.7134702774383765,1.0,48/105,32.49%,RPA1;KAT7;REV3L;TIPIN;RPAIN;BLM;WRNIP1;KIN;ORC1;TIMELESS;ING4;ORC2;RHNO1;NBN;BARD1;RPA2;RMI1;CDC45;ORC5;PCLAF;POLA1;DUT;SET;RFC4;CHEK1;POLA2;MCMBP;TOP1;MCM3;WDHD1;POLD4;POLB;POLG2;RBMS1;POLE3;MCM5;MCM6;RFC2;CDK2;RECQL5;FAM111A;HELB;GRWD1;ORC3;CDK1;CDC6;PIF1;FEN1
prerank,negative regulation of RNA splicing (GO:0033119),0.38041081846410485,1.0331191258051857,0.391304347826087,0.9245611262911069,1.0,8/19,18.54%,PTBP2;SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;PTBP3;SRSF6
prerank,regulation of protein kinase activity (GO:0045859),-0.2561931447282469,-1.0330686910705562,0.40694789081885857,0.7135305503481584,1.0,32/106,23.67%,PLCE1;RAPGEF2;LRP6;GAS6;RASSF2;RAP1A;IQGAP1;CACUL1;UBASH3B;PAK2;XRCC5;PPIA;CCN1;CEACAM1;SOD1;HSPB1;GSKIP;PTK2B;DBNDD2;PTPRC;TAB1;RAP2B;AKT1S1;AGAP2;TRIB2;TRAF4;MMD2;MMD;PRKRIP1;TRIB3;TARBP2;CAMKK2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.32399944626010596,1.0327827843890727,0.4146341463414634,0.9243177161745052,1.0,10/41,10.67%,ACTN2;ANK2;KCNJ5;KCNJ10;KCNH2;GABBR1;KCNN4;PDZK1;KCNJ16;GABBR2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.37047979018769095,-1.032610022209005,0.42946058091286304,0.7141359493807783,1.0,6/17,17.01%,JAG1;STAT3;CD55;BACH2;CD46;GNL1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4370379688897181,1.031961381705282,0.4472049689440994,0.9254759077827159,1.0,6/12,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,adipose tissue development (GO:0060612),-0.4243970441014646,-1.0319087734111854,0.42452830188679247,0.7154418358444835,1.0,6/11,30.57%,LRP5;SH3PXD2B;PGRMC2;SOX8;RORC;NAMPT
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.26346720111842237,-1.031757345465452,0.3871794871794872,0.7152277130797475,1.0,21/88,14.26%,STXBP6;MYO1B;CLINT1;RAB14;VPS13C;EXOC6;APP;EXOC4;SORT1;RABIF;FTL;RP2;EXOC1;HGS;STEAP2;SCAMP1;SH3GL2;VPS13A;SYS1;AP2A1;PUM1
prerank,positive regulation of cation channel activity (GO:2001259),0.33135078665800444,1.0311025454014566,0.3840304182509506,0.9268197122564825,1.0,8/40,11.59%,ACTN2;ANK2;LRRC38;ANTKMT;GSTM2;NLGN3;HTT;GSTO1
prerank,negative regulation of binding (GO:0051100),-0.26471260746847686,-1.0310982183595176,0.4043062200956938,0.7163520372247939,1.0,12/81,6.70%,LEF1;ACTB;CAV1;WAPL;DISC1;NFKBIA;JUN;RALB;CARD16;CSNK1E;RACK1;PRKCD
prerank,regulation of extracellular matrix organization (GO:1903053),0.40105866813557767,1.0308307545816178,0.4296875,0.9263798033252105,1.0,1/15,0.06%,AEBP1
prerank,regulation of filopodium assembly (GO:0051489),-0.31049652587775156,-1.030761943798835,0.3986784140969163,0.716627578614474,1.0,11/38,17.17%,NRP1;MYO10;PIK3R1;ARAP1;PPP1R16B;PRKCD;TGFB3;FNBP1L;AGRN;FMR1;FXR1
prerank,cellular protein catabolic process (GO:0044257),-0.281452111312338,-1.0303300719794488,0.4034334763948498,0.7171737070025813,1.0,19/59,20.39%,DAB2IP;FAP;AP2B1;CAPN2;PSMA6;CTSO;MALT1;CTSB;VLDLR;RNF123;AP2A1;CTSF;TCIRG1;ADAMTS12;CTSS;UBE2G1;RSPRY1;RIPK1;MYLIP
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36519249054449165,-1.0302702225237181,0.4205020920502092,0.7167676113256233,1.0,9/18,27.88%,FLNA;DHX33;EIF2AK3;MAF1;ATF4;UBTF;SIRT7;RASL11A;LYAR
prerank,protein-DNA complex assembly (GO:0065004),-0.25400286908092035,-1.03024680749867,0.3787128712871287,0.7162474838467408,1.0,31/116,22.03%,RPA1;H3-3A;UBC;RPS27A;XPC;UBB;PSMA6;PSMB7;CHD1L;GTF2H5;PSMB6;PSMB5;GTF2H1;RAD23B;DMC1;ERCC2;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;CHAF1A;ORC5;PSMD10;XPA;PSME1;CCNH;MCM3
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.30562443768011704,-1.029258957168071,0.42916666666666664,0.7182922717346452,1.0,12/42,20.47%,ACTB;ARID1B;SMARCC1;GATAD2B;RBBP4;ARID1A;PBRM1;NASP;ACTR6;HDAC2;SMARCA4;CHD8
prerank,embryonic organ morphogenesis (GO:0048562),-0.3059707873017876,-1.0289436765974869,0.4231678486997636,0.7185340516789553,1.0,15/42,19.87%,MFAP5;ACVR1;SIX1;TBX1;FBN1;SOX17;NIPBL;HES1;DSCAML1;RARG;ID2;ALDH1A3;EFEMP1;FOXE1;HOXA4
prerank,regulation of cellular pH (GO:0030641),-0.32180138761815075,-1.0288217222713851,0.4251012145748988,0.718285720883935,1.0,6/29,14.87%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2
prerank,retinal metabolic process (GO:0042574),0.4274357408069084,1.0284180482241199,0.43047619047619046,0.9326141896012184,1.0,2/12,2.38%,ALDH8A1;ABCA4
prerank,response to reactive oxygen species (GO:0000302),-0.28583656792379675,-1.0284092598726355,0.40189125295508277,0.7187848299900222,1.0,12/54,9.75%,EGFR;PTPRK;JUN;PXN;APOD;MAPK1;RPS3;STK24;SOD1;CAT;APOE;GPX1
prerank,vesicle coating (GO:0006901),0.29408343670812254,1.0282240148605717,0.4244604316546763,0.9291855211029363,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,COPII vesicle coating (GO:0048208),0.29408343670812254,1.0282240148605717,0.4244604316546763,0.9291855211029363,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29408343670812254,1.0282240148605717,0.4244604316546763,0.9291855211029363,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,histone lysine methylation (GO:0034968),0.3409348522867559,1.0281921232415585,0.4120982986767486,0.9279560919662395,1.0,7/33,13.72%,DOT1L;KMT2A;N6AMT1;DYDC2;SMYD3;SMYD2;MEN1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2929996832255928,-1.0280839272546973,0.41647597254004576,0.7191088102751286,1.0,12/50,11.60%,CAV1;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;FBXO5;SQSTM1;ISG15
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.36507598671821795,-1.0278430369648595,0.4212860310421286,0.7191940018385891,1.0,7/18,23.96%,PIK3R1;ERN1;NCK1;BAK1;FCGR2B;ATXN3;BOK
prerank,DNA strand elongation (GO:0022616),0.3923335602513439,1.0276742736634132,0.4158415841584158,0.9282422865938118,1.0,6/18,16.77%,GINS1;POLD2;MRE11;TERT;MCM7;MCMDC2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.44211939210741513,1.027626690538076,0.41841004184100417,0.9270597421810669,1.0,2/10,3.24%,CDH3;FURIN
prerank,peptidyl-threonine modification (GO:0018210),0.2950035602755776,1.0274334718663085,0.40034071550255534,0.9263717665547662,1.0,22/66,18.35%,ROCK2;OXSR1;WNK3;GALNT11;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;GALNT3;GALNT2;MAP3K12;GALNT1;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,MAPK cascade (GO:0000165),-0.2212233883442429,-1.0273650458989592,0.32727272727272727,0.7198352678635184,1.0,73/295,20.32%,SPTBN1;KITLG;TEK;MEF2C;SHANK3;RAPGEF2;DAB2IP;RASAL2;MAP3K5;RASGRP3;YWHAE;PIK3R1;EGFR;BCL2L1;RASGRF2;KDR;IL17RD;UBC;YWHAB;TNIK;MAP3K20;RPS27A;UBB;MET;PSMA6;PSMB7;MAPK1;SPTAN1;SHOC2;GRIN2B;PIK3CA;PDE6D;MAP4K4;FGF2;MAPKAPK2;FGF7;PSMB6;JAK1;FGF13;PSMB5;KRAS;NRAS;RANBP9;PRKG2;RET;RASA3;PEBP1;ABHD17C;IRS1;PPP1CC;PSMB8;MT3;PAQR3;PSMC4;ICMT;KBTBD7;PSMD11;TAOK3;FGFR3;MRAS;MAP3K8;DUSP6;PSMB4;GRIN1;PSMD14;TAOK1;MAPK12;MAPK3;MARK3;JAK3;GOLGA7;PSMD10;ABHD17B
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4013318119149619,-1.0272387794375966,0.4288747346072187,0.7196128794014666,1.0,2/13,7.91%,CAV1;BCAP31
prerank,mRNA transport (GO:0051028),0.2787531897381883,1.027108034932237,0.4176182707993475,0.9260627107990795,1.0,38/101,27.34%,MCM3AP;CPSF3;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;DDX39A;RAE1;RBM15B;SRSF2;ZFP36;U2AF2;NUP160;ZC3H11A;ZFP36L1;NUP133;THOC2;FIP1L1;POLDIP3
prerank,hyaluronan catabolic process (GO:0030214),-0.36759810332152343,-1.0270123846471517,0.4245472837022133,0.7196255592054785,1.0,5/18,15.20%,CD44;FGF2;HEXA;CEMIP;CEMIP2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.37726157430792856,-1.0267201461113449,0.4206008583690987,0.719815865614195,1.0,8/17,29.06%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4023180773525662,1.0265617424256,0.4135188866799205,0.9264853514325849,1.0,3/16,8.77%,PIK3CB;AUTS2;ARHGAP24
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.34156843137827225,1.0262874717358386,0.4064748201438849,0.926011058477427,1.0,2/30,0.69%,NOTCH2;IGF1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.30694123966914455,-1.0261440013726404,0.4046610169491525,0.720747811743221,1.0,15/38,30.67%,HJURP;H3-3A;RBBP4;NASP;UBN1;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ASF1B
prerank,negative regulation of phosphorylation (GO:0042326),-0.2635390149739798,-1.025878165130387,0.37142857142857144,0.7208512431922592,1.0,25/85,17.39%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;BMP4;CBFA2T3;XDH;PPIA;LYN;OCLN;CDKN1C;EPHB2;TERF2IP;SH3GL2;DYNLL1;PAQR3;PLPP3;GIT1;FKBP8;TRAF3IP1;PTEN
prerank,protein homooligomerization (GO:0051260),0.2708048880995516,1.0258217821945983,0.3912310286677909,0.9262372159220574,1.0,26/114,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;VSTM5;ATL1;GSDMD;CLYBL;ADCY8;GOLGA2;ELAVL1;RNF135;KCNC2;SSBP1;TRPM2;BEND3;MICU1;ACACA;RNF213;CTH;ALAD;TRMT61B;NLRC4;ALDH9A1;ACOT13;USP16
prerank,positive regulation of lipid transport (GO:0032370),-0.4104127062396166,-1.0258030038172126,0.4451345755693582,0.7205114416755475,1.0,3/12,13.83%,ABCA3;APOE;LRP1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2677182967478499,-1.0257341617839095,0.41336633663366334,0.7201502857473256,1.0,28/76,26.03%,CAV1;DCUN1D3;CRY1;GNL3;UBB;SAE1;XIAP;FBXO4;FAM107A;AMER1;MALT1;DCUN1D5;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23;ZC3H12A;PSMD10;CENPX;RIPK2;NSMCE3;BCL10;CUL3;PIAS3;MUL1;UBQLN1;WFS1
prerank,positive regulation of gene expression (GO:0010628),-0.21282560289919883,-1.0250845494718646,0.35587188612099646,0.7211943643539772,1.0,77/442,12.95%,LEF1;ACTB;LIMS1;MEF2C;NTRK3;PID1;CLDN5;NOS3;NIBAN1;GSN;ETS1;RAMP2;THBS1;NOTCH1;ACTG1;GAS6;PIK3R1;F3;EGFR;CD34;CTCF;NGF;RBM3;STAT3;BMP4;SFRP4;AGO1;PLSCR1;RPL5;APP;FN1;NOS1AP;PLA2R1;EIF3E;PLCG2;TFRC;SMAD1;WNT5A;S100A13;ERN1;EEF2;PDE2A;AR;MAPK1;SEC16B;RPS7;OCLN;SPRY2;MYBBP1A;ADAM19;RPS3;ACTA2;HEY2;TMEM119;GATA2;SOD1;EIF2AK3;FGF2;TENT4B;AGO2;IL15;FGF7;KLF4;EPHB2;PIK3CD;HGS;RPL23;TWIST1;DYRK1A;CD74;KRAS;DNMT3B;SERPINB9;BMP2;SMO;RAB27A;AGPAT1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2793686965242713,1.024962251760085,0.42226148409893993,0.9274983797699375,1.0,12/86,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;RBPJ;CITED1;INHA;GDF9;TGFBR1
prerank,positive regulation of reproductive process (GO:2000243),-0.3205615055617814,-1.0249267900257164,0.4108695652173913,0.7210209777305474,1.0,5/31,13.82%,PDE3A;LHFPL2;AGO2;PGAM4;VEGFA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3269191728945664,1.0249235859868362,0.42429906542056073,0.9262848755366415,1.0,10/38,16.68%,RORA;TNIP3;NLRC3;NLRX1;CACTIN;STAT1;MAPKBP1;OTUD7A;SIRT1;PPM1B
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.31097539868672097,-1.0246407392603747,0.4171907756813417,0.7211664703344566,1.0,17/37,27.91%,PHLDB1;STMN1;PHLDB2;EFNA5;FAM107A;GAS2L1;BICD2;TRAF3IP1;TAOK1;STMN4;MAPRE2;ROCK1;CYLD;MAP6D1;MAPRE3;SKA3;MAPT
prerank,regulation of axon regeneration (GO:0048679),-0.4107384300779488,-1.0244115652993282,0.4444444444444444,0.7211986734318854,1.0,3/12,8.17%,PTN;SCARF1;STK24
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4307411909550107,-1.0241617579981896,0.4534653465346535,0.7212387541885963,1.0,4/11,6.75%,RSPO3;MLLT3;CSNK1E;PLEKHA4
prerank,mRNA catabolic process (GO:0006402),0.3134562164510372,1.0240045822301842,0.42379182156133827,0.9277751639728805,1.0,8/44,14.28%,HSPA1A;DDX5;DHX34;SUPV3L1;LSM5;TUT4;AGO3;HSPA1B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2892250556652928,1.023954319476905,0.4092526690391459,0.9266105386733149,1.0,13/72,11.39%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3
prerank,embryonic hemopoiesis (GO:0035162),-0.4044279762097731,-1.0238460171642156,0.42653061224489797,0.7214619637091556,1.0,4/12,9.95%,KITLG;TGFBR2;KDR;TAL1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3094928388113966,-1.0233270524516223,0.39433551198257083,0.7221835083433934,1.0,20/34,34.99%,PDE4D;KCNQ1;CALM3;PRKACA;PLN;ZC3H12A;GJA5;PIK3CG;SLC8A1;STC1;RGS2;CALM1;HCN4;SMAD7;RNF207;NOS1;ADRA1A;ATP1B1;TNNI3K;CALM2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2792914805710747,-1.0232982753217346,0.42105263157894735,0.7216918066928393,1.0,25/57,25.52%,RPS15;RPL38;RPL5;RPS24;RPL7;RPS17;RPS16;RPL35A;RPS7;RPS28;SURF6;RPS25;RPL14;GTF3A;URB2;MRPL36;LTV1;MRTO4;EBNA1BP2;SDAD1;RRS1;NOP16;RPS19;CUL4A;RIOK1
prerank,actin filament network formation (GO:0051639),-0.4134352447194115,-1.0228250072332936,0.44488977955911824,0.7224080967809007,1.0,2/11,4.45%,PLS3;ACTN1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2956491180449959,1.0225943317372979,0.40202702702702703,0.9296217660887937,1.0,8/66,10.29%,ROBO1;FGF1;TENM1;KIT;ADRA2A;LRRK2;MAP3K10;SASH1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.31579764338058,-1.022552864479032,0.4269406392694064,0.722572447310235,1.0,6/33,11.79%,PRKG1;MEF2C;APOD;TAFA5;TGFB3;PDCD4
prerank,regulation of histone acetylation (GO:0035065),0.3333150053084132,1.0221226519512534,0.424408014571949,0.9297669104181319,1.0,8/33,13.56%,KMT2A;CAMK1;RUVBL2;ARRB1;PPARGC1A;BRD7;RAPGEF3;NOC2L
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3992254659584742,-1.021810422829748,0.4381551362683438,0.7238905991790172,1.0,6/14,30.54%,RHOA;RAP2A;CDC42;MSN;FOXJ1;CAMSAP3
prerank,positive regulation of nervous system process (GO:0031646),-0.3689890306045827,-1.0217649695710476,0.42418032786885246,0.7234296531460314,1.0,3/18,3.68%,PARD3;TNFRSF1B;UNC13B
prerank,regulation of actomyosin structure organization (GO:0110020),0.42146122623701343,1.0215570812004604,0.4307400379506641,0.9301246289718818,1.0,4/13,15.08%,ROCK2;FHOD1;TSC1;WAS
prerank,connective tissue development (GO:0061448),-0.30922257101897466,-1.0215272839308003,0.4004149377593361,0.7234382075723446,1.0,5/35,5.93%,ZBTB16;LRP5;PKD1;CD44;SH3PXD2B
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2776692586031597,1.0212867759520214,0.4205128205128205,0.9296772653376897,1.0,15/95,10.07%,TGFBR3;DAB2;SNX6;HSPA1A;SMAD3;PPARA;STRAP;DKK3;NREP;CITED1;PDPK1;MTMR4;SPRED3;VEPH1;TGFBR1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3433875379939317,-1.021269506872082,0.4282608695652174,0.7235776310705413,1.0,6/22,19.47%,SLC7A5;TNFRSF1B;WNT5A;TRIL;NOD2;BTK
prerank,response to cholesterol (GO:0070723),-0.3753732755393214,-1.0211713503861173,0.4472573839662447,0.7232802465794324,1.0,5/17,12.66%,LRP6;TGFBR2;GRAMD1A;PTCH1;SMO
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.219494593758035,1.0209171580209653,0.3797953964194373,0.9295096439311918,1.0,122/807,12.63%,PRDM6;AEBP1;BMP7;WWOX;BMP6;WNT4;DAB2;SNX6;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;DNMT3L;SCML4;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;ZBTB38;CDKN2A;SCRT1;ARID4A;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;CAPN3;TFDP2;CCAR2;DKK3;ENO1;ZHX1;LOXL3;IFI27;DLG1;PEG3;PRMT2;PAX6;IKZF1;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;RCOR3;ZKSCAN3;E2F1;CEBPA;CITED1;DPF1;ATN1;PBXIP1;NRG1;MOSPD1;FGFR2;LBH;JARID2;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;PRDX5;CHD3;MIER3;IMPACT;MED1;KDM2A;HINFP;MAP3K10;MAX;DMAP1;NR1H3;E2F8;ZIC2;MED25;NKAP;RXRA;CLOCK;CBX6;ZFP90;PRDM2;C1QBP;MPHOSPH8;COMMD7;NSD1;FOXP4;LDB2;LDB1;PLCB1;BRD7;RITA1;LCOR;STAT1;FST;MBD1;TAF1;MXI1;KDM5C;QARS1;GATAD2A;PCGF6;CDC73;KDM4A;SOX9;CIPC;RLIM;BEND3;PML;RCOR2;RING1;RBAK;BHLHE41;PIAS4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.30576157483572897,-1.0208472842854348,0.4021276595744681,0.723572854748795,1.0,6/39,6.32%,UTRN;NEDD4L;FXYD5;YWHAE;FHL1;TRPC6
prerank,hexose transmembrane transport (GO:0008645),0.3751898415560335,1.0207291254338644,0.43357933579335795,0.9288101135876546,1.0,3/21,2.69%,SLC2A12;SLC5A3;SLC5A10
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4469274373801819,1.0206386085286607,0.4354166666666667,0.9277689289400625,1.0,5/10,24.97%,PRKAA2;KLF15;SIRT1;DIP2A;SETD5
prerank,regulation of cholesterol esterification (GO:0010872),-0.42787447362062686,-1.0204876375873153,0.452755905511811,0.7239268629088761,1.0,5/10,27.83%,AGTR1;APOE;STARD4;APOC1;AGT
prerank,steroid metabolic process (GO:0008202),0.2909227250775605,1.020308732625897,0.4007029876977153,0.9275118869777499,1.0,19/72,21.56%,LIPA;CYP26B1;CYP11B1;DHCR24;PRLR;DHRS11;CYP27A1;AMACR;FDX1;PIAS4;CYP51A1;STAR;GBA2;FDX2;MSMO1;HSD17B4;NPC1;FDXR;HSD11B1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3401418158769487,1.0201037444402752,0.4309090909090909,0.9268040778688773,1.0,10/30,18.92%,DAB2;DDX5;PRMT2;RNF14;RNF6;SAFB2;SIRT1;NCOR2;KDM1A;NCOR1
prerank,cellular response to osmotic stress (GO:0071470),0.3720857142604742,1.0190912637380192,0.4098671726755218,0.9286871683630483,1.0,4/21,4.13%,OXSR1;WNK3;CAPN3;STK39
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.32252445607383934,-1.0186616273568063,0.4269911504424779,0.7281240125757729,1.0,10/31,23.25%,GPHN;GCH1;LIAS;NFS1;MOCS1;LSS;NOXRED1;SRD5A1;PYCR3;SCP2
prerank,protein destabilization (GO:0031648),0.3364378466516988,1.0186280338296199,0.42413162705667273,0.9288715517757745,1.0,10/32,19.07%,DERL1;CAPN3;PLK1;HTT;CTSH;CDC73;SIRT1;MDM2;RNF139;PRNP
prerank,regulation of sodium ion transport (GO:0002028),0.3273783706398619,1.0183544498814028,0.41682974559686886,0.9284309179274732,1.0,5/34,6.71%,WNK3;SNTA1;DLG1;FGF12;WNK4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.269732518064026,-1.01814564140368,0.4104803493449782,0.7288895931932506,1.0,11/63,8.77%,CAV1;ITGA6;ACVR1;TNFSF10;THBS1;BMP4;FAS;PAK2;AR;FEM1B;SRC
prerank,regulation of telomere capping (GO:1904353),-0.34888017368808005,-1.018044125928319,0.4444444444444444,0.7285833778934745,1.0,10/23,26.19%,NEK7;TNKS;MAPK1;USP7;NBN;MAPK3;MAP2K7;MAP3K4;HNRNPD;TERF2
prerank,negative regulation of cell death (GO:0060548),-0.25963359155961835,-1.018001434745445,0.4246913580246914,0.7281298420037434,1.0,14/88,9.34%,MECOM;PDE8A;CD200;CD34;BMP4;TNFRSF1B;CCN3;PRKD1;NCK1;CHMP4B;CHMP4A;CCN1;CDK5;FGF2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2586136958032205,1.0176158666435482,0.40279937791601866,0.9294691605945451,1.0,17/140,9.59%,ADCY5;CCR9;ACKR2;PDGFRA;TAC1;CACNB3;C5AR2;BDKRB1;JPH1;LPAR2;BDKRB2;ADCY8;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,regulation of chromatin binding (GO:0035561),-0.4318206767716506,-1.017447873019822,0.45544554455445546,0.7289757999801384,1.0,2/10,9.60%,WAPL;HMBOX1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2966442764106727,-1.0172382024313533,0.4337606837606838,0.7289360392117108,1.0,18/42,31.31%,SHLD1;TERF2IP;FUS;SMCHD1;FANCB;PPP4R2;TIMELESS;MAD2L2;RPA2;SPIDR;CHEK1;SIRT6;SHLD3;RAD51AP1;PARP1;CGAS;HELB;MRNIP
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3163584951708415,1.0171433242544226,0.42759795570698467,0.929675230736146,1.0,12/46,15.41%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,mitochondrial translation (GO:0032543),-0.25594199506790727,-1.0166286622900103,0.4230769230769231,0.7299900220400127,1.0,29/104,20.20%,GATB;DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MTIF3;GFM1;LARS2;MRPL23;MRPS31;NDUFA7;EARS2;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,response to light stimulus (GO:0009416),0.3008379901861954,1.016599259773784,0.42439862542955326,0.9300965795021441,1.0,9/55,10.96%,DDB2;CCAR2;UBE4B;SPRTN;MSH6;REV1;CLOCK;MAPK10;USF1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.32493318789141135,-1.01631729866219,0.4272930648769575,0.7302227525424548,1.0,11/27,20.35%,TEK;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2;AGAP2
prerank,pinocytosis (GO:0006907),-0.4395438965407853,-1.0161948152483105,0.44271844660194176,0.7299432497649349,1.0,7/10,32.71%,DOCK2;MAPKAPK2;SNX5;CARMIL1;AHSG;MAPKAPK3;RAB34
prerank,T cell receptor signaling pathway (GO:0050852),-0.23866767856688148,-1.0161821149055588,0.40554156171284633,0.7294128192843501,1.0,37/138,23.25%,PDE4D;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;PTPRC;PSMB8;PSMC4;PSMD11;DENND1B;EIF2B1;PSMB4;PSMD14;ZC3H12A;PSMD10;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.30807952396571403,-1.0161198880586506,0.4090909090909091,0.7289932089712884,1.0,7/35,10.78%,GHR;CAV1;NOTCH1;CYP1B1;HES1;VHL;HGS
prerank,miRNA metabolic process (GO:0010586),0.3705335751572305,1.0160560720006298,0.43478260869565216,0.9305092914980262,1.0,6/20,15.04%,TRIM71;DDX17;BCDIN3D;TUT4;DICER1;SND1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.38729594813812934,-1.0159175705084755,0.42998027613412226,0.7289818277788915,1.0,4/14,15.55%,TFRC;SHLD1;NECTIN2;MAD2L2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4280871551964891,1.0158617873715379,0.4459203036053131,0.9298318087556319,1.0,2/11,6.77%,GCK;C1QTNF3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.37357470694819317,-1.0155599771959862,0.43902439024390244,0.7293816252992485,1.0,5/16,17.65%,CAV1;TRIM14;TRIM25;NECTIN2;EXOC7
prerank,cellular response to amino acid starvation (GO:0034198),0.28496602542263677,1.015062261663743,0.418212478920742,0.9309801297427356,1.0,17/71,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,pre-miRNA processing (GO:0031054),-0.3886310615169275,-1.0148850580525695,0.45625,0.7305490837125658,1.0,6/14,23.33%,AGO1;AGO2;DROSHA;AGO4;MRPL44;TARBP2
prerank,calcium ion import (GO:0070509),-0.32468685996711943,-1.0148701890343086,0.4460580912863071,0.7300221599427495,1.0,10/28,15.31%,MICU3;CACNB2;CACNA1G;TRPC4;MCUB;CACNA1B;TRPV4;MICU2;SMDT1;CACNA1I
prerank,ureteric bud morphogenesis (GO:0060675),-0.37037295673794834,-1.0147738943617928,0.42792792792792794,0.7297190919735599,1.0,4/16,12.38%,BMP4;SIX1;FGF2;BMP2
prerank,hexose metabolic process (GO:0019318),0.31973268581908126,1.0147517361949154,0.42990654205607476,0.9306598609521416,1.0,11/39,17.05%,CHST15;SORD;PGM1;ALDOB;GALT;FUCA1;BRAT1;PMM2;HECTD4;HK1;ALDOC
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35478385719143224,1.0143797472742866,0.44573643410852715,0.9305293691687461,1.0,5/27,7.33%,BRD8;ATAT1;SGF29;RUVBL2;KAT5
prerank,negative regulation of mRNA processing (GO:0050686),0.3959509406094185,1.0138345374708035,0.4311740890688259,0.9309344084097669,1.0,6/15,18.54%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.28784273634726165,-1.0135493893763365,0.4059633027522936,0.732278068718026,1.0,20/46,31.73%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3935827207197755,1.0124330191110784,0.45297504798464494,0.9339353808056458,1.0,2/14,4.92%,IL18;EBI3
prerank,regulation of mitochondrial fission (GO:0090140),-0.33587895770660836,-1.0123640638014242,0.4263392857142857,0.7348312020227914,1.0,4/24,9.05%,DCN;KDR;MFF;MYO19
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3543031990035573,1.0122791212096143,0.425414364640884,0.9331087031740121,1.0,2/23,1.77%,IGF1;PRKAA2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.23674210166667403,-1.0121791250109704,0.3965014577259475,0.7347002884127114,1.0,27/158,13.32%,ROR1;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;MID2;FLNA;BRD4;CARD16;TFRC;PRKD1;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;MALT1;TERF2IP;EDA2R;CD74;BIRC3;TNFRSF19;ECM1;CD40
prerank,mitotic spindle organization (GO:0007052),-0.2373007989860609,-1.0121728583164522,0.4241645244215938,0.7341548058330464,1.0,57/153,28.45%,RHOA;STMN1;EML1;DYNC1I2;FLNA;SMC1A;MAP4;TNKS;PLK2;STAG1;NUP107;MAP9;DYNC1I1;PIBF1;KIF23;RPS27;RMDN1;MZT1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;STAG2;CENPQ;CENPL;TOGARAM1;DYNC1H1;TAOK1;ARHGEF10;RAB11A;PRC1;NUP85;B9D2;GPSM2;TPX2;AAAS;KIFC1;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2;VCP;BIRC5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4354475888689875,1.01206270832615,0.47912524850894633,0.9324953687097317,1.0,2/11,8.49%,COLEC12;TNIP2
prerank,neuronal action potential (GO:0019228),-0.3377496961791091,-1.0119569712064542,0.4303534303534304,0.7341511645865625,1.0,7/22,21.60%,CACNA1G;KCNMB2;CACNA1I;SCN3A;GPER1;CACNA1H;SCN7A
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4388190658515874,1.0118025047663382,0.45951417004048584,0.9319806755055121,1.0,3/10,11.76%,RENBP;GNPDA1;NPL
prerank,positive regulation of protein catabolic process (GO:0045732),-0.26134322708925456,-1.0117884749521784,0.4194312796208531,0.7340500280434923,1.0,25/84,24.87%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;TNFRSF1B;WNT5A;PLK2;APC;APOE;AMER1;CSNK2A1;FZR1;BARD1;HACE1;NEDD4;MSN;FAF1;CDKN1B;STX5;OAZ1;PLK3;AREL1;DTL
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4166158647740982,-1.0116078650966505,0.4335511982570806,0.7339480806995298,1.0,5/11,15.67%,NOS3;GCH1;QDPR;PRKG2;DHFR
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.39861001628436304,-1.011501723468712,0.43452380952380953,0.733662185733324,1.0,6/13,18.76%,CACNA1G;STX1A;SYT4;CACNA1I;KCNB1;CACNA1H
prerank,histone modification (GO:0016570),0.2686397463663894,1.0111818840948665,0.4425385934819897,0.9324777961531372,1.0,27/109,20.32%,EYA1;EYA4;EYA2;BRD8;SGF29;RUVBL2;PRMT2;RCOR3;KAT5;MIER3;TAF10;NSD1;KDM4A;RCOR2;MAP3K12;HDAC4;TBL1XR1;NTMT1;SIRT1;NSD3;USP21;USP16;SIN3A;KAT6B;BRMS1L;KAT8;PHC1
prerank,early endosome to Golgi transport (GO:0034498),-0.4215712321366553,-1.011059691131101,0.458,0.7342426020406206,1.0,7/11,33.21%,RAB6A;SNX1;SURF4;SNX2;STX5;LMAN1;RBSN
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3954733074777184,-1.0107904431522183,0.451417004048583,0.7343601735549249,1.0,3/13,13.07%,EPS8;EPS8L2;PFN1
prerank,lysine catabolic process (GO:0006554),0.41712637406558695,1.0106786474228249,0.44140625,0.9314904519689237,1.0,2/12,11.65%,ALDH7A1;GCDH
prerank,lysine metabolic process (GO:0006553),0.41712637406558695,1.0106786474228249,0.44140625,0.9314904519689237,1.0,2/12,11.65%,ALDH7A1;GCDH
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.37060700613813957,1.0103099907284043,0.42771084337349397,0.9313394637492606,1.0,3/20,6.12%,PPIL6;PPIF;NKTR
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3444927599723665,-1.0100873156419912,0.4482758620689655,0.735631601299968,1.0,10/23,25.52%,UBC;RPS27A;XPC;UBB;RAD23B;GPS1;XPA;COPS6;COPS4;CUL4A
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.42678706627241303,1.0099199393606295,0.45436893203883494,0.9312412252112082,1.0,3/12,15.93%,STRAP;SOX9;RBP4
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3650395626671071,-1.0096998783510007,0.43190661478599224,0.736087163706172,1.0,6/18,20.25%,ADAM10;ADAM19;APOE;LDLRAP1;PSEN2;PSENEN
prerank,protein palmitoylation (GO:0018345),0.33957389101828733,1.00956142081169,0.4338919925512104,0.9310732136467151,1.0,10/30,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,activation of protein kinase A activity (GO:0034199),0.39682798147618964,1.0095117965185632,0.4263261296660118,0.9299692334161137,1.0,3/16,6.20%,ADCY5;ADCY1;ADCY8
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.380222569654738,1.0093697184287644,0.4494163424124514,0.929151811363931,1.0,1/17,0.50%,LPGAT1
prerank,presynaptic endocytosis (GO:0140238),0.3584979916926038,1.009325052045054,0.45436507936507936,0.9280409177999913,1.0,7/24,15.04%,CEL;NLGN2;SYT1;NLGN3;SYNJ2;CANX;AMPH
prerank,fatty acid catabolic process (GO:0009062),0.29007810746390145,1.0091279287155857,0.4371584699453552,0.9273593096055284,1.0,14/67,12.22%,CEL;ACAT2;LPIN1;ACAT1;PCCA;ACAD10;ECHS1;MMUT;ABCD1;ACAD11;ECHDC2;PLA2G15;ABHD3;CROT
prerank,kidney development (GO:0001822),0.2870110595859133,1.0090055534867288,0.4263157894736842,0.9265102919548818,1.0,13/65,14.87%,BMP7;WNT4;GREB1L;OSR1;CITED1;LRP4;VANGL2;CEP290;TGFBR1;CTSH;BAG6;FOXC1;ARL3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.27824301250686395,-1.0087087891450448,0.42410714285714285,0.7380188846000855,1.0,22/59,25.76%,DAB2IP;NFKBIA;UBC;REL;RPS27A;UBB;RELB;NKIRAS1;TBKBP1;BIRC3;IRAK2;TAB1;RIPK1;TICAM1;ROCK1;RIPK2;BCL3;IRAK1BP1;BCL10;AZI2;TLR4;MAP3K14
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3191953940044882,-1.0086810444449856,0.44789356984478934,0.7375393053025644,1.0,5/31,10.52%,SHANK3;PDLIM5;CDK5;ABI3;CFL1
prerank,vacuolar acidification (GO:0007035),0.3657111142449396,1.00859001128466,0.42441860465116277,0.926534577257533,1.0,7/21,14.53%,ATP6V0A2;ATP6V1H;CCDC115;TMEM199;ATP6V0E2;CLN5;ATP6V0D2
prerank,camera-type eye development (GO:0043010),-0.33666570289172115,-1.0085536740648708,0.4272930648769575,0.7372694667330562,1.0,9/25,21.97%,LAMA1;CYP1B1;FBN1;STRA6;VEGFA;ALDH1A3;EFEMP1;FOXL2;SKI
prerank,eye photoreceptor cell development (GO:0042462),0.4014621412324806,1.0085457583189454,0.4538152610441767,0.9254279963675712,1.0,3/15,10.22%,USH1C;CEP290;TOPORS
prerank,carbohydrate transport (GO:0008643),0.4301154585276354,1.0085154937842264,0.44639376218323584,0.9243088740346729,1.0,2/11,2.73%,SLC23A2;SLC23A1
prerank,actin filament bundle organization (GO:0061572),0.3322544972344824,1.0080368608012027,0.4359925788497217,0.9246003981079004,1.0,6/33,6.79%,USH1C;RFLNA;BAIAP2;PAWR;ADD2;CORO1B
prerank,establishment of spindle orientation (GO:0051294),0.3453110967932611,1.0079412538050723,0.4588910133843212,0.9236338977239936,1.0,7/28,9.52%,PLK1;CLASP1;LLGL2;HTT;NDC80;MAD2L1;LLGL1
prerank,DNA duplex unwinding (GO:0032508),-0.2874746269306034,-1.0078951142838093,0.43982494529540483,0.7383940183710092,1.0,12/50,12.95%,RPA1;UBC;RPS27A;XPC;UBB;ANXA1;CHD1L;GTF2H5;GTF2H1;RAD23B;BLM;ERCC2
prerank,RNA export from nucleus (GO:0006405),0.2747349053379573,1.0078579839496087,0.44390243902439025,0.9226586516277046,1.0,25/100,19.97%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;NUP62CL;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,negative regulation of DNA binding (GO:0043392),-0.3213399880604585,-1.0076514205287554,0.4189473684210526,0.7384350777248224,1.0,9/28,17.19%,LEF1;NFKBIA;JUN;TNKS;HEY2;SMO;MAD2L2;SP100;HEY1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4210162687322591,1.007499964320504,0.458252427184466,0.9212788931504543,1.0,1/12,1.69%,FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4210162687322591,1.007499964320504,0.458252427184466,0.9212788931504543,1.0,1/12,1.69%,FHL2
prerank,fatty acid oxidation (GO:0019395),0.2974079832707911,1.0069637553378195,0.447841726618705,0.9217058752962599,1.0,11/57,12.22%,ADH7;ADH4;ACAT2;ACAT1;ACAD10;ECHS1;PPARGC1A;ABCD1;ACAD11;ECHDC2;CROT
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3342328562544074,-1.0068444065013138,0.4400871459694989,0.7399301354162663,1.0,7/24,12.34%,BMPR2;ACVRL1;DACH1;XRCC5;RPS3;TERF2IP;BLM
prerank,epithelium development (GO:0060429),0.26638970327079153,1.0065542515655301,0.43874172185430466,0.9217506020216746,1.0,10/107,6.95%,ALDH1A2;WNT4;ERRFI1;OSR1;HNRNPH3;LOXL3;TRIM71;PGK1;NDRG4;FGFR2
prerank,fibrinolysis (GO:0042730),0.4089145625139052,1.0063172799210898,0.44834307992202727,0.9212590766826261,1.0,3/13,10.36%,PLAT;PLG;HRG
prerank,androgen receptor signaling pathway (GO:0030521),0.414954075945445,1.005572230414869,0.44820295983086683,0.9222249174491782,1.0,3/11,7.14%,DDX5;RNF14;DDX17
prerank,metanephros development (GO:0001656),0.34956591490335326,1.0055721703962122,0.4691588785046729,0.9210034274922919,1.0,3/26,6.63%,BMP7;OSR1;CITED1
prerank,ether lipid biosynthetic process (GO:0008611),-0.4319469754829386,-1.0054817245318648,0.475103734439834,0.7428854633123956,1.0,3/10,8.56%,PLA2G4A;DHRS7B;PEX7
prerank,neuron differentiation (GO:0030182),0.2496109795547131,1.005077913360354,0.4304,0.9212557230076013,1.0,21/165,10.11%,WNT4;HS6ST1;IL1RAPL1;VXN;WNT5B;TENM1;PBX2;DTNB;WNT7A;PAX6;FZD8;PBX4;CASP3;FZD3;WNT6;NTRK2;PTPRD;FZD7;TDP2;TGFBR1;LDB1
prerank,brain development (GO:0007420),-0.23800779266306216,-1.0047314625468249,0.4601990049751244,0.7442612520461221,1.0,20/136,12.19%,ADGRL2;SHANK3;RAPGEF2;PBX1;ZFHX3;COL4A1;SHROOM4;PBX3;TGFBR2;EML1;BPTF;NIPBL;APOD;UFC1;GRIN2B;DSCAML1;ADGRG1;ATXN1;PTCH1;MFSD2A
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.26351896967840616,-1.004538072747128,0.4253393665158371,0.7441918280772173,1.0,25/66,30.42%,FOXP1;STAT3;APP;CARD16;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;GIT1;USP50;NOD2;ZC3H12A;MYD88;RIPK2;CASP1;CASP8;TLR4;F2R;CPTP;TMEM106A;CD36;TLR6;LGALS9
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.27933929574940736,-1.004493594845513,0.427536231884058,0.7437515030428996,1.0,26/57,25.72%,TNFSF10;MAP3K5;NOD1;AIM2;PERP;BCAP31;CTSD;GRIN2B;MALT1;SOX7;TBC1D10A;ACVR1C;BAK1;USP50;GPER1;GRIN1;FOXL2;HMGB1;SYK;RIPK2;FYN;CASP1;BCL10;DAPK1;CASP8;F2R
prerank,positive regulation of transmembrane transport (GO:0034764),0.4061329251107083,1.004356186060364,0.4309623430962343,0.922125125431992,1.0,3/13,11.54%,ACSL1;CLIP3;AZIN2
prerank,regulation of interferon-alpha production (GO:0032647),0.35867447356183896,1.0042194088532121,0.45219123505976094,0.9212978850362666,1.0,8/23,23.59%,CHUK;NLRC3;STAT1;HAVCR2;TLR8;DDX3X;PTPRS;SETD2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4133822070530706,1.0039337584901404,0.47280334728033474,0.9209631017745542,1.0,3/12,8.19%,PRKCZ;GKAP1;SORBS1
prerank,coenzyme A metabolic process (GO:0015936),0.3998588768432869,1.0038615457862625,0.45129224652087474,0.9199844664175354,1.0,4/14,12.22%,PANK1;ACAT1;PANK2;CROT
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.38159311848835814,1.0038120081056716,0.4457593688362919,0.9189213367021001,1.0,3/18,7.03%,CACNG7;NLGN2;NLGN3
prerank,cholesterol homeostasis (GO:0042632),-0.2710718356499822,-1.0037976233455124,0.455188679245283,0.7450291906829976,1.0,13/64,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,establishment of protein localization to organelle (GO:0072594),0.2831873346620295,1.0036216769921593,0.4498327759197324,0.9183048573394683,1.0,17/72,18.35%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;LAMP2;NXT1;RYR2;IL10RA;IPO8;TNPO2;HK1;IPO4;NUP88;AKT1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.28823985996999757,-1.0034507633866232,0.46004319654427644,0.7454297874389062,1.0,9/46,12.56%,YWHAE;GAS6;PIK3R1;CDH1;FLNA;PRKCD;IPO5;NCBP2;TPR
prerank,female gonad development (GO:0008585),0.3762094603392656,1.0032649158171325,0.44529750479846447,0.918170632750307,1.0,5/19,10.52%,KIT;NR2F2;INHA;EIF2B4;COL9A3
prerank,nitric oxide metabolic process (GO:0046209),0.3980706629042772,1.002864394085895,0.43159922928709055,0.9181819725618653,1.0,3/14,4.43%,GCHFR;NQO1;ARG2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.38174581101927685,1.0027862110622292,0.44854368932038835,0.9172063192381877,1.0,4/17,5.34%,NOTCH2;GALNT11;BMPR1A;RBPJ
prerank,regulation of trophoblast cell migration (GO:1901163),-0.38539755446654034,-1.0022188035498174,0.4780793319415449,0.7480879183060138,1.0,4/14,14.57%,ARHGDIB;AGO2;VEGFA;ACVR1C
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.37312248356654343,-1.0021451978260656,0.45213849287169044,0.7477420320364006,1.0,2/15,2.44%,YWHAE;GAS6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3799357305090312,-1.0017595984971328,0.4489795918367347,0.7481919558055303,1.0,3/14,9.96%,GAS6;CARD16;CCDC3
prerank,determination of bilateral symmetry (GO:0009855),-0.33668885408784055,-1.0014159065188795,0.45665961945031713,0.748520624834771,1.0,14/24,35.59%,NOTCH1;TBX1;DNAH11;STIL;CFAP53;DLL1;ODAD2;ODAD3;ZIC3;FOXJ1;NPHP3;LEFTY1;DNAAF4;BBS7
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2405441448142762,-1.001015434278851,0.4444444444444444,0.7490376030918181,1.0,30/108,23.36%,RHOBTB1;TJP1;RHOA;CLIC4;PHLDB1;IQGAP1;F11R;PHLDB2;CAPN2;PAK2;PRKCD;ARHGAP35;MAPK1;EFNA5;FAM107A;HIP1R;RND3;LRP1;BICD2;TRAF3IP1;TAOK1;RHOBTB3;MAPK3;ARHGEF5;RHOB;RAC3;ROCK1;RND2;CYLD;MAP6D1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3930860740478283,1.000602193733177,0.44550669216061184,0.9224751512740332,1.0,5/15,12.34%,SPHK1;SMPD3;ORMDL2;SMPD2;SPHK2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.23842960876497485,-1.000569725287649,0.4417989417989418,0.7496561968044032,1.0,31/133,15.99%,CAV1;STIM2;ATP2B1;TRPC3;YWHAE;SLC10A7;MICU3;SLC30A1;CAMK2D;NPTN;TRPC6;CXCL12;SLC35G1;TPT1;TRPC4;CCL13;ATP2A3;MCUB;TRPC1;TMCO1;EDN1;CAV2;EDN3;HTR2A;TRPV4;CD40;MICU2;SMDT1;VAPB;BAK1;PRKACA
prerank,response to amino acid starvation (GO:1990928),0.2810779607027513,1.000325155718346,0.4451939291736931,0.9221081726840056,1.0,17/72,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,cochlea morphogenesis (GO:0090103),-0.4273679026548213,-1.0003247375099122,0.45918367346938777,0.7497566238066822,1.0,2/10,4.34%,TBX18;TBX1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.40302111098510585,1.0001435185643575,0.4709418837675351,0.9214672807505156,1.0,2/15,0.78%,IGF1;ROCK2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.20779760967008043,0.9999070110921766,0.4836527621195039,0.9209753300968588,1.0,271/1668,15.61%,PRDM6;AEBP1;ZKSCAN2;MAF;RORA;FGF1;WWOX;EPAS1;HLF;BMP6;DAB2;CREB5;PPARGC1B;IGF1;DDX5;CBX7;IL18;SMAD3;KCNIP3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;MAGEA2;HMX2;MSX2;CXXC5;SOX5;BEX1;OVOL2;CTR9;FHL2;THRB;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;NR6A1;ARNT2;DOT1L;PBX2;KIT;ZNF431;PCGF2;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;HOXB9;BMPR1A;TFDP2;BRD8;SIM1;WNT7A;CSRP3;CHUK;CCNT2;ENO1;ZHX1;SMARCD3;TNRC6A;KMT2A;HOXB3;MAFG;LPIN1;TET1;MEIS1;IFI27;CAMK1;DLG1;TIAL1;PEG3;RUVBL2;TCEA1;MLXIP;PAX6;IKZF1;PHF8;RBPJ;PLK1;IKZF2;MZF1;DNMT3A;AUTS2;ARID3A;HNRNPU;ZFHX2;TNIP3;WWTR1;ZBTB26;HOXA7;ZNF462;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;IKBKG;PCGF5;E2F1;CEBPA;CITED1;DPF1;ATN1;MOSPD1;FGFR2;HOXB6;DDX17;BCL11B;KAT5;NR2F2;TEF;ARRB1;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KDM6B;NLRP3;ZNF467;MIER3;PHF2;IMPACT;NFATC2IP;HES6;MED1;MAFA;TNIP2;PPARGC1A;ZFX;KDM2A;HINFP;HIF3A;MAX;DMAP1;EAF2;NR1H3;RHOQ;PHIP;E2F8;ZBTB22;HDX;ZIC2;MED25;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CBX6;ZFP90;PRDM2;PSIP1;C1QBP;NSD1;SALL3;FOXP4;LDB2;LDB1;PRKCB;CSRNP3;BRD7;ZNF260;PPM1D;RNF10;RITA1;LCOR;BCLAF3;E2F4;CSRNP1;MAPK14;STAT1;USF1;BATF;FST;TAF1;MXI1;STAT2;WASL;FZD5;GATAD2A;PCGF6;ZBTB49;CDC73;DMTF1;SOX9;SRA1;MED12L;BEND3;RCOR2;RBAK;FHOD1;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;JAZF1;GABPA;ZIC5;AGO3;YEATS4;SMYD2;ABCA2;ABHD14B;EN2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;DICER1;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;ZFP64;CREB3L4;PRKDC;ZNF507;GABPB1;MLLT10;WBP2;SAFB2;TBL1XR1;BCL11A;PER2;WAS;MED15;HEXIM2;PTOV1;ZBTB43;ERF;ABL1;TADA1;MUC1;PPP3R1;MSX1;HNF4G;GADD45A;TFE3;HIC2;SIRT1;DPF3;IL6;HGF
prerank,protein ubiquitination (GO:0016567),0.22405840863453888,0.9996827533742791,0.46629986244841815,0.9204426334670428,1.0,113/471,21.25%,RNF220;RNF152;EPAS1;RNF43;UBE2E2;DDB2;SH3RF2;CTR9;ASB2;PDZRN3;DTX1;DERL1;FBXL19;TRIM62;PSMD3;SIAH2;RNF41;RNF126;TRIM5;FBXL12;LEO1;PLK1;DZIP3;TRIM71;KLHL13;SHPRH;RNF14;TNKS2;UBE4B;UBA1;FBXO11;TRIM35;ARRB1;DTX2;PELI3;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;SASH1;BCL2;FBXO6;RNF10;RNF20;RNF6;CAND2;PRPF19;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;CDC73;RLIM;RNF31;NEDD8;FBXO17;FBXO41;PSMD1;SPSB2;PSMC5;RNF138;RNF7;PRKDC;PSMA1;UBE2R2;RBCK1;UCHL3;EIPR1;SIRT1;PSMD12;RNF213;KLHL20;TRIM3;FBXL16;MDM2;RBBP6;UBE2S;ANKIB1;ANAPC7;USP9X;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;FBXO22;PSMD7;TRIM2;TRIM13;BFAR;FBXL5;KLHL7;SPSB1;KLHL42;TRIM41;PHC1;NFX1;RNF146;MYCBP2;RMND5A;UBOX5;KLHL21;HECW1;FBXL15;ZSWIM8;PSME2;TRIM32;RNF103-CHMP3
prerank,purine nucleotide metabolic process (GO:0006163),-0.33811329090893627,-0.9996428459194131,0.4808510638297872,0.7509142800088355,1.0,13/24,37.84%,XDH;HPRT1;GPX1;NT5C1A;NT5E;NT5C;GDA;FHIT;PRPSAP1;GART;PRPS2;NUDT15;PPAT
prerank,cognition (GO:0050890),-0.2881534452066027,-0.9995867027664537,0.4774193548387097,0.7504744457097638,1.0,8/42,12.19%,ST3GAL4;SHROOM4;APP;CHMP2B;NIPBL;STRA6;FAM107A;MFSD2A
prerank,regulation of Golgi organization (GO:1903358),-0.3603290620861325,-0.9993773879808637,0.4603174603174603,0.750451160757017,1.0,9/17,33.21%,USP6NL;ARMH3;MAPK1;MAPK3;STX5;AKAP9;CAMSAP2;CAMSAP3;RBSN
prerank,negative regulation of GTPase activity (GO:0034260),-0.34310830757802224,-0.9993671694059567,0.45010183299389,0.7499178753499054,1.0,4/22,3.89%,LRCH1;DAB2IP;SH3BP4;F11R
prerank,protein kinase B signaling (GO:0043491),0.35152727488964836,0.9993134698072043,0.45,0.920364986434416,1.0,2/23,2.36%,IGF1;PIK3R3
prerank,microtubule anchoring (GO:0034453),0.41938645074250797,0.999242290431683,0.4468937875751503,0.9193714005985165,1.0,3/12,11.11%,CLASP1;BICD1;PCM1
prerank,maturation of LSU-rRNA (GO:0000470),0.3433386583214643,0.9985419086571724,0.446360153256705,0.9202780694914693,1.0,1/26,0.08%,NSA2
prerank,membrane lipid metabolic process (GO:0006643),-0.34236882305342964,-0.9983766569521967,0.4455852156057495,0.7518713704772266,1.0,4/22,4.01%,ST3GAL6;CYP1B1;AGK;B4GALT4
prerank,regulation of stem cell differentiation (GO:2000736),-0.25222040454718164,-0.9983695114399649,0.4603960396039604,0.7513293341963295,1.0,25/89,23.25%,PTN;JAG1;TCF12;NOTCH1;LMO2;RUNX1;HES1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;SP7;PSMB4;PSMD14;METTL3;PSMD10;PSME1;RBM24;PSMB3
prerank,error-free translesion synthesis (GO:0070987),-0.34182961208790796,-0.9982780530272172,0.45474613686534215,0.7509982594892995,1.0,4/22,5.64%,RPA1;UBC;RPS27A;UBB
prerank,regulation of exit from mitosis (GO:0007096),-0.29502578425592496,-0.998195990375941,0.45414847161572053,0.7506450754423932,1.0,6/38,7.05%,CDC27;UBC;ANAPC5;RPS27A;UBB;CDC16
prerank,striated muscle cell differentiation (GO:0051146),-0.3696345614717917,-0.9980599655261735,0.4669260700389105,0.7504250972713626,1.0,11/16,37.17%,MEF2C;SORT1;MYOCD;BMP2;PLD3;SKI;CBY1;SIK1;POPDC3;POPDC2;MYEF2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.27871414731814464,0.99801838071664,0.46621621621621623,0.9206876842207353,1.0,22/74,18.35%,EYA1;IGF1;HSPA1A;EYA4;EYA2;SIAH2;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;FAIM;TERT;SCG2;HSPA1B;NOL3;FAIM2;RELA;IL1A;TCF7L2;AKT1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.28166153478690004,-0.9980079814505106,0.45260663507109006,0.7499891742646478,1.0,10/49,15.24%,SGMS1;CAV1;BCL2L1;RACK1;BCAP31;SRC;EIF2AK3;PTPMT1;BBC3;PLAUR
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2782749088088219,-0.9978056208929702,0.44930875576036866,0.7499438360680787,1.0,19/57,23.95%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3;CRLF1;PPP2CA;CTF1;HCLS1;SOCS1
prerank,positive regulation of integrin activation (GO:0033625),-0.4186390324233267,-0.9975783562396301,0.47766990291262135,0.7499605334818119,1.0,4/11,15.34%,PIEZO1;RASIP1;SRC;FERMT2
prerank,regulation of immunoglobulin production (GO:0002637),-0.34035946940373896,-0.9972917003425189,0.4410480349344978,0.7501423332822618,1.0,5/23,13.79%,VAMP3;EPHB2;PHB2;PTPRC;CD86
prerank,7-methylguanosine RNA capping (GO:0009452),-0.308243408789973,-0.9969896899035405,0.4460580912863071,0.7498240473296583,1.0,11/31,26.40%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.308243408789973,-0.9969896899035405,0.4460580912863071,0.7498240473296583,1.0,11/31,26.40%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.310560648158336,-0.9969536495378019,0.42951541850220265,0.7493530523949752,1.0,11/30,24.43%,EIF3H;UBXN1;USP7;BAG5;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9;SVIP
prerank,positive regulation of cell communication (GO:0010647),0.34511460692266654,0.9968631161305972,0.5081669691470054,0.9228886234532732,1.0,5/28,9.52%,WLS;SYT1;GRIK2;RIMS1;DLG4
prerank,regulation of programmed cell death (GO:0043067),-0.23089049643614315,-0.9968340653077814,0.4594594594594595,0.749113809396841,1.0,58/161,30.16%,HIP1;MECOM;ACTN4;STEAP3;ACER2;APAF1;ACTN1;FAS;CRADD;PERP;TPT1;TGM2;RPS3;CDK5;BCAR1;IFT57;MALT1;CTSB;PHLPP1;BIRC3;RARG;NME2;MADD;ALK;RTN4;RBM25;TMEM219;OSGIN1;PTPN6;STK26;TIGAR;RIPK1;JAK3;AKT1S1;ACER3;LCMT1;BCL3;SLK;CHM;CASP1;NUP62;FANK1;TRIAP1;DAPK1;ZBTB7A;LRP8;WFS1;RTKN;DAPK2;DDX42;AGT;VCP;BIRC5;FBXO10;MARK4;FLT3;PMAIP1;IRF3
prerank,nitric oxide biosynthetic process (GO:0006809),0.40212292341459643,0.9967227990622431,0.4516765285996055,0.9221054013043254,1.0,3/13,4.43%,GCHFR;NQO1;ARG2
prerank,cytosolic transport (GO:0016482),-0.2431700880040689,-0.9964433834255042,0.4691358024691358,0.7495283198190245,1.0,42/108,27.31%,MYO1D;RAB14;VPS53;VPS13C;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;EMP2;VPS26A;SORT1;TMEM87B;PIK3C3;GOSR1;VPS13A;SYS1;TBC1D10A;AP2A1;STX8;SNX2;ANKRD27;STX6;RHOBTB3;DCTN1;PREPL;EPS15;SNX5;RIC1;VPS26B;VPS52;STX5;GAK;EVI5;DOP1B;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2631178662250427,-0.9959633958836672,0.4428904428904429,0.7501374418151301,1.0,27/68,33.08%,STAT3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;TWIST1;CD74;IFIH1;NOD2;IL33;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;TYROBP
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.31028212051029935,-0.9956524698966889,0.4617169373549884,0.7503788453314958,1.0,7/34,13.79%,SLC7A5;VAMP3;WNT5A;EPHB2;PHB2;PTPRC;CD86
prerank,acylglycerol catabolic process (GO:0046464),-0.31691299073067736,-0.9955086045590968,0.4517543859649123,0.750205773652096,1.0,4/30,12.54%,ABHD2;MGLL;PNPLA2;ABHD6
prerank,early endosome to late endosome transport (GO:0045022),0.3640925183775173,0.9953603852211892,0.4640776699029126,0.9250712695981175,1.0,6/20,17.36%,WDR91;SNX16;KIF16B;SNF8;HOOK1;PTPN23
prerank,cellular response to reactive oxygen species (GO:0034614),-0.2709175247162829,-0.995312561739329,0.4434589800443459,0.7501289541388131,1.0,11/59,7.89%,NET1;MAP3K5;EGFR;CYP1B1;PTPRK;JUN;ANXA1;PRKCD;PXN;MAPK1;RPS3
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.41480334244484507,-0.9950934055035394,0.47023809523809523,0.7501556254506613,1.0,3/11,13.36%,P4HA1;CRTAP;P4HA2
prerank,cGMP biosynthetic process (GO:0006182),-0.4118022265965113,-0.9950905059555714,0.470954356846473,0.7496117690371364,1.0,3/10,18.89%,GUCY1B1;GUCY1A1;NPPC
prerank,intracellular protein transport (GO:0006886),0.23131588451045307,0.9949343122796724,0.46953937592867756,0.9251359231117517,1.0,68/304,18.93%,RANBP3L;SNX6;TRAK1;APPL2;CTSA;WLS;IPO13;FAM53A;POM121;RAB21;STAM;NAPB;NUP155;CLIP3;COX18;SGSM3;NUP62CL;VPS26C;ARFGAP3;STX16;GGA2;STRADB;TNPO3;RUNDC1;TBC1D9B;KIF13B;NAPA;SNF8;RAB6B;ARL5B;NSF;SEC23IP;LAMP2;NXT1;TMED9;TMED4;SGSM2;IPO8;USO1;SNX8;RAB1A;TBC1D14;AP4M1;TBC1D10B;DESI1;FUT10;GGA1;VPS45;TBC1D16;AKAP6;RAB23;TNPO2;STX4;RAB19;TMED2;RPGR;IPO4;SEC31B;NUP88;SYNDIG1;PICK1;OXA1L;AKT1;HPS4;VPS29;GRTP1;SNX9;RAB38
prerank,cellular response to acid chemical (GO:0071229),-0.3209134647071232,-0.9949208095299432,0.4685466377440347,0.7495030050913557,1.0,10/27,14.92%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;VEGFA;KLF2;GLRA2
prerank,primary miRNA processing (GO:0031053),0.423328027035823,0.9947682159404926,0.45691382765531063,0.9244576670217869,1.0,2/10,4.91%,SMAD3;HNRNPA2B1
prerank,steroid catabolic process (GO:0006706),0.44269394928445893,0.9947290996404033,0.49304174950298213,0.9233870425140727,1.0,10/10,55.76%,HSD17B11;HSD11B1;SPP1;HSD17B14;HSD17B6;CYP19A1;FGF23;YWHAH;CYP24A1;CYP27B1
prerank,retrograde axonal transport (GO:0008090),-0.36989109336695253,-0.9940138610222956,0.4742268041237113,0.7512539030672646,1.0,5/16,17.93%,DST;SOD1;KIF1C;PAFAH1B1;DYNC1H1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.32670835349210114,-0.9937525373996401,0.4669509594882729,0.7513409607619457,1.0,5/26,10.47%,FOXP1;CRY1;STRN3;HEYL;PER1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3340436667057993,-0.9937278760053897,0.4723320158102767,0.7508516483962574,1.0,7/24,15.85%,NOTCH1;CREB3L1;VEGFA;KLF2;MT3;ATF6B;ATF4
prerank,regulation of cation channel activity (GO:2001257),0.272179297012144,0.9937174515084429,0.4867549668874172,0.9252529317991698,1.0,19/89,15.09%,CACNG7;ACTN2;CACNB1;ANK2;CACNB3;NLGN2;JPH1;DLG1;FGF12;SHISA7;SHANK1;GSG1L;DLG4;CNIH3;FGF14;OPRM1;SHISA8;LRRC7;GRIA2
prerank,regulation of secretion by cell (GO:1903530),0.29586936505702643,0.9936082808035803,0.4467713787085515,0.9243662927190447,1.0,19/54,20.07%,SNCAIP;RAB21;SYT1;RAB3C;LLGL2;STXBP5L;RIMS1;NSF;LLGL1;CPLANE2;RAB13;CPLX1;SYN1;STX4;HTR1A;CPLX2;RHBDF1;SCG5;RAB15
prerank,T cell differentiation in thymus (GO:0033077),-0.38833724850066353,-0.993502750300663,0.4743083003952569,0.7508925104230347,1.0,6/14,33.14%,GLI3;PTPRC;LIG4;ZFP36L2;FADD;RABL3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3918996208860751,0.9934069233139705,0.48349514563106794,0.9237938317000356,1.0,4/14,10.51%,LPIN1;ETNK2;PCYT2;CHKB
prerank,vesicle transport along microtubule (GO:0047496),0.34693281828165673,0.9933082760544211,0.45681381957773515,0.9229073847565448,1.0,8/23,19.57%,TRAK1;FYCO1;HTT;KIF3A;RAB1A;KIF3B;KIF1A;NDE1
prerank,glycolipid metabolic process (GO:0006664),-0.28796329327668246,-0.9932432675824718,0.43973214285714285,0.7510065118949875,1.0,10/47,13.30%,ST3GAL4;ST6GALNAC3;ESYT2;ST3GAL6;ST8SIA6;ESYT3;HEXA;PSAP;UGCG;ARSA
prerank,protein localization to cilium (GO:0061512),0.32595501706852814,0.9931786570750432,0.4830188679245283,0.9221026934722047,1.0,7/32,14.87%,TTC21B;TULP3;WDR19;WDR35;IFT122;TCTN2;ARL3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35981961082884073,0.9928859571877742,0.4514285714285714,0.9205630777061928,1.0,8/22,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35981961082884073,0.9928859571877742,0.4514285714285714,0.9205630777061928,1.0,8/22,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3955012628974449,-0.9928336930994426,0.45546558704453444,0.7514666317013203,1.0,5/13,18.85%,NOS3;GLS;DDAH1;GLUD1;PRODH
prerank,sensory perception of light stimulus (GO:0050953),0.27057940998038743,0.9922742854029197,0.45595854922279794,0.9211351749381015,1.0,23/87,22.59%,USH1C;GPR143;EYA4;WHRN;EML2;ARR3;PAX6;PCDH15;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA;CLRN1
prerank,histone H3 acetylation (GO:0043966),-0.29271871291527074,-0.9918213101259491,0.4966442953020134,0.7535840740586168,1.0,10/40,16.91%,LEF1;KAT7;KAT6A;TRIM16;PER1;JADE2;TAF5L;BRCA2;BRPF3;ING4
prerank,positive regulation of viral genome replication (GO:0045070),0.33144732845368385,0.9912442027697037,0.47101449275362317,0.922939105124875,1.0,4/29,7.53%,HACD3;TOP2B;PPARA;IFIT1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.405368445059663,-0.991054863333616,0.4807692307692308,0.7550170398211978,1.0,4/11,30.30%,AGTR1;PLA2G7;AGT;PLA2G5
prerank,negative regulation of lyase activity (GO:0051350),0.38587303727167327,0.9910301247089219,0.47410358565737054,0.9224203344000235,1.0,4/16,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,receptor clustering (GO:0043113),0.33991460932154594,0.990984554700207,0.4722753346080306,0.9213788621446742,1.0,8/27,17.81%,MAGI2;DLG1;LRP4;DLG4;ITGB7;LRRC7;DNAJA3;PICK1
prerank,dendritic spine organization (GO:0097061),-0.32187485452530307,-0.990903023235462,0.4620253164556962,0.7548884222935216,1.0,3/26,2.11%,SHANK3;DOCK10;INSR
prerank,exit from mitosis (GO:0010458),-0.40496627743832725,-0.9908094768961392,0.4743083003952569,0.7545919696536404,1.0,3/12,6.91%,PPP2R2D;EPS8;CHMP4B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.28288100087322926,-0.9905827824474247,0.4528301886792453,0.754647431457498,1.0,15/52,15.19%,YWHAE;YWHAB;UBE2D3;SAE1;ABLIM3;ARIH2;YWHAQ;YWHAZ;SREBF2;MICALL2;UBE2L3;FBXW7;UBL5;BBC3;UBE2J2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.41537077317019117,-0.9903381784868527,0.499054820415879,0.7547452181046175,1.0,5/10,31.09%,EIF2AK3;ATF4;QRICH1;HERPUD1;HSPA5
prerank,negative regulation of potassium ion transport (GO:0043267),-0.38219893616858225,-0.9902675223795522,0.47368421052631576,0.7543592388769946,1.0,3/13,4.88%,CAV1;NEDD4L;CAB39
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.30211856659231434,0.9902410236060665,0.4597495527728086,0.9223935425227064,1.0,9/48,8.98%,ADCY5;ADCY1;SLC26A1;PANK1;ACAT1;ADCY8;PANK2;AK5;AMPD3
prerank,plasma membrane tubulation (GO:0097320),-0.38550303030177524,-0.990212914824628,0.4721115537848606,0.7539489658173322,1.0,5/13,12.00%,CAVIN2;CHMP4A;WHAMM;EHD2;FNBP1L
prerank,mitotic cytokinetic process (GO:1902410),-0.34872452136765003,-0.9899802765231175,0.4796747967479675,0.7540111719942407,1.0,4/20,6.92%,RHOA;CHMP2B;CHMP4B;CHMP4A
prerank,phospholipid catabolic process (GO:0009395),-0.32889301271009075,-0.9897331010929092,0.4489795918367347,0.7540852374313081,1.0,4/24,14.67%,PLA2G4A;GPCPD1;PRDX6;SMPDL3A
prerank,protein-containing complex assembly (GO:0065003),0.23458913146108193,0.9896119967404551,0.4774774774774775,0.9230753382506834,1.0,69/259,20.29%,AFDN;F5;USH1C;CD247;WDCP;BET1;WDR19;CAPN3;PLEKHA7;PICALM;RSPH4A;KMT2A;DNAJB14;AFG3L2;ADD2;LEO1;GSDMD;ADCY8;IKBKG;KAT5;SHANK1;NAPA;RIMS1;LRRK2;GOLGA2;WASF1;PPARGC1A;NSF;TUBGCP4;LLGL1;DLG4;SEC23IP;CAND2;WASL;EPRS1;CDC73;SOX9;PML;CNIH3;TRAPPC1;USO1;WASF3;TERT;RAB1A;MEN1;PPP6C;TRAPPC4;TRAPPC3;WAS;TAPBP;TMED2;MDM2;MCFD2;HFE;NOL3;SEC22B;SKAP2;TFG;TCF7L2;F8;CX3CL1;MITF;SNX9;TFAP4;HGSNAT;PYGO1;PEF1;DNM1L;PDCD6
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3272625617553849,-0.9895633171444153,0.4626865671641791,0.7539782471449931,1.0,8/24,17.39%,NUBPL;NFU1;HSCB;NFS1;GLRX3;BOLA2;ISCA2;NUBP1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3498643234442484,-0.9892895386112173,0.4543524416135881,0.7540953684273358,1.0,6/19,13.71%,PRKCD;ABCD2;TWIST1;PNPLA2;AKT2;IRS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2707073596542082,0.9891409202815737,0.48613376835236544,0.9232799587571591,1.0,24/96,19.97%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,negative regulation of protein kinase activity (GO:0006469),-0.24563511004595354,-0.9891045431255802,0.45320197044334976,0.7540077865654791,1.0,18/88,13.63%,PTPRB;CAV1;DAB2IP;LRP6;LRP5;CORO1C;ADARB1;UBASH3B;PAK2;PPIA;CEACAM1;CDKN1C;PTPN1;DUSP3;HSPB1;GSKIP;DBNDD2;PTPRC
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3651348077023739,-0.9890226574188201,0.48502994011976047,0.7536673692383822,1.0,8/17,28.06%,FAF2;HM13;RHBDD1;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.34244217938050936,-0.9888585346894081,0.4895833333333333,0.7535490833838109,1.0,15/21,45.71%,DUSP3;PIBF1;JAK3;FCGR2B;SOX11;FOXJ1;SAMSN1;IL4I1;LAPTM5;GPNMB;VTCN1;TNFAIP3;FGL1;TNFAIP8L2;BANK1
prerank,translational elongation (GO:0006414),-0.24828778578469382,-0.9888380225706986,0.4742014742014742,0.7530612247751849,1.0,28/101,20.20%,EEF2K;EEF1A1;DAP3;MRPS10;MRPL20;RACK1;EEF2;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;EEF1G;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3831488034837392,0.9883386499193898,0.47474747474747475,0.9244870846673681,1.0,1/17,0.29%,FGF1
prerank,dendrite morphogenesis (GO:0048813),-0.29973195517963935,-0.9881848753391024,0.458980044345898,0.7540913025989239,1.0,7/35,10.32%,SHANK3;FARP1;DOCK10;PTN;KLF7;BTBD3;EPHB2
prerank,spinal cord development (GO:0021510),-0.38843186118261636,-0.987755431931705,0.4750499001996008,0.7546455883950576,1.0,5/12,22.64%,VIT;PKD1;SOX12;DLL1;SOX11
prerank,regulation of phagocytosis (GO:0050764),-0.27388445670663747,-0.9873283105892121,0.47342995169082125,0.7551917702447061,1.0,12/53,13.63%,SCARB1;MERTK;GAS6;PLSCR1;RACK1;TGM2;DOCK2;GATA2;IL15;DYSF;RAB27A;PTPRC
prerank,phospholipid biosynthetic process (GO:0008654),-0.295174240830684,-0.9872958691586606,0.46547884187082406,0.7547461121076697,1.0,5/36,4.99%,SGMS1;SGMS2;MBOAT1;AGK;CPNE3
prerank,response to nitric oxide (GO:0071731),-0.39164285361956597,-0.9872043141011113,0.4939516129032258,0.7544442656809222,1.0,2/13,2.33%,FOXO1;GUCY1B1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3512504735464871,-0.9868197945188464,0.45161290322580644,0.754895555089794,1.0,3/18,5.64%,UBC;RPS27A;UBB
prerank,endoplasmic reticulum organization (GO:0007029),-0.2554521999588618,-0.9867941063129947,0.4759725400457666,0.7544228405460974,1.0,26/72,25.25%,ATL3;APP;LMAN2L;STX1A;SEC16B;EIF2AK3;CAV2;SEC31A;SEC61A1;SHTN1;REEP3;REEP5;VAPB;UBE2J2;RTN4;TOR1AIP2;RTN3;WDR83OS;REEP1;STX5;GAK;LPCAT3;DOP1B;TLE6;REEP2;VAPA
prerank,positive regulation of cell aging (GO:0090343),0.4231445329101069,0.9867214423719023,0.44841269841269843,0.9280963697141578,1.0,3/11,4.43%,CDKN2A;LMNA;ARG2
prerank,JNK cascade (GO:0007254),-0.2942870424245177,-0.986707845085629,0.4966139954853273,0.7541018566251846,1.0,13/40,22.59%,MAP3K5;UBC;NOD1;RPS27A;UBB;TNFRSF19;IRAK2;TAB1;GPS1;NOD2;MAP2K7;RIPK2;MAP4K3
prerank,axonemal dynein complex assembly (GO:0070286),0.3342998366953366,0.986050753824633,0.466789667896679,0.9288478218536932,1.0,9/27,26.85%,DNAH1;DNAL1;DRC1;DNAAF2;DNAAF5;DNAAF3;DNAH5;DNAH17;ODAD4
prerank,negative regulation of macrophage activation (GO:0043031),0.3916544744142388,0.9860495959879756,0.48659003831417624,0.9276857830688755,1.0,3/16,9.10%,SYT11;TAFA3;NR1H3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3865613223839239,0.985772026303292,0.48643410852713176,0.9273481940537481,1.0,3/15,3.58%,FGF1;FGF4;SMOC2
prerank,nucleotide biosynthetic process (GO:0009165),-0.34458111829374616,-0.9857334932391029,0.44612068965517243,0.7560609529554201,1.0,10/18,38.99%,ME1;HPRT1;RRM2B;NMNAT1;PRPSAP1;RRM1;GART;PRPS2;PPAT;RRM2
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.38201123291551564,-0.985643598662134,0.49,0.7557565198255978,1.0,4/14,14.71%,FOXO3;FASTKD1;EARS2;MRPL12
prerank,mammary gland development (GO:0030879),-0.3395883607005542,-0.9854414490984513,0.4684873949579832,0.7557367265923225,1.0,6/21,13.82%,CAV1;TBX3;ARHGAP35;TGFB3;NOTCH4;VEGFA
prerank,regulation of muscle cell differentiation (GO:0051147),-0.30903993109234296,-0.9853792669049936,0.48775510204081635,0.7553540214010184,1.0,10/31,20.10%,MEF2C;BOC;CTNNA1;HDAC9;IGF2;MYOCD;CDH2;ID2;MAPK12;CDC42
prerank,ubiquinone metabolic process (GO:0006743),0.38892202736502646,0.9851374129336254,0.47297297297297297,0.9280496112308032,1.0,6/15,20.55%,COQ10A;COQ8B;AIFM2;COQ7;COQ3;FDXR
prerank,response to growth factor (GO:0070848),-0.2839204587406399,-0.9848608371160249,0.4778761061946903,0.756126095115145,1.0,10/41,14.57%,BMPR2;ACVR1;ACVRL1;TGFBR2;CPNE3;RACK1;KLF4;HDAC6;TBC1D7;ACVR1C
prerank,actin nucleation (GO:0045010),-0.34905945311073,-0.9848348516063682,0.49690721649484537,0.7556494288601793,1.0,10/21,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;SPIRE2;SCIN;ARPC5
prerank,positive regulation of cholesterol transport (GO:0032376),-0.32490655785674216,-0.9848177174644597,0.48123620309050774,0.7551390375764128,1.0,8/27,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,purine-containing compound catabolic process (GO:0072523),-0.39750242522541085,-0.984296572725001,0.49072164948453606,0.7558688982598729,1.0,6/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;GDA
prerank,endomembrane system organization (GO:0010256),-0.2260994550171163,-0.9842673002758313,0.49586776859504134,0.755407900440953,1.0,37/178,16.55%,SPTBN1;SYNE1;ATP8B1;ATL3;LMAN2L;TMED10;WASHC4;USP6NL;CHMP2B;PRKD1;FBXW8;CSNK1A1;COG3;SEC16B;ALS2CL;RAB22A;EIF2AK3;GOLPH3;CAV2;BAG5;DYSF;SUN1;SEC31A;SQSTM1;LEMD3;SNX10;UBXN2A;SEC61A1;REEP3;SURF4;REEP5;ZW10;VAPB;TLCD1;LYSMD3;SYNGR2;USP50
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4007741855558803,-0.9840440301503665,0.48526522593320237,0.7554128479705149,1.0,7/11,24.28%,VCL;CCN3;ITGB5;SERPINB8;DSP;JUP;THBS4
prerank,apoptotic mitochondrial changes (GO:0008637),0.32288659773109274,0.9838977699858111,0.4650735294117647,0.9304344249872959,1.0,10/32,20.76%,IFIT2;CCAR2;FZD9;NDUFS1;BCL2;CLU;AIFM2;ATP2A1;DNM1L;BAX
prerank,cellular response to purine-containing compound (GO:0071415),0.43123949919451665,0.9837926654938559,0.48068669527896996,0.9295749636101989,1.0,3/10,11.47%,GSTM2;RYR2;TRPM2
prerank,alanine transport (GO:0032328),-0.41987150112468147,-0.9837917114997617,0.49902152641878667,0.75548730637333,1.0,1/10,0.35%,SLC6A6
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.28991472762564124,-0.9835281861092472,0.46733668341708545,0.7556203010777528,1.0,11/44,20.01%,GSN;CDC42EP5;CDC42EP3;NCK1;WHAMM;CDC42EP2;PTK2B;PFN1;NCKAP1L;FCHSD1;HCK
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2943148402915735,0.9831600830344911,0.47266313932980597,0.930293054513227,1.0,13/52,17.34%,ADHFE1;ALDH1L1;ME2;HAAO;SLC19A1;MTHFS;GOT1;MTHFD1;IDH2;MTHFR;GOT2;FPGS;MTHFD2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4266725933522719,0.982952504624911,0.4801587301587302,0.9297435062954087,1.0,2/10,7.90%,BMP6;PLG
prerank,smoothened signaling pathway (GO:0007224),-0.3006847602377151,-0.9828315008536328,0.49671772428884026,0.7568647138621521,1.0,12/32,20.93%,HIPK1;GLI3;ARL13B;TCTN3;PTCH1;SMO;PTCH2;EVC2;STIL;IFT27;DISP3;DYRK2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.25771570579014474,-0.9826856208376317,0.49047619047619045,0.7566695123456318,1.0,13/76,9.91%,DAB2IP;TMSB4X;CD200;CYP1B1;PTGIS;NFKBIA;IRAK3;TRIM37;AIM2;NLRC5;DAP;USP7;KLF4
prerank,cellular response to alkaloid (GO:0071312),0.3789758670010449,0.9820274698433044,0.47578947368421054,0.9313286170342817,1.0,4/17,11.04%,TRPV1;CASP3;GSTM2;RYR2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2819257015045192,-0.9817605940811568,0.4988558352402746,0.7585569055709173,1.0,19/48,27.53%,PDE4D;PLCG1;UBASH3B;CAMK2D;CALM3;TRPC1;JPH2;CEMIP;PTK2B;PRKACA;APLNR;GPER1;DMD;NPSR1;JPH3;F2R;SELENON;CASQ1;CALM1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21414780126100094,0.9812620162611787,0.5319426336375489,0.9324012686430759,1.0,120/572,19.24%,PRDM6;AEBP1;WWOX;BMP6;DAB2;HSPA1A;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;SCRT1;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;ENO1;ZHX1;IFI27;DLG1;PEG3;PAX6;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;ZKSCAN3;E2F1;ATN1;MOSPD1;FGFR2;KAT5;NR2F2;CHD3;MIER3;IMPACT;MED1;MAX;DMAP1;NR1H3;E2F8;MED25;NKAP;RXRA;CBX6;ZFP90;PRDM2;C1QBP;NSD1;FOXP4;LDB2;LDB1;RITA1;LCOR;STAT1;FST;TAF1;MXI1;GATAD2A;CDC73;SOX9;BEND3;BHLHE41;JAZF1;SMYD2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;DICER1;TBL1XR1;BCL11A;PER2;HEXIM2;ERF;GADD45A;SIRT1;TENM2;RARA;NCOR2;MDM2;MDFI;DNAJA3;CITED2;IRF8;RELA;MTF2;KDM1A;USP9X;TCF7L2;TCF25;FNIP1;HDGF;APBB1;ARID5B;PCGF1;MLX;MITF;IRF2BP2;NFKB1;POU6F1;NCOR1;MEF2A;SOX2;LIN37;CPEB3;SIN3A
prerank,regulation of dendritic spine development (GO:0060998),-0.34681883776198724,-0.9810324088152017,0.4927835051546392,0.7599036437681048,1.0,2/19,0.56%,MEF2C;SHANK3
prerank,protein autoprocessing (GO:0016540),0.36594093813225625,0.9807875304082002,0.49404761904761907,0.9325700334070036,1.0,3/17,7.31%,AFG3L2;HTRA2;SPRTN
prerank,endosome organization (GO:0007032),-0.28954901225646085,-0.9803577221299418,0.4878587196467991,0.7610677758671002,1.0,8/41,12.78%,CORO1C;WASHC4;CHMP2B;ALS2CL;RAB22A;SQSTM1;SNX10;RAB27A
prerank,blood vessel endothelial cell migration (GO:0043534),0.3571157248306527,0.9803200857779978,0.49190283400809715,0.9328022655818662,1.0,3/22,2.36%,ROBO1;EFNB2;PIK3R3
prerank,smooth muscle contraction (GO:0006939),-0.3766734083751523,-0.9793491263133874,0.5010438413361169,0.7630253026016759,1.0,5/14,8.19%,EDNRA;SMTN;PIK3C2A;ACTA2;MYH11
prerank,glial cell differentiation (GO:0010001),-0.31181515600851506,-0.9790668252798329,0.5117773019271948,0.76316038317105,1.0,10/28,22.64%,ADGRG6;STAT3;CDK5;PTPRZ1;CDH2;GPC1;SOX8;MYRF;METRN;SOX11
prerank,epithelial cell morphogenesis (GO:0003382),0.3755315253770257,0.9786997970410467,0.4879518072289157,0.9363480355389154,1.0,4/17,9.77%,COL22A1;RILPL2;RILPL1;DACT2
prerank,proteasome assembly (GO:0043248),-0.3993835818363275,-0.978416052418994,0.46808510638297873,0.7642560492515706,1.0,4/11,21.90%,PSMD11;ADRM1;PSMD10;PSMG1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.39632749899163855,-0.9780885254674372,0.5109170305676856,0.7645326046036077,1.0,5/11,20.30%,ICMT;ATG12;ATG5;AGTPBP1;LCMT1
prerank,regulation of presynapse assembly (GO:1905606),0.3672308948343329,0.97795243488953,0.4704761904761905,0.9362390752502305,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,regulation of presynapse organization (GO:0099174),0.3672308948343329,0.97795243488953,0.4704761904761905,0.9362390752502305,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.34909985675005295,0.977238622839005,0.49809160305343514,0.9371402506175226,1.0,2/22,6.93%,BMP7;FLOT2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.219207308930863,-0.9768199570788213,0.523943661971831,0.767190745593531,1.0,40/198,15.95%,PTPRB;PLCB4;PLCE1;PLA2G4A;PIP4K2A;INPP4A;LIMD1;LIMK2;PLCG1;STAT3;ALPL;AGK;PLCG2;PANK3;TNFAIP8L3;PAK2;INPP5D;PPP3CA;ALDOA;PRKCG;PIK3CA;PLPP1;CDK5;PPP1CA;PFKL;DUSP3;BCKDK;EPHB2;PIK3CD;GFPT2;DUSP23;AGPAT1;PTPRC;ENPP1;ALK;PLPP3;THNSL2;IPMK;NT5C;ACYP1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4000536230588566,0.9767649500251391,0.4573643410852713,0.9373057314608849,1.0,4/12,12.04%,HNRNPU;PCGF5;YTHDC1;RLIM
prerank,axon extension (GO:0048675),-0.33030826438338007,-0.976374379013439,0.49901768172888017,0.7677906866558035,1.0,11/23,21.38%,NRP1;NRP2;SLIT2;CDK5;SEMA5B;MAP1B;SEMA5A;ULK2;SLIT1;SLIT3;SEMA3F
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.36968880485080996,-0.9763593179474742,0.5061475409836066,0.7672850084919975,1.0,7/15,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;BGN;B3GAT3;NCAN
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29976264487843324,-0.9763422385780538,0.48478260869565215,0.7667943458154921,1.0,6/36,10.47%,MECOM;FOXO1;PPIA;AIDA;DUSP3;PER1
prerank,fatty acid elongation (GO:0030497),0.3984762105479691,0.9762525681282105,0.4990138067061144,0.9376080455070346,1.0,4/13,9.07%,HACD3;HACD4;HACD1;ABCD1
prerank,regulation of mRNA processing (GO:0050684),0.3246252390032846,0.9761126477048816,0.474169741697417,0.9368215543800825,1.0,13/32,26.13%,PABPN1;SLTM;SRSF10;SON;TIA1;YTHDC1;SAFB2;SAFB;LARP7;SRPK1;AHCYL1;JMJD6;ZFP36L1
prerank,sterol homeostasis (GO:0055092),-0.26349605148897914,-0.9757821897910088,0.513126491646778,0.7676344876993494,1.0,13/65,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3611125271854549,-0.9756649199498508,0.49101796407185627,0.7673870744167381,1.0,10/17,38.15%,CXCL12;SERPINE1;HMGB1;PLA2G7;CCR2;ANO6;AIF1;CXCL17;CCL5;CCR1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.36973340352815875,0.9755516908835368,0.48526522593320237,0.9372842282698076,1.0,4/17,11.04%,ANK2;SNTA1;KCNH2;RYR2
prerank,double-strand break repair (GO:0006302),0.24378795912868462,0.9753875053956441,0.49059561128526646,0.9365943593924804,1.0,33/158,18.13%,EYA1;PAXX;POLM;ERCC1;RECQL4;XRCC1;ACTR8;AUNIP;TENT4A;ABRAXAS1;MEIOB;EME2;KAT5;KDM2A;ZFYVE26;TDP2;MDC1;MRE11;PRPF19;KDM4A;CHEK2;PIAS4;RAD51D;RNF138;PRKDC;RPA3;ATM;AP5Z1;RAD52;POLN;XRCC2;APBB1;NHEJ1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3580197565832184,0.9753419308488086,0.49007936507936506,0.9355906564686245,1.0,5/19,10.07%,TGFBR3;BMPR1A;RBPJ;FGFR2;TGFBR1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2975639567372014,-0.9746712702224825,0.4603174603174603,0.7693353115568689,1.0,11/36,17.95%,ENG;RASSF2;RAP2A;CALM3;PPP2R5C;PDGFC;PDGFD;ENPP1;VEGFA;TNKS1BP1;NBN
prerank,nuclear body organization (GO:0030575),-0.3891712717718819,-0.9746515157691593,0.501984126984127,0.7688526099724059,1.0,4/12,16.55%,ETS1;SERBP1;USPL1;USP50
prerank,regulation of spindle assembly (GO:0090169),0.33994502445088853,0.9745067885096548,0.5,0.9369167038948989,1.0,8/25,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;SPAG5;CHMP1A
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3834522501484118,-0.9744390704381168,0.48490945674044267,0.7688266676913288,1.0,6/13,21.54%,RPS15;ABCE1;NMD3;LTV1;SDAD1;RRS1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3850598532352485,0.9743719709869433,0.4871287128712871,0.9361743733343035,1.0,2/14,4.13%,OXSR1;STK39
prerank,protein deacetylation (GO:0006476),-0.2897241250278193,-0.9742681848920904,0.4758771929824561,0.7687099656250554,1.0,14/41,23.64%,MIER1;FLNA;PRDM5;HDAC7;HDAC9;SIRT5;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6
prerank,regulation of fibrinolysis (GO:0051917),-0.38336252602957205,-0.9742197769116578,0.4707112970711297,0.7683007703713799,1.0,3/13,9.35%,FAP;THBS1;SERPINE1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31760136776579667,-0.9736237873252326,0.48316831683168315,0.7692744055129355,1.0,6/25,13.25%,RPL5;GABARAPL2;RPS7;PRKCG;RPL23;CSNK2A1
prerank,regulation of gluconeogenesis (GO:0006111),0.3307233468730738,0.9735147095516993,0.48811700182815354,0.9374214065407483,1.0,6/27,16.17%,GCK;C1QTNF3;PDK2;PPARGC1A;SIRT1;CLK2
prerank,sodium ion import across plasma membrane (GO:0098719),0.3725380413944451,0.973354099588447,0.48659003831417624,0.9367308807135344,1.0,1/17,0.21%,SLC6A1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3115719182449058,-0.9732335039602007,0.49369747899159666,0.7697030443372058,1.0,17/30,32.89%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,regulation of p38MAPK cascade (GO:1900744),-0.30191501241620644,-0.9730497592118375,0.5236051502145923,0.769626888344799,1.0,14/35,23.61%,DAB2IP;MFHAS1;XDH;PER1;PHLPP1;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;DUSP1;CYLD;PRMT1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.34134652620676287,-0.973025146604477,0.504,0.7691427975500321,1.0,7/20,15.59%,NRP1;SLIT2;SERPINE1;S100A11;CCN4;LRP1;VTN
prerank,cellular response to fatty acid (GO:0071398),-0.3947358958698556,-0.9727173828339046,0.5110220440881763,0.7693490231154769,1.0,4/12,19.09%,PID1;IRS1;NR1H4;ZC3H12A
prerank,protein O-linked glycosylation (GO:0006493),0.26350918648200594,0.9725319037521574,0.495,0.9380350557817068,1.0,20/96,15.98%,GXYLT2;TRAK1;CHST4;MUC19;ST3GAL3;TMTC4;GALNT11;GALNT14;TET1;LARGE1;GALNT12;GALNT3;FKTN;GALNT2;B3GLCT;DPM1;GALNT1;CRPPA;MUC1;TET2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.34141260472396195,0.9724893950552669,0.48880597014925375,0.9370219530381927,1.0,9/25,17.41%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;STAT5B
prerank,peripheral nervous system development (GO:0007422),-0.33074990056633974,-0.9724581839081642,0.5169491525423728,0.7695124418990881,1.0,6/23,19.58%,ADGRG6;NGF;GPC1;PMP22;NFASC;SOX8
prerank,establishment of protein localization to membrane (GO:0090150),0.282729657658033,0.9724238364299969,0.5052083333333334,0.9360617348254074,1.0,9/66,9.20%,AFDN;SYNE3;MICALL1;ZDHHC12;RAB3GAP1;COX18;PRKCI;ZDHHC24;ZDHHC1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3453603664716074,-0.9723720523441899,0.4989293361884368,0.7692038267093088,1.0,4/20,6.06%,CRY1;STMN1;YWHAB;MET
prerank,regulation of interleukin-13 production (GO:0032656),0.39631621061398353,0.9722734886499588,0.4979757085020243,0.9353687371928034,1.0,2/13,1.59%,IL18;PRKCZ
prerank,protein autophosphorylation (GO:0046777),-0.2268539924733809,-0.9719600686204636,0.517426273458445,0.7696068378396126,1.0,40/157,20.01%,TEK;INSR;PEAK1;EGFR;EEF2K;KDR;BMX;TNIK;CAMK2D;PAK2;TEC;PRKD1;ERN1;LYN;FLT1;PRKX;STK24;SRC;FLT4;EIF2AK3;STK33;MAPKAPK2;GRK5;STK10;DYRK1A;PTK2B;STK16;ALK;CSF1R;MKNK2;TAOK3;CAD;FGFR3;TAOK1;STK26;MAPK3;MARK3;STK17B;RIPK1;HCK
prerank,regulation of vacuole organization (GO:0044088),0.36555347388448745,0.9714546808498362,0.4757630161579892,0.9366794306076053,1.0,11/20,26.50%,NPRL3;ENO1;ENO4;TBC1D14;NPRL2;ANXA2;ADPRH;PIKFYVE;IFT20;MTM1;ENO3
prerank,negative regulation of dephosphorylation (GO:0035305),0.3636130926801521,0.9709395309122412,0.5019607843137255,0.9369978599816133,1.0,2/18,2.54%,SH3RF2;SH2D4A
prerank,regulation of mitotic nuclear division (GO:0007088),0.2888779785902652,0.970744934848613,0.5067796610169492,0.9364251984746554,1.0,7/55,9.15%,BMP7;IGF1;OBSL1;CDC25C;TOM1L2;DRD3;PHIP
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.34207079540003327,-0.970562675572219,0.5041322314049587,0.7725754103350753,1.0,2/19,1.66%,PARD3;CLIC4
prerank,icosanoid secretion (GO:0032309),-0.39134894327869973,-0.9704984451999746,0.5117647058823529,0.7721849229569397,1.0,2/12,6.64%,ABCC4;ANXA1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.23904300359616631,-0.9701932113543759,0.5184275184275184,0.7718801534523156,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,cellular response to lectin (GO:1990858),-0.23904300359616631,-0.9701932113543759,0.5184275184275184,0.7718801534523156,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,positive regulation of mRNA processing (GO:0050685),-0.3387720016265851,-0.9699217384757514,0.5163265306122449,0.7720145733828301,1.0,9/21,25.86%,RBM3;PRDX6;PAF1;NCBP2;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3517845158226047,0.9696791251250833,0.5027027027027027,0.9383907855485581,1.0,5/21,17.21%,OSBPL8;PLA1A;OSBPL5;PLAAT3;OSBPL10
prerank,negative regulation of histone methylation (GO:0031061),0.4228058081515451,0.9695763731807998,0.5030425963488844,0.9375721395825731,1.0,4/10,17.54%,JARID2;PHF1;MTF2;KDM1A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.34681042380960236,0.969134249082857,0.502868068833652,0.9376999861552242,1.0,5/22,8.73%,CACNB1;CACNB3;CRHR1;GNB5;DRD3
prerank,negative regulation of cellular component movement (GO:0051271),0.3800007946495691,0.9685139766089209,0.5,0.9383408413320345,1.0,2/15,2.23%,TGFBR3;FBLN1
prerank,response to calcium ion (GO:0051592),0.25744358833676595,0.968467353940382,0.5149501661129569,0.9373302816149467,1.0,18/102,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SLC25A12;SYT10;RYR2;TRPM2;CPNE6
prerank,peroxisome organization (GO:0007031),-0.3170027705410689,-0.9681153978591057,0.4668094218415418,0.776041443140268,1.0,5/25,8.56%,TMEM135;MFF;SEC16B;ABCD2;PEX7
prerank,protein hydroxylation (GO:0018126),-0.3627660029017749,-0.9680961076759926,0.5029821073558648,0.7755460329345595,1.0,9/15,38.08%,PLOD2;PLOD3;JMJD4;EGLN3;JMJD7;P3H1;VIPAS39;PLOD1;P3H2
prerank,endodermal cell fate commitment (GO:0001711),0.43440222647103555,0.9679266176299507,0.5040983606557377,0.9376969320036946,1.0,3/10,11.83%,CTR9;LEO1;CDC73
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.35612991436368835,-0.9679077673214976,0.48412698412698413,0.7754823454664069,1.0,4/17,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,negative regulation of kinase activity (GO:0033673),0.282126138907402,0.9676141697249057,0.4891304347826087,0.9374185250788557,1.0,5/62,6.70%,PRKAG2;DEPTOR;HNRNPU;WWTR1;PDPK1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.2609511585251474,-0.9675326768784688,0.5209302325581395,0.7758697014466591,1.0,20/66,23.39%,KAT7;PIK3R1;LIMK2;CDH1;FLNA;TFRC;PRKCD;ORMDL3;EIF2AK3;IPO5;NMD3;TPR;CCT2;FERMT2;ZC3H12A;MEPCE;JUP;DTX3L;DKC1;HCLS1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3110466519761035,-0.9673501862609752,0.4794238683127572,0.7758120271642687,1.0,6/28,12.56%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.368797339229119,-0.967310406840153,0.48096192384769537,0.7753743287491521,1.0,5/15,14.72%,CDC27;HECW2;CDC16;TPR;PTTG1
prerank,lymphocyte proliferation (GO:0046651),-0.32573456880926993,-0.9671491752663369,0.48717948717948717,0.77521619523538,1.0,5/22,13.63%,MEF2C;ELF4;CTPS1;CD40;PTPRC
prerank,cell part morphogenesis (GO:0032990),-0.382195842451429,-0.9663789041900999,0.511727078891258,0.77661779602198,1.0,3/13,8.00%,PID1;MFF;NUBPL
prerank,regulation of transposition (GO:0010528),0.3891048467215807,0.9662067729707626,0.4759036144578313,0.9402077989758552,1.0,3/13,14.13%,TDRD9;SPOCD1;MYBL1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3839997322197697,-0.9656362961928049,0.5080321285140562,0.7779903042908886,1.0,4/13,17.10%,NFU1;GLRX3;BOLA2;ISCA2
prerank,dendritic spine morphogenesis (GO:0060997),-0.3603790723475916,-0.9654778409295189,0.49385245901639346,0.7778665848224152,1.0,2/15,0.82%,SHANK3;DOCK10
prerank,negative regulation of lipid storage (GO:0010888),0.35854950502636623,0.965307380716318,0.49298597194388777,0.9416582423244454,1.0,4/19,9.10%,OSBPL8;PPARA;ABHD5;NR1H3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.29933168034791874,0.9652706847706648,0.5063291139240507,0.9406405682328018,1.0,16/46,18.53%,IGF1;IL18;OGN;IGFBP3;NOX1;NDRG4;VIP;STAT1;MFN2;PRKDC;IL6;RBPMS2;TCF7L2;AKT1;IL12A;CX3CL1
prerank,regulation of translation (GO:0006417),-0.2199368922949678,-0.9652694934731286,0.5663956639566395,0.7778585110816582,1.0,60/173,29.77%,NIBAN1;THBS1;FOXO3;RBM3;RPL5;APP;RPS6KA3;RPL10;EIF3E;ALKBH1;EIF3H;RACK1;EEF2;RPS3;MTRF1;EIF2B2;EIF2AK3;EIF4E;HSPB1;NCBP2;SYNCRIP;EIF1B;NCBP1;EIF4G3;DHFR;FMR1;PRR16;DDX25;FXR1;GAPDH;RIDA;METTL3;NCL;PIWIL2;MTG1;EIF4H;BCL3;CAPRIN1;KLHL25;EIF4A3;NANOS3;EIF3B;RPL13A;DAPK1;BTG2;SHMT2;TYMS;HNRNPD;MTIF2;LTN1;METTL14;RPS6KA1;RPS4X;GEMIN5;SHMT1;NSUN5;IGF2BP2;PCIF1;IGF2BP1;CNOT1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2480042238198551,-0.9650110568047031,0.5220417633410673,0.7779693407997365,1.0,28/78,26.95%,ACTB;PKD1;EGFR;CCNY;APC;CDKN1C;IPO7;SERTAD1;MYOCD;GTF2H1;IPO5;HHEX;BLM;PTEN;LATS1;CCNF;CCND1;PSMD10;CCND2;CCNH;CCNB2;CDKN1B;RGCC;LATS2;CDKN3;MAPRE3;CDKN2B;CCNT1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.22314537883982521,0.9646998276582623,0.576437587657784,0.9411460106636842,1.0,50/327,12.40%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;DMTF1;PML;CHEK2;RBAK
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2590209003320341,-0.9645261542158827,0.5284738041002278,0.7786382522467199,1.0,18/70,21.47%,TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;METTL3;PSMD10;PSME1
prerank,regulation of TOR signaling (GO:0032006),0.2773587055291214,0.9642351206730502,0.5125628140703518,0.9413919123382088,1.0,25/67,24.50%,PRKAA2;NPRL3;RRAGC;RICTOR;DEPTOR;SLC38A9;PIH1D1;FBXO9;LAMTOR2;TSC1;NPRL2;LAMTOR3;SIRT1;TELO2;RRAGB;FNIP1;PDCD6;MLST8;LAMTOR1;TMEM127;EPM2A;ARAF;TTI1;GPAT3;UBR2
prerank,ion transport (GO:0006811),0.25211840774908295,0.9642089982987216,0.5091210613598673,0.9403434102090942,1.0,13/111,11.52%,TRPM3;SLC8A3;SLC5A5;SLC24A3;SLC26A1;GLRA1;WNK4;SLC15A2;CHRNB2;KCNN4;SLC12A5;SLC12A1;PLP2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3119294402151123,-0.963936626785147,0.4831932773109244,0.7795995726409093,1.0,4/27,5.95%,PRKCH;NFKBIA;ABCA1;AGTR1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.23752319360136875,-0.9639050049465978,0.5197044334975369,0.7791270824031519,1.0,28/105,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,negative regulation of nervous system development (GO:0051961),0.36905446951779886,0.9634756045219601,0.49343339587242024,0.9412888304746807,1.0,5/17,15.60%,APPL2;WNT7A;PAX6;PCM1;IL6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4081702657626132,-0.9634320659034646,0.5224719101123596,0.7798574607168002,1.0,4/10,16.87%,CSGALNACT1;XYLT1;B3GAT1;B3GAT3
prerank,mitochondrial protein processing (GO:0034982),0.4090923657519001,0.9633681627760866,0.5062761506276151,0.9404629291870255,1.0,2/11,5.63%,AFG3L2;IMMP1L
prerank,protein polymerization (GO:0051258),-0.2667768462778647,-0.9629218909850217,0.5095693779904307,0.7805659268142021,1.0,12/55,13.24%,GSN;MSRB2;CHMP4B;CHMP4A;MAP7D3;TPPP3;WASHC3;FAM107A;FGF13;MICALL2;PSTPIP2;TRPV4
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3862367898294732,-0.9627548403509412,0.4959016393442623,0.7804271891666438,1.0,3/12,10.53%,SERINC5;SRR;SERINC3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.258413189188684,-0.962648811314631,0.5098039215686274,0.780125079734801,1.0,20/70,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;LNPEP;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.37379547860418844,0.9626294672317915,0.5221987315010571,0.9414278525287295,1.0,6/15,16.23%,KIT;WHRN;ADGRV1;KCNK4;PDZD7;LHFPL5
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3448374988818032,0.9623004480991381,0.5211538461538462,0.9412840178032017,1.0,12/22,27.51%,ANK2;GSTM2;HTT;RYR2;GSTO1;AKAP6;ATP2A1;STAC3;VMP1;SLC9A1;HAP1;STAC2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3531766619294823,0.9619485282940325,0.511070110701107,0.9411305170514885,1.0,6/20,13.17%,DAB2;PICALM;PKDCC;RHOQ;MRAP2;MRAP
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.30127510046196543,-0.9618825860383048,0.52,0.7814352795585684,1.0,6/32,6.49%,RAPGEF2;NEDD4L;HECW2;TNIK;RAP2A;FBXW8
prerank,cellular response to topologically incorrect protein (GO:0035967),0.31490605101959895,0.9618670109648857,0.4782608695652174,0.9402578203801548,1.0,4/31,4.40%,HSPA1A;DNAJC18;OPTN;DNAJB14
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.25900335987945305,0.9616099339959056,0.5033444816053512,0.939847263091737,1.0,26/95,17.06%,HS3ST3A1;UST;HS3ST3B1;OGN;CHST15;ST3GAL3;HS6ST1;OMD;NDST1;PXYLP1;B4GALT2;B4GALT1;B3GALT6;B4GALT3;HS3ST6;HS3ST5;HS6ST2;HYAL1;FMOD;CSPG5;ABCC5;DSE;NDST2;HS2ST1;CHST9;CHST3
prerank,regulation of blood circulation (GO:1903522),-0.29654539804579716,-0.961526620102789,0.5176211453744494,0.781807966141853,1.0,10/34,18.76%,ECE1;CAMK2D;AGTR1;KCNMB2;KCNQ1;KCNJ12;ACE2;TBX2;PLN;CACNA1H
prerank,neuromuscular synaptic transmission (GO:0007274),0.3626678023604637,0.9615144491794714,0.48698884758364314,0.9390307004472321,1.0,2/18,8.71%,DTNA;CHRNB2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.41857755985087586,0.9613872671770581,0.5203252032520326,0.9382884832645968,1.0,3/10,11.20%,RUVBL2;PIH1D2;PIH1D1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3368880469771369,0.9610722241690987,0.492156862745098,0.9380959943915695,1.0,4/24,8.34%,ERRFI1;ROCK2;HOXA7;MED1
prerank,regulation of mitochondrion organization (GO:0010821),-0.27365798782570694,-0.9608851769152672,0.5386416861826698,0.7828929550084124,1.0,21/47,31.01%,PID1;MFF;PDE2A;IAPP;MYO19;GOLPH3;SREBF2;SQSTM1;HDAC6;FBXW7;PRMT6;SIRT7;SREBF1;RHOT2;MUL1;TREM2;MAPT;STOX1;FLCN;VPS35;USP36
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2704633523492879,-0.960656838935143,0.5339168490153173,0.7828927887273516,1.0,21/56,26.98%,SPTBN1;RHOA;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;DCTN3;INCENP;IST1;NUSAP1;RHOB;RAB35;ROCK1;RASA1;ALKBH4;KIF4A;JTB;CEP55;RTKN
prerank,regulation of DNA replication (GO:0006275),-0.26981187114646527,-0.9605049408283,0.5147058823529411,0.7827651681212181,1.0,15/49,24.66%,BCAR3;ACVRL1;KAT7;WAPL;EGFR;S100A11;FBXO5;BLM;BRPF3;ORC5;PPP2CA;FAF1;NUCKS1;EGF;CTC1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.322584821920089,0.9602877878147565,0.5102803738317757,0.93927231582487,1.0,8/28,17.57%,HSPA1A;CLASP1;ARL2;DRG1;HSPA1B;MAPRE1;NAV3;CDK5R1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.39907205098063303,-0.9601092747479957,0.5166666666666667,0.782694010656833,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.39907205098063303,-0.9601092747479957,0.5166666666666667,0.782694010656833,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,phospholipid metabolic process (GO:0006644),0.2718958544882769,0.9600471118471365,0.5197368421052632,0.9388373496156995,1.0,16/71,17.39%,FITM2;AGPAT4;PLA2G4C;SMPD3;PCYT2;PLCD1;CLN8;PLPPR3;SMPD2;ACP6;PLA2G15;GDE1;ABCA2;PLBD2;PLAAT3;AGPAT2
prerank,regulation of DNA binding (GO:0051101),-0.2798591246320152,-0.9599571317327628,0.54292343387471,0.7825330415280323,1.0,6/44,6.07%,LEF1;HJURP;NGF;NFKBIA;JUN;HES1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2757858711025414,-0.959700863147346,0.536036036036036,0.7826472580766489,1.0,6/47,4.37%,SPTBN1;STXBP6;MACF1;EXOC6;RAB31;EXOC4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.36465423090003757,0.9596012247813903,0.504950495049505,0.9390062330816916,1.0,3/16,11.97%,APPL2;WDTC1;SOX9
prerank,regulation of transferase activity (GO:0051338),0.3644037363412723,0.9595369228530116,0.5059055118110236,0.9380793710842534,1.0,9/17,21.55%,PPP1R3F;LDB2;LDB1;PARP4;FEM1A;SMG6;ATM;PINX1;JMJD8
prerank,negative regulation of gene expression (GO:0010629),0.22396440814867283,0.9594694706293552,0.5617647058823529,0.937168156999024,1.0,46/302,14.43%,ROBO1;NOTCH2;WNT4;LGR4;SYT11;IGF1;HSPA1A;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;TWSG1;CPNE1;OPRD1;BMPR1A;PICALM;TNRC6A;LRP3;TRIM71;DNMT3A;PTBP2;FLOT2;JARID2;PPHLN1;PTBP1;PHF1;LSM5;HINFP;EIF2AK2;PARP14;PAIP2B;MPHOSPH8;PPM1D;PAIP2;TAF1;EPRS1;KDM4A;EIF4E2;AGO3;TERT;TSC1;DICER1;HSPA1B;HAVCR2;FXR2
prerank,regulation of sensory perception of pain (GO:0051930),-0.4013887818241939,-0.959327058840294,0.512396694214876,0.7830620204734949,1.0,6/11,25.72%,CCN3;MGLL;TMEM100;ATPSCKMT;ACP3;F2R
prerank,regulation of urine volume (GO:0035809),0.42003512101812135,0.9588459787441475,0.49075975359342916,0.9378672843103569,1.0,3/10,20.59%,NPR3;ADCY6;INPP5K
prerank,somite development (GO:0061053),-0.39262029969511764,-0.9586741001910469,0.5349716446124764,0.7841497454010415,1.0,4/11,13.20%,MEOX2;PTCH1;SMO;PPP2R3A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.31818429391575803,-0.9580905604803038,0.5169491525423728,0.7850590940816166,1.0,6/26,20.34%,CAV1;MFHAS1;IFI35;RSAD2;RTN4;HMGB1
prerank,cellular response to pH (GO:0071467),0.3689879605241418,0.9579767585965707,0.5123809523809524,0.9393002405957129,1.0,4/17,13.35%,TRPV1;IMPACT;KCNK4;HYAL1
prerank,negative regulation of inflammatory response (GO:0050728),-0.22060442850189138,-0.9578476231183092,0.5485564304461942,0.7851359275946205,1.0,30/182,11.81%,TEK;CALCRL;CD200;PPARD;RAMP2;MYH9;PTGIS;PLCG1;TNFRSF1B;MFHAS1;CCN3;PLCG2;ADCY4;GNB1;PTGDR;LYN;PRKCD;ADCY7;GNG2;PLK2;IAPP;MDK;SRC;ADCY2;APOE;KLF4;YES1;ADM;CYSLTR2;CYSLTR1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.26339420867865576,0.9573475296843799,0.5291181364392679,0.9399791374624636,1.0,7/87,3.11%,NOTCH2;ROCK2;PDGFRA;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,protein polyglutamylation (GO:0018095),0.40225263765471686,0.957039483327892,0.5168316831683168,0.9397652215125846,1.0,4/11,21.52%,TTLL6;CFAP20;TTLL11;TTLL4
prerank,apical protein localization (GO:0045176),-0.4105687397588291,-0.9568776600980701,0.5369261477045908,0.7870748694837824,1.0,2/10,0.62%,ACTB;ATP8B1
prerank,RNA splicing (GO:0008380),0.25801005908235725,0.9566686144551251,0.5409836065573771,0.9396805057771733,1.0,31/95,24.43%,RRAGC;NOVA1;CCAR2;HNRNPH3;SRSF10;PTBP1;PPARGC1A;ZMAT5;LSM4;MPHOSPH10;USP39;SRSF11;USB1;RNPS1;DHX8;PRPF6;NOL3;PRPF3;DDX39B;DDX47;SF3B2;SF3B1;SNRPB;CDK12;SCNM1;SF3B3;SRPK1;SNRPN;HNRNPC;WDR83;SRSF2
prerank,membrane repolarization during action potential (GO:0086011),-0.3669625724629242,-0.9566476700548889,0.5147058823529411,0.7871166452801887,1.0,5/13,15.86%,YWHAE;KCNJ2;KCNQ1;ATP1A1;KCNE4
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3030858964737031,-0.9566360726490518,0.5251641137855579,0.7866084618626203,1.0,13/33,22.53%,SLC39A8;GLS;GCLC;DDAH1;GCLM;ALDH18A1;GLUD1;ALDH5A1;CAD;PRODH;PYCR3;DDAH2;GGT1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3383600066798865,0.956559384517088,0.539047619047619,0.9389103610139026,1.0,7/20,17.57%,CHRM2;CHRNB2;LY6G6D;PLCB1;CHRM1;RGS8;CDK5R1
prerank,body fluid secretion (GO:0007589),0.3781620026125815,0.955993812039874,0.5294117647058824,0.9394742108705432,1.0,3/15,12.82%,PRLR;VIP;SLC22A2
prerank,negative regulation of cell communication (GO:0010648),-0.33880638839344734,-0.9559472042160972,0.52834008097166,0.7878260952202024,1.0,5/21,9.53%,ACVR1;UBASH3B;HHIP;PTPN1;SOCS5
prerank,negative regulation of interferon-beta production (GO:0032688),0.410880078314558,0.9558455878912862,0.49146110056925996,0.938846812278819,1.0,6/10,20.22%,NLRC3;CACTIN;PPM1B;SIRPA;PYCARD;PTPRS
prerank,regulation of myotube differentiation (GO:0010830),-0.31737081097104347,-0.9555842963611104,0.5188284518828452,0.7881809586057577,1.0,5/24,8.65%,NOTCH1;PIEZO1;CCN3;HDAC9;TMEM119
prerank,cellular response to ketone (GO:1901655),0.3127915831664189,0.9555147751687992,0.5238095238095238,0.9387635483588526,1.0,6/35,12.34%,ADCY5;ROCK2;ADCY1;ADCY8;NDOR1;SPHK2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.26008181999919977,0.9553008567307412,0.5152603231597845,0.9383196957414511,1.0,26/88,22.19%,BMP7;SMAD3;STX18;ERCC1;STAM;SMPD3;NRG1;SNF8;GNL3L;PIH1D1;CHGA;CLU;HYAL1;PRKCA;TRABD2B;SLF1;FNIP1;CX3CL1;BRK1;TIRAP;BAX;EMILIN1;ATP13A2;SDCBP;SLX4;PLEK
prerank,odontogenesis (GO:0042476),-0.29853449571721113,-0.955201850303691,0.5226244343891403,0.7886263763289795,1.0,7/35,12.38%,LRP6;TGFB2;BMP4;TBX1;AXIN2;TGFB3;BMP2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4020549413053582,0.9549601655472256,0.5079681274900398,0.9381706610386945,1.0,4/11,19.22%,DERL1;BAG6;RNF5;UGGT2
prerank,gastrulation (GO:0007369),-0.3618571497776887,-0.9548696811437887,0.5183585313174947,0.788951896193261,1.0,3/15,14.11%,LRP5;LMBRD1;TASOR
prerank,cardiolipin metabolic process (GO:0032048),-0.37616436249061336,-0.9543456223575603,0.5178947368421053,0.7896740715466632,1.0,4/13,17.92%,PLA2G4A;PTPMT1;PLA2G6;TAMM41
prerank,hyaluronan metabolic process (GO:0030212),-0.3265946454746691,-0.9542358410293442,0.5238095238095238,0.7893942032367028,1.0,6/23,15.20%,CD44;FGF2;HEXA;CEMIP;HAS1;CEMIP2
prerank,regulation of cell motility (GO:2000145),-0.22966329263518093,-0.9539038845649251,0.5864864864864865,0.789680859264443,1.0,34/121,20.50%,FRMD5;SPOCK2;DOCK10;RHOA;TMSB4X;NTN1;EGFR;MACF1;SPATA13;FLNA;ROBO4;PRKX;CEACAM1;FGF2;ABI3;FGF7;TMSB10;PLXNC1;TWIST1;CCDC25;SST;AKT2;AMOT;CAVIN1;CSF1R;MEMO1;PLXNA4;OSGIN1;PRAG1;CDK6;AMOTL1;HACE1;RHOB;PLXND1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.390952275059197,0.953889275488562,0.5061475409836066,0.938984109658478,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.390952275059197,0.953889275488562,0.5061475409836066,0.938984109658478,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.30410244980603873,-0.9531340580078879,0.5336048879837068,0.7910627084771196,1.0,9/29,16.95%,ELOVL7;ELOVL5;ACSL5;FASN;ELOVL6;ACSL3;SCD;ELOVL1;ACSL4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.33088078394095116,-0.9529336235428583,0.5093945720250522,0.7910005828604608,1.0,8/23,16.95%,ELOVL7;FAR2;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.24430232768269539,-0.9527421608119412,0.57,0.7909667483272226,1.0,28/87,27.02%,FBXL7;DCUN1D3;FHL1;PSMA6;PSMB7;APC;KLF4;PSMB6;FAM107A;PSMB5;FBXO5;USP47;PSMB8;PSMC4;PSMD11;PTEN;PSMB4;PSMD14;CDK6;PSMD10;PSME1;PSMB3;E2F7;RGCC;JADE1;ZFP36L2;CDKN2B;CUL1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.4018429601779199,0.9525732578424272,0.5216535433070866,0.9415654055607876,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,regulation of fibroblast proliferation (GO:0048145),0.28940969906294384,0.9524724953102559,0.5160142348754448,0.94074361868409,1.0,8/45,11.83%,IGF1;PDGFRA;SPHK1;E2F1;NLRC3;MED25;CD300A;CDC73
prerank,ear morphogenesis (GO:0042471),0.35568344147635444,0.9522172141776402,0.5145067698259188,0.9403861524544066,1.0,3/20,6.95%,OSR1;USH1C;FGFR2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3881428861375132,0.9521775107994014,0.5211267605633803,0.939424791469891,1.0,3/12,8.19%,IGF1;GCK;SORBS1
prerank,regulation of superoxide anion generation (GO:0032928),-0.3659138724373934,-0.9521619724925348,0.5172413793103449,0.7918836759124118,1.0,7/14,36.33%,PRKCD;SOD1;SYK;AATF;MAPT;TYROBP;CRP
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.39846600158414897,0.9519904161639525,0.512241054613936,0.9388636129957452,1.0,2/10,8.15%,HSPA1A;IMPACT
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3444932493918483,-0.9519251050792064,0.5379746835443038,0.7919252646383311,1.0,4/17,9.91%,TMSB4X;ANXA1;OTUD7B;KLF4
prerank,response to UV (GO:0009411),-0.24035141552679345,-0.951741385046155,0.5367088607594936,0.7918644321614331,1.0,33/95,25.03%,DCUN1D3;EGFR;PTPRK;PRKCD;MFAP4;ZBTB1;CAT;GPX1;USP47;ERCC2;COPS9;SCARA3;RHBDD1;BAK1;FMR1;ATF4;UBE2A;N4BP1;RHNO1;PRIMPOL;CCND1;PCLAF;METTL3;NEDD4;XPA;MAP2K7;NSMCE3;BCL3;MAP3K4;MAP4K3;TRIAP1;DTL;USP1
prerank,glutathione derivative metabolic process (GO:1901685),0.3489199332297806,0.951661060632184,0.5199203187250996,0.9376352840950923,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3489199332297806,0.951661060632184,0.5199203187250996,0.9376352840950923,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,polyol biosynthetic process (GO:0046173),0.36790838801785486,0.9515924338545487,0.47689075630252103,0.9367533901340716,1.0,4/16,17.52%,ISYNA1;CYP27A1;IPPK;IP6K2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.21581979850077468,-0.9515763463658693,0.6,0.7918002715661991,1.0,61/184,27.86%,YWHAE;CDC27;PKD1;HECW2;UBC;DYNC1I2;ANAPC5;CSNK1E;RPS27A;XPC;UBB;PSMA6;PSMB7;CDC16;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;ERCC2;ODF2;DYNLL1;FZR1;PSMB8;CCP110;ZW10;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;ID2;PRKACA;PSMB4;DYNC1H1;PSMD14;PTPN6;CDC26;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDC23;CDK5RAP2;CUL3;RGCC;CEP152;HMMR;KIF14;ZFP36L2;AKAP9;ACTR1A;CUL1;CDK2;ANAPC1;CNTRL
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.36606988834038134,0.950986512952434,0.5019083969465649,0.9373074423976255,1.0,4/16,9.07%,APPL2;PPARA;NLRC3;ABCD1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3405362443628643,0.9508955435378829,0.532347504621072,0.9365145993142037,1.0,2/22,1.35%,IL18;SPHK1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.38992305358318674,-0.9508629025076502,0.525,0.793026822760286,1.0,6/11,30.94%,SCARB1;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,cellular response to amyloid-beta (GO:1904646),0.30539234345863714,0.9506589873115072,0.519774011299435,0.9361135837518535,1.0,3/35,1.71%,SNX6;IGF1;CACNB1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.26869214727231017,-0.9505408238188087,0.527114967462039,0.7933144172670756,1.0,20/50,32.32%,ACTB;CDKN1C;SERTAD1;GTF2H1;BLM;CCNF;CCND1;CCND2;CCNH;CCNB2;CDKN1B;CDKN3;CDKN2B;CCNT1;CCNJ;STOX1;CDK5R2;CAMK2N1;CCNE1;CDC6
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3385321567063627,-0.9505396493008126,0.525974025974026,0.7927857515982432,1.0,9/17,40.30%,NOS1AP;KCNE4;KCNAB1;KCNS2;RNF207;ANK3;VAMP2;KCNG1;KCNE5
prerank,cellular response to interleukin-12 (GO:0071349),-0.2683128449930083,-0.9505234519374155,0.5390070921985816,0.7922969031139105,1.0,21/48,33.01%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B;CD47
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2660957596461849,-0.9501029756122925,0.5467289719626168,0.7928443910376635,1.0,26/54,26.01%,RPL5;RPL10;RPL7;MRPL20;RPLP0;RPL35A;RPF1;RPL7A;SURF6;RPL6;RPL24;RPL10A;RPL14;RRP15;GTF3A;MRPL1;MRTO4;EBNA1BP2;RPL3;SDAD1;NHP2;RRS1;NOP16;RPL23A;PPAN;MDN1
prerank,regulation of synapse assembly (GO:0051963),-0.2743176818247088,-0.949841269365722,0.5362637362637362,0.7929717168141409,1.0,9/46,14.47%,GPC6;MEF2C;PDLIM5;APP;CLSTN2;IL1RAP;EPHB2;LHFPL4;SRPX2
prerank,regulation of RNA splicing (GO:0043484),0.2738240246458809,0.9497829231940997,0.5456081081081081,0.9374325451226836,1.0,27/69,23.03%,HSPA1A;HNRNPH3;PQBP1;FASTK;PTBP2;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;CLK3;YTHDC1;AFF2;GRSF1;MBNL3;CLK2;ZPR1;FAM50A;HNRNPH2;PTBP3;CLK1;POLR2A;LARP7;HNRNPH1;SRPK1;CELF1
prerank,regulation of protein metabolic process (GO:0051246),-0.2732449525366208,-0.9495124951303783,0.5244444444444445,0.7932303865161476,1.0,11/44,16.11%,LTBP4;NEDD4L;APP;SPOPL;APOE;KLF4;HGS;GSAP;KLF2;PLAUR;ZDHHC2
prerank,ncRNA metabolic process (GO:0034660),0.30787085337057113,0.9494646177373781,0.5259259259259259,0.9372538910669805,1.0,7/37,13.90%,DTD1;TDRD9;TRIM71;DDX17;BCDIN3D;TUT4;DICER1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.40168521822887626,-0.9492781444155176,0.5264150943396226,0.793247903412609,1.0,9/11,45.87%,IL34;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1
prerank,protein import (GO:0017038),0.26357878625501685,0.9489828412167438,0.5458937198067633,0.9374931058448723,1.0,20/84,19.04%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;ATAD1;TOMM22;ABCD1;LAMP2;NXT1;CLU;IPO8;TNPO2;IPO4;SNX33;NUP88;AKT1;HSP90AA1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3120970456703475,0.948486212175734,0.5358490566037736,0.9378510452249377,1.0,7/33,11.83%,PLK5;APPL2;E2F1;CRNN;STXBP4;TAF1;CDC73
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2983906317652141,-0.9480396317572264,0.5467479674796748,0.7957472719658619,1.0,6/33,7.89%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2532163881000569,-0.9479217083927116,0.5767441860465117,0.7955175191463747,1.0,19/67,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,positive regulation of autophagy (GO:0010508),0.2637606137282615,0.9478535190316171,0.5431472081218274,0.9385107857046124,1.0,13/81,10.33%,RNF152;PRKAA2;PLEKHF1;OPTN;PIK3CB;TRIM5;IKBKG;KAT5;GPSM1;LRRK2;SESN1;HTT;PAFAH1B2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.34219120590102925,-0.9476948369982605,0.5345911949685535,0.7955402449332671,1.0,4/17,13.63%,PPP1R12A;ITGA1;CALM3;PTPRC
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3199438260066916,-0.9474016618909235,0.5224215246636771,0.7957337618887202,1.0,9/23,30.62%,PLA2G4A;MBOAT1;ABHD4;PLA2G6;LPCAT3;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,ceramide transport (GO:0035627),-0.3784071454291803,-0.9473007854231263,0.5257731958762887,0.7954436309731993,1.0,8/12,28.25%,CERT1;PLTP;PLEKHA8;PSAP;SGPP1;GLTP;PLEKHA3;CPTP
prerank,mesenchymal cell development (GO:0014031),-0.34325268129199427,-0.9472270892435635,0.575098814229249,0.7950913915481107,1.0,11/18,34.67%,NOTCH1;HEYL;HEY2;CDH2;SOX8;SOX11;TAPT1;SNAI2;TBX20;KBTBD8;NOLC1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2970879255003486,0.9471622857113438,0.5679012345679012,0.9393948709678459,1.0,13/45,19.72%,HSPA1A;DDX5;RIOK2;SUPV3L1;ZC3H18;WDR75;GRSF1;IL6;ZPR1;UTP15;RELA;NFKB1;POLR2A
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.34761602375486317,0.9470349513812414,0.538,0.9386805665756195,1.0,5/20,11.83%,CTR9;MEIS1;LEO1;LDB1;CDC73
prerank,neuron remodeling (GO:0016322),-0.39668520745946984,-0.9469397178862393,0.5509803921568628,0.7952898846579719,1.0,3/10,3.64%,ANKS1A;SCARF1;APP
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.332743781561618,0.946818283007453,0.5387523629489603,0.9382720569743405,1.0,2/23,2.77%,PLK5;ZWINT
prerank,icosanoid metabolic process (GO:0006690),0.2986330679954245,0.9466169010507293,0.5420393559928444,0.9377787652118645,1.0,6/40,7.80%,PTGS1;PON1;DAGLA;PLA2G4C;PNPLA8;PTGR1
prerank,response to peptide hormone (GO:0043434),0.29347099010695454,0.9465102037233097,0.5193929173693086,0.9369960460194504,1.0,14/43,19.03%,TGFBR3;ROCK2;CYP11B1;CITED1;EIF2B4;STAT1;STAT2;TSC1;SIRT1;CREB1;STAT5B;AKT1;STAT6;KHK
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3189848323252379,0.9464688143109178,0.5457943925233645,0.9360492480913376,1.0,8/30,12.73%,LEPROT;PDCD5;HTRA2;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,regulation of protein modification process (GO:0031399),-0.2683740290331612,-0.9461307117411272,0.5548245614035088,0.7967616504843167,1.0,10/50,11.50%,CORO1C;FN1;FNIP2;SPRED2;LYN;PPP1R16B;HPF1;IGF2;PARG;HSPB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3878353071728411,0.9459204739041681,0.5149253731343284,0.9365220689648224,1.0,4/13,11.47%,NUPR1;NR1H3;USP19;CLU
prerank,renal water homeostasis (GO:0003091),0.3358337442995937,0.9456225309520715,0.5227272727272727,0.9362811358835567,1.0,3/23,6.20%,ADCY5;ADCY1;ADCY8
prerank,cellular response to insulin stimulus (GO:0032869),0.24443728480158167,0.9450072568526325,0.5479674796747968,0.9368938159068992,1.0,27/124,14.89%,CPEB2;GCK;BAIAP2;PIK3R3;ATP6V0A2;INSIG2;LPIN1;ATP6V0B;ATP6V1H;SOS1;PDPK1;PDK2;PRKCI;SORBS1;ATP6V1B2;RHOQ;PHIP;ATP6V1E1;USF1;EPRS1;RAB13;ATP6V0E2;ATP6V1C1;SLC27A4;PRKDC;ATP6V0D2;GOT1
prerank,sensory organ development (GO:0007423),0.2831111333762242,0.9449717323010153,0.5411985018726592,0.9359496391286254,1.0,15/51,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;SHROOM2;FOXC1;ADAMTS18;RBP4;HIPK2;SOX2;MEIS3
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2819973531050564,-0.944685280980259,0.5475113122171946,0.7997452035733653,1.0,8/39,12.00%,MYO1D;ACTN4;MYO1B;SYT4;MYO19;MYO1F;DYNC1I1;FNBP1L
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.40623348621151156,-0.9445596210302125,0.5440313111545988,0.7995241239318742,1.0,7/10,30.39%,MYD88;TICAM1;CD68;TLR4;TREM2;CD36;TLR6
prerank,negative regulation of viral process (GO:0048525),0.28319376332996865,0.9440513357668239,0.5413005272407733,0.9374855020291748,1.0,27/57,28.72%,OAS2;TRIM62;UBP1;TRIM5;TRIM35;IFIT1;EIF2AK2;OAS3;STAT1;PML;TRIM13;ILF3;LARP7;TRIM32;CHMP3;PARP10;BST2;SLPI;SRPK1;BTBD17;ZFP36;RNASEL;TRIM28;MAVS;TRIM8;MBL2;TRIM11
prerank,inner dynein arm assembly (GO:0036159),0.40684993203255293,0.943770186749438,0.5308151093439364,0.9372248365160792,1.0,1/10,2.77%,DNAH1
prerank,peptide hormone secretion (GO:0030072),-0.3053427759694106,-0.9436699334727562,0.5204301075268817,0.8012098398358373,1.0,5/26,11.67%,LTBP4;SNX19;ANXA1;EDN1;EDN3
prerank,DNA catabolic process (GO:0006308),-0.38400533417801214,-0.9431112038175243,0.5263157894736842,0.8020311262983069,1.0,5/11,36.14%,REXO4;DFFB;XRN2;ISG20;MUS81
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2191579121275271,-0.9430146463851617,0.6308539944903582,0.8017307948503665,1.0,29/159,16.90%,HIP1;STXBP6;RPL38;PIK3C2A;TBCD;FCHO2;SGIP1;SMAD1;VAMP3;CLTB;NCK1;PXN;CHMP4B;CHMP4A;PTGES3;SRP19;SRC;NUP107;TIAM1;BBS12;IMMP2L;HIP1R;TPR;HIGD2A;CCT2;PSMD11;RTN4;DNAI4;ADRM1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.32715381561420215,0.9429713658963523,0.5495495495495496,0.9383779306689498,1.0,10/27,18.21%,DDX5;KMT5A;SPRED3;SMYD2;MSX1;SIRT1;ATM;MDM2;KDM1A;SPRED1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2758748604175913,-0.9428162762980925,0.5488372093023256,0.8016979972523665,1.0,14/46,17.73%,SEMA6A;DAB2IP;SPRED2;LYN;SPRY2;PTPN1;DUSP3;EPHB2;RANBP9;PTPRC;SPRY1;PTEN;GPER1;DUSP6
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3218310809582656,0.9427731190152097,0.5387453874538746,0.9378822979307733,1.0,6/30,9.69%,ACSL1;HACD3;HACD4;HACD1;ABCD1;SLC27A6
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24073606898373462,-0.9425457518195288,0.5396039603960396,0.8018851906372776,1.0,24/91,23.32%,CDC27;ANAPC5;XPC;PSMA6;PSMB7;CDC16;PSMB6;PSMB5;FBXO5;ERCC2;TCIM;FBXW7;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CDC26;PSMD10;PSME1;CDKN1B;PSMB3;CDC23
prerank,protein localization to cell junction (GO:1902414),-0.32359412085656036,-0.9425082213709806,0.5469728601252609,0.8014429319181029,1.0,6/22,11.47%,HEG1;TJP1;TJP2;PAK2;JAK1;JAM3
prerank,positive regulation of proteolysis (GO:0045862),0.2775500215522324,0.9423827410500234,0.5354058721934369,0.9379281820419803,1.0,18/55,23.50%,SH3D19;FURIN;CAPN3;ADRA2A;CYFIP2;PLK1;CTSH;NRDC;NDUFA13;SNX33;ASPH;NLRC4;SNX9;ATP5IF1;TRIM32;RCN3;BTRC;PACSIN3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.23696241448428662,-0.9422133002106345,0.60431654676259,0.8016384302872568,1.0,35/96,26.03%,MEF2C;TGFB2;NDNF;FOXO3;NGF;SIX1;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;NSMF;UNC5B;PTPRZ1;PTK2B;LANCL1;MT3;KCNB1;ATF4;SIX4;CRLF1;LIG4;AKT1S1;AGAP2;SET;RASA1;KDM2B;NFATC4;EGLN3;EPHA7;F2R;KIF14;WFS1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.34359662509772726,-0.9416721915245242,0.5345528455284553,0.8024251791468023,1.0,7/18,16.95%,ELOVL7;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3430073681617192,0.941411791777433,0.5271629778672032,0.9395438768003381,1.0,7/21,23.65%,GCK;HKDC1;G6PC3;HK1;GPI;PGLS;SHPK
prerank,maintenance of protein localization in organelle (GO:0072595),0.35328637573439525,0.941356510561941,0.5180722891566265,0.9386407719105351,1.0,6/19,18.35%,HNRNPU;ARL2;TOPORS;PML;HK1;AKT1
prerank,response to exogenous dsRNA (GO:0043330),-0.34134189470264104,-0.9412270623066,0.540948275862069,0.8029998953231088,1.0,4/18,4.57%,CAV1;RFTN1;IRAK3;RALB
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.30234185986735734,-0.9411341691080031,0.5427974947807933,0.8026852505364087,1.0,8/26,20.75%,ST3GAL4;ST8SIA6;GOLPH3;B4GALT5;GCNT1;ST3GAL2;ALG6;RRM2B
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24233738072440844,0.9404559636038743,0.5804794520547946,0.9399947237636816,1.0,15/138,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,phospholipid homeostasis (GO:0055091),-0.3794077608936265,-0.9402426740113369,0.5288461538461539,0.8043485725547431,1.0,3/11,25.93%,ABCA1;TLCD1;FABP3
prerank,Golgi organization (GO:0007030),0.24533396264626214,0.9398547243893567,0.5928449744463373,0.940581206845328,1.0,22/112,13.42%,PLK5;OBSL1;DYM;TANGO2;BET1;OPTN;CLASP1;FAM174B;STX16;LRRK2;GOLGA2;TRAPPC11;HTT;SEC23IP;MYO18A;VPS51;TMED9;GOLGA8B;GOLGA5;TMED4;STK25;RAB1A
prerank,negative regulation of telomere maintenance (GO:0032205),0.36643124264616556,0.939807389424157,0.5345528455284553,0.9396578377769675,1.0,7/15,22.08%,ERCC1;TNKS2;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,triglyceride metabolic process (GO:0006641),0.28599989790668573,0.9390798133462761,0.5364485981308411,0.9405721296440973,1.0,7/48,16.09%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2;SIRT1;PLAAT3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3254117133179652,0.9385461951676407,0.5529865125240848,0.9410279159651842,1.0,5/27,4.37%,CACNB1;ANK2;CACNB3;JPH1;ADRA2A
prerank,fatty acid beta-oxidation (GO:0006635),0.2808408842234221,0.938481693651408,0.5586080586080586,0.9401791458404642,1.0,11/51,12.22%,ACAT2;IVD;ACAT1;ACAD10;ECHS1;ABCD1;AMACR;ACAD11;ECHDC2;GCDH;CROT
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.32183523930222346,-0.9383606678222784,0.5505154639175258,0.8084054352791947,1.0,5/23,15.44%,MYO10;DYNC1I2;TUBA1A;DYNC1I1;KIF1C
prerank,pseudouridine synthesis (GO:0001522),-0.3740572446224308,-0.938268368892932,0.5553319919517102,0.8080836779270613,1.0,6/13,27.20%,PUS3;PUS7L;NHP2;DKC1;PUSL1;NOP10
prerank,regulation of mRNA stability (GO:0043488),-0.2223828139775548,-0.9381079818706418,0.5824468085106383,0.8079726439513044,1.0,42/145,23.25%,FTO;UBC;YWHAB;SERBP1;RPS27A;FASTKD1;PABPC1;UBB;EXOSC1;AXIN2;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;FUS;PUM1;PSMB8;PSMC4;PSMD11;FMR1;TENT5C;TBRG4;FXR1;CARHSP1;PSMB4;PSMD14;RIDA;TENT5A;METTL3;PSMD10;SET;ROCK1;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.30973586860542834,-0.937918566513502,0.5619469026548672,0.8078859412572544,1.0,6/26,6.44%,ST3GAL4;ST3GAL6;B3GNT2;B4GALT4;ST3GAL1;LUM
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.24204555014949808,0.9379024217993274,0.576,0.9407511976004802,1.0,15/129,9.83%,RNF220;LGR4;LRRK1;WLS;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2;LRRK2;RSPO1;LYPD6
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3950816883280413,0.9377103221272125,0.5401174168297456,0.9402191962687975,1.0,3/12,9.89%,TET1;PPHLN1;MPHOSPH8
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22753211223992406,-0.9371710155640186,0.5839793281653747,0.8091436706341149,1.0,34/121,23.25%,PRR5L;UBC;YWHAB;SERBP1;RPS27A;PABPC1;UBB;EXOSC1;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;PUM1;PSMB8;PSMC4;PSMD11;FMR1;FXR1;CARHSP1;PSMB4;PSMD14;ZC3H12A;PSMD10;SET;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.3861250942319011,-0.9369128230749615,0.5494949494949495,0.8092303848257749,1.0,3/11,10.02%,IL6ST;STAT3;JAK1
prerank,cilium organization (GO:0044782),0.226833016746904,0.9360125054048073,0.6232771822358346,0.9437787673837394,1.0,53/209,20.22%,CFAP44;DCDC2;INTU;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;CEP78;RILPL1;SNAP29;CFAP61;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;IFT122;B9D1;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;CDC14B;RAB1A;CFAP20;TCTN2;ARL3;RAB23;FUZ;RPGR;GBF1;PTPN23;OCRL;KIF3B;ARMC2;DYNC2H1;TTC36;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,monocarboxylic acid catabolic process (GO:0072329),0.343456995515831,0.9358151612125327,0.5458089668615984,0.9432817448115298,1.0,3/21,4.59%,CEL;CYP26B1;LPIN1
prerank,negative regulation of T cell activation (GO:0050868),-0.28254304172881367,-0.9355785240760173,0.5608695652173913,0.8119321770875759,1.0,17/35,39.54%,TNFRSF21;CEACAM1;DUSP3;CD86;NCKAP1L;JAK3;GLMN;FCGR2B;CEBPB;IL4I1;LAPTM5;GPNMB;SDC4;VTCN1;ARG1;PDCD1LG2;CD80
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.24040790422843625,-0.9351669490916682,0.582089552238806,0.8124270203684725,1.0,27/88,27.22%,FBXL7;PSMA6;PSMB7;FBXO31;FBXO4;PSMB6;PSMB5;FBXO44;FBXW7;FBXL18;PSMB8;PSMC4;PSMD11;PSMB4;AMN1;PSMD14;CCNF;FBXL4;FBXW5;PSMD10;PSME1;FBXL6;PSMB3;CUL4A;KIF14;CUL1;FBXW11
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27059963347563226,0.9349545449063761,0.5657439446366782,0.9445702874482687,1.0,16/68,19.11%,GTPBP1;ACSM2A;ACSM2B;ACAT1;GLYAT;LRRK2;AMPD3;RHOQ;CROT;ABHD14B;RAB23;ACOT1;ACOT6;TPST1;AK3;ACOT13
prerank,positive regulation of lyase activity (GO:0051349),0.37398987744197987,0.9348456379245409,0.5223577235772358,0.9438318304005638,1.0,1/14,0.44%,CACNA1D
prerank,telomere maintenance (GO:0000723),-0.26115542095088823,-0.9344008849989756,0.6009070294784581,0.8136867895657628,1.0,18/50,26.19%,RPA1;XRCC5;PTGES3;SMC5;TERF2IP;BLM;TEP1;SP100;ZBTB48;NBN;RPA2;POLD4;TEN1;PARP3;XRCC3;CTC1;TINF2;TERF2
prerank,response to ionizing radiation (GO:0010212),0.2669671004519098,0.9340667733257985,0.5709515859766278,0.9449033229716571,1.0,17/70,19.36%,EYA1;FANCD2;ABRAXAS1;KAT5;CLOCK;INIP;MAPK14;BRAT1;AEN;MEN1;GADD45A;SIRT1;ATM;CLK2;NHEJ1;FIGNL1;TRIM13
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3375549916947988,-0.9340290881754959,0.5483870967741935,0.8140693527932537,1.0,5/18,18.87%,RAD51B;BRD4;FBXO5;CCND1;RAB11A
prerank,response to interferon-beta (GO:0035456),-0.31732517503539287,-0.933914556327506,0.5546038543897216,0.8138287993184781,1.0,4/22,7.87%,PLSCR1;IFITM3;AIM2;XAF1
prerank,macromolecule catabolic process (GO:0009057),0.3269278807451693,0.9337698358208264,0.5514705882352942,0.9446878588364505,1.0,6/26,14.99%,CAPN3;KIF16B;CTRL;CLN8;CLN5;UCHL3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.332123354838216,0.9336815085053546,0.5480225988700564,0.9439223130603104,1.0,3/23,8.03%,IGF1;NLRP2B;NLRP3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3008042947795524,0.9333918090762455,0.5471014492753623,0.9436857500915885,1.0,9/38,12.73%,LEPROT;HTRA2;LRRK2;BAG4;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,sterol transport (GO:0015918),-0.3298552047150951,-0.9332050576903519,0.5578512396694215,0.8150445289976151,1.0,3/19,6.51%,CAV1;NPC2;OSBP
prerank,neurotrophin signaling pathway (GO:0038179),-0.32534922185528553,-0.9331123247381814,0.5406593406593406,0.814738985184608,1.0,5/21,9.86%,RAPGEF2;RAP1A;NGF;BCAR1;SORT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.37200792055797893,0.932821137457153,0.5398058252427185,0.9441849651062886,1.0,6/15,18.35%,IGF1;PPIF;CLU;HGF;NOL3;AKT1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3633130614296357,0.9327623981297921,0.5233644859813084,0.9433270956076982,1.0,5/15,12.49%,SOS1;CASP3;NTRK2;FRS2;BDNF
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3817620615098841,-0.9326517760364901,0.583969465648855,0.8153377644850668,1.0,2/11,6.40%,MFHAS1;LYN
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.33639186631061113,0.9325816169266815,0.5387596899224806,0.9428471131395117,1.0,7/20,19.29%,FITM2;ACSM2A;GCDH;DGAT2;ACACA;FAR1;HSD17B4
prerank,positive regulation of cell cycle process (GO:0090068),-0.23477657321411993,-0.932229722692915,0.6495098039215687,0.815841371558253,1.0,31/91,25.85%,RHOA;SVIL;INSR;LRP5;PLSCR1;MAP3K20;CIT;IGF2;EDN1;EDN3;KIF23;TPR;RAD21;NUSAP1;CEP295;RHNO1;DYNC1H1;RANBP1;NUDT16;KIF20B;CDC42;GPSM2;EGF;GIPC1;E2F7;NUP62;CUL3;RGCC;XRCC3;PRKCE;KIF14
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.24118657421386308,-0.9321161768293534,0.6047058823529412,0.8155632116365971,1.0,15/78,11.06%,CAV1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;BCAP31;ARIH2;SOCS5;ARIH1;PABIR1
prerank,positive regulation of telomere capping (GO:1904355),-0.3518379167569073,-0.9319009403884554,0.5668662674650699,0.8155673898663915,1.0,7/17,25.93%,NEK7;TNKS;MAPK1;MAPK3;MAP2K7;MAP3K4;HNRNPD
prerank,myelin maintenance (GO:0043217),-0.3952392068062527,-0.9315605163114207,0.5369261477045908,0.815866576349068,1.0,6/10,24.61%,ABCD2;SOD1;PRX;PTEN;MYRF;CXCR4
prerank,regulation of fat cell differentiation (GO:0045598),0.2609289842059428,0.9311168080951159,0.5887230514096186,0.9456802933559646,1.0,11/74,12.33%,RORA;TMEM64;SMAD3;LMO3;LRP3;WWTR1;E2F1;CREBL2;AAMDC;ADIG;CDS1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3920879392763225,-0.9304393846594798,0.5725806451612904,0.8180053245069728,1.0,2/10,1.92%,ZBTB16;ACVRL1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.382868539761423,0.9302355993328392,0.5652173913043478,0.9470365091954359,1.0,5/13,18.21%,DDX5;SPRED3;MSX1;ATM;SPRED1
prerank,generation of neurons (GO:0048699),-0.21204409312174946,-0.9296898140843665,0.625,0.8191963284791798,1.0,35/190,17.26%,NRP1;MEF2C;RAPGEF2;MARK1;TGFB2;NDNF;DISC1;RUNX2;RUNX1;SIX1;EML1;CEP85L;BHLHE40;LHX6;WNT5A;CIT;MET;HES1;HEYL;HEY2;CDK5;FGF13;ACSL3;FZD4;WNT9A;NGRN;FZD1;NR4A2;MAP1B;PAFAH1B1;SIX4;DDIT4;ACSL4;HEY1;IER2
prerank,ion homeostasis (GO:0050801),-0.2955900769775434,-0.9296670114344587,0.5854700854700855,0.8187164755221756,1.0,4/30,5.60%,SLC4A10;NEDD4L;FHL1;CAMK2D
prerank,protein dephosphorylation (GO:0006470),0.23985182060567536,0.9295799804549135,0.6127527216174183,0.9477667808203109,1.0,24/135,13.75%,PPP2R2B;EYA1;DUSP29;EYA4;PTPN9;EYA2;PPM1M;PTPN4;PTPN13;DUSP11;PPEF2;PPM1G;TNS2;MTMR4;PTPRD;PTPN21;PPM1D;PPP1CB;MTMR2;CDC14B;PTPN14;PTPRO;PTPRU;PPP6C
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.36783404810863074,-0.9295321978974658,0.5562130177514792,0.8185084148947891,1.0,6/13,19.30%,MDFIC;APOD;TPR;SP100;BARD1;CABP1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3930316622277932,-0.9294013471091161,0.5582329317269076,0.8182989771042444,1.0,2/10,4.57%,PIP4K2A;RALB
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3348385520729063,0.9293959154080259,0.5536723163841808,0.9472358209970031,1.0,2/22,5.02%,ROCK2;PPP4R4
prerank,regulation of lipid catabolic process (GO:0050994),0.33963890892202725,0.9292068307210276,0.5586592178770949,0.9467051756115187,1.0,3/19,9.07%,ADRA2A;LONP2;ABCD1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.36518695399982026,-0.9289335606120099,0.5516569200779727,0.8189615284339902,1.0,8/14,23.54%,SEC24D;SEC23A;SEC31A;SEC24B;SAR1A;SEC13;SEC24A;TBC1D20
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.388568828901504,0.9288757960834707,0.5384615384615384,0.946545947953047,1.0,1/12,0.87%,IL18
prerank,N-glycan processing (GO:0006491),-0.3346150301193013,-0.928850771455395,0.566,0.8186508864813999,1.0,6/18,14.69%,ST8SIA4;FUT8;ST8SIA6;MGAT4A;MGAT4B;ST8SIA2
prerank,nuclear transport (GO:0051169),0.353638867988079,0.9287560815907353,0.5667311411992263,0.9458496654688988,1.0,4/16,11.89%,CITED1;PSIP1;NXT1;NUP98
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21291641343136922,0.9283513576657905,0.6648351648351648,0.9459327719811325,1.0,90/366,20.71%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;EIF2B4;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;OBI1;DMTF1;CYFIP1;PML;CHEK2;RBAK;TGFBRAP1;FOXC1;TSC1;MYBL1;SMC3;ABL1;ANKRD17;ELAVL2;METTL18;RBBP6;SOX6;RELA;MYCBP;MYT1;MTF2;SRRT;APBB1;NSD3;NLK;PCGF1;MLXIPL;MLX;MITF;SOX2;KAT6B;DDIT3;POLR2A;PUM3;REST;SUPT4H1;EIF2A;SPTY2D1;MLLT6;NFX1;GCFC2;HOXB7;TGIF2
prerank,diacylglycerol metabolic process (GO:0046339),-0.3168858860711784,-0.9282493852591757,0.5594989561586639,0.8195630867075189,1.0,3/23,3.37%,PLCE1;DGKH;DGKZ
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3947450696606688,-0.9279678062620356,0.5663366336633663,0.8197248499199749,1.0,3/10,16.03%,THBS1;AKT2;CTTNBP2NL
prerank,calcium ion homeostasis (GO:0055074),0.24476319733393664,0.9278283316326108,0.5724137931034483,0.9463343012259294,1.0,8/95,4.15%,SLC8A3;SLC24A3;ATP13A5;ANK2;DMPK;FAM20A;CSRP3;ATP13A3
prerank,tRNA methylation (GO:0030488),-0.2866040138492655,-0.9275841178306039,0.5526315789473685,0.8201400989821096,1.0,10/34,19.64%,METTL2B;METTL2A;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;METTL6;TRMT112;LCMT2
prerank,protein localization to organelle (GO:0033365),0.2364138432820943,0.92738142075343,0.6122112211221122,0.9464274558244476,1.0,28/133,17.01%,BMP7;ANK2;MICALL1;OBSL1;TTC21B;TULP3;CSRP3;LMNA;OPTN;WDR35;LRRK2;TIA1;TOR1B;BICD1;SCG3;TOPORS;IFT122;LAMP2;CCDC47;CYB5A;ARL3;FAM83H;MSX1;BANP;GET1;GBF1;MDM2;MTCH2
prerank,regulation of protein neddylation (GO:2000434),0.4001657541604956,0.9271609478140865,0.5338809034907598,0.9460274309239766,1.0,2/10,7.62%,EPAS1;DCUN1D4
prerank,positive regulation of axonogenesis (GO:0050772),-0.2681597038319226,-0.9271290549016102,0.58675799086758,0.8207558306997733,1.0,7/43,4.42%,SLIT2;RHOA;NTN1;SEMA7A;NGF;MACF1;TIAM2
prerank,lipoxygenase pathway (GO:0019372),-0.3566792808775403,-0.9269782550329302,0.5584415584415584,0.8205762263095707,1.0,3/14,9.75%,PTGS2;PON2;GPX1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2968314525145553,0.9269100709447785,0.5627306273062731,0.9456728060044102,1.0,3/39,2.86%,NNAT;GCK;NLGN2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3842095549449898,0.9265741565621484,0.5596868884540117,0.9455051626218933,1.0,4/12,17.22%,DPYD;CRMP1;DPYSL2;UMPS
prerank,negative regulation of cell projection organization (GO:0031345),-0.26031248493268233,-0.9265613954862179,0.5902335456475584,0.8210433835327454,1.0,17/48,22.98%,RAPGEF2;KANK1;SPRY2;GRIN2B;APOE;BAG5;TRPV4;MT3;PAQR3;RTN4RL1;PTEN;HDAC2;PRAG1;MYLIP;RTN4R;FYN;GAK
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.21223441035981044,-0.9260398563033672,0.6685714285714286,0.8217859069179587,1.0,54/190,20.85%,PDE3A;PDE4D;CAV1;DAB2IP;SLIT2;TMSB4X;THBS1;SH3BP4;LIMD1;BCL2L1;PTPRJ;CCN3;ESR1;PDE10A;PIK3IP1;XDH;CIT;RACK1;PDE2A;LYN;OTUD7B;PPP2R5C;IFI35;HDAC7;SRC;DUSP3;CD2AP;PER1;PHLPP1;TWIST1;TNFAIP8L1;PEBP1;TBC1D7;PLAUR;NR1H4;DDIT4;RNF157;APLNR;PHLPP2;PTEN;GPER1;UBR1;CARD19;USP10;ZC3H12A;MCL1;MARK3;RIPK1;SPI1;ARRB2;AKT1S1;PSMD10;PPP2R5B;AJUBA
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.1923634401344407,0.9254849550155825,0.819304152637486,0.9474038964892875,1.0,241/1646,14.25%,DENND4A;ZKSCAN2;MAF;BMP7;RORA;EPAS1;HLF;WNT4;CREB5;PPARGC1B;SNX6;IGF1;DDX5;SMAD3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;DNMT3L;HMX2;SCML4;MSX2;SOX5;OVOL2;CTR9;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;CRABP2;NR6A1;ARNT2;TENM1;PBX2;KIT;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;TULP3;HOXB9;CAPN3;TFDP2;SIM1;WNT7A;PICALM;MSANTD1;CCAR2;CHUK;CCNT2;DKK3;ENO1;ZHX1;SMARCD3;LOXL3;KMT2A;HOXB3;MAFG;MEIS1;ASCC2;TIAL1;PEG3;CCAR1;RUVBL2;PCID2;PQBP1;PRMT2;MLXIP;PAX6;IKZF1;PHF8;RBPJ;ACTR8;IKZF2;MZF1;ARID3A;BICRAL;ZFHX2;WWTR1;ZBTB26;HOXA7;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;PCGF5;E2F1;CEBPA;CITED1;DPF1;PBXIP1;NRG1;LBH;HOXB6;DDX17;BCL11B;JARID2;SRSF10;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;TEF;ARRB1;ARHGEF11;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KCNH2;ZNF467;PHF1;PHF2;HES6;MED1;MAFA;CEP290;PPARGC1A;ZFX;KDM2A;HINFP;MAP3K10;HIF3A;MAX;DMAP1;ZNF711;NR1H3;PHIP;E2F8;ZBTB22;HDX;ZIC2;FZD7;MLLT11;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CREBL2;ZFP90;PRDM2;PSIP1;MPHOSPH8;COMMD7;GON4L;NSD1;SALL3;TGFBR1;FOXP4;LDB1;PLCB1;PRKCB;CSRNP3;BRD7;ZNF260;RNF10;RNF20;RNF6;LCOR;E2F4;CSRNP1;CAND2;MAPK14;STAT1;USF1;BATF;ZFPL1;MBD1;MAGED1;MXI1;STAT2;KDM5C;QARS1;GATAD2A;PCGF6;ZBTB49;DMTF1;KDM4A;SOX9;SRA1;CIPC;MED12L;RLIM;PML;RCOR2;RING1;CHEK2;RBAK;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;CBFA2T2;GABPA;ZIC5;YEATS4;TGFBRAP1;ABCA2;MAP3K12;NIF3L1;EN2;HDAC4;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;POLR3C;CREB3L4
prerank,protein K48-linked ubiquitination (GO:0070936),0.2738122942803759,0.9251150623190312,0.5761821366024519,0.9473901661906073,1.0,4/54,4.67%,RNF152;UBE2E2;RNF126;IFI27
prerank,regulation of catabolic process (GO:0009894),-0.3251961580224602,-0.9249787712060801,0.5677799607072691,0.8238008586986407,1.0,7/18,16.11%,NEDD4L;FAP;ITGB1;HGS;ZDHHC7;RARRES2;ZDHHC2
prerank,protein modification by small protein conjugation (GO:0032446),0.21125973799445943,0.9249435970445542,0.7022160664819944,0.9468319034137385,1.0,80/361,21.25%,RNF220;EYA1;RNF152;EPAS1;RNF43;CTR9;ASB2;PDZRN3;DTX1;DERL1;TRIM62;POM121;RNF41;NUP155;TRIM5;LEO1;PLK1;KLHL13;SHPRH;RNF14;UBA1;FBXO11;TRIM35;ARRB1;DCUN1D4;DTX2;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;RNF20;RNF6;CAND2;HLTF;UBE2W;FBXO9;CDC73;NUP98;RLIM;PIAS4;NEDD8;SPSB2;RNF138;RNF7;PRKDC;UBE2R2;BCL11A;UCHL3;EIPR1;SIRT1;RNF213;KLHL20;NUP37;MDM2;RANGAP1;NUP88;UBE2S;ANAPC7;USP9X;RNF139;KCTD13;TRIM63;RNF26;TRIM13;NDC1;FBXL5;KLHL7;SPSB1;TRIM41;NFX1;MYCBP2;KLHL21;HECW1;FBXL15;ZSWIM8;TRIM32;URM1;RNF103-CHMP3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3684438595339219,0.924611397077659,0.5591182364729459,0.9466982001580274,1.0,2/15,3.93%,TMEM33;ATL1
prerank,cellular response to UV (GO:0034644),-0.23581170116463626,-0.924520371548959,0.5875576036866359,0.8244187879609666,1.0,21/76,21.67%,PTPRK;CARD16;CRIP1;XPC;PRKCD;MFAP4;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;MMP2;N4BP1;RHNO1;METTL3;NEDD4;XPA;CHEK1;NSMCE3
prerank,chromatin remodeling at centromere (GO:0031055),-0.29205470748908385,-0.9244535399601881,0.5859213250517599,0.824018361036711,1.0,12/31,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3633013801975545,-0.924434167398653,0.5779467680608364,0.8235367707047934,1.0,3/13,13.74%,BPNT2;TPST2;ENPP1
prerank,cell proliferation in forebrain (GO:0021846),0.4086632108074778,0.9244203583214853,0.5635245901639344,0.9462238225620505,1.0,3/10,11.14%,WNT7A;PCM1;DOCK7
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.344807261795015,0.9241876345293236,0.578,0.9458315086194845,1.0,4/19,11.54%,RENBP;GNPNAT1;GNPDA1;PMM2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.27618101451015137,-0.9240825389349139,0.5912087912087912,0.8238957371628797,1.0,15/39,31.31%,SHLD1;FUS;SMCHD1;FANCB;TIMELESS;MAD2L2;SLF2;SPIDR;DTX3L;PARP3;SHLD3;RAD51AP1;PARP1;SPIRE2;MRNIP
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.39591825158302696,-0.9240391870021271,0.5924528301886792,0.8234988663546045,1.0,3/10,2.27%,BMP5;LRP6;NOTCH1
prerank,phasic smooth muscle contraction (GO:0014821),-0.39154918174250875,-0.9237946680002164,0.5823293172690763,0.8235443527919933,1.0,6/10,38.90%,EDN1;EDN3;PTGER3;DRD2;TIFAB;HTR1D
prerank,B cell differentiation (GO:0030183),-0.2619743179682787,-0.9237620124734263,0.5736607142857143,0.823078968588684,1.0,9/46,13.63%,VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;HHEX;ITGA4;PTPRC
prerank,regulation of viral release from host cell (GO:1902186),0.33554743249462676,0.9237129469849179,0.545271629778672,0.94606978934992,1.0,7/21,21.25%,TRIM62;TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3
prerank,defense response to virus (GO:0051607),0.24786920021639552,0.9236083265432112,0.6019736842105263,0.9453304266447778,1.0,17/100,11.49%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;ZDHHC1;RNF135;BCL2;STAT1;STAT2
prerank,protein heterooligomerization (GO:0051291),0.349824705319508,0.9234243876277086,0.537864077669903,0.9448407368251283,1.0,4/17,9.39%,TMEM120B;CPSF6;CPSF7;KCNC2
prerank,negative regulation of bone remodeling (GO:0046851),-0.3724623954667193,-0.923191709553657,0.5469061876247505,0.8239331365732822,1.0,3/11,18.96%,UBASH3B;TMEM119;GREM1
prerank,carboxylic acid metabolic process (GO:0019752),-0.2809945229239097,-0.9231823518471836,0.5827956989247312,0.8234209084710477,1.0,6/33,6.34%,SLC2A1;PLA2G4A;CSGALNACT1;PTGIS;ST3GAL1;SLC2A3
prerank,regulation of intracellular protein transport (GO:0033157),-0.2907985456703509,-0.9231480775916816,0.5760869565217391,0.8229711346328675,1.0,14/32,24.55%,PRR5L;BMP4;ICE1;PTPN1;RIPOR1;TPR;ZFAND1;B3GAT3;KIF20B;SIRT7;CEP131;OAZ1;PLK3;NDEL1
prerank,dendritic cell differentiation (GO:0097028),-0.31781360104527556,-0.9230965849581795,0.5619469026548672,0.8225690681430062,1.0,3/22,6.40%,GAS6;TGFBR2;LYN
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2435041872073132,-0.9228716444619208,0.6275862068965518,0.8225784313076105,1.0,14/75,13.40%,ACTB;MEF2C;FARP1;PARD3;APP;KLF7;TBCD;BTBD3;CDK5;S100A6;DSCAML1;RAB3A;MFSD2A;SHTN1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2942521996404724,-0.9226136105099257,0.5735607675906184,0.8226997784757203,1.0,9/32,23.86%,DEFA6;RPL39;RPL30;CCL13;ROMO1;GAPDH;HMGN2;RPS19;PGLYRP1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2765576530478728,0.9226092178883742,0.5861456483126111,0.9460095394177264,1.0,12/58,16.00%,PAXX;POLM;ERCC1;ABRAXAS1;KAT5;KDM2A;MDC1;MRE11;PRPF19;PIAS4;PRKDC;ATM
prerank,negative regulation of metabolic process (GO:0009892),0.2799261763977828,0.9225063475949871,0.5863247863247864,0.9452994607706571,1.0,12/54,15.41%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2901370417591499,-0.9222996070697385,0.5862785862785863,0.8229053192734014,1.0,4/29,5.72%,CAV1;TNFSF10;THBS1;PAK2
prerank,axon development (GO:0061564),-0.23703127716684408,-0.9216330591537534,0.6323185011709602,0.8239908307651379,1.0,17/78,16.66%,ACTB;PARD3;APP;KLF7;GRM7;ARHGAP35;CDK5;S100A6;EPHB2;DSCAML1;RAB3A;SHTN1;MAP1B;DHFR;SEMA5A;RTN4;RTN4RL1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.37427855451032804,-0.9214922406631225,0.5770020533880903,0.8238121497207896,1.0,3/11,8.77%,MAPK1;USP7;SRC
prerank,membrane lipid catabolic process (GO:0046466),0.39239071650039564,0.9212540541630235,0.52465483234714,0.9476107947840332,1.0,4/10,18.30%,NAGA;FUCA1;SMPD2;MGST2
prerank,regulation of neurogenesis (GO:0050767),-0.25199343333151447,-0.9209772058849467,0.6179039301310044,0.8244966167649493,1.0,10/55,8.50%,B2M;NOTCH1;SERPINF1;BHLHE40;NUMB;HES1;HEYL;TGM2;SPEN;HEY2
prerank,cellular response to ionizing radiation (GO:0071479),-0.26060655098119956,-0.920913308114848,0.5956521739130435,0.8241293493734269,1.0,15/47,28.05%,NET1;MAP3K20;NIPBL;XRCC5;BLM;TNKS1BP1;RHNO1;LIG4;SPIDR;RHOB;TMEM109;NUCKS1;YAP1;GRB2;RAD51AP1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3552452696142544,-0.9206676608765691,0.5663900414937759,0.8241530370922361,1.0,5/13,18.15%,NOS3;GCH1;QDPR;PRKG2;MTHFD1L
prerank,positive regulation of protein polymerization (GO:0032273),-0.24261969164958105,-0.9206240980013063,0.6004962779156328,0.8237258603981624,1.0,21/65,26.29%,CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;TPPP3;CDC42EP2;PTK2B;PFN1;CLIP1;NCKAP1L;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,glutamate receptor signaling pathway (GO:0007215),0.29201648086822946,0.9205161892433391,0.5771324863883848,0.9485901200377553,1.0,9/37,17.57%,DAGLA;GRIN3A;GRID2;GRIK2;CPEB4;PLCB1;GRIA2;GRM8;CDK5R1
prerank,negative regulation of protein secretion (GO:0050709),-0.2730684470934282,-0.920318024210116,0.5711206896551724,0.8239225653245249,1.0,11/38,17.52%,CD200;CCN3;RAB11FIP5;MIDN;RAB11FIP1;APOE;RSAD2;IRS1;KCNB1;DPH3;RAB11FIP3
prerank,negative regulation of peptidase activity (GO:0010466),-0.2612681856652886,-0.9202683108755845,0.6516587677725119,0.8235194793662534,1.0,21/47,31.99%,SPOCK2;SERPINF1;CST3;UBXN1;SERPINE1;SERPINB8;SERPINB9;ECM1;LRP1;VTN;GAPDH;SERPINH1;SERPINI1;TIMP1;AGT;AHSG;PARK7;SERPINE2;SERPINC1;TIMP2;CRB2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2061903857587412,-0.9200765973343764,0.6920731707317073,0.8234451130580288,1.0,34/208,12.61%,ROR1;DAB2IP;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;ESR1;MID2;PLCG2;FLNA;BRD4;CARD16;TFRC;PRKD1;WNT5A;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;OTUD7B;PER1;MALT1;TERF2IP;EDA2R;HSPB1;SQSTM1;CD74;BIRC3;TNFRSF19;ECM1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.305713638409396,0.9199989708293433,0.5891181988742964,0.949021013327841,1.0,10/32,18.38%,MAP2;CLIP3;TTBK2;EML2;CLASP1;APC2;TUBB4A;MAPRE1;NAV3;MID1IP1
prerank,cellular response to chemical stress (GO:0062197),-0.232372479634408,-0.9195998682872348,0.6414141414141414,0.8241050101583179,1.0,21/96,16.08%,CAV1;LRRC8D;FOXO1;FOXO3;PRR5L;FAS;PRKD1;PPIA;ETV5;PIK3CA;SOD1;CAT;GPX1;NCF2;PRDX6;TRPV4;MT3;VKORC1L1;ZFAND1;ATF4;SRXN1
prerank,protein sumoylation (GO:0016925),0.28127856300659493,0.919357051292618,0.5800344234079173,0.9497032158204594,1.0,10/49,17.12%,EYA1;POM121;NUP155;TOPORS;NUP98;PIAS4;BCL11A;NUP37;RANGAP1;NUP88
prerank,negative regulation of ATP metabolic process (GO:1903579),0.35016017147337036,0.9193031870896478,0.5656370656370656,0.9488504032288648,1.0,3/17,5.44%,NUPR1;PPARA;PPIF
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3169960228604368,0.9192538973101353,0.5711610486891385,0.9479791502282054,1.0,5/25,12.21%,LEPROT;CHMP6;VTA1;UBXN6;DENND10
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3626589475178161,-0.9190214694607576,0.5668789808917197,0.8249758846948241,1.0,3/13,7.09%,GJC1;CACNB2;KCNQ1
prerank,positive regulation of chromosome organization (GO:2001252),-0.34702065767793916,-0.9188297181260733,0.5753424657534246,0.8249136137633429,1.0,7/15,23.82%,GNL3;RAD21;SHCBP1L;NBN;LIG4;SIRT6;PPP1R10
prerank,cellular response to cAMP (GO:0071320),-0.29065916916451284,-0.9187842164764118,0.5861297539149888,0.8244878509311512,1.0,7/30,16.14%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6;CFTR
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2970077165179727,-0.9183607027889884,0.5944206008583691,0.8249452556899419,1.0,12/26,27.91%,MET;OCLN;RPS3;TRPV4;CLIP1;KATNB1;TOGARAM1;DCTN1;CDK5RAP2;FES;AKAP9;MAPT
prerank,negative regulation of cilium assembly (GO:1902018),-0.36950285318405274,-0.9179536622268991,0.5612244897959183,0.8254036877717229,1.0,6/12,19.78%,LIMK2;MAP4;EVI5L;TBC1D7;CCP110;CEP97
prerank,pyruvate metabolic process (GO:0006090),0.27455352614791756,0.9179300908750939,0.6065573770491803,0.9505730487562932,1.0,8/52,7.67%,GCK;ME2;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,protein polyubiquitination (GO:0000209),-0.19652005640228887,-0.9178176024110613,0.7586206896551724,0.8251815399446802,1.0,68/297,20.39%,FBXL7;NEDD4L;TRAF5;WWP1;ZNRF1;CDC27;SMURF1;HECW2;UBC;ANAPC5;LMO7;RNF144A;RNF166;UBE2V2;RNF144B;RPS27A;RNF125;UBB;UBE2D3;TNKS;FBXW8;TRIM14;TRIM56;UBE2J1;PSMA6;ZNRF2;PSMB7;CDC16;CBFB;FBXO31;FBXO30;ARIH2;FBXO4;ARIH1;PSMB6;FBXO32;PSMB5;UBE2L3;UBE2Q1;FBXW2;FBXO44;LNPEP;FBXW7;FBXL18;TPP2;FBXO28;FZR1;PPIL2;PSMB8;UBE2J2;PSMC4;KBTBD7;PSMD11;KLHL3;UBE2A;RNF19A;UBE2G1;PSMB4;PSMD14;BARD1;CCNF;FBXL4;CDC26;HACE1;FBXW5;NEDD4;PSMD10;MYLIP
prerank,negative regulation of neuron projection development (GO:0010977),0.266195112436244,0.9177810795369095,0.5745454545454546,0.9499602436712742,1.0,12/56,15.22%,EFNB2;PTPN9;CRMP1;RUFY3;NGEF;LRP4;LPAR1;EPHA4;CBFA2T2;PTPRO;BCL11A;TSKU
prerank,regulation of lymphocyte activation (GO:0051249),-0.3761202610161785,-0.9174599586466524,0.5630081300813008,0.8255277194341237,1.0,7/12,38.09%,DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,"transcription, DNA-templated (GO:0006351)",0.2219419509210524,0.9172187409008408,0.6524390243902439,0.9504273320460215,1.0,24/207,11.83%,MAF;DDX5;SOX5;CTR9;THRB;RRAGC;DTX1;GLIS3;CCNT2;POLRMT;TCEA1;LEO1;E2F1;TAF10;EAF2;CREBL2;DRG1;TOPORS;RNMT;MBD1;TSC22D1;TAF1;MLLT1;CDC73
prerank,negative regulation of cartilage development (GO:0061037),-0.35936572671540473,-0.917032613425183,0.562015503875969,0.8260514648974137,1.0,7/13,26.11%,WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.26815063793650273,0.9170006829988179,0.6055363321799307,0.9500383884708443,1.0,18/59,18.35%,ROCK2;OXSR1;WNK3;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;MAP3K12;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.38140504904351324,-0.9166775423768446,0.597979797979798,0.8263718168139099,1.0,3/10,5.60%,NEDD4L;HECW2;CAMK2D
prerank,peptidyl-proline modification (GO:0018208),0.3142992001924047,0.9166266966872448,0.5676190476190476,0.9500519792150266,1.0,3/25,6.12%,PPIL6;PPIF;NKTR
prerank,myeloid cell development (GO:0061515),-0.3273648949897022,-0.9164964382735845,0.5862068965517241,0.8263073775003666,1.0,5/18,16.13%,FOXP1;APP;SRC;NCKAP1L;NRROS
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.22581092660494728,-0.9156928617593082,0.6530612244897959,0.8277179732813625,1.0,34/116,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;FCGR2B;GGT1;PRKAR1B
prerank,regulation of protein polymerization (GO:0032271),0.3017918746579277,0.915213278019633,0.5747747747747748,0.952662344454757,1.0,11/35,23.15%,MAP2;ARHGAP28;PRUNE1;ARL2;ABL1;GBA2;HSP90AA1;ABITRAM;TTBK1;DBNL;PAK3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.28790720856551166,-0.9148007731097856,0.5614035087719298,0.8293443347313469,1.0,7/31,15.37%,YWHAE;YWHAB;YWHAQ;YWHAZ;HIP1R;BBC3;BAK1
prerank,synaptic membrane adhesion (GO:0099560),-0.34850238683859563,-0.9147154300603064,0.5643153526970954,0.8290119799834103,1.0,1/14,0.21%,GPC6
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.34266780479879433,-0.9146454946551053,0.556910569105691,0.8286369092351483,1.0,6/14,14.99%,ABCD2;TWIST1;MFSD2A;AKT2;IRS1;TYSND1
prerank,cellular response to nutrient levels (GO:0031669),-0.2461933402492162,-0.9145108617377944,0.6304347826086957,0.8284443197509883,1.0,18/62,18.43%,BMPR2;FOXO1;WIPI1;RALB;TFEB;MAP1LC3B;STK24;RPTOR;RIPOR1;FAM107A;SREBF2;MFSD2A;RRAGA;GAS2L1;KCNB1;CLEC16A;WDR45B;STK26
prerank,lipid phosphorylation (GO:0046834),-0.386181979442924,-0.9144835314034226,0.5546875,0.8279950861306123,1.0,2/10,3.37%,DGKH;DGKZ
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.39171038491837906,-0.914427333851315,0.6100746268656716,0.8275870786299558,1.0,3/10,15.59%,ITGA5;MT3;VTN
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.27373202275422354,-0.9143792878946904,0.6197478991596639,0.8271740062305465,1.0,10/35,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.1949522989784876,-0.9136115652679322,0.7508532423208191,0.8284177177385518,1.0,102/341,26.21%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;NTAN1;HECW2;RNF111;SPOPL;ANAPC5;RNF144A;RNF166;UBR4;COP1;RNF144B;RNF125;UBE2D3;KCTD10;PSMA6;ZNRF3;PSMB7;CDC16;TRIM25;OTUD7B;FEM1B;PPP2R5C;ARIH2;UBXN1;ARIH1;MVB12B;PSMB6;PSMB5;SQSTM1;MTA1;RAD23B;UBXN2A;UBE2L3;FBXW7;FZR1;PSMB8;PTTG1;VPS37A;RNF149;CBL;PSMC4;KLHL22;KBTBD7;PSMD11;KLHL3;KCTD5;OS9;UBE2A;RNF19A;UBA6;ADRM1;PCBP2;UBE2G1;PSMB4;RNF128;PSMD14;KCTD6;PPP1R11;ATE1;UCHL1;RMND5B;FBXL4;CDC26;HACE1;FBXW5;TGFB1I1;TRPC4AP;ARRB2;NEDD4;PSMD10;MYLIP;PSME1;FAF1;DTX3L;KLHL25;AGAP3;RNF150;RNF40;PSMB3;CDC23;FBXO45;ATXN3;TOM1L1;TSG101;KCTD17;CUL3;CDC34;AREL1;NHLRC3;DTL;UFD1;CUL4A;KIF14;UBQLN1;SPSB3;RNF168
prerank,development of primary male sexual characteristics (GO:0046546),-0.28230273454152255,-0.9135217650363097,0.5851318944844125,0.8281112772867334,1.0,5/34,6.86%,KITLG;TGFB2;LHFPL2;WNT5A;AR
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2984883527756439,-0.9134143383133017,0.5806451612903226,0.827860095607835,1.0,7/27,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.319915053365514,-0.9131481908373648,0.5857740585774058,0.8279223738346962,1.0,5/20,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,peptidyl-lysine modification (GO:0018205),0.24520766119936693,0.9131077352716779,0.6206896551724138,0.9571921501629305,1.0,19/99,17.12%,EYA1;NNAT;SENP3;POM121;NUP155;LOXL3;LOXL1;KAT5;TOPORS;NUP98;PIAS4;HDAC4;BCL11A;SIRT1;NUP37;ATP7A;CTH;RANGAP1;NUP88
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4003263871453678,0.912557965877131,0.5708502024291497,0.9576420497143174,1.0,10/10,59.99%,CLU;HSP90AA1;SORL1;RB1;HSP90AB1;IFNG;DKK1;NAB2;C5AR1;EGR1
prerank,calcium ion transport into cytosol (GO:0060402),0.32752115390972664,0.9124830851822456,0.5757009345794393,0.9568139013948952,1.0,5/21,11.47%,CACNB3;JPH1;GRIN2D;RYR2;TRPM2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.3707012267139166,-0.9119386634469029,0.5946502057613169,0.830223668980163,1.0,3/11,3.58%,ACVR1;TGFB2;TGFBR2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3706228485303444,0.911726037909538,0.570873786407767,0.9578094513150032,1.0,6/12,21.10%,CHRNB2;EPHA4;TSKU;EPHB1;MYCBP2;GLI2
prerank,calcium-mediated signaling (GO:0019722),0.24950807239557435,0.9115789488781334,0.6340640809443507,0.9572052594266668,1.0,14/93,11.47%,CCR9;ACKR2;SPHK1;ANK2;GPR143;DMPK;PDPK1;NUDT4;LRRK2;NMUR1;ADGRL1;RYR2;KSR2;TRPM2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2653436930269353,-0.9110299391055772,0.5986842105263158,0.831770364871552,1.0,8/42,14.67%,DEFA6;RPL30;IL6R;SERPINE1;DROSHA;MPEG1;RARRES2;ROMO1
prerank,response to insulin (GO:0032868),0.2538505819007619,0.9106122190391128,0.5966666666666667,0.9587513893312328,1.0,26/80,22.04%,CPEB2;GCK;INSIG2;LPIN1;CITED1;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;TSC1;PRKDC;GOT1;SIRT1;AKT1;KHK;INHBB;RAB15;EIF6;INPP5K;MYO5A;DENND4C;CAPN10;SLC27A1
prerank,positive regulation of cell cycle (GO:0045787),-0.24757239264553635,-0.9105349648607939,0.6157407407407407,0.8323536544976068,1.0,10/62,10.10%,LRP6;TGFB2;TBX3;PKD1;EGFR;APP;CCNY;EIF4E;TAL1;DUSP3
prerank,positive regulation of organelle assembly (GO:1902117),-0.2643397324805785,-0.910032677965753,0.6017130620985011,0.8329655485251296,1.0,14/44,23.98%,PIP4K2A;RALB;CNOT6L;ARHGAP35;G3BP1;CAPG;CCP110;RAB3GAP2;DYNC1H1;GPSM2;ENTR1;TAPT1;NUP62;KCTD17
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.37580558597064107,-0.9096063395244258,0.5870841487279843,0.8334713019339355,1.0,4/10,16.59%,ABCA3;PHB2;MFSD2A;MTMR1
prerank,endocrine system development (GO:0035270),0.33451310155860436,0.9094164406954073,0.5955056179775281,0.9609425986111599,1.0,3/21,10.07%,WNT4;DKK3;TGFBR1
prerank,tRNA wobble uridine modification (GO:0002098),0.3616584892364149,0.909130773681263,0.5756972111553785,0.9606847725928241,1.0,5/14,23.53%,TRMT9B;GTPBP3;KTI12;URM1;ELP1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3057428509739365,0.9088646462293145,0.5890151515151515,0.9603796761556316,1.0,6/30,11.04%,CACNA1D;ANK2;SNTA1;FGF12;KCNH2;RYR2
prerank,response to UV-A (GO:0070141),-0.3476407853000828,-0.9087343538624485,0.5917525773195876,0.8350002315579017,1.0,5/14,30.20%,EGFR;MMP2;CCND1;TIMP1;MMP3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30023485894003,-0.9084678084850603,0.6043478260869565,0.8350680706754895,1.0,6/24,11.83%,BCL2L1;CD44;CXCL12;TPT1;ACKR3;CD74
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.24948520323764506,-0.9082977027672434,0.6595744680851063,0.8349578905682535,1.0,19/60,24.19%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;FBXO4;FGF2;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;RFC4;MAP3K4;DKC1;POLG2;RGCC
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.30661418727877965,-0.9080169634165252,0.5929549902152642,0.835080994483921,1.0,11/23,29.59%,FAF2;SURF4;AUP1;OS9;SEC13;UFD1;HERPUD1;VCP;TECPR2;RANGRF;LMAN1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22131599729698642,-0.9075929626005643,0.6593137254901961,0.8355230387489021,1.0,15/104,12.38%,ACTB;DAB2IP;RHOA;LRP6;LRP5;RALB;CAB39;CALM3;SRC;RPTOR;HGS;SERTAD1;GTF2H1;BLM;INCENP
prerank,regulation of cellular response to heat (GO:1900034),-0.2365142537955104,-0.9075661846429613,0.6716791979949874,0.8350607336637703,1.0,25/77,24.75%,RPA1;YWHAE;CD34;CAMK2D;MAPK1;PTGES3;NUP107;MAPKAPK2;RPTOR;BAG5;TPR;HSBP1;HIKESHI;BAG1;SEC13;DNAJC2;RPA2;MAPK3;NUP50;AKT1S1;NUP85;AAAS;NUP62;NUP214;IER5
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.34478859899453934,0.9072895173140121,0.5964912280701754,0.9635493342559551,1.0,4/18,13.46%,C5AR2;SPG21;C3AR1;BAG6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.39001680259099997,-0.9069183084393598,0.5843137254901961,0.8360284059370608,1.0,2/10,10.72%,PFKL;GFPT2
prerank,negative regulation of protein binding (GO:0032091),0.2565224932034082,0.9069126617943984,0.6179577464788732,0.9635321167584548,1.0,10/71,8.46%,IFIT2;DAB2;MAP2;TFIP11;CAMK1;TTBK2;IFIT1;LRRK2;GNL3L;GOLGA2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.22056178715071625,-0.9067083766317481,0.6829268292682927,0.8359841938665376,1.0,39/124,25.56%,PTPRM;FRY;RAPGEF2;APP;STMN1;FAM161A;STX3;MAP4;LYN;MYOC;CDK5;APOE;LIMA1;FRYL;MICALL2;SH3GL2;ODF2;CSF1R;ATCAY;MANF;STMN4;CDK16;RAB11A;FAM161B;MNS1;NEDD4;HMGB1;TTC17;RAB35;ROCK1;IQCG;RYK;NPY;PRMT1;BTG2;KIFAP3;ULK1;VAPA;CARMIL1
prerank,positive regulation of histone acetylation (GO:0035066),0.3293197381436265,0.9061428638040445,0.5996204933586338,0.9645506546197306,1.0,8/23,15.28%,RUVBL2;ARRB1;PPARGC1A;BRD7;PIH1D1;SPHK2;WBP2;MUC1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.30915802260837233,-0.9058789195108117,0.6,0.8373983904795135,1.0,6/24,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,neuromuscular process (GO:0050905),-0.32433520124421134,-0.905872634051578,0.5957446808510638,0.8368888261101116,1.0,5/16,21.28%,GCH1;STRA6;PAFAH1B1;AGTPBP1;DCTN1
prerank,positive regulation of secretion by cell (GO:1903532),-0.24397585819914536,-0.9056155663715849,0.6682692307692307,0.8369283604265626,1.0,22/70,20.36%,SLC12A2;TGFB2;UNC13B;STX1A;TMED10;PPIA;TGFB3;GOLPH3;CD2AP;EDN1;EXOC1;EDN3;RAB3A;BMP2;RAB27A;APBB3;KCNB1;CFTR;GPER1;EXPH5;MYOM1;RAB27B
prerank,ceramide catabolic process (GO:0046514),-0.34741555955994585,-0.9055308044226779,0.6021052631578947,0.8366108164476411,1.0,4/14,20.23%,ACER2;HEXA;ASAH2;ACER3
prerank,neuron projection development (GO:0031175),-0.2096273748778723,-0.9053403251515276,0.721763085399449,0.8365152956367065,1.0,42/168,21.29%,PTPRM;FRY;SHANK3;DOCK10;RAPGEF2;DAB2IP;NGF;APP;STMN1;TNIK;STX3;UBB;MAP4;LYN;GRM7;DCLK1;MYOC;CDK5;MAP4K4;APOE;EPHB2;FRYL;MICALL2;SH3GL2;SHTN1;ANKRD27;NCKAP1L;TAOK3;PTEN;ATCAY;TAOK1;MANF;STMN4;KIF20B;CDK16;RAB11A;CDC42;TRIO;NEDD4;HMGB1;RAB35;ROCK1
prerank,protein deubiquitination (GO:0016579),-0.20038470852348567,-0.9050338624065855,0.7683284457478006,0.836701864001483,1.0,64/242,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;MINDY1;USP7;USP35;EIF3F;PSMB6;SPATA2;BABAM2;HGS;PSMB5;MINDY2;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;ENY2;CFTR;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,positive regulation of protein import (GO:1904591),-0.28517151174388944,-0.9045383840249245,0.6033057851239669,0.8373348369794489,1.0,10/30,23.39%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR;ZC3H12A;ARHGEF5;JUP;HCLS1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3147736169535668,0.9040162590568978,0.5775193798449613,0.969104275541438,1.0,9/25,21.98%,LEO1;HNRNPU;EAF2;LDB1;CDC73;SUPT4H1;LARP7;CDK12;WDR43
prerank,positive regulation of viral transcription (GO:0050434),-0.2997998211550893,-0.9039362954530936,0.6104417670682731,0.8381890300164598,1.0,12/25,37.01%,MDFIC;GTF2F1;POLR2I;POLR2F;POLR2H;NELFCD;CCNT1;RSF1;POLR2E;POLR2J;NELFE;DHX9
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3852112554716197,0.9036466010012936,0.5747126436781609,0.9690695067830729,1.0,1/10,0.97%,ACTN2
prerank,regulation of protein transport (GO:0051223),-0.29600690723531636,-0.903547249727766,0.6192468619246861,0.8385827561349741,1.0,5/27,8.94%,DISP1;DNAJC1;DNAJA1;GAPVD1;PTPN1
prerank,cell chemotaxis (GO:0060326),-0.24692345641367894,-0.9032150356427362,0.645933014354067,0.838836533997513,1.0,10/60,10.56%,NRP1;LEF1;ABCC1;CCN3;AGTR1;CXCL12;PRKCD;BCAR1;PARVA;ACKR3
prerank,type I interferon signaling pathway (GO:0060337),0.28091807507145183,0.9031579707922655,0.62756052141527,0.9683926940405074,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,cellular response to type I interferon (GO:0071357),0.28091807507145183,0.9031579707922655,0.62756052141527,0.9683926940405074,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.3900047903112572,0.9031571248986107,0.5936883629191322,0.9674002609551168,1.0,3/10,14.46%,GABRG1;GABRG3;GABRB2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.26605264264789896,-0.903023299763287,0.6082949308755761,0.8387728794891791,1.0,6/40,7.90%,DAB2IP;EGFR;IRAK3;FLNA;CST3;PRKCG
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31138070129261636,0.9030045126385241,0.5775193798449613,0.9668124458167316,1.0,4/25,8.94%,GPR143;ITPR1;LRRK2;HTT
prerank,neuron projection regeneration (GO:0031102),-0.37908247259206274,-0.9027151716289397,0.600418410041841,0.8390184016813453,1.0,3/10,16.66%,PTN;DHFR;RTN4RL1
prerank,signal peptide processing (GO:0006465),-0.37049670289700914,-0.9025611632013439,0.5752895752895753,0.8388655604576926,1.0,3/11,14.21%,PCSK5;SPPL3;HM13
prerank,granulocyte differentiation (GO:0030851),-0.3240354221973316,-0.9024863488854529,0.5879828326180258,0.8385245509678126,1.0,3/18,9.95%,LEF1;CBFA2T3;TAL1
prerank,activation of phospholipase C activity (GO:0007202),-0.2955618035744789,-0.9024267881167619,0.634453781512605,0.8381464695312113,1.0,7/29,14.23%,EDNRA;EGFR;PLCG1;PHB2;HTR2A;CD86;P2RY6
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3609570274924164,0.9023564308543055,0.5754716981132075,0.967479664995304,1.0,2/14,8.07%,HSPA1A;LRRK2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2269598708888347,0.9021902394362883,0.673469387755102,0.9669016361758005,1.0,14/152,6.95%,RNF220;LGR4;LRRK1;RSPO2;WLS;WNT5B;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2
prerank,iron ion transport (GO:0006826),-0.25839260614714676,-0.902116520831604,0.632183908045977,0.8383425949952805,1.0,10/47,14.34%,SCARA5;STEAP3;ATP6V0A4;SLC40A1;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24837271490691523,0.9019889340388347,0.6341880341880342,0.9664294541560725,1.0,22/84,20.88%,IGF1;SPHK1;RTN1;TRIM71;NTRK2;ORMDL2;EIF2AK2;PAIP2B;PAIP2;CLU;EPRS1;EIF4E2;TSC1;FXR2;RNF139;GIGYF2;PRNP;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2608272044630263,0.9010056963449008,0.6228668941979523,0.9680525632526793,1.0,20/66,21.13%,UBE2E2;PLK5;APPL2;CDKN2A;DLG1;PRMT2;E2F1;PLCB1;BRD7;CDC73;LSM11;HYAL1;ANKRD17;AKT1;WEE1;FGF10;CDK2AP2;DDX3X;PSME2;KANK2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2996043210033667,-0.9009086001820257,0.6182212581344902,0.8405613321997537,1.0,9/24,27.53%,PDE4D;CAMK2D;CALM3;JPH2;PRKACA;DMD;JPH3;SELENON;CALM1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.25876619989693656,-0.9003269096985497,0.6473214285714286,0.8413552764283844,1.0,11/47,15.64%,AGK;TIMM22;ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;GHITM;ROMO1;ATP5F1D;TIMM29
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2859887696046832,-0.89958681394296,0.6338329764453962,0.8424918558793566,1.0,11/29,25.19%,WNT5A;NLRC5;PTPN1;ISG15;ABCE1;PTPN6;METTL3;ZBP1;TTLL12;MUL1;PTPN11
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.28366939128061275,-0.8992614972174078,0.6124197002141327,0.842727659861576,1.0,17/31,41.45%,LYN;TNFRSF21;CD86;GLMN;FCGR2B;SOX11;CEBPB;IL4I1;GPNMB;TYROBP;SDC4;VTCN1;ARG1;PDCD1LG2;CD80;CTLA4;BLK
prerank,TOR signaling (GO:0031929),0.30978872445338945,0.8986263641539521,0.5952380952380952,0.9731805555615891,1.0,2/26,2.19%,NPRL3;RICTOR
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.34084975016851954,-0.8982272057319302,0.6,0.8445071358013654,1.0,8/16,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,regulation of intracellular pH (GO:0051453),-0.27600958661161457,-0.8967223155816213,0.6280623608017817,0.8474797993922506,1.0,7/34,16.14%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2;CFTR
prerank,regulation of NMDA receptor activity (GO:2000310),0.29564810885244963,0.8966325872806608,0.6185185185185185,0.9772671949117608,1.0,9/32,19.03%,ACTN2;SLC6A9;DLG1;DLG4;OPRM1;LRRC7;GRIA2;NEFL;MAPK8IP2
prerank,membrane protein proteolysis (GO:0033619),-0.2724086373662991,-0.8965852215573074,0.5968468468468469,0.847277629364355,1.0,12/37,26.39%,MYH9;ADAM10;ADAM19;SPPL3;RET;HM13;RHBDD1;PSEN2;PSENEN;ERAP1;MBTPS2;PRTN3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.388586821521801,0.8965319161060227,0.5734126984126984,0.9765504777935609,1.0,2/10,11.77%,TFIP11;RTEL1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.31527264034458485,-0.8963845006307574,0.615866388308977,0.8472131964080966,1.0,7/20,21.75%,SYNE1;SUN1;MORC3;ARL2BP;SP100;BARD1;BCL3
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.24167093925410316,-0.8963697916153088,0.697841726618705,0.8467257581302331,1.0,11/64,11.23%,PLA2G4A;CYP1B1;PTGS2;ACOX1;MGLL;ELOVL5;ACSL5;GPX1;ELOVL6;ACSL3;HACL1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2242793479512468,-0.8962220440898874,0.6576819407008087,0.8465546774757109,1.0,33/100,23.57%,EIF3H;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;UBXN1;USP7;SOCS5;ARIH1;BAG5;PABIR1;RAD23B;FOXF2;GABARAP;GNA12;RNF19A;N4BP1;RYBP;PSMD10;TRIB2;CSNK1D;UCHL5;GLMN;FHIT;TRIB3;GIPC1;TAF9
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2026205862222613,-0.8961992126890154,0.7542372881355932,0.8460907228207161,1.0,59/193,25.22%,FBXL7;NEDD4L;CDC27;SMURF1;NTAN1;RNF111;UBC;ANAPC5;RNF144A;RNF166;UBR4;RNF144B;RPS27A;RNF125;UBB;KCTD10;ZNRF3;CDC16;TRIM25;ARIH2;ARIH1;SQSTM1;ISG15;UBE2L3;FZR1;PTTG1;RNF149;CBL;PSMD11;KLHL3;OS9;UBE2A;RNF19A;UBA6;ADRM1;UBE2G1;RNF128;PSMD14;KCTD6;PPP1R11;PCYOX1L;FBXL4;CDC26;HACE1;TRPC4AP;NEDD4;MYLIP;DTX3L;KLHL25;RNF150;RNF40;CDC23;FBXO45;ATXN3;CUL3;CDC34;AREL1;DTL;UFD1
prerank,defense response to symbiont (GO:0140546),0.24290073173953036,0.8961548220083548,0.6773675762439807,0.9765273568824283,1.0,15/92,11.49%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;BCL2;STAT1;STAT2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.36769003998096217,0.8960216605153031,0.6080305927342257,0.9758488258742317,1.0,3/13,9.32%,PCID2;NDC80;MAD2L1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.33179241883135724,0.8957444380872696,0.5970425138632163,0.9755592332140474,1.0,3/21,3.86%,IGF1;BMPR1A;FGF9
prerank,negative regulation of immune effector process (GO:0002698),0.3706825914744194,0.8954895627689003,0.5699797160243407,0.9752413457831365,1.0,3/13,14.32%,ENPP3;CD300A;HAVCR2
prerank,regulation of lipid storage (GO:0010883),-0.3087649080105379,-0.8954394854428199,0.5882352941176471,0.8472251346631874,1.0,6/22,19.90%,FTO;NFKBIA;FBXW7;C3;ZC3H12A;MEST
prerank,positive regulation of nervous system development (GO:0051962),0.27983637759658,0.8952393248867835,0.6159695817490495,0.9748991484633155,1.0,11/42,17.49%,IL1RAPL1;NLGN2;WNT7A;GRID2;NLGN3;PTPRD;FAIM;BDNF;OPRM1;EPHB1;SYNDIG1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3347134307130548,0.8950834379245305,0.5935727788279773,0.9742935605102152,1.0,3/20,10.07%,NUPR1;FLOT2;CFLAR
prerank,homocysteine metabolic process (GO:0050667),0.3749397714447882,0.8948718032980943,0.6147859922178989,0.973868964316843,1.0,5/11,26.01%,MMUT;MTHFR;CTH;BLMH;DPEP1
prerank,positive regulation of insulin secretion (GO:0032024),0.29077076114228,0.8948550059896371,0.60546875,0.9729258999986732,1.0,4/36,6.20%,NNAT;GCK;NLGN2;ADCY8
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3559810817777876,-0.894629771829447,0.597678916827853,0.848527756198663,1.0,4/12,23.06%,DDC;MAOA;ODC1;HNMT
prerank,nucleotide-excision repair (GO:0006289),-0.22284151107553263,-0.8944813309611993,0.6923076923076923,0.848370698346752,1.0,30/101,24.21%,RPA1;RNF111;UBC;RPS27A;XPC;UBB;SLC30A9;USP7;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2;AQR;BRCA2;PPIE;GPS1;RPA2;LIG4;POLA1;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;ATXN3;POLB;COPS4
prerank,mitotic cytokinesis (GO:0000281),-0.25862221415273084,-0.8944026859643,0.6386036960985626,0.8480181463619483,1.0,17/47,26.98%,SPTBN1;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;INCENP;NUSAP1;RHOB;RAB35;ROCK1;RASA1;KIF4A;JTB;CEP55;RTKN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.24504232367375642,0.8942864891432818,0.6556521739130434,0.9734052279975683,1.0,16/87,13.35%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3;DSTYK;FGFBP1;HYAL1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.26649521420207367,-0.894232783520001,0.6443514644351465,0.8478878721287837,1.0,15/38,26.63%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;RHNO1;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;CDKN2B;TFDP1
prerank,cellular response to UV-A (GO:0071492),-0.3663558134991582,-0.8940874893267516,0.5988023952095808,0.8476812771884192,1.0,9/11,49.00%,MMP2;TIMP1;MMP3;MME;OPN5;MMP9;CERS1;PPID;OPN1SW
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2876297331629447,0.8938170671779887,0.6363636363636364,0.9735654851730473,1.0,11/35,17.41%,HSPA1A;ABCB10;MED1;LDB1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;HSPA9;STAT5B
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3517324133709161,0.8937279493845675,0.6069364161849711,0.9728007419407935,1.0,3/15,8.02%,KCND3;KCNJ5;KCNH2
prerank,negative regulation of hemostasis (GO:1900047),-0.36304698646265426,-0.893718371941546,0.6069246435845214,0.8480099635856683,1.0,5/12,15.59%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3730438912929708,-0.8936712850171699,0.6181474480151229,0.8475929045817919,1.0,8/11,37.12%,FGF2;IPMK;PPIP5K1;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3
prerank,membrane raft organization (GO:0031579),-0.3395032476676324,-0.8936523905901154,0.6008771929824561,0.8471046393930383,1.0,5/15,19.29%,RFTN1;EMP2;S100A10;NAXE;YJEFN3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.32803773981347367,-0.8936496398856599,0.5902912621359223,0.846592306944305,1.0,4/17,11.50%,PPIA;SOD1;BAG5;HSPB1
prerank,regulation of isotype switching (GO:0045191),-0.33805027415041966,-0.8935835163468463,0.6264822134387352,0.8462292401804394,1.0,5/14,25.89%,TFRC;SHLD1;MAD2L2;PARP3;SHLD3
prerank,regulation of endocytosis (GO:0030100),0.25985491643481134,0.8929047894769864,0.6330434782608696,0.9738803873051513,1.0,6/61,4.69%,DAB2;SYT11;SPHK1;PICALM;CLIP3;RUFY2
prerank,cAMP metabolic process (GO:0046058),0.37187491476326445,0.8927339461490852,0.5938775510204082,0.9733349989680458,1.0,3/13,6.20%,ADCY5;ADCY1;ADCY8
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2936538705650122,-0.8925916248642675,0.6271929824561403,0.8479702218089766,1.0,9/24,23.59%,RPA1;UBC;RPS27A;UBB;RPA2;LIG4;RFC4;POLD4;POLB
prerank,calcium import into the mitochondrion (GO:0036444),-0.37652439022373724,-0.8922558325485226,0.6053130929791272,0.8482144591467788,1.0,4/10,14.31%,MICU3;MCUB;MICU2;SMDT1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3777365321033518,-0.8919777840092655,0.6060606060606061,0.8483430844157344,1.0,4/10,23.33%,AGO2;DROSHA;MRPL44;TARBP2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.31150197990005923,0.8919725014245882,0.6066176470588235,0.9742883020322233,1.0,3/24,11.37%,LPGAT1;PNPLA8;PLA2G15
prerank,urogenital system development (GO:0001655),0.3738352199973908,0.8919415266057001,0.6007751937984496,0.9733923471420008,1.0,2/11,11.97%,OSR1;SOX9
prerank,ether lipid metabolic process (GO:0046485),-0.3457758510812975,-0.8915136947622813,0.6097087378640776,0.8488672324121839,1.0,4/14,15.75%,DHRS7B;PEX7;PLA2G6;PAFAH1B1
prerank,response to retinoic acid (GO:0032526),0.2638562578088212,0.8912948506289055,0.6552346570397112,0.974073761838926,1.0,15/59,18.15%,HSD17B2;WNT5B;PTK7;WNT6;HTRA2;FZD7;RXRA;CTSH;SOX9;NDUFA13;RBP4;ATM;RARA;CREB1;FZD10
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3784639583481605,-0.8912507611168659,0.6336633663366337,0.8489845570204638,1.0,2/10,2.04%,CAV1;ENG
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3239156151549068,0.8912286866032909,0.6019607843137255,0.9732707248212511,1.0,5/21,12.71%,HS3ST3B1;HS6ST1;HS6ST3;HS3ST5;HS6ST2
prerank,regulation of interleukin-4 production (GO:0032673),-0.30913946219568417,-0.8911903192677048,0.6196319018404908,0.8486067806991735,1.0,2/21,3.21%,LEF1;SLC7A5
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3154043386810591,0.8911161354387965,0.603448275862069,0.9725816635264288,1.0,4/23,10.91%,IGF1;EFNB2;NRG1;MAPK14
prerank,glycerolipid metabolic process (GO:0046486),-0.3621371564478378,-0.8910747332914848,0.5906313645621182,0.8483506336412688,1.0,8/11,43.93%,DGKZ;DGKB;DGKG;DGKA;PIP5K1A;DGKQ;PDXP;PNPLA3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.281209062547136,-0.890665424884612,0.6346153846153846,0.8487018252489967,1.0,8/30,17.32%,MLLT3;BMP4;KDR;FLT1;FLT4;PTPRC;CSF1R;SP7
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3634489955695971,-0.8904091279931897,0.6003824091778203,0.8487393035877986,1.0,6/12,29.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,centromere complex assembly (GO:0034508),-0.27165619570980687,-0.8902605207720192,0.6666666666666666,0.8485478444744211,1.0,13/36,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;MIS12;RSF1;SMARCA5
prerank,regulation of aerobic respiration (GO:1903715),0.3501043145311894,0.8902275447890157,0.5992217898832685,0.9737823910633205,1.0,4/15,16.57%,COX7A1;COX7A2L;ABCD1;ATP7A
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.37780225916117605,-0.8900119759803183,0.6041666666666666,0.8485777198346357,1.0,4/10,18.16%,CRY1;FEM1B;WDR76;RPA2
prerank,megakaryocyte differentiation (GO:0030219),0.3808741823939611,0.8899539657289971,0.6032388663967612,0.9735281878688005,1.0,2/11,8.34%,KIT;MED1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.26652152859344574,-0.8899432079170299,0.6425339366515838,0.8482336683463843,1.0,9/38,15.93%,CAV1;GAS6;APP;IL34;PTPN1;NEDD9;PTPRC;CSF1R;RAP2B
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.26857700039594046,0.8899269899646337,0.6197916666666666,0.972625299149064,1.0,8/49,13.88%,PRKCZ;OPRD1;TFIP11;NLRP2B;NLRC3;IMPACT;CLU;PMEPA1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3226578112038643,0.8899135154429917,0.6012145748987854,0.971688943495349,1.0,9/21,25.76%,COX18;COX10;COX14;TIMM21;COX20;OXA1L;COA6;COX19;FASTKD3
prerank,RNA metabolic process (GO:0016070),0.2293010239472956,0.8899017817058894,0.6946688206785138,0.9707506201799885,1.0,29/127,18.86%,CELF2;RNASEH2A;PABPN1;NOVA1;TFIP11;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;SUPV3L1;DDX17;HNRNPL;PTBP1;BICD1;MPHOSPH10;AGO3;DICER1;RBM5;SND1;LSM8;POLR2D;DHX8;HNRNPH2;DDX39B;MTREX;THOC1;ADAR
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3784940631360285,0.8894934114123237,0.5821205821205822,0.9707674504238595,1.0,1/11,0.43%,WNT4
prerank,cellular response to interleukin-15 (GO:0071350),-0.34742086602914707,-0.8893995562712678,0.5888429752066116,0.8484059507406471,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.34742086602914707,-0.8893995562712678,0.5888429752066116,0.8484059507406471,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.23482697717010828,-0.8893177249351284,0.6642512077294686,0.8480939157687599,1.0,20/74,23.51%,NOTCH1;LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3;EGLN3
prerank,phosphatidylserine metabolic process (GO:0006658),0.29108207345934844,0.889140977302098,0.6226086956521739,0.9706596629163764,1.0,5/32,11.37%,OSBPL8;PLA1A;PTDSS2;OSBPL5;PLA2G15
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.2887799225645786,-0.8891021429849145,0.6529774127310062,0.8480759201413361,1.0,12/27,29.83%,ERN1;TRIR;NUDT16;ZC3H12A;TOE1;NYNRIN;NHP2;RNASE4;PCF11;POP7;XRN1;CSTF3
prerank,insulin secretion (GO:0030073),-0.3178730775840212,-0.8890250875429148,0.6282051282051282,0.8477149086932932,1.0,4/19,14.34%,RAB11FIP5;SNX19;ANXA1;RAB11B
prerank,response to amyloid-beta (GO:1904645),0.27293834438400555,0.8887874379491219,0.6363636363636364,0.9706238640498843,1.0,3/44,1.71%,SNX6;IGF1;CACNB1
prerank,response to glucose (GO:0009749),-0.2521672313413212,-0.8886459305007888,0.6613995485327314,0.8480331371071668,1.0,12/46,18.95%,THBS1;GAS6;UNC13B;ERN1;RACK1;EIF2B2;PFKL;KCNB1;PRKACA;EIF2B1;GPER1;NKX6-1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3204904888532393,0.8883772722655262,0.616822429906542,0.9707147621516733,1.0,3/21,6.20%,ADCY5;ADCY1;ADCY8
prerank,regulation of cholesterol transport (GO:0032374),0.32626570797284105,0.8882760199515364,0.6254681647940075,0.9700144692143544,1.0,8/20,22.03%,ABCA13;NR1H3;ABCA2;ABCB4;ABCA5;NUS1;NFKB1;LAMTOR1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3439802190530914,-0.888266136740488,0.6266094420600858,0.8483273803944666,1.0,7/14,34.79%,PUM2;PUM1;ZCCHC3;USP15;OASL;TLR3;TLR2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.34457601929645154,0.8881653586201883,0.6143667296786389,0.9693163215553546,1.0,7/16,21.97%,MRAP2;GRP;CHGA;MRAP;PRKCA;KLK6;PRMT5
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.32191695576770807,0.8880443336843044,0.6007677543186181,0.9667671120200791,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.32191695576770807,0.8880443336843044,0.6007677543186181,0.9667671120200791,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.32191695576770807,0.8880443336843044,0.6007677543186181,0.9667671120200791,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2664474932819093,-0.8876875664587628,0.6488222698072805,0.849122725882379,1.0,9/35,18.14%,PPP1R12A;ITGA1;NUAK1;CALM3;PPP1R2;PPP6R1;BOD1L1;PPP1R11;MASTL
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2221810919433832,-0.8876811606035432,0.7007125890736342,0.8486258271379362,1.0,35/88,31.21%,DAB2IP;DNAJC1;CST3;RACK1;RPS3;CDK5;EIF2AK3;APOE;EDN1;SYNCRIP;HDAC6;DHFR;FMR1;FXR1;GAPDH;RIDA;NCL;CAPRIN1;EIF4A3;RIC1;NANOS3;RPL13A;DAPK1;BTG2;TYMS;SHMT1;IGF2BP2;PCIF1;IGF2BP1;CNOT1;SERPINE2;PATL2;CLN3;CAMK2N1;CNOT10
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.21771710104749653,-0.8876526862598129,0.7160804020100503,0.8481705650115284,1.0,33/117,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;GGT1;PRKAR1B
prerank,nuclear envelope organization (GO:0006998),0.32473607988642805,0.887473770797148,0.6335282651072125,0.9671888562068415,1.0,3/20,8.40%,DMPK;NUP155;TOR1B
prerank,protein-containing complex subunit organization (GO:0043933),0.2354354379814693,0.8873154888796464,0.6813008130081301,0.9666370674184801,1.0,30/109,19.51%,CD247;WDR19;CAPN3;PICALM;KMT2A;AFG3L2;ADD2;IKBKG;SHANK1;RIMS1;WASF1;PPARGC1A;TUBGCP4;LLGL1;DLG4;WASL;EPRS1;NUP98;SOX9;PML;WASF3;WAS;TAPBP;MDM2;HFE;SKAP2;MITF;SNX9;TFAP4;NDC1
prerank,organelle assembly (GO:0070925),-0.1850270148696329,-0.8873029755727195,0.9384057971014492,0.8484268024678295,1.0,66/384,15.14%,ABCC4;PGM5;ABLIM1;NEK7;GSN;NOTCH1;PKD1;DISC1;CD34;LIMD1;STARD9;ATG3;WIPI1;EXOC6;RPS23;EXOC4;FAM161A;FLNA;CHMP2B;GABARAPL2;IFT140;TNKS;SH3PXD2B;ABLIM3;CHMP4B;CHMP4A;ARL13B;MAP1LC3B;RB1CC1;ABCA3;BBS9;RPS3;G3BP1;VPS36;ATP6V0D1;TMOD3;PDE6D;ATG16L1;RP2;PARVA;EHD2;EXOC1;HGS;WDR11;TCTN3;PIK3C3;PIBF1;SNX10;FNBP1L;EHD4;UBXN2A;ATP6V1D;STX7;HDAC6;GABARAP;IST1;DYNLL1;AVIL;CYS1;UBAP2L;DZIP1L;VPS37A;BBIP1;RAB1B;TMEM216;CFAP43
prerank,transferrin transport (GO:0033572),-0.2721001870630975,-0.8866232585080571,0.6488222698072805,0.8494403270767614,1.0,9/33,16.78%,STEAP3;ATP6V0A4;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B;TCIRG1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.19000858500214973,-0.8864117540612956,0.8671328671328671,0.8493852074594357,1.0,106/336,26.92%,FOXP1;ACER2;RPA1;RAD51B;FOXO1;BCL2L1;TNFRSF1B;CRY1;HERC2;FNIP2;ALKBH1;SMC1A;CSNK1E;CRIP1;XPC;NIPBL;XRCC5;LYN;REXO4;FBXO31;APC;RPS3;ZBTB1;HPF1;CHD1L;SMC5;XIAP;RPAIN;STK33;MAPKAPK2;CDKN2AIP;WDR76;RNF169;BABAM2;OARD1;GTF2H1;NFATC2;SUSD6;DCUN1D5;BLM;KIN;USP47;NCOA6;SUV39H1;TIMELESS;BAK1;FMR1;UBE2A;TAOK3;UBA6;FANCG;GNL1;SLF2;TOP2A;NBN;BOD1L1;BARD1;MASTL;TAOK1;CCND1;MAPK12;USP10;MAPK3;ZC3H12A;MCL1;TIGAR;PCLAF;SIRT7;POLA1;METTL3;XPA;SPIDR;DYRK2;RFC4;CHEK1;NSMCE4A;MUTYH;NSMCE3;DTX3L;BCL3;WDHD1;TRRAP;RBM24;FBXO45;TAF9;POLB;PARP3;TRAIP;BOK;AATF;ZBTB40;ASH2L;PLK3;BTG2;XRCC3;DTL;POLE3;YAP1;CUL4A;NUDT1;VAV3;RNF168;OTUB1;FANCL;GRB2;RFC2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2681950451382008,0.8858411336770203,0.6581818181818182,0.9692627074761092,1.0,11/51,13.90%,BMP7;GAS7;CNTNAP2;LRRK2;WASF1;KLK8;GPM6A;DTNBP1;BDNF;NYAP2;DICER1
prerank,protein acylation (GO:0043543),0.27940712432845116,0.8856307636808602,0.6181172291296625,0.968821864931533,1.0,10/38,17.44%,SPHK1;ZDHHC12;ZDHHC1;CLOCK;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,endoderm development (GO:0007492),-0.34387879735094895,-0.8853732535832375,0.6320939334637965,0.8511157255171273,1.0,8/13,38.97%,SOX17;SOX7;DUSP1;LHX1;TBX20;DUSP5;DUSP2;GATA4
prerank,positive regulation of organelle organization (GO:0010638),0.29417489350572507,0.8853190935969414,0.6171875,0.9686704225386983,1.0,6/32,11.52%,STX18;RAB3GAP1;FYCO1;HTRA2;PPARGC1A;TMED9
prerank,regulation of interleukin-6 production (GO:0032675),-0.22097275609419434,-0.8850379498250752,0.7088607594936709,0.8513203374852583,1.0,38/96,33.08%,CD200;GAS6;AFAP1L2;STAT3;IRAK3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;MAPKAPK2;TWIST1;CD74;IFIH1;NCKAP1L;NOD2;IL33;PTPN6;ZC3H12A;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TREM2;FOXJ1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;CD47;TYROBP
prerank,necroptotic process (GO:0070266),-0.32204202426578865,-0.8849000731687772,0.6365546218487395,0.8511263657301525,1.0,8/16,32.89%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,striated muscle cell development (GO:0055002),-0.33775690710022277,-0.884452114162578,0.6196319018404908,0.8515895689969661,1.0,2/14,8.89%,PGM5;TMOD3
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2149714792482899,-0.8842249654819041,0.7361809045226131,0.851572664717541,1.0,20/110,14.94%,DAB2IP;NEDD4L;WWP1;FOXO1;NFKBIA;SMURF1;HECW2;APP;WNT5A;AGTR1;PLK2;APC;APOE;KLF4;RANBP9;CSNK2A1;CD86;KLF2;FZR1;RAB1B
prerank,response to amino acid (GO:0043200),-0.2759315246476136,-0.8836789056226294,0.6592920353982301,0.8522701489206932,1.0,11/31,20.24%,SH3BP4;CAPN2;GLRB;SPAAR;RPTOR;NSMF;IPO5;RRAGA;GLRA2;GRIN1;RRAGD
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.30212393858957703,0.8835050194972609,0.6434108527131783,0.9720937668217399,1.0,7/26,20.75%,IGF1;FHL2;PTBP1;CHERP;AKAP6;PRNP;RCAN1
prerank,positive regulation of cyclase activity (GO:0031281),0.35584683947371387,0.8834418548950587,0.6052631578947368,0.971309953688024,1.0,1/14,0.44%,CACNA1D
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.3810540398685149,0.8831478531040828,0.5852156057494866,0.9710691620160277,1.0,3/10,11.65%,IVD;ACAD11;GCDH
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.28094601764495614,-0.8831271257162179,0.6233183856502242,0.852961513825321,1.0,4/31,5.07%,PARD3;RHOA;WDR1;RAP2A
prerank,mitochondrial translational termination (GO:0070126),-0.22622324720351672,-0.8830983629754147,0.7259615384615384,0.8525149573153165,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,regulation of neuron differentiation (GO:0045664),0.24855147153824408,0.8830233173518751,0.6946308724832215,0.9704368513397421,1.0,10/76,8.34%,BMP7;DTX1;CPNE1;GPRC5B;BEND6;ZFHX2;NREP;LRRK2;IMPACT;MED1
prerank,glutathione biosynthetic process (GO:0006750),-0.37045681718932305,-0.882860134826339,0.6240601503759399,0.8525473461125866,1.0,6/11,29.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,gene silencing by miRNA (GO:0035195),-0.27546481187523564,-0.8828444301433582,0.6584362139917695,0.8520744175070956,1.0,11/32,23.33%,LIMD1;AGO1;ZC3H7A;PUM2;AGO2;NOTCH4;PUM1;AGO4;XPO5;AJUBA;TARBP2
prerank,innate immune response (GO:0045087),-0.19778977443686077,-0.8826479803271833,0.7976878612716763,0.8519977431460706,1.0,50/217,21.58%,B2M;ALPK1;APP;MFHAS1;REL;SERINC5;MID2;DEFA6;PLCG2;IFITM3;GCH1;RPL39;LYN;NLRC5;TRIM14;TRIM56;TRIM25;RELB;MFAP4;SRC;CAPZA2;NCF2;YES1;MALT1;SERINC3;PIK3CD;ISG15;CD74;PHB2;PTK2B;CD40;RARRES2;ADAM15;IFIH1;NRROS;SP100;IFITM1;NOD2;C3;IRF5;BTK;KYNU;HCK;POLR3A;CAPZA1;HMGB1;MYD88;SYK;RIPK2;IFITM2
prerank,oligodendrocyte development (GO:0014003),-0.3313516259116258,-0.882617848967415,0.6523605150214592,0.8515513131468738,1.0,7/15,32.35%,EIF2B2;B4GALT5;EIF2B1;MYRF;NSUN5;B4GALT6;PRDM8
prerank,ovarian follicle development (GO:0001541),0.3622008074821353,0.8825319952902785,0.6032719836400818,0.9707408204071624,1.0,3/13,8.19%,KIT;INHA;EIF2B4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.32020329283583504,-0.8825037028013265,0.6535947712418301,0.8513192096270185,1.0,4/18,12.38%,NOTCH1;CCN3;TMEM119;BMP2
prerank,glycine metabolic process (GO:0006544),0.3696658108875891,0.8821208598352203,0.6084452975047985,0.9708437034194147,1.0,3/12,16.00%,GLDC;GLYAT;GCAT
prerank,cilium assembly (GO:0060271),0.20561239445511265,0.8820491332646453,0.7741935483870968,0.9700589220703091,1.0,70/296,20.22%,CFAP44;DCDC2;INTU;TTC21B;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;RSPH4A;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;DYNC2LI1;PLK1;CEP78;RILPL1;CLASP1;KIF3C;SNAP29;BBOF1;VANGL2;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;TUBG1;IFT122;B9D1;E2F4;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;SFI1;CDC14B;RAB1A;TUBB4A;CFAP20;TCTN2;ARL3;MAPRE1;RAB23;NINL;NEDD1;FUZ;CETN2;RPGR;GBF1;PTPN23;C2CD3;OCRL;KIF3B;DYNC2H1;HSP90AA1;TTC36;NDE1;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.29566430720126513,-0.8818834310084748,0.6276150627615062,0.852164758663872,1.0,6/26,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,protein-DNA complex disassembly (GO:0032986),-0.3309657378656722,-0.8816088785539513,0.6378947368421053,0.8522573928474052,1.0,5/16,20.48%,SMARCC1;ARID1A;RPL23;SMARCA4;SET
prerank,zinc ion transmembrane transport (GO:0071577),-0.29647130295562407,-0.8811051088511812,0.653558052434457,0.8528158268013823,1.0,5/22,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,sister chromatid segregation (GO:0000819),0.29163325361991754,0.8807933225014553,0.6153846153846154,0.972288461165249,1.0,6/31,9.75%,TOP2B;ZWINT;PLK1;DSN1;NDC80;TUBG1
prerank,axonal fasciculation (GO:0007413),-0.35382384127046324,-0.8806563033944513,0.625,0.8532662033409051,1.0,4/12,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,positive regulation of hormone secretion (GO:0046887),0.3243499948401388,0.8805823788139694,0.5984405458089669,0.9718759163466199,1.0,4/17,16.92%,VAMP7;C1QTNF3;GRP;HFE
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2190574664732891,-0.8803490367325952,0.7053140096618358,0.853378286939692,1.0,15/91,14.91%,HIP1;NRP1;STON2;SCARB1;CDH13;MAPK1;USP7;SRC;PTPN1;ZFYVE16;RAB3A;HIP1R;PTPRC;RAB11B;RAB5C
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3568318832404378,0.8803207202188073,0.6206896551724138,0.9715920798860396,1.0,6/13,26.06%,SRSF10;PRPF19;PRPF6;PRPF3;SART3;PRPF8
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.32344508779344955,-0.8801199370965505,0.6110019646365422,0.8533672160300505,1.0,2/16,6.84%,CLDN5;CLDN14
prerank,RNA biosynthetic process (GO:0032774),-0.27553465942589905,-0.880076294246208,0.6595289079229122,0.8529558235005854,1.0,13/31,30.26%,NCOA6;SMN1;POLA1;TBPL1;POLA2;NAT14;PRIM2;BRF2;SETX;RSF1;HELB;TAF7;SMARCA5
prerank,positive regulation of neurogenesis (GO:0050769),0.2517328419982999,0.8799218444920996,0.6696588868940754,0.971620405787309,1.0,10/68,9.03%,ROBO1;OBSL1;IL1RAPL1;PLXNA2;SMARCD3;FZD3;PLXNA1;NTRK2;PTPRD;PLXNA3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.36511228459892975,0.8798768124659557,0.6170212765957447,0.9707894019988614,1.0,3/12,11.04%,DSC2;DLG1;RYR2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3546567758708906,-0.8792894317755632,0.6302521008403361,0.854118337013626,1.0,5/12,27.62%,IAPP;APOE;PFDN6;TREM2;LDLR
prerank,muscle tissue morphogenesis (GO:0060415),-0.32154945470151064,-0.8788729175037838,0.6417910447761194,0.8545134501485839,1.0,5/16,12.38%,NOTCH1;BMP4;TBX1;HEY2;BMP2
prerank,regulation of phosphorylation (GO:0042325),0.22743381320048325,0.8787756338506033,0.6973478939157566,0.9725435400934371,1.0,15/120,12.11%,PRKAG2;BMP7;GCK;CDKN2A;POM121;NUP155;INHA;PHIP;ROPN1L;FZD7;LDB2;LDB1;STAT2;NUP98;PML
prerank,negative regulation of defense response (GO:0031348),0.2457418087263411,0.8786402535329144,0.6625441696113075,0.9719330560629248,1.0,10/77,9.85%,RORA;ENPP3;PPARA;METRNL;C1QTNF3;NLRC3;NLRP3;CACTIN;NR1H3;C1QBP
prerank,cellular defense response (GO:0006968),0.2731272952587214,0.8786087325540184,0.6534839924670434,0.9710602403419196,1.0,2/40,1.32%,CCR9;DCDC2
prerank,regulation of mast cell degranulation (GO:0043304),0.3544713715887827,0.8785152067258313,0.6193293885601578,0.9703185071092819,1.0,3/14,12.34%,UNC13D;CD300A;SPHK2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3641702263544615,-0.8781198804599873,0.6194331983805668,0.8557058526442105,1.0,2/11,9.75%,CAT;GPX1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2337650283556693,-0.8777786829372765,0.7193396226415094,0.8559492314218244,1.0,25/69,26.03%,MEF2C;NDNF;NGF;SIX1;MDK;PRKCG;FOXQ1;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;SIX4;CRLF1;LIG4;AGAP2;SET;RASA1;KDM2B;NFATC4;F2R;KIF14;WFS1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.23995342472927142,0.8760689512129433,0.6970198675496688,0.9752966655834294,1.0,19/85,18.66%,DAB2;HSPA1A;NUPR1;SH3RF2;PLK1;RNF14;CEBPA;LRRK2;TAF1;RNFT1;CLU;BAG6;PSMC5;HSPA1B;DNAJB2;MDM2;ANKIB1;RNF180;FBXO22
prerank,negative regulation of response to external stimulus (GO:0032102),-0.22013722761255203,-0.8757909777546906,0.775,0.8595888797135873,1.0,16/105,10.10%,TEK;PPARD;PTGIS;IRAK3;MFHAS1;CD109;CCN3;CASK;CARD16;AJAP1;PRKCD;FGF2;SERPINE1;APOE;KLF4;DUSP3
prerank,response to organic cyclic compound (GO:0014070),0.2613124486194336,0.8755742242463791,0.6625441696113075,0.9755743322703597,1.0,11/52,15.34%,IL18;TRPV1;GLDC;LRRK2;CHRNB2;DRD3;PAQR7;TRPM2;ABCA2;ABCB4;GGT5
prerank,female gamete generation (GO:0007292),-0.2825223437387704,-0.8755267081039227,0.6455696202531646,0.8596294779127769,1.0,17/29,46.81%,PTN;MDK;DMC1;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;BMP15;IHO1;FSHR;MARF1;NANOS2;M1AP;BCL2L10;FMN2;HORMAD1
prerank,quinone biosynthetic process (GO:1901663),0.3513577271757542,0.8748419785375176,0.6505791505791506,0.9763267766324634,1.0,5/14,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2287109414656311,-0.8745819456985394,0.7202797202797203,0.8611064899594277,1.0,18/75,18.38%,PLCE1;RGS3;RGS12;RGS5;CRY1;YWHAB;MGLL;RGS6;EDN1;GRK5;ZDHHC7;RGS4;GIT1;GIT2;RNF157;GPER1;PDE6H;C3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.2858997459639303,-0.8739959562787675,0.6651270207852193,0.8618341095142606,1.0,14/27,29.16%,PDE4D;CAV1;CAMK2D;CTNNA3;FGF13;DSG2;PLN;DSP;JUP;GJA5;STC1;AKAP9;HCN4;RANGRF
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3362189185944725,-0.8739905195886081,0.6297872340425532,0.8613356492728381,1.0,6/14,26.19%,TNKS;XRCC5;TERF2IP;BRCA2;TINF2;TERF2
prerank,proteoglycan biosynthetic process (GO:0030166),0.2873022214812842,0.8738387298739876,0.6577437858508605,0.9778282080724492,1.0,5/31,7.91%,IGF1;HS3ST3B1;CHST10;PXYLP1;B3GALT6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2823849728820567,0.8737229172391121,0.6395563770794824,0.97718270835908,1.0,9/35,16.96%,PPARGC1B;DDX5;RNF14;DDX17;MED1;PMEPA1;WBP2;SAFB;TADA3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.29577976055136385,0.8736210103628573,0.6292134831460674,0.9765007391393928,1.0,3/30,8.53%,ROBO1;ARRB1;LPAR1
prerank,regulation of gastrulation (GO:0010470),-0.3347983986530792,-0.8735185537309633,0.6201550387596899,0.861822297174337,1.0,3/14,6.03%,PHLDB1;PHLDB2;RACK1
prerank,regulation of innate immune response (GO:0045088),-0.24429706857278324,-0.873457983544577,0.713953488372093,0.8614555225198144,1.0,22/57,27.88%,POLR3F;PLSCR1;IRAK3;GBP5;IFI35;XIAP;PTPN1;ABCE1;BIRC3;POLR3B;N4BP1;PTPN6;POLR3D;NMI;FCGR2B;ERAP1;MUL1;CASP8;PTPN11;LRP8;TREM2;LYAR
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.36132474002211123,-0.8733893607542728,0.6129032258064516,0.8611062998038347,1.0,4/11,13.71%,GHR;PIK3R1;EIF2AK3;IRS1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2904467548632163,-0.8730233759461669,0.665948275862069,0.8613653137737346,1.0,9/24,25.13%,MEF2C;BOC;CTNNA1;MYOCD;CDH2;MAPK12;CDC42;MAPK11;BNIP2
prerank,regulation of ion transmembrane transport (GO:0034765),0.2867601394638543,0.8728745872803649,0.6398537477148081,0.9773964054926784,1.0,6/33,9.74%,KCNJ13;WNK3;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,protein localization to chromatin (GO:0071168),0.3237340561689891,0.8727220151002568,0.6478599221789884,0.9768070457352386,1.0,5/18,11.20%,SGF29;RUVBL2;PLK1;PPHLN1;PIH1D1
prerank,renal absorption (GO:0070293),-0.37002313729398995,-0.8726931854907208,0.6317829457364341,0.8616046920984493,1.0,4/10,22.49%,GSN;KCNQ1;KLHL3;HAS2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.26410724649546596,-0.8726845176690318,0.6813953488372093,0.8611185217495264,1.0,12/37,22.58%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,male gonad development (GO:0008584),0.2835124541658105,0.872286443893929,0.6537785588752196,0.9769081512199458,1.0,3/34,3.86%,WNT4;KIT;FGF9
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32880383306859406,-0.8722359093173899,0.6449579831932774,0.8615456591661748,1.0,6/16,25.89%,SHLD1;SMCHD1;MAD2L2;DTX3L;PARP3;SHLD3
prerank,neuron maturation (GO:0042551),-0.3087757904256837,-0.8720423444935098,0.6514522821576764,0.861480938444375,1.0,5/18,10.32%,ANKS1A;SCARF1;APP;LGI4;B4GALT5
prerank,regulation of endocytic recycling (GO:2001135),0.3697749000506199,0.8717760765565542,0.6177062374245473,0.9771821536438438,1.0,1/11,0.97%,ACTN2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.27795183845058513,-0.8713611106180447,0.6578947368421053,0.8624429432106225,1.0,2/27,1.61%,PLA2G4A;GPCPD1
prerank,protein secretion (GO:0009306),-0.24283003521235308,-0.871008215565263,0.684964200477327,0.8627024917810793,1.0,11/56,12.39%,STEAP3;PCSK5;ABCA1;MIA2;MON1A;SNX19;ANXA1;MTTP;GOLPH3;RAB3A;PDIA4
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.35044826597786,-0.8709341527986872,0.6370808678500987,0.8623719549545235,1.0,3/12,16.14%,ANO1;PLA2G6;CFTR
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.35353395024473855,-0.8704663722063389,0.6460554371002132,0.8628659803874259,1.0,6/12,24.01%,PROM1;STAT3;VEGFA;AGTPBP1;MYO7A;RORB
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.34090438604854556,-0.8702328325713348,0.604,0.8628783852721797,1.0,9/13,47.49%,PRKCD;SOD1;SYK;MAPT;TYROBP;CRP;GSTP1;F2RL1;CD177
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3011496081852542,-0.8701257592736433,0.6437246963562753,0.8626045364413728,1.0,6/20,13.66%,BMP5;ASXL3;CEACAM1;BMP2;ACADVL;FBXW7
prerank,protein methylation (GO:0006479),0.2873578373412532,0.8700769313910794,0.6594594594594595,0.9803055827999367,1.0,13/40,21.97%,EEF2KMT;PRMT2;N6AMT1;FAM98B;NSD1;PCMT1;PRMT3;ETF1;NTMT1;NSD3;SNRPB;VCPKMT;PRMT5
prerank,hematopoietic stem cell differentiation (GO:0060218),0.37664389560064787,0.8700440368945569,0.591715976331361,0.9794525133582063,1.0,3/10,10.98%,LMBR1L;HOXB4;BATF
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.34670492131204933,0.8698150855285024,0.6061776061776062,0.979057896916339,1.0,2/16,0.78%,IGF1;ROCK2
prerank,regulation of protein ubiquitination (GO:0031396),-0.2128232206952685,-0.8687144203587019,0.8077922077922078,0.8650734583683298,1.0,23/108,14.30%,CAV1;CRY1;SPOPL;DNAJA1;UBB;SPRY2;RPS3;PRKCG;UBXN1;XIAP;FBXO4;FAM107A;AMER1;MALT1;BAG5;SQSTM1;ISG15;FOXF2;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23
prerank,potassium ion export across plasma membrane (GO:0097623),-0.33945306335414827,-0.8682771750387767,0.6307053941908713,0.8654539432979897,1.0,3/13,8.97%,KCNT2;KCNQ1;KCNK5
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2815736080939252,0.8681028368494506,0.6538461538461539,0.9822315166813604,1.0,6/33,11.83%,PLK5;CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3129764522429167,-0.8680411372240279,0.6184486373165619,0.8654426625772526,1.0,4/16,9.64%,SCARB1;NOS1AP;GCH1;APOE
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.27212261278683586,-0.867925281993224,0.6443965517241379,0.8651805038071955,1.0,20/29,41.81%,RPS16;RPS8;BMS1;DCAF13;PWP2;RRS1;RPS21;RPS19;WDR46;HELB;DHX37;TSR1;NOP14;RPP40;HEATR1;UTP4;NOL10;UTP20;UTP6;MRPS11
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3234803106066395,-0.8677901816994709,0.6445783132530121,0.8649673239619441,1.0,8/17,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3542395368653101,0.8669398375950945,0.6274509803921569,0.9841059966143856,1.0,3/13,6.42%,HACD3;HACD4;HACD1
prerank,histone H3 deacetylation (GO:0070932),-0.3298586311447699,-0.866896793797528,0.6465863453815262,0.8663530699542855,1.0,6/15,24.90%,HDAC9;PER1;HDAC2;SIRT7;SIRT6;ELK4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3730319065268005,0.8668492468224029,0.603448275862069,0.9833807200683242,1.0,5/11,24.24%,PARP14;PARP4;PARP16;PARP10;TIPARP
prerank,negative regulation of cell activation (GO:0050866),-0.3340952098731065,-0.8663508114860649,0.6340956340956341,0.8669910006488131,1.0,3/14,9.64%,NOS3;CD200;APOE
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.285090585372277,-0.8656225872137429,0.679324894514768,0.8680492984698825,1.0,5/24,8.25%,BCL2L1;CREB3L1;AQP11;RACK1;UBXN1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3218125324881706,-0.8656118876848307,0.6518046709129511,0.8675693343990203,1.0,4/15,5.55%,SIX1;TGFBR2;TBX1;NIPBL
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32839287672002104,0.8652844615348129,0.6234817813765182,0.9861929237688822,1.0,5/18,15.07%,NAGA;FUCA1;FBXO6;FBXO17;ADAMTS9
prerank,chromosome organization (GO:0051276),0.2285313879986103,0.8651861117259817,0.7254575707154742,0.9854926271833485,1.0,26/99,20.72%,DDB2;TOP2B;DOT1L;HMGN3;NUP155;PHF1;MSH6;NDC80;LDB1;SETD7;MSH3;ABL1;MTHFR;BAHD1;SIRT1;CETN2;FAM50A;SAFB;MTF2;TCF7L2;CENPV;SOX2;ACTL6B;COPS7A;SUPT4H1;NUF2
prerank,regulation of DNA repair (GO:0006282),0.27321614892737817,0.8651790219345046,0.691358024691358,0.9845767677211965,1.0,3/44,2.60%,EYA1;EYA4;EYA2
prerank,regulation of cellular catabolic process (GO:0031329),0.251689620791953,0.8645750686178028,0.6808873720136519,0.9850371703205644,1.0,9/62,9.07%,NUPR1;RRAGC;WDR91;ITPR1;MTMR4;RMC1;LRRK2;LONP2;ABCD1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3348138967071041,0.8644907014388135,0.6383399209486166,0.9843261058668179,1.0,4/17,16.37%,PRKCZ;NLRP3;HAVCR2;RARA
prerank,gonad development (GO:0008406),0.26843133880808934,0.8644231427596292,0.6833046471600689,0.983553032165107,1.0,6/41,11.97%,WNT4;KIT;FGF9;NR2F2;COL9A3;SOX9
prerank,regulation of primary metabolic process (GO:0080090),0.2234196971749761,0.864401273029382,0.762063227953411,0.9826752016389044,1.0,28/126,19.41%,ROCK2;NQO1;PPARA;NFYB;PSMD3;SMARCD3;NFYC;CHD9;MED1;SC5D;RXRA;PSMD1;PSMC5;SQLE;CYP51A1;PSMA1;TBL1XR1;RUBCNL;ACACA;PSMD12;TM6SF2;NCOR2;GGPS1;HMGCR;PSMD7;NCOR1;SIN3A;OPA3
prerank,mRNA 3'-end processing (GO:0031124),0.2420352977916952,0.8637198235177522,0.6934673366834171,0.9833580696210541,1.0,20/78,18.54%,PABPN1;CPSF3;SRSF5;CPSF6;LEO1;CPSF7;SLBP;CDC73;UPF3B;LSM11;RPRD2;SRSF11;PAPOLB;GRSF1;POLR2D;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,stress-activated MAPK cascade (GO:0051403),-0.236789115229451,-0.8631817847025396,0.723744292237443,0.8721983932282926,1.0,18/61,22.62%,MAP3K5;UBC;NOD1;MAP3K20;RPS27A;UBB;MAPK1;TNFRSF19;IRAK2;TAB1;GPS1;MAP3K8;NOD2;MAPK3;MAP2K7;RIPK2;MAP4K3;MAPK11
prerank,mitochondrial translational elongation (GO:0070125),-0.2219193516705833,-0.8630466112983359,0.7598039215686274,0.8719892376890928,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.30178699758044897,-0.8630133202292252,0.6372745490981964,0.8715489578240927,1.0,6/20,20.85%,LIMD1;AGO1;AGO2;HELZ;AGO4;AJUBA
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.32149835778339525,0.8624840554211132,0.6406844106463878,0.9853546920516546,1.0,3/17,8.02%,ANK2;SNTA1;KCNH2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3093971910658724,-0.8624685199855062,0.6569037656903766,0.8722080931906713,1.0,3/18,4.28%,EGFR;BMP4;ESR1
prerank,regulation of necroptotic process (GO:0060544),-0.2912831080782513,-0.8623825635111563,0.6736842105263158,0.8718738412525614,1.0,10/23,27.08%,ARHGEF2;YBX3;SPATA2;BIRC3;MLKL;RIPK1;ZBP1;CYLD;CASP8;PELI1
prerank,regulation of cellular response to stress (GO:0080135),0.22800783790489215,0.8622845255109187,0.7523076923076923,0.9848933318985439,1.0,21/115,16.21%,HSPA1A;ROCK2;NUPR1;POM121;CCAR2;NUP155;ADCY8;ARMT1;ABCD1;USP19;BAG4;NUP98;OPRM1;HSPA1B;AIFM2;RPA3;VASH1;ABL1;SIRT1;ATM;NUP37
prerank,determination of left/right symmetry (GO:0007368),-0.2642299717819411,-0.8614284678738093,0.6899563318777293,0.8733268408452164,1.0,17/36,35.59%,NOTCH1;TBX1;SMO;DNAH11;STIL;CFAP53;DLL1;ODAD2;ENKUR;ODAD3;ZIC3;FOXJ1;NPHP3;CCDC40;LEFTY1;DNAAF4;BBS7
prerank,myotube cell development (GO:0014904),0.3702893881413651,0.8611776646530271,0.6120857699805068,0.9865288889694648,1.0,1/10,0.69%,IGF1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3074582500179113,-0.8611189560827046,0.6536082474226804,0.8734085590235737,1.0,6/20,24.78%,ADAM10;HM13;RHBDD1;PSEN2;PSENEN;MBTPS2
prerank,protein targeting (GO:0006605),0.2256673461190862,0.8609223973673462,0.7504105090311987,0.9861730101583924,1.0,22/118,15.85%,TRAK1;MICALL1;ZDHHC12;PITRM1;TOMM40;ZFAND6;TIMM17A;KIF13B;PRKCI;LONP2;TOMM22;ZDHHC24;ZDHHC1;PEX1;LAMP2;MFN2;ZDHHC6;ZDHHC3;AP4M1;FUT10;AKAP6;ZDHHC21
prerank,regulation of peptidase activity (GO:0052547),-0.3045452132371176,-0.8608423816471493,0.6864406779661016,0.8734843238263927,1.0,5/19,18.62%,CAV1;CST3;ECM1;PSMB8;MAPK12
prerank,myeloid dendritic cell activation (GO:0001773),-0.3432376641010073,-0.8607600300657022,0.648590021691974,0.8731720655783586,1.0,2/12,7.73%,TGFBR2;DOCK2
prerank,signal transduction by p53 class mediator (GO:0072331),0.28983148421995836,0.860574146167708,0.6552901023890785,0.9861136759421479,1.0,5/30,10.98%,DDX5;MAGEA2;PDK2;NDRG1;BATF
prerank,regulation of axon extension (GO:0030516),-0.25916235428528483,-0.8605419445516151,0.7048458149779736,0.8731103513887082,1.0,9/37,16.45%,NTN1;SEMA7A;MACF1;APOE;SEMA3G;SHTN1;MT3;LIMK1;RTN4
prerank,muscle cell migration (GO:0014812),-0.36673938000623674,-0.8603558259198671,0.6410256410256411,0.8729712106543169,1.0,2/10,4.28%,SIX1;CCN3
prerank,ncRNA 3'-end processing (GO:0043628),-0.3308221122765901,-0.8600987933760829,0.6464646464646465,0.8730112490472532,1.0,6/14,35.07%,ELAC2;TOE1;INTS6L;ERI1;PTCD1;INTS12
prerank,negative regulation of transport (GO:0051051),0.2595452394180723,0.8599183223714784,0.6839378238341969,0.9867331014539515,1.0,9/51,16.72%,SYT11;NDFIP1;NRG1;NR1H3;SCAMP5;MTMR2;SNX3;NDFIP2;SNX33
prerank,regulation of feeding behavior (GO:0060259),0.3685926203311126,0.8599157648453184,0.6459143968871596,0.9858184369736605,1.0,1/11,0.68%,LEPR
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.329898607618489,-0.8592633469288148,0.6416666666666667,0.874202874650558,1.0,4/14,11.83%,SEMA7A;PLCG2;WNT5A;CD74
prerank,positive regulation of cell death (GO:0010942),-0.23857819393129537,-0.859238237921712,0.7265822784810126,0.8737473211880813,1.0,20/59,22.51%,SLC6A6;ACER2;MAP3K5;BMP4;WNT5A;AXIN2;APC;GRIN2B;RARG;LRP1;MT3;DDIT4;PRODH;ZC3H12A;RIPK1;RIPK2;FAF1;FYN;CDKN1B;FCGR2B
prerank,regulation of biosynthetic process (GO:0009889),0.3696566442784508,0.8588239710310932,0.6196078431372549,0.9875392503756283,1.0,11/11,63.06%,SPHK2;MID1IP1;ALOX5;PIKFYVE;SNCA;PCK1;UCP1;SLC25A33;CCN6;GSTP1;THRSP
prerank,positive regulation of intracellular transport (GO:0032388),0.27606716744088633,0.8586552149114045,0.6856649395509499,0.9869750859285762,1.0,9/38,17.80%,ACTN2;STX18;TENM1;RUFY3;CEP290;PCM1;EIPR1;SPAG5;ATP2A1
prerank,positive regulation of receptor internalization (GO:0002092),-0.28938044686996106,-0.858493421623266,0.6709129511677282,0.874754066478289,1.0,8/22,23.12%,INSR;SFRP4;TBC1D5;VEGFA;FMR1;GREM1;ARRB2;EGF
prerank,snRNA metabolic process (GO:0016073),-0.3098154421438312,-0.8580878644191907,0.6869747899159664,0.8750554315631884,1.0,5/17,20.00%,INTS11;RBM7;INTS10;INTS9;MEPCE
prerank,activin receptor signaling pathway (GO:0032924),0.3335595977345429,0.8580313060251883,0.6517509727626459,0.987499946527606,1.0,2/15,10.07%,SMAD3;TGFBR1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.30070077738731077,0.8578931648700419,0.6417624521072797,0.9868965880831763,1.0,6/24,10.43%,DNMT3A;JARID2;PPHLN1;PHF1;MPHOSPH8;PPM1D
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2893840103530171,-0.8576723588762893,0.6855983772819473,0.8754030802497176,1.0,7/21,17.39%,RPL5;RPS7;RPL23;FBXO5;FZR1;MAD2L2;PTEN
prerank,zymogen activation (GO:0031638),0.27082784692501216,0.8575561468545609,0.6697761194029851,0.9867456926887179,1.0,11/39,23.29%,FURIN;CYFIP2;PGK1;PLAT;CTSH;KLK1;ASPH;NLRC4;OMA1;C1RL;LGMN
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3184154812239366,0.8572201424513358,0.6575342465753424,0.9866259534261547,1.0,5/20,19.36%,HSPA1A;PTGES3L;CLU;HSP90AA1;LONP1
prerank,aminoglycan biosynthetic process (GO:0006023),0.2597227397211216,0.8571509578766094,0.6882882882882883,0.9858507776379594,1.0,9/49,12.71%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;HS3ST6;HS3ST5;HS6ST2
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19648800516840317,-0.8571189703352988,0.8333333333333334,0.8760037337817834,1.0,43/171,23.32%,TTC28;NEK7;CDC27;IQGAP1;AFAP1L2;BTG1;APP;ANAPC5;XPC;PSMA6;PSMB7;CDC16;CDKN1C;EIF4E;TAL1;PSMB6;DUSP3;CAV2;BTG3;PSMB5;FBXO5;ERCC2;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;KIF20B;CDC26;ASAH2;PSMD10;L3MBTL1;THAP1;PSME1;TTLL12;CDKN1B;RNF40;CDK11B;MKI67;PSMB3;CYLD;CDC23
prerank,response to purine-containing compound (GO:0014074),-0.3117396176816626,-0.8570906405265313,0.6528301886792452,0.8755564592332686,1.0,2/17,2.31%,TRPC3;ABCC9
prerank,chromatin remodeling (GO:0006338),-0.2133838718327177,-0.8567936355892214,0.8054187192118226,0.8756813847358124,1.0,12/100,8.61%,ACTB;ESR1;BPTF;ARID1B;SMARCC1;BAZ2B;EZH1;ZBTB1;GATAD2B;RBBP4;CHD1L;ARID1A
prerank,positive regulation of signaling (GO:0023056),0.2743162820294213,0.8563894791538462,0.6954225352112676,0.9867404686473954,1.0,6/37,9.52%,WLS;SYT1;GRIK2;RIMS1;NSF;DLG4
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.35437185290295187,0.8558038230652435,0.6548323471400395,0.9871809944641308,1.0,5/13,27.46%,SPHK2;ITGAM;STX4;LAMP1;AP1G1
prerank,positive regulation of viral life cycle (GO:1903902),-0.2964332879287927,-0.8554959907951127,0.6700404858299596,0.877811013775682,1.0,4/22,15.68%,CHMP2B;CD74;KPNA2;FMR1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.32886735479322315,0.8554326203716863,0.6370808678500987,0.9871120858384996,1.0,4/15,17.73%,CAMK1;MAPK14;RAPGEF3;RIPOR2
prerank,myelin assembly (GO:0032288),-0.36003946217047533,-0.8554021038520676,0.6566265060240963,0.8775080469701727,1.0,3/10,18.39%,CD9;GPC1;PMP22
prerank,positive regulation of biosynthetic process (GO:0009891),0.2685436238289983,0.8552920981580842,0.6713780918727915,0.9865237254521109,1.0,9/40,18.41%,WNT4;SLC5A3;PPARA;SORBS1;CREBL2;CYBA;CREB1;AKT1;MLXIPL
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2801198755743641,-0.854843976452252,0.6595289079229122,0.878122476529478,1.0,13/25,32.41%,ARHGEF2;ATXN7;APC;FGF13;TRPV4;KATNB1;MAP1B;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,primary neural tube formation (GO:0014020),0.28692468709532504,0.8546771163449749,0.6911487758945386,0.9870439124453025,1.0,8/30,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,response to glucocorticoid (GO:0051384),-0.2791252003060386,-0.8542467408166569,0.6703056768558951,0.8788160271010396,1.0,4/26,12.71%,SLIT2;ANXA1;FAM107A;UBE2L3
prerank,synaptic vesicle localization (GO:0097479),0.3533052394487416,0.8540695428446783,0.6234567901234568,0.9874803856190582,1.0,6/13,25.66%,KIF5C;SNAPIN;SPG11;SYNDIG1;SYNJ1;KIF5A
prerank,diol biosynthetic process (GO:0034312),-0.32457846691722847,-0.8539917758893112,0.6608695652173913,0.8788335693828829,1.0,6/15,20.23%,ACER2;GCH1;QDPR;DHFR;ASAH2;ACER3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3012007377432588,-0.8539698762916559,0.6732456140350878,0.8783763190735714,1.0,11/21,38.65%,RAD51B;BRD4;FBXO5;CCND1;RAB11A;DTL;STOX1;CDK1;DYRK3;CCNB1;VPS4B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.35265645527992995,0.8539048270387715,0.6475095785440613,0.986931803506252,1.0,2/12,8.17%,SOAT2;SOAT1
prerank,nucleus organization (GO:0006997),-0.24084132508167322,-0.8535737042244165,0.7074829931972789,0.8786693756912604,1.0,12/47,18.79%,SYNE1;CHMP2B;ATXN7;CHMP4B;CHMP4A;SUN1;LEMD3;TPR;REEP3;PITPNB;CTDNEP1;CHMP1B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.32189226875111765,-0.8535520099486409,0.6619718309859155,0.878209845010529,1.0,4/15,17.64%,LRP6;TBX1;BMP2;HDAC2
prerank,protein stabilization (GO:0050821),-0.19589497933811065,-0.8534634217707787,0.8594594594594595,0.8778861523913398,1.0,35/168,18.40%,HIP1;RASSF2;STK3;PIK3R1;RPL5;NAA16;FLNA;SOX17;PRKCD;COG3;RPS7;PTGES3;USP7;VHL;CRTAP;PARVA;MFSD1;RPL23;BAG5;MORC3;PHB2;HIP1R;PFN1;FBXW7;CCT2;MT3;PLPP3;BAG1;RTN4;NCLN;PTEN;SUGT1;GAPDH;ATF7IP;DNLZ
prerank,negative regulation of DNA replication (GO:0008156),0.35028080080989976,0.8533278281570706,0.6526717557251909,0.9873034891957049,1.0,2/13,4.97%,GMNC;TSPYL2
prerank,multivesicular body organization (GO:0036257),-0.2626532149587174,-0.8529280295242149,0.7109704641350211,0.8784704330280699,1.0,10/31,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;RAB27A;IST1;VPS37A;CHMP1B;RAB11A
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3297179278670589,-0.8528818801681206,0.6632860040567952,0.8780464945952932,1.0,4/13,20.46%,PIK3C3;PIK3R4;IRAK2;MYD88
prerank,peptidyl-methionine modification (GO:0018206),0.35450157307744057,0.8528344640477059,0.6421471172962226,0.9875222509430833,1.0,1/12,0.84%,METAP2
prerank,regulation of pH (GO:0006885),0.36336007523163416,0.8527464179923079,0.657314629258517,0.9868024400344978,1.0,3/11,13.33%,LACC1;PDK2;CLCN3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.32674433864941604,-0.8526846946531601,0.6937901498929336,0.8779676080148149,1.0,4/14,14.83%,AR;PELP1;SERPINB9;ARID5A
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.31118965210452826,0.8525664655120255,0.6750972762645915,0.9863040804761606,1.0,7/19,21.64%,HTRA2;HTT;CSNK2A2;FZD5;VDAC1;DNM1L;ATP13A2
prerank,positive regulation of cell killing (GO:0031343),0.346885131659556,0.8519955800635665,0.6314779270633397,0.9866636243679339,1.0,3/13,13.78%,NOX1;FZD7;CYBA
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.32175305883119104,0.8517639590329058,0.6607142857142857,0.9862506533957432,1.0,5/19,22.27%,NQO1;CHRNB2;RAPSN;ACHE;RIC3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2533007423216102,-0.8516359228278146,0.7175398633257403,0.8796056220138463,1.0,12/39,22.58%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,positive regulation of transport (GO:0051050),-0.2167090816084053,-0.8514306213144474,0.7945544554455446,0.8795115074018279,1.0,18/85,17.98%,ACTB;NEDD4L;MERTK;GAS6;ANXA1;DOCK2;GATA2;IL15;APOE;ACSL3;HIP1R;RAB27A;AKT2;LRP1;BAK1;FMR1;DYNC1H1;CD151
prerank,actin filament bundle assembly (GO:0051017),0.2812542911798295,0.8513900052597162,0.6812386156648452,0.9861840046706037,1.0,5/33,6.79%,USH1C;BAIAP2;PAWR;ADD2;CORO1B
prerank,positive regulation of filopodium assembly (GO:0051491),0.29751720644763446,0.8513394160784797,0.6802325581395349,0.9853930281714506,1.0,8/24,17.73%,DOCK11;TENM1;RHOQ;GPM6A;WASL;MIEN1;TENM2;RIPOR2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2339025919007412,-0.8513044680421384,0.7266666666666667,0.8792783207665834,1.0,8/51,9.60%,NEK7;TNKS;XRCC5;MAPK1;SRC;FBXO4;TENT4B;HMBOX1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.349653007663279,-0.8510004588240035,0.6252390057361377,0.8793632389061685,1.0,5/11,26.87%,TENT4B;EXOSC4;DKC1;EXOSC5;EXOSC3
prerank,regulation of double-strand break repair (GO:2000779),-0.2528033182368232,-0.8507225468848632,0.7379454926624738,0.8793911556483783,1.0,16/39,31.31%,RNF169;TERF2IP;TWIST1;PPP4R2;TIMELESS;SLF2;RPA2;SIRT7;SPIDR;CHEK1;SIRT6;OTUB2;OTUB1;RAD51AP1;SPIRE2;MRNIP
prerank,embryonic digit morphogenesis (GO:0042733),-0.30983212135526184,-0.8506631136100303,0.6694214876033058,0.8790187723714314,1.0,6/18,12.91%,ECE1;TBX3;GLI3;MAP3K20;TWIST1;TBX2
prerank,negative regulation of hippo signaling (GO:0035331),-0.3443280085762007,-0.8506019492713236,0.6526946107784432,0.8786252265753521,1.0,4/12,20.85%,LIMD1;CIT;MARK3;AJUBA
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3298986067326257,0.8505669906950609,0.6476578411405295,0.9861839565963254,1.0,4/15,11.49%,USP18;CACTIN;OAS3;STAT2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22428808071960837,-0.8503933538503183,0.7552941176470588,0.8785722569483914,1.0,17/72,21.47%,REL;CARD14;PSMA6;PSMB7;RELB;PSMB6;MALT1;PSMB5;BIRC3;PSMB8;PSMC4;PSMD11;NFKB2;PSMB4;PSMD14;PSMD10;PSME1
prerank,RNA transport (GO:0050658),0.24134274883812495,0.8503511012593713,0.7470881863560732,0.9857842381669515,1.0,25/71,26.52%,SIDT1;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;NUP62CL;SLBP;UPF3B;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6;RBFOX1;SARNP;DDX39A;RAE1;SRSF2;ZFP36;U2AF2;ZC3H11A;ZFP36L1;THOC2
prerank,negative regulation of insulin secretion (GO:0046676),-0.30704814850508977,-0.8501240372563134,0.6728016359918201,0.8786343366929719,1.0,5/17,15.35%,CCN3;KLF7;MIDN;IRS1;KCNB1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.24399312336397874,-0.8500708493396153,0.7358490566037735,0.8782230019333143,1.0,3/48,3.21%,PDE4D;IL1R1;SLC7A5
prerank,phosphate ion homeostasis (GO:0055062),-0.3602039047573129,-0.8498629528558682,0.6513409961685823,0.8781287134101865,1.0,2/10,13.74%,SFRP4;ENPP1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.21140984599472867,0.8498277379733907,0.8118022328548644,0.9860371590249013,1.0,16/166,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;POLRMT;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,glycosaminoglycan metabolic process (GO:0030203),0.25146000445502653,0.8497884897143727,0.7455830388692579,0.9852189016592408,1.0,16/54,19.43%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;FUCA1;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1;CHST9;B3GAT2;IDUA;HGSNAT
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3434864415743827,0.84971901400193,0.631578947368421,0.9844760851273157,1.0,3/12,9.07%,PPARA;PPARGC1A;ABCD1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.30868362726761356,-0.8493653626249069,0.6768916155419223,0.8786458108316976,1.0,7/16,21.29%,GSN;KANK1;RACK1;PTK2B;SHTN1;KIF20B;ROCK1
prerank,lysosome localization (GO:0032418),-0.2525849188544811,-0.8490207290481866,0.70276008492569,0.8788489691236243,1.0,17/37,32.71%,MYH9;TFEB;S100A13;PIK3CD;RAB3A;HDAC6;ARL8B;NDEL1;MILR1;BORCS6;PIK3CG;HPS6;TMEM106B;PLEKHM1;FLCN;SYTL4;RAB34
prerank,regulation of cell development (GO:0060284),0.2749166392742375,0.8488821464616412,0.6868131868131868,0.9854992399019169,1.0,10/36,18.66%,NOTCH2;PRUNE1;HES6;CLOCK;DOCK7;BHLHE41;PER2;AKT1;CX3CL1;FBXO22
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23572670906936852,0.8488529171274392,0.7286184210526315,0.9846570009043297,1.0,12/76,10.95%,ACTN2;C5AR2;OPRD1;ADRA2A;CHRM2;LPAR1;NMUR1;DRD3;C3AR1;VIP;GRPR;CHRM1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2605183316331279,-0.8487765602384917,0.7136465324384788,0.8788462183742777,1.0,5/33,7.25%,RUNX1;H3-3A;ESR1;AR;CBFB
prerank,T cell differentiation (GO:0030217),0.27030061965643587,0.8486706936835899,0.6907407407407408,0.9841484908074486,1.0,3/40,3.31%,LEPR;KIT;LMBR1L
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.2865306683403305,-0.8485653240438822,0.7073170731707317,0.8787632508888708,1.0,5/24,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,diterpenoid metabolic process (GO:0016101),0.25244991803344063,0.8484986309132683,0.7035775127768313,0.9836282768636385,1.0,4/55,2.46%,ADH7;ADH4;ABCA4;RBP1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2539286472607341,-0.8483643504356073,0.7415254237288136,0.8786639126252486,1.0,10/40,15.22%,SNRPD1;BACH2;MALT1;RSRC1;ATXN1;SNRPD2;NCBP2;GEMIN8;SNRPE;NCBP1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3030214805032245,-0.8479927651499096,0.6823027718550106,0.8788844883856048,1.0,5/19,10.11%,POLR3F;ICE1;AR;RPTOR;MAF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2445962209861845,0.8479090415509012,0.7252559726962458,0.9840238583035316,1.0,18/62,21.20%,HSPA1A;CCAR2;ENO1;PPIF;DDIAS;HTRA2;LRRK2;BCL2;CLU;NOC2L;NDUFA13;SIRT1;MDM2;NOL3;AKT1;DDX3X;HYOU1;TRIM32
prerank,protein targeting to membrane (GO:0006612),-0.21863483035583028,-0.847803887796168,0.794392523364486,0.8787794734753959,1.0,24/83,23.69%,PARD3;ATG3;ZDHHC20;AQP11;CHMP4B;CHMP4A;ABCD2;SRP19;SEC61A1;ZDHHC7;VPS37A;SRP14;ICMT;ZDHHC2;ACBD5;PEX14;SRPRA;PEX2;GDAP1;GOLGA7;CHM;MYO1C;SEC62;PEX12
prerank,negative regulation of reproductive process (GO:2000242),0.3236521557240175,0.8473965347628666,0.6634799235181644,0.9842408198778352,1.0,1/17,0.69%,IGF1
prerank,vitamin transport (GO:0051180),-0.27060762687769363,-0.847231060174507,0.6951754385964912,0.8793999309219137,1.0,3/29,8.59%,ABCG2;SLC5A6;CUBN
prerank,response to nutrient levels (GO:0031667),-0.3092480476102194,-0.8472014541171996,0.6700404858299596,0.8789619118733979,1.0,10/17,35.02%,RPTOR;FAM107A;KCNB1;ATF4;CD68;ULK1;MEAK7;EIF4G1;PRKAA1;RPS6KB1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3588376723261379,0.8471782530586479,0.6247582205029013,0.9838108090742572,1.0,2/11,6.37%,NUPR1;FZD9
prerank,tube closure (GO:0060606),0.281611908605525,0.8470742073305263,0.6930320150659134,0.983160655179661,1.0,8/31,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3578665396003243,-0.8470173177559572,0.6888454011741683,0.8788441817401007,1.0,1/10,0.88%,RAPGEF2
prerank,regulation of cell cycle process (GO:0010564),-0.20820298348348082,-0.8468564510962276,0.8268733850129198,0.8786894857433466,1.0,31/104,23.15%,DCUN1D3;BCL2L1;PLK2;CALM3;APC;TIPIN;MYO19;CAV2;MAP9;FBXO5;PIK3C3;CSNK2A1;PIK3R4;CCP110;GIT1;RAB11FIP3;GPER1;DYNC1H1;NUDT16;KIF20B;RAB11A;KIF13A;PRC1;CDC42;L3MBTL1;CHEK1;RPRD1B;KNSTRN;ENTR1;FSD1;MKI67
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3122794980076851,0.8466931814405376,0.6833667334669339,0.9831074931545001,1.0,1/20,0.87%,IL18
prerank,excitatory postsynaptic potential (GO:0060079),0.31466700013142057,0.8461627318686984,0.6692913385826772,0.9833949823855869,1.0,4/19,8.07%,RAB3GAP1;GRID2;GRIN2D;LRRK2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.27014515238860987,-0.8460191610051649,0.6991525423728814,0.8798718905776852,1.0,14/29,38.75%,GAS6;CXCL12;SERPINE1;HMGB1;PLA2G7;JAM2;CCR2;ANO6;AIF1;LGALS9;CXCL17;CCL5;CCR1;IL4
prerank,positive regulation of lipid metabolic process (GO:0045834),0.31210543380756517,0.8459556770012119,0.6753731343283582,0.9829749631424942,1.0,6/22,18.41%,PPARA;SORBS1;CREBL2;CREB1;AKT1;MLXIPL
prerank,regulation of phospholipase activity (GO:0010517),0.37191222008398317,0.8458380233518596,0.6349206349206349,0.9823439380766089,1.0,2/10,6.95%,PDPK1;FGFR2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3735778333082144,0.8455150285371045,0.6640625,0.9821831350241834,1.0,3/10,16.38%,NDFIP1;SNX3;NDFIP2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.30840171770065317,-0.8454473672916691,0.6541666666666667,0.8805391627194665,1.0,5/18,15.25%,CD200;RPS6KA5;PRKD1;VEGFA;CRTC3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.33557157852123565,0.8451200483982708,0.6666666666666666,0.9821700341309851,1.0,4/14,18.26%,ENPP3;AK5;AK1;AK3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24285310373110142,0.8450365313104681,0.7356521739130435,0.9814580764321571,1.0,11/63,13.52%,LEPR;NUPR1;TIMP3;ZKSCAN3;GOLGA2;BCL2;ATRAID;IL10RA;KDM4A;MTMR2;TBC1D14
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.33772678766697717,-0.8449964613825204,0.6804733727810651,0.8809200825174329,1.0,2/12,3.16%,NFKBIA;ABCA1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.22918753562187963,0.8448758415601123,0.7534246575342466,0.980914676336453,1.0,28/80,22.42%,STX18;ARFGAP3;ARFGAP2;KIF3C;NAPA;RAB6B;HTT;NSF;RINT1;KIF3A;COPG1;TMED9;COPG2;RAB1A;RER1;TAPBP;COPE;TMED2;GBF1;COPB1;SEC22B;PICK1;KIF3B;KLC1;KLC2;UVRAG;ATP9B;LMAN2
prerank,sphingoid biosynthetic process (GO:0046520),0.36798718140455355,0.8446317273803421,0.6527777777777778,0.9796998617900983,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),0.36798718140455355,0.8446317273803421,0.6527777777777778,0.9796998617900983,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,regulation of cytokinesis (GO:0032465),-0.21927112990117414,-0.8445147938155749,0.8098591549295775,0.8813746048358202,1.0,37/78,33.15%,RHOA;SVIL;BCL2L1;CIT;PLK2;CALM3;MYO19;MAP9;PIK3C3;KIF23;PIK3R4;CCP110;GIT1;RAB11FIP3;KIF20B;RAB11A;KIF13A;PRC1;CDC42;ENTR1;FSD1;GIPC1;E2F7;CUL3;PLK3;PRKCE;KIF14;CALM1;DRD2;FLCN;CSPP1;SH3GLB1;KIF20A;AURKA;CDC6;OPN1MW;BIRC6
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3631265337511752,0.8444925230112914,0.6428571428571429,0.9791165887350849,1.0,2/10,10.26%,APPL2;PRKCB
prerank,histone methylation (GO:0016571),0.2951991361053376,0.843888445264333,0.6715867158671587,0.9795759035055661,1.0,7/26,18.08%,PRMT2;N6AMT1;NSD1;SMYD3;SMYD2;NTMT1;NSD3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23186266264415908,0.8436798229590413,0.7351524879614767,0.9791720590934241,1.0,11/80,10.22%,MAGEA2;SPHK1;NDFIP1;DERL1;PLK1;ARRDC3;SPRTN;DCUN1D4;LRRK2;FANCI;TOPORS
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3109990874581573,-0.8436473010553094,0.6505494505494506,0.8825179911198817,1.0,4/15,13.42%,ERN1;TSEN2;CPSF4;CLP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.25463093243716745,0.8435857188791451,0.7145390070921985,0.9785280046454627,1.0,3/47,1.73%,WNT4;ROCK2;GCK
prerank,translational termination (GO:0006415),-0.21198966030803915,-0.8431993609980677,0.8211764705882353,0.8828744082115154,1.0,25/95,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;ABCE1;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;TRMT112;MRPL33;MRPL35
prerank,response to axon injury (GO:0048678),0.3114454550961717,0.8430107691244954,0.6896551724137931,0.978873495934401,1.0,5/18,14.34%,FLRT3;NREP;GAP43;SARM1;MORN4
prerank,regulation of organelle assembly (GO:1902115),0.2431265710985493,0.8428971235832414,0.7486818980667839,0.9782432648461682,1.0,10/72,8.17%,DCDC2;NPRL3;STX18;DYNLT2B;STAM;SGSM3;DYNC2LI1;ATXN2L;TBC1D9B;RABEP2
prerank,DNA metabolic process (GO:0006259),-0.18252100220914888,-0.842787780401647,0.9385113268608414,0.8831771286344411,1.0,85/270,28.22%,RPA1;RAD51B;UBC;ALKBH1;SMC1A;UBE2V2;CSNK1E;RPS27A;XPC;UBB;AXIN2;XRCC5;REXO4;ZBTB1;PTGES3;USP7;CHD1L;RPAIN;PARG;TERF2IP;GTF2H1;DMC1;BLM;ORC1;RAD21;TIMELESS;ZNF445;DDX23;KPNA2;NT5E;UBE2A;SP100;DFFB;FANCG;TOP2A;TDG;ORC2;NEIL3;NBN;BARD1;RPA2;PRIMPOL;CDC45;ORC5;LIG4;SIRT7;POLA1;XPA;HMGB1;RFC4;CHEK1;NSMCE4A;POLA2;DNMT1;MUTYH;TOP1;NSMCE3;MCM3;WDHD1;TRRAP;PURA;POLD4;SMUG1;POLB;PARP3;BTG2;XRCC3;CDC34;CTC1;TINF2;PRIM2;POLE3;TYMS;UHRF2;NUDT1;MCM5;TERF2;FANCL;MCM6;RFC2;CDK2;RECQL5;RAD51AP1;VCP;CBS
prerank,synaptic vesicle transport (GO:0048489),0.3588769301387872,0.8427491911169912,0.6356275303643725,0.9777029771702497,1.0,3/11,13.83%,KIF5C;SNAPIN;SPG11
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2831890692863017,0.8423809079933817,0.6914498141263941,0.9776444887699859,1.0,10/29,18.86%,SMAD3;HNRNPA2B1;TRIM71;TUT4;ZC3H7B;AGO3;DICER1;SNIP1;SRRT;ADAR
prerank,histone H4 acetylation (GO:0043967),0.2578412526059251,0.8423749482733447,0.7158878504672898,0.9767833669892387,1.0,17/47,21.30%,BRD8;KANSL2;KMT2A;RUVBL2;MEAF6;DMAP1;EP400;BEND3;YEATS4;CHD5;MCRS1;TADA3;APBB1;MSL1;ACTL6B;KAT8;ACTL6A
prerank,heart process (GO:0003015),-0.32547627164026394,-0.8423567895343436,0.6915708812260536,0.8835540845368737,1.0,3/14,9.75%,SGCD;SOD1;GPX1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.19348031361255189,-0.8423328172078156,0.8820375335120644,0.883101530544021,1.0,55/166,27.62%,NIBAN1;BCAR3;SCARB1;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;RPL5;NOS1AP;PTGS2;EIF3E;ELOVL5;EEF2;NNMT;IGF2;FGF2;KLF4;EDN1;STARD4;DDAH1;NMD3;MFSD2A;AKT2;IRS1;KLF2;FMR1;BRPF3;PRR16;FXR1;PTH1R;ASS1;CTDNEP1;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;DDAH2;SREBF1;EGF;GIPC1;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;FABP3;METTL14;RPS4X;SLC25A37;LDLR
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3039843014418168,0.8422328910126917,0.6787072243346007,0.9762245385393136,1.0,2/22,0.78%,IGF1;ROCK2
prerank,phagosome-lysosome fusion (GO:0090385),-0.36982788082316886,-0.8420892961597226,0.6979591836734694,0.8830815308856245,1.0,8/10,44.10%,ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34;RAB7B;RAB7A
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.21956635878285352,-0.841502923140272,0.8019323671497585,0.8837486153495032,1.0,16/76,13.66%,SMURF1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;SOCS5;ARIH1;PABIR1;GABARAP;FBXW7
prerank,mRNA stabilization (GO:0048255),0.26100096831647973,0.8412172317765578,0.7306397306397306,0.9776281264427723,1.0,8/40,11.92%,ANGEL2;ELAVL4;HNRNPU;E2F1;ELAVL1;VIP;MAPK14;BOLL
prerank,regulation of complement activation (GO:0030449),0.2683487008497707,0.8407840234076295,0.7344322344322345,0.9777070009973422,1.0,7/40,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,inositol phosphate metabolic process (GO:0043647),-0.24220492637293145,-0.8404958776189284,0.7358916478555305,0.8852362751294749,1.0,7/46,9.34%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D;FGF2
prerank,response to UV-B (GO:0010224),-0.3393058934605303,-0.8396190352563777,0.6659919028340081,0.8864743860482648,1.0,2/12,7.72%,CRIP1;MFAP4
prerank,regulation of neuroblast proliferation (GO:1902692),0.33290980406508935,0.8394933745284294,0.6659919028340081,0.9796532716721646,1.0,4/15,8.07%,TAFA3;SMARCD3;FZD3;LRRK2
prerank,regulation of receptor internalization (GO:0002090),-0.25727408479709796,-0.8393498440438095,0.7346491228070176,0.8865254579288502,1.0,12/35,24.06%,INSR;SFRP4;MKLN1;TBC1D5;ANKRD13A;VEGFA;FMR1;ANKRD13B;GREM1;ARRB2;EGF;ANKRD13D
prerank,positive regulation of protein transport (GO:0051222),0.2408596237747909,0.8388167981166161,0.7195121951219512,0.9802680073566601,1.0,9/67,11.11%,BMP6;IGF1;FRMD4A;TENM1;RUFY3;CEP290;MYO18A;IER3IP1;PCM1
prerank,response to acidic pH (GO:0010447),0.3401409702182263,0.8382932003814509,0.6692456479690522,0.9804995104990819,1.0,2/13,8.15%,TRPV1;IMPACT
prerank,photoperiodism (GO:0009648),-0.2710433282439581,-0.8380936463867993,0.7430406852248393,0.8883769592219336,1.0,7/28,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,regulation of interleukin-17 production (GO:0032660),0.27901302294408026,0.8378930663969363,0.710431654676259,0.980499745643761,1.0,2/31,1.35%,IL18;SPHK1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.33725685043715314,-0.837879792758227,0.7108695652173913,0.8882968135168563,1.0,5/12,21.03%,ARHGAP35;B4GALT5;EPHB2;PTEN;EPHB6
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.37264315721829233,0.8378067156929916,0.6626746506986028,0.9798223517323552,1.0,4/10,18.87%,KAT5;MUC1;HIPK2;TFAP4
prerank,diol metabolic process (GO:0034311),-0.29412714491605313,-0.8377784882294774,0.7097457627118644,0.8879934487551858,1.0,8/19,19.49%,NOS3;DEGS2;GCH1;PLPP1;PRKG2;PLPP3;SGPP1;ASAH2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.30629123474059594,0.8373265181946612,0.6593186372745491,0.9799854544922499,1.0,4/20,13.20%,SLC8A3;AFG3L2;SLC25A23;MICU1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3493227749390623,0.8370938535945504,0.6554455445544555,0.9796441817560649,1.0,4/12,19.29%,ACSL1;ABCD1;FADS2;HSD17B4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3134213093224061,-0.8370376463084976,0.6707070707070707,0.8888762634863807,1.0,2/15,5.95%,PRKCH;AGTR1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2624875639449833,0.8369443250873247,0.702846975088968,0.9791047776562684,1.0,10/42,16.04%,CTSA;ST3GAL5;SUMF1;LARGE1;SMPD3;SMPD2;ST6GALNAC6;ABCA2;CERK;GBA2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3125559720766305,-0.8368996215724385,0.7058823529411765,0.888644208341717,1.0,8/16,23.95%,CAV1;VHL;HGS;PIBF1;SOCS3;PPP2CA;BCL3;SOCS1
prerank,lung epithelium development (GO:0060428),0.3597236180962294,0.8366865188133369,0.6882352941176471,0.9787730445950371,1.0,1/10,0.50%,ERRFI1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.31377234479934574,0.8364607309210104,0.6745562130177515,0.9784140413388825,1.0,5/18,16.77%,GINS1;POLD2;POLE;MCM7;MCMDC2
prerank,spermatid development (GO:0007286),0.27665380002331563,0.8362470159339049,0.6654275092936803,0.9780163004007986,1.0,2/32,4.95%,CCDC42;TDRD5
prerank,regulation of chemotaxis (GO:0050920),0.2807141648436984,0.8362095639143597,0.7145557655954632,0.9772353982196126,1.0,2/30,1.53%,PDGFRA;EFNB2
prerank,RNA catabolic process (GO:0006401),0.25601608749834,0.8357761130473594,0.7286245353159851,0.9773116835496093,1.0,9/46,18.14%,HSPA1A;RNASEH2A;SUPV3L1;LSM5;AGO3;HSPA1B;SND1;ZPR1;MTREX
prerank,regulation of cellular metabolic process (GO:0031323),0.2575199724144916,0.8355840661795426,0.7301038062283737,0.9768374268203115,1.0,17/45,24.49%,PPARA;RNF41;KIF16B;PDK2;PANK2;MPV17;RSPO1;ABCA2;TBC1D16;ACACA;NCOR2;COQ7;EIF6;LAMTOR1;PDK4;ARF1;BCO2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3151305621720435,-0.8355065894436033,0.689161554192229,0.8908774035646304,1.0,9/15,30.94%,SCARB1;MFSD2A;FBXW7;C3;CTDNEP1;SREBF1;LDLR;SIK1;NR1H2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.34555009638353323,-0.8353197479022221,0.6673387096774194,0.8907171194177083,1.0,6/11,23.95%,CAV1;VHL;HGS;SOCS3;BCL3;SOCS1
prerank,brain morphogenesis (GO:0048854),-0.33146691693988783,-0.8351126171815272,0.6680327868852459,0.890625370140488,1.0,5/12,27.22%,SHANK3;PAFAH1B1;PTEN;SPEF2;FBXW11
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.27369072181490284,-0.8350843911724651,0.721030042918455,0.890180155242111,1.0,10/28,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,negative regulation of viral transcription (GO:0032897),-0.32985225180573857,-0.8342934704184607,0.6876267748478702,0.8911503275309408,1.0,3/13,6.52%,MID2;IFITM3;TRIM14
prerank,negative regulation of macroautophagy (GO:0016242),0.2919054604728167,0.8337210053247179,0.6966292134831461,0.9799145010360691,1.0,10/26,26.28%,NUPR1;QSOX1;LRRK2;TSC1;SEC22B;AKT1;NRBP2;LZTS1;FEZ1;MTM1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3093167670742536,0.832501904983434,0.6852589641434262,0.9816662987293668,1.0,4/20,11.57%,IL18;PRKCZ;NLRP3;FZD5
prerank,cortical cytoskeleton organization (GO:0030865),-0.2424784457341645,-0.8323251216593983,0.8062360801781737,0.8943622979177385,1.0,3/41,1.39%,FMNL2;RHOBTB1;RHOA
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.32117465816582513,-0.8323024233851103,0.6857142857142857,0.8939016890014726,1.0,2/13,3.22%,PPARD;BMP4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3470690639832956,0.832190092809691,0.6711798839458414,0.9814480849978607,1.0,1/12,0.98%,PLK5
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.30454739804417275,-0.8320691553629002,0.7099391480730223,0.8938505949887238,1.0,2/16,1.96%,PTN;TGFB2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.31262525405271346,-0.8319623284052117,0.6736401673640168,0.8935600501362981,1.0,4/14,15.22%,ERN1;CPSF4;NCBP2;NCBP1
prerank,protein neddylation (GO:0045116),-0.323866252126681,-0.8319427006047047,0.6968421052631579,0.8930943320823426,1.0,3/13,11.76%,DCUN1D3;UBE2F;DCUN1D5
prerank,RNA 3'-end processing (GO:0031123),0.23707051539956425,0.8318261377089258,0.7800338409475466,0.9813672047967585,1.0,15/69,18.54%,PABPN1;CPSF3;SRSF5;TENT4A;SUPV3L1;CPSF7;TUT4;UPF3B;RPRD2;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.28618603084623995,-0.831232020873549,0.7261146496815286,0.8940007393178705,1.0,9/23,20.71%,GLI3;RACK1;HHIP;HERC4;PTCH1;ENPP1;PTCH2;KCTD6;MOSMO
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2127708389437273,-0.8312069534392061,0.8114942528735632,0.893556328635231,1.0,32/80,29.59%,VPS53;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;VPS26A;TMEM87B;GOSR1;TBC1D10A;SURF4;SNX2;STX6;RHOBTB3;DCTN1;PREPL;SNX5;RIC1;VPS26B;VPS52;STX5;EVI5;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B;GOSR2;HEATR5A;LMAN1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.24672419100987228,-0.8309815751514896,0.7582417582417582,0.8934768331328642,1.0,14/37,28.37%,ENTPD1;ENTPD6;SIDT2;ENTPD2;ADPRM;NCBP1;DFFB;NUDT16;PPP1R8;NUDT1;HNRNPD;RNASEH2B;XRN2;PABPC4
prerank,cardiocyte differentiation (GO:0035051),-0.3554705205485888,-0.8306235141177821,0.688622754491018,0.8936236638716989,1.0,3/10,12.38%,TGFB2;MYOCD;BMP2
prerank,receptor recycling (GO:0001881),-0.3494357839119102,-0.8304703183845186,0.6746031746031746,0.8934084107873395,1.0,5/10,30.32%,RAB11B;PHETA1;PHETA2;NSG1;LMTK2
prerank,protein deneddylation (GO:0000338),-0.35175512321125,-0.8302773661308845,0.6861598440545809,0.8932934459607154,1.0,3/10,24.21%,GPS1;COPS6;COPS4
prerank,regulation of actin filament-based movement (GO:1903115),0.3583377183227723,0.8301524735339112,0.6653696498054474,0.9840567995167327,1.0,2/10,6.78%,ANK2;PDPN
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.20236998924525898,-0.8300459009539084,0.8605898123324397,0.893237346589135,1.0,11/112,5.85%,FOXP1;THBS1;GAS6;CD34;STAT3;PTPRJ;IRAK3;APP;PLCG2;ARHGEF2;WNT5A
prerank,cellular response to leucine starvation (GO:1990253),0.36435024220663825,0.8297020342115407,0.6851485148514852,0.9841583078216116,1.0,3/10,16.73%,IMPACT;SESN1;RRAGB
prerank,protein modification by small protein removal (GO:0070646),-0.1845826021532969,-0.8295524632997432,0.9478527607361963,0.8936530564042713,1.0,64/252,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;USP7;USP35;USPL1;EIF3F;SENP6;PSMB6;BABAM2;HGS;PSMB5;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;CFTR;GPS1;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;COPS6;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3389560247839911,-0.8292010104723071,0.7021276595744681,0.8937791293300605,1.0,6/12,24.64%,BMP4;TPR;SIRT7;NEDD4;AAAS;NUP214
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3186937427102645,-0.8281440824870615,0.7170626349892009,0.8952168229194198,1.0,5/14,27.01%,RAPGEF2;PRKAR2B;PRKAR1B;PKIA;PRKAR2A
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2564438321117154,-0.8275812447465004,0.7384615384615385,0.8957137879980885,1.0,8/33,11.93%,KMT2E;EGFR;PLCG2;ANXA1;ADAMTS1;RPTOR;PAF1;PHB2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.22856603203682394,-0.8269494238001608,0.7775175644028103,0.8963503736364041,1.0,13/59,18.58%,LEF1;RUNX2;AGO1;JUN;CBFB;MED27;TWIST1;MED31;CSF1R;MED14;PTEN;AGO4;CCND1
prerank,negative regulation of coagulation (GO:0050819),-0.31921498283920335,-0.8269015644845349,0.6901408450704225,0.8959631151427473,1.0,5/14,15.59%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,regulation of calcium ion transport (GO:0051924),0.2428892344870798,0.8263009304694175,0.738898756660746,0.99037400560889,1.0,4/54,4.37%,CACNA1D;ANK2;WNK3;ADRA2A
prerank,cholesterol transport (GO:0030301),0.24998387083779328,0.826182375929416,0.736013986013986,0.9897740119419689,1.0,13/45,21.58%,CEL;ABCG5;SOAT2;STARD5;SOAT1;OSBPL5;CLU;TSKU;STAR;ABCA5;RELCH;NPC1;SERAC1
prerank,response to ATP (GO:0033198),-0.3015379623612524,-0.826015226427115,0.7253668763102725,0.8971031902447864,1.0,2/18,2.31%,TRPC3;ABCC9
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2949001819072498,0.8255054068951881,0.6872659176029963,0.9903666539063269,1.0,4/21,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,glycerophospholipid metabolic process (GO:0006650),-0.21337709193780569,-0.8250255311369697,0.7830188679245284,0.8983777728772283,1.0,14/75,15.76%,PLA2G4A;GPCPD1;DGKH;PLCG1;AGK;SERINC5;CPNE3;ABCA3;PIGC;PRDX6;ABHD6;PLA2G6;PAFAH1B1;CSF1R
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3378971895006594,-0.8249603263320362,0.7142857142857143,0.8980004768191898,1.0,6/11,24.11%,TPR;TASOR;ATF7IP;DNMT1;SIRT6;SETDB2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3279189988609124,0.824406203708735,0.6603053435114504,0.9917226591761227,1.0,5/16,12.34%,PPARA;ENO1;ANTKMT;PPARGC1A;SPHK2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.30564461837129453,-0.8243586510289751,0.6993987975951904,0.898558956617025,1.0,9/16,43.28%,NAA16;NAA10;NAA15;NAA50;AANAT;NAA60;NAA40;NAA35;NAA11
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2167957441651968,-0.8241823943968618,0.8394160583941606,0.8983877111788122,1.0,31/72,36.96%,RPA1;UBC;DCP1B;RPS27A;UBB;REXO4;CHD1L;GTF2H5;GTF2H1;ERCC2;ENPP1;RPA2;ZC3H12A;XPA;RFC4;POLD4;RNASE4;PNRC2;CUL4A;RFC2;XRN2;PARP1;ISG20;OGG1;FEN1;EDC3;GTF2H2;DDX1;MUS81;ANKLE1;IHO1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.29090789784990423,0.8240488823013763,0.7184643510054844,0.9915924273687311,1.0,6/24,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,regulation of cellular senescence (GO:2000772),-0.266222138528066,-0.8240250280703593,0.7505567928730512,0.8981916450097862,1.0,9/28,18.98%,B2M;AKT3;NUAK1;ABI3;FBXO5;TWIST1;EEF1E1;YPEL3;CDK6
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.34051756963472213,-0.8240216506058132,0.6991869918699187,0.8977048840293848,1.0,5/11,18.13%,PAPOLA;PAF1;NCBP2;NCBP1;BARD1
prerank,DNA conformation change (GO:0071103),-0.2997724498914855,-0.8238179857601711,0.7055084745762712,0.897580879137281,1.0,6/17,21.40%,KAT6A;HHEX;NAA10;TOP2A;HMGB1;TOP1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35919717625640274,0.8236046685869365,0.6884920634920635,0.9916205288733067,1.0,1/11,0.82%,DDX5
prerank,DNA repair (GO:0006281),0.1945396913772505,0.8234656690364237,0.9167883211678832,0.9910548573597409,1.0,53/284,18.00%,EYA1;DDB2;RNASEH2A;DOT1L;ERCC1;RECQL4;PMS2;FANCD2;XRCC1;ASCC2;ACTR8;TENT4A;POLD2;ABRAXAS1;EME2;SPRTN;KAT5;MBD4;MSH6;EXO5;HINFP;RFC5;TDP2;MDC1;FANCI;KMT5C;PARP4;MRE11;INIP;MLH3;FBXO6;KDM4A;CHEK2;PIAS4;MSH3;MEN1;RAD51D;POLI;POLE;PRKDC;RPA3;NEIL1;ABL1;GADD45A;FAAP100;SIRT1;ATM;CETN2;RAD52;POLN;XRCC2;RAD17;APBB1
prerank,regulation of humoral immune response (GO:0002920),0.2563053408704731,0.8233922184899364,0.7517857142857143,0.990341698518799,1.0,7/44,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3523087864788559,-0.8230777834118379,0.6754221388367729,0.8984286529490111,1.0,2/10,6.04%,GNL3;SAE1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.31953753228809023,-0.8229621689503391,0.690522243713733,0.898137337380585,1.0,3/14,15.37%,DAB2IP;PTPN1;BAK1
prerank,cell differentiation in hindbrain (GO:0021533),0.3503178452719753,0.8229360664349882,0.6776699029126214,0.990424935949552,1.0,4/11,20.12%,GRID2;ATP7A;FAIM2;KNDC1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.32779384423901037,-0.8229289641204324,0.7089108910891089,0.897697392776304,1.0,7/12,37.84%,HPRT1;AMPD2;ADA;PRPSAP1;GART;PRPS2;PPAT
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.21572551920200536,-0.8228959101281909,0.8387850467289719,0.8972703916555813,1.0,23/72,26.92%,RPA1;UBC;RPS27A;UBB;USP7;GTF2H5;GTF2H1;ERCC2;AQR;PPIE;GPS1;RPA2;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;COPS4;CUL4A;POLR2H;RFC2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.2968239694921496,-0.8228847964777674,0.7181069958847737,0.8968016430991869,1.0,6/17,23.96%,BCL2L1;MFF;BBC3;BAK1;TIMM50;BOK
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2529608199866723,-0.8227013463320159,0.7525773195876289,0.8966467207383516,1.0,13/33,22.09%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;SESN3;GLRA2;KLHL22;UBR1;RRAGD;FYN
prerank,regulation of synapse organization (GO:0050807),-0.2694392357065828,-0.8226675232100525,0.7612903225806451,0.8962292854980181,1.0,5/26,13.56%,MEF2C;PDLIM5;WNT5A;YWHAZ;ABHD17C
prerank,endocytic recycling (GO:0032456),-0.23638309149919493,-0.8225068580869801,0.7972665148063781,0.8960333901670056,1.0,18/50,22.82%,RAB14;VPS53;CMTM6;VPS26A;EHD2;MICALL2;EHD4;RAB11B;ANKRD27;STX6;DENND1B;RAB11FIP3;RAB35;EPS15;CCDC22;DENND1A;ENTR1;VPS52
prerank,positive regulation of sodium ion transport (GO:0010765),0.3383020762208345,0.8222618205359854,0.684931506849315,0.9909433186633614,1.0,1/12,2.29%,WNK3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.3547439636999101,0.8209024196850753,0.6944444444444444,0.992897616454603,1.0,3/10,11.82%,FURIN;ATRAID;EPHA4
prerank,positive regulation of catalytic activity (GO:0043085),0.26383974106504,0.8209012683645017,0.7357142857142858,0.9920407078827164,1.0,13/37,18.38%,SLC5A3;PHACTR4;MSH6;SSBP1;MAPK14;AZIN2;APH1A;MSH3;ABL1;STX4;ATP7A;NHEJ1;MID1IP1
prerank,sulfur compound catabolic process (GO:0044273),0.2589627331757719,0.8207611725076167,0.7402135231316725,0.9914769407894507,1.0,10/38,16.79%,OGN;OMD;FITM2;ACAT1;GALNS;HYAL1;FMOD;CSPG5;GGT5;CTH
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3322031470966444,0.82058579112926,0.6848249027237354,0.990984005554183,1.0,1/13,1.86%,GTPBP1
prerank,positive regulation of cellular protein localization (GO:1903829),0.2362678940499376,0.8205564358888271,0.7598627787307033,0.9901768333116735,1.0,9/69,9.94%,SYT11;PRKAA2;SLC5A3;PLK1;WWTR1;GNL3L;NDC80;PDZK1;BICD1
prerank,regulation of autophagosome maturation (GO:1901096),-0.332515447884821,-0.8202115915459245,0.6748466257668712,0.8997232366447802,1.0,4/13,16.38%,PHF23;TBC1D25;CLEC16A;TMEM39A
prerank,protein import into nucleus (GO:0006606),0.23373426450493967,0.819725229045931,0.7716150081566069,0.9909863112178225,1.0,7/66,6.98%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,homologous chromosome segregation (GO:0045143),0.3056175563105765,0.8196701386412298,0.688212927756654,0.9902561774923303,1.0,3/20,14.10%,FANCD2;MEIOB;CENPC
prerank,regulation of immune effector process (GO:0002697),0.25876601765270063,0.819270665510449,0.7725631768953068,0.9901856849040858,1.0,7/41,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,cellular response to oxidative stress (GO:0034599),0.21402800792585122,0.8184185810782819,0.8491803278688524,0.9910811737079396,1.0,28/118,20.59%,CPEB2;HSPA1A;PDGFRA;PRKAA2;RBM11;CHUK;PDK2;HTRA2;PRDX5;LRRK2;PPARGC1A;MPV17;CYCS;ALDH3B1;MAPK9;CYBA;ARNT;HSPA1B;ABL1;STX4;RAD52;ERO1A;AKT1;NCF1;LONP1;EIF2S1;PYROXD1;ERCC6L2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.22439528778060674,-0.8183434061231304,0.7868852459016393,0.902509126248064,1.0,13/60,18.58%,LEF1;RUNX2;AGO1;CBFB;HEY2;MED27;MED31;CSF1R;MED14;PTEN;AGO4;ATF7IP;CCND1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3055732258234719,0.8179277433125929,0.7137014314928425,0.9912311635432273,1.0,5/18,18.04%,COX18;COX14;TIMM21;COX20;OXA1L
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2996220475012429,-0.8170274425105294,0.7177242888402626,0.9043608044704334,1.0,11/17,41.10%,TERF2IP;TDG;NEIL3;MUTYH;SMUG1;TINF2;TERF2;OGG1;UNG;NTHL1;TERF1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2270669015939975,0.8159031492881759,0.7823834196891192,0.9943634412828294,1.0,23/80,20.34%,ROCK2;PICALM;PASK;CASP3;SMPD3;ELAVL1;SMPD2;CLU;EPHA4;SPHK2;UPF3B;ABCA2;FXR2;PRKDC;METTL5;IL6;PYM1;UPF3A;RELA;CPEB3;LARP4B;DDX3X;EIF6
prerank,establishment of protein localization to extracellular region (GO:0035592),0.25598363671021435,0.8152405468830092,0.7553571428571428,0.9947693732967512,1.0,15/39,21.69%,TANGO2;ARFGAP3;RAB3C;COPG1;CANX;TVP23B;RAB13;COPG2;SCG2;MIA3;NECAB3;TANGO6;LTBP2;RAB15;RCN3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2666380477801395,0.8152403185149294,0.7428057553956835,0.9939169573813298,1.0,5/30,11.35%,SH3BP5L;PRKCZ;SH3BP5;PARP14;CD300A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.35767668512034123,0.8150618988917551,0.682261208576998,0.9933964705411452,1.0,3/10,18.78%,ADRA2A;HBEGF;NCF1
prerank,cellular response to radiation (GO:0071478),-0.24146832154358935,-0.8148539480128154,0.7625570776255708,0.9076623238047676,1.0,16/40,34.02%,NET1;BLM;TNKS1BP1;RHNO1;LIG4;GPR88;SPIDR;RHOB;NSMCE3;GRB2;RAD51AP1;GPR52;RRH;OPN1MW3;OPN1MW;TP53
prerank,triglyceride catabolic process (GO:0019433),-0.28574667870425596,-0.8147660094291685,0.7388663967611336,0.9073277704184967,1.0,10/19,52.92%,PNPLA2;FABP5;FABP3;FABP4;LPL;FABP12;PNPLA3;FABP7;LIPG;CPS1
prerank,negative regulation of cell cycle process (GO:0010948),0.23993410853358493,0.8147518075536142,0.7867132867132867,0.993165540456565,1.0,9/61,12.26%,BMP7;PCGF2;TFDP2;E2F1;TOM1L2;MAX;E2F8;PCGF6;RING1
prerank,ubiquinone biosynthetic process (GO:0006744),0.32257957134415105,0.8146714035362986,0.725,0.9924773530984172,1.0,5/15,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,motile cilium assembly (GO:0044458),0.33662524764192864,0.8145328166132844,0.707983193277311,0.9919265325909203,1.0,3/12,10.81%,BBOF1;BBS5;E2F4
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.22210526601524636,-0.8142477957096567,0.8337078651685393,0.9072206904890321,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.22210526601524636,-0.8142477957096567,0.8337078651685393,0.9072206904890321,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,I-kappaB phosphorylation (GO:0007252),-0.3534213872398115,-0.8132611487100949,0.6853932584269663,0.908427803108566,1.0,1/10,0.94%,DAB2IP
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2409482975051927,-0.8131463325442508,0.8155555555555556,0.9081423741389152,1.0,14/37,20.96%,STAT3;GBP5;ADCY7;APOD;ABCD2;CHID1;PER1;PDCD4;NOD2;ZC3H12A;PLD3;CUEDC2;MYD88;TICAM1
prerank,cellular response to nitrogen compound (GO:1901699),0.2919017582457074,0.8128315776792526,0.7342007434944238,0.9944202678200743,1.0,1/20,0.78%,ROCK2
prerank,NAD biosynthetic process (GO:0009435),-0.28884039970680503,-0.8122538236018964,0.76431718061674,0.9091985684176063,1.0,7/20,23.73%,PTGIS;PTGS2;NNMT;NUDT12;NAXE;KYNU;NMNAT1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.35010342781295783,0.8122335630700583,0.717741935483871,0.9947633026107985,1.0,2/10,11.35%,APPL2;CD300A
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.34211872971681145,-0.811697786826524,0.696798493408663,0.909701450676169,1.0,1/10,6.03%,GNB1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2367947303366077,0.810885793975085,0.7892857142857143,0.9965265311016165,1.0,3/59,2.70%,ALDH1A2;ACSM2A;ACSM2B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.17408975807027244,-0.81073781035279,0.99,0.9108304763656764,1.0,98/314,28.92%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;HECW2;UBC;FAF2;SPOPL;ANAPC5;COP1;RPS27A;UBB;UBE2D3;KCTD10;UBE2J1;PSMA6;PSMB7;CDC16;TRIM25;FBXO31;FEM1B;PPP2R5C;UBXN1;STT3B;FBXO4;PSMB6;PSMB5;FBXO5;MTA1;RAD23B;UBXN2A;FBXO44;FBXW7;FBXL18;FZR1;PSMB8;PTTG1;UBE2J2;PSMC4;KLHL22;KBTBD7;AUP1;PSMD11;KCTD5;OS9;UBE2A;PCBP2;UBE2G1;ECRG4;PSMB4;AMN1;PSMD14;UCHL1;CCNF;RMND5B;UBR1;FBXL4;CDC26;HACE1;FBXW5;ARRB2;NEDD4;PSMD10;PSME1;FAF1;AGAP3;FBXL6;PSMB3;CDC23;FBXO45;ATXN3;KCTD17;CUL3;CDC34;AREL1;NHLRC3;UFD1;CUL4A;KIF14;UBQLN1;WFS1;SPSB3;LTN1;CUL1;PELI1;FBXW11;CDK2;ANAPC1;ZFAND2B;HERPUD1;VCP;EDEM1;ZFAND2A;ARMC8;FBXO2
prerank,regulation of viral life cycle (GO:1903900),0.2942146357200229,0.8107076583270943,0.7126213592233009,0.9960279062012325,1.0,5/21,16.29%,TRIM62;TRIM5;HS3ST5;TYRO3;AXL
prerank,negative regulation of organelle assembly (GO:1902116),0.26405194846725405,0.8101743779550576,0.7401433691756273,0.9961957438917294,1.0,4/35,8.07%,NUPR1;ODF2L;TCHP;LRRK2
prerank,isotype switching (GO:0045190),0.3498545058062036,0.8100348897561299,0.6797642436149313,0.9956249348189955,1.0,2/10,10.98%,MSH6;BATF
prerank,tRNA modification (GO:0006400),-0.21868428228226586,-0.8099042541215618,0.8266978922716628,0.9117703076006269,1.0,15/62,19.64%,ALKBH1;METTL2B;METTL2A;THUMPD2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRIT1;TRMT44;CDKAL1;TYW3;METTL6;TRMT112;LCMT2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.3231518780028542,-0.8097657545759579,0.7088353413654619,0.9115462386201483,1.0,4/12,16.30%,WDR1;PIK3CA;LIMA1;SEMA5A
prerank,aerobic electron transport chain (GO:0019646),-0.21522840245074384,-0.8096032976682217,0.8285714285714286,0.9113258382076105,1.0,18/68,19.55%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,regulation of protein localization to centrosome (GO:1904779),-0.34060349510355364,-0.8093601374790159,0.7026476578411406,0.9112707421035818,1.0,5/10,33.38%,APC;NUP62;MARK4;PARD6A;CEP250
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.34182383416821394,-0.8090392942879586,0.6988188976377953,0.9113389249628094,1.0,1/10,0.90%,PLA2G4A
prerank,androgen metabolic process (GO:0008209),0.30230366637948725,0.808991489850123,0.7140221402214022,0.996820295356255,1.0,4/18,23.75%,MED1;HSD17B11;HSD17B4;SHH
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.23839393836469785,0.8088171582182893,0.8091743119266055,0.9963035090155073,1.0,14/54,17.43%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,regulation of cilium assembly (GO:1902017),0.23419296389480823,0.808342297768284,0.7893864013266998,0.9964261462086113,1.0,9/62,8.94%,DCDC2;ODF2L;DYNLT2B;SGSM3;DYNC2LI1;TCHP;TBC1D9B;RABEP2;HTT
prerank,mitotic sister chromatid segregation (GO:0000070),0.21622482488642505,0.808168657248649,0.8338983050847457,0.995926877748001,1.0,12/98,10.44%,KMT5A;NCAPD2;EML4;CHMP6;ZWINT;PHF8;PLK1;TENT4A;DSN1;NDC80;TUBG1;CSNK2A2
prerank,neural tube closure (GO:0001843),0.26574877754190085,0.8076661029830123,0.7673076923076924,0.9960809128045045,1.0,8/34,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2035432313658108,-0.80758479659314,0.864406779661017,0.9133371160001752,1.0,29/95,28.72%,RPA1;RAD51B;HELQ;NIPBL;REV3L;MMS22L;SMC5;RAD54B;BLM;RAD21;FANCB;PALB2;BRCA2;NBN;PSMD14;RPA2;RMI1;CDC45;RAD51AP2;SPIDR;MCM3;NUCKS1;XRCC3;REC8;MCM5;MCM6;RECQL5;RAD51AP1;PARP1
prerank,zinc ion transport (GO:0006829),0.29290573763722827,0.807460842676206,0.7441860465116279,0.9956648384936619,1.0,4/21,11.47%,SLC30A6;SLC30A10;SLC39A13;TRPM2
prerank,mesenchymal to epithelial transition (GO:0060231),0.34941996354672966,0.8070086366319713,0.6871287128712872,0.9956724258454558,1.0,2/10,9.38%,CITED1;FZD7
prerank,water-soluble vitamin metabolic process (GO:0006767),0.23302810256500567,0.8064975060863475,0.8211805555555556,0.995847740840881,1.0,18/68,17.34%,ALDH1L1;SLC23A2;SLC23A1;PCCA;PANK2;GSTO2;SLC19A1;MMUT;AMN;MTHFS;GSTO1;CYB5A;THTPA;MTHFD1;MTHFR;FPGS;AASDHPPT;MTHFD2
prerank,histone acetylation (GO:0016573),0.22663385590511947,0.8064643905137803,0.7775862068965518,0.9950775797010016,1.0,20/69,19.95%,BRD8;SGF29;RUVBL2;MEAF6;KAT5;TAF10;DMAP1;EP400;KAT14;BEND3;YEATS4;TADA1;CHD5;TADA3;APBB1;KAT6B;DR1;MAP3K7;ACTL6B;KAT8
prerank,defense response to tumor cell (GO:0002357),0.3508425777172435,0.805929459903352,0.7073684210526315,0.9952784138301672,1.0,1/10,0.98%,PLK5
prerank,cellular response to unfolded protein (GO:0034620),0.27176453527356725,0.8058535631260836,0.7357414448669202,0.9945859047408601,1.0,3/26,5.52%,HSPA1A;OPTN;ABCB10
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2854474195843713,0.8056472761925451,0.7281368821292775,0.9941543962972821,1.0,8/22,21.80%,CCNT2;LEO1;CDC73;ALYREF;DDX39B;THOC1;SUPT4H1;CDK12
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.20003968467237176,-0.8053878379950344,0.9,0.91659889365437,1.0,36/101,30.94%,NIBAN1;THBS1;NFKBIA;RBM3;RPL5;EIF3E;AGTR1;PERP;EEF2;KLF4;AMER1;IST1;TBC1D10A;BAK1;FMR1;PRR16;FXR1;HDAC2;METTL3;PIWIL2;MSN;FAF1;BCL3;EIF4A3;CASP8;HNRNPD;METTL14;FBXW11;RPS4X;AGT;NSUN5;PTTG1IP;PCIF1;FADD;VPS35;NR1H2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.27594339117142025,0.804988754925169,0.7329650092081031,0.9945426057396773,1.0,2/29,6.95%,TGFBR3;FGFR2
prerank,regulation of centrosome cycle (GO:0046605),-0.2748188673009457,-0.804806372443283,0.754601226993865,0.917103551478423,1.0,12/21,40.95%,CHMP2B;CHMP4B;CHMP1B;FBXW5;CEP131;XRCC3;MARK4;AURKA;PKHD1;ATF5;VPS4B;PDCD6IP
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3144443642009332,-0.8039407955143916,0.744,0.9180653281921914,1.0,6/14,31.31%,FUS;FANCB;TIMELESS;RAD51AP1;PARP1;MRNIP
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.32432782657299297,0.8037255515222178,0.703125,0.9961469472490773,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.21843495394338286,-0.8035529082120385,0.8644859813084113,0.9181999898212478,1.0,20/62,24.64%,LIMD1;STAT3;H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;FXR1;NUP50;NUP85;POLR2I;AJUBA;AAAS;POLR2F;NUP62;NUP214
prerank,snRNA processing (GO:0016180),-0.29962250950384683,-0.8031261706788487,0.7439516129032258,0.9184334463585161,1.0,5/16,22.48%,INTS11;INTS10;INTS9;TOE1;INTS6L
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2444094847366469,0.8029762333423904,0.7564575645756457,0.9967861985183989,1.0,17/48,20.76%,E2F1;HTRA2;MSH6;IKBKE;TOPORS;BCL2;PML;CHEK2;BAG6;AEN;PRKDC;ABL1;SIRT1;ATM;HIPK2;PYCARD;BAX
prerank,negative regulation of autophagosome assembly (GO:1902902),0.33612692219043205,0.8028601269019064,0.717479674796748,0.9961702404029079,1.0,2/13,8.07%,NUPR1;LRRK2
prerank,central nervous system neuron development (GO:0021954),-0.3033426484445167,-0.8026132767814433,0.7429805615550756,0.9187887256578123,1.0,4/15,10.32%,RAPGEF2;LHX6;ARHGAP35;B4GALT5
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2746607508320906,-0.8025487557637355,0.7417943107221007,0.9179081160150427,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2746607508320906,-0.8025487557637355,0.7417943107221007,0.9179081160150427,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.21529911616292272,0.801887756348011,0.8279932546374368,0.997200071844351,1.0,29/94,20.76%,DDX5;ITPR1;AIFM1;E2F1;PDK2;HTRA2;TMEM117;MSH6;DNAJC10;IKBKE;MLLT11;C1QBP;TOPORS;BCL2;PML;CHEK2;PDK1;BAG6;PRKDC;ABL1;ATM;ERO1A;ATP2A1;HIPK2;RRP8;DDIT3;PYCARD;DDX3X;BAX
prerank,nuclear pore complex assembly (GO:0051292),-0.34784038210399987,-0.8018837555150509,0.7134020618556701,0.9186089913595672,1.0,3/10,16.45%,NUP107;TPR;RTN4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2948891268664138,0.801875510432311,0.7338551859099804,0.9963920281584272,1.0,8/20,20.24%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,protein deacylation (GO:0035601),-0.27103861800595336,-0.8015046760789604,0.7674418604651163,0.9187334006814484,1.0,7/23,23.64%,HDAC7;SIRT5;HDAC6;ABHD17C;SIRT7;ABHD17B;SIRT6
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.1900152146812424,-0.8012834426320602,0.9297297297297298,0.918602621040355,1.0,24/132,15.22%,RPS15;RPL38;RPL5;RPL10;MRPL20;COIL;SNRNP200;XRCC5;RPLP0;RPS5;SNRPD1;RPS28;PTGES3;RPL6;PRMT7;RPL24;RPS27;SNRPD2;RRP7A;CLP1;GEMIN8;SNRPE;DDX23;NCBP1
prerank,histone exchange (GO:0043486),-0.24544016915398686,-0.801011641717683,0.8408602150537634,0.9185698704135415,1.0,14/37,31.29%,HJURP;RBBP4;NASP;ACTR6;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ANP32E
prerank,DNA replication checkpoint signaling (GO:0000076),-0.29663242057286665,-0.8002817792421602,0.7575150300601202,0.9193076166155988,1.0,7/16,33.23%,TIPIN;ORC1;TIMELESS;CDC45;HUS1B;CDC6;TICRR
prerank,axonal transport (GO:0098930),0.2596546178427389,0.8002081783049768,0.7672727272727272,0.9987115270725537,1.0,11/36,20.74%,RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2593753457265857,-0.7999961160845377,0.7745535714285714,0.9193132298284368,1.0,8/28,22.21%,DAB2IP;SMURF1;ECSCR;FBXW7;FMR1;PTEN;TMTC3;CCDC22
prerank,protein insertion into ER membrane (GO:0045048),0.25468824853523053,0.7995775461886229,0.7845303867403315,0.9990897973239892,1.0,12/37,19.13%,EMC2;EMC4;CCDC47;CYB5A;BAG6;MMGT1;GET1;UBL4A;EMC10;TRAM1;PRNP;EMC1
prerank,snRNA transcription (GO:0009301),-0.213191348374149,-0.7995477017689634,0.8663484486873508,0.9195943861846254,1.0,20/70,26.95%,ICE1;INTS11;USPL1;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3350696785668758,-0.7989110099895442,0.7387914230019493,0.9201608185795987,1.0,2/10,5.61%,SEC14L1;RNF125
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3293852530773692,-0.7985723320310544,0.7208835341365462,0.9202127465013098,1.0,2/11,7.08%,LYN;TNFRSF21
prerank,polyol metabolic process (GO:0019751),-0.23073070532854523,-0.7983894879087932,0.81859410430839,0.919997642637723,1.0,6/46,6.96%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.29196891010113624,-0.7981185458101397,0.7489451476793249,0.9199784917088486,1.0,6/17,19.55%,COX6C;COX7C;NDUFA4;COX8A;COX4I1;COX15
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.263390118072648,-0.7979785679173561,0.7726315789473684,0.9197204219871578,1.0,10/27,25.59%,DTYMK;CTPS1;NME2;AK4;CTPS2;DUT;RRM2B;AK2;TYMS;DCTD
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2252617791961787,-0.7977775965248723,0.8333333333333334,0.9195438100204433,1.0,16/53,23.30%,PSMA6;PSMB7;PSMB6;BCKDK;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.32643297616921696,-0.7977644656261841,0.7465346534653465,0.9190820467970305,1.0,6/12,32.70%,CEACAM1;PIBF1;ACADVL;TRIB3;APOC1;ERLIN1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.24243873669061827,-0.7973319846080822,0.8097251585623678,0.9193229316077381,1.0,13/36,26.63%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;TFDP1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.22652100752278104,-0.797223882566209,0.8064516129032258,0.9190130763113661,1.0,15/50,23.30%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.29685275075946305,-0.7972222314936842,0.7251585623678647,0.9185287049742212,1.0,9/15,30.39%,DHX33;GBP5;USP50;MYD88;TLR4;TREM2;CPTP;CD36;TLR6
prerank,cholesterol efflux (GO:0033344),0.2908138194250545,0.7967728734699594,0.7287822878228782,1.0,1.0,3/20,8.17%,ABCG5;SOAT2;SOAT1
prerank,mitochondrion localization (GO:0051646),0.3042236093551688,0.7965041109927057,0.7362204724409449,1.0,1.0,6/19,18.95%,TRAK1;LRRK2;BRAT1;MFN2;ATP2A1;MEF2A
prerank,mitotic cell cycle phase transition (GO:0044772),-0.1798814250204575,-0.7963519467188701,0.9436201780415431,0.9194698605534014,1.0,63/203,27.44%,FBXL7;ACVR1;YWHAE;CDC27;PPP1R12A;CDK14;DYNC1I2;CACUL1;PPP2R2D;CSNK1E;EPS8;CCNY;PLK2;CHMP4B;CDC16;TUBA1A;EIF4E;CEP76;DCTN3;NASP;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;CCNF;CCND1;CDK6;LCMT1;AJUBA;CSNK1D;CCND2;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CDKN1B;CEP131;CDC23;CDK5RAP2;CUL3;LATS2;CEP152;PLK3;CDC34;PIM2;KDM8;CDKN3;CUL4A;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;ANAPC1
prerank,peptide catabolic process (GO:0043171),0.2813678329116715,0.7953742026439306,0.7538461538461538,1.0,1.0,5/23,15.34%,ADAMTS13;CPQ;CTSH;TRHDE;GGT5
prerank,autophagosome maturation (GO:0097352),0.2659741151258776,0.7949874704441736,0.766859344894027,1.0,1.0,6/32,11.53%,SNX14;VAMP7;SNAP29;VPS16;LAMP2;LIX1L
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2106744971701352,-0.7947670188928154,0.8387850467289719,0.9215813834646145,1.0,18/69,19.55%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2758476148433354,-0.7941592108834982,0.7964989059080962,0.9220824879906333,1.0,8/20,27.84%,CAMK2D;TGM2;BCAP31;TMCO1;BAK1;KCTD17;WFS1;HERPUD1
prerank,regulation of telomere maintenance (GO:0032204),-0.25947642153805683,-0.7940102849413578,0.7929515418502202,0.9218292499019908,1.0,11/26,26.19%,GNL3;XRCC5;USP7;TERF2IP;YLPM1;NBN;SIRT6;PPP1R10;TINF2;HNRNPD;TERF2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.23574918187572838,0.7937512634089965,0.8058925476603119,1.0,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.23574918187572838,0.7937512634089965,0.8058925476603119,1.0,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,histone mRNA catabolic process (GO:0071044),-0.3037037145805411,-0.79365513925987,0.7413793103448276,0.9219250442860587,1.0,6/15,28.74%,TENT2;TENT4B;MTPAP;EXOSC4;ERI1;XRN1
prerank,negative regulation of signaling (GO:0023057),0.2762960468461908,0.7934842686353554,0.746615087040619,1.0,1.0,5/25,13.54%,IGFBP3;GLRA1;OPTN;BRAP;OPRM1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3009926333989166,-0.7933767176568979,0.7296222664015904,0.921857214627781,1.0,4/14,13.82%,WNT5A;FLT4;CD40;VEGFA
prerank,response to muscle stretch (GO:0035994),-0.3001485328361361,-0.793253627477717,0.7409766454352441,0.921574232931478,1.0,8/15,34.61%,GSN;PIK3CA;CDH2;DMD;SLC8A1;TTN;CTNNB1;TCAP
prerank,chromatin assembly (GO:0031497),-0.23630642942145802,-0.7931336531749758,0.802547770700637,0.9212787790117847,1.0,6/38,12.68%,CTCF;H3-3A;EZH1;RBBP4;PAF1;LIN54
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.26070851864281036,0.7931271120336935,0.7657657657657657,1.0,1.0,8/33,14.47%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC
prerank,RNA methylation (GO:0001510),-0.21868384542904845,-0.7931128041077579,0.848780487804878,0.9208284378526315,1.0,15/60,20.15%,METTL2B;METTL2A;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;WTAP;METTL6;DIMT1;TRMT112;LCMT2;NSUN4;MEPCE;METTL3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2563215570296234,-0.7930004730729642,0.7872340425531915,0.9205303340237909,1.0,7/28,15.85%,DAB2IP;MAP3K5;ERN1;ATP2A3;BBC3;BAK1;ATF4
prerank,peptidyl-arginine modification (GO:0018195),-0.29838809766167873,-0.7925531040316207,0.7619047619047619,0.9207889302091115,1.0,10/15,47.03%,ART3;PRMT7;KRTCAP2;PRMT1;PARK7;ART1;PADI1;PADI4;PRMT8;ART5
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3410958208896865,-0.7923604310220186,0.7561904761904762,0.9206139183267464,1.0,4/10,22.36%,ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,negative regulation of locomotion (GO:0040013),-0.315221075246092,-0.7922870265333729,0.75625,0.9202466745930574,1.0,2/12,10.10%,FRMD5;DUSP3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24514878321092315,0.7918689962632662,0.8078994614003591,1.0,1.0,9/46,15.83%,PITRM1;AIFM1;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;TIMM21;HK1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2230421024107627,0.7917017573476461,0.8481228668941979,1.0,1.0,24/72,22.83%,TFDP2;ARID3A;CDC25C;E2F1;KAT5;E2F8;NDRG1;E2F4;BATF;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3;HIPK2;TFAP4;BAX;CNOT8;MYO6;ATRX;MDM4
prerank,cellular response to retinoic acid (GO:0071300),0.25034564272222265,0.7915525195531349,0.7913533834586466,1.0,1.0,10/42,18.15%,WNT5B;PTK7;WNT6;HTRA2;FZD7;SOX9;NDUFA13;ATM;CREB1;FZD10
prerank,positive regulation of nuclear division (GO:0051785),-0.2628059456017576,-0.7912478983752855,0.8072805139186295,0.9214565355218183,1.0,9/25,24.19%,INSR;LRP5;IGF2;EDN1;EDN3;NUSAP1;EGF;NUP62;RGCC
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.26697272955541435,-0.790949017010089,0.7609561752988048,0.9214636160221948,1.0,9/22,23.61%,MFHAS1;XDH;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;PRMT1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.27866246935501043,0.790884809699099,0.7608695652173914,1.0,1.0,3/26,6.20%,ADCY5;ADRA2A;ADCY8
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.25548367054766885,-0.7903744938232848,0.7931034482758621,0.9219305535300967,1.0,11/29,27.24%,RPA1;PPIA;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,glutamate metabolic process (GO:0006536),-0.27815452649463424,-0.7902499987296621,0.7479508196721312,0.9216396592865509,1.0,8/19,22.53%,GLS;GCLC;GCLM;ALDH18A1;GLUD1;ALDH5A1;PRODH;GGT1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.32512671926590375,-0.7901413253416016,0.7514563106796116,0.921336366908876,1.0,2/12,4.28%,STAT3;ESR1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24993217602564596,-0.7896126845257744,0.7922077922077922,0.921713078188021,1.0,12/33,27.24%,RPA1;PTGES3;TERF2IP;TNKS1BP1;ZBTB48;NHP2;DKC1;CTC1;TINF2;TERF2;NOP10;CDK2
prerank,regulation of hormone secretion (GO:0046883),0.31104141599063423,0.7894944770755883,0.7546391752577319,1.0,1.0,1/15,0.66%,SNX6
prerank,intracellular protein transmembrane transport (GO:0065002),-0.23170569560123133,-0.7889489936415088,0.8484848484848485,0.9223004714447524,1.0,15/42,27.66%,PEX7;SEC61A1;AKT2;ROMO1;GRPEL1;TIMM23;PEX14;DNLZ;PEX2;TOMM40L;TIMM50;SEC62;PEX12;RTN2;ZFAND2B
prerank,positive regulation of RNA splicing (GO:0033120),-0.25404528982741803,-0.788914637879145,0.8021505376344086,0.9218691272897909,1.0,12/29,30.49%,PIK3R1;RBM3;ERN1;PRDX6;DYRK1A;NCBP1;NCL;SNW1;TRA2B;DAZAP1;SETX;HABP4
prerank,transcription by RNA polymerase III (GO:0006383),-0.2608784863579569,-0.7887383181932097,0.7855530474040632,0.9216584353462639,1.0,11/27,35.74%,ICE1;GTF3C5;POLR3H;GTF3A;ELL;GTF3C3;SNAPC5;GTF3C6;SNAPC4;GTF3C2;SNAPC3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3331118022939866,-0.7887024953892807,0.724,0.9212265484846195,1.0,3/10,22.21%,APC;CDC42;KNSTRN
prerank,non-motile cilium assembly (GO:1905515),-0.2536356872251929,-0.7883930285932371,0.7927107061503417,0.9212023877229564,1.0,10/30,21.28%,DISC1;ARL13B;IFT57;PIBF1;GORAB;TMEM216;TOGARAM1;TMEM107;CSNK1D;DCTN1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.31009517098043493,0.7882653791242723,0.7278350515463917,1.0,1.0,5/16,16.60%,ANK2;LRRK2;RYR2;MIA3;GBF1
prerank,regulation of neuron death (GO:1901214),0.21855638628586643,0.7882053072116602,0.8461538461538461,1.0,1.0,23/82,20.10%,EFNB2;PM20D1;PICALM;GRID2;DHCR24;RILPL1;IKBKG;HTRA2;LRRK2;PPARGC1A;CHGA;CLU;TSC1;SARM1;ITGAM;EPHB1;FAIM2;AKT1;C1QA;TRIM2;PRNP;REST;EIF2S1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33260254402040135,-0.7881804467638683,0.7419354838709677,0.9210450090356775,1.0,2/11,7.25%,RUNX1;CBFB
prerank,lipoprotein localization (GO:0044872),0.3374647478619014,0.7874883429787151,0.7368421052631579,1.0,1.0,5/11,26.09%,PRKCB;ZDHHC3;MIA3;VMP1;PPARG
prerank,response to cAMP (GO:0051591),-0.23537308611649121,-0.7870912795129813,0.8058035714285714,0.9222454979864297,1.0,6/37,12.77%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6
prerank,cell-cell junction maintenance (GO:0045217),-0.32650989175163375,-0.7866724258450348,0.7582846003898636,0.9224324752013126,1.0,5/11,26.39%,TJP1;FERMT2;CSF1R;F2R;PRTN3
prerank,erythrocyte development (GO:0048821),0.34221947687482956,0.7863319352730401,0.7538461538461538,1.0,1.0,2/10,8.34%,ABCB10;MED1
prerank,DNA recombination (GO:0006310),-0.2351930528722618,-0.7860536591290164,0.8017817371937639,0.9229219079713255,1.0,10/37,20.34%,RPA1;RAD51B;RPAIN;RAD54B;DMC1;BLM;RAD21;RHNO1;LIG4;HMGB1
prerank,second-messenger-mediated signaling (GO:0019932),0.21766532723861237,0.7858884154637029,0.8438030560271647,1.0,1.0,11/82,11.28%,CCR9;ACKR2;SPHK1;GPR62;PDPK1;NUDT4;LRRK2;MAFA;NMUR1;RYR2;KSR2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.28096128532972514,0.7854383517598286,0.7523452157598499,1.0,1.0,12/23,27.60%,MTMR4;INPP5J;SYNJ2;MTMR2;MTMR10;OCRL;INPP5K;PIP4P2;SYNJ1;MTM1;TPTE;PIP4P1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26440424601768064,-0.7852600376355943,0.7849462365591398,0.9236435146539572,1.0,7/22,22.29%,NUBPL;NFU1;HSCB;NFS1;ISCA2;NUBP1;FXN
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.30365427626195507,-0.7852254024515121,0.7647058823529411,0.9232061913556384,1.0,9/14,37.84%,RFK;ADSS1;IMPDH1;ADSS2;ADK;PAICS;IMPDH2;GART;PPAT
prerank,positive regulation of isotype switching (GO:0045830),-0.2964305183460445,-0.7849171684095694,0.7269076305220884,0.9231883880396898,1.0,4/15,15.55%,TFRC;SHLD1;CD40;MAD2L2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3193168024404834,0.7838999352302218,0.7309236947791165,1.0,1.0,1/12,0.36%,UST
prerank,long-chain fatty acid import into cell (GO:0044539),0.3339606616266259,0.7838287867197934,0.7198364008179959,1.0,1.0,1/10,0.68%,ACSL1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.29397077349748046,-0.7834840749050496,0.7782426778242678,0.9249707643272654,1.0,4/16,22.64%,TNFRSF1B;AHR;TNFSF8;SOX11
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.1937008416969132,0.7832188454348756,0.9349593495934959,1.0,1.0,40/173,17.94%,F5;ANK1;ANK2;BET1;PROZ;F10;VAMP7;ARFGAP3;ARFGAP2;NAPA;GOLGA2;TRAPPC11;NSF;IER3IP1;COPG1;TMED9;CNIH3;TMED4;TRAPPC1;SPTBN2;COPG2;USO1;RAB1A;MIA3;ACTR10;SPTA1;TRAPPC4;CAPZB;TRAPPC3;GOLT1A;CNIH4;DYNC1LI2;COPE;TMED2;GBF1;COPB1;MCFD2;SEC22B;TFG;F8
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.25653448806087814,0.7827120527802642,0.8091603053435115,1.0,1.0,7/34,14.18%,LGR4;NLRP2B;OTUD4;CACTIN;CD300A;SARM1;TYRO3
prerank,organophosphate biosynthetic process (GO:0090407),0.2543329471118349,0.7824958379936889,0.7900552486187845,1.0,1.0,4/37,6.93%,GK;FITM2;AGPAT4;PCYT2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2799389611991636,-0.7824560838243816,0.7843137254901961,0.9260672808993095,1.0,12/18,39.24%,EGFR;ESR1;NRIP1;GPER1;NCOA3;CCDC62;SSTR2;POU4F1;RAMP3;CRHBP;FAM210B;SSTR1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.27278083572521566,-0.7822167955650932,0.7770419426048565,0.9259485475684536,1.0,4/21,9.16%,BCL2L1;CREB3L1;NCK1;EIF2AK3
prerank,regulation of macrophage activation (GO:0043030),-0.2504910645547229,-0.7822095204279967,0.8057395143487859,0.925474711934349,1.0,4/30,5.85%,CD200;THBS1;MFHAS1;WNT5A
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2836229424141372,-0.7821447468179357,0.8004032258064516,0.9250888066070428,1.0,4/19,9.46%,RUNX1;BMP4;CREB3L1;TGFB3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2669151373157154,0.7820940605829777,0.7523629489603024,1.0,1.0,7/29,15.25%,MAGEA2;PLK1;ARRDC3;DCUN1D4;TOPORS;FEM1A;ABL1
prerank,tRNA aminoacylation (GO:0043039),-0.23450354201993726,-0.7820562191117243,0.8140589569160998,0.9247337581266003,1.0,7/37,13.40%,GATB;WARS2;DARS1;LARS2;YARS2;EEF1E1;GARS1
prerank,recombinational repair (GO:0000725),-0.20420170685962047,-0.7813465311567215,0.9060240963855422,0.9253722896995937,1.0,17/77,20.42%,RPA1;RAD51B;HELQ;REV3L;MMS22L;SMC5;RAD54B;BLM;PALB2;BRCA2;RHNO1;NBN;PSMD14;RPA2;RMI1;RAD51AP2;SPIDR
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30219578092279165,-0.7809940719226999,0.7720739219712526,0.9254294869561288,1.0,2/14,10.53%,CARD14;MALT1
prerank,nucleotide metabolic process (GO:0009117),0.2725244927892844,0.7807172348678522,0.7561904761904762,1.0,1.0,5/23,15.11%,ENPP3;AK5;DCK;AK1;GUK1
prerank,negative regulation of histone modification (GO:0031057),0.31507905038518996,0.7805387745302792,0.7308411214953271,1.0,1.0,3/14,13.56%,JARID2;SPHK2;NOC2L
prerank,negative regulation of biosynthetic process (GO:0009890),0.30082901057377387,0.7802027829592476,0.7485148514851485,1.0,1.0,7/16,21.84%,PPARA;SLC30A10;ABCD1;TRAP1;IL6;EMILIN1;CIITA
prerank,tRNA metabolic process (GO:0006399),0.29779670688893256,0.7801100177453048,0.746268656716418,1.0,1.0,3/17,11.67%,DTD1;TRPT1;DARS2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.26006746680777215,-0.7799158446192292,0.8221258134490239,0.9265766284322392,1.0,6/23,16.03%,SLIT2;MPP1;MDK;JAM3;CD74;NCKAP1L
prerank,phosphatidylcholine metabolic process (GO:0046470),0.22125660150938375,0.7797271850966587,0.8159203980099502,1.0,1.0,11/70,11.81%,PON1;STARD7;PLA2G4C;LPIN1;PNPLA8;NR1H3;CHPT1;CSNK2A2;CHKB;PLA2G15;ABHD3
prerank,defense response to bacterium (GO:0042742),0.20859372933897002,0.7796631984883264,0.8733974358974359,1.0,1.0,19/105,20.02%,COLEC12;OAS2;PGLYRP3;CFP;OPTN;GSDMD;OAS3;CHGA;GBP6;RAB1A;TNFRSF14;IL6;ANKRD17;STAB2;IL12A;NLRC4;TIRAP;SHC1;PYCARD
prerank,DNA packaging (GO:0006323),-0.29106209338765215,-0.7794838282310782,0.7763975155279503,0.9267130792794777,1.0,9/16,39.19%,KAT6A;RBBP4;NAA10;CHAF1A;BANF2;BANF1;TP53;H1-0;CHAF1B
prerank,negative regulation of protein metabolic process (GO:0051248),-0.22132575558823017,-0.7789958382149981,0.8413461538461539,0.9269510774678227,1.0,12/48,21.87%,EGFR;IRAK3;FLNA;IAPP;PRKCG;APOE;EDN1;MAD2L2;PFDN6;AGAP2;ROCK1;AZIN1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.24740279842732432,-0.778695239765733,0.8085106382978723,0.926920217261795,1.0,13/31,34.79%,PLCG2;MDK;CD40;IRF5;HMGB1;SYK;RIPK2;MAPK11;TLR4;LGALS9;LAPTM5;TLR3;TLR2
prerank,inflammatory response (GO:0006954),0.1897836600817599,0.7782167201182824,0.943217665615142,1.0,1.0,36/195,18.84%,IL18;TAC1;C5AR2;KIT;IL17D;ADCY1;CHUK;LOXL3;PLA2G4C;BDKRB2;NOX1;ADCY8;IKBKG;PRDX5;NLRP3;KLRG1;LTB4R2;PTGER1;C3AR1;PARP4;HYAL1;HDAC4;CDO1;SCG2;CYBA;TLR5;GGT5;IL6;TAC4;HRH1;RELA;IL1A;TPST1;CX3CL1;NLRC4;NFKB1
prerank,positive regulation of bone resorption (GO:0045780),-0.31945002291995583,-0.7781038781726193,0.7638297872340426,0.9273326632267402,1.0,5/11,34.42%,TNFRSF11A;SYK;PLEKHM1;MC4R;ATP6AP1
prerank,tRNA processing (GO:0008033),-0.21458791464859567,-0.7774415797132758,0.8676470588235294,0.927859397121633,1.0,29/61,36.23%,TSEN2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRMT10B;CPSF4;TRIT1;ELAC2;CLP1;CDKAL1;RPP21;ADAT1;LCMT2;RTCB;WDR4;AARS2;RTRAF;ADAT2;POP7;CTU2;TRMT61A;CTU1;PTCD1;RPP40;THG1L;DDX1;KARS1;DTWD1
prerank,neurogenesis (GO:0022008),0.23852596305409773,0.7774061945880821,0.8131868131868132,1.0,1.0,6/43,10.61%,TRAK1;VXN;DAGLA;WDR62;LPAR1;RITA1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2834892715682813,0.7768312375216264,0.7773584905660378,1.0,1.0,4/21,13.14%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2518860627436287,-0.7764310953242278,0.7688984881209503,0.9289028584949156,1.0,8/27,18.81%,CDC27;ANAPC5;UBE2D3;CDC16;UBE2L3;FZR1;UBE2A;CDC26
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.277312270128808,-0.7758214827285946,0.7741273100616016,0.9293221944973713,1.0,3/17,9.86%,PCSK5;HDAC9;SORT1
prerank,regulation of RNA export from nucleus (GO:0046831),0.3410562805098709,0.7752425157549203,0.7520325203252033,1.0,1.0,3/11,16.67%,CPSF6;NSUN2;AKAP8L
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.27311166527425745,-0.7752194594153236,0.7825242718446602,0.9297516275149525,1.0,9/18,38.05%,NCKAP1L;PRDM1;METTL3;CCR2;ZFP36L2;IL4I1;IKZF3;PRELID1;CRTAM
prerank,cristae formation (GO:0042407),-0.2535769070656939,-0.7750921458405239,0.80625,0.929447030503824,1.0,9/27,25.63%,ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD;LETM1
prerank,inner ear morphogenesis (GO:0042472),0.2803918570938973,0.7749353042158222,0.7763401109057301,1.0,1.0,4/22,11.97%,USH1C;FGFR2;MYO3A;SOX9
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.26942145293523134,-0.7748873558142795,0.8,0.929274923343487,1.0,4/22,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,negative regulation of type I interferon production (GO:0032480),-0.22968446943963927,-0.7744632710802617,0.85,0.9294224139429567,1.0,9/40,17.21%,REL;RNF125;NLRC5;TRIM25;RELB;ISG15;IFIH1;TRAF3IP1;PCBP2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24156266003695095,-0.773969180676332,0.824,0.9296847094954092,1.0,12/30,29.47%,SHLD1;RNF169;TWIST1;SMCHD1;FANCB;MAD2L2;NUDT16L1;OTUB2;SHLD3;OTUB1;CGAS;HELB
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.263952858083093,0.773869565800346,0.7724770642201835,1.0,1.0,9/25,24.34%,DERL1;UBE2W;BAG6;RNF5;UGGT2;LONP1;OMA1;NGLY1;KLHL15
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3339191564147629,0.7737366575271143,0.7272727272727273,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3339191564147629,0.7737366575271143,0.7272727272727273,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,fluid transport (GO:0042044),-0.30473462419916014,-0.773636870804963,0.7599164926931107,0.9296860787196434,1.0,2/12,12.77%,AQP11;SLC26A6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.2920572391653214,0.773619667136574,0.7734375,1.0,1.0,4/18,9.52%,ROCK2;RUFY3;LLGL2;LLGL1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.26646760054365753,0.7733688187033706,0.7756653992395437,1.0,1.0,10/26,22.21%,NLRC3;CACTIN;C1QBP;MAPKBP1;TYRO3;PPM1B;RNF26;NFKBIL1;ILRUN;DHX58
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.2926142975929871,-0.7733125211590366,0.7777777777777778,0.9296999147366771,1.0,6/15,28.06%,FAF2;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,positive regulation of cellular senescence (GO:2000774),0.3377288211845746,0.7732938019477702,0.7338709677419355,1.0,1.0,2/10,4.43%,CDKN2A;ARG2
prerank,peptidyl-lysine acetylation (GO:0018394),0.3364327024842714,0.7730982938105739,0.726,1.0,1.0,3/10,15.49%,KAT5;BAG6;SIRT1
prerank,nucleosome disassembly (GO:0006337),-0.3010517305264714,-0.7729939517900407,0.7809330628803245,0.9291840984838151,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,chromatin disassembly (GO:0031498),-0.3010517305264714,-0.7729939517900407,0.7809330628803245,0.9291840984838151,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25181252913068064,0.7728782383765261,0.8236434108527132,1.0,1.0,7/30,14.60%,VAMP5;OPTN;GGA2;NSF;AMN;GGA1;GOLGA4
prerank,multivesicular body assembly (GO:0036258),-0.23930903510405474,-0.772539327948225,0.8204592901878914,0.9293744224068327,1.0,9/30,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;IST1;VPS37A;CHMP1B;RAB11A
prerank,regulation of neurotransmitter transport (GO:0051588),-0.28347058771282385,-0.7725269679579686,0.7904564315352697,0.9289149223250758,1.0,4/16,16.51%,MEF2C;MCTP2;FMR1;MCTP1
prerank,cellular respiration (GO:0045333),0.2430923846392774,0.7724318574389231,0.8049713193116634,1.0,1.0,13/41,21.46%,COQ10A;NDUFS1;PPARGC1A;UQCRH;CYCS;SDHC;COX10;LYRM7;OXA1L;SDHB;ETFDH;NR4A3;SLC25A13
prerank,GPI anchor metabolic process (GO:0006505),0.2672628342564948,0.7724137357809465,0.7996031746031746,1.0,1.0,11/26,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGB;MPPE1;PGAP3;PIGW
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3139015551139031,0.7723051058885962,0.7626774847870182,1.0,1.0,5/13,16.06%,OAS2;EBI3;STAT1;CANX;TYK2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3239404147861681,-0.772206037871292,0.767175572519084,0.9289003213043863,1.0,5/10,29.94%,PDE8A;STK26;RIPK1;PARK7;PYCR1
prerank,pyroptosis (GO:0070269),0.29985818429401434,0.7720076111970001,0.7883495145631068,1.0,1.0,2/15,5.72%,GSDME;GSDMD
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2639517469990802,-0.7718974885725329,0.8020618556701031,0.9288739599068896,1.0,11/21,32.41%,ARHGEF2;ATXN7;APC;FGF13;KATNB1;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,receptor catabolic process (GO:0032801),-0.25900267103470787,-0.7718924595272405,0.8046709129511678,0.9284016974340483,1.0,9/24,23.19%,SMURF1;AP2B1;ZNRF3;VLDLR;AP2A1;PIK3R4;NEDD4;MYLIP;AP2M1
prerank,proteasomal protein catabolic process (GO:0010498),0.18639139679703082,0.7717094788782232,0.9653092006033183,1.0,1.0,51/201,21.17%,DERL1;FBXL19;HECTD3;PSMD3;SIAH2;RNF41;RNF126;IFI27;MAEA;TRIM71;SOCS6;UBE4B;KAT5;ARRB1;CLOCK;TOPORS;PRPF19;UBE2W;CCDC47;UBXN6;PML;PSMD1;BAG6;SPSB2;PSMC5;RNF5;PSMA1;FEM1C;TBL1XR1;RBCK1;SIRT1;PSMD12;KLHL20;TRIM3;MDM2;KCTD2;RNF139;FBXL22;KCTD13;PSMD7;TRIM2;TRIM13;BFAR;DDIT3;SPSB1;KLHL42;RMND5A;HECW1;ZSWIM8;PSME2;TRIM9
prerank,regulation of interferon-beta production (GO:0032648),0.23996948871659485,0.7716202144379876,0.8195777351247601,1.0,1.0,14/46,20.22%,OAS2;NLRC3;CACTIN;OAS3;RNF135;POLR3C;TLR8;PPM1B;SIRPA;TIRAP;HSP90AA1;PYCARD;DDX3X;PTPRS
prerank,positive regulation of type I interferon production (GO:0032481),-0.20014894101109332,-0.771560111535815,0.9125295508274232,0.928437050675942,1.0,29/73,32.89%,LRRFIP1;POLR3F;DHX33;XRCC5;TRIM56;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;GAPDH;IRF5;POLR3A;MYD88;ZBP1;POLR3D;RIPK2;POLR2F;PTPN11;TLR4;POLR2H;CGAS;POLR1C;POLR2E;IRF3;CD14;CTNNB1;TLR3
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.2926430923337875,-0.7713833629023528,0.7677824267782427,0.928215667627177,1.0,3/15,13.83%,FAP;CST3;LRP1
prerank,regulation of B cell activation (GO:0050864),-0.2547101108595596,-0.7712838104377223,0.8183807439824945,0.9278756948135499,1.0,10/25,34.02%,AHR;NOD2;FCGR2B;ZFP36L2;FOXJ1;SAMSN1;IL4I1;LAPTM5;IKZF3;THEMIS2
prerank,histone deubiquitination (GO:0016578),-0.28025916868949396,-0.7709396859317479,0.8161616161616162,0.9278975613998086,1.0,8/18,34.85%,ATXN7;USP7;ENY2;TRRAP;USP15;USP36;BRCC3;ATXN7L3
prerank,phagosome maturation (GO:0090382),0.24760249860892433,0.7705179952022961,0.8086303939962477,1.0,1.0,8/35,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,actin filament polymerization (GO:0030041),-0.24192862269608906,-0.7703103753437128,0.8333333333333334,0.9283217961706046,1.0,9/29,20.57%,GSN;MSRB2;WASHC3;FAM107A;MICALL2;PSTPIP2;PREX1;DIAPH3;TTC17
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.30642201698725563,-0.7700752518568882,0.792156862745098,0.9281895773345782,1.0,5/13,23.12%,MGAT5;HES1;PTPRC;JAK3;EGF
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.27824610816781215,0.7700667624364057,0.7801556420233463,1.0,1.0,8/22,20.24%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2750123343212788,0.770007332181462,0.8059701492537313,1.0,1.0,3/22,7.85%,STAM;RNF126;SNF8
prerank,defense response to fungus (GO:0050832),-0.2828535015616084,-0.7700025335732738,0.7606490872210954,0.9278125292043089,1.0,4/17,23.22%,PLCG2;RARRES2;GAPDH;BCL10
prerank,dermatan sulfate metabolic process (GO:0030205),0.3074089708695824,0.7699476170067545,0.7719298245614035,1.0,1.0,1/13,0.36%,UST
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.29081813222577874,-0.7696839358692243,0.7578947368421053,0.9277796851609311,1.0,4/15,17.68%,ANXA1;FAM107A;UBE2L3;GPER1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3247559561475445,-0.7696250084724785,0.7766798418972332,0.9273837092218622,1.0,6/10,30.76%,PIBF1;SOCS3;PPP2CA;SOCS1;INPP5F;PPP2R1A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2717250577111808,0.769551851814809,0.7718940936863544,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2717250577111808,0.769551851814809,0.7718940936863544,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,replicative senescence (GO:0090399),0.3263344729000576,0.7694475344669083,0.7673956262425448,1.0,1.0,4/12,16.00%,CDKN2A;CHEK2;TERT;ATM
prerank,embryonic axis specification (GO:0000578),0.30668724439260586,0.7691639798524327,0.7621832358674464,1.0,1.0,2/15,3.68%,CXXC4;WNT7A
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.2912535919156294,-0.7688889481073341,0.7903225806451613,0.9279430743601221,1.0,6/15,25.71%,STAT3;GBP5;NOD2;MYD88;TICAM1;TLR4
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2275796216071641,0.7686374408658986,0.8669001751313485,1.0,1.0,13/57,17.82%,FANCD2;PLK1;ABRAXAS1;EME2;RINT1;MDC1;MRE11;CHEK2;CDC14B;PRKDC;ATM;CLSPN;RAD17
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.25460274582348075,0.7679117806466799,0.8093385214007782,1.0,1.0,9/29,16.82%,NAPA;RAB6B;NSF;COPG1;GOLGA5;COPG2;TRAPPC3;COPE;COPB1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.2603820694982847,0.7676950287382507,0.78125,1.0,1.0,5/29,10.46%,DHX34;HNRNPU;E2F1;ELAVL1;VIP
prerank,negative regulation of immune response (GO:0050777),0.1924737544239208,0.7674619054371604,0.9378068739770867,1.0,1.0,29/154,18.50%,ADCY5;PTH2R;CD247;ENPP3;FURIN;ADCY1;CRHR1;GPR45;ADCY8;HTR7;HRH2;NLRC3;CACTIN;C1QBP;VIP;MAPK14;CD300A;MAPKBP1;TYRO3;HAVCR2;GGT5;IL6;GIPR;PPM1B;CREB1;COL3A1;VIPR2;ADCY6;RNF26
prerank,establishment of mitotic spindle localization (GO:0040001),0.26542974279764076,0.7674535398142815,0.8015122873345936,1.0,1.0,5/28,9.32%,PLK1;CLASP1;HTT;NDC80;MAD2L1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.30237953919806404,0.7669555352973896,0.754,1.0,1.0,4/14,17.46%,RFLNA;TGFBR1;SOX9;ADAMTS7
prerank,phosphatidic acid metabolic process (GO:0046473),-0.21682693110977608,-0.7669385982150241,0.8839907192575406,0.930360044018787,1.0,8/48,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;PLA2G6;AGPAT5
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.21955440208153007,-0.7668574051547679,0.8624708624708625,0.9300101428028954,1.0,22/49,32.89%,F3;AFAP1L2;STAT3;NOD1;SERPINE1;CD74;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,histone deacetylation (GO:0016575),-0.22542618821868582,-0.7667880217642679,0.8533333333333334,0.929630073342373,1.0,14/43,26.26%,MIER1;PRDM5;HDAC9;PER1;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6;ELK4;RCOR1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2858747634725606,-0.7665587170626077,0.8065134099616859,0.9294672153504211,1.0,7/16,30.94%,SCARB1;PNPLA2;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3116038089872572,0.766556484839666,0.7543859649122807,1.0,1.0,1/13,0.87%,IL18
prerank,protein import into peroxisome matrix (GO:0016558),-0.3124732611268173,-0.7650527040773331,0.7817047817047817,0.9311024511850654,1.0,4/12,23.69%,PEX7;PEX14;PEX2;PEX12
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.23872286232752618,-0.7649215577891179,0.8454935622317596,0.9308222760210455,1.0,6/33,12.21%,PTPRJ;DGKZ;RPS3;CEACAM1;DUSP3;NECTIN2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.24549476213031396,0.7648606367930777,0.8139963167587477,1.0,1.0,5/33,12.97%,PABPN1;CPSF3;CPSF7;SLBP;LSM11
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.27811394953237456,0.764799751330912,0.8062015503875969,1.0,1.0,2/21,3.27%,DDB2;ERCC1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.27811394953237456,0.764799751330912,0.8062015503875969,1.0,1.0,2/21,3.27%,DDB2;ERCC1
prerank,regulation of endopeptidase activity (GO:0052548),0.22514086105614842,0.7643498106002946,0.8516579406631762,1.0,1.0,10/59,14.45%,TIMP3;SERPINA10;FURIN;PICALM;SERPIND1;HRG;APH1A;NRDC;SERPINA9;SERPINE3
prerank,estrogen metabolic process (GO:0008210),0.30000825898705075,0.7641553917407036,0.7996146435452793,1.0,1.0,3/15,19.29%,HSD17B2;HSD17B11;HSD17B4
prerank,telomere organization (GO:0032200),0.23906080624729,0.7636484132264971,0.8384201077199281,1.0,1.0,10/43,16.00%,DOT1L;RECQL4;POLD2;MRE11;RTEL1;TERT;RAD51D;PRKDC;RPA3;ATM
prerank,positive regulation of lymphocyte activation (GO:0051251),0.2582081816731338,0.7634364953547483,0.813780260707635,1.0,1.0,7/28,20.02%,TNIP2;PRKDC;IL6;IL12A;SIRPA;FGF10;PYCARD
prerank,regulation of cellular protein localization (GO:1903827),-0.21761763970557865,-0.7633158479807912,0.8810068649885584,0.9326612675624729,1.0,16/45,28.72%,GPC6;RAB11FIP5;RALB;CSNK1E;PTPN1;RAB11B;GPC1;GPC4;SPIDR;EGF;NDEL1;SUMO3;TRIM67;MAPT;VCP;PARP1
prerank,oligodendrocyte differentiation (GO:0048709),0.2813468285718064,0.76274456724951,0.7859778597785978,1.0,1.0,3/19,11.97%,SLC8A3;EIF2B4;SOX9
prerank,regulation of cell death (GO:0010941),0.2080030715351457,0.7626917158021445,0.8824503311258278,1.0,1.0,14/94,14.28%,BMP7;HSPA1A;CCN2;OLFM4;DHCR24;RILPL1;LRRK2;IMPACT;PRR7;CLU;PARP16;TSC1;SARM1;HSPA1B
prerank,regulation of autophagosome assembly (GO:2000785),0.2552275701648196,0.7614647140836371,0.8173598553345389,1.0,1.0,4/33,8.07%,NUPR1;NPRL3;RAB3GAP1;LRRK2
prerank,positive regulation of histone modification (GO:0031058),-0.23740989200685503,-0.761247269527887,0.8725701943844493,0.9350678345119686,1.0,8/33,19.05%,RPS6KA5;GLYR1;NIPBL;SAP30BP;PAF1;FMR1;APLNR;MAPK3
prerank,negative regulation of DNA recombination (GO:0045910),-0.21925654784877638,-0.7611077331413699,0.8823529411764706,0.9347769990490883,1.0,16/43,30.12%,SHLD1;TERF2IP;BLM;SMCHD1;FANCB;MAD2L2;POLR2I;POLR2F;PARP3;TINF2;SHLD3;TERF2;POLR2H;CGAS;HELB;POLR2E
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.286067588320689,0.7610458356862063,0.7798861480075902,1.0,1.0,3/18,10.41%,SLC25A5;PPIF;BCL2
prerank,protein targeting to mitochondrion (GO:0006626),0.23024573271093415,0.7607489632521094,0.8447653429602888,1.0,1.0,10/52,15.15%,PITRM1;AIFM1;IMMP1L;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;NDUFA13;TIMM21
prerank,regulation of mRNA metabolic process (GO:1903311),0.3206416649681924,0.7607129948577308,0.7470817120622568,1.0,1.0,4/11,22.91%,SLTM;SAFB2;SAFB;SRPK1
prerank,regulation of interferon-gamma production (GO:0032649),-0.20348646719460456,-0.7606969096112791,0.9012658227848102,0.9348844771425877,1.0,4/71,3.21%,PDE4D;IL1R1;GAS6;SLC7A5
prerank,DNA double-strand break processing (GO:0000729),0.288504133641774,0.7598503331325124,0.7869481765834933,1.0,1.0,6/18,22.08%,KAT5;MRE11;RNF138;ATM;RAD52;SLX4
prerank,regulation of actin filament-based process (GO:0032970),0.21612756271225608,0.759823334666718,0.8773747841105354,1.0,1.0,5/70,3.11%,ROCK2;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,microtubule bundle formation (GO:0001578),-0.22466886523701718,-0.7597094943200597,0.8669724770642202,0.9357421936373147,1.0,17/42,34.92%,NCKAP5;TPPP3;GAS2L1;NCKAP5L;CLIP1;TOGARAM1;RP1;AAAS;CDK5RAP2;CFAP46;FOXJ1;MARK4;KIF20A;PSRC1;CFAP206;NAV1;CCDC40
prerank,establishment of melanosome localization (GO:0032401),0.2827865099453639,0.7593651047337144,0.7652859960552268,1.0,1.0,3/19,13.11%,GPR143;BBS5;SHROOM2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.31990854380279526,0.7592804431319445,0.7620889748549323,1.0,1.0,1/11,1.96%,LRRC38
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.29499483268134963,-0.7589278297618444,0.8111332007952287,0.9362828865215046,1.0,2/13,8.86%,BMP4;SOD1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.2893693062388437,-0.7587287457110968,0.7835671342685371,0.9360766759592017,1.0,8/15,33.12%,CD200;GPER1;ZC3H12A;FCGR2B;MILR1;CD300LF;GRN;CD84
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3305360656292713,0.7586977792883633,0.7739307535641547,1.0,1.0,1/10,3.27%,ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3305360656292713,0.7586977792883633,0.7739307535641547,1.0,1.0,1/10,3.27%,ERCC1
prerank,t-circle formation (GO:0090656),0.3305360656292713,0.7586977792883633,0.7739307535641547,1.0,1.0,1/10,3.27%,ERCC1
prerank,establishment of spindle localization (GO:0051293),0.30283505882939193,0.758204739295558,0.7494949494949495,1.0,1.0,3/14,9.52%,CLASP1;LLGL2;LLGL1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.33206877278624414,0.7581935679156397,0.7752577319587629,0.999737034905107,1.0,4/10,18.53%,SMARCD3;FZD3;KDM1A;CX3CL1
prerank,sphingosine metabolic process (GO:0006670),-0.27513333921171435,-0.758067331634688,0.7954070981210856,0.9365055593807028,1.0,7/17,22.64%,ACER2;PLPP1;PLPP3;SGPP1;ASAH2;ACER3;PLPP2
prerank,snRNA 3'-end processing (GO:0034472),0.28170893662739416,0.7577341199382696,0.7948207171314741,0.9997036840953576,1.0,4/19,15.58%,EXOSC8;EXOSC2;USB1;INTS8
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2336874197393674,0.7577149840706978,0.8229755178907722,0.9989592597439216,1.0,3/44,4.31%,ROCK2;GTPBP1;TNRC6A
prerank,regulation of viral genome replication (GO:0045069),-0.207927570181255,-0.7575451937576768,0.8905109489051095,0.9367325993621023,1.0,13/56,17.37%,PLSCR1;ADARB1;IFITM3;PABPC1;PPIA;ISG15;RSAD2;IFIH1;VAPB;PPIE;TMEM39A;IFITM1;N4BP1
prerank,regulation of T cell activation (GO:0050863),-0.22066708008104702,-0.7575112809563244,0.8896103896103896,0.9363071044613579,1.0,25/42,49.65%,TNFRSF1B;DUSP3;JAK3;METTL3;TNFSF8;CCR2;IL4I1;LAPTM5;LAT;GPNMB;CD47;CCL5;PRELID1;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9;FGL1;TNFAIP8L2;TBX21;LGALS3;TNFSF18;CD2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.21086942746289192,-0.7573723481158384,0.8997722095671982,0.9360116627980088,1.0,19/54,27.91%,RHOA;DST;LIMK2;CLIP4;CLIP2;TRPV4;CLIP1;KATNAL1;DYNC1H1;CRIPT;RAB11A;DCTN1;SLK;FSD1;PLK3;KATNA1;CAMSAP2;CIB1;MAPT
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2483714712064019,-0.7571207248462459,0.8387755102040816,0.935858322588121,1.0,5/26,10.10%,APP;HES1;EIF4E;TAL1;DUSP3
prerank,dendritic cell migration (GO:0036336),-0.2779530953360192,-0.7569942887863735,0.7917525773195876,0.9355408611157918,1.0,11/16,44.94%,EPS8;HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2727328461753703,-0.7568720954050745,0.8135593220338984,0.9352153512838542,1.0,4/18,18.27%,THBS1;WNT5A;NECTIN2;IL33
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.19413815216435718,-0.7566929482382972,0.9390243902439024,0.9349912122243175,1.0,27/82,27.86%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;DYNC1H1;CSNK1D;DCTN1;CEP41;TPX2;TUBA4A;CEP131;CDK5RAP2;CEP152;HMMR;KIF14;AKAP9;ACTR1A;CDK2;CNTRL
prerank,integrated stress response signaling (GO:0140467),0.30726273640739254,0.7566846194752225,0.7795918367346939,0.9997951760671349,1.0,5/14,20.83%,IMPACT;EIF2AK1;DDIT3;EIF2S1;OMA1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.32850913686742095,0.7566081511829245,0.7659137577002053,0.9991212236937547,1.0,4/10,22.81%,JARID2;SIRT1;KDM1A;ATRX
prerank,natural killer cell mediated immunity (GO:0002228),0.29467437251516504,0.7562856149325456,0.783625730994152,0.9988535578732473,1.0,1/15,2.98%,KLRD1
prerank,negative regulation of proteolysis (GO:0045861),0.24753504078655508,0.7556737050328655,0.8069852941176471,0.999049165746264,1.0,7/34,13.46%,TIMP3;PLAT;LRRK2;CLN8;EPHA4;GAS1;BAG6
prerank,inositol phosphate catabolic process (GO:0071545),0.3158512291500087,0.7554516998175316,0.744721689059501,0.9986226316338286,1.0,7/12,27.75%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A;NUDT3
prerank,positive regulation of macrophage activation (GO:0043032),0.28963330595865466,0.7552505620492124,0.8253968253968254,0.9981520343514131,1.0,3/17,8.49%,TAFA3;CEBPA;TNIP2
prerank,fatty acid biosynthetic process (GO:0006633),-0.20516285624188685,-0.7548657337010912,0.9154929577464789,0.9370411663977278,1.0,14/63,19.49%,ABHD2;ELOVL7;PTGS2;ELOVL5;FADS3;ELOVL6;LIAS;SCD;ELOVL1;TECRL;ELOVL4;MCAT;MLYCD;ASAH2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.33100451886857085,0.7547622525844618,0.7828810020876826,0.9981421622199769,1.0,2/10,11.40%,ALDH7A1;COMT
prerank,positive regulation of translation (GO:0045727),-0.18804519724943752,-0.7547324785736431,0.955,0.9367578236500982,1.0,19/94,22.20%,NIBAN1;THBS1;RBM3;RPL5;EIF3E;EEF2;YBX3;CDC123;AGO2;RPS9;NGRN;FMR1;PRR16;FXR1;METTL3;PIWIL2;BCL3;EIF4A3;JMJD4
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3085284351123236,-0.7545534646493304,0.7874762808349146,0.9365396697513552,1.0,5/10,31.36%,NHP2;DKC1;NOP10;RPUSD3;TSR3
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.22816010799242561,-0.7540835084324663,0.8772321428571429,0.9367038853119473,1.0,9/35,22.53%,FAR2;GGTA1;HMGCLL1;FASN;AACS;SCD;GGT7;AWAT2;GGT1
prerank,N-terminal protein amino acid modification (GO:0031365),0.30229642135124124,0.7539569969778095,0.7869822485207101,0.9986050456968668,1.0,1/14,0.84%,METAP2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.27857851796794436,0.7536208839431574,0.7964774951076321,0.9983532969665125,1.0,6/18,17.57%,CHRM2;PLCB1;CHRM1;OPRM1;RGS8;CDK5R1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.2788389045181364,-0.7533672250660474,0.8072562358276644,0.9371946828487301,1.0,7/17,22.25%,RHOA;CCN1;TMEM119;BMP2;GREM1;SOX8;HPSE
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3273809244885948,0.7524505350948366,0.7846790890269151,0.9993800516575969,1.0,2/10,10.92%,NPTX1;NPTXR
prerank,regulation of cell division (GO:0051302),-0.19905124867019974,-0.7522989451956102,0.9263657957244655,0.9381860865380564,1.0,34/72,33.43%,MLLT3;BCL2L1;RACK1;PLK2;CALM3;MYO19;TXNIP;TAL1;PIK3C3;BLM;PIK3R4;CCP110;GIT1;RAB11FIP3;RAB11A;KIF13A;PRC1;NCOA3;ENTR1;DLL1;FSD1;TLE6;PLK3;SUSD2;CALM1;CIB1;FLCN;CSPP1;SH3GLB1;MYC;KIF20A;AURKA;BIRC6;ESRRB
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18832625504077882,-0.7519187444584683,0.949874686716792,0.938264570081601,1.0,21/95,23.22%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HMGB1;MYD88;TICAM1;SBNO2;CASP1;FCGR2B;BCL10
prerank,sensory perception of chemical stimulus (GO:0007606),0.29107804357380523,0.751283515185222,0.7888675623800384,1.0,1.0,15/15,70.92%,SYT10;SLC24A4;UBR3;GNAL;MKKS;GFY;OBP2B;OMP;BEST2;C5AR1;BBS4;ADCY3;GNAS;CD36;DRD2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2514949948964588,0.7510376795629164,0.8363970588235294,0.9999199953291317,1.0,6/31,15.15%,AIFM1;TOMM40;TIMM17A;PEX1;PAM16;TIMM21
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2626816452238675,0.7509231481044153,0.8055555555555556,0.9993240120262341,1.0,3/26,4.38%,NPR3;CDH3;PIK3CB
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2200379351423924,0.7508005001213132,0.8774080560420315,0.9987366499785707,1.0,9/53,16.76%,OPRD1;CHRM2;HTR7;HRH2;HTR1F;CHRM1;OPRM1;HTR1A;HRH1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.28085393224294214,-0.7506125517611725,0.7879417879417879,0.9390068484817721,1.0,6/15,32.22%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.28085393224294214,-0.7506125517611725,0.7879417879417879,0.9390068484817721,1.0,6/15,32.22%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,positive regulation of TOR signaling (GO:0032008),0.23737148592031923,0.750213351365153,0.8568773234200744,0.9988477876067438,1.0,10/40,17.90%,RRAGC;RICTOR;GPR137C;SLC38A9;PIH1D1;LAMTOR2;LAMTOR3;TELO2;RRAGB;FNIP1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.28340650526913835,0.749666503127098,0.8055555555555556,0.9988901135403999,1.0,6/16,24.20%,ACAT1;GCDH;ACACA;CBR4;ACSS1;DIP2A
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2443660064297424,0.7496334016005932,0.8239700374531835,0.9981719904558184,1.0,9/30,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,mitochondrial gene expression (GO:0140053),-0.22037099153780765,-0.7486732755110559,0.8507795100222717,0.9410384187770037,1.0,9/42,17.19%,GATB;FOXO3;LARS2;MRPL23;NDUFA7;MRPL12;GFM2;PTCD3;MRPS12
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.2427829125212217,-0.7479552362603888,0.8426966292134831,0.9414378638585723,1.0,7/26,21.29%,SHANK3;ACTG1;SYNPO2;PFN1;LIMK1;CDC42;ROCK1
prerank,protein targeting to peroxisome (GO:0006625),0.2573787694027327,0.7475767199213785,0.8249097472924187,1.0,1.0,5/29,10.43%,ZFAND6;ATAD1;LONP2;ABCD1;PEX1
prerank,import into nucleus (GO:0051170),0.2106373719673768,0.7474662502062577,0.9029605263157895,0.9997782823381728,1.0,7/73,6.98%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,melanosome localization (GO:0032400),0.27162272860379877,0.7473447589649392,0.8098039215686275,0.9991702640166793,1.0,3/21,13.11%,GPR143;BBS5;SHROOM2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.26003064311242985,-0.7473139896442917,0.8158995815899581,0.9417889304178899,1.0,8/21,33.69%,JUN;TWIST1;MED14;MED13;MED24;SETX;MED30;PAXIP1
prerank,negative regulation of translation (GO:0017148),0.20221631606221882,0.7462209339703088,0.928082191780822,1.0,1.0,20/87,20.88%,CPEB2;ROCK2;TRIM71;UNK;CPEB4;EIF2AK2;PAIP2B;PAIP2;EPRS1;EIF4E2;TSC1;FXR2;EIF4EBP3;RNF139;GIGYF2;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,nuclear membrane reassembly (GO:0031468),0.22000923466537833,0.7447896149181112,0.8563922942206655,1.0,1.0,20/54,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,response to tumor necrosis factor (GO:0034612),-0.1856302906777233,-0.7446720592471447,0.9669211195928753,0.9446874645986286,1.0,10/91,8.06%,PID1;DAB2IP;TNFRSF11A;GCH1;ARHGEF2;ADAM10;YBX3;TNFRSF21;RPS3;CCL13
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.28589569046213514,-0.7440101299550255,0.8109161793372319,0.9450314281131431,1.0,1/14,0.48%,ACTN4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2875171901902447,-0.743490090213225,0.8366935483870968,0.9452128131297036,1.0,3/13,17.16%,NECTIN2;STX7;PVR
prerank,aerobic respiration (GO:0009060),-0.25738733259009006,-0.7432339044220225,0.8208333333333333,0.9450639691597603,1.0,8/20,23.65%,ATP5F1D;UQCRB;NDUFS7;MTFR2;NDUFS8;SLC25A14;UQCR10;UQCRC1
prerank,T cell proliferation (GO:0042098),-0.29818142306846307,-0.743045075146348,0.8301486199575372,0.9448087178219132,1.0,8/13,38.05%,DOCK8;CTPS1;CADM1;MSN;PIK3CG;RASGRP1;TNFRSF4;CRTAM
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.29897853823315207,-0.7428484639810606,0.8021978021978022,0.9446009163311637,1.0,8/12,51.07%,ZBTB1;CCR2;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,cellular lipid catabolic process (GO:0044242),-0.24486192467257814,-0.7425481429412711,0.8637316561844863,0.9445157093352892,1.0,7/27,20.40%,PPARD;CYP1B1;ACOX1;LPIN3;MT3;ACBD5;SMPDL3B
prerank,heterochromatin assembly (GO:0031507),0.27198515092569214,0.7424936774609096,0.8343313373253493,1.0,1.0,8/20,21.63%,CDKN2A;BEND3;BAHD1;SIRT1;CENPV;RRP8;BAZ2A;HELLS
prerank,positive regulation of translational initiation (GO:0045948),0.28169029319535943,0.742239959174805,0.7996146435452793,1.0,1.0,7/18,24.44%,BOLL;POLR2D;UHMK1;DDX3X;LARP1;YTHDF3;YTHDF2
prerank,rRNA 3'-end processing (GO:0031125),0.32424552756810565,0.7422043707419064,0.782435129740519,1.0,1.0,2/10,11.29%,EXOSC8;EXOSC2
prerank,peptidyl-asparagine modification (GO:0018196),0.24114415572631462,0.741330451338458,0.8412098298676749,1.0,1.0,9/31,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.24130024040153045,0.7410822351251817,0.8513274336283185,1.0,1.0,8/35,16.02%,XRCC1;POLD2;MBD4;RFC5;POLE;RPA3;NEIL1;POLG
prerank,regulation of neutrophil migration (GO:1902622),-0.31908440264919724,-0.7402252891961192,0.8128772635814889,0.9469917504444327,1.0,3/10,16.03%,MPP1;JAM3;NCKAP1L
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3115332212580872,-0.739700780148951,0.8,0.9471741521641094,1.0,5/10,29.99%,AKT2;IRS1;PTH1R;PRKCE;PMAIP1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.2399888105864148,0.7393988647864411,0.8675623800383877,1.0,1.0,5/35,11.87%,PCDHB11;CDH17;CDH10;CDH18;PCDHB3
prerank,regulation of response to biotic stimulus (GO:0002831),0.24724541810696307,0.7388459898177896,0.8365896980461812,1.0,1.0,4/28,9.37%,APPL2;TKFC;TRIM5;RNF135
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1777547442394048,-0.7381091730572079,0.9760191846522782,0.9485777486346632,1.0,40/125,27.78%,STMN1;EML1;DYNC1I2;MAP4;TNKS;PLK2;NUP107;DYNC1I1;RPS27;RMDN1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;CENPQ;CENPL;NUSAP1;DYNC1H1;TAOK1;NUP85;B9D2;GPSM2;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.2573835804368224,0.7373796564287677,0.8131021194605009,1.0,1.0,3/25,6.70%,ANK2;CAPN3;PDPK1
prerank,cell junction maintenance (GO:0034331),0.2869163786939083,0.7372618812234345,0.7924901185770751,1.0,1.0,1/14,2.86%,NLGN2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.19661439549450324,-0.7371968327428934,0.9302884615384616,0.9492439157044362,1.0,26/69,35.74%,ICE1;INTS11;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1;SNAPC5;POLR2E;SNAPC4;POLR2J;TAF5;INTS12;SNAPC3
prerank,response to unfolded protein (GO:0006986),0.22502087882929372,0.7368146035734269,0.8808664259927798,1.0,1.0,4/48,4.35%,HSPA1A;DERL1;OPTN;DNAJB4
prerank,regulation of mitotic spindle organization (GO:0060236),0.2394222950262911,0.7367316995036064,0.8513274336283185,1.0,1.0,7/35,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.18945649781593524,-0.7367047703407064,0.9691211401425178,0.9493460715962462,1.0,23/86,23.51%,LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;KLF2;PSMB8;PSMC4;PSMD11;ATF4;PSMB4;PSMD14;PSMD10;ATF3;CHEK1;PSME1;PSMB3;EGLN3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.27107195665712525,0.7362633352523827,0.8181818181818182,1.0,1.0,6/21,18.53%,SMARCD3;FZD3;FZD9;NES;KDM1A;CX3CL1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2768803300900554,-0.7361018485748888,0.8052208835341366,0.9495898436674546,1.0,4/16,14.94%,SNRNP200;SFSWAP;NCBP2;DDX23
prerank,covalent chromatin modification (GO:0016569),-0.28866154600872407,-0.735892735413709,0.8132530120481928,0.9493646007042933,1.0,10/14,44.75%,CHD1;MT3;SIRT7;PARK7;HDAC1;PARP2;MBD2;AURKB;HLCS;AURKC
prerank,glycogen catabolic process (GO:0005980),-0.27536097761293654,-0.7357046768767366,0.8200836820083682,0.949098951337388,1.0,5/15,15.47%,RB1CC1;PYGB;GAA;PGM2;PHKA2
prerank,respiratory electron transport chain (GO:0022904),0.28775902000390485,0.7354641525176272,0.7896825396825397,1.0,1.0,6/14,23.32%,PPARGC1A;SLC25A12;SDHB;ETFDH;SLC25A13;SLC25A18
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3178992983296797,0.735233151827602,0.8170731707317073,1.0,1.0,4/11,11.20%,HTRA2;PRR7;CAAP1;PIH1D1
prerank,protein N-linked glycosylation (GO:0006487),0.20576160089334,0.7349333191204653,0.9218181818181819,1.0,1.0,19/66,22.76%,MAN1C1;ASGR1;B4GALT1;TUSC3;MGAT4C;MAGT1;PMM2;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPAGT1;DPM2;ALG2;ALG12;PGM3;DOLPP1;ST6GAL1
prerank,"phototransduction, visible light (GO:0007603)",-0.2798715062677827,-0.7346308059662926,0.8189134808853119,0.9499300794968014,1.0,2/14,6.03%,GNA11;GNB1
prerank,regulation of nuclear division (GO:0051783),0.2705628030815307,0.7345981771565235,0.8198874296435272,1.0,1.0,2/20,5.79%,OBSL1;CDC25C
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24663585778389602,0.7344082273624928,0.8298279158699808,1.0,1.0,5/28,15.08%,TFIP11;AUNIP;KMT5C;PRKDC;WAS
prerank,positive regulation of neuron death (GO:1901216),0.22396258814797387,0.7343089173767385,0.8743545611015491,1.0,1.0,13/46,20.76%,NUPR1;EFNB2;PICALM;CLU;SARM1;ITGAM;CDK5R1;C1QA;PRNP;DDIT3;REST;EIF2S1;BAX
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.24164640457868555,-0.7333615680618166,0.8454746136865342,0.9509557218720147,1.0,5/26,9.78%,KMT2E;EGFR;ANXA1;ADAMTS1;RPTOR
prerank,regulation of viral transcription (GO:0046782),-0.2157307360700258,-0.7332079794241889,0.9110169491525424,0.9506560777950549,1.0,5/39,10.09%,MDFIC;MID2;IFITM3;TRIM14;GTF2F1
prerank,chromatin organization (GO:0006325),-0.1717190215378667,-0.7324954615843928,0.9849246231155779,0.9510448275772092,1.0,14/132,11.05%,MECOM;PRDM16;ESR1;BPTF;SMARCC1;BAZ2B;EZH1;ZBTB1;RBBP4;CHD1L;ARID1A;BRWD1;CHD1;PBRM1
prerank,membrane depolarization (GO:0051899),-0.22360880873183092,-0.7324667692222253,0.888646288209607,0.9506156141289341,1.0,8/32,21.60%,CAV1;CACNA1G;CACNA1B;CACNB4;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,heme biosynthetic process (GO:0006783),-0.25212289014092704,-0.7314392367315306,0.8304721030042919,0.9513489659697297,1.0,7/22,24.86%,ABCG2;NFE2L1;UROS;HMBS;COX15;FXN;FECH
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.30981949489226757,0.7310954428728892,0.8181818181818182,1.0,1.0,3/11,10.75%,EFNB2;FZD7;FRS2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.29399172553493147,0.7307974998346712,0.7963340122199593,1.0,1.0,5/13,19.69%,MSX2;TAF1;PER2;SIN3A;DDIT3
prerank,negative regulation of axonogenesis (GO:0050771),0.2476065233487083,0.7304972320915928,0.8523364485981308,1.0,1.0,4/27,10.62%,MAP2;RUFY3;LRP4;RNF6
prerank,apoptotic DNA fragmentation (GO:0006309),0.2797947261267124,0.7303365897758363,0.8349514563106796,1.0,1.0,4/16,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,response to gamma radiation (GO:0010332),-0.2414048662137765,-0.7297964588630791,0.8599137931034483,0.9528154678141723,1.0,3/24,6.25%,DCUN1D3;MAP3K20;XRCC5
prerank,negative regulation of protein depolymerization (GO:1901880),-0.2455482048681752,-0.7296771849035919,0.8778947368421053,0.9524909822119497,1.0,8/24,18.23%,ARHGEF2;ATXN7;APC;PIK3CA;FGF13;LIMA1;KATNB1;TAOK1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2398908662515424,-0.729419576055177,0.8530020703933747,0.9523336748377821,1.0,5/26,15.85%,PDE8A;PPIA;BAG5;HSPB1;ATF4
prerank,proteoglycan metabolic process (GO:0006029),-0.24354126483503705,-0.7287426872093851,0.8697478991596639,0.9526503076077165,1.0,3/26,4.80%,BMPR2;CSGALNACT1;CHST8
prerank,sphingolipid catabolic process (GO:0030149),0.28922864792421965,0.7286141023390325,0.7972166998011928,1.0,1.0,2/15,10.24%,SPHK1;SMPD2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2508060118289774,0.7282150916159128,0.8693957115009746,1.0,1.0,6/24,21.52%,TTLL6;AGBL4;GGCX;CFAP20;TTLL11;TTLL4
prerank,nucleosome organization (GO:0034728),-0.2056765100169361,-0.7280594587923648,0.9366515837104072,0.95297862170338,1.0,9/55,13.28%,CTCF;H3-3A;BPTF;SMARCC1;ARID1A;PAF1;NASP;LIN54;ACTR6
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.20907241559190062,0.7279420914726275,0.927689594356261,1.0,1.0,15/63,17.43%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;PRKDC;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,melanosome transport (GO:0032402),0.2747213261466111,0.7265979447751141,0.8042635658914729,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,pigment granule transport (GO:0051904),0.2747213261466111,0.7265979447751141,0.8042635658914729,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.24257072008710825,0.7262854559953527,0.8422018348623853,1.0,1.0,9/32,20.02%,DDX5;PDK2;PML;BAG6;AEN;SIRT1;HIPK2;RRP8;PYCARD
prerank,synaptic vesicle membrane organization (GO:0048499),-0.26460487486092105,-0.725921726560236,0.8228699551569507,0.9549543660902399,1.0,5/17,17.48%,STX1A;STX3;SYNGR2;SNAP23;SYNGR1
prerank,regulation of calcium ion import (GO:0090279),-0.25287466602731534,-0.7258369124301957,0.8459915611814346,0.9545879929179574,1.0,7/21,25.77%,SLC30A1;CXCL12;PLN;PSEN2;FYN;EGF;STC1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.26259064013196215,-0.7258092436409611,0.8585858585858586,0.9541463292860364,1.0,10/18,39.99%,APOE;AMER1;RNF128;MSN;FAF1;PTTG1IP;VPS35;DACT1;EZR;RDX
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3072685600502686,-0.7258036583980554,0.8257261410788381,0.9536767480662303,1.0,4/10,21.33%,LYN;CD40;CD24;BTLA
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.29858364195308007,0.7256423628742741,0.810379241516966,1.0,1.0,3/12,18.35%,PPARA;MIA3;AKT1
prerank,histone H2A ubiquitination (GO:0033522),0.27724607701087006,0.7245787044732301,0.8295880149812734,1.0,1.0,7/17,26.88%,DDB2;RING1;PCGF1;UBR2;RNF8;BCOR;UBE2B
prerank,placenta development (GO:0001890),0.30004343995158106,0.7242689013365525,0.7983193277310925,1.0,1.0,6/12,26.09%,CITED1;E2F8;PLAC1;CUL7;PTK2;PPARG
prerank,regulation of response to stress (GO:0080134),0.31828920335006583,0.7241767555371249,0.7936210131332082,1.0,1.0,2/10,13.54%,ADCY8;OPRM1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.29259660072172716,0.7239497129709052,0.8007736943907157,1.0,1.0,4/13,14.17%,RAB3GAP1;GRIK2;SHISA7;SHISA8
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3039369461285457,-0.723699163316195,0.8065843621399177,0.9556482217957364,1.0,4/10,22.51%,CEACAM1;PTPRC;ARRB2;FCGR2B
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3064641905722668,0.7235003487662903,0.826171875,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3064641905722668,0.7235003487662903,0.826171875,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,sphingoid metabolic process (GO:0046519),-0.2869636960526654,-0.7233353658931148,0.8261802575107297,0.9555541828076117,1.0,6/12,22.64%,DEGS2;PLPP1;PLPP3;SGPP1;ASAH2;PLPP2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.21821370870041223,-0.7229565286529813,0.89587852494577,0.9554759672244787,1.0,11/38,23.17%,POLR3F;PLSCR1;GBP5;PUM2;IFI35;PUM1;POLR3B;ZCCHC3;POLR3D;NMI;USP15
prerank,visual perception (GO:0007601),0.19699347375179543,0.7227711543000954,0.9536082474226805,1.0,1.0,19/84,22.27%,GPR143;EYA4;EML2;ARR3;PAX6;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA
prerank,mRNA destabilization (GO:0061157),0.22789808288975824,0.7220265352385034,0.8955223880597015,1.0,1.0,12/38,26.13%,ROCK2;TRIM71;TUT4;POLR2D;GIGYF2;CPEB3;DCPS;YTHDF3;CELF1;YTHDF2;ZFP36;ZFP36L1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.25524566381177566,-0.7211836115266701,0.8450413223140496,0.956988927331799,1.0,8/20,24.61%,ENTPD1;APP;TXNIP;NT5E;SUGT1;C3;CASP1;ANO6
prerank,response to hexose (GO:0009746),-0.23712428544221575,-0.721009201273105,0.8727678571428571,0.9567039037573544,1.0,3/25,9.44%,THBS1;EIF2B2;PFKL
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.1817522127672503,-0.7209644063667076,0.9690721649484536,0.9562796866799603,1.0,25/101,25.71%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;LYN;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HCK;HMGB1;MYD88;TICAM1;SBNO2;CASP1;BCL10;CD68;PRKCE;TLR4
prerank,mitotic metaphase plate congression (GO:0007080),-0.1999503118598705,-0.720623748920903,0.9218390804597701,0.9562106861970018,1.0,19/51,26.72%,CHMP2B;CHMP4B;CHMP4A;PIBF1;RMDN1;ZW10;CHMP1B;RAB11A;RRS1;KIFC1;CDC23;NUP62;CUL3;KIF22;KIF14;SPDL1;MIS12;CDCA8;CEP55
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25548315991091836,0.7200108512722495,0.8605108055009824,1.0,1.0,7/23,19.69%,INHA;C1QBP;HAVCR2;AXL;RARA;PRNP;DDIT3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.22683774790622332,-0.7199789681854946,0.890625,0.956416663746016,1.0,19/33,47.19%,FBN1;UBASH3B;TLR4;GPR137B;CEBPB;LRRC17;TLR3;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;CCL3;IL12B
prerank,negative regulation of catabolic process (GO:0009895),0.2194977011922897,0.7195997211605117,0.9068541300527241,1.0,1.0,11/47,18.92%,NUPR1;PPARA;ADRA2A;MAD2L1;AZIN2;HDAC4;CYP51A1;SNX3;BANP;HMGCR;NCOR1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.17061924081792387,-0.7195947845426863,0.9731903485254692,0.9563677385668176,1.0,41/128,27.86%,FBXL7;YWHAE;PPP1R12A;CDK14;DYNC1I2;CSNK1E;CCNY;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;LCMT1;AJUBA;CSNK1D;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CEP131;CDK5RAP2;CEP152;PLK3;KDM8;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;CNTRL
prerank,regulation of interleukin-8 production (GO:0032677),-0.19137524774435402,-0.719172158623679,0.9575471698113207,0.9563546023135452,1.0,29/69,32.89%,TMSB4X;F3;AFAP1L2;STAT3;NOD1;ANXA1;OTUD7B;SERPINE1;KLF4;CD74;PTPRC;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL3;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;TLR6;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23072404938097768,-0.718818950761397,0.8803418803418803,0.9562581256106663,1.0,13/28,39.54%,TNFRSF21;CD86;GLMN;CEBPB;IL4I1;LGALS9;GPNMB;SDC4;VTCN1;ARG1;CRTAM;PDCD1LG2;CD80
prerank,regulation of macrophage differentiation (GO:0045649),-0.2764716107602843,-0.7186078250010133,0.8470588235294118,0.9560070214101649,1.0,11/15,46.04%,IL34;C1QC;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1;PTPN2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2032244015144535,-0.7174859708318925,0.9488888888888889,0.9563028127031817,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2032244015144535,-0.7174859708318925,0.9488888888888889,0.9563028127031817,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,regulation of protein targeting to membrane (GO:0090313),-0.22745565586613786,-0.7173883822501439,0.8778467908902692,0.955933841940781,1.0,11/28,31.06%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C;DMTN;CIB1;GDI1;ITGB1BP1
prerank,DNA biosynthetic process (GO:0071897),0.2740464655837397,0.7169804085497534,0.825426944971537,1.0,1.0,4/16,15.49%,POLD2;TERT;POLE;SIRT1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2711272032171753,0.7163468830731037,0.8195777351247601,1.0,1.0,4/18,15.15%,TOMM40;TIMM17A;PAM16;TIMM21
prerank,regulation of cell aging (GO:0090342),0.310477097340671,0.7162249638079266,0.816247582205029,1.0,1.0,3/11,20.21%,LMNA;VASH1;NEK4
prerank,protein insertion into membrane (GO:0051205),-0.22344744607397043,-0.7160751299224759,0.9190283400809717,0.9568768480802573,1.0,3/32,4.03%,EGFR;APP;STX1A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.22751150323764666,-0.7153148578854385,0.9082774049217002,0.9572434243442371,1.0,12/32,27.53%,PLCG1;CALM3;TRPC1;JPH2;CEMIP;P2RY6;APLNR;GPER1;NPSR1;F2R;CASQ1;CALM1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.23258370099244738,-0.7152801928732798,0.8838174273858921,0.9568152025015783,1.0,9/26,22.09%,STAT3;AIM2;LYN;GRIN2B;USP50;GRIN1;PSENEN;PSME1;FYN
prerank,regulation of secretion (GO:0051046),0.30044177541854755,0.7152459972928805,0.8132530120481928,1.0,1.0,2/13,6.82%,OAS2;NRG1
prerank,protein acetylation (GO:0006473),-0.22822421598843048,-0.7150459358153918,0.9048672566371682,0.9566077624321874,1.0,3/30,4.55%,FOXO1;NAA16;KAT6A
prerank,microtubule polymerization (GO:0046785),0.2456610725716723,0.7147640968774431,0.8701298701298701,1.0,1.0,5/28,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.21406735787431175,-0.7142839599089393,0.928416485900217,0.9569040484924264,1.0,9/38,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2975711418318458,0.7138272865149922,0.8557692307692307,1.0,1.0,3/12,8.74%,SNAP29;SNAP47;SNAP25
prerank,RNA destabilization (GO:0050779),0.2640621407358579,0.7138187137244991,0.8392857142857143,1.0,1.0,1/18,0.78%,ROCK2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.26603866633276857,0.7137167409255225,0.8353658536585366,1.0,1.0,7/19,28.31%,CHUK;STAT1;TLR8;DDX3X;SETD2;TLR7;MAVS
prerank,digestive tract morphogenesis (GO:0048546),0.28731861087708593,0.7136089274412671,0.8216432865731463,1.0,1.0,2/14,6.95%,PDGFRA;FGFR2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3093736933332861,0.7135259053052847,0.8156862745098039,1.0,1.0,4/10,17.34%,MTHFS;MTHFD1;MTHFR;MTHFD2
prerank,negative regulation of developmental growth (GO:0048640),-0.2261218960015617,-0.7122468680320607,0.8483516483516483,0.9585333776552427,1.0,12/30,27.89%,FGF13;PTCH1;SEMA3G;MT3;RTN4;FGFR3;PTEN;ULK2;RTN4R;CDKN1B;ULK1;DCC
prerank,cellular response to interferon-beta (GO:0035458),0.28217611340012505,0.7120185302805244,0.8385214007782101,1.0,1.0,3/14,14.97%,HTRA2;STAT1;NDUFA13
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.21321496091632175,-0.7119684161975406,0.9207708779443254,0.9583409823286241,1.0,9/40,20.46%,DEFA6;GBP4;RPL39;DROSHA;MPEG1;RARRES2;ROMO1;PPP1R11;MYD88
prerank,dendritic cell chemotaxis (GO:0002407),-0.27356473351392013,-0.7119582367737374,0.8594059405940594,0.9578833678979365,1.0,10/14,44.94%,HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,synaptonemal complex assembly (GO:0007130),-0.2747768906539497,-0.71138335987971,0.8556701030927835,0.9575321469978728,1.0,7/15,35.25%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),-0.2747768906539497,-0.71138335987971,0.8556701030927835,0.9575321469978728,1.0,7/15,35.25%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,fatty acid transport (GO:0015908),0.2723622455612377,0.7112002178932895,0.8352490421455939,1.0,1.0,4/17,15.79%,ACSL1;SLC27A6;SLC27A4;GOT2
prerank,interstrand cross-link repair (GO:0036297),-0.19620660591062175,-0.7107296090858896,0.965675057208238,0.9577449897196231,1.0,18/53,28.06%,RPA1;UBC;RPS27A;UBB;FANCB;FANCG;NEIL3;RPA2;RAD51AP2;XPA;CENPX;NUCKS1;XRCC3;USP1;RNF168;FANCL;RAD51AP1;VCP
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.20141317024116578,-0.7101404178272895,0.9300225733634312,0.957911610417528,1.0,7/46,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;AGPAT5
prerank,tRNA 5'-end processing (GO:0099116),0.2680245686968797,0.7100478253813128,0.8336673346693386,1.0,1.0,4/15,21.60%,POP4;RPP25L;TRMT10C;RPP30
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.30903463777341056,0.7100341319525315,0.8250497017892644,1.0,1.0,6/11,26.82%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.30903463777341056,0.7100341319525315,0.8250497017892644,1.0,1.0,6/11,26.82%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,tRNA wobble base modification (GO:0002097),0.2837162029519199,0.7099953177796363,0.8444022770398482,1.0,1.0,2/14,5.85%,TRMT9B;GTPBP3
prerank,regulation of receptor recycling (GO:0001919),-0.26142191485148814,-0.7098233699422553,0.8657587548638133,0.9577716696076825,1.0,2/16,5.49%,ECE1;VAMP3
prerank,negative regulation by host of viral process (GO:0044793),-0.29954908730001517,-0.7097370702654836,0.837890625,0.9573877369817966,1.0,7/10,50.36%,ZC3H12A;VAPA;CRP;CCL8;PTX3;PSMC3;LTF
prerank,positive regulation of neutrophil migration (GO:1902624),0.2682412729316293,0.7088223426671935,0.8519230769230769,1.0,1.0,6/18,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,negative regulation of B cell activation (GO:0050869),-0.2414924618463714,-0.708773581483023,0.8747433264887063,0.9579131617269957,1.0,9/21,33.08%,LYN;TNFRSF21;ID2;FCGR2B;PARP3;FOXJ1;SAMSN1;LAPTM5;TYROBP
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22448382947004036,-0.7083845028433966,0.9014373716632443,0.9578336223204229,1.0,10/31,24.93%,OTUD7B;USP7;SPATA2;BABAM2;USP50;PSMD14;CYLD;ATXN3;OTUB2;SHMT2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.252151558009338,-0.7081666705471148,0.8601694915254238,0.9571143160868825,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.252151558009338,-0.7081666705471148,0.8601694915254238,0.9571143160868825,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23504383381951643,0.7080955597434788,0.8979963570127505,1.0,1.0,6/32,11.81%,STARD7;LPIN1;CHPT1;CSNK2A2;CHKB;ABHD3
prerank,negative regulation of cellular senescence (GO:2000773),0.28444704644374763,0.7071155232481879,0.8311444652908068,1.0,1.0,4/13,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.30321849414184915,0.7068688226058362,0.808300395256917,1.0,1.0,4/11,18.87%,KAT5;MUC1;HIPK2;TFAP4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2472434540496462,-0.706861407621338,0.8870292887029289,0.9579381510691318,1.0,4/21,16.39%,CNOT6L;CNOT11;PAN3;TNKS1BP1
prerank,glucan catabolic process (GO:0009251),0.27511578282348287,0.7057074285532237,0.8120300751879699,1.0,1.0,4/15,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,regulation of myoblast fusion (GO:1901739),0.2919407606626506,0.7056215113790126,0.8081632653061225,1.0,1.0,3/11,17.73%,CFLAR;MAPK14;RIPOR2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.30366114428527463,0.7054682947241518,0.8256704980842912,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.30366114428527463,0.7054682947241518,0.8256704980842912,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2866702766087045,0.7048109771235269,0.83640081799591,1.0,1.0,2/13,9.11%,KRI1;NOP9
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2724094405412375,0.7045626363457612,0.8619329388560157,1.0,1.0,6/17,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.1742254758213397,-0.7039553480070501,0.982051282051282,0.9603938492105697,1.0,27/94,24.33%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;TCTN3;DCTN3;ODF2;DYNLL1;CCP110;TMEM216;PRKAR2B;PAFAH1B1;KIF24;NPHP1;PRKACA;DYNC1H1;RAB11A;CEP97;CSNK1D;DCTN1;B9D2;CEP41;TUBA4A;CEP131;CDK5RAP2;CEP152
prerank,establishment of mitotic spindle orientation (GO:0000132),0.24976946113307244,0.703380563296585,0.852670349907919,1.0,1.0,8/23,23.39%,PLK1;HTT;NDC80;MAD2L1;INSC;NDE1;CENPA;MISP
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.30429324629676124,0.7033126140823365,0.8455284552845529,1.0,1.0,10/10,69.59%,PRNP;PRKAR1A;SCRIB;CD274;RC3H1;BTN2A2;FOXP3;PDCD1LG2;CRTAM;LGALS9
prerank,miRNA mediated inhibition of translation (GO:0035278),0.2932764730638874,0.7031973291118201,0.8045267489711934,1.0,1.0,7/11,26.60%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2932764730638874,0.7031973291118201,0.8045267489711934,1.0,1.0,7/11,26.60%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2366443924070923,-0.7031185335017452,0.893305439330544,0.9607596433289518,1.0,8/24,24.86%,ABCG2;NFE2L1;RSAD1;UROS;HMBS;COX15;FXN;FECH
prerank,midbody abscission (GO:0061952),-0.25583633302509085,-0.7027463969372422,0.8588709677419355,0.960653578667842,1.0,3/17,6.92%,CHMP2B;CHMP4B;CHMP4A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.21285812195798665,-0.701667942385974,0.9048582995951417,0.9612650394042536,1.0,12/33,25.29%,PIK3R1;PIK3C2A;PIK3CA;EDN1;PIK3CD;HTR2A;IRS1;PTEN;NYAP1;IGF1R;PIK3C2B;PIK3CG
prerank,RNA modification (GO:0009451),-0.2004982306369262,-0.701477165676774,0.965034965034965,0.9609863635622727,1.0,21/54,31.83%,ADARB1;ALKBH1;PUS3;THUMPD1;FTSJ1;TRIT1;CDKAL1;PUS7L;LCMT2;NSUN4;MEPCE;METTL3;WDR4;AARS2;NOP10;ADAT2;NSUN5;CTU2;TRMT61A;TSR3;CTU1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.23498905812396226,0.7005495428496141,0.879472693032015,1.0,1.0,9/29,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,tyrosine metabolic process (GO:0006570),-0.28559409842124983,-0.7002869722865258,0.8393574297188755,0.9617008677985502,1.0,3/11,29.98%,FAH;HGD;IL4I1
prerank,telomere capping (GO:0016233),0.2723555940484956,0.7002830704275415,0.8511796733212341,1.0,1.0,3/16,14.47%,TFIP11;MRE11;PRKDC
prerank,macrophage chemotaxis (GO:0048246),-0.29453142778167724,-0.699455631020856,0.8336448598130841,0.9620546365588062,1.0,6/10,50.19%,TAFA4;CXCL17;CCL5;CCL3;LGALS3;CKLF
prerank,negative regulation of translational initiation (GO:0045947),-0.27324137314915253,-0.6976055158454973,0.8471074380165289,0.9633685228481264,1.0,4/13,15.68%,EIF3E;AGO2;TPR;FMR1
prerank,mRNA methylation (GO:0080009),0.27296132875604584,0.6973705713940166,0.8397683397683398,1.0,1.0,6/15,23.41%,NSUN2;TRMT6;TRMT61B;TRMT10C;ZC3H13;METTL8
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.29238794520215106,0.6972134544678892,0.8293650793650794,1.0,1.0,1/12,0.53%,DAB2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.25060860608830143,-0.6971585965835787,0.8707627118644068,0.9633176424516371,1.0,10/18,40.85%,ANXA1;FAM107A;UBE2L3;ZFP36L2;SSTR2;AQP1;KLF9;PCK2;ISL1;BCL2L11
prerank,organelle transport along microtubule (GO:0072384),0.22687195249090386,0.6968899944233857,0.8972972972972973,1.0,1.0,6/31,13.42%,TRAK1;HTT;BICD1;COPG1;COPG2;RAB1A
prerank,water transport (GO:0006833),-0.2773857847592111,-0.6960199934323594,0.8474226804123711,0.9639013579869882,1.0,2/12,16.14%,AQP11;CFTR
prerank,Rac protein signal transduction (GO:0016601),0.2582636150264044,0.6953988636994268,0.8651252408477842,1.0,1.0,3/18,11.95%,HACD3;WASF1;CYFIP1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.2748886172547368,0.6932952554262635,0.8469387755102041,1.0,1.0,4/14,18.35%,SLC45A3;PPARGC1A;SIRT1;AKT1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2279739344013858,0.692730297627503,0.8917431192660551,1.0,1.0,7/32,16.86%,PLK1;ABRAXAS1;RINT1;MRE11;CDC14B;ATM;CLSPN
prerank,cellular senescence (GO:0090398),0.23609025106180254,0.692653200155337,0.9050279329608939,1.0,1.0,2/27,1.98%,MAGEA2;CDKN2A
prerank,epithelial structure maintenance (GO:0010669),0.3007554021436009,0.6911729084339012,0.8546511627906976,1.0,1.0,1/11,3.11%,STRAP
prerank,outer dynein arm assembly (GO:0036158),0.2803071518819649,0.6907238716906358,0.8588709677419355,1.0,1.0,5/14,26.85%,DNAL1;DNAAF5;DNAH5;DNAH17;ODAD4
prerank,protein prenylation (GO:0018342),-0.2930290863720667,-0.6907034186719984,0.860236220472441,0.9683910186639805,1.0,4/10,24.70%,PTAR1;RCE1;CHM;CHML
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2751687713329541,0.6902595772642244,0.8448275862068966,1.0,1.0,3/15,8.55%,PPARA;PPM1K;SLC45A3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.2578261744732978,0.6900132699113583,0.877906976744186,1.0,1.0,6/19,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.20287865586743742,-0.6891987128742545,0.941834451901566,0.969317931309843,1.0,9/40,23.85%,MMS22L;TIPIN;BLM;TIMELESS;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.29081282195032193,0.6884772437629284,0.8254901960784313,1.0,1.0,5/10,26.13%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,negative regulation of phagocytosis (GO:0050765),0.26156670398923154,0.6880315090496609,0.8618042226487524,1.0,1.0,1/17,0.56%,SYT11
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2650671249004777,0.6866551529398279,0.8311444652908068,1.0,1.0,4/16,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17311852938254946,-0.686055087019998,0.9798994974874372,0.9716257210921015,1.0,18/87,19.94%,SDHAF2;TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;IMMP2L;NDUFA7;SDHAF4;NDUFA5;NDUFAF6;SCO1;UQCRFS1;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.28558672060264256,-0.6858029115640689,0.884453781512605,0.9713709311465626,1.0,7/11,29.66%,NOVA2;ZNF445;PCBP2;PCBP1;RASA1;IGF2BP2;IGF2BP1
prerank,superoxide anion generation (GO:0042554),0.27720977160165083,0.6856215600331896,0.8565573770491803,1.0,1.0,3/13,18.78%,NOX1;CYBA;NCF1
prerank,sensory perception of smell (GO:0007608),0.29100495888519257,0.6855845947321395,0.8483033932135728,1.0,1.0,11/11,70.92%,SYT10;SLC24A4;UBR3;MKKS;GFY;OBP2B;OMP;BEST2;BBS4;ADCY3;DRD2
prerank,C4-dicarboxylate transport (GO:0015740),-0.26184484827784593,-0.6854113609581401,0.8927125506072875,0.9712289640600805,1.0,1/14,0.97%,LRRC8D
prerank,histone H4-K16 acetylation (GO:0043984),0.2560009970692889,0.6851232903307723,0.8677685950413223,1.0,1.0,3/19,6.62%,KANSL2;KMT2A;MEAF6
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2817007252088195,-0.684279113445059,0.8559837728194726,0.9717352073040211,1.0,5/11,23.65%,UQCR11;UQCRFS1;UQCRB;UQCR10;UQCRC1
prerank,regulation of cilium movement (GO:0003352),-0.2948607892710753,-0.6841848361709173,0.8686274509803922,0.9713486017033643,1.0,5/10,34.92%,DNAH11;CFAP43;ODAD2;CFAP206;CCDC40
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24294483180699913,-0.6838663754319833,0.8855291576673866,0.971152181272383,1.0,6/19,22.07%,HIPK1;DDIT4;DYRK2;TMEM109;BCL3;SNW1
prerank,lytic vacuole organization (GO:0080171),0.22721830773421184,0.6830304234475565,0.90625,1.0,1.0,10/32,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,detection of visible light (GO:0009584),0.26721333693414207,0.6823683599509105,0.8828282828282829,1.0,1.0,1/16,2.38%,ABCA4
prerank,organelle disassembly (GO:1903008),0.22378418653935,0.6823658389023844,0.9134615384615384,1.0,1.0,9/33,22.86%,PLK5;RETREG1;GOLGA2;ATG2B;MRRF;GBF1;KLC1;EIF2D;DENR
prerank,cell cycle G1/S phase transition (GO:0044843),0.1989283045833186,0.6821651498491621,0.9679715302491103,1.0,1.0,7/61,8.86%,CDKN2A;PHF8;TRIM71;E2F1;USP26;HINFP;MAX
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18878935700585428,-0.6821430680975357,0.9533799533799534,0.9722017101014899,1.0,21/57,32.03%,DCN;TNFSF10;KDR;MFF;HIP1R;BBC3;PLAUR;BAK1;GPER1;MIEF1;BIK;CAMKK2;BOK;MUL1;TREM2;HRK;PARK7;PMAIP1;VPS35;BMF;AURKA
prerank,glycogen biosynthetic process (GO:0005978),0.28263798565721976,0.6820527563136547,0.8769230769230769,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.28263798565721976,0.6820527563136547,0.8769230769230769,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.25280454754115866,0.6816499042929823,0.8648111332007953,1.0,1.0,6/18,18.92%,PTBP2;PTBP1;TERT;NCOR2;PTBP3;NCOR1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.2144134565259911,0.6815647560513458,0.925,1.0,1.0,12/42,19.41%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;PPA1;IARS2;FARSA;IARS1;YARS1
prerank,regulation of actin nucleation (GO:0051125),-0.27126789091046627,-0.6808326530161029,0.8551587301587301,0.9728605367136509,1.0,2/12,10.16%,GSN;WHAMM
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.23057080756050774,-0.6806020709780038,0.911578947368421,0.9726047853374921,1.0,11/22,31.06%,MDFIC;APOD;INSIG1;SP100;BARD1;CABP1;DMTN;LMAN1;PARK7;GDI1;ITGB1BP1
prerank,neuropeptide signaling pathway (GO:0007218),0.2020130520514372,0.6803904076913811,0.9433962264150944,1.0,1.0,10/58,17.17%,OPRD1;GLRA1;NTS;NMUR1;LTB4R2;GPR37;GRP;OPRM1;PENK;GPR149
prerank,detection of calcium ion (GO:0005513),-0.2714614363017552,-0.6802998999132318,0.8824701195219123,0.9723750308224499,1.0,8/13,36.66%,KCNMB2;CALM3;STIM1;CALM1;KCNMB4;KCNIP2;CALM2;KCNMB1
prerank,cellular response to gamma radiation (GO:0071480),-0.2482017953711081,-0.6787067679583022,0.8805031446540881,0.973225235089161,1.0,2/17,6.25%,MAP3K20;XRCC5
prerank,transport along microtubule (GO:0010970),0.27574604524797813,0.678517455078092,0.876984126984127,1.0,1.0,5/13,17.65%,CLIP3;COPG1;COPG2;SPG11;BORCS5
prerank,transition metal ion homeostasis (GO:0055076),0.22789560918134255,0.678383560799227,0.9087523277467412,1.0,1.0,4/28,10.12%,HEPHL1;PICALM;CP;CUTC
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27709589546953717,0.6781309307961106,0.8519230769230769,1.0,1.0,4/12,20.72%,NDC80;CENPC;BOD1;NUF2
prerank,oxoacid metabolic process (GO:0043436),0.23003048870676068,0.67808580630504,0.9166666666666666,1.0,1.0,6/27,18.85%,DDO;ABHD14B;PPA1;MINPP1;TPST1;LIPT1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.22606450998590144,-0.6774217782279175,0.9038854805725971,0.9737726584749182,1.0,7/24,22.73%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.24756810091173076,-0.6773867276206205,0.8884381338742393,0.9733326887250338,1.0,7/18,30.64%,DAB2IP;AMER1;MSN;FAF1;RIC1;PTTG1IP;VPS35
prerank,protein mannosylation (GO:0035268),0.24296749899699197,0.6769747993090498,0.9032882011605415,1.0,1.0,9/22,22.13%,TMTC4;LARGE1;FKTN;DPM1;DPY19L1;CRPPA;POMT1;DPM2;FKRP
prerank,negative regulation of bone mineralization (GO:0030502),0.27494165846961904,0.6769724821792336,0.8728323699421965,1.0,1.0,1/13,1.65%,RFLNA
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2572334601148588,-0.6767312067092597,0.9028571428571428,0.9734028591891603,1.0,7/15,28.88%,SEC61A1;SRP14;RAB3GAP2;SRPRA;ZFAND2B;EDEM1;ZFAND2A
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.22951506292727908,-0.6760713410477713,0.9045643153526971,0.9734692923348272,1.0,6/24,19.31%,TGFB2;FOXO3;CDK5;FBXW7;ATF4;MCL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.28074238496431125,-0.6755878173722056,0.8935281837160751,0.9734030063409288,1.0,3/11,13.63%,CEACAM1;AHR;PTPRC
prerank,ERK1 and ERK2 cascade (GO:0070371),0.24528056752001953,0.6753970338354959,0.8974358974358975,1.0,1.0,3/21,11.97%,IGF1;CTSH;SOX9
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2101184177062741,-0.6749028355046374,0.9392712550607287,0.9734895390545724,1.0,11/33,25.71%,POLR3F;TRIM56;ISG15;IFIH1;POLR3B;IRF5;POLR3A;POLR3D;RIPK2;PTPN11;TLR4
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.27211019821892174,-0.6743307601276276,0.8605108055009824,0.9735033121436106,1.0,1/12,2.11%,INSR
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.24592196747316059,-0.6733655194811278,0.8902439024390244,0.973833885825763,1.0,3/18,13.63%,CD34;HDAC7;PTPRC
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2826721701430121,-0.6733601814975276,0.8709677419354839,0.9733703523597939,1.0,6/10,43.07%,EFHB;STIM1;CASQ1;CD84;GRAMD2A;HOMER2
prerank,negative regulation of catalytic activity (GO:0043086),0.2376870914666477,0.6733174066492755,0.9165120593692022,1.0,1.0,4/24,10.27%,APBA3;CCAR2;IFIT1;NES
prerank,regulation of phosphate metabolic process (GO:0019220),-0.25226261948616463,-0.6730808953194634,0.8951781970649895,0.9731146116799565,1.0,5/16,19.46%,CD24;PGAM1;SRPX2;BARD1;TIGAR
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.23190158351789075,0.6730215749171821,0.9034090909090909,1.0,1.0,5/26,11.96%,ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,protein O-linked mannosylation (GO:0035269),0.2540626214630356,0.6724616006816305,0.9013806706114399,1.0,1.0,8/18,22.13%,TMTC4;LARGE1;FKTN;DPM1;CRPPA;POMT1;DPM2;FKRP
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19609975469461197,-0.6722439960515704,0.9350348027842227,0.9733345668020184,1.0,7/40,15.83%,PID1;BCL2L1;UBB;SOD1;AKT2;BAK1;SLC25A36
prerank,positive regulation of cytokinesis (GO:0032467),-0.20648771932177679,-0.6721300475665622,0.9385245901639344,0.9729535817213477,1.0,14/32,32.98%,RHOA;SVIL;CIT;KIF23;KIF20B;CDC42;GIPC1;CUL3;PRKCE;KIF14;DRD2;CSPP1;CDC6;OPN1MW
prerank,negative regulation of cell division (GO:0051782),-0.2776292876042217,-0.6721233063842866,0.8757396449704142,0.9724889251314853,1.0,5/11,31.46%,TXNIP;BLM;E2F7;SUSD2;MYC
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22143173034379418,0.6717956570774218,0.908411214953271,1.0,1.0,9/31,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2187512417995307,0.6713520822689589,0.9171075837742504,1.0,1.0,5/31,11.83%,CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,actin crosslink formation (GO:0051764),-0.27378958620953264,-0.670762498258396,0.8676470588235294,0.9731391962500121,1.0,3/12,13.49%,FLNA;EPS8;GAS2L1
prerank,telomere maintenance via telomerase (GO:0007004),-0.2198322267994631,-0.6695669554888106,0.9251559251559252,0.9736032871280699,1.0,10/28,27.24%,RPA1;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22906564743810504,-0.6695376556941105,0.9201596806387226,0.9731529734041379,1.0,8/22,34.02%,ESR1;PSMC4;MED14;MED13;MED24;MED30;PAXIP1;TP53
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.19473625799199354,0.6688176097663026,0.9575221238938053,1.0,1.0,8/62,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,telomere maintenance via recombination (GO:0000722),0.27724842676151906,0.668745151161581,0.8583333333333333,1.0,1.0,2/11,14.01%,ERCC1;RAD51D
prerank,neuron fate commitment (GO:0048663),0.2651810364986738,0.6683757618934261,0.8837675350701403,1.0,1.0,2/14,10.07%,PAX6;TGFBR1
prerank,negative regulation of defense response to virus (GO:0050687),-0.28174063979821046,-0.6675833726435717,0.8961038961038961,0.9742013154574268,1.0,5/10,24.48%,TRAF3IP1;PCBP2;TSPAN6;TARBP2;MUL1
prerank,negative regulation of histone acetylation (GO:0035067),0.28548191395871936,0.6675457939892725,0.8609958506224067,1.0,1.0,3/11,19.24%,NOC2L;SIRT1;SIN3A
prerank,phosphate ion transport (GO:0006817),0.25808155124456844,0.6669026720077456,0.8913480885311871,1.0,1.0,2/16,9.13%,SLC25A11;SLC34A3
prerank,maturation of SSU-rRNA (GO:0030490),-0.20434152554876764,-0.6663081518792453,0.9393939393939394,0.9747310567170464,1.0,15/34,33.66%,RPS16;RPS8;RPS28;BMS1;DCAF13;PWP2;RPS19;WDR46;RIOK1;HELB;DHX37;TSR3;TSR1;NOP14;HEATR1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.27881477388848735,0.6660085275512472,0.8651911468812877,1.0,1.0,2/12,13.62%,CYP26B1;CTBP2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2557857321673477,0.6655561711566869,0.877906976744186,1.0,1.0,4/15,18.52%,RUVBL2;CCT3;CCT5;CCT8
prerank,positive regulation of rRNA processing (GO:2000234),0.29343133372312163,0.6653581399542318,0.873015873015873,1.0,1.0,4/10,21.98%,RIOK2;WDR75;UTP15;WDR43
prerank,mitotic recombination (GO:0006312),0.25410193107960943,0.6652950283364841,0.8765182186234818,1.0,1.0,4/15,17.54%,ERCC1;MSH3;RAD51D;RAD52
prerank,regulation of stem cell population maintenance (GO:2000036),-0.24152793890964153,-0.6641797657226806,0.9058577405857741,0.9758650789110462,1.0,1/18,1.04%,PTN
prerank,chromatin assembly or disassembly (GO:0006333),-0.27274297646297585,-0.6638491056257982,0.875,0.9756591361898329,1.0,2/11,19.36%,RBBP4;CHAF1A
prerank,protein lipidation (GO:0006497),0.19480122844915693,0.6637737630747818,0.9640933572710951,1.0,1.0,16/59,19.92%,ZDHHC12;ZDHHC1;ZDHHC16;PIGH;PIGG;ZDHHC6;ZDHHC3;DPM1;PGAP4;ZDHHC21;GLUL;PGAP2;ZDHHC23;WDR45;PIGO;DPM2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2683410397678321,-0.6630931293492678,0.8951612903225806,0.9757233435503556,1.0,6/12,34.82%,SLC37A3;SLC25A14;SLC20A1;SLC37A4;XPR1;SLC20A2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22163738396012694,-0.6623882671762811,0.9329140461215933,0.9757971910664379,1.0,8/22,27.88%,DHX33;EIF2AK3;ATF4;UBTF;SMARCA4;NCL;RASL11A;LYAR
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.26223537737592495,-0.6622995272078405,0.9059304703476483,0.9754000621139841,1.0,6/13,29.82%,PERP;TBC1D10A;BAK1;RIPK2;CASP8;FADD
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2483612902067318,-0.6604458212110524,0.900390625,0.9763045001449411,1.0,4/14,23.73%,ME1;NME2;AK4;NMNAT1
prerank,protein localization to kinetochore (GO:0034501),-0.2528507728123707,-0.6592036807998797,0.9107142857142857,0.976763653951307,1.0,9/14,43.43%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;RCC2;MTBP
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.270516709879938,0.6585262302445924,0.8842504743833017,1.0,1.0,1/12,2.11%,SLC5A3
prerank,positive regulation of telomere maintenance (GO:0032206),0.22104306118773726,0.6584115624931414,0.9174852652259332,1.0,1.0,6/31,12.11%,ERCC1;HNRNPA2B1;TNKS2;MRE11;RTEL1;PML
prerank,secretory granule organization (GO:0033363),-0.27788691971075014,-0.6579966819312487,0.883399209486166,0.9771794012109004,1.0,1/10,3.16%,ABCA1
prerank,nuclear membrane organization (GO:0071763),0.24916517678555342,0.6578576165754028,0.9161793372319688,1.0,1.0,7/19,24.38%,PLK1;TOR1B;TMEM43;AKAP8L;CHMP7;SPAST;TOR1AIP1
prerank,T cell activation (GO:0042110),0.18694502437829658,0.6573057677946367,0.971830985915493,1.0,1.0,5/69,7.71%,LEPR;KIT;LMBR1L;NLRC3;KIF13B
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.23027746217801973,-0.6571076393070859,0.9262295081967213,0.9773546064726244,1.0,2/20,4.59%,BCL2L1;FAS
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22553801419647734,0.6571062947901832,0.9163424124513618,1.0,1.0,4/29,15.41%,FANCD2;MEIOB;BAG6;SYCE2
prerank,defense response to protozoan (GO:0042832),-0.26923507359979976,-0.6565173509592449,0.8861283643892339,0.9772787306770526,1.0,7/12,39.65%,GBP4;CD40;MYD88;BATF2;LYST;PF4;GBP7
prerank,rRNA modification (GO:0000154),-0.22265518475341828,-0.6546890063702371,0.9191919191919192,0.9781287516804854,1.0,8/21,31.36%,THUMPD1;DIMT1;TRMT112;NSUN4;NHP2;DKC1;NOP10;TSR3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2525502024046729,0.6544880057234772,0.9065420560747663,1.0,1.0,6/16,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,modulation by host of viral genome replication (GO:0044827),-0.26010613556385204,-0.6528172258222898,0.9165009940357853,0.9789495734333457,1.0,6/13,25.25%,FMR1;ZC3H12A;PPIB;NUCKS1;TBC1D20;VAPA
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2569649400198128,0.6523136224614736,0.8884297520661157,1.0,1.0,9/15,29.58%,TNRC6A;TENT4A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2055338671368239,0.651619729612519,0.9366197183098591,1.0,1.0,11/40,20.76%,IGF1;PPIF;PDCD5;MLLT11;CLU;HGF;NOL3;AKT1;PYCARD;DNM1L;BAX
prerank,positive regulation of dendritic spine development (GO:0060999),0.23988100555667585,0.6515507804845864,0.8938223938223938,1.0,1.0,7/20,22.39%,CAMK1;LLPH;SHANK1;CAPRIN2;CPEB3;DLG5;DBNL
prerank,glycolipid biosynthetic process (GO:0009247),0.20498516455669583,0.651401826099881,0.953757225433526,1.0,1.0,10/38,19.92%,ST3GAL5;LARGE1;PIGH;PIGG;DPM1;SCCPDH;PGAP4;PGAP2;PIGO;DPM2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.18748172239642963,0.6503386518920689,0.9663716814159292,1.0,1.0,8/64,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,regulation of protein export from nucleus (GO:0046825),0.23579715433611342,0.649529121744955,0.9013282732447818,1.0,1.0,7/23,19.17%,IFI27;CAMK1;RAPGEF3;PTPN14;RANGAP1;TCF7L2;UHMK1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2112867072926667,0.648918460001764,0.941712204007286,1.0,1.0,2/36,2.64%,HSPA1A;CPNE1
prerank,cell cycle G2/M phase transition (GO:0044839),0.16642835468285266,0.6478605710368152,0.9967897271268058,1.0,1.0,28/129,19.57%,USH1C;OPTN;FBXL12;PLK1;CEP78;CLASP1;CDC25C;CEP290;TUBG1;PLCB1;NES;PCM1;CHEK2;PPP1CB;SFI1;TUBB4A;ENSA;AKAP8;MAPRE1;NINL;NEDD1;CETN2;AKAP8L;PKMYT1;FBXL22;HSP90AA1;WEE1;NDE1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.2621633498650261,0.6474888675482797,0.9001956947162426,1.0,1.0,13/13,73.81%,HNRNPU;SUPT4H1;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,skeletal muscle contraction (GO:0003009),0.24927311040514852,0.6465599806594443,0.92,1.0,1.0,5/19,22.87%,TNNI1;MYH14;STAC3;TNNC1;TNNI3
prerank,reticulophagy (GO:0061709),0.26822029287402366,0.6458355710848409,0.8805394990366089,1.0,1.0,2/12,11.80%,RETREG1;ATG2B
prerank,cellular component maintenance (GO:0043954),0.2626018221428134,0.6456572705541731,0.889795918367347,1.0,1.0,4/12,19.07%,SUPV3L1;MTMR2;PICK1;PRNP
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25106633563944764,0.6455418800755909,0.8968253968253969,1.0,1.0,5/17,19.55%,HNRNPU;CITED1;TERT;KDM1A;LTBP3
prerank,protein K48-linked deubiquitination (GO:0071108),-0.21921559333995783,-0.6450615275241769,0.9448979591836735,0.9837163198243302,1.0,7/23,26.65%,OTUD7B;MINDY1;MINDY2;USP50;ATXN3;OTUB2;OTUB1
prerank,serine family amino acid catabolic process (GO:0009071),-0.27677091237912343,-0.6450444296186142,0.9020833333333333,0.9832616053418773,1.0,7/10,39.66%,THNSL2;SHMT2;CBS;DLD;SHMT1;DAO;AMT
prerank,positive regulation of DNA binding (GO:0043388),0.21546392909374268,0.6450270412242842,0.9339449541284404,1.0,1.0,1/31,0.69%,IGF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2682712926215739,0.6449920346864383,0.8980392156862745,1.0,1.0,4/12,18.92%,ELAVL1;TERT;NCOR2;NCOR1
prerank,base-excision repair (GO:0006284),-0.17879656611486638,-0.6443518035986191,0.9645390070921985,0.9832747836459484,1.0,13/48,23.59%,RPA1;PARG;USP47;PRMT6;TDG;NEIL3;RPA2;XPA;RFC4;MUTYH;POLD4;SMUG1;POLB
prerank,negative regulation of secretion (GO:0051048),-0.2766979132809121,-0.644275505028716,0.8966861598440545,0.9828526643188643,1.0,4/10,23.12%,VAMP3;CD74;PTGER3;EGF
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.22076796337500518,0.64401850853914,0.9282945736434108,1.0,1.0,3/26,7.55%,TCTA;HOXA7;INHA
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2648853554067215,-0.6439600940814426,0.9164969450101833,0.9825809938408367,1.0,2/11,15.85%,RACK1;ATF4
prerank,purine-containing compound salvage (GO:0043101),-0.2616580348219581,-0.6435413528892739,0.9030303030303031,0.9824234189724945,1.0,6/12,29.26%,GMPR;HPRT1;DGUOK;AMPD2;ADA;ADK
prerank,nuclear pore organization (GO:0006999),-0.24861309022195185,-0.6423055926994489,0.9102564102564102,0.9827620660251518,1.0,3/14,16.45%,NUP107;TPR;RTN4
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.23983651041267817,-0.6412144308228178,0.9215686274509803,0.9829926796126516,1.0,3/15,11.93%,PLCG2;PAF1;PHB2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.22650521108931365,0.6406363925116602,0.9333333333333333,1.0,1.0,4/25,13.27%,PICALM;DLG4;MTMR2;ABCA2
prerank,anterior/posterior axis specification (GO:0009948),0.25417162325642784,0.6397588234248037,0.9035916824196597,1.0,1.0,1/15,1.66%,WLS
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2457014612229662,0.6396356855797295,0.912,1.0,1.0,5/18,18.35%,HTRA2;TRAP1;SIRT1;NOL3;AKT1
prerank,GPI anchor biosynthetic process (GO:0006506),0.2100650105977565,0.6396249821294804,0.9456928838951311,1.0,1.0,12/30,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGS;PIGB;MPPE1;PGAP3;PIGW
prerank,histone H4-K5 acetylation (GO:0043981),-0.24058343220965933,-0.6396143171186627,0.9260700389105059,0.9830636905328333,1.0,6/15,26.31%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),-0.24058343220965933,-0.6396143171186627,0.9260700389105059,0.9830636905328333,1.0,6/15,26.31%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2630750019123595,-0.6392576117216919,0.8901515151515151,0.9828365571289867,1.0,7/12,33.04%,IDH3B;GLUD1;ASS1;IDH3G;SIRT4;ACLY;IDH1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23951059558578078,0.6388525103257842,0.9154411764705882,1.0,1.0,4/19,13.37%,POLD2;DCK;AMPD3;TERT
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2792199897130182,0.6379899241070742,0.8951612903225806,1.0,1.0,3/10,14.31%,GALNT3;GALNT2;GALNT1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.24614214630598902,0.6374150886132646,0.9116465863453815,1.0,1.0,4/16,16.77%,RECQL4;SSBP1;MCM7;MCMDC2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.277815571100024,-0.6362624837420945,0.9071729957805907,0.9841754141963831,1.0,2/10,12.49%,SLC1A3;SLC1A1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.26306723066775095,0.6347390258291044,0.8923076923076924,1.0,1.0,5/11,26.13%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.23363228389581675,-0.6338260290846831,0.9275653923541247,0.9851233962961811,1.0,3/17,14.65%,CTCF;ZWILCH;ZW10
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20133177202288605,0.6337842481960319,0.9607142857142857,1.0,1.0,4/38,8.73%,MAGI2;PPARA;PIK3CB;DRD3
prerank,protein localization to condensed chromosome (GO:1903083),-0.25878756513413514,-0.6337837326437721,0.9158316633266533,0.9846873983854326,1.0,8/12,43.43%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;MTBP
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2559937956414362,0.6337728832353846,0.9183266932270916,1.0,1.0,5/14,25.76%,C1QBP;TRMT10C;MPV17L2;RCC1L;FASTKD3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.2241154244661408,0.6331937271595716,0.9460966542750929,1.0,1.0,6/22,19.36%,MAN1C1;RNF5;MAN1A2;RNF139;UGGT2;TRIM13
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.24063374688541816,0.6331501853002137,0.9260628465804066,1.0,1.0,6/17,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,negative regulation of cell aging (GO:0090344),0.2454711681555648,0.6328405304925576,0.9070208728652751,1.0,1.0,4/16,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.2383075587549338,0.6327099844395011,0.9226305609284333,1.0,1.0,5/18,19.84%,ADRA2A;BMP8A;CHGA;INHBB;REST
prerank,negative regulation of endopeptidase activity (GO:0010951),0.1955347678779449,0.6321273926047519,0.9551166965888689,1.0,1.0,7/47,14.45%,TIMP3;SERPINA10;PCID2;SERPIND1;HRG;SERPINA9;SERPINE3
prerank,Golgi localization (GO:0051645),0.26892834887117895,0.6316770938833085,0.9011406844106464,1.0,1.0,3/11,12.65%,TBCCD1;COPG1;STK25
prerank,membrane fusion (GO:0061025),0.2059128784514851,0.6311760400820132,0.9476534296028881,1.0,1.0,5/33,9.01%,SNAP29;MYOF;NAPA;RIMS1;NSF
prerank,mitochondrial transcription (GO:0006390),-0.27096142668725104,-0.6310067408400402,0.9110251450676983,0.9858327600093435,1.0,2/10,14.71%,FOXO3;MRPL12
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.25935607954704043,-0.630495390285218,0.9094567404426559,0.9856588068800222,1.0,5/11,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,negative regulation of viral genome replication (GO:0045071),0.20070222628578863,0.6304691304191361,0.9518716577540107,1.0,1.0,13/40,24.70%,OAS2;IFIT1;EIF2AK2;OAS3;MPHOSPH8;ILF3;INPP5K;PARP10;BST2;SLPI;SRPK1;SETDB1;BTBD17
prerank,regulation of DNA recombination (GO:0000018),0.20859933282550971,0.6302296052977981,0.9571984435797666,1.0,1.0,8/32,18.36%,MSH6;MRE11;RTEL1;MSH3;ALYREF;KDM1A;FIGNL1;THOC1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2621468926553674,0.6298016388405568,0.9163346613545816,1.0,1.0,12/12,73.81%,HNRNPU;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,aminoglycan metabolic process (GO:0006022),-0.27160580980259375,-0.6294933957131013,0.9072978303747534,0.985733080995709,1.0,3/10,16.87%,XYLT1;B3GAT1;B3GAT3
prerank,actin-myosin filament sliding (GO:0033275),-0.18473848812270172,-0.6283022014406793,0.9629629629629629,0.985435446849544,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,muscle filament sliding (GO:0030049),-0.18473848812270172,-0.6283022014406793,0.9629629629629629,0.985435446849544,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.24831598248371467,0.6282830720117726,0.9053254437869822,1.0,1.0,1/15,3.39%,DAGLA
prerank,mitotic DNA replication (GO:1902969),-0.2650688708949546,-0.627689935659753,0.900562851782364,0.9853194497799336,1.0,5/10,26.82%,CDC45;POLA1;MCM3;GINS3;MCM6
prerank,regulation of rRNA processing (GO:2000232),0.24436706486836757,0.6270299847485712,0.9311023622047244,1.0,1.0,6/16,24.44%,RIOK2;WDR75;METTL18;UTP15;WDR43;YTHDF2
prerank,amyloid-beta metabolic process (GO:0050435),-0.23079612334629962,-0.6252650790911236,0.939203354297694,0.9862567382770742,1.0,4/16,23.99%,DYRK1A;PSEN2;PSENEN;MGAT3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2579197724013649,0.6235674766011934,0.914,1.0,1.0,6/12,26.13%,GNL3L;CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.1840236568896827,-0.6233200928753843,0.9720930232558139,0.9868679543603835,1.0,17/43,33.64%,FOXN3;BABAM2;PABIR1;BLM;ORC1;FZR1;TAOK3;NBN;TAOK1;CHEK1;DTL;HUS1B;MRNIP;CDK1;CDC6;TICRR;BRCC3
prerank,glutathione metabolic process (GO:0006749),0.20040936899850786,0.6224976971743649,0.9594594594594594,1.0,1.0,9/38,18.30%,ETHE1;GSTM2;CNDP2;GGT5;GSTM1;OPLAH;GSTA3;GSTZ1;MGST2
prerank,positive regulation of lipid storage (GO:0010884),-0.21141873466939712,-0.622481060723476,0.9607438016528925,0.9868578000877044,1.0,5/21,19.09%,SCARB1;SREBF2;C3;PLIN2;ZC3H12A
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.2615849164788922,-0.6223488226254077,0.9282608695652174,0.9864708152071227,1.0,7/11,49.03%,MALT1;NFKBID;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,lysosome organization (GO:0007040),0.20236149239607487,0.6208921966469989,0.9745916515426497,1.0,1.0,10/36,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,Golgi to lysosome transport (GO:0090160),0.2640539985117365,0.6206819432092946,0.9122448979591836,1.0,1.0,1/11,2.01%,CCDC91
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.20018997563126872,0.6204501006825712,0.9636363636363636,1.0,1.0,7/41,13.10%,GPRC5B;ADRA2A;NTRK2;DLG4;EPHA4;BDNF;HBEGF
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.24142545511008306,-0.6204253705700256,0.9385245901639344,0.9870637566849239,1.0,9/14,36.68%,ACOX1;ECI2;ACOX3;SCP2;DECR2;ACOX2;CRAT;ACOXL;ACOT8
prerank,polyamine metabolic process (GO:0006595),0.24978237024450178,0.6202212757405289,0.9010309278350516,1.0,1.0,3/13,22.30%,SAT1;DHPS;OAZ2
prerank,regulation of ERAD pathway (GO:1904292),0.2651660735711444,0.6201909995036269,0.9029304029304029,1.0,1.0,3/11,13.46%,USP19;RNFT1;BAG6
prerank,negative regulation of immune system process (GO:0002683),0.24474611246824218,0.6201193525637082,0.9313725490196079,1.0,1.0,4/16,17.41%,IL17D;HOXA7;SOX9;COL3A1
prerank,photoreceptor cell development (GO:0042461),-0.2361623371759644,-0.6183516442504063,0.934560327198364,0.9877050655993768,1.0,6/14,26.42%,MFSD2A;VEGFA;RP1;MYO7A;RORB;CDHR1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2275183567173757,-0.6180383168391252,0.95,0.9874148399304383,1.0,8/16,30.55%,RRAGA;KLHL22;CLEC16A;RRAGD;SIK3;GPR137B;LAMTOR5;FLCN
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20849019878370798,0.61761142937751,0.9596330275229358,1.0,1.0,5/29,16.64%,PLA2G4C;PNPLA8;NR1H3;PLAAT3;TMEM86B
prerank,B cell activation involved in immune response (GO:0002312),0.24718229078959914,0.6175784855193572,0.9134020618556701,1.0,1.0,2/13,10.98%,MSH6;BATF
prerank,ESCRT III complex disassembly (GO:1904903),-0.26391830323522325,-0.6168323574817359,0.8934108527131783,0.9871277484786195,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),-0.26391830323522325,-0.6168323574817359,0.8934108527131783,0.9871277484786195,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,stem cell development (GO:0048864),0.24044246076268316,0.6162003721017754,0.9288617886178862,1.0,1.0,2/16,6.82%,WNT7A;NRG1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.24917908963642604,-0.6158350630281103,0.9298969072164949,0.9871889690589579,1.0,3/11,20.62%,SIRT7;SMARCA4;NCL
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.25309329657579505,0.6155689641662524,0.9251559251559252,1.0,1.0,8/13,29.58%,TNRC6A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19130425624271474,0.6152749401907471,0.9720670391061452,1.0,1.0,2/42,4.13%,OXSR1;STK39
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2345218561835721,-0.6151685785143544,0.9487704918032787,0.9870751288877961,1.0,5/15,29.75%,HOGA1;PRODH;GGT7;GGT1;CHAC2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.24102473155807347,0.6148240699826525,0.9187620889748549,1.0,1.0,2/15,11.01%,MAGI2;FST
prerank,protein heterotetramerization (GO:0051290),0.24674188270030822,0.612392424312357,0.9279112754158965,1.0,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,cell cycle checkpoint signaling (GO:0000075),0.25039121601437053,0.6118864299701232,0.921455938697318,1.0,1.0,3/12,19.49%,ZWINT;PRCC;WEE1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.23117222917858468,0.6093895348461467,0.952755905511811,1.0,1.0,7/18,27.53%,PPARA;MIA3;AKT1;PAG1;WNK1;PTPN22;LAX1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.20540551010145602,-0.6089900786404102,0.9574468085106383,0.989701827802702,1.0,14/25,37.84%,GMPR;HPRT1;DGUOK;AMPD2;ADA;SHMT2;SHMT1;ADK;PRPSAP1;PAICS;GART;PRPS2;AMPD1;PPAT
prerank,regulation of lymphocyte migration (GO:2000401),0.2612397456571549,0.6089418675395623,0.8835877862595419,1.0,1.0,4/10,23.93%,WASL;MIA3;AKT1;SLC8B1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.22790784415093704,-0.6083599122175756,0.9424603174603174,0.9895625339489148,1.0,7/16,31.28%,PIGC;PIGL;PIGX;PIGQ;PIGN;PIGF;PIGV
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.24047228555886097,-0.607623636643239,0.9125248508946322,0.989470329229245,1.0,5/12,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,T cell homeostasis (GO:0043029),-0.25643750354148387,-0.6070673938060192,0.9401709401709402,0.989299191051462,1.0,5/10,29.99%,FAS;NCKAP1L;JAK3;FADD;PMAIP1
prerank,negative regulation of innate immune response (GO:0045824),0.1964432896872987,0.6070377619738911,0.9716446124763705,1.0,1.0,6/34,14.18%,USP18;NLRC3;CACTIN;OAS3;STAT2;TYRO3
prerank,regulation of response to interferon-gamma (GO:0060330),-0.23956899109420077,-0.6069233287584606,0.9285714285714286,0.9889150188377257,1.0,3/14,23.95%,JAK1;SOCS3;SOCS1
prerank,protein import into peroxisome membrane (GO:0045046),-0.2110090849769239,-0.6069036912516018,0.9659863945578231,0.9884593832253139,1.0,11/22,38.93%,ABCD2;ACBD5;PEX14;PEX2;GDAP1;PEX12;RAB8B;SLC25A17;FIS1;PXMP4;PEX3
prerank,peroxisomal membrane transport (GO:0015919),-0.19935369514610904,-0.6068279606692351,0.9724770642201835,0.9880320589578135,1.0,7/27,23.69%,ABCD2;PEX7;ACBD5;PEX14;PEX2;GDAP1;PEX12
prerank,ruffle organization (GO:0031529),0.2333477631793459,0.6065612495191535,0.9305555555555556,1.0,1.0,4/16,22.19%,CORO1B;CYFIP1;INPP5K;PLEK
prerank,negative regulation of chemokine production (GO:0032682),0.24255253880524408,0.6061169930738125,0.9290060851926978,1.0,1.0,4/14,18.76%,C1QTNF3;OAS3;IL6;SIRPA
prerank,lipoprotein transport (GO:0042953),0.2668093743340849,0.6057897943093584,0.9217758985200846,0.9996979679867435,1.0,4/10,26.09%,PRKCB;MIA3;VMP1;PPARG
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2643158328532304,0.6050388086483377,0.9288537549407114,0.9994217792985369,1.0,3/10,19.23%,LEO1;CDC73;CPEB3
prerank,ncRNA catabolic process (GO:0034661),-0.19898839163437765,-0.6039138011943709,0.9680851063829787,0.9889418081533318,1.0,10/28,30.05%,TENT4B;RBM7;TRIR;NUDT16;NUDT16L1;EXOSC4;EXOSC5;EXOSC3;XRN1;DIS3L2
prerank,positive regulation of lipid localization (GO:1905954),-0.24579968394130952,-0.6038605771574497,0.9404761904761905,0.9885045811415302,1.0,4/11,26.12%,LRP1;C3;ZC3H12A;HILPDA
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22692766678861742,0.6036642952564437,0.9341317365269461,0.999465471923896,1.0,6/18,26.13%,RUVBL2;CCT3;CCT5;CCT8;DCP2;CCT6A
prerank,positive regulation of immune effector process (GO:0002699),0.20806698146010283,0.6031317383688735,0.9596330275229358,0.9990631185768971,1.0,1/27,1.08%,APPL2
prerank,regulation of B cell differentiation (GO:0045577),-0.21541619555511965,-0.6029313253877319,0.9594882729211087,0.988456422266226,1.0,7/17,33.52%,ID2;NCKAP1L;BTK;SYK;ZFP36L2;IL4I1;IKZF3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.21091858242255768,0.6022217334444131,0.9430740037950665,0.9988635614690509,1.0,10/25,28.01%,SRSF10;MPHOSPH10;PRPF6;PRPF3;SF3B1;SF3B3;WDR83;PRPF8;BCAS2;SNRNP40
prerank,negative regulation of transferase activity (GO:0051348),-0.19328266534481503,-0.6008837370752961,0.9869565217391304,0.988913448529617,1.0,12/28,34.02%,CDKN1C;SRC;BAG5;FBXO5;LIMK1;DTX3L;CDKN1B;MAPT;SMAD7;PARK7;PIF1;TP53
prerank,protein kinase A signaling (GO:0010737),0.24506328072204853,0.5999582281966505,0.9272030651340997,0.9993441880870755,1.0,2/12,12.77%,TCP11;RAB13
prerank,macrophage migration (GO:1905517),0.240379182622889,0.5999119112444382,0.9140461215932913,0.9986991007721074,1.0,13/13,75.98%,P2RX4;P2RY12;EDNRB;CCL2;SAA1;EDN2;CKLF;LGALS3;CCL3;CCL5;CXCL17;CCR2;TAFA4
prerank,regulation of defense response to virus by host (GO:0050691),0.20465408815622074,0.5990088370640347,0.9566854990583804,0.9984822086220413,1.0,6/30,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,phospholipid dephosphorylation (GO:0046839),0.19097653215467128,0.5985136001507265,0.9781420765027322,0.9980561865480676,1.0,10/37,20.98%,MTMR4;INPP5J;PLPPR3;SYNJ2;MTMR2;MTMR10;EPHX2;OCRL;INPP5K;PIP4P2
prerank,regulation of lamellipodium organization (GO:1902743),-0.2317785275672688,-0.5958455745571041,0.9530916844349681,0.9907273119420771,1.0,5/14,26.41%,CD44;CDC42;CARMIL1;DMTN;TWF2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19791480018464386,-0.5955469638704695,0.9393939393939394,0.9903888717491147,1.0,5/25,17.68%,TNFSF10;MFF;BBC3;PLAUR;GPER1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2462270558580809,0.595263945543273,0.9053254437869822,0.9983022916187082,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2462270558580809,0.595263945543273,0.9053254437869822,0.9983022916187082,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.22614115991029954,-0.5951693683439376,0.9481981981981982,0.990080906693504,1.0,3/14,13.42%,TSEN2;CPSF4;CLP1
prerank,positive regulation of peptidase activity (GO:0010952),0.22069586121589593,0.5944064824134182,0.95,0.9980304040412754,1.0,5/20,21.69%,CTSH;APH1A;NDUFA13;PSME2;RCN3
prerank,protein localization to centrosome (GO:0071539),-0.2138929172760537,-0.5937716238796622,0.9565217391304348,0.9901940837752927,1.0,11/17,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;GOLGB1;CCDC14;HOOK3;BBS4;DCTN2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.24725710225369685,0.5927787549936409,0.9307535641547862,0.9981310417731468,1.0,3/12,15.19%,INSIG2;ANKRD13C;RER1
prerank,vitamin D metabolic process (GO:0042359),-0.2313036567671859,-0.5923640017759307,0.9447731755424064,0.9903254706427732,1.0,8/13,46.28%,CUBN;CYP2R1;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,histone H4 deacetylation (GO:0070933),-0.2532362153267277,-0.5905685300928799,0.9362549800796812,0.9906149994393995,1.0,3/10,26.26%,HDAC9;HDAC2;RCOR1
prerank,methylguanosine-cap decapping (GO:0110156),0.26219400054046643,0.5898895915330237,0.9343936381709742,0.9987999085097599,1.0,4/10,23.18%,PATL1;EDC4;DCPS;DCP2
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.23350076070620684,-0.5896939001952204,0.9521829521829522,0.9904887132782474,1.0,3/13,16.47%,SAE1;SENP6;UBA6
prerank,transcription preinitiation complex assembly (GO:0070897),0.24161958568738223,0.5891251637991064,0.9411764705882353,0.9984714845512781,1.0,12/12,75.86%,TAF1;DR1;GTF2A2;TAF12;GTF2B;TBP;TAF11;TAF7L;TAF1B;BDP1;TAF7;POLR1E
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.22717803502783196,-0.5891105384156905,0.9349593495934959,0.990278176171615,1.0,3/14,17.60%,RPL7;RPL35;ZNHIT6
prerank,positive regulation of viral process (GO:0048524),-0.1613280540115893,-0.588952156298507,0.9953810623556582,0.989873228980643,1.0,16/60,26.95%,MDFIC;ADARB1;PABPC1;PPIA;GTF2F1;VAPB;KPNA2;PPIE;TMEM39A;POLR2I;POLR2F;TARBP2;TBC1D20;POLR2H;NELFCD;CCNT1
prerank,cell differentiation in spinal cord (GO:0021515),0.2539476339903526,0.5889417020376234,0.9216061185468452,0.9978931556282745,1.0,2/10,17.37%,MDGA2;SOX6
prerank,replication fork processing (GO:0031297),-0.17556314304724732,-0.5869396215019104,0.9823008849557522,0.9902243210364331,1.0,8/38,23.85%,MMS22L;BLM;BRCA2;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,programmed necrotic cell death (GO:0097300),-0.20623869945473236,-0.5869297696469353,0.9443298969072165,0.9897673391786816,1.0,8/18,32.89%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23383373680240896,0.5856630242225227,0.9385796545105566,0.9986869586967047,1.0,5/14,25.10%,IKBKG;KCNN4;RELA;CD81;CD226
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.23150637169199864,0.5852982201885113,0.9500998003992016,0.9981929295434773,1.0,5/15,17.54%,BCL2;MUC1;SIRT1;MDM2;KDM1A
prerank,positive regulation of chemokine production (GO:0032722),-0.17145106536316146,-0.5844816091053019,0.9933920704845814,0.9902288663516827,1.0,12/44,27.00%,APP;WNT5A;IL6R;TWIST1;CD74;CSF1R;IL33;HMGB1;SYK;TLR4;AIF1;HMOX1
prerank,stress granule assembly (GO:0034063),0.21384921536134935,0.5833544131509036,0.9646365422396856,0.9983659736057877,1.0,8/20,24.80%,ATXN2L;BICD1;OGFOD1;EIF2S1;DDX3X;YTHDF3;YTHDF2;CSDE1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2029613553072852,-0.5820780867372799,0.9691358024691358,0.9907088010355688,1.0,8/19,32.42%,SRC;TENT4B;TEN1;CTC1;TINF2;TERF2;XRN1;PIF1
prerank,RNA stabilization (GO:0043489),0.19106953983667216,0.581924845714924,0.97632058287796,0.9982779004658494,1.0,6/33,15.24%,HNRNPU;E2F1;ELAVL1;VIP;NSUN2;PAIP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.23591198187307535,0.5817246439170661,0.9330708661417323,0.9976990646358911,1.0,3/13,14.64%,MBD4;UPP2;NEIL1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21701973148094977,-0.5815523036566093,0.9661354581673307,0.9904399130518188,1.0,10/15,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;CCDC14;HOOK3;BBS4;DCTN2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.20349196648735285,0.5810763041944389,0.9826254826254827,0.9973174189542061,1.0,3/24,8.29%,HNRNPU;TNKS2;GNL3L
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.21117033989913034,-0.5809029904126456,0.9529914529914529,0.9902377267803028,1.0,3/16,13.63%,CEACAM1;STX7;PTPRC
prerank,sulfur amino acid catabolic process (GO:0000098),0.25131810193321613,0.580868013362847,0.9169960474308301,0.996744558091398,1.0,10/10,74.88%,CTH;BLMH;MTRR;MAT1A;GADL1;TST;TXN2;ADO;CBS;MPST
prerank,ncRNA export from nucleus (GO:0097064),0.18998306691797295,0.5780770373279378,0.9824561403508771,0.9972503515958048,1.0,12/36,26.44%,POM121;NUP155;NUP98;TSC1;NUP37;NUP88;NDC1;RAE1;PHAX;NUP160;NPM1;NUP133
prerank,nucleic acid metabolic process (GO:0090304),0.1650888410363508,0.5777473211152682,0.9947735191637631,0.9967402500967382,1.0,17/69,23.82%,HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;HNRNPL;PTBP1;LSM8;POLR2D;POLG;HNRNPH2;POLR2A;HNRNPH1;DNASE1L2;MMS19;DDX24;POLR2B;HNRNPC
prerank,spliceosomal snRNP assembly (GO:0000387),0.18484321548624277,0.5763468694073937,0.9863813229571985,0.9966312645640656,1.0,13/38,26.33%,STRAP;SRSF10;PRPF19;LSM4;SNUPN;PRPF6;PRPF3;SNRPB;PRMT5;SART3;SNRPC;PRPF8;GEMIN7
prerank,toxin transport (GO:1901998),-0.24581994332288143,-0.5761473967006647,0.9474747474747475,0.991455857012698,1.0,1/10,6.18%,ADAM10
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.21620550279269976,0.576107459645311,0.9691991786447639,0.9960760871161104,1.0,4/18,11.83%,NLRC3;MED25;CD300A;CDC73
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.20627216789017327,0.5759570668946953,0.9607072691552063,0.9954826115099233,1.0,3/23,10.95%,NR1H3;PARP14;STAT1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2331017105762624,-0.5757094773787249,0.9495145631067962,0.9911564451023531,1.0,8/12,40.01%,SREBF2;SREBF1;LPCAT3;MBTPS2;H6PD;RAN;DGKQ;KPNB1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.23419785350725764,-0.5756916012353054,0.9543650793650794,0.9907028616955166,1.0,1/12,4.20%,JUN
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2162362385072716,-0.5749432659734915,0.9678714859437751,0.9904886012893375,1.0,8/16,38.75%,APOE;MYOCD;LRP1;ROCK1;TREM2;ABCA7;HDAC1;IL4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.2482425307557118,-0.5747433214050482,0.9477911646586346,0.9896472324878464,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.2482425307557118,-0.5747433214050482,0.9477911646586346,0.9896472324878464,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,regulation of leukocyte migration (GO:0002685),-0.21495593240115454,-0.5746546636295156,0.9678068410462777,0.9892168732805674,1.0,3/16,16.03%,ANXA1;VEGFA;NCKAP1L
prerank,inhibitory synapse assembly (GO:1904862),0.2411844679357245,0.5738615305783968,0.9278752436647173,0.995664404323031,1.0,3/11,18.56%,CBLN4;GABRB2;GABRB3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.22299837870164302,-0.573437119257048,0.952,0.9891818090928276,1.0,4/13,27.91%,UBB;RHOT2;SYBU;MAPT
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.2180253064590068,-0.5693566054167297,0.9774127310061602,0.9901312226154095,1.0,10/15,48.62%,NUDT16;ZC3H12A;NYNRIN;POP7;RPP40;ZC3H12D;RNASEH1;LACTB2;ZC3H12C;SLFN14
prerank,regulation of defense response to virus (GO:0050688),0.2266341519246043,0.5668811861936971,0.950920245398773,0.9976571404024961,1.0,4/14,21.26%,C1QBP;PPM1B;RNF26;ILRUN
prerank,negative regulation of interleukin-17 production (GO:0032700),0.2432548708508756,0.5638784676646563,0.944337811900192,0.9981220699405989,1.0,3/10,19.69%,IL12A;PRNP;DDIT3
prerank,axoneme assembly (GO:0035082),0.18819566913295227,0.5635872751067025,0.9896729776247849,0.9975748132162963,1.0,3/30,13.59%,RSPH4A;DRC1;DNAAF2
prerank,tRNA 5'-leader removal (GO:0001682),0.22064133919450285,0.5624623028928238,0.9430255402750491,0.9973121987374692,1.0,3/13,21.60%,POP4;RPP25L;RPP30
prerank,microtubule-based transport (GO:0099111),-0.2265394082801258,-0.5623460875252676,0.9495798319327731,0.9919291180140676,1.0,5/12,26.04%,DYNC1I2;DYNC1I1;CABYR;ADCY10;SPEF2
prerank,P-body assembly (GO:0033962),-0.22864770767280118,-0.5621555644369106,0.9402697495183044,0.9915271697329958,1.0,5/12,32.62%,LIMD1;DYNC1H1;LSM3;PATL2;EDC3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20203715147886314,-0.561378699653309,0.9727463312368972,0.99131741329594,1.0,8/19,32.52%,TRIL;NR1H4;NMI;RAB11FIP2;PRKCE;TLR4;LGALS9;CD14
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.21776740238588668,0.5599387391468409,0.958984375,0.9975144113560984,1.0,5/15,23.97%,EBI3;NKAP;IL12A;SHH;PNP
prerank,negative regulation of receptor internalization (GO:0002091),-0.22684306051384132,-0.5598220299069371,0.955193482688391,0.9913475162041653,1.0,5/12,30.07%,ANKRD13A;ANKRD13B;ANKRD13D;NECAB2;WDR54
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.22951848829179478,0.5593948331750451,0.9512195121951219,0.9970604543970484,1.0,13/13,77.07%,VDAC2;BAX;RHOT1;BLOC1S2;BAD;RTL10;MOAP1;BNIP3L;BNIP3;BCL2L11;BMF;PMAIP1;RHOT2
prerank,piRNA metabolic process (GO:0034587),0.20800100483577214,0.5586914539888104,0.9763313609467456,0.9966549917530817,1.0,19/19,79.22%,TDRD9;MYBL1;DDX4;TDRD12;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;TEX15;FKBP6;TDRKH;PIWIL4;EXD1;PIWIL2
prerank,protein ADP-ribosylation (GO:0006471),-0.18179433188327776,-0.5572258891272228,0.9914529914529915,0.9916907665418071,1.0,8/28,25.10%,TNKS;ART3;HPF1;SIRT5;PARP8;SIRT6;PARP3;PARP12
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.1669257166944798,-0.5568791756087158,0.9849785407725322,0.991339893354157,1.0,7/37,17.90%,ANKRD13A;APOE;EDN1;SIRT5;AP1AR;MT3;ANKRD13B
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.22109649482959323,-0.5561278724814552,0.9592668024439919,0.9911060919558629,1.0,7/12,37.84%,ADSS1;IMPDH1;ADSS2;PAICS;IMPDH2;GART;PPAT
prerank,eosinophil migration (GO:0072677),-0.2137662388262294,-0.5542628318887214,0.9610894941634242,0.9906933724238819,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.2137662388262294,-0.5542628318887214,0.9610894941634242,0.9906933724238819,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,protein targeting to lysosome (GO:0006622),0.2029917906348828,0.553939568998663,0.9784313725490196,0.9975949208907887,1.0,4/20,13.79%,SNX16;LAMP2;CLU;AP4M1
prerank,B cell mediated immunity (GO:0019724),-0.2369087116341545,-0.5525990269611624,0.9543650793650794,0.9907184326561362,1.0,5/10,44.07%,CD74;FCGR2B;FCER1G;CARD9;SLA2
prerank,mitochondrial genome maintenance (GO:0000002),-0.22217871350372648,-0.5510050029787937,0.9646569646569647,0.9906677225465457,1.0,1/11,3.36%,AKT3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.19032346174875653,-0.5495495740650215,0.985655737704918,0.9905861915822568,1.0,11/20,37.84%,HPRT1;ADSS1;IMPDH1;AK4;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.19388574847091541,0.5487042895453247,0.9887005649717514,0.9986212395502156,1.0,6/23,20.76%,COX18;TOMM22;NDUFA13;HSP90AA1;MAIP1;BAX
prerank,apoptotic nuclear changes (GO:0030262),0.1944473930679264,0.5478888565750899,0.9843444227005871,0.9981908939861557,1.0,5/24,16.96%,CASP3;DFFA;ACIN1;DICER1;EXOG
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.21943504114000606,-0.5466771631702764,0.96900826446281,0.9909197990461163,1.0,6/11,42.00%,HDAC2;TMEM106A;TAF7;PF4;IL4;XBP1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.19485262720376714,-0.5432491643986361,0.9795081967213115,0.9913159423912127,1.0,8/18,35.93%,PTP4A3;CCT2;CEP295;DKC1;TREM2;CCT7;CORO2B;CEP135
prerank,V(D)J recombination (GO:0033151),-0.22432247831335647,-0.5412995975838659,0.948559670781893,0.9913191404076352,1.0,3/11,23.02%,LIG4;HMGB1;DCAF1
prerank,positive regulation of cilium assembly (GO:0045724),0.20384521179843793,0.536679201047867,0.9790076335877863,1.0,1.0,2/18,8.94%,SEPTIN9;HTT
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.1612261646992033,0.5333928443765475,0.9981412639405205,1.0,1.0,14/52,23.21%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;TUT4;POLR2D;EDC4;CNOT3;CNOT8;DCPS;PNLDC1;DCP2;PAN2
prerank,extracellular transport (GO:0006858),0.22366393419588193,0.53127060273272,0.9718574108818011,1.0,1.0,3/12,18.94%,ROPN1L;DNAAF2;SPA17
prerank,glycoprotein catabolic process (GO:0006516),-0.19157171055682998,-0.5300989478644879,0.9801192842942346,0.9934633978500995,1.0,6/17,28.92%,STT3B;FBXO44;ADAMTS12;EDEM2;EDEM1;FBXO2
prerank,histone mRNA metabolic process (GO:0008334),0.18027430805589542,0.529521142449006,0.9849624060150376,1.0,1.0,5/27,16.00%,CPSF3;TUT4;SLBP;LSM11;ATM
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.19844260236121591,0.5291763067943684,0.9805068226120858,1.0,1.0,18/18,80.18%,ROPN1L;DNAAF2;SPA17;ODAD4;OFD1;CCDC39;SPAG17;AQP4;NEK10;DNAAF1;RFX3;DNAAF4;CCDC40;NPHP3;SPEF2;ADCY10;CFAP53;CABYR
prerank,mRNA modification (GO:0016556),0.18778053387939797,0.525685760788251,0.9806576402321083,1.0,1.0,8/22,25.21%,NSUN2;TRMT6;TRMT61B;TRMT10C;RPUSD2;ZC3H13;METTL8;TRUB1
prerank,negative regulation of centrosome duplication (GO:0010826),0.22358934880906045,0.5229276849534434,0.969758064516129,1.0,1.0,2/11,11.10%,CENATAC;TMEM67
prerank,protein localization to phagophore assembly site (GO:0034497),0.2187761575080525,0.522136929405503,0.9723320158102767,0.9999430479825929,1.0,5/11,24.29%,MFN2;ATG13;WDR45;TRAPPC8;PACS2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.1774199560461815,-0.5187255035377537,0.9932432432432432,0.9953558305988119,1.0,8/23,30.42%,PIK3R6;NECTIN2;PVR;ARRB2;CADM1;RAET1E;RASGRP1;LGALS9
prerank,regulation of oxidoreductase activity (GO:0051341),0.20958777184275157,0.5182676240590068,0.9779116465863453,1.0,1.0,4/13,19.96%,ABL1;ATP7A;OXA1L;ECSIT
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.17201681763297305,0.5169254648031755,0.9931740614334471,0.9991952564336648,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,tRNA export from nucleus (GO:0006409),0.17201681763297305,0.5169254648031755,0.9931740614334471,0.9991952564336648,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.1770949160989,-0.5162614210696596,0.9918032786885246,0.9953902802931343,1.0,8/22,28.05%,PPP1CA;DUSP6;PPP2CA;DUSP1;PDP1;DUSP7;DUSP18;PPP5C
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2187581896465004,-0.5159495231301061,0.9612244897959183,0.9949956806258354,1.0,4/10,34.45%,QDPR;KYNU;IL4I1;PCBD1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.19789921442958483,0.5151423753102521,0.9753593429158111,0.998943143591739,1.0,7/16,32.59%,TRIM71;CPEB3;ZFP36;ZFP36L1;UPF1;PLEKHN1;TARDBP
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.1850261512158642,-0.5066620885395354,0.9959514170040485,0.9961513505323696,1.0,6/18,32.89%,FBN1;FBXW7;TLR4;GPR137B;LRRC17;TLR3
prerank,regulation of mitochondrial translation (GO:0070129),-0.17619241218544565,-0.5052300685020576,0.9978813559322034,0.9959209058310184,1.0,9/21,36.22%,ALKBH1;NGRN;MTG1;SHMT2;RPUSD3;MTG2;MRPS27;MALSU1;TRUB2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.19311653385503397,0.5029369586518768,0.9923371647509579,1.0,1.0,1/16,5.33%,VAMP7
prerank,negative regulation of lipid catabolic process (GO:0050995),0.188989060035427,0.5020997051424719,0.9825581395348837,1.0,1.0,1/17,4.37%,ADRA2A
prerank,intermediate filament organization (GO:0045109),-0.1812342274461864,-0.5008139090054319,0.9920792079207921,0.9961672199846459,1.0,3/17,21.30%,GFAP;DSP;BFSP2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.21779277250912243,0.49993604538630354,0.9692307692307692,0.9999294684226496,1.0,1/10,6.92%,PDK2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.20583252598207058,-0.4982940500102606,0.9780439121756487,0.9960974938505973,1.0,6/12,36.14%,CDC45;MCM3;MCM5;MCM6;GINS2;MUS81
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.17252073927850034,0.49375536676405407,0.9925373134328358,1.0,1.0,4/23,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,tRNA transport (GO:0051031),0.1613510050315956,0.4936497442822627,0.9965277777777778,0.9997325044621228,1.0,6/35,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.1973758553581518,-0.4934382801081785,0.9897330595482546,0.9963475569163205,1.0,13/13,80.28%,ALG6;ALG3;ALG11;ALG13;ALG1;SRD5A3;ALG8;ALG14;ALG9;MPDU1;ALG12;ALG2;DPAGT1
prerank,serine family amino acid metabolic process (GO:0009069),0.1920383612830688,0.49211494130582883,0.9829545454545454,0.9993134055450769,1.0,4/16,16.79%,GLYAT;CDO1;MTHFD1;CTH
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20336180914020827,0.4920412330529066,0.9797979797979798,0.9986796224365053,1.0,4/12,23.09%,CHEK2;CLSPN;RAD17;NAE1
prerank,cranial nerve development (GO:0021545),-0.2024407161470675,-0.4907076118436589,0.9896907216494846,0.9962957595268545,1.0,6/11,40.21%,TMEM126A;SALL1;POU4F1;TIFAB;ISL1;ERBB3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.200569798256293,0.4899775440166894,0.9821428571428571,0.9983650636374739,1.0,5/13,23.25%,STX4;SNX33;GPD1L;RIC3;MAP1A
prerank,central nervous system myelination (GO:0022010),-0.20094143480387808,-0.48948777666138055,0.9892703862660944,0.9960021193081537,1.0,5/11,34.49%,B4GALT5;PTEN;MYRF;B4GALT6;TENM4
prerank,rRNA catabolic process (GO:0016075),0.1845722076903097,0.48645644158174195,0.9805068226120858,0.9982529510252327,1.0,2/16,11.29%,EXOSC8;EXOSC2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.1931787393611435,-0.48553629756262195,0.9904942965779467,0.9960540639537235,1.0,5/12,28.72%,TNKS;PARP8;PARP3;PARP12;PARP1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.17110684751662603,0.4848510812742293,0.9907407407407407,0.997853743696949,1.0,6/23,23.04%,GSTM2;EPHX2;GSTM1;ALOX5;ACSBG1;GPX4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.18365950216151558,0.4843615184315958,0.9885496183206107,0.9972939229739979,1.0,7/17,29.24%,NUS1;DPAGT1;ALG2;ALG12;DOLPP1;MPDU1;ALG9
prerank,positive regulation of calcium ion import (GO:0090280),-0.19226526405149424,-0.4787767326920872,0.9795539033457249,0.9964170096650672,1.0,1/12,6.52%,CXCL12
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.15920062916135808,0.4752789722663604,0.9963768115942029,0.9978872554833589,1.0,9/29,27.46%,KLRD1;SLAMF6;ITGAM;IL12A;IL12RB1;LAMP1;CD226;CYRIB;AP1G1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.1985437197916014,0.4737775080936796,0.9878296146044625,0.9974350827418448,1.0,11/11,80.16%,ITGAM;STX4;MAVS;CAMK4;ITGB2;CD177;F2RL1;STAP1;TYROBP;TICAM1;SPI1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.17316139326169397,-0.47176325121788826,0.9959595959595959,0.9967709562714838,1.0,9/16,37.84%,ADSS1;IMPDH1;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,nucleosome assembly (GO:0006334),0.15681127232635586,0.4690440118252798,0.9980879541108987,0.9973471840190252,1.0,11/31,26.19%,SOX9;BRD2;NAP1L2;CABIN1;IPO4;KAT6B;SPTY2D1;SART3;ATRX;NPM1;ANP32B
prerank,cytoplasmic translational initiation (GO:0002183),0.17653771820354902,0.463732008111753,0.9846153846153847,0.9973202220092621,1.0,8/17,29.83%,EIF4A2;EIF3A;EIF2D;DENR;EIF3D;RBM4;EIF2S2;DHX29
prerank,immunoglobulin mediated immune response (GO:0016064),-0.19374269600965474,-0.45678861981396246,0.9882352941176471,0.9976779504022023,1.0,2/10,22.51%,CD74;FCGR2B
prerank,regulation of protein kinase A signaling (GO:0010738),-0.1568321504824443,-0.44780499422204806,0.9978401727861771,0.997899938453839,1.0,11/20,42.17%,IAPP;TCIM;PRKAR2B;PRKAR1B;PRKAR2A;MIF;RAMP3;AKAP12;FSHR;PJA2;MC1R
prerank,regulation of response to oxidative stress (GO:1902882),0.18879655462647155,0.44616041579676546,0.9904580152671756,0.9983597477140721,1.0,2/11,14.30%,ABCD1;AIFM2
prerank,microglial cell activation (GO:0001774),-0.1502682050715069,-0.4430806603765144,0.9979296066252588,0.9977760387641061,1.0,1/21,3.64%,APP
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.19032983080333504,0.4385840870839492,0.9920159680638723,0.9983400730971786,1.0,2/10,18.82%,NR1H3;TIRAP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.14842168538827322,0.4316049242714637,1.0,0.9981619932672181,1.0,3/27,9.59%,LPAR1;DRD3;C3AR1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.1594846313419712,-0.4197569109739344,0.9960707269155207,0.9985757763143929,1.0,6/15,32.57%,ACACB;MLYCD;PMVK;HMGCS2;NUDT7;ACLY
prerank,long-term memory (GO:0007616),0.1512157061496862,0.4035664157580626,1.0,0.9988438530864782,1.0,7/19,30.10%,SHANK1;PRNP;CPEB3;SGK1;RASGRF1;CAMK4;EIF2AK4
